id,text,AMR3_structbart_L_amr,split,source_set,gold_amr,text_detok,elit_amr,elit_smatch,AMR3_structbart_L_smatch,gpt_3.5_turbo_0613_amr,gpt4_0613_amr,gpt_3.5_turbo_0613_smatch,gpt4_0613_smatch
a_pmid_2234_3622.61,"Mechanistic biomarker studies of the effects of selumetinib in human tumour xenograft models have shown that, in addition to pERK1/2 downregulation, a sustained exposure to the agent results in an increase in downstream apoptotic signalling and a decrease in cell cycle progression (<xref ref-type=""bibr"" rid=""bib6"">Davies <i>et al</i>, 2007</xref>).","(s / show-01
    :ARG0 (s3 / study-01
        :ARG1 (a2 / affect-01
            :ARG0 (p2 / protein
                :name (n / name
                    :op1 ""selumetinib""))
            :ARG1 (m2 / model-01
                :ARG1 (x / xenograft
                    :mod (c / cell
                        :mod (h / human)))))
        :ARG1-of (m / mechanize-01)
        :mod (b / biomarker))
    :ARG1 (r / result-01
        :ARG1 (e2 / expose-01
            :ARG1-of (s4 / sustain-01)
            :ARG2 (a3 / agent))
        :ARG1-of (a / add-02
            :ARG2 (d3 / down-03
                :ARG1 (e / enzyme
                    :name (n2 / name
                        :op1 ""pERK"")
                    :op2 ""1/2"")))
        :ARG2 (a4 / and
            :op1 (i / increase-01
                :ARG1 (s2 / signal-07
                    :ARG1 (a5 / apoptotic)
                    :mod (d4 / downstream)))
            :op2 (d2 / decrease-01
                :ARG1 (p / progress-01
                    :ARG1 (c3 / cycle-02
                        :ARG1 (c2 / cell))))))
    :ARG1-of (p4 / publication-91
        :ARG4 (p3 / publication
            :name (n3 / name
                :op1 ""Jew""))
        :time (d / date-entity
            :year 2007)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (s2 / study-01
            :ARG1 (a / affect-01
                  :ARG0 (s3 / small-molecule :name (n3 / name :op1 ""selumetinib""))
                  :ARG1 (m2 / model
                        :mod (x / xenograft
                              :mod (t / tumor))
                        :mod (h / human)))
            :mod (b / biomarker
                  :mod (m / mechanistic)))
      :ARG1 (r / result-01
            :ARG1 (e / expose-01
                  :ARG2 s3
                  :ARG1-of (s4 / sustain-01))
            :ARG2 (a7 / and
                  :op1 (d2 / downregulate-01
                        :ARG1 (e2 / enzyme :name (n / name :op1 ""ERK1/2"")
                              :ARG3-of (p / phosphorylate-01)))
                  :op2 (i / increase-01
                        :ARG1 (s5 / signal-07
                              :mod (a5 / apoptosis)
                              :location (d4 / downstream)))
                  :op3 (d3 / decrease-01
                        :ARG1 (p2 / progress-01
                              :ARG1 (c / cycle-02
                                    :ARG1 (c2 / cell))))))
      :ARG1-of (d5 / describe-01
            :ARG0 (p5 / publication-91
                  :ARG0 (a3 / and
                        :op1 (p3 / person :name (n2 / name :op1 ""Davies""))
                        :op2 (p4 / person
                              :mod (o / other)))
                  :time (d / date-entity :year 2007))))","Mechanistic biomarker studies of the effects of selumetinib in human tumour xenograft models have shown that, in addition to pERK1/2 downregulation, a sustained exposure to the agent results in an increase in downstream apoptotic signalling and a decrease in cell cycle progression (<xref ref-type=""bibr"" rid=""bib6"">Davies <i>et al</i>, 2007</xref>).","(z1 / show-01
    :ARG0 (z2 / study-01
              :ARG1 (z3 / affect-01
                        :ARG0 (z4 / small-molecule
                                  :wiki ""Selumetinib""
                                  :name (z5 / name
                                            :op1 ""selumetinib""))
                        :ARG1 (z6 / model
                                  :mod (z7 / xenograft
                                           :mod (z8 / tumor
                                                    :mod (z9 / human)))
                                  :mod (z10 / cell-cycle
                                            :wiki ""Xenograft""
                                            :name (z11 / name
                                                       :op1 ""xenograft""))))
              :mod (z12 / biomarker
                        :mod (z13 / mechanism)))
    :ARG1 (z14 / result-01
               :ARG1 (z15 / expose-01
                          :ARG2 z4
                          :ARG1-of (z16 / sustain-01))
               :ARG2 (z17 / and
                          :op1 (z18 / increase-01
                                    :ARG1 (z19 / signal-07
                                               :ARG1 (z20 / apoptotic-01
                                                          :mod (z21 / downstream))))
                          :op2 (z22 / decrease-01
                                    :ARG1 (z23 / progress-01
                                               :ARG1 (z24 / cycle-02
                                                          :ARG1 (z25 / cell)))))
               :ARG1-of (z26 / add-02
                             :ARG2 (z27 / down-03
                                        :ARG1 (z28 / protein
                                                   :wiki ""PERK1/2""
                                                   :name (z29 / name
                                                              :op1 ""pERK1/2""))))))",0.5857142857142857,0.513888888888889,"(m / mechanism-01
        :ARG0 (s / study-01
              :ARG1 (b / biomarker
                    :mod (m2 / mechanistic)
                    :mod (e / effect-01
                          :ARG1 (s2 / selumetinib)
                          :ARG2 (m3 / model
                                :mod (t / tumour)
                                :mod (x / xenograft))))
              :ARG2 (s3 / show-01
                    :ARG1 (a / addition
                          :op1 (d / downregulation
                                :ARG1 (p / pERK1/2))
                          :op2 (e2 / exposure-01
                                :ARG1 (a2 / agent)))
                    :ARG2 (i / increase-01
                          :ARG1 (s4 / signalling
                                :ARG1-of (a3 / apoptotic))
                          :ARG2 (d2 / decrease-01
                                :ARG1 (p2 / progression
                                      :mod (c / cell)
                                      :mod (c2 / cycle))))))","(s / study-01
    :ARG0 (b / biomarker
        :mod (m / mechanistic))
    :ARG1 (e / effect-01
        :ARG0 (s2 / selumetinib)
        :ARG1 (m2 / model
            :mod (x / xenograft)
            :mod (t / tumor
                :mod (h / human))))
    :ARG2-of (s3 / show-01
        :ARG1 (a / and
            :op1 (d / downregulate-01
                :ARG0 (p / pERK1/2)
                :accompanier (a2 / addition))
            :op2 (e2 / expose-01
                :ARG0 (a3 / agent)
                :ARG1 (s4 / sustain)
                :result (a4 / and
                    :op1 (i / increase-01
                        :ARG1 (s5 / signal-01
                            :mod (a5 / apoptotic)
                            :direction (d2 / downstream)))
                    :op2 (d3 / decrease-01
                        :ARG1 (p2 / progress-01
                            :ARG1 (c / cycle
                                :mod (c2 / cell))))))))
    :source (d4 / document
        :name (n / name :op1 ""Davies"" :op2 ""et"" :op3 ""al"" :op4 "", 2007"")
        :mod (x2 / xref
            :mod (b2 / bibr)
            :mod (r / rid :op1 ""bib6""))))",-1.0,-1.0
a_pmid_2234_3622.62,"Furthermore, a chronic dosing schedule of selumetinib (25 mg kg<sup>–1</sup> per bid for 14 doses) in HCT-116 xenografts increased the levels of the pro-apoptotic BH3 protein Bim-EL (∼4-fold increase) compared with no change with the level of this protein following a shorter dosing period (three doses) (<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>).","(a / and
    :ARG1-of (d / describe-01
        :ARG0 (f2 / figure
            :mod 1))
    :op2 (i2 / increase-01
        :ARG0 (s / schedule
            :mod (d2 / dose-01
                :ARG1 (s3 / small-molecule
                    :name (n / name
                        :op1 1000))
                :consist-of (r / rate-entity-91
                    :ARG1 (m / mass-quantity
                        :quant 25
                        :unit (m3 / milligram))
                    :ARG1 (d3 / dose-01
                        :quant 14)
                    :ARG2 (b / bid-01)))
            :mod (c3 / chronic))
        :ARG1 (l / level
            :quant (p2 / product-of
                :op1 4)
            :ARG1-of (i3 / increase-01)
            :mod (s4 / small-molecule
                :name (n2 / name
                    :op1 ""Al-Qaeda""
                    :op1 ""BH3"")
                :ARG0-of (f / favor-01
                    :ARG1 (c / cell
                        :name (n3 / name
                            :op1 ""nonsense"")))
                :mod (i / idiot)))
        :ARG1-of (c4 / compare-01
            :ARG2 (c2 / change-01
                :ARG1 (l2 / level
                    :poss s4)
                :ARG1-of (f3 / follow-01
                    :ARG2 (p / period
                        :ARG1-of (h / have-degree-91
                            :ARG2 (s2 / short-07
                                :ARG1 p)
                            :ARG3 (m4 / more))
                        :ARG1-of (m2 / mean-01
                            :ARG2 (d5 / dose-01
                                :quant 3))
                        :time-of (d4 / dose-01)))
                :polarity -))))
",test,bio_amr0.8,"(a / and
      :op2 (i / increase-01
            :ARG0 (s / schedule-01
                  :ARG1 (d2 / dose-01 :quant 14
                        :ARG2 (s2 / small-molecule :name (n4 / name :op1 ""selumetinib"")
                              :quant (c4 / concentration-quantity :quant 25
                                    :unit (m / milligram-per-kilogram)))
                        :mod (c / chronic)
                        :frequency (r / rate-entity-91
                              :ARG1 2
                              :ARG2 (t / temporal-quantity :quant 1
                                    :unit (d5 / day)))))
            :ARG1 (l / level
                  :quant-of (p / protein :name (n2 / name :op1 ""Bim-EL"")
                        :ARG0-of (f / favor-01
                              :ARG1 (a2 / apoptosis))
                        :ARG1-of (i2 / include-91
                              :ARG2 (p4 / protein-family :name (n3 / name :op1 ""BH3"")))))
            :ARG4 (p2 / product-of :op1 4)
            :compared-to (c2 / change-01 :polarity -
                  :ARG1 (l2 / level
                        :quant-of p)
                  :ARG1-of (f3 / follow-01
                        :ARG2 (p3 / period
                              :time-of (d3 / dose-01)
                              :ARG1-of (s3 / short-07
                                    :degree (m2 / more))
                              :ARG1-of (m3 / mean-01
                                    :ARG3 (d4 / dose-01 :quant 3)))))
            :location (x / xenograft
                  :mod (c3 / cell-line :name (n / name :op1 ""HCT-116""))))
      :ARG1-of (d / describe-01
            :ARG0 (f2 / figure :mod 1)))","Furthermore, a chronic dosing schedule of selumetinib (25 mg kg<sup>–1</sup> per bid for 14 doses) in HCT-116 xenografts increased the levels of the pro-apoptotic BH3 protein Bim-EL (∼4-fold increase) compared with no change with the level of this protein following a shorter dosing period (three doses) (<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>).","(z1 / increase-01
    :ARG0 (z2 / schedule-01
              :ARG1 (z3 / dose-01
                        :ARG1 (z4 / small-molecule
                                  :wiki ""Selumetinib""
                                  :name (z5 / name
                                            :op1 ""selumetinib"")
                                  :ARG1-of (z6 / rate-entity-91
                                               :ARG2 (z7 / bid-02
                                                         :ARG3 (z8 / dose
                                                                   :quant 14))
                                               :ARG4 (z9 / product-of
                                                         :op1 (z10 / mass-quantity
                                                                   :quant 25
                                                                   :unit (z11 / milligram))
                                                         :op2 (z12 / mass-quantity
                                                                   :quant 1
                                                                   :unit (z13 / kilogram))))))
              :mod (z14 / chronic))
    :ARG2 (z15 / xenograft
               :mod (z16 / product
                         :wiki ""Histidine-activated_protein_kinase""
                         :name (z17 / name
                                    :op1 ""HCT-116""))))",0.2601626016260162,0.4720496894409938,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (l / level
                  :mod (p / pro-apoptotic
                        :mod (b / BH3
                              :mod (p2 / protein
                                    :name (n / name :op1 ""Bim-EL""))))
                  :mod (c / compare-01
                        :ARG2 (c2 / change-01
                              :ARG1 (l2 / level
                                    :mod (p3 / protein
                                          :mod (t / this)))
                              :ARG2 (p4 / period
                                    :mod (d / dosing
                                          :mod (s / short))))
                        :ARG1 (d2 / dosing
                              :mod (p5 / period
                                    :mod (l3 / long
                                          :ARG1 (s2 / schedule
                                                :mod (c3 / chronic)
                                                :ARG1 (s3 / selumetinib
                                                      :mod (d3 / dose
                                                            :quant (n2 / number :op1 25)
                                                            :unit (u / kilogram)
                                                            :ARG1 (b / bid
                                                                  :ARG1 (n3 / number :op1 14)
                                                                  :ARG2 (d4 / dose)))))))))
        :snt2 (c4 / compare-01
            :ARG2 (c5 / change-01
                  :ARG1 (l4 / level
                        :mod (p6 / protein
                              :mod (t2 / this)))
                  :ARG2 (p7 / period
                        :mod (d5 / dosing
                              :mod (s4 / short)
                              :ARG1 (d6 / dose
                                    :ARG1 (n4 / number :op1 3)))))
            :ARG1 (l5 / level
                  :mod (p8 / protein
                        :mod (t3 / this)
                        :mod (f / following
                              :ARG1 (p9 / period
                                    :mod (d7 / dosing
                                          :mod (s5 / shorter)))))))
        :snt3 (i2 / increase-01
            :ARG1 l5
            :ARG2 (n5 / number :op1 4)
            :degree (f2 / fold)
            :mod (a / approximately))
        :snt4 (c6 / compare-01
            :ARG2 (c7 / change-01
                  :ARG1 l
                  :ARG2 (l6 / level
                        :mod (p10 / protein
                              :mod (t4 / this))))
            :ARG1 (f3 / following
                  :ARG1 (p11 / period
                        :mod (d8 / dosing
                              :mod (s6 / shorter)
                              :ARG1 (d9 / dose
                                    :ARG1 (n6 / number :op1 3)))))))","(i / increase-01
    :ARG0 (s / schedule-01
        :ARG1 (d / dose-01
            :ARG1 (s2 / selumetinib)
            :mod (c / chronic)
            :quant (n / number :value 14)
            :unit (d2 / dose))
        :location (x / xenograft
            :mod (h / HCT-116)))
    :ARG1 (l / level
        :ARG1 (p / protein
            :mod (b / Bim-EL)
            :mod (p2 / pro-apoptotic)
            :mod (b2 / BH3)))
    :degree (f / fold
        :quant (n2 / number :value 4))
    :compared-to (c2 / change-01
        :ARG1 l
        :ARG0 (s3 / schedule-01
            :ARG1 (d3 / dose-01
                :quant (n3 / number :value 3)
                :unit d2
                :ARG1 s2)
            :location x))
    :conjunction (f2 / furthermore)
    :mod (r / reference
        :mod (f3 / figure)
        :name (n4 / name :op1 ""1"")))",-1.0,0.2463768115942028
a_pmid_2234_3622.69,"The combination of selumetinib and TMZ in the SW-620 human tumour xenograft model resulted in a significantly enhanced anti-tumour efficacy (103.5% inhibition; <i>P</i><0.0005), compared with selumetinib (52% inhibition; <i>P</i><0.0005) and TMZ (88% inhibition; <i>P</i><0.0005) alone (<xref ref-type=""fig"" rid=""fig2"">Figure 2A</xref>).","(r / result-01
    :ARG1 (c2 / combine-01
        :ARG1 (s2 / small-molecule
            :name (n / name)
            :ARG1-of (i / inhibit-01
                :quant (p / percentage-entity
                    :value 103.5)))
        :ARG2 (c3 / company
            :name (n2 / name
                :op1 ""TMZ""))
        :ARG3 (m / model
            :name (n3 / name
                :op1 ""W""
                :op2 620)
            :mod (x / xenograft
                :mod (c / cell
                    :mod (h / human)))))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 2))
    :ARG2 (e / effective-04
        :ARG1 (c5 / counter-01
            :ARG1 s2
            :ARG2 (t / tumor))
        :ARG1-of (e2 / enhance-01
            :ARG1-of (s / significant-02)
            :ARG1-of (c4 / compare-01
                :ARG2 (p4 / protein
                    :name (n4 / name
                        :op1 ""selumetinib"")))))
    :rel (i2 / inhibit-01
        :quant (p2 / percentage-entity
            :value 52)
        :quant (p3 / percentage-entity
            :value 52)
        :ARG1 p4
        :ARG2 (a2 / and
            :op1 s2
            :op2 c3)
        :mod (a / alone))
    :rel 88)
",test,bio_amr0.8,"(r / result-01
      :ARG1 (c2 / combine-01
            :ARG1 s2
            :ARG2 s3
            :location (c3 / cell-line :name (n / name :op1 ""SW-620"")
                  :mod (x / xenograft
                        :mod (t3 / tumor
                              :mod (h / human)))))
      :ARG2 (e / efficacy
            :ARG0-of (c / counter-01
                  :ARG1 t3)
            :ARG1-of (e2 / enhance-01
                  :ARG1-of (s / significant-02))
            :ARG1-of (m5 / mean-01
                  :ARG2 (a3 / and
                        :op1 (i3 / inhibit-01
                              :degree (p / percentage-entity :value 103.5))
                        :op2 (s4 / statistical-test-91
                              :ARG2 (l / less-than :op1 0.0005)))))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""2A""))
      :compared-to (a / and
            :op1 (s2 / small-molecule :name (n2 / name :op1 ""selumetinib"")
                  :ARG0-of (i / inhibit-01
                        :degree (p2 / percentage-entity :value 52))
                  :mod s4)
            :op2 (s3 / small-molecule :name (n3 / name :op1 ""TMZ"")
                  :ARG0-of (i2 / inhibit-01
                        :degree (p3 / percentage-entity :value 88))
                  :mod s4)
            :mod (a2 / alone)))","The combination of selumetinib and TMZ in the SW-620 human tumour xenograft model resulted in a significantly enhanced anti-tumour efficacy (103.5% inhibition; <i>P</i><0.0005), compared with selumetinib (52% inhibition; <i>P</i><0.0005) and TMZ (88% inhibition; <i>P</i><0.0005) alone (<xref ref-type=""fig"" rid=""fig2"">Figure 2A</xref>).","(z1 / result-01
    :ARG1 (z2 / combine-01
              :ARG1 (z3 / small-molecule
                        :wiki ""Selumetinib""
                        :name (z4 / name
                                  :op1 ""selumetinib""))
              :ARG2 (z5 / company
                        :wiki ""TMZ""
                        :name (z6 / name
                                  :op1 ""TMZ""))
              :location (z7 / model
                            :wiki ""SW-620""
                            :name (z8 / name
                                      :op1 ""SW-620"")
                            :mod (z9 / xenograft
                                     :mod (z10 / tumor
                                               :mod (z11 / human)))))
    :ARG2 (z12 / effective-04
               :ARG0 z3
               :ARG1 (z13 / counter-01
                          :ARG0 z3
                          :ARG1 (z14 / tumor))
               :ARG1-of (z15 / enhance-01
                             :ARG2 (z16 / significant-02))
               :ARG1-of (z17 / compare-01
                             :ARG2 (z18 / and
                                        :op1 (z19 / inhibit-01
                                                  :ARG1 z3
                                                  :ARG2 (z20 / percentage-entity
                                                             :value ""103.5"")
                                                  :ARG3 (z21 / small-molecule
                                                             :wiki ""Selumetinib""
                                                             :name (z22 / name
                                                                        :op1 ""Selumetinib""))
                                                  :ARG4 (z23 / percentage-entity
                                                             :value ""0.0005""))
                                        :op2 (z24 / inhibit-01
                                                  :ARG1 z5
                                                  :ARG2 (z25 / percentage-entity
                                                             :value 52)
                                                  :ARG3 z21
                                                  :ARG4 (z26 / small-molecule
                                                             :wiki ""P/ritonavir""
                                                             :name (z27 / name
                                                                        :op1 ""P"")))
                                        :op3 (z28 / inhibit-01
                                                  :ARG1 z5
                                                  :ARG2 (z29 / percentage-entity
                                                             :value ""0.0005"")
                                                  :ARG3 z21
                                                  :ARG4 (z30 / small-molecule
                                                             :wiki ""TMZ""
                                                             :name (z31 / name
                                                                        :op1 ""TMZ""))
                                                  :mod (z32 / alone))
                                        :ARG1-of (z33 / hyperlink-91
                                                      :ARG3 (z34 / url-entity
                                                                 :value ""Figure_2A""))))))",0.4197530864197531,0.4927536231884057,"(m / multi-sentence
        :snt1 (r / result-01
            :ARG1 (e / enhance-01
                  :ARG1 (e2 / efficacy
                        :mod (a / anti-01
                              :ARG1 (t / tumour)))
                  :ARG2 (c / combination
                        :op1 (s / selumetinib)
                        :op2 (t2 / TMZ)))
            :ARG2 (i / inhibition
                  :degree (p / percent
                        :quant 103.5))
            :ARG3 (m2 / model
                  :mod (x / xenograft
                        :mod (t3 / tumour
                              :mod (h / human
                                    :mod (s2 / SW-620)))))
        :snt2 (c2 / compare-01
            :ARG1 (r2 / result-01
                  :ARG1 (i2 / inhibition
                        :degree (p2 / percent
                              :quant 52))
                  :ARG2 (s3 / selumetinib))
            :ARG2 (r3 / result-01
                  :ARG1 (i3 / inhibition
                        :degree (p3 / percent
                              :quant 88))
                  :ARG2 (t4 / TMZ))
            :ARG3 (a2 / alone
                  :op1 (x / xref
                        :ref-type ""fig""
                        :rid ""fig2""
                        :op1 ""Figure 2A"")))
        :snt3 (p4 / P
            :op1 (l / less-than
                  :op1 (i4 / i)
                  :op2 (q / quant
                        :op1 0.0005))))","(c / combine-01
    :ARG1 (s / selumetinib)
    :ARG2 (t / TMZ)
    :ARG3 (m / model
        :mod (x / xenograft)
        :mod (t2 / tumour)
        :mod (h / human)
        :name (n / name :op1 ""SW-620""))
    :result (r / result-01
        :ARG1 (e / efficacy
            :mod (a / anti-tumour)
            :degree (s2 / significant)
            :quant 103.5
            :unit ""%""
            :mod (i / inhibit-01)
            :compared-to (c2 / compare-01
                :ARG1 (s3 / selumetinib
                    :quant 52
                    :unit ""%""
                    :mod (i2 / inhibit-01))
                :ARG2 (t3 / TMZ
                    :quant 88
                    :unit ""%""
                    :mod (i3 / inhibit-01))
                :mod (a2 / alone)))
        :condition (p / probability
            :quant 0.0005
            :mod (i4 / inhibit-01)
            :mod (l / less)
            :mod (p2 / P-value)))
    :ARG1-of (r2 / reference-91
        :ARG2 (f / figure
            :name (n2 / name :op1 ""2A""))))",-1.0,0.2137404580152672
a_pmid_2234_3622.75,"IHC analysis and histological scoring was performed on all the tissues collected to examine, selumetinib effects (pERK1/2), DNA damage (<i>γ</i>H2A.X), apoptosis (cleaved caspase 3) and the cell cycle (pHH3) (scoring data not shown).","(p / perform-02
    :ARG1 (a4 / and
        :op1 (a3 / analyze-01
            :ARG1 (t / tissue
                :ARG1-of (c2 / collect-01
                    :purpose (e4 / examine-01
                        :ARG0 a4
                        :ARG1 (a5 / and
                            :op1 (a / affect-01
                                :ARG1 (e / enzyme
                                    :name (n / name
                                        :op1 ""selumetinib""))
                                :example (e2 / enzyme
                                    :name (n2 / name
                                        :op1 ""pERK""
                                        :op2 ""1/2"")))
                            :op2 (d / damage-01
                                :ARG1 (n6 / nucleic-acid
                                    :name (n3 / name
                                        :op1 ""DNA"")))
                            :op3 (a6 / apoptosis
                                :ARG1-of (m / mean-01
                                    :ARG2 (p2 / protein
                                        :name (n5 / name
                                            :op1 ""pHH3""))
                                    :ARG2 (e3 / enzyme
                                        :name (n4 / name
                                            :op1 ""caspase""
                                            :op2 3)
                                        :ARG1-of (k / kill-01))))
                            :op4 (c3 / cycle-02
                                :ARG1 (c / cell))
                            :op5 (d2 / data
                                :ARG1-of (s4 / show-01
                                    :polarity -)
                                :topic (s3 / score-01)))))
                :mod (a2 / all))
            :ARG1-of (s / say-01
                :degree (h / high-02)))
        :op2 (s2 / score-01
            :mod (h2 / history)))
    :ARG2 t)
",test,bio_amr0.8,"(p / perform-02
      :ARG1 (a5 / and
            :op1 (a6 / analyze-01
                  :mod (i / immunohistochemistry))
            :op2 (s2 / score-01
                  :ARG3 (h / histology)))
      :location (t / tissue
            :mod (a7 / all)
            :ARG1-of (c3 / collect-01
                  :purpose (a4 / and
                        :op1 (e / examine-01
                              :ARG1 (a3 / affect-01
                                    :ARG0 (s / small-molecule
                                          :name (n5 / name :op1 ""selumetinib""))
                                    :ARG2 (e2 / enzyme
                                          :name (n / name :op1 ""ERK1/2"")
                                          :ARG3-of (p2 / phosphorylate-01))))
                        :op2 (e3 / examine-01
                              :ARG1 (d / damage-01
                                    :ARG1 (n7 / nucleic-acid :wiki ""DNA""
                                          :name (n8 / name :op1 ""DNA"")))
                              :instrument (p5 / protein
                                    :name (n2 / name :op1 ""γH2A.X"")))
                        :op3 (e4 / examine-01
                              :ARG1 (a2 / apoptosis)
                              :instrument (p6 / protein
                                    :name (n3 / name :op1 ""Cleaved"" :op2 ""Caspase"" :op3 3)))
                        :op4 (e5 / examine-01
                              :ARG1 (c / cycle-02
                                    :ARG1 (c2 / cell))
                              :instrument (p4 / protein
                                    :name (n4 / name :op1 ""HH3"")
                                    :ARG3-of (p3 / phosphorylate-01))))))
      :ARG1-of (s3 / show-01 :polarity -
            :ARG0 (d3 / data
                  :mod (s4 / score-01))))","IHC analysis and histological scoring was performed on all the tissues collected to examine, selumetinib effects (pERK1/2), DNA damage (<i>γ</i>H2A.X), apoptosis (cleaved caspase 3) and the cell cycle (pHH3) (scoring data not shown).","(z1 / perform-02
    :ARG1 (z2 / and
              :op1 (z3 / analyze-01
                       :ARG1 (z4 / small-molecule
                                 :wiki ""Inositol_trisphosphate_receptor""
                                 :name (z5 / name
                                           :op1 ""IHC"")))
              :op2 (z6 / score-01
                       :ARG1 z4
                       :mod (z7 / histology)))
    :ARG2 (z8 / tissue
              :mod (z9 / all)
              :ARG1-of (z10 / collect-01
                            :purpose (z11 / examine-01
                                          :ARG1 z8))
              :example (z12 / and
                            :op1 (z13 / affect-01
                                      :ARG0 (z14 / small-molecule
                                                 :wiki ""Protease_kinase_1/2""
                                                 :name (z15 / name
                                                            :op1 ""pERK1/2"")))
                            :op2 (z16 / damage-01
                                      :ARG1 (z17 / nucleic-acid
                                                 :wiki ""DNA""
                                                 :name (z18 / name
                                                            :op1 ""DNA""))
                                      :ARG2 (z19 / small-molecule
                                                 :wiki ""Histidine-activated_protein_kinase""
                                                 :name (z20 / name
                                                            :op1 ""H2A.X"")))
                            :op3 (z21 / apoptose-00
                                      :ARG1-of (z22 / mean-01
                                                    :ARG2 (z23 / enzyme
                                                               :wiki ""Caspase_3""
                                                               :name (z24 / name
                                                                          :op1 ""caspase""
                                                                          :op2 ""3"")
                                                               :ARG1-of (z25 / cut-01))))
                            :op4 (z26 / cycle-02
                                      :ARG1 (z27 / cell)
                                      :ARG2 (z28 / enzyme
                                                 :wiki ""PHLDA3""
                                                 :name (z29 / name
                                                            :op1 ""pHH3"")))
                            :op5 (z30 / data
                                      :ARG0-of (z31 / score-01)
                                      :ARG1-of (z32 / show-01
                                                    :polarity -)))))",0.4444444444444445,0.4487179487179487,"(m / multi-sentence
        :snt1 (p / perform-01
            :ARG0 (a / analysis
                  :mod (i / ihc))
            :ARG1 (s / score-01
                  :ARG0 a
                  :ARG1 (h / histological)
                  :ARG2 (t / tissue
                        :ARG0-of (c / collect-01)))
            :ARG2 (e / examine-01
                  :ARG1 t
                  :ARG2 (e2 / effect-01
                        :ARG1 (s2 / selumetinib)
                        :ARG2 (p2 / protein
                              :ARG0-of (p3 / phosphorylate-01
                                    :ARG1 (e3 / erk1/2))))
                        :ARG2 (d / damage-01
                              :ARG1 (d2 / dna)
                              :ARG2 (h2 / h2a.x))
                        :ARG2 (a2 / apoptosis-01
                              :ARG1 (c2 / caspase-03)
                              :ARG2 (c3 / cleave-01))
                        :ARG2 (c4 / cycle-01
                              :ARG1 (c5 / cell)
                              :ARG2 (h3 / hh3))))
        :snt2 (s4 / show-01
            :ARG1 (d3 / data
                  :mod (s5 / score-01))
            :ARG2 (n / not)))","(p / perform-01
    :ARG0 (a / analysis
        :mod (i / IHC))
    :ARG1 (s / score-01
        :ARG1 (h / histology))
    :ARG2 (t / tissue
        :quant (a2 / all)
        :ARG1-of (c / collect-01))
    :purpose (e / examine-01
        :ARG1 (e2 / effect
            :ARG0 (s2 / selumetinib)
            :ARG1 (p / pERK1/2)
            :ARG2 (d / damage
                :ARG1 (d2 / DNA)
                :mod (g / γH2A.X))
            :ARG3 (a3 / apoptosis
                :mod (c2 / cleaved-caspase-3))
            :ARG4 (c3 / cell-cycle
                :mod (p2 / pHH3))))
    :mod (s3 / score-01
        :ARG1 (d3 / data)
        :ARG2 (s4 / show-01 :polarity -)))",-1.0,-1.0
a_pmid_2234_3622.76,"The sampling timepoint, which gave us the greatest insight into the mechanistic effects of these agents was that taken when we started to see the TMZ and combination groups diverge (PD2).","(t / take-01
    :ARG0 (w / we)
    :ARG1 (t3 / timepoint
        :ARG0-of (g / give-01
            :ARG1 (i / insight
                :ARG1-of (h / have-degree-91
                    :ARG2 (g2 / great)
                    :ARG3 (m / most))
                :topic (a / affect-01
                    :ARG0 (a2 / agent
                        :mod (t2 / this))
                    :ARG2 (o / operation)))
            :ARG2 w)
        :mod (s / sample-01))
    :time (s3 / start-01
        :ARG0 w
        :ARG1 (s2 / see-01
            :ARG0 w
            :ARG1 (d / diverge-01
                :ARG0 (a3 / and
                    :op1 (c2 / company
                        :name (n / name
                            :op1 ""TMZ""))
                    :op2 (g3 / group
                        :ARG1-of (c / combine-01)))))))
",test,bio_amr0.8,"(t3 / timepoint
      :mod (t5 / thing :name (n / name :op1 ""PD2""))
      :ARG1-of (t4 / take-01
            :ARG0 w
            :time (s3 / start-01
                  :ARG0 w
                  :ARG1 (s2 / see-01
                        :ARG0 w
                        :ARG1 (d / diverge-01
                              :ARG0 (g4 / group
                                    :mod (s4 / small-molecule :name (n2 / name :op1 ""TMZ"")))
                              :ARG1 (g3 / group
                                    :mod (c / combine-01)
                                    :ARG1-of (m3 / mean-01))))))
      :domain (t / timepoint
            :time-of (s / sample-01)
            :ARG0-of (g2 / give-01
                  :ARG1 (i / insight
                        :mod (g / great
                              :degree (m / most))
                        :topic (a / affect-01
                              :ARG0 (a2 / agent
                                    :mod (t2 / this))
                              :mod (m2 / mechanistic)))
                  :ARG2 (w / we))))","The sampling timepoint, which gave us the greatest insight into the mechanistic effects of these agents was that taken when we started to see the TMZ and combination groups diverge (PD2).","(z1 / take-01
    :ARG1 (z2 / timepoint
              :mod (z3 / sample-01)
              :ARG0-of (z4 / give-01
                           :ARG1 (z5 / insight
                                     :topic (z6 / affect-01
                                                :ARG0 (z7 / agent
                                                          :mod (z8 / this))
                                                :manner (z9 / mechanistic))
                                     :ARG1-of (z10 / have-degree-91
                                                   :ARG2 (z11 / great)
                                                   :ARG3 (z12 / most))))
              :ARG2 (z13 / we)))",0.4050632911392405,0.6060606060606061,"(s / see-01
        :ARG0 (w / we)
        :ARG1 (t / timepoint
              :mod (s2 / sample-01)
              :ARG1-of (g / give-01
                    :ARG1 (i / insight
                          :ARG1-of (m / mechanistic)
                          :ARG2 (e / effect
                                :ARG1-of (a / agent
                                      :mod (t2 / these)))
                          :degree (g2 / great)))
              :ARG1-of (t2 / take-01
                    :ARG0 w))
        :ARG1-of (d / diverge-01
              :ARG1 (g3 / group
                    :mod (c / combination)
                    :mod (t3 / TMZ)))
        :ARG1-of (P / PD2))","(t / timepoint
    :mod (s / sample-01)
    :ARG1-of (g / give-01
        :ARG0 (t2 / that)
        :ARG2 (i / insight-01
            :ARG1 (e / effect-01
                :ARG0 (a / agent-01
                    :mod (t3 / these))
                :mod (m / mechanism-01))
            :degree (g2 / great-02 :degree most)))
    :time (w / when-01
        :ARG1 (s2 / start-01
            :ARG0 (w2 / we)
            :ARG1 (s3 / see-01
                :ARG0 w2
                :ARG1 (d / diverge-01
                    :ARG1 (g3 / group-01
                        :mod (t4 / TMZ))
                    :ARG2 (g4 / group-01
                        :mod (c / combine-01))
                    :mod (p / PD2))))))",-1.0,0.3789473684210526
a_pmid_2234_3622.77,"As expected, in response to selumetinib or TMZ alone we saw changes in the mechanistic biomarkers pERK1/2 (decrease) and <i>γ</i>H2A.X (increase), respectively, and a reduction in mitotic cells as shown by pHH3 in the selumetinib group compared with an increase in the TMZ tissues (<xref ref-type=""fig"" rid=""fig2"">Figure 2B</xref>).","(s / see-01
    :ARG0 (w / we)
    :ARG1 (a2 / and
        :op1 (p2 / protein
            :name (n3 / name
                :op1 ""pERK""
                :op2 ""1/2""))
        :op2 (c2 / change-01
            :ARG1 (r / racist
                :mod (b / biology))
            :ARG3 (d / decrease-01
                :ARG1 p2)))
    :ARG1 (a3 / and
        :op1 c2
        :op2 (r2 / reduce-01
            :ARG1 (c / cell
                :mod (m / mitotic))
            :ARG1-of (s2 / show-01
                :ARG0 (p4 / protein
                    :name (n5 / name
                        :op1 ""pHH3"")
                    :ARG0 (g / group
                        :mod (p / protein
                            :name (n / name
                                :op1 ""selumetinib"")))))
            :ARG1-of (c4 / compare-01
                :ARG2 (i2 / increase-01
                    :ARG1 (t / tissue
                        :mod (c3 / company
                            :name (n2 / name
                                :op1 ""TMZ"")
                            :mod (a / alone)))))))
    :ARG1-of (e / expect-01)
    :ARG2-of (r3 / respond-01
        :ARG0 w
        :ARG1 (o / or
            :op1 p
            :op2 c3))
    :rel (f / figure
        :ARG1-of (h / hyperlink-91
            :ARG2 2)
        :mod 2
        :mod (p5 / publication
            :name (n6 / name)))
    :rel (p3 / protein
        :name (n4 / name)
        :ARG1-of (i / increase-01)))
",test,bio_amr0.8,"(r2 / respond-01
      :ARG1 (o / or
            :op1 (s2 / small-molecule :name (n4 / name :op1 ""selumetinib""))
            :op2 (s4 / small-molecule :name (n5 / name :op1 ""TMZ""))
            :mod (a / alone))
      :ARG2 (s3 / see-01
            :ARG0 w
            :ARG1 (a3 / and
                  :op1 (c / change-01
                        :ARG1 (b2 / biomarker
                              :mod (m3 / mechanistic)
                              :ARG1-of (m5 / mean-01
                                    :ARG2 (a4 / and
                                          :op1 (e2 / enzyme :name (n / name :op1 ""ERK1/2"")
                                                :ARG1-of (d / decrease-01)
                                                :ARG3-of p2)
                                          :op2 (p3 / protein :name (n2 / name :op1 ""γH2A.X"")
                                                :mod m3
                                                :ARG1-of (i / increase-01))))))
                  :op2 (r / reduce-01
                        :ARG1 (c2 / cell
                              :mod (m4 / mitosis))
                        :ARG1-of (s / show-01
                              :ARG0 (p / protein :name (n3 / name :op1 ""HH3"")
                                    :ARG3-of (p2 / phosphorylate-01))
                              :location (g / group
                                    :mod s2))
                        :compared-to (i2 / increase-01
                              :ARG1 (t2 / tissue
                                    :mod s4))))
            :ARG1-of (e / expect-01
                  :ARG0 (w / we))))","As expected, in response to selumetinib or TMZ alone we saw changes in the mechanistic biomarkers pERK1/2 (decrease) and <i>γ</i>H2A.X (increase), respectively, and a reduction in mitotic cells as shown by pHH3 in the selumetinib group compared with an increase in the TMZ tissues (<xref ref-type=""fig"" rid=""fig2"">Figure 2B</xref>).","(z1 / see-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / and
              :op1 (z4 / change-01
                       :ARG1 (z5 / and
                                 :op1 (z6 / protein
                                          :wiki ""PERK1/2""
                                          :name (z7 / name
                                                    :op1 ""pERK1/2""
                                                    :op2 ""pERK1/2"")
                                          :ARG1-of (z8 / decrease-01)
                                          :mod (z9 / mechanistic))
                                 :op2 (z10 / protein
                                           :wiki ""H2A.X""
                                           :name (z11 / name
                                                      :op1 ""H2A.X"")
                                           :ARG1-of (z12 / increase-01)
                                           :mod z9)))
              :op2 (z13 / reduce-01
                        :ARG1 (z14 / cell
                                   :mod (z15 / mitotic))
                        :ARG1-of (z16 / show-01
                                      :ARG0 (z17 / enzyme
                                                 :wiki ""PHLDA3""
                                                 :name (z18 / name
                                                            :op1 ""pHH3"")
                                                 :part-of (z19 / group
                                                               :mod (z20 / small-molecule
                                                                         :wiki ""Selumetinib""
                                                                         :name (z21 / name
                                                                                    :op1 ""selumetinib""))))
                                      :ARG1-of (z22 / compare-01
                                                    :ARG2 (z23 / increase-01
                                                               :ARG1 (z24 / tissue
                                                                          :mod (z25 / company
                                                                                    :wiki ""TMZ""
                                                                                    :name (z26 / name
                                                                                               :op1 ""TMZ"")))))))))",0.5362318840579711,0.5419354838709677,"(m / multi-sentence
        :snt1 (e / expect-01
            :ARG1 (r / response-01
                  :ARG2 (s / selumetinib)
                  :ARG2 (t / TMZ)
                  :ARG1 (c / change-01
                        :ARG1 (b / biomarker
                              :mod (m2 / mechanistic))
                        :ARG2 (d / decrease-01
                              :ARG1 (p / pERK1/2)))
                  :ARG1 (c2 / change-01
                        :ARG1 (b2 / biomarker
                              :mod (g / γH2A.X))
                        :ARG2 (i / increase-01)))
            :ARG1 (r2 / reduction-01
                  :ARG1 (c3 / cell
                        :mod (m3 / mitotic))
                  :ARG2 (s2 / show-01
                        :ARG1 (p2 / pHH3)
                        :ARG2 (g2 / group
                              :mod (s3 / selumetinib))))
            :ARG1 (i2 / increase-01
                  :ARG1 (t2 / tissue
                        :mod (f / fig)
                        :mod (t3 / TMZ))
                  :ARG2 (g3 / group)))
        :snt2 (c4 / compare-01
            :ARG1 g2
            :ARG2 g3))","(r / respond-01
    :ARG0 (w / we)
    :ARG1 (c / change-01
        :ARG1 (b / biomarker
            :mod (m / mechanistic)
            :example (p / protein :name (n / name :op1 ""pERK1/2""))
            :example (g / gene :name (n2 / name :op1 ""γH2A.X""))
            :quant (a / and))
        :ARG2 (d / decrease-01
            :ARG1 p)
        :ARG2 (i / increase-01
            :ARG1 g))
    :ARG1-of (e / expect-01)
    :time (a2 / alone
        :op1 (s / selumetinib)
        :op2 (t / TMZ))
    :condition (a3 / and
        :op1 (r2 / reduce-01
            :ARG1 (c2 / cell
                :mod (m2 / mitotic))
            :manner (s2 / show-01
                :ARG1 (p2 / protein :name (n3 / name :op1 ""pHH3""))
                :ARG2 (g2 / group
                    :mod (s3 / selumetinib))))
        :op2 (c3 / compare-01
            :ARG1 g2
            :ARG2 (i2 / increase-01
                :ARG1 (t2 / tissue
                    :mod (t3 / TMZ))
                :location (f / figure :name (n4 / name :op1 ""2B""))))))",-1.0,0.4335664335664336
a_pmid_2234_3622.81,"Continuous, concurrent combinations of selumetinib and docetaxel resulted in significant anti-tumour effects in several models (<xref ref-type=""table"" rid=""tbl1"">Table 1</xref> and <xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(r / result-01
    :ARG1 (c / combine-01
        :ARG1 (p / protein
            :name (n / name
                :op1 ""Great""
                :op2 ""selumetinib""))
        :ARG1-of (c2 / concurrent-02)
        :ARG1-of (c3 / continue-01)
        :ARG2 (p2 / protein
            :name (n2 / name
                :op1 ""docetaxel"")))
    :ARG2 (a / affect-01
        :ARG0 c
        :ARG1-of (s2 / significant-02)
        :ARG2 (c4 / counter-01
            :ARG0 p
            :ARG1 (t2 / tumor))
        :location (m / model
            :quant (s / several)))
    :rel (t / table
        :example (a2 / and
            :op1 (p3 / publication)
            :op2 (f / figure
                :mod 3))
        :mod 1))
",test,bio_amr0.8,"(r / result-01
      :ARG1 (c / combine-01
            :ARG1 (s / small-molecule :name (n / name :op1 ""selumetinib""))
            :ARG2 (s4 / small-molecule :name (n2 / name :op1 ""docetaxel""))
            :ARG1-of (c2 / concurrent-02)
            :ARG1-of (c3 / continue-01))
      :ARG2 (a / affect-01
            :ARG2 (c4 / counter-01
                  :ARG0 (t / tumor))
            :location (m / model
                  :quant (s2 / several))
            :ARG1-of (s3 / significant-02))
      :ARG1-of (d2 / describe-01
            :ARG0 (a2 / and
                  :op1 (t2 / table :mod 1)
                  :op2 (f / figure :mod ""3A""))))","Continuous, concurrent combinations of selumetinib and docetaxel resulted in significant anti-tumour effects in several models (<xref ref-type=""table"" rid=""tbl1"">Table 1</xref> and <xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(z1 / result-01
    :ARG1 (z2 / combine-01
              :ARG1 (z3 / small-molecule
                        :wiki ""Selumetinib""
                        :name (z4 / name
                                  :op1 ""selumetinib""))
              :ARG2 (z5 / drug
                        :wiki ""Lopinavir/ritonavir""
                        :name (z6 / name
                                  :op1 ""docetaxel""))
              :ARG1-of (z7 / concurrent-02)
              :ARG1-of (z8 / continue-01))
    :ARG2 (z9 / effect-03
              :ARG0 z2
              :ARG1 (z10 / counter-01
                         :ARG1 (z11 / tumor))
              :ARG1-of (z12 / significant-02))
    :location (z13 / model
                   :quant (z14 / several)
                   :example (z15 / and
                                 :op1 (z16 / table
                                           :mod 1
                                           :ARG1-of (z17 / hyperlink-91
                                                         :ARG3 (z18 / url-entity
                                                                    :value ""Table_1"")))
                                 :op2 (z19 / figure
                                           :mod ""Figure_3A""
                                           :ARG1-of (z20 / hyperlink-91
                                                         :ARG3 (z21 / url-entity
                                                                    :value ""Figure""
                                                                    :op2 ""3A""))))))",0.5681818181818182,0.6835443037974684,"(m / multi-sentence
        :snt1 (r / result-01
            :ARG1 (c / combination
                  :mod (c2 / continuous)
                  :mod (c3 / concurrent)
                  :ARG1-of (r2 / result-01
                        :ARG1 (e / effect-01
                              :ARG1 (a / anti
                                    :ARG1 (t / tumour
                                          :mod (s / significant))))
                        :ARG2 (m2 / model
                              :quant (s2 / several))))
            :ARG2 (t / table
                  :ARG1 (n / name :op1 ""1""))
            :ARG3 (f / figure
                  :ARG1 (n2 / name :op1 ""3A""))))","(c / cause-01
    :ARG0 (c2 / combine-01
        :ARG1 (s / selumetinib)
        :ARG2 (d / docetaxel)
        :mod (c3 / concurrent)
        :mod (c4 / continuous))
    :ARG1 (r / result-01
        :ARG1 (e / effect-01
            :mod (a / anti-tumour)
            :degree (s2 / significant)
            :location (m / model
                :quant (s3 / several)))
        :ARG2 (a2 / and
            :op1 (t / table :wiki - :name (n / name :op1 ""Table 1""))
            :op2 (f / figure :wiki - :name (n2 / name :op1 ""Figure 3A"")))))",-1.0,0.4210526315789473
a_pmid_2234_3622.82,"However, we were interested to explore the effect of dose sequencing on the anti-tumour efficacy of these two agents as administration of selumetinib and docetaxel as monotherapies results in distinct cell cycle phenotypes; a G1 or mitotic arrest, respectively.","(c3 / contrast-01
    :ARG2 (i / interest-01
        :ARG1 (w / we)
        :ARG2 (e3 / explore-01
            :ARG0 w
            :ARG1 (a2 / affect-01
                :ARG0 (s / sequence-01
                    :ARG1 (d2 / dose-01))
                :ARG1 (e / effective-04
                    :ARG0 (a3 / agent
                        :quant 2
                        :mod (t / this))
                    :ARG1 (c4 / counter-01
                        :ARG1 (t2 / tumor)))
                :example (r / result-01
                    :ARG1 (a / administer-01
                        :ARG1 (a4 / and
                            :op1 (p3 / protein
                                :name (n / name
                                    :op1 ""selumetinib""))
                            :op2 (p2 / product
                                :name (n2 / name
                                    :op1 ""docetaxel"")))
                        :prep-as (c / carrier))
                    :ARG2 (p / phenomenon
                        :domain (o / or
                            :op1 (e2 / enzyme
                                :name (n3 / name
                                    :op1 ""G1""))
                            :op2 (a5 / arrest-01
                                :mod (m / mitotic))
                            :op3 (a6 / arrest-01
                                :mod m))
                        :mod (c5 / cycle-02
                            :ARG1 (c2 / cell))
                        :mod (d / distinct)))))))
",test,bio_amr0.8,"(c / contrast-01
      :ARG2 (c2 / cause-01
            :ARG0 (r / result-01
                  :ARG1 (a3 / administer-01
                        :ARG1 (a4 / and
                              :op1 (s2 / small-molecule :name (n2 / name :op1 ""selumetinib""))
                              :op2 (s3 / small-molecule :name (n3 / name :op1 ""docetaxel"")))
                        :manner (m / monotherapy))
                  :ARG2 (p / phenotype
                        :mod (c4 / cycle-02
                              :ARG1 (c5 / cell)
                              :mod (d2 / distinct))
                        :ARG1-of (m5 / mean-01
                              :ARG2 (a5 / and
                                    :op2 (a6 / arrest-02
                                          :time (e3 / event :name (n / name :op1 ""G1"")))
                                    :op3 (a7 / arrest-02
                                          :time (m2 / mitosis))))))
            :ARG1 (i / interest-01
                  :ARG1 (w / we)
                  :ARG2 (e / explore-01
                        :ARG0 w
                        :ARG1 (a / affect-01
                              :ARG0 (s / sequence-01
                                    :ARG1 (d / dose-01))
                              :ARG1 (e2 / efficacy
                                    :poss (a2 / agent :quant 2
                                          :mod (t2 / this)
                                          :ARG1-of (m4 / mean-01
                                                :ARG2 a4)
                                          :ARG0-of (c3 / counter-01
                                                :ARG1 (t / tumor)))))))))","However, we were interested to explore the effect of dose sequencing on the anti-tumour efficacy of these two agents as administration of selumetinib and docetaxel as monotherapies results in distinct cell cycle phenotypes; a G1 or mitotic arrest, respectively.","(z1 / contrast-01
    :ARG2 (z2 / interest-01
              :ARG1 (z3 / we)
              :ARG2 (z4 / explore-01
                        :ARG0 z3
                        :ARG1 (z5 / affect-01
                                  :ARG0 (z6 / sequine-01
                                            :ARG1 (z7 / dose))
                                  :ARG1 (z8 / efficacy
                                            :poss (z9 / agent
                                                      :quant 2
                                                      :mod (z10 / this))
                                            :ARG0-of (z11 / counter-01
                                                          :ARG1 (z12 / tumor)))))
              :ARG1-of (z13 / cause-01
                            :ARG0 (z14 / result-01
                                       :ARG1 (z15 / administer-01
                                                  :ARG1 (z16 / and
                                                             :op1 (z17 / small-molecule
                                                                       :wiki ""Selumetinib""
                                                                       :name (z18 / name
                                                                                  :op1 ""selumetinib""))
                                                             :op2 (z19 / product
                                                                       :wiki ""Lopinavir/ritonavir""
                                                                       :name (z20 / name
                                                                                  :op1 ""docetaxel""))
                                                             :prep-as (z21 / monotherapie)))
                                       :ARG2 (z22 / phenotype
                                                  :ARG1-of (z23 / distinct-01)
                                                  :mod (z24 / cycle-02
                                                            :ARG1 (z25 / cell))
                                                  :ARG1-of (z26 / mean-01
                                                                :ARG2 (z27 / or
                                                                           :op1 (z28 / arrest-01
                                                                                     :mod (z29 / gene
                                                                                               :wiki ""G1_(g3000 / gene)""
                                                                                               :name (z30 / name
                                                                                                          :op1 ""G1"")))
                                                                           :op2 (z31 / arrest-01
                                                                                     :mod (z32 / mitotic)))))))))",0.6527777777777778,0.6086956521739131,"(m / multi-sentence
        :snt1 (i / interest-01
            :ARG0 (w / we)
            :ARG1 (e / explore-01
                  :ARG0 w
                  :ARG1 (e2 / effect
                        :ARG1 (s / sequence-01
                              :ARG0 (d / dose)
                              :ARG1 (o / on
                                    :ARG1 (e3 / efficacy
                                          :ARG1 (a / agent
                                                :mod (t / two)
                                                :mod (t2 / these))
                                          :ARG2 (a2 / anti-tumour))))
                        :ARG2 (p / phenotype
                              :ARG1 (r / result-01
                                    :ARG0 (a3 / administration)
                                    :ARG1 (c / cycle
                                          :mod (d2 / distinct)
                                          :mod (p2 / phenotype
                                                :ARG1 (a4 / arrest-01
                                                      :ARG1 (g / G1))
                                                :mod (m / mitotic))))))))
        :snt2 (r2 / respectively
            :op1 (a5 / arrest-01
                  :ARG1 (m2 / mitotic))
            :op2 (a6 / arrest-01
                  :ARG1 (g2 / G1))))","(h / however
    :op1 (i / interest-01
        :ARG0 (w / we)
        :ARG1 (e / explore-01
            :ARG0 w
            :ARG1 (e2 / effect-01
                :ARG0 (s / sequence-01
                    :ARG1 (d / dose))
                :ARG1 (e3 / efficacy-01
                    :ARG0 (a / anti-01
                        :ARG1 (t / tumor))
                    :ARG1 (a2 / agent-01
                        :mod (t2 / this)
                        :quant 2)
                    :condition (a3 / administer-01
                        :ARG1 (s2 / selumetinib)
                        :ARG2 (d2 / docetaxel)
                        :mod (m / monotherapy)
                        :result (r / result-01
                            :ARG1 (p / phenotype-01
                                :mod (c / cell-cycle)
                                :mod (d3 / distinct)
                                :op1 (a4 / arrest-01
                                    :ARG1 (g / G1-phase))
                                :op2 (a5 / arrest-01
                                    :ARG1 (m2 / mitosis)))))))))
    :op2 (r2 / respect-01))",-1.0,0.3548387096774194
a_pmid_2234_3622.88,"In order to determine the mechanism of action in the scheduling studies with docetaxel, a series of tumour tissue samples were taken at different time points following exposure to the two dosing regimens (<xref ref-type=""fig"" rid=""fig4"">Figure 4Ai and Bi</xref>).","(t / take-01
    :purpose (d / determine-01
        :ARG1 (m / mechanism
            :ARG0-of (a / act-02)
            :beneficiary (s4 / study-01
                :ARG1 (p2 / product
                    :name (n / name
                        :op1 ""docetaxel""))
                :ARG1-of (s2 / schedule-01))))
    :ARG1 (s / sample-01
        :quant (s3 / series)
        :ARG1 (t3 / tissue
            :part-of (t4 / tumor)))
    :ARG1-of (f3 / follow-01
        :ARG2 (e / expose-01
            :ARG1 t3
            :ARG2 (r / regime
                :quant 2
                :ARG2-of (d3 / dose-01)
                :example (a2 / and
                    :op1 (f / figure
                        :mod 4Ai
                        :source (p3 / publication
                            :name (n2 / name)))
                    :op2 (f2 / figure
                        :mod ""1/2"")))))
    :time (p / point
        :ARG1-of (d2 / differ-02)
        :mod (t2 / time)))
",test,bio_amr0.8,"(s / sample-01
      :ARG1 (t2 / tissue
            :mod (t3 / tumor))
      :time (p / point
            :mod (t / time)
            :ARG1-of (d4 / differ-02))
      :ARG1-of (f / follow-01
            :ARG2 (e / expose-01
                  :ARG2 (r2 / regimen :quant 2
                        :ARG0-of (d / dose-01))))
      :ARG1-of (d2 / describe-01
            :ARG0 (a / and
                  :op1 (f2 / figure :mod ""4Ai"")
                  :op2 (f3 / figure :mod ""4Bi"")))
      :quant (s2 / series)
      :purpose (d3 / determine-01
            :ARG1 (m / mechanism
                  :mod (a2 / act-02)
                  :purpose (s3 / study-01
                        :ARG1 (s5 / small-molecule :name (n / name :op1 ""docetaxel""))
                        :ARG1-of (s4 / schedule-01)))))","In order to determine the mechanism of action in the scheduling studies with docetaxel, a series of tumour tissue samples were taken at different time points following exposure to the two dosing regimens (<xref ref-type=""fig"" rid=""fig4"">Figure 4Ai and Bi</xref>).","(z1 / take-01
    :ARG1 (z2 / series
              :consist-of (z3 / sample-01
                              :ARG1 (z4 / tissue
                                        :mod (z5 / tumor))))
    :purpose (z6 / determine-01
                 :ARG1 (z7 / mechanism
                           :mod (z8 / action)
                           :part-of (z9 / study-01
                                        :ARG1 (z10 / schedule-01
                                                   :ARG1 (z11 / study-01
                                                              :ARG1 (z12 / product
                                                                         :wiki ""Lopinavir/ritonavir""
                                                                         :name (z13 / name
                                                                                    :op1 ""docetaxel""))))))))",0.3783783783783784,0.6391752577319587,"(m / multi-sentence
        :snt1 (d / determine-01
            :ARG0 (o / order
                  :ARG1 (m2 / mechanism
                        :ARG1-of (a / action-01)))
            :ARG1 (s / study-01
                  :ARG0 (s2 / schedule-01)
                  :ARG1 (e / expose-01
                        :ARG0 (t / tumour)
                        :ARG1 (s3 / sample-01
                              :ARG0 t
                              :time (p / point
                                    :mod (d2 / different)
                                    :op1 (e2 / expose-01
                                          :ARG0 t
                                          :ARG1 (r / regimen
                                                :mod (d3 / dose-01
                                                      :ARG1 (t2 / two))))))))
        :snt2 (t / take-01
            :ARG0 (s4 / sample-01
                  :ARG0 (t3 / tissue)
                  :ARG1 (p2 / point
                        :mod (t4 / time)
                        :op1 (f / follow-01
                              :ARG0 (e3 / exposure
                                    :ARG1 (t5 / two)
                                    :ARG2 (r2 / regimen
                                          :mod (d4 / dose-01
                                                :ARG1 (d5 / docetaxel))))
                              :ARG1 (x / xref
                                    :ref-type ""fig""
                                    :rid ""fig4""
                                    :op1 (f2 / figure
                                          :op1 ""4Ai""
                                          :op2 ""Bi""))))))","(d / determine-01
    :purpose (m / mechanism
        :ARG1-of (a / act-01
            :ARG1 (s / study-01
                :topic (s2 / schedule-01)
                :ARG1 (d2 / docetaxel))))
    :ARG1 (s3 / series
        :consist-of (s4 / sample-01
            :ARG1 (t / tissue
                :part-of (t2 / tumor))
            :time (t3 / time
                :op1 (p / point
                    :mod (d3 / different))
                :ARG1-of (f / follow-01
                    :ARG1 (e / expose-01
                        :ARG1 t
                        :ARG2 (r / regimen
                            :mod (d4 / dose-01)
                            :quant 2))))))
    :mod (o / order
        :op1 (i / in))
    :medium (f2 / figure
        :name (n / name
            :op1 ""4Ai""
            :op2 ""and""
            :op3 ""Bi"")
        :mod (x / xref
            :ref-type ""fig""
            :rid ""fig4"")))",-1.0,0.3505154639175257
a_pmid_2234_3622.92,When selumetinib was administered alone levels of pHH3 decreased at several measurement points compared with controls (PD2 <i>P</i><0.0005; PD4 <i>P</i><0.005; PD5 <i>P</i><0.0005; PD6 <i>P</i><0.0005) consistent with the inhibition of the MEK/ERK pathway resulting in a G1/S arrest.,"(d / decrease-01
    :ARG1 (l / level
        :mod (p3 / protein
            :name (n2 / name
                :op1 3
                :op1 ""serotonin"")))
    :ARG1-of (c / compare-01
        :ARG2 (c3 / control-01
            :ARG1 (p4 / protein
                :name (n3 / name
                    :op1 ""PD2""
                    :op1 ""PD6""))))
    :ARG1-of (c2 / consistent-01
        :ARG2 (i / inhibit-01
            :ARG0 p4
            :ARG1 (p / pathway
                :mod (p5 / protein
                    :name (n5 / name
                        :op1 ""ERK""
                        :op1 ""G1""))
                :mod (e / enzyme
                    :name (n4 / name
                        :op1 ""MEK"")))
            :ARG1-of (r / result-01
                :ARG2 (a3 / arrest-01
                    :ARG1 p5))))
    :ARG2 (p2 / point
        :quant (s / several)
        :mod (m / measure-01))
    :condition (a / administer-01
        :ARG1 (s2 / small-molecule
            :name (n / name
                :op1 ""selumetinib""))
        :manner (a2 / alone)))
",test,bio_amr0.8,"(d / decrease-01
      :ARG1 (l / level
            :quant-of (p7 / protein :name (n3 / name :op1 ""HH3"")
                  :ARG3-of (p8 / phosphorylate-01)))
      :time (a / administer-01
            :ARG1 (s / small-molecule :name (n8 / name :op1 ""selumetinib"")
                  :mod (a3 / alone)))
      :time (p2 / point
            :quant (s2 / several)
            :mod (m3 / measure-01)
            :ARG1-of (m4 / mean-01
                  :ARG2 (a4 / and
                        :op1 (t / thing :name (n4 / name :op1 ""PD2""))
                        :op2 (t2 / thing :name (n5 / name :op1 ""PD4""))
                        :op3 (t4 / thing :name (n6 / name :op1 ""PD5""))
                        :op4 (t5 / thing :name (n7 / name :op1 ""PD6"")))))
      :compared-to (c / control)
      :ARG1-of (c2 / consistent-01
            :ARG2 (i / inhibit-01
                  :ARG1 (p / pathway :name (n / name :op1 ""MEK/ERK""))
                  :ARG1-of (r / result-01
                        :ARG2 (a2 / arrest-02
                              :time (e / event :name (n2 / name :op1 ""G1/S""))))))
      :ARG1-of (s3 / statistical-test-91
            :ARG2 (l2 / less-than :op1 0.0005)))",When selumetinib was administered alone levels of pHH3 decreased at several measurement points compared with controls (PD2 <i>P</i><0.0005; PD4 <i>P</i><0.005; PD5 <i>P</i><0.0005; PD6 <i>P</i><0.0005) consistent with the inhibition of the MEK/ERK pathway resulting in a G1/S arrest.,"(z1 / decrease-01
    :ARG1 (z2 / level
              :consist-of (z3 / small-molecule
                              :wiki ""Proteus_protein_kinase_3""
                              :name (z4 / name
                                        :op1 ""pHH3"")))
    :time (z5 / administer-01
              :ARG1 (z6 / small-molecule
                        :wiki ""Selumetinib""
                        :name (z7 / name
                                  :op1 ""selumetinib""))
              :manner (z8 / alone))
    :ARG1-of (z9 / compare-01
                 :ARG2 (z10 / point
                            :quant (z11 / several)
                            :ARG2-of (z12 / measure-01)))
    :ARG1-of (z13 / compare-01
                  :ARG2 (z14 / control-01
                             :ARG1 (z15 / and
                                        :op1 (z16 / small-molecule
                                                  :wiki ""PHLDA""
                                                  :name (z17 / name
                                                             :op1 ""PD2""
                                                             :op2 ""P""))
                                        :op2 (z18 / small-molecule
                                                  :wiki ""PHLDA4""
                                                  :name (z19 / name
                                                             :op1 ""PD4""
                                                             :op2 ""P""))
                                        :op3 (z20 / small-molecule
                                                  :wiki ""PHLDA5""
                                                  :name (z21 / name
                                                             :op1 ""PD5""
                                                             :op2 ""P""))
                                        :op4 (z22 / small-molecule
                                                  :wiki ""PHLDA6""
                                                  :name (z23 / name
                                                             :op1 ""PD6""
                                                             :op2 ""P"")))
                             :ARG1-of (z24 / consistent-01
                                           :ARG2 (z25 / inhibit-01
                                                      :ARG1 (z26 / pathway
                                                                 :mod (z27 / slash
                                                                           :op1 (z28 / enzyme
                                                                                     :wiki ""Mitogen/activated_protein_kinase_kinase""
                                                                                     :name (z29 / name
                                                                                                :op1 ""MEK/ERK""))
                                                                           :op2 (z30 / enzyme
                                                                                     :wiki ""Mitogen/activated_protein_kinase""
                                                                                     :name (z31 / name
                                                                                                :op1 ""G1/S""))))
                                                      :ARG0-of (z32 / result-01
                                                                    :ARG2 (z33 / arrest-01
                                                                               :ARG2 (z34 / enzyme
                                                                                          :wiki ""Mitogen/activated_protein_kinase""
                                                                                          :name (z35 / name
                                                                                                     :op1 ""G1/S"")))))))))",0.4431137724550898,0.3909774436090225,"(s / sentence
        :ARG0 (a / administer-01
              :ARG1 (s2 / selumetinib)
              :ARG2 (l / level
                    :mod (a2 / alone)))
        :ARG1 (d / decrease-01
              :ARG1 (p / pHH3)
              :ARG2 (m / measurement-point
                    :mod (s3 / several)
                    :mod (c / compare-01
                          :ARG1 (c2 / control))))
        :ARG2 (c2 / consistent
              :ARG1 (i / inhibit-01
                    :ARG1 (p2 / pathway
                          :mod (m2 / MEK/ERK)))
              :ARG2 (a3 / arrest-01
                    :ARG1 (g / G1/S)
                    :ARG2 (r / result-01))))","(w / when
    :ARG1 (a / administer-01
        :ARG0 (s / selumetinib)
        :ARG1 (a2 / alone)))
    :ARG2 (d / decrease-01
        :ARG0 (l / level
            :poss (p / pHH3))
        :time (m / measure-01
            :ARG1 (p2 / point
                :quant (s2 / several)))
        :compared-to (c / control)
        :ARG1-of (c2 / compare-01
            :ARG2 (p3 / PD2
                :value ""<i>P</i><0.0005"")
            :ARG3 (p4 / PD4
                :value ""<i>P</i><0.005"")
            :ARG4 (p5 / PD5
                :value ""<i>P</i><0.0005"")
            :ARG5 (p6 / PD6
                :value ""<i>P</i><0.0005"")))
    :mod (c3 / consistent-02
        :ARG1 (i / inhibit-01
            :ARG0 (p7 / pathway
                :name (n / name
                    :op1 ""MEK""
                    :op2 ""/""
                    :op3 ""ERK""))
            :result (a3 / arrest-01
                :ARG1 (g / G1/S)))))",-1.0,-1.0
a_pmid_2234_3622.95,"In comparison, tumour tissue analysed in the same study after the chronic dosing schedule of selumetinib did not demonstrate an increase in cleaved caspase 3 levels in the combination group when compared with the single agents alone.","(c4 / compare-01
    :ARG2 (d / demonstrate-01
        :ARG0 (t / tissue
            :ARG1-of (a4 / analyze-01
                :location (s4 / study-01
                    :ARG1-of (s / same-01))
                :time (a / after
                    :op1 (s2 / schedule-01
                        :ARG1 (d2 / dose-01
                            :ARG1 (p / product
                                :name (n / name
                                    :op1 ""selumetinib"")))
                        :mod (c2 / chronic))))
            :part-of (t2 / tumor))
        :ARG1 (i / increase-01
            :ARG1 (l2 / level
                :ARG0-of (l / leaf-02)
                :mod 3)
            :ARG1-of (c5 / compare-01
                :ARG2 (a2 / agent
                    :ARG1-of (s3 / single-02)
                    :mod (a3 / alone)))
            :location (g / group
                :ARG3-of (c3 / combine-01)))
        :polarity -)
    :rel (c / caspase))
",test,bio_amr0.8,"(c / compare-01
      :ARG1 (d / demonstrate-01 :polarity -
            :ARG0 (t / tissue
                  :source (t2 / tumor)
                  :ARG1-of (a3 / analyze-01
                        :ARG0 (s2 / study-01
                              :ARG1-of (s3 / same-01)
                              :time (a4 / after
                                    :op1 (s4 / schedule-01
                                          :ARG1 (d2 / dose-01
                                                :ARG2 (s5 / small-molecule :name (n2 / name :op1 ""selumetinib""))
                                                :mod (c4 / chronic)))))))
            :ARG1 (i / increase-01
                  :ARG1 (l / level
                        :location (g / group
                              :mod (c2 / combine-01))
                        :quant-of (p / protein :name (n / name :op1 ""cleaved"" :op2 ""caspase"" :op3 ""3""))))
            :time (c3 / compare-01
                  :ARG2 (a / agent
                        :ARG1-of (s / single-02))
                  :mod (a2 / alone))))","In comparison, tumour tissue analysed in the same study after the chronic dosing schedule of selumetinib did not demonstrate an increase in cleaved caspase 3 levels in the combination group when compared with the single agents alone.","(z1 / compare-01
    :ARG1 (z2 / demonstrate-01
              :polarity -
              :ARG0 (z3 / tissue
                        :part-of (z4 / tumor)
                        :ARG1-of (z5 / analyze-01
                                     :location (z6 / study
                                                   :ARG1-of (z7 / same-01))
                                     :time (z8 / after
                                               :op1 (z9 / schedule-01
                                                        :ARG1 (z10 / dose-01
                                                                   :ARG1 (z11 / small-molecule
                                                                              :wiki ""Selumetinib""
                                                                              :name (z12 / name
                                                                                         :op1 ""selumetinib""))
                                                                   :mod (z13 / chronic))))))
              :ARG1 (z14 / increase-01
                         :ARG1 (z15 / level
                                    :mod (z16 / enzyme
                                              :wiki ""Caspase_3""
                                              :name (z17 / name
                                                         :op1 ""caspase""
                                                         :op2 3)
                                              :ARG1-of (z18 / cleave-01)))
                         :location (z19 / group
                                        :mod (z20 / combine-01)))
              :condition (z21 / compare-01
                              :ARG1 z5
                              :ARG2 (z22 / group
                                         :mod (z23 / agent
                                                   :ARG1-of (z24 / single-02)
                                                   :mod (z25 / alone))))))",0.6111111111111113,0.6262626262626263,"(m / multi-sentence
        :snt1 (c / compare-01
            :ARG1 (t / tissue
                  :mod (t2 / tumour))
            :ARG2 (a / analyse-01
                  :ARG1 t
                  :ARG2 (s / study
                        :mod (s2 / same)
                        :ARG1 (d / dose-01
                              :ARG1 (s3 / schedule
                                    :mod (c2 / chronic)
                                    :ARG0 (s4 / selumetinib))))
                        :ARG2 (g / group
                              :mod (c3 / combination)
                              :ARG1-of (i / increase-01
                                    :ARG1 (l / level
                                          :mod (c4 / cleaved)
                                          :ARG1 (c5 / caspase-03)))))))
        :snt2 (c6 / compare-01
            :ARG1 (a2 / agent
                  :mod (s5 / single))
            :ARG2 (a3 / alone)))","(c / compare-01
    :ARG1 (a / analyze-01
        :ARG0 (t / tissue
            :mod (t2 / tumor))
        :ARG1 (s / study
            :mod (s2 / same))
        :time (a2 / after
            :op1 (d / dose-01
                :ARG1 (s3 / schedule
                    :mod (c2 / chronic))
                :ARG2 (s4 / selumetinib))))
    :ARG2 (i / increase-01
        :ARG1 (l / level
            :mod (c3 / caspase
                :mod (c4 / cleave-01)
                :mod (n / numeral :value 3)))
        :location (g / group
            :mod (c5 / combine-01))
        :time (w / when
            :op1 (c6 / compare-01
                :ARG1 g
                :ARG2 (a3 / agent
                    :mod (s5 / single)
                    :mod (a4 / alone-01))))))
    :mod (i2 / in)
    :mod (c7 / comparison))",-1.0,-1.0
a_pmid_2234_3622.102,"The CaLu-6 NSCLC human tumour xenograft model was used in this study as previous experience with both agents allowed us to select appropriate dose levels in order to investigate these schedules (<xref ref-type=""bibr"" rid=""bib6"">Davies <i>et al</i>, 2007</xref>; <xref ref-type=""bibr"" rid=""bib29"">Wilkinson <i>et al</i>, 2007</xref>).","(u / use-01
    :ARG1 (m / model
        :mod (c2 / cell
            :name (n2 / name
                :mod ""xenograft""
                :op2 ""Chromosome""
                :op2 ""tumor"")
            :mod (h2 / human))
        :mod (d2 / disease
            :name (n / name
                :op1 (h / ""healthy""
                    :op1 6))
            :mod (p2 / publication-91
                :name (n3 / name
                    :op1 6)
                :ARG0 (i / i)
                :ARG1-of (h3 / hyperlink-91)
                :time (d / date-entity
                    :year 2007
                    :year 2007))))
    :ARG1-of (c / cause-01
        :ARG0 (a2 / allow-01
            :ARG0 (e / experience-01
                :ARG1 (a / agent
                    :mod (b / both))
                :time (p / previous))
            :ARG1 (s2 / select-01
                :purpose (i2 / investigate-01
                    :ARG0 (w / we)
                    :ARG1 (s / schedule-01
                        :mod (t2 / this)))
                :ARG0 w
                :ARG1 (l / level
                    :ARG1-of (a3 / appropriate-02)
                    :ARG2-of (d3 / dose-01)))))
    :ARG2 (s3 / study-01
        :mod (t / this)))
",test,bio_amr0.8,"(u / use-01
      :ARG1 (m / model
            :mod (x2 / xenograft :name (n / name :op1 ""CaLu-6"")
                  :mod (t / tumor
                        :mod (h / human)
                        :mod (d / disease :name (n2 / name :op1 ""NSCLC"")))))
      :ARG2 (t2 / thing
            :ARG1-of (s / study-01)
            :mod (t3 / this))
      :ARG1-of (c2 / cause-01
            :ARG0 (a / allow-01
                  :ARG0 (e / experience-01
                        :ARG0 w
                        :ARG1 (a2 / agent
                              :mod (b / both))
                        :time (p7 / previous))
                  :ARG1 (s2 / select-01
                        :ARG0 (w / we)
                        :ARG1 (l / level
                              :quant-of (d2 / dose-01
                                    :ARG1-of (a3 / appropriate-02)))
                        :ARG3 (i / investigate-01
                              :ARG0 w
                              :ARG1 (s3 / schedule
                                    :mod t3)))))
      :ARG1-of (d3 / describe-01
            :ARG0 (a4 / and
                  :op1 (p / publication-91
                        :ARG0 (a5 / and
                              :op1 (p2 / person :name (n3 / name :op1 ""Davies""))
                              :op2 (p3 / person
                                    :mod (o / other)))
                        :time (d4 / date-entity :year 2007))
                  :op2 (p4 / publication-91
                        :ARG0 (a6 / and
                              :op1 (p5 / person :name (n4 / name :op1 ""Wilkinson""))
                              :op2 p3)
                        :time d4))))","The CaLu-6 NSCLC human tumour xenograft model was used in this study as previous experience with both agents allowed us to select appropriate dose levels in order to investigate these schedules (<xref ref-type=""bibr"" rid=""bib6"">Davies <i>et al</i>, 2007</xref>; <xref ref-type=""bibr"" rid=""bib29"">Wilkinson <i>et al</i>, 2007</xref>).","(z1 / use-01
    :ARG1 (z2 / model
              :mod (z3 / xenograft
                       :mod (z4 / tumor
                                :wiki ""Cancer_cell""
                                :wiki ""Cancer""
                                :name (z5 / name
                                          :op1 ""cancer"")
                                :mod (z6 / human))
                       :mod (z7 / cell
                                :wiki ""C-calcium_exchanger""
                                :name (z8 / name
                                          :op1 ""CaLu-6"")
                                :mod (z9 / small-molecule
                                         :wiki ""Selective_serotonin_reuptake_inhibitor""
                                         :name (z10 / name
                                                    :op1 ""NSCLC"")))))
    :ARG2 (z11 / study-01
               :mod (z12 / this))
    :ARG1-of (z13 / cause-01
                  :ARG0 (z14 / allow-01
                             :ARG0 (z15 / experience-01
                                        :ARG1 (z16 / agent
                                                   :mod (z17 / both))
                                        :time (z18 / previous))
                             :ARG1 (z19 / select-01
                                        :ARG0 (z20 / we)
                                        :ARG1 (z21 / level
                                                   :ARG2-of (z22 / dose-01)
                                                   :ARG1-of (z23 / appropriate-02))
                                        :purpose (z24 / investigate-01
                                                      :ARG0 z20
                                                      :ARG1 (z25 / schedule-01
                                                                 :mod (z26 / this)))))))",0.513888888888889,0.5100671140939597,"(m / multi-sentence
        :snt1 (u / use-01
            :ARG0 (m2 / model
                  :mod (x / xenograft
                        :mod (t / tumour
                              :mod (h / human))))
            :ARG1 (s / study
                  :ARG0 (e / experience
                        :ARG1 (a / agent
                              :mod (b / both)))
                  :ARG1-of (a2 / allow-01
                        :ARG0 (u2 / us)
                        :ARG1 (s2 / select-01
                              :ARG0 (l / level
                                    :mod (d / dose
                                          :mod (a3 / appropriate))))
                              :ARG1 (i / investigate-01
                                    :ARG0 (o / order)
                                    :ARG1 (s3 / schedule
                                          :ARG1-of (t2 / these))))))
            :ARG2 (p / previous
                  :mod (e2 / experience
                        :ARG1 (w / with
                              :op1 (a4 / agent)))))
        :snt2 (c / cite-01
            :ARG0 (d / Davies
                  :name (n / name :op1 ""Davies"")
                  :mod (a5 / al))
            :ARG1 (y / year :op1 2007))
        :snt3 (c2 / cite-01
            :ARG0 (w / Wilkinson
                  :name (n2 / name :op1 ""Wilkinson"")
                  :mod (a6 / al))
            :ARG1 y)","(u / use-01
    :ARG0 (w / we)
    :ARG1 (m / model
        :mod (x / xenograft
            :mod (t / tumor
                :mod (h / human)
                :mod (n / NSCLC)
                :mod (c / CaLu-6))))
    :location (s / study
        :mod (t2 / this))
    :purpose (i / investigate-01
        :ARG1 (s2 / schedule
            :mod (t3 / these)))
    :condition (a / allow-01
        :ARG0 (e / experience
            :mod (p / previous)
            :ARG1 (a2 / agent
                :mod (b / both)))
        :ARG1 w
        :ARG2 (s3 / select-01
            :ARG0 w
            :ARG1 (l / level
                :mod (a3 / appropriate)
                :mod (d / dose))))
    :mod (r / reference-91
        :ARG1 (d2 / document
            :name (n2 / name :op1 ""Davies"" :op2 ""et"" :op3 ""al"" :op4 "", 2007""))
        :ARG2 (d3 / document
            :name (n3 / name :op1 ""Wilkinson"" :op2 ""et"" :op3 ""al"" :op4 "", 2007""))))",-1.0,0.4054054054054054
a_pmid_2234_3622.107,"Interestingly, the tumours in the group where barasertib was administered before selumetinib (schedule 1) tumour re-growth was delayed (<xref ref-type=""fig"" rid=""fig5"">Figure 5B</xref>).","(d / delay-01
    :ARG1 (g2 / grow-01
        :ARG1 (p2 / protein
            :name (n2 / name
                :op1 ""serotonin""
                :op1 ""arm""
                :op1 ""selumetinib"")
            :ARG1-of (s / schedule-01
                :ARG2 1))
        :mod (a2 / again))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure
            :mod 5))
    :mod (i2 / interesting)
    :rel (t / tumor
        :ARG1-of (i / include-91
            :ARG2 (g / group
                :location-of (a / administer-01
                    :ARG1 (p / product
                        :name (n / name
                            :op1 ""barasertib""))
                    :time (b / before))))))
",test,bio_amr0.8,"(d / delay-01
      :ARG1 (g / grow-01
            :ARG1 (t / tumor
                  :source (g2 / group
                        :ARG2-of (a / administer-01
                              :ARG1 (s / small-molecule :name (n / name :op1 ""barasertib""))
                              :time (b / before
                                    :op1 (a2 / administer-01
                                          :ARG1 (s2 / small-molecule :name (n2 / name :op1 ""selumetinib""))))
                              :ARG2-of (m / mean-01
                                    :ARG1 (s3 / schedule :mod 1))))))
      :mod (i / interesting)
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod ""5B"")))","Interestingly, the tumours in the group where barasertib was administered before selumetinib (schedule 1) tumour re-growth was delayed (<xref ref-type=""fig"" rid=""fig5"">Figure 5B</xref>).","(z1 / delay-01
    :ARG1 (z2 / tumor
              :location (z3 / group
                            :location-of (z4 / administer-01
                                             :ARG1 (z5 / barasertib)
                                             :time (z6 / before
                                                       :op1 (z7 / grow-03
                                                                :ARG1 (z8 / tumor
                                                                          :mod (z9 / regrow-01
                                                                                   :ARG1 (z10 / selumetinib
                                                                                              :ARG1-of (z11 / schedule-01
                                                                                                            :ARG2 1))))))))))",0.3859649122807018,0.5352112676056339,"(m / multi-sentence
        :snt1 (i / interest-01
            :ARG1 (t / tumour
                  :mod (g / group
                        :ARG1-of (a / administer-01
                              :ARG1 (b / barasertib)
                              :ARG2 (s / selumetinib
                                    :ARG1-of (b2 / before
                                          :ARG2 (s2 / schedule-01
                                                :ARG1 (t2 / tumour
                                                      :mod (r / re-growth
                                                            :ARG1-of (d / delay-01
                                                                  :ARG1 t2))))))))
            :ARG2 (f / figure
                  :ARG1 (x / xref
                        :ref-type ""fig""
                        :rid ""fig5""
                        :ARG2 (f2 / figure
                              :mod (b / b)))))
        :snt2 (d2 / delay-01
            :ARG1 (t3 / tumour
                  :mod (r2 / re-growth
                        :ARG1-of (d3 / delay-01
                              :ARG1 t3))))","(d / delay-01
    :ARG1 (r / re-grow-01
        :ARG1 (t / tumor
            :location (g / group
                :mod (w / where
                    :op1 (a / administer-01
                        :ARG1 (b / barasertib)
                        :ARG2 (s / schedule-01
                            :mod (n / number :value 1))
                        :time (b2 / before
                            :op1 (s2 / selumetinib))))))
    :degree (i / interesting)
    :ARG2 (f / figure
        :mod (n2 / number :value 5)
        :mod (l / letter :op1 ""B""))
    :mod (x / xref
        :ref-type ""fig""
        :rid ""fig5""))",-1.0,0.3380281690140845
bel_pmid_1002_9589.23888,"In addition, constitutive activation of the pathway via expression of the constitutively active mutants of MAPKK1 or MAPKK2 induced the expression of the platelet/megakaryocytic-specific genes alpha IIb and eta 3 .","(a3 / and
    :op2 (i / induce-01
        :ARG0 (a / activate-01
            :ARG0-of (c3 / constitute-01)
            :ARG1 (p / pathway)
            :manner (e2 / express-01
                :ARG0 (m2 / mutate-01
                    :ARG0-of (a2 / activity-06
                        :mod (c4 / constitution))
                    :ARG1 (o / or
                        :op1 (e / enzyme
                            :name (n / name
                                :op1 ""MAPKK1""))
                        :op2 (p3 / protein
                            :name (n2 / name
                                :op1 ""MAPKK2""
                                :op3 (c2 / ""cell""
                                    :name (n5 / name
                                        :op1 ""eta""
                                        :op2 3))))))))
        :ARG1 (e3 / express-01
            :ARG1 (a4 / and
                :op1 (g / gene
                    :name (n4 / name
                        :op1 ""alpha""
                        :op2 ""IIb"")
                    :ARG1-of (s / specific-02
                        :ARG2 (c / cell
                            :name (n3 / name
                                :op1 ""megakaryocytic""
                                :op2 ""factor"")
                            :op1 (m / multiple)))
                    :mod (p2 / platelet))
                :op2 (g2 / gene
                    :mod c)))))
",test,bio_amr0.8,"(a / and
      :op2 (i / induce-01
            :ARG0 (a2 / activate-01
                  :ARG1 (p / pathway)
                  :mod (c / constitutive)
                  :manner (e / express-03
                        :ARG2 (o / or
                              :op1 (e2 / enzyme :name (n / name :op1 ""MAPKK1""))
                              :op2 (e3 / enzyme :name (n2 / name :op1 ""MAPKK2""))
                              :ARG1-of (m2 / mutate-01)
                              :ARG0-of (a3 / activity-06
                                    :mod c))))
            :ARG2 (e4 / express-03
                  :ARG1 (a5 / and
                        :op1 (g / gene :name (n3 / name :op1 ""alpha"" :op2 ""IIb""))
                        :op2 (g2 / gene :name (n4 / name :op1 ""beta3""))
                        :ARG1-of (s / specific-02
                              :ARG2 (c3 / cell :name (n5 / name :op1 ""platelet"")
                                    :source (c4 / cell :name (n6 / name :op1 ""megakaryocyte""))))))))","In addition, constitutive activation of the pathway via expression of the constitutively active mutants of MAPKK1 or MAPKK2 induced the expression of the platelet/megakaryocytic-specific genes alpha IIb and eta 3 .","(z1 / and
    :op2 (z2 / induce-01
             :ARG0 (z3 / activate-01
                       :ARG1 (z4 / pathway)
                       :manner (z5 / activate-01
                                   :ARG0 (z6 / express-02
                                             :ARG1 (z7 / mutant
                                                       :ARG0-of (z8 / activity-06
                                                                    :ARG1 (z9 / or
                                                                              :op1 (z10 / protein
                                                                                        :wiki ""Mitogen-activated_protein_kinase_1""
                                                                                        :name (z11 / name
                                                                                                   :op1 ""MAPKK1""))
                                                                              :op2 (z12 / protein
                                                                                        :wiki ""MAPKK2""
                                                                                        :name (z13 / name
                                                                                                   :op1 ""MAPKK2"")))
                                                                    :mod (z14 / constitutive)))))
                       :ARG1 z4)
             :ARG1-of (z15 / create-01))
    :ARG1 (z16 / express-01
               :ARG1 (z17 / and
                          :op1 (z18 / gene
                                    :wiki ""BRAF-alpha""
                                    :name (z19 / name
                                               :op1 ""alpha""
                                               :op2 ""IIb"")
                                    :ARG1-of (z20 / specific-02
                                                  :ARG2 (z21 / slash
                                                             :op1 (z22 / platelet)
                                                             :op2 (z23 / megakaryocytize-00))
                                                  :ARG1 z24))
                          :op2 (z24 / gene
                                    :wiki ""BRAF-alpha""
                                    :name (z25 / name
                                               :op1 ""eta""
                                               :op2 ""3"")))))",0.4915254237288136,0.4615384615384615,"(m / multi-sentence
        :snt1 (a / addition
            :ARG1 (a2 / activate-01
                  :ARG0 (a3 / activation
                        :ARG1 (p / pathway)))
            :ARG2 (e / express-01
                  :ARG0 (e2 / expression)
                  :ARG1 (m2 / mutant
                        :mod (a4 / active
                              :ARG1 (c / constitutive
                                    :mod (m3 / MAPKK1)
                                    :mod (m4 / MAPKK2))))
                  :ARG2 (g / gene
                        :mod (g2 / platelet/megakaryocytic-specific)
                        :ARG1 (a5 / alpha)
                        :ARG1 (e3 / eta)
                        :ARG1 (n / number :op1 ""3"")))))","(a / addition
    :op1 (a2 / activate-01
        :ARG1 (p / pathway)
        :manner (c / constitutive)
        :instrument (e / express-01
            :ARG1 (m / mutant
                :mod (a3 / active)
                :mod (c2 / constitutive)
                :ARG1-of (o / or
                    :op1 (g / gene :name (n / name :op1 ""MAPKK1""))
                    :op2 (g2 / gene :name (n2 / name :op1 ""MAPKK2""))))))
    :op2 (i / induce-01
        :ARG0 a2
        :ARG1 (e2 / express-01
            :ARG1 (g3 / gene
                :mod (s / specific)
                :mod (p2 / platelet)
                :mod (m2 / megakaryocyte)
                :ARG1-of (o2 / or
                    :op1 (n3 / name :op1 ""alpha"" :op2 ""IIb"")
                    :op2 (n4 / name :op1 ""eta"" :op2 ""3""))))))",-1.0,0.4112149532710281
bel_pmid_1008_0909.24618,"It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)","(m5 / multi-sentence
    :rel (i / induce-01
        :ARG0 (e / enzyme
            :name (n2 / name
                :op1 ""TPO""))
        :ARG2 (a / activate-01
            :ARG1 (a3 / and
                :op1 (p3 / protein
                    :name (n3 / name))
                :op2 (e2 / enzyme
                    :name (n4 / name)
                    :name (n5 / name
                        :op1 ""5A""))
                :op2 (s2 / small-molecule
                    :name (n6 / name
                        :op1 ""STAT3""
                        :op1 ""tyrosine"")))))
    :rel 38
    :rel 5B
    :rel (n / name)
    :rel 26
    :rel 28
    :rel 30
    :rel 37
    :snt1 (d2 / difficult
        :domain (i2 / interpret-01
            :ARG1 (r3 / role
                :purpose (d / develop-02
                    :ARG1 (m / megakaryocyte))
                :mod (b2 / biology)
                :poss (s / signal-07))))
    :snt2 (r2 / report-01
        :location (l / line
            :quant (m6 / multiple)
            :mod (c / cell)))
    :snt3 (c2 / contrast-01
        :ARG2 (f / find-01
            :ARG0 (w / we)
            :ARG1 (h / have-degree-91
                :ARG1 s2
                :ARG2 (p2 / pronounced-02
                    :location (a4 / and
                        :op1 (p / phosphorylate-01
                            :ARG1 ""tyrosine"")
                        :op2 (a2 / activity-06
                            :ARG1 (b / bind-01
                                :ARG1 (n8 / nucleic-acid
                                    :name (n7 / name
                                        :op1 ""DNA""
                                        :op1 ""STAT5""))))))
                :ARG3 (m3 / more
                    :quant (m4 / much))
                :ARG4 (s3 / small-molecule
                    :name n7)
                :ARG6 32)
            :time (e3 / examine-01
                :ARG0 w
                :ARG1 (e4 / extract-01
                    :ARG1 (m2 / megakaryocyte
                        :mod (m7 / murine))
                    :ARG1-of (r / refine-01))))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (d / difficult
            :domain (i / interpret-01
                  :ARG1 (r / role
                        :mod (p2 / physiologic)
                        :poss (s / signal-07
                              :ARG0 (p3 / protein :name (n / name :op1 ""STAT"")))
                        :purpose (d2 / develop-02
                              :ARG1 (c / cell :name (n2 / name :op1 ""megakaryocyte""))))))
      :snt2 (r2 / report-01
            :ARG1 (i2 / induce-01
                  :ARG0 (p4 / protein :name (n3 / name :op1 ""TPO""))
                  :ARG2 (a / activate-01
                        :ARG1 (a2 / and
                              :op1 (p5 / protein :name (n4 / name :op1 ""STAT3""))
                              :op2 (p6 / protein :name (n5 / name :op1 ""STAT5""))
                              :mod (b / both))))
            :ARG1-of (d3 / describe-01
                  :ARG0 (a3 / and
                        :op1 (f / figure :mod ""5A"")
                        :op2 (f2 / figure :mod ""5B"")
                        :op3 (p7 / publication
                              :ARG1-of (c2 / cite-01
                                    :ARG2 (a4 / and :op1 26 :op2 28 :op3 30 :op4 37 :op5 38)))))
            :location (c5 / cell-line
                  :quant (m5 / multiple)))
      :snt3 (c6 / contrast-01
            :ARG2 (f3 / find-01
                  :ARG0 (w / we)
                  :ARG1 (p / pronounced-02
                        :ARG1 (p9 / protein :name (n6 / name :op1 ""STAT3""))
                        :degree (m2 / more
                              :quant (m3 / much))
                        :condition (a5 / and
                              :op1 (p10 / phosphorylate-01
                                    :ARG1 (a6 / amino-acid :name (n7 / name :op1 ""tyrosine"")))
                              :op2 (a7 / activity-06
                                    :ARG1 (b2 / bind-01
                                          :ARG1 (n9 / nucleic-acid :wiki ""DNA"" :name (n10 / name :op1 ""DNA""))))
                              :mod (b3 / both))
                        :compared-to (p11 / protein :name (n8 / name :op1 ""STAT5"")))
                  :time (e / examine-01
                        :ARG1 (t / thing
                              :ARG1-of (e2 / extract-01
                                    :ARG2 (m6 / megakaryocyte
                                          :mod (m4 / murine))
                                    :ARG1-of (p13 / purify-01)))))
            :ARG1-of (d5 / describe-01
                  :ARG0 (p12 / publication
                        :ARG1-of (c3 / cite-01
                              :ARG2 32)))))","It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)","(z1 / difficult
    :domain (z2 / interpret-01
                :ARG1 (z3 / role
                          :mod (z4 / physiologic)
                          :poss (z5 / signal-07
                                    :ARG0 (z6 / protein
                                              :wiki ""STAT_(t3000 / threonine)""
                                              :name (z7 / name
                                                        :op1 ""STAT"")))
                          :purpose (z8 / develop-02
                                       :ARG1 (z9 / megakaryocyte)))))",0.1948051948051948,0.4937238493723849,"(m / multi-sentence
        :snt1 (d / difficult-02
            :ARG1 (i / interpret-01
                  :ARG0 (r / role
                        :mod (p / physiologic))
                  :ARG1 (s / signaling
                        :ARG1-of (s2 / STAT
                              :ARG1-of (d2 / develop-01
                                    :ARG1 (m / megakaryocyte)))))
        :snt2 (r2 / report-01
            :ARG0 (i2 / it)
            :ARG1 (a / activation
                  :ARG1-of (i3 / induce-01
                        :ARG1 (t / TPO))
                  :ARG2 (a2 / and
                        :op1 (s3 / STAT3)
                        :op2 (s4 / STAT5
                              :op1 (n / name :op1 ""5A"")
                              :op2 (n2 / name :op1 ""5B""))))
        :snt3 (e / examine-01
            :ARG0 (w / we)
            :ARG1 (e2 / extract
                  :mod (m2 / megakaryocyte)
                  :ARG1-of (p2 / purify-01
                        :ARG1 w))
            :ARG2 (p3 / pronounced-01
                  :ARG1 (s5 / STAT3)
                  :ARG2 (a3 / activity
                        :ARG1-of (b / bind-01
                              :ARG1 (d3 / DNA)
                              :ARG2 w)))
            :ARG3 (p4 / pronounced-01
                  :ARG1 (s6 / STAT5)
                  :ARG2 (a4 / activity
                        :ARG1-of (b2 / bind-01
                              :ARG1 (d4 / DNA)
                              :ARG2 w))))
        :snt4 (m3 / much
            :ARG1 (p5 / pronounced-01
                  :ARG1 s5
                  :ARG2 (p6 / phosphorylation
                        :ARG1-of (t2 / tyrosine)))
            :ARG2 (p7 / pronounced-01
                  :ARG1 s6
                  :ARG2 (p8 / phosphorylation
                        :ARG1-of (t3 / tyrosine))))
        :snt5 (c / compare-01
            :ARG1 (s7 / STAT3)
            :ARG2 (s8 / STAT5))
        :snt6 (c2 / compare-01
            :ARG1 (s9 / STAT3)
            :ARG2 (s10 / STAT5)))","(i / interpret-01
    :ARG1 (r / role
        :ARG1-of (p / physiologic-01)
        :ARG2 (s / signal-01
            :ARG1-of (s2 / STAT)
            :ARG2-of (d / develop-01
                :ARG1 (m / megakaryocyte))))
    :ARG0 (i2 / it)
    :mod (d2 / difficult)
    :time (b / be-03
        :ARG1 i2
        :time (p2 / past)))
(and / and
    :op1 (r2 / report-01
        :ARG0 (i3 / it)
        :ARG1 (a / activate-01
            :ARG0 (t / TPO)
            :ARG1 (s3 / STAT3)
            :ARG2 (s4 / STAT5)
            :ARG3 (s5 / STAT5
                :mod (5 / 5A))
            :ARG4 (s6 / STAT5
                :mod (5 / 5B)))
        :location (l / line
            :mod (c / cell)
            :quant (m2 / multiple)))
    :op2 (f / find-01
        :ARG0 (w / we)
        :ARG1 (p3 / pronounce-01
            :ARG1 (s7 / STAT3)
            :degree (m3 / more)
            :compared-to (s8 / STAT5)
            :ARG2-of (a2 / and
                :op1 (p4 / phosphorylation-01
                    :ARG1 (t2 / tyrosine))
                :op2 (b2 / bind-01
                    :ARG1 (d3 / DNA)
                    :ARG2 s7)))
        :location (e / extract-01
            :ARG1-of (p5 / purify-01)
            :ARG2-of (m4 / megakaryocyte))
        :time (w2 / when)))
(and / and
    :op1 (h / however)
    :op2 f)",-1.0,-1.0
bel_pmid_1019_4465.17324,"c-Cbl is tyrosine-phosphorylated, binds to Fyn upon insulin stimulation, and is translocated to small invaginations of the plasma membrane, called caveolae, after insulin stimulation","(a2 / and
    :op1 (p / phosphorylate-01)
    :op2 (p2 / phosphorylate-01)
    :op3 (b / bind-01
        :time (s2 / stimulate-01
            :ARG1 (i / insulin)))
    :op4 (t / translate-01
        :ARG2 (i2 / invade-01
            :ARG1 (m / membrane
                :name (n3 / name
                    :op1 ""caveolae"")
                :mod (p3 / plasma))
            :mod (s / small))
        :time (a / after
            :op1 s2))
    :rel (n / name
        :op1 ""C"")
    :rel (n2 / name
        :op1 ""Fyn""))
",test,bio_amr0.8,"(a / and
      :op1 (p / phosphorylate-01
            :ARG1 (a2 / amino-acid :name (n2 / name :op1 ""tyrosine"")
                  :part-of (p3 / protein :name (n / name :op1 ""c-Cbl""))))
      :op2 (b / bind-01
            :ARG1 p3
            :ARG2 (e / enzyme :name (n3 / name :op1 ""Fyn""))
            :condition (s / stimulate-01
                  :ARG2 (p4 / protein :name (n4 / name :op1 ""insulin""))))
      :op3 (t / translocate-01
            :ARG1 p3
            :ARG2 (i / invaginate-01
                  :ARG1 (m / membrane
                        :mod (p2 / plasma)
                        :ARG1-of (c / call-01
                              :ARG2 (c2 / caveolae)))
                  :mod (s2 / small))
            :time (a3 / after
                  :op1 s)))","c-Cbl is tyrosine-phosphorylated, binds to Fyn upon insulin stimulation, and is translocated to small invaginations of the plasma membrane, called caveolae, after insulin stimulation","(z1 / and
    :op1 (z2 / phosphorylate-01
             :ARG1 (z3 / small-molecule
                       :wiki ""Cyclin-calcium_exchanger_<lit>_C-Cbl""
                       :name (z4 / name
                                 :op1 ""c-Cbl""))
             :ARG2 (z5 / tyrosine))
    :op2 (z6 / bind-01
             :ARG1 (z7 / fyn)
             :ARG2 z3
             :time (z8 / stimulate-01
                       :ARG2 (z9 / insulin)))
    :op3 (z10 / translocate-01
              :ARG1 z3
              :ARG2 (z11 / invaginate-01
                         :ARG1 (z12 / membrane
                                    :mod (z13 / plasma)
                                    :ARG1-of (z14 / call-01
                                                  :ARG2 (z15 / caveolae))
                                    :mod (z16 / small)))
              :time (z17 / after
                         :op1 z8)))",0.627906976744186,0.3950617283950617,"(s / sentence
        :snt (b / bind-01
              :ARG0 (p / phosphorylate-01
                    :ARG1 (c / c-Cbl))
              :ARG1 (f / Fyn
                    :ARG0-of (s2 / stimulate-01
                          :ARG1 (i / insulin))))
        :snt (t / translocate-01
              :ARG0 c
              :ARG1 (i2 / invagination
                    :mod (s3 / small)
                    :mod (p2 / plasma
                          :mod (m / membrane))))
        :snt (c2 / call-01
              :ARG1 (c3 / caveolae)
              :ARG2 (i2 / invagination))
        :snt (s4 / stimulate-01
              :ARG1 (i3 / insulin)))","(p / phosphorylate-01 :passive +
    :ARG1 (c / c-Cbl)
    :mod (t / tyrosine)
    :time (a / after
        :op1 (s / stimulate-01
            :ARG1 (i / insulin)))
    :location (i2 / invagination
        :mod (s2 / small)
        :part (m / membrane
            :mod (p2 / plasma))
        :name (n / name :op1 ""caveolae""))
    :ARG2 (b / bind-01
        :ARG0 c
        :ARG1 (f / Fyn)
        :time (u / upon
            :op1 s))
    :ARG3 (t2 / translocate-01
        :ARG0 c
        :ARG1 i2
        :time a))",-1.0,0.3333333333333333
bel_pmid_1019_4465.19902,"Interestingly, this NPXY sequence is also a receptor internalization motif found in many members of the tyrosine kinase receptor family, the low-density lipoprotein receptor (11-13), and the transferrin receptor (14), all of which are internalized in a ligand-dependent fashion.","(m3 / motif
    :ARG1-of (f3 / find-01
        :location (a3 / and
            :ARG1-of (i4 / internalize-01
                :ARG0-of (d2 / depend-01
                    :ARG1 (l / ligand)))
            :mod (a / all)
            :op1 (f / family
                :name (n2 / name
                    :op1 ""tyrosine""
                    :op2 ""kinase""
                    :op3 ""receptor"")
                :ARG1-of (i / include-91
                    :ARG2 (m2 / member
                        :quant (m / many))
                    :ARG2 (f2 / family)))
            :op2 (p / protein
                :name (n3 / name
                    :op1 ""lipoprotein""
                    :op2 ""receptor"")
                :mod (d / dense
                    :ARG1-of (l2 / low-04))
                :mod (v / value-interval
                    :op1 13
                    :op2 11))))
    :ARG2-of (i3 / internalize-01
        :ARG1 (r / receptor))
    :domain (s / sequence
        :name (n / name
            :op1 ""NPXY"")
        :mod (t / this))
    :mod (a2 / also)
    :mod (i2 / interesting)
    :rel 14
    :rel (t2 / transferrin)
    :rel (r2 / receptor))
",test,bio_amr0.8,"(m / motif
      :ARG0-of (i / internalize-01
            :ARG1 (r / receptor))
      :domain (d / dna-sequence :name (n / name :op1 ""NPXY"")
            :mod (t / this))
      :ARG1-of (f2 / find-01
            :location (m2 / member
                  :quant (m3 / many)
                  :ARG1-of (i2 / include-91
                        :ARG2 (p / protein-family :name (n2 / name :op1 ""tyrosine"" :op2 ""kinase"" :op3 ""receptor"")))
                  :ARG1-of (i4 / internalize-01
                        :manner (d4 / depend-01
                              :ARG1 (l / ligand)))
                  :example (a / and
                        :op1 (p2 / protein :name (n3 / name :op1 ""low-density"" :op2 ""lipoprotein"" :op3 ""receptor"")
                              :ARG1-of (d2 / describe-01
                                    :ARG0 (p3 / publication
                                          :ARG1-of (c / cite-01
                                                :ARG2 (v / value-interval :op1 11 :op2 13)))))
                        :op2 (p4 / protein :name (n4 / name :op1 ""transferrin"" :op2 ""receptor"")
                              :ARG1-of (d3 / describe-01
                                    :ARG0 (p5 / publication
                                          :ARG1-of (c2 / cite-01
                                                :ARG2 14)))))))
      :ARG2-of (i3 / interest-01)
      :mod (a2 / also))","Interestingly, this NPXY sequence is also a receptor internalization motif found in many members of the tyrosine kinase receptor family, the low-density lipoprotein receptor (11-13), and the transferrin receptor (14), all of which are internalized in a ligand-dependent fashion.","(z1 / motif
    :mod (z2 / internalize-01
             :ARG1 (z3 / receptor))
    :domain (z4 / sequence
                :mod (z5 / protein
                         :wiki ""PHLDA1""
                         :name (z6 / name
                                   :op1 ""NPXY"")
                         :mod (z7 / this)))
    :ARG1-of (z8 / find-01
                 :location (z9 / and
                               :op1 (z10 / member
                                         :quant (z11 / many)
                                         :ARG1-of (z12 / include-91
                                                       :ARG2 (z13 / family
                                                                  :wiki ""tyrosine_kinase_receptor""
                                                                  :name (z14 / name
                                                                             :op1 ""tyrosine""
                                                                             :op2 ""kinase""
                                                                             :op3 ""receptor"")))
                                         :example (z15 / and
                                                       :op1 (z16 / protein
                                                                 :wiki ""Lipoprotein_receptor""
                                                                 :name (z17 / name
                                                                            :op1 ""lipoprotein""
                                                                            :op2 ""receptor"")
                                                                 :ARG1-of (z18 / dense-02
                                                                               :ARG1-of (z19 / low-04)))
                                                       :op2 (z20 / protein
                                                                 :wiki ""Transient_receptor""
                                                                 :name (z21 / name
                                                                            :op1 ""transferrin""
                                                                            :op2 ""receptor"")
                                                                 :ARG1-of (z22 / include-91
                                                                               :ARG2 (z23 / family
                                                                                          :wiki ""BRAF_(g3000 / gene)""
                                                                                          :name (z24 / name
                                                                                                     :op1 ""tyrosine""
                                                                                                     :op2 ""kinase""
                                                                                                     :op3 ""receptor"")))))
                                         :example (z25 / protein
                                                       :wiki ""Lopinavir/ritonavir""
                                                       :name (z26 / name
                                                                  :op1 ""Loprotein""
                                                                  :op2 ""receptor"")
                                                       :ARG1-of (z27 / include-91
                                                                     :ARG2 (z28 / protein
                                                                                :wiki ""Transient_receptor""
                                                                                :name (z29 / name
                                                                                           :op1 ""transferrin""
                                                                                           :op2 ""receptor"")
                                                                                :ARG1-of (z30 / include-91
                                                                                              :ARG2 z13))))))
                 :op2 (z31 / protein
                           :wiki ""PHLDA1""
                           :name (z32 / name
                                      :op1 ""PHLDA1""
                                      :op2 ""receptor"")
                           :ARG1-of (z33 / include-91
                                         :ARG2 (z34 / protein
                                                    :wiki ""TRG-14""
                                                    :name (z35 / name
                                                               :op1 ""TRG-14""))))))",0.4047619047619047,0.4661654135338345,"(m / multi-sentence
        :snt1 (i / interest-01
            :ARG1 (t / this)
            :degree (l / low))
        :snt2 (f / find-01
            :ARG1 (m2 / motif
                  :mod (s / sequence
                        :mod (n / npxy))
                  :mod (r / receptor
                        :mod (i2 / internalization)))
            :ARG2 (m3 / member
                  :mod (f2 / family
                        :mod (r2 / receptor
                              :mod (t2 / tyrosine
                                    :mod (k / kinase))))
                  :mod (l2 / lipoprotein
                        :mod (d / density
                              :degree (l3 / low))))
            :ARG2-of (f3 / find-01
                  :ARG1 (r3 / receptor
                        :mod (l4 / lipoprotein
                              :mod (d2 / density
                                    :degree (l5 / low))))
                  :ARG2 (t3 / transferrin))
            :ARG2-of (i2 / internalize-01
                  :ARG1 (a / all)
                  :mod (w / which)
                  :mod (i3 / internalize-01
                        :ARG1 (l6 / ligand-dependent))))
        :snt3 (f4 / fashion))","(i / interesting-01
    :ARG1 (s / sequence
        :name (n / name :op1 ""NPXY"")
        :ARG1-of (a / also-01
            :ARG2 (m / motif
                :mod (r / receptor-internalization)
                :location (m2 / member-01
                    :ARG1-of (f / find-01
                        :ARG1 (f2 / family
                            :mod (r2 / receptor)
                            :mod (t / tyrosine-kinase))
                        :ARG1 (r3 / receptor
                            :name (n2 / name :op1 ""low-density"" :op2 ""lipoprotein"")
                            :mod (n3 / number :value 11)
                            :mod (n4 / number :value 13))
                        :ARG1 (r4 / receptor
                            :name (n5 / name :op1 ""transferrin"")
                            :mod (n6 / number :value 14)))))
        :ARG1-of (i2 / internalize-01
            :manner (f3 / fashion
                :mod (l / ligand-dependent))
            :ARG0 (a2 / all))))",-1.0,0.2644628099173554
bel_pmid_1019_4465.23382,"Since an inhibitor against SERCA induces apoptosis in some cell lines (76), the IRS/SERCA complex might be involved in an insulin and IGF-1-dependent antiapoptotic effect.","(c / cause-01
    :ARG0 (i / induce-01
        :ARG0 (i2 / inhibit-01
            :ARG1 (s / small-molecule
                :name (n / name
                    :op1 ""IRS"")))
        :ARG2 (a / apoptosis)
        :location (l / line
            :mod (c2 / cell)
            :mod (s2 / some)))
    :ARG1 (p / possible-01
        :ARG1 (i4 / involve-01
            :ARG1 (c4 / complex
                :mod s)
            :ARG2 (t / thing
                :ARG0-of (d / depend-01
                    :ARG1 (p2 / protein
                        :name (n3 / name
                            :op1 ""insulin""
                            :op2 1)))
                :ARG0-of (i3 / inhibit-01))
            :ARG2 (e / effect-03
                :ARG0 c4
                :ARG1 t)))
    :ARG1-of (d2 / describe-01
        :ARG0 (p3 / publication
            :ARG1-of (c3 / cite-01
                :ARG2 76)))
    :rel (n2 / name
        :op1 ""SERCA""))
",test,bio_amr0.8,"(c / cause-01
      :ARG0 (i2 / induce-01
            :ARG0 (m2 / molecular-physical-entity
                  :ARG0-of (i / inhibit-01
                        :ARG1 (p2 / protein :name (n / name :op1 ""SERCA""))))
            :ARG2 (a / apoptosis)
            :ARG1-of (d / describe-01
                  :ARG0 (p3 / publication
                        :ARG1-of (c4 / cite-01
                              :ARG2 76)))
            :location (c3 / cell-line
                  :mod (s / some)))
      :ARG1 (p / possible-01
            :ARG1 (i3 / involve-01
                  :ARG1 (m / macro-molecular-complex
                        :part (p4 / protein :name (n2 / name :op1 ""IRS""))
                        :part p2)
                  :ARG2 (a2 / affect-01
                        :ARG2 (c2 / counter-01
                              :ARG1 (a5 / apoptosis))
                        :ARG0-of (d2 / depend-01
                              :ARG1 (a4 / and
                                    :op1 (p5 / protein :name (n3 / name :op1 ""insulin""))
                                    :op2 (p6 / protein :name (n5 / name :op1 ""IGF-1""))))))))","Since an inhibitor against SERCA induces apoptosis in some cell lines (76), the IRS/SERCA complex might be involved in an insulin and IGF-1-dependent antiapoptotic effect.","(z1 / cause-01
    :ARG0 (z2 / induce-01
              :ARG0 (z3 / inhibitor
                        :ARG0-of (z4 / counter-01
                                     :ARG1 (z5 / small-molecule
                                               :wiki ""Selective_serotonin_reuptake_inhibitor""
                                               :name (z6 / name
                                                         :op1 ""SERCA""))))
              :ARG1 (z7 / apoptosis)
              :location (z8 / line
                            :mod (z9 / cell)
                            :mod (z10 / some))
              :ARG1-of (z11 / describe-01
                            :ARG0 (z12 / publication
                                       :ARG1-of (z13 / cite-01
                                                     :ARG2 76))))
    :ARG1 (z14 / possible-01
               :ARG1 (z15 / involve-01
                          :ARG1 (z16 / complex
                                     :mod (z17 / slash
                                               :op1 (z18 / small-molecule
                                                         :wiki ""IRS""
                                                         :name (z19 / name
                                                                    :op1 ""IRS""))
                                               :op2 z5))
                          :ARG2 (z20 / affect-01
                                     :ARG0 z16
                                     :ARG2 (z21 / counter-01
                                                :ARG1 z7
                                                :ARG0-of (z22 / depend-01
                                                              :ARG1 (z23 / and
                                                                         :op1 (z24 / insulin)
                                                                         :op2 (z25 / small-molecule
                                                                                   :wiki ""IGF-1""
                                                                                   :name (z26 / name
                                                                                              :op1 ""IGF-1"")))))))))",0.6499999999999999,0.5272727272727272,"(s / since
        :op1 (i / induce-01
              :ARG1 (a / apoptosis)
              :ARG2 (l / line
                    :mod (c / cell))
              :ARG3 (i2 / inhibitor
                    :mod (s2 / serca)))
        :op2 (i3 / involve-01
              :ARG0 (c2 / complex
                    :mod (i4 / irs/serca))
              :ARG1 (e / effect
                    :mod (a2 / antiapoptotic)
                    :ARG1-of (d / dependent-02
                          :ARG1 (i5 / insulin)
                          :ARG2 (i6 / igf-1)))))","(i / induce-01
    :ARG0 (i2 / inhibitor
        :ARG1-of (a / against-01
            :ARG1 (s / protein :name (n / name :op1 ""SERCA""))))
    :ARG1 (a2 / apoptosis)
    :location (c / cell-line
        :quant (s2 / some))
    :time (s3 / since)
    :condition (c2 / complex
        :consist-of (i3 / IRS)
        :consist-of s
        :ARG1-of (m / might-01
            :ARG1 (i4 / involve-01
                :ARG0 c2
                :ARG1 (e / effect
                    :mod (a3 / antiapoptotic)
                    :ARG1-of (d / depend-01
                        :ARG1 (i5 / insulin)
                        :ARG2 (i6 / IGF-1))))))",-1.0,0.3298969072164948
bel_pmid_1019_4465.23766,"The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.","(m3 / multi-sentence
    :rel (s / several
        :op2 (p4 / protein
            :ord (s4 / string-entity
                :value ""IP3"")))
    :rel (p2 / presume-01)
    :snt1 (c2 / contrast-01
        :ARG1 (k / know-01
            :ARG1 (e / enzyme
                :ARG0-of (t / target-01
                    :ARG1 (p3 / protein
                        :name (n / name
                            :op1 2)
                        :ARG2-of (e7 / express-03))
                    :ARG1 (l / law
                        :name (n5 / name
                            :op2 ""low""
                            :op3 ""after""
                            :op4 ""year""
                            :op5 1)))
                :mod (p / physiology))
            :polarity -)
        :ARG2 (m2 / moderate-01
            :ARG0 e7
            :ARG1 (a3 / and
                :op1 (b / bond-01
                    :ARG1 (c / cell))
                :op2 (m / migrate-01
                    :ARG1 c)
                :op3 (a / activate-01
                    :ARG0 (i2 / insulin)
                    :ARG1 (e2 / enzyme
                        :name (n2 / name
                            :op1 ""Ras"")
                        :mod (e3 / enzyme
                            :name (n3 / name
                                :op1 ""fund""
                                :op2 ""pathway"")))))))
    :snt2 (s3 / show-01
        :ARG1 (a5 / associate-01
            :ARG1 (a4 / and
                :op1 (e4 / enzyme
                    :name (n4 / name
                        :op1 ""IP3""
                        :op1 ""RXRXXpS"")
                    :mod (s5 / string-entity
                        :value ""E""
                        :value ""z""))
                :op2 e4)
            :ARG2 (r / region
                :name n5
                :ARG1-of (i / include-91
                    :ARG2 (e5 / enzyme
                        :quant (s2 / several)
                        :part-of ""fund""
                        :part-of l))
                :domain e4
                :part-of (e6 / enzyme
                    :name n5)))
        :mod (a2 / also)))
",test,bio_amr0.8,"(m3 / multi-sentence
      :snt1 (c / contrast-01
            :ARG1 (k / know-01 :polarity -
                  :ARG1 (s / substrate
                        :mod (p2 / physiology)
                        :topic (p3 / protein :name (n2 / name :op1 ""SHP-2""))))
            :ARG2 (a / and
                  :op1 (m / modulate-01
                        :ARG0 (o / overexpress-01
                              :ARG1 p3)
                        :ARG1 (a4 / and
                              :op1 (a2 / and
                                    :op1 (a3 / adhere-01
                                          :ARG1 (c2 / cell))
                                    :op2 (m2 / migrate-01
                                          :ARG0 c2))
                              :op2 (a5 / activate-01
                                    :ARG0 (i3 / insulin)
                                    :ARG1 (p4 / pathway :name (n3 / name :op1 ""Ras/MAP-kinase"")))))))
      :snt2 (s2 / show-01
            :ARG1 (a8 / associate-01
                  :ARG1 (i / isoform
                        :mod (p / protein :name (n / name :op1 ""14-3-3""))
                        :ARG1-of (d / describe-01
                              :ARG2 (a7 / and
                                    :op1 (p5 / protein :name (n4 / name :op1 ""14-3-3β""))
                                    :op2 (p8 / protein :name (n5 / name :op1 ""14-3-3ε""))
                                    :op3 (p9 / protein :name (n8 / name :op1 ""14-3-3ζ""))))
                        :quant (s3 / several))
                  :ARG2 (p6 / protein :name (n6 / name :op1 ""IRS-1""))
                  :instrument (m5 / motif
                        :ARG1-of (i2 / include-91
                              :ARG2 (m4 / motif :name (n7 / name :op1 ""RXRXXpS"")
                                    :part-of p6))
                        :ARG1-of (p7 / presume-01)))
            :mod (a6 / also)))","The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.","(z1 / contrast-01
    :ARG1 (z2 / know-01
              :polarity -
              :ARG1 (z3 / thing
                        :ARG2-of (z4 / catalyze-01
                                     :ARG1 (z5 / protein
                                               :wiki ""Selective_serotonin_reuptake_inhibitor""
                                               :name (z6 / name
                                                         :op1 ""SHP-2""))
                                     :mod (z7 / physiology))))
    :ARG2 (z8 / show-01
              :ARG1 (z9 / associate-01
                        :ARG1 (z10 / protein
                                   :mod (z11 / isoform
                                             :quant (z12 / several)
                                             :example (z13 / and
                                                           :op1 (z14 / protein
                                                                     :wiki ""BRAF-14""
                                                                     :name (z15 / name
                                                                                :op1 ""b""))
                                                           :op2 (z16 / protein
                                                                     :wiki ""E""
                                                                     :name (z17 / name
                                                                                :op1 ""e""))
                                                           :op3 (z18 / protein
                                                                     :wiki ""Z""
                                                                     :name (z19 / name
                                                                                :op1 ""z"")))))
                        :ARG2 (z20 / protein
                                   :wiki ""IRS-1""
                                   :name (z21 / name
                                              :op1 ""IRS-1"")
                                   :part z24)
                        :manner (z22 / motif
                                     :quant 1
                                     :ARG1-of (z23 / include-91
                                                   :ARG2 (z24 / motif
                                                              :wiki ""RXRXXpS""
                                                              :name (z25 / name
                                                                         :op1 ""RXRXXpS"")
                                                              :quant (z26 / several))))))
    :mod (z27 / also))",0.3558282208588957,0.387434554973822,"(m / multi-sentence
        :snt1 (k / know-01
            :ARG1 (s / substrate
                  :mod (p / physiological))
            :ARG0 (n / not))
        :snt2 (m2 / modulate-01
            :ARG0 (o / overexpression)
            :ARG1 (s2 / SHP-2)
            :ARG2 (a / adhesion)
            :ARG2 (m3 / migration))
        :snt3 (a2 / associate-01
            :ARG0 (s3 / show-01
                  :ARG1 (i / isoform)
                  :ARG2 (p2 / protein
                        :mod (n2 / name :op1 ""14-3-3"")
                        :mod (b / b)
                        :mod (e / e)
                        :mod (z / z))))
            :ARG1 (w / with
                  :ARG2 (i2 / IRS-1
                        :mod (p3 / presumably)
                        :mod (m4 / motif
                              :mod (r / RXRXXpS)
                              :mod (s4 / several))))))","(p / physiological-01
    :ARG1 (s / substrate
        :mod (s2 / SHP-2))
    :ARG1-of (k / know-01 :polarity -)
    :ARG1-of (c / contrast-01
        :ARG2 (m / multi-sentence
            :snt1 (o / overexpression
                :ARG1 s2
                :ARG1-of (m2 / modulate-01
                    :ARG2 (a / and
                        :op1 (c2 / cell-adhesion)
                        :op2 (m3 / migration-01))
                    :ARG1-of (a2 / as-well-as
                        :op1 (a3 / activate-01
                            :ARG0 (i / insulin)
                            :ARG1 (p2 / pathway
                                :mod (r / Ras/MAP-kinase)))))
            :snt2 (h / have-org-role-91
                :ARG0 (i2 / isoform
                    :mod (p3 / protein
                        :name (n / name :op1 ""14-3-3"")))
                :ARG1 (a4 / associate-01
                    :ARG0 i2
                    :ARG1 (i3 / IRS-1)
                    :ARG1-of (p4 / presume-01
                        :ARG2 (o2 / one
                            :quant (s3 / several)
                            :mod (m4 / motif
                                :mod (r2 / RXRXXpS)
                                :part-of i3)))
                :ARG2 (a5 / and
                    :op1 (b / b)
                    :op2 (e / e)
                    :op3 (z / z))))))",-1.0,-1.0
bel_pmid_1019_4465.23788,"Recently, b1 integrins have also been reported to enhance IRS-1 phosphorylation and interaction, but not glucose transport, with downstream molecules such as PI3-kinase and Akt (74). These results suggest that integrins and insulin/IGF-1 receptor signaling pathways converge at an early point in the signaling cascade around the IRS proteins.","(m3 / multi-sentence
    :rel (p2 / phosphorylate-01
        :ARG1 (s3 / slash
            :op1 (i / insulin)
            :op2 (p8 / protein
                :name (n6 / name
                    :op1 ""enough""
                    :op1 ""i""))))
    :rel (n2 / name
        :op1 ""way""
        :op2 (p4 / politics
            :name (n7 / name
                :op1 ""IRS""))
        :op3 ""cell"")
    :snt1 (r2 / report-01
        :ARG1 (c3 / contrast-01
            :ARG1 (e2 / enhance-01
                :ARG0 (p5 / protein
                    :name (n / name
                        :op1 ""b1""))
                :ARG1 (a2 / and
                    :op1 (p / phosphorylate-01
                        :ARG1 ""way"")
                    :op2 (i2 / interact-01
                        :ARG0 p5
                        :ARG2 ""way""
                        :ARG3 (m2 / molecule
                            :example (a3 / and
                                :op1 (e4 / enzyme
                                    :name (n3 / name
                                        :op1 ""PI3""
                                        :op2 ""kinase""))
                                :op2 (p6 / protein
                                    :name (n4 / name
                                        :op1 ""Akt"")))
                            :mod (d2 / downstream)))))
            :ARG2 (e3 / enhance-01
                :ARG0 p5
                :ARG1 (t3 / transport-01
                    :ARG1 (g / glucose))
                :polarity -))
        :ARG1-of (d / describe-01
            :ARG0 (p10 / publication
                :ARG1-of (c2 / cite-01
                    :ARG2 74)))
        :mod (a / also)
        :time (r / recent))
    :snt2 (s4 / suggest-01
        :ARG0 (t / thing
            :ARG2-of (r3 / result-01)
            :mod (t2 / this))
        :ARG1 (c4 / converge-01
            :ARG0 (a4 / and
                :op1 (p7 / protein
                    :name (n5 / name))
                :op2 (m / mechanism
                    :ARG0-of (s / signal-07)
                    :mod s3))
            :time (p3 / point
                :mod (e / early)
                :part-of (c / cascade
                    :ARG0-of (s2 / signal-07)
                    :location (a5 / around
                        :op1 (p9 / protein
                            :mod ""way"")))))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (r / report-01
            :ARG1 (c / contrast-01
                  :ARG1 (e / enhance-01
                        :ARG0 (p12 / protein :name (n / name :op1 ""b1"" :op2 ""integrin""))
                        :ARG1 (a / and
                              :op1 (p3 / phosphorylate-01
                                    :ARG1 (p4 / protein :name (n2 / name :op1 ""IRS-1"")))
                              :op2 (i / interact-01
                                    :ARG0 p4
                                    :ARG1 (m2 / molecule
                                          :mod (d / downstream)
                                          :example (a2 / and
                                                :op1 (e3 / enzyme :name (n4 / name :op1 ""PI3-kinase""))
                                                :op2 (e5 / enzyme :name (n5 / name :op1 ""Akt"")))))))
                  :ARG2 (e2 / enhance-01 :polarity -
                        :ARG0 (t2 / transport-01
                              :ARG1 (s4 / small-molecule :name (n3 / name :op1 ""glucose"")))
                        :ARG1 a))
            :time (r2 / recent)
            :ARG1-of (d2 / describe-01
                  :ARG0 (p6 / publication
                        :ARG1-of (c2 / cite-01
                              :ARG2 74)))
            :mod (a5 / also))
      :snt2 (s / suggest-01
            :ARG0 (t3 / thing
                  :ARG2-of (r3 / result-01)
                  :mod (t / this))
            :ARG1 (c3 / converge-01
                  :ARG0 (p10 / protein :name (n8 / name :op1 ""integrin""))
                  :ARG1 (p9 / pathway :name (n6 / name :op1 ""insulin/IGF-1"" :op2 ""receptor"")
                        :ARG0-of (s3 / signal-07
                              :mod (r5 / receptor)))
                  :time (p7 / point
                        :mod (e4 / early)
                        :subevent-of (c4 / cascade
                              :subevent (s2 / signal-07)
                              :location (a4 / around
                                    :op1 (p8 / protein :name (n7 / name :op1 ""IRS""))))))))","Recently, b1 integrins have also been reported to enhance IRS-1 phosphorylation and interaction, but not glucose transport, with downstream molecules such as PI3-kinase and Akt (74). These results suggest that integrins and insulin/IGF-1 receptor signaling pathways converge at an early point in the signaling cascade around the IRS proteins.","(z1 / report-01
    :ARG1 (z2 / contrast-01
              :ARG1 (z3 / enhance-01
                        :ARG0 (z4 / integrin
                                  :mod (z5 / molecular-physical-entity
                                           :wiki ""BRAF1""
                                           :name (z6 / name
                                                     :op1 ""b1"")))
                        :ARG1 (z7 / and
                                  :op1 (z8 / phosphorylate-01
                                           :ARG1 (z9 / protein
                                                     :wiki ""IRS-1""
                                                     :name (z10 / name
                                                                :op1 ""IRS-1"")))
                                  :op2 (z11 / interact-01
                                            :ARG0 z4
                                            :ARG1 (z12 / molecule
                                                       :example (z13 / and
                                                                     :op1 (z14 / enzyme
                                                                               :wiki ""PHLDA3_kinase""
                                                                               :name (z15 / name
                                                                                          :op1 ""PI3-kinase""))
                                                                     :op2 (z16 / enzyme
                                                                               :wiki ""Akt""
                                                                               :name (z17 / name
                                                                                          :op1 ""Akt"")))))))
              :ARG2 (z18 / enhance-01
                         :polarity -
                         :ARG0 z4
                         :ARG1 (z19 / transport-01
                                    :ARG1 (z20 / glucose))
                         :ARG2 z12))
    :time (z21 / recent)
    :mod (z22 / also))",0.4125,0.5925925925925927,"(m / multi-sentence
        :snt1 (r / report-01
            :ARG0 (i / integrin
                  :mod (b1 / b1))
            :ARG1 (e / enhance-01
                  :ARG0 i
                  :ARG1 (p / phosphorylation
                        :ARG1 (i2 / IRS-1)))
            :ARG1-of (r2 / result
                  :ARG1 (s / suggest-01
                        :ARG1 (c / converge-01
                              :ARG1 (p2 / point
                                    :mod (e2 / early))
                              :ARG2 (c2 / cascade
                                    :mod (s2 / signaling)
                                    :ARG1 (p3 / protein
                                          :mod (i3 / IRS))))
                        :ARG2 (p4 / pathway
                              :mod (s3 / signaling)
                              :mod (i4 / insulin/IGF-1)
                              :ARG1 (r3 / receptor))))
            :ARG2 (m2 / molecule
                  :mod (d / downstream)
                  :mod (s4 / such-as
                        :op1 (p5 / PI3-kinase)
                        :op2 (a / Akt))))
        :snt2 (s5 / suggest-01
            :ARG1 (r4 / result
                  :ARG1 (c3 / converge-01
                        :ARG1 (p6 / point
                              :mod (e3 / early))
                        :ARG2 (c4 / cascade
                              :mod (s6 / signaling)
                              :ARG1 (p7 / protein
                                    :mod (i5 / IRS))))
                  :ARG2 (p8 / pathway
                        :mod (s7 / signaling)
                        :mod (i6 / insulin/IGF-1)
                        :ARG1 (r5 / receptor))))
            :ARG2 (p9 / point
                  :mod (a2 / around)
                  :ARG1 (c5 / cascade
                        :mod (s8 / signaling)
                        :ARG1 (p10 / protein
                              :mod (i7 / IRS))))))","(r / report-01 :mode recent
    :ARG1 (e / enhance-01
        :ARG0 (i / integrin :name (n / name :op1 ""b1""))
        :ARG1 (p / phosphorylate-01
            :ARG0 i
            :ARG1 (p2 / protein :name (n2 / name :op1 ""IRS-1"")))
        :ARG2 (i2 / interact-01
            :ARG0 i
            :ARG1 p2)
        :ARG3 (m / molecule
            :mod (d / downstream)
            :example (p3 / protein :name (n3 / name :op1 ""PI3-kinase""))
            :example (p4 / protein :name (n4 / name :op1 ""Akt""))))
    :ARG2 (t / transport-01 :polarity -
        :ARG1 (g / glucose))
    :ARG3 (c / contrast-01
        :ARG1 e
        :ARG2 t))
(s / suggest-01
    :ARG0 r
    :ARG1 (c2 / converge-01
        :ARG1 (p5 / pathway
            :mod (s2 / signaling)
            :mod (r2 / receptor
                :mod (i3 / insulin)
                :mod (i4 / IGF-1)))
        :ARG2 (p6 / protein
            :mod (i5 / IRS)
            :mod (s3 / signaling)
            :mod (c3 / cascade
                :location (a / around)))
        :ARG3 (i6 / integrin)
        :time (e2 / early)
        :location (p7 / point)))",-1.0,0.4022346368715084
bel_pmid_1022_8560.5928,"Inhibition of MEK1 also led to reduced expression of alpha-enolase, phosphoglycerate kinase, elongation factor 2 and heterogeneous nuclear ribonucleoprotein A3, the latter two being detected as truncated proteins.","(l / lead-03
    :ARG0 (i / inhibit-01
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""MEK1"")))
    :ARG2 (r / reduce-01
        :ARG1 (e4 / express-03
            :ARG1 (a2 / and
                :ARG1-of (d / detect-01
                    :ARG3 (p / protein
                        :ARG1-of (t / truncate-01)))
                :op1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""vitamin""
                        :op2 ""enolase""))
                :op2 (e3 / enzyme
                    :name (n3 / name
                        :op1 ""phosphoglycerate""
                        :op2 ""kinase""))
                :op3 (v / variable
                    :name (n5 / name
                        :op1 ""nuclear""
                        :op2 ""ribonucleoprotein""
                        :op3 ""A3"")))))
    :mod (a / also)
    :rel (n4 / name
        :op1 ""elongation""
        :op2 ""factor""
        :op3 ""2"")
    :rel (h / heterogeneous))
",test,bio_amr0.8,"(l / lead-03
      :ARG0 (i / inhibit-01
            :ARG1 (e / enzyme :name (n / name :op1 ""MEK1"")))
      :ARG2 (e2 / express-03
            :ARG1 (a / and
                  :op1 (e3 / enzyme :name (n2 / name :op1 ""alpha-enolase""))
                  :op2 (e4 / enzyme :name (n3 / name :op1 ""phosphoglycerate"" :op2 ""kinase""))
                  :op3 (p / protein :name (n4 / name :op1 ""elongation"" :op2 ""factor"" :op3 ""2"")
                        :ARG0-of (d / detect-01
                              :ARG1 (p3 / protein
                                    :ARG1-of (t / truncate-01))
                              :ord (o / ordinal-entity :value ""-2"")))
                  :op4 (p2 / protein :name (n5 / name :op1 ""heterogeneous"" :op2 ""nuclear"" :op3 ""ribonucleoprotein"" :op4 ""A3"")
                        :ARG0-of d))
            :ARG1-of (r / reduce-01))
      :mod (a2 / also))","Inhibition of MEK1 also led to reduced expression of alpha-enolase, phosphoglycerate kinase, elongation factor 2 and heterogeneous nuclear ribonucleoprotein A3, the latter two being detected as truncated proteins.","(z1 / lead-03
    :ARG0 (z2 / inhibit-01
              :ARG1 (z3 / enzyme
                        :wiki ""Mitogen-activated_protein_kinase_1""
                        :name (z4 / name
                                  :op1 ""MEK1"")))
    :ARG2 (z5 / reduce-01
              :ARG1 (z6 / express-03
                        :ARG1 (z7 / and
                                  :op1 (z8 / enzyme
                                           :wiki ""Alfaenolase""
                                           :name (z9 / name
                                                     :op1 ""alpha-enolase""))
                                  :op2 (z10 / kinase
                                            :wiki ""phosphoglycerate_kinase""
                                            :name (z11 / name
                                                       :op1 ""phosphoglycerate""
                                                       :op2 ""kinase""))
                                  :op3 (z12 / enzyme
                                            :wiki ""Extracellular_signal-regulated_factor_2""
                                            :name (z13 / name
                                                       :op1 ""elongation""
                                                       :op2 ""factor""
                                                       :op3 2))
                                  :op4 (z14 / protein
                                            :wiki ""BRAF-3""
                                            :name (z15 / name
                                                       :op1 ""ribonucleoprotein""
                                                       :op2 ""A3"")
                                            :mod (z16 / nucleus)
                                            :mod (z17 / heterogeneous)
                                            :ARG1-of (z18 / detect-01
                                                          :ARG2 (z19 / protein
                                                                     :ARG1-of (z20 / truncate-01)
                                                                     :domain z14)))))))",0.537037037037037,0.5294117647058822,"(m / multi-sentence
        :snt1 (l / lead-01
            :ARG0 (i / inhibition
                  :ARG1 (m2 / MEK1))
            :ARG1 (r / reduce-01
                  :ARG1 (e / expression
                        :ARG1 (a / alpha-enolase)
                        :ARG1 (k / kinase
                              :ARG1 (p / phosphoglycerate)
                              :ARG2 (e2 / elongation-factor-2)
                              :ARG1 (h / heterogeneous
                                    :ARG1 (n / nuclear-ribonucleoprotein-A3)
                                    :ARG1 (d / detect-01
                                          :ARG1 (p2 / protein
                                                :mod (t / truncate-01))))))))
        :snt2 (d / detect-01
            :ARG1 (p3 / protein
                  :mod (t2 / truncate-01))))","(i / inhibit-01
    :ARG1 (m / MEK1)
    :ARG2 (l / lead-01
        :ARG0 m
        :ARG1 (r / reduce-01
            :ARG0 l
            :ARG1 (e / express-01
                :ARG0 (a / alpha-enolase)
                :ARG1 (p / phosphoglycerate-kinase)
                :ARG2 (e2 / elongation-factor-2)
                :ARG3 (h / heterogeneous-nuclear-ribonucleoprotein-A3)
                :mod (t / truncate-01
                    :ARG1 (a2 / and
                        :op1 e2
                        :op2 h)
                    :ARG0-of (d / detect-01
                        :ARG1 (t2 / two
                            :mod (l2 / latter))))))))",-1.0,0.2117647058823529
bel_pmid_1023_2608.16572,expression of MLK3 strongly activated SAPK? to the same extent seen with the established JNK/SAPK activator arsenite (45),"(a / activate-01
    :ARG0 (e3 / express-01
        :ARG1 (p / person
            :name (n / name
                :op1 ""MLK3"")))
    :ARG1 (e / enzyme
        :name (n2 / name
            :op1 ""SAPK""))
    :ARG1-of (s3 / strong-02)
    :ARG1-of (s / same-01
        :ARG2 (a2 / activate-01
            :ARG0 (a4 / arsenite
                :ARG1-of (e2 / establish-01)
                :mod (s2 / slash
                    :op1 (t / thing
                        :name (n3 / name
                            :op1 ""JNK""))
                    :op2 (p2 / product
                        :name (n4 / name
                            :op1 ""activator""))))))
    :ARG1-of (d / describe-01
        :ARG0 (p3 / publication
            :ARG1-of (c / cite-01
                :ARG2 45)))
    :polarity (a3 / amr-unknown))
",test,bio_amr0.8,"(a / activate-01
      :ARG0 (e / express-03
            :ARG2 (e2 / enzyme :name (n / name :op1 ""MLK3"")))
      :ARG1 (e4 / enzyme :name (n2 / name :op1 ""SAPK""))
      :ARG1-of (s / strong-02)
      :extent (s2 / see-01
            :ARG1 (a2 / arsenite
                  :ARG0-of (a3 / activate-01
                        :ARG1 (p2 / pathway :name (n3 / name :op1 ""JNK/SAPK"")))
                  :ARG1-of (e3 / establish-01))
            :ARG1-of (s3 / same-01))
      :ARG1-of (d / describe-01
            :ARG0 (p3 / publication
                  :ARG1-of (c / cite-01
                        :ARG2 45))))",expression of MLK3 strongly activated SAPK? to the same extent seen with the established JNK/SAPK activator arsenite (45),"(z1 / activate-01
    :ARG0 (z2 / express-03
              :ARG1 (z3 / enzyme
                        :wiki ""Mitogen-activated_protein_kinase_kinase_3""
                        :name (z4 / name
                                  :op1 ""MLK3"")))
    :ARG1 (z5 / enzyme
              :wiki ""Specific_enzyme""
              :wiki ""Sulfuric_acid""
              :name (z6 / name
                        :op1 ""SAPK""))
    :polarity (z7 / amr-unknown)
    :ARG1-of (z8 / strong-02)
    :ARG1-of (z9 / same-01
                 :ARG2 (z10 / activate-01
                            :ARG0 (z11 / arsenite
                                       :ARG0-of (z12 / activate-01
                                                     :ARG1 (z13 / enzyme
                                                                :wiki ""JNK""
                                                                :name (z14 / name
                                                                           :op1 ""JNK"")))
                                       :ARG0-of (z15 / activate-01
                                                     :ARG1 z5)
                                       :ARG1-of (z16 / establish-01))
                            :ARG1-of (z17 / describe-01
                                          :ARG0 (z18 / publication
                                                     :ARG1-of (z19 / cite-01
                                                                   :ARG2 45))))
                 :degree (z20 / extent)))",0.5517241379310346,0.5542168674698796,"(e / expression-01
        :ARG0 (m / mlk3)
        :ARG1 (a / activate-01
              :ARG0 m
              :ARG1 (s / sapk)
              :degree (e2 / extent
                    :ARG1 (s2 / same)
                    :ARG2 (s3 / see-01
                          :ARG1 (w / with
                                :op1 (a2 / activator
                                      :ARG0 (j / jnk/sapk)
                                      :ARG1 (a3 / arsenite)
                                      :degree (e3 / establish-01))))))","(e / express-01
    :ARG1 (m / molecule :name (n / name :op1 ""MLK3""))
    :ARG2 (a / activate-01
        :ARG0 m
        :ARG1 (s / molecule :name (n2 / name :op1 ""SAPK""))
        :degree (s2 / strong)
        :time (w / when
            :op1 (s3 / see-01
                :ARG1 (e2 / extent
                    :mod (s4 / same))
                :ARG0 (a2 / activate-01
                    :ARG0 (m2 / molecule :name (n3 / name :op1 ""JNK"" :op2 ""/"" :op3 ""SAPK""))
                    :ARG1 s
                    :ARG2 (m3 / molecule :name (n4 / name :op1 ""arsenite""))
                    :degree (e3 / establish-01)))
            :op2 (n5 / number :value 45))))",-1.0,0.36144578313253
bel_pmid_1034_3541.46,"Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation","(p / possible-01
    :ARG1 (a3 / and
        :op1 (i2 / induce-01
            :ARG0 (t / transmit-01
                :ARG1 (s / signal-07)
                :ARG1-of (s4 / stimulate-01
                    :ARG0 (e / enzyme
                        :name (n2 / name
                            :op1 ""Thrombin""
                            :op2 ""receptor""))))
            :ARG1 (e4 / express-01
                :ARG0 (a2 / and
                    :op1 (e2 / enzyme
                        :name (n / name
                            :op1 ""IL6""))
                    :op2 (s2 / small-molecule
                        :name (n4 / name)
                        :name (n5 / name
                            :op1 ""CHO-K1""
                            :op1 ""histidine-rich""
                            :op2 ""B"")))))
        :op2 (i / increase-01
            :ARG0 t
            :ARG1 (e3 / event
                :ARG0-of (i3 / inflame-01)
                :location (c / cavum
                    :part-of (a4 / articulare))
                :manner (a / activate-01
                    :ARG1 (s3 / small-molecule
                        :name n5)))))
    :rel (n3 / name
        :op1 ""G-8""
        :op2 ""CSF"")
    :rel (n6 / name))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (a / and
            :op1 (i / induce-01
                  :ARG0 (t / transduce-01
                        :ARG1 (s / signal-07)
                        :ARG1-of (m / mediate-01
                              :ARG0 (r / receptor :name (n / name :op1 ""thrombin""))))
                  :ARG2 (e / express-03
                        :ARG2 (a2 / and
                              :op1 (p2 / protein :name (n2 / name :op1 ""IL6""))
                              :op2 (p3 / protein :name (n3 / name :op1 ""G-CSF"")))))
            :op2 (i2 / increase-01
                  :ARG0 t
                  :ARG1 (e2 / event
                        :mod (i3 / inflame-01))
                  :location (c / cavum
                        :mod (a3 / articulare))
                  :manner (a4 / activate-01
                        :ARG1 (p4 / protein :name (n4 / name :op1 ""NF-kappa-B""))))))","Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-kappa B activation","(z1 / possible-01
    :ARG1 (z2 / and
              :op1 (z3 / induce-01
                       :ARG0 (z4 / transduction-01
                                 :ARG1 (z5 / signal)
                                 :instrument-of (z6 / mediate-01
                                                    :ARG0 (z7 / receptor
                                                              :wiki ""Thrombin_receptor""
                                                              :name (z8 / name
                                                                        :op1 ""Thrombin""
                                                                        :op2 ""receptor""))))
                       :ARG1 (z9 / express-01
                                 :ARG1 (z10 / and
                                            :op1 (z11 / small-molecule
                                                      :wiki ""Inositol_trisphosphate_receptor""
                                                      :name (z12 / name
                                                                 :op1 ""IL6""))
                                            :op2 (z13 / small-molecule
                                                      :wiki ""G-CSF""
                                                      :name (z14 / name
                                                                 :op1 ""G-CSF"")))))
              :op2 (z15 / increase-01
                        :ARG0 z4
                        :ARG1 (z16 / event
                                   :ARG0-of (z17 / inflame-01)
                                   :location (z18 / cavum
                                                  :mod (z19 / articulare)))
                        :manner (z20 / activate-01
                                     :ARG1 (z21 / enzyme
                                                :wiki ""NF-kappaB""
                                                :name (z22 / name
                                                           :op1 ""NF-kappa""
                                                           :op2 ""B""))))))",0.5576923076923076,0.5794392523364486,"(s / signal-01
        :ARG0 (t / thrombin-receptor)
        :ARG1 (m / mediate-01
              :ARG0 t
              :ARG1 (t2 / transduction
                    :ARG1 (i / induce-01
                          :ARG0 t2
                          :ARG1 (e / expression-01
                                :ARG0 (i2 / IL6))
                          :ARG1 (e2 / expression-01
                                :ARG0 (g / G-CSF))))
              :ARG1 (i2 / increase-01
                    :ARG0 t2
                    :ARG1 (e3 / event
                          :ARG1-of (i3 / inflammatory
                                :ARG0 (c / cavum-articulare))))
              :ARG1 (a / activate-01
                    :ARG0 (n / NF-kappa-B))))","(t / transduce-01
    :ARG0 (r / receptor
        :mod (t2 / thrombin))
    :ARG1 (s / signal)
    :ARG2 (i / induce-01
        :ARG1 (e / express-01
            :ARG1 (a / and
                :op1 (i2 / IL6)
                :op2 (g / G-CSF))))
    :ARG2 (i3 / increase-01
        :ARG1 (e2 / event
            :mod (i4 / inflammatory))
        :location (c / cavum-articulare))
    :instrument (a2 / activate-01
        :ARG1 (n / NF-kappa-B)))",-1.0,0.3291139240506329
bel_pmid_1034_3541.18504,"Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-êB activation","(p / possible-01
    :ARG1 (a3 / and
        :op1 (i2 / induce-01
            :ARG0 (t / transmit-01
                :ARG1 (s / signal-07)
                :ARG1-of (s3 / stimulate-01
                    :ARG0 (e / enzyme
                        :name (n2 / name
                            :op1 ""Thrombin""
                            :op2 ""receptor"")
                        :name (n6 / name
                            :op1 ""Thrombin""
                            :op2 ""receptor""))))
            :ARG1 (e4 / express-01
                :ARG0 (a2 / and
                    :op1 (e2 / enzyme
                        :name (n / name
                            :op1 ""IL6""))
                    :op2 (s2 / small-molecule
                        :name (n4 / name
                            :op1 ""wealth""
                            :op1 ""white""
                            :op2 ""histidine-rich"")
                        :name (n5 / name
                            :op1 ""oh"")))))
        :op2 (i / increase-01
            :ARG0 t
            :ARG1 (e3 / event
                :ARG0-of (i3 / inflame-01)
                :location (c / cavum
                    :part-of (a4 / articulare))
                :manner (a / activate-01
                    :ARG1 s2))))
    :rel (n3 / name))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (a / and
            :op1 (i / induce-01
                  :ARG0 (t / transduce-01
                        :ARG1 (s / signal-07)
                        :ARG1-of (m / mediate-01
                              :ARG0 (r / receptor :name (n / name :op1 ""thrombin""))))
                  :ARG2 (e / express-03
                        :ARG2 (a2 / and
                              :op1 (p2 / protein :name (n2 / name :op1 ""IL6""))
                              :op2 (p3 / protein :name (n3 / name :op1 ""G-CSF"")))))
            :op2 (i2 / increase-01
                  :ARG0 t
                  :ARG1 (e2 / event
                        :mod (i3 / inflame-01))
                  :location (c / cavum
                        :mod (a3 / articulare))
                  :manner (a4 / activate-01
                        :ARG1 (p4 / protein :name (n4 / name :op1 ""NF-κB""))))))","Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-êB activation","(z1 / possible-01
    :ARG1 (z2 / and
              :op1 (z3 / induce-01
                       :ARG0 (z4 / transduction-01
                                 :ARG1 (z5 / signal)
                                 :instrument-of (z6 / mediate-01
                                                    :ARG0 (z7 / receptor
                                                              :wiki ""Thrombin_receptor""
                                                              :name (z8 / name
                                                                        :op1 ""Thrombin""
                                                                        :op2 ""receptor""))))
                       :ARG1 (z9 / express-01
                                 :ARG1 (z10 / and
                                            :op1 (z11 / small-molecule
                                                      :wiki ""Inositol_trisphosphate_receptor""
                                                      :name (z12 / name
                                                                 :op1 ""IL6""))
                                            :op2 (z13 / small-molecule
                                                      :wiki ""G-CSF""
                                                      :name (z14 / name
                                                                 :op1 ""G-CSF"")))))
              :op2 (z15 / increase-01
                        :ARG0 z4
                        :ARG1 (z16 / event
                                   :ARG0-of (z17 / inflame-01)
                                   :location (z18 / cavum
                                                  :mod (z19 / articulare)))
                        :manner (z20 / activate-01
                                     :ARG1 (z21 / enzyme
                                                :wiki ""NF-Eβ""
                                                :name (z22 / name
                                                           :op1 ""NF-êB""))))))",0.6213592233009709,0.5471698113207547,"(s / signal-01
        :ARG0 (t / thrombin-receptor)
        :ARG1 (m / mediate-01
              :ARG0 t
              :ARG1 (t2 / transduction
                    :ARG1 (i / induce-01
                          :ARG0 t2
                          :ARG1 (e / expression-01
                                :ARG0 (i2 / IL6))
                          :ARG1-of (i2 / increase-01
                                :ARG0 t2
                                :ARG1 (e2 / event
                                      :ARG1-of (i3 / inflammatory-01
                                            :ARG0 t2
                                            :ARG1 (c / cavum-articulare))))
                          :ARG1-of (a / activate-01
                                :ARG0 (n / NF-êB))))))","(t / transduce-01
    :ARG0 (r / receptor
        :mod (t2 / thrombin))
    :ARG1 (s / signal)
    :ARG2 (i / induce-01
        :ARG1 (e / express-01
            :ARG1 (a / and
                :op1 (i2 / IL6)
                :op2 (g / G-CSF))))
    :ARG2 (i3 / increase-01
        :ARG1 (e2 / event
            :mod (i4 / inflammatory))
        :location (c / cavum-articulare))
    :instrument (a2 / activate-01
        :ARG1 (n / NF-êB))
    :mod (c2 / could))",-1.0,0.3209876543209876
bel_pmid_1034_3541.23056,The levels of IL6 and of G-CSF mRNAs showed a time dependent increase during two to eight hours after thrombin stimulation....Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin,"(m2 / multi-sentence
    :rel (r / rheumatoid)
    :rel (e3 / eye)
    :rel (r2 / rich)
    :snt1 (s / show-01
        :ARG0 (a2 / and
            :op1 (l / level
                :mod (p / protein
                    :name (n / name
                        :op1 ""IL6"")))
            :op2 (l2 / level
                :mod (s2 / small-molecule
                    :name (n2 / name
                        :op1 ""histidine-rich""
                        :op2 ""glycoprotein""))))
        :ARG1 (i2 / increase-01
            :ARG1-of (d / depend-01
                :ARG0 (t4 / time))
            :time (a / after
                :quant (b / between
                    :op1 (t2 / temporal-quantity
                        :quant 2
                        :unit (h / hour))
                    :op2 (t / temporal-quantity
                        :quant 8
                        :unit (h2 / hour)))
                :op1 (s3 / stimulate-01
                    :ARG0 (t3 / thrombin)))))
    :snt2 (m / measure-01
        :ARG1 (e / enzyme
            :name (n3 / name
                :op1 ""Cytokines""
                :op2 ""embassy"")
            :part-of (c / cell
                :ARG1-of (s4 / stimulate-01)
                :mod (s5 / synovial)
                :mod (c2 / culture)))
        :instrument (a3 / ass
            :ARG1-of (l3 / link-01
                :ARG2 (e2 / enzyme))
            :mod (i / immunosorbent))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (s / show-01
            :ARG0 (a / and
                  :op1 (l / level
                        :quant-of (n9 / nucleic-acid :name (n / name :op1 ""mRNA"")
                              :ARG0-of (e4 / encode-01
                                    :ARG1 (p3 / protein :name (n2 / name :op1 ""IL6"")))))
                  :op2 (l2 / level
                        :quant-of (n10 / nucleic-acid :name (n3 / name :op1 ""mRNA"")
                              :ARG0-of (e3 / encode-01
                                    :ARG1 (p2 / protein :name (n4 / name :op1 ""G-CSF""))))))
            :ARG1 (i / increase-01
                  :ARG0-of (d / depend-01
                        :ARG1 (t / time))
                  :time (a2 / after
                        :op1 (s2 / stimulate-01
                              :ARG1 (e / enzyme :name (n5 / name :op1 ""thrombin"")))
                        :quant (b / between
                              :op1 (t2 / temporal-quantity :quant 2
                                    :unit (h / hour))
                              :op2 (t3 / temporal-quantity :quant 8
                                    :unit h)))))
      :snt2 (m2 / measure-01
            :ARG1 (p / protein :name (n8 / name :op1 ""cytokine""))
            :location (s3 / supernatant
                  :part-of (c2 / culture-01
                        :ARG1 (f / fibroblast
                              :location (s4 / synovia)
                              :mod (r3 / rheumatoid)))
                  :ARG1-of (s5 / stimulate-01
                        :ARG0 e))
            :manner (a3 / assay-01
                  :instrument (i2 / immunosorbent
                        :ARG1-of (l3 / link-01
                              :ARG2 (e2 / enzyme))))))",The levels of IL6 and of G-CSF mRNAs showed a time dependent increase during two to eight hours after thrombin stimulation....Cytokines were measured by enzyme linked immunosorbent assay (ELISA) in the supernatants of cultured rheumatoid synovial fibroblasts stimulated by thrombin,"(z1 / measure-01
    :ARG1 (z2 / cyclotokine)
    :ARG2 (z3 / supernatant
              :part-of (z4 / fibroblast
                           :ARG1-of (z5 / cultured-02)
                           :mod (z6 / rheumatoid-synovial)
                           :ARG1-of (z7 / stimulate-01
                                        :ARG0 (z8 / thrombin))))
    :instrument (z9 / assay
                    :wiki ""ELISA""
                    :name (z10 / name
                               :op1 ""ELISA"")
                    :ARG1-of (z11 / link-01
                                  :ARG2 (z12 / enzyme))))",0.2105263157894736,0.4539877300613497,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (l / level
                  :mod (i / IL6))
            :ARG2 (i2 / increase-01
                  :ARG1 l
                  :time (d / during
                        :op1 (i3 / interval
                              :op1 (t / two)
                              :op2 (t2 / eight)
                              :unit (h / hour))))
            :ARG3 (s2 / stimulation
                  :ARG0 (t2 / thrombin)))
        :snt2 (m2 / measure-01
            :ARG1 (c / cytokine)
            :ARG2 (a / assay-01
                  :ARG1 c
                  :ARG2 (e / enzyme)
                  :ARG3 (i4 / immunosorbent
                        :ARG1 e
                        :ARG2 (l2 / link-01)))
            :ARG3 (s3 / supernatant
                  :ARG1-of (c2 / culture-01
                        :ARG1 (f / fibroblast
                              :mod (s4 / synovial)
                              :mod (r / rheumatoid))
                        :ARG2 (s5 / stimulate-01
                              :ARG1 f
                              :ARG2 (t3 / thrombin))))))","(m2 / multi-sentence
    :snt1 (s4 / show-01
        :ARG0 (m / mRNA
            :mod (l2 / level
                :quant (t4 / the))
            :example (a3 / and
                :op1 (i / IL6)
                :op2 (g / G-CSF)))
        :ARG1 (i2 / increase-01
            :ARG1-of (d3 / depend-01
                :ARG2 (t5 / time))
            :time (d4 / during
                :op1 (t6 / two)
                :op2 (t7 / eight)
                :unit (h3 / hour))
            :condition (a4 / after
                :op1 (s5 / stimulate-01
                    :ARG1 (t8 / thrombin)))))
    :snt2 (m3 / measure-01
        :ARG0 (c / cytokine)
        :instrument (a5 / assay
            :mod (e2 / enzyme-linked-immunosorbent)
            :name (n4 / name :op1 ""ELISA""))
        :location (s6 / supernatant
            :part (c2 / culture-01
                :ARG1 (f3 / fibroblast
                    :mod (s7 / synovial)
                    :mod (r2 / rheumatoid))
                :condition (s8 / stimulate-01
                    :ARG1 t8)))))",-1.0,0.4054054054054054
bel_pmid_1034_3541.35586,"Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-êB activation","(p / possible-01
    :ARG1 (a3 / and
        :op1 (i2 / induce-01
            :ARG0 (t / transmit-01
                :ARG1 (s / signal-07)
                :ARG1-of (s3 / stimulate-01
                    :ARG0 (e / enzyme
                        :name (n2 / name
                            :op1 ""Thrombin""
                            :op2 ""receptor"")
                        :name (n6 / name
                            :op1 ""Thrombin""
                            :op2 ""receptor""))))
            :ARG1 (e4 / express-01
                :ARG0 (a2 / and
                    :op1 (e2 / enzyme
                        :name (n / name
                            :op1 ""IL6""))
                    :op2 (s2 / small-molecule
                        :name (n4 / name
                            :op1 ""wealth""
                            :op1 ""white""
                            :op2 ""histidine-rich"")
                        :name (n5 / name
                            :op1 ""oh"")))))
        :op2 (i / increase-01
            :ARG0 t
            :ARG1 (e3 / event
                :ARG0-of (i3 / inflame-01)
                :location (c / cavum
                    :part-of (a4 / articulare))
                :manner (a / activate-01
                    :ARG1 s2))))
    :rel (n3 / name))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (a / and
            :op1 (i / induce-01
                  :ARG0 (t / transduce-01
                        :ARG1 (s / signal-07)
                        :ARG1-of (m / mediate-01
                              :ARG0 (r / receptor :name (n / name :op1 ""thrombin""))))
                  :ARG2 (e / express-03
                        :ARG2 (a2 / and
                              :op1 (p2 / protein :name (n2 / name :op1 ""IL6""))
                              :op2 (p3 / protein :name (n3 / name :op1 ""G-CSF"")))))
            :op2 (i2 / increase-01
                  :ARG0 t
                  :ARG1 (e2 / event
                        :mod (i3 / inflame-01))
                  :location (c / cavum
                        :mod (a3 / articulare))
                  :manner (a4 / activate-01
                        :ARG1 (p4 / protein :name (n4 / name :op1 ""NF-κB""))))))","Thrombin receptor mediated signal transduction could induce the expressions of IL6 and G-CSF, and increase inflammatory events in the cavum articulare via NF-êB activation","(z1 / possible-01
    :ARG1 (z2 / and
              :op1 (z3 / induce-01
                       :ARG0 (z4 / transduction-01
                                 :ARG1 (z5 / signal)
                                 :instrument-of (z6 / mediate-01
                                                    :ARG0 (z7 / receptor
                                                              :wiki ""Thrombin_receptor""
                                                              :name (z8 / name
                                                                        :op1 ""Thrombin""
                                                                        :op2 ""receptor""))))
                       :ARG1 (z9 / express-01
                                 :ARG1 (z10 / and
                                            :op1 (z11 / small-molecule
                                                      :wiki ""Inositol_trisphosphate_receptor""
                                                      :name (z12 / name
                                                                 :op1 ""IL6""))
                                            :op2 (z13 / small-molecule
                                                      :wiki ""G-CSF""
                                                      :name (z14 / name
                                                                 :op1 ""G-CSF"")))))
              :op2 (z15 / increase-01
                        :ARG0 z4
                        :ARG1 (z16 / event
                                   :ARG0-of (z17 / inflame-01)
                                   :location (z18 / cavum
                                                  :mod (z19 / articulare)))
                        :manner (z20 / activate-01
                                     :ARG1 (z21 / enzyme
                                                :wiki ""NF-Eβ""
                                                :name (z22 / name
                                                           :op1 ""NF-êB""))))))",0.6213592233009709,0.5471698113207547,"(s / signal-01
        :ARG0 (t / thrombin-receptor)
        :ARG1 (m / mediate-01
              :ARG0 t
              :ARG1 (t2 / transduction
                    :ARG1 (i / induce-01
                          :ARG0 t2
                          :ARG1 (e / expression-01
                                :ARG0 (i2 / IL6))
                          :ARG1-of (i2 / increase-01
                                :ARG0 t2
                                :ARG1 (e2 / event
                                      :ARG1-of (i3 / inflammatory-01
                                            :ARG0 t2
                                            :ARG1 (c / cavum-articulare))))
                          :ARG1-of (a / activate-01
                                :ARG0 (n / NF-êB))))))","(t / transduce-01
    :ARG0 (r / receptor
        :mod (t2 / thrombin))
    :ARG1 (s / signal)
    :ARG2 (i / induce-01
        :ARG1 (e / express-01
            :ARG1 (a / and
                :op1 (i2 / IL6)
                :op2 (g / G-CSF))))
    :ARG2 (i3 / increase-01
        :ARG1 (e2 / event
            :mod (i4 / inflammatory))
        :location (c / cavum-articulare))
    :instrument (a2 / activate-01
        :ARG1 (n / NF-êB))
    :mod (c2 / could))",-1.0,0.3209876543209876
bel_pmid_1034_7197.8888,Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.,"(b / block-01
    :ARG0 (e4 / express-03
        :ARG1 (a / and
            :op1 (c / construct-01
                :ARG0-of (d / dominate-01)
                :ARG1-of (e5 / express-03))
            :op2 (c2 / construct-01
                :ARG1 (n3 / name
                    :op1 ""SF""
                    :op1 ""Met""
                    :op1 ""Sos1""
                    :op2 ""serotonin"")))
        :ARG2 (e3 / enzyme
            :name n3))
    :ARG1 (r / reduce-01
        :ARG0 (s / slash
            :op1 (e / enzyme
                :name (n / name
                    :op1 ""HGF""
                    :op1 ""Grb2""))
            :op2 (e2 / enzyme
                :name (n2 / name
                    :op2 ""Treaty"")))
        :ARG1 (p / promote-02
            :ARG1 (u / urokinase))
        :path e3)
    :rel (n4 / negative-02
        :ARG0-of d))
",test,bio_amr0.8,"(b / block-01
      :ARG0 (c / coexpress-01
            :ARG2 (c2 / construct-01
                  :ARG1 (a / and
                        :op1 (p / protein :name (n / name :op1 ""Grb2"")
                              :ARG2-of (m / mutate-01 :mod ""-/-"")
                              :ARG0-of (d / dominate-01))
                        :op2 (e / express-03
                              :ARG2 (p2 / protein :name (n2 / name :op1 ""Sos1""))))))
      :ARG1 (i / induce-01
            :ARG0 (p3 / protein :name (n3 / name :op1 ""HGF/SF""))
            :ARG2 (m2 / molecular-physical-entity
                  :ARG0-of (p4 / promote-01
                        :ARG1 (e2 / enzyme :name (n4 / name :op1 ""urokinase""))))
            :medium (r / receptor :name (n5 / name :op1 ""Met""))))",Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.,"(z1 / block-01
    :ARG0 (z2 / coexpress-01
              :ARG1 (z3 / construct
                        :mod (z4 / express-02
                                 :ARG1 (z5 / enzyme
                                           :wiki ""Grb2""
                                           :name (z6 / name
                                                     :op1 ""Grb2"")
                                           :ARG1-of (z7 / negative-05
                                                        :ARG0-of (z8 / dominate-01))))
                        :mod (z9 / express-101
                                 :ARG1 (z10 / enzyme
                                            :wiki ""Sos1""
                                            :name (z11 / name
                                                       :op1 ""Sos1"")
                                            :ARG1-of (z12 / negative-05)))))
    :ARG1 (z13 / induce-01
               :ARG0 (z14 / slash
                          :op1 (z15 / small-molecule
                                    :wiki ""Histidine-rich_glycoprotein""
                                    :name (z16 / name
                                               :op1 ""HGF/SF""))
                          :op2 (z17 / protein
                                    :wiki ""Met_receptor""
                                    :name (z18 / name
                                               :op1 ""Met""
                                               :op2 ""receptor"")))
               :ARG1 (z19 / protein
                          :ARG0-of (z20 / promote-02
                                        :ARG1 (z21 / urokinase)))))",0.3333333333333333,0.3076923076923077,"(m / multi-sentence
        :snt1 (b / block-01
            :ARG0 (i / induction
                  :ARG1 (p / promoter
                        :mod (u / urokinase)))
            :ARG1 (b2 / by
                  :ARG0 (c / co-expression
                        :ARG1 (g / Grb2
                              :mod (d / dominant-negative))
                        :ARG2 (e / expression
                              :ARG1 (c2 / construct
                                    :ARG1 (s / Sos1)))))
            :ARG2 (b3 / by
                  :ARG0 (h / HGF/SF)
                  :ARG1 (r / receptor
                        :ARG1-of (b4 / block-01
                              :ARG0 i
                              :ARG1 p))))
        :snt2 (b5 / be-01
            :ARG1 (b6 / block-01
                  :ARG0 (i2 / induction
                        :ARG1 (p2 / promoter
                              :mod (u2 / urokinase)))
                  :ARG1 (b7 / by
                        :ARG0 (c3 / co-expression
                              :ARG1 (g2 / Grb2
                                    :mod (d2 / dominant-negative))
                              :ARG2 (e2 / expression
                                    :ARG1 (c4 / construct
                                          :ARG1 (s2 / Sos1)))))
                  :ARG2 (b8 / by
                        :ARG0 (h2 / HGF/SF)
                        :ARG1 (r2 / receptor))))","(i / induce-01
    :ARG0 (p / promoter
        :mod (u / urokinase))
    :ARG1 (b / block-01
        :ARG0 (c / co-express-01
            :ARG1 (g / Grb2
                :mod (d / dominant-negative))
            :ARG2 (s / Sos1)
            :ARG1-of (e / express-01
                :ARG2 (c2 / construct
                    :mod (e2 / expression))))
        :ARG1 (r / receptor
            :mod (m / Met)
            :ARG1-of (v / via-01
                :ARG2 (h / HGF/SF))))
    :time (w / when))",-1.0,-1.0
bel_pmid_1034_7197.20912,"Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.","(a / abate-01
    :ARG0 (o / or
        :op1 (e7 / express-01
            :ARG1 (m / mutate-01
                :ARG0-of (a2 / activity-06
                    :ARG1-of (p / phosphorylate-01))
                :ARG1 (a4 / and
                    :op1 (e2 / enzyme
                        :name (n / name
                            :op1 ""ha""))
                    :op2 (e3 / enzyme
                        :name (n2 / name
                            :op1 ""RhoA""))
                    :op3 (e4 / enzyme
                        :name (n3 / name
                            :op1 ""B-Raf""))
                    :op4 (p3 / protein
                        :name (n4 / name
                            :op1 ""Erk2"")))))
        :op2 (a3 / add-02
            :ARG1 (e5 / enzyme
                :name (n5 / name
                    :op1 ""PD"")
                :ARG0-of (i / inhibit-01)
                :ARG1-of (s2 / specific-02))))
    :ARG1 (s3 / stimulate-01
        :ARG0 (s / slash
            :op1 (e6 / enzyme
                :name (n6 / name
                    :op1 ""HGF""))
            :op2 (t / thing
                :name (n7 / name
                    :op1 ""urokinase""))
            :op2 (t2 / thing
                :name (n8 / name
                    :op1 ""SF"")))
        :ARG1 (p2 / promote-02
            :ARG1 ""urokinase""))
    :mod (f / further)
    :rel (e / Mek1)
    :rel 098059)
",test,bio_amr0.8,"(a / and
      :op2 (a2 / abrogate-01
            :ARG1 (s / stimulate-01
                  :ARG0 (p / protein :name (n / name :op1 ""HGF/SF""))
                  :ARG1 (m / molecular-physical-entity
                        :ARG0-of (p2 / promote-01
                              :ARG1 (e / enzyme :name (n2 / name :op1 ""urokinase"")))))
            :ARG2 (o / or
                  :op1 (e2 / express-03
                        :ARG2 (m2 / mutate-01
                              :ARG1 (a3 / and
                                    :op1 (e6 / enzyme :name (n3 / name :op1 ""Ha-Ras""))
                                    :op2 (p4 / protein :name (n4 / name :op1 ""RhoA""))
                                    :op3 (e3 / enzyme :name (n5 / name :op1 ""c-Raf""))
                                    :op3 (e4 / enzyme :name (n6 / name :op1 ""Erk2"")))
                              :ARG1-of (a4 / activate-01 :polarity -
                                    :manner (c / catalytic))))
                  :op2 (a5 / add-02
                        :ARG1 (m3 / molecular-physical-entity :name (n7 / name :op1 ""PD-098059"")
                              :ARG0-of (i / inhibit-01
                                    :ARG1-of (s2 / specific-02
                                          :ARG2 (e5 / enzyme :name (n8 / name :op1 ""Mek1"")))))))))","Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.","(z1 / abrogate-01
    :ARG0 (z2 / or
              :op1 (z3 / express-03
                       :ARG1 (z4 / mutant
                                 :ARG1-of (z5 / activity-06
                                              :polarity -
                                              :ARG0 (z6 / catalyze-01))
                                 :mod (z7 / gene
                                          :wiki ""Ha-Ras""
                                          :name (z8 / name
                                                    :op1 ""Ha-Ras""))
                                 :mod (z9 / amino-acid
                                          :wiki ""RhoA""
                                          :name (z10 / name
                                                     :op1 ""RhoA""))
                                 :mod (z11 / amino-acid
                                           :wiki ""C-Raf""
                                           :name (z12 / name
                                                      :op1 ""c-Raf""))
                                 :mod (z13 / enzyme
                                           :wiki ""Erk2""
                                           :name (z14 / name
                                                      :op1 ""Erk2"")))))
    :op2 (z15 / add-02
              :ARG1 (z16 / enzyme
                         :wiki ""Cyclin-dependent_protein""
                         :wiki ""Cyclin-dependent_protein_kinase""
                         :name (z17 / name
                                    :op1 ""PD""
                                    :op2 ""98059"")
                         :ARG0-of (z18 / inhibit-01
                                       :ARG1 (z19 / enzyme
                                                  :wiki ""Mek1""
                                                  :name (z20 / name
                                                             :op1 ""Mek1""))
                                       :ARG1-of (z21 / specific-02)))))",0.3174603174603175,0.2836879432624113,"(m / multi-sentence
        :snt1 (e / expression-01
            :ARG1 (m2 / mutant
                  :mod (i / inactive)
                  :mod (c / catalytically))
            :ARG0 (h / Ha-Ras)
            :ARG0-of (a / and
                  :op1 (r / RhoA)
                  :op2 (c2 / c-Raf)
                  :op3 (e2 / Erk2))
            :ARG1-of (a2 / abrogate-01
                  :ARG0 (a3 / addition)
                  :ARG1 (i2 / inhibitor
                        :mod (s / specific)
                        :ARG1 (p / PD-098059)
                        :ARG2 (m3 / Mek1)))
            :ARG1-of (s / stimulate-01
                  :ARG0 (p2 / promoter
                        :mod (u / urokinase))
                  :ARG1 (h2 / HGF/SF)))
        :snt2 (n / none))","(e / express-01
    :ARG1 (m / mutant
        :mod (i / inactive)
        :mod (c / catalytic)
        :ARG1-of (a / and
            :op1 (p / protein :wiki ""H-Ras"" :name (n / name :op1 ""Ha-Ras""))
            :op2 (p2 / protein :wiki ""RhoA"" :name (n2 / name :op1 ""RhoA""))
            :op3 (p3 / protein :wiki ""C-Raf"" :name (n3 / name :op1 ""c-Raf""))
            :op4 (p4 / protein :wiki ""ERK"" :name (n4 / name :op1 ""Erk2""))))
    :ARG2 (a2 / addition
        :ARG1 (i2 / inhibit-01
            :ARG0 (c2 / compound :wiki ""PD_098059"" :name (n5 / name :op1 ""PD"" :op2 ""098059""))
            :ARG1 (p5 / protein :wiki ""Mitogen-activated_protein_kinase_kinase"" :name (n6 / name :op1 ""Mek1""))))
    :concession (s / stimulate-01
        :ARG0 (c3 / compound :wiki ""Hepatocyte_growth_factor"" :name (n7 / name :op1 ""HGF"" :op2 ""/"" :op3 ""SF""))
        :ARG1 (p6 / promoter
            :mod (u / urokinase))))
    :mod (f / further))",-1.0,-1.0
bel_pmid_1036_2713.15636,Treatment with TNF-a significantly decreased the intracellular GSH content of HS-24 cells. Pretreatment of this culture with DMSO recovered the TNF-a-induced decrease in GSH (Table 1).,"(m / multi-sentence
    :snt1 (d / decrease-01
        :ARG0 (t3 / treat-03
            :ARG2 (d4 / disease
                :name (n / name
                    :op1 ""TNF"")
                :ARG1-of (c2 / condition-01
                    :ARG2 d4)))
        :ARG1 (c3 / content-01
            :ARG1 (c / cell
                :name (n3 / name
                    :op1 ""RS-24""))
            :ARG2 (s2 / small-molecule
                :name (n2 / name
                    :op1 ""GSH"")
                :ARG1-of (i2 / ionize-01)))
        :ARG1-of (s / significant-02))
    :snt2 (r / recover-02
        :ARG0 (p / pretend-01
            :ARG1 (c4 / culture
                :mod (t2 / this))
            :ARG2 (s3 / small-molecule
                :name (n4 / name
                    :op1 ""DMSO"")))
        :ARG1 (d2 / decrease-01
            :ARG1 s2
            :ARG1-of (i / induce-01
                :ARG0 d4))
        :ARG1-of (d3 / describe-01
            :ARG0 (t / table
                :mod 1))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (d / decrease-01
            :ARG0 (t / treat-04
                  :ARG2 (p / protein :name (n / name :op1 ""TNF-α"")))
            :ARG1 (s3 / small-molecule :name (n2 / name :op1 ""GSH"")
                  :ARG1-of (c / contain-01
                        :ARG0 (c2 / cell :name (n3 / name :op1 ""HS-24""))
                        :location (i / intracellular)))
            :ARG2 (s / significant-02))
      :snt2 (r / recover-02
            :ARG0 (p2 / pretreat-01
                  :ARG1 (c3 / culture
                        :mod (t2 / this))
                  :ARG3 (s2 / small-molecule :name (n4 / name :op1 ""DMSO"")))
            :ARG1 (d2 / decrease-01
                  :ARG1 (s4 / small-molecule :name (n5 / name :op1 ""GSH""))
                  :ARG2-of (i2 / induce-01
                        :ARG0 (p3 / protein :name (n6 / name :op1 ""TNF-α""))))
            :ARG1-of (d3 / describe-01
                  :ARG0 (t3 / table :mod 1))))",Treatment with TNF-a significantly decreased the intracellular GSH content of HS-24 cells. Pretreatment of this culture with DMSO recovered the TNF-a-induced decrease in GSH (Table 1).,"(z1 / decrease-01
    :ARG0 (z2 / treat-03
              :ARG2 (z3 / small-molecule
                        :wiki ""TNF-a""
                        :name (z4 / name
                                  :op1 ""TNF-a"")))
    :ARG1 (z5 / content-01
              :ARG1 (z6 / cell
                        :wiki ""Histidine-rich_small-molecule""
                        :wiki ""Histidine-rich_serine""
                        :name (z7 / name
                                  :op1 ""HS-24""))
              :ARG2 (z8 / small-molecule
                        :wiki ""GSH""
                        :name (z9 / name
                                  :op1 ""GSH"")))
    :ARG1-of (z10 / significant-02))",0.2117647058823529,0.4864864864864864,"(m / multi-sentence
        :snt1 (d / decrease-01
            :ARG1 (c / content
                  :mod (g / GSH
                        :mod (i / intracellular)))
            :ARG2 (c2 / cell
                  :mod (h / HS-24)))
        :snt2 (r / recover-01
            :ARG0 (p / pretreatment)
            :ARG1 (c3 / culture
                  :mod (t / this))
            :ARG2 (d2 / decrease-01
                  :ARG1 (g2 / GSH)
                  :ARG2 (i2 / induce-01
                        :ARG1 (t2 / TNF-a))))
        :snt3 (t / table
            :op1 ""1""))","(t / treat-01
    :ARG1 (c / cell :name (n / name :op1 ""HS-24""))
    :ARG2 (t2 / TNF-a)
    :result (d / decrease-01
        :ARG1 (c2 / content-01
            :ARG1 (g / GSH)
            :location (c3 / cell :name (n2 / name :op1 ""HS-24"")))
        :degree (s / significant))
    :condition (p / pretreat-01
        :ARG1 c
        :ARG2 (d2 / DMSO)
        :result (r / recover-01
            :ARG1 (d3 / decrease-01
                :ARG1 (c4 / content-01
                    :ARG1 g
                    :location c3)
                :cause t2)
            :location (t3 / table-01 :name (n3 / name :op1 ""Table 1"")))))",-1.0,0.303030303030303
bel_pmid_1036_2713.18726,An XO enzyme activity of 5.0 mU/ml led to a twofold increase in IL-6 secretion in NHBE cells. And incubation of HS-24 cells with XO (20 mU/ml) induced a 1.8-fold increase in IL-6 production,"(m4 / multi-sentence
    :snt1 (l / lead-03
        :ARG0 (a / activity-06
            :quant (r / rate-entity-91
                :ARG2 (v / volume-quantity
                    :quant 5.0
                    :unit (m3 / milligram)))
            :ARG0 (e / enzyme
                :name (n / name
                    :op1 ""XO"")))
        :ARG2 (i / increase-01
            :ARG1 (s / secret
                :mod (s2 / small-molecule
                    :name (n2 / name
                        :op1 6
                        :op1 ""vitamin"")))
            :ARG2 (p2 / product-of
                :op1 2)
            :location (c / cell
                :name (n3 / name
                    :op1 ""NHBE""))))
    :snt2 (a2 / and
        :op2 (i3 / induce-01
            :ARG0 (c3 / culture
                :consist-of (c2 / cell
                    :name (n4 / name
                        :op1 24)
                    :ARG1-of (r2 / rate-entity-91
                        :ARG2 (m / mass-quantity
                            :quant 20))
                    :op2 (m2 / military
                        :name (n5 / name
                            :op1 ""vitamin""
                            :op2 ""vitamin""))))
            :ARG2 (i2 / increase-01
                :ARG1 (p / produce-01
                    :ARG1 s2)
                :ARG3 (t / times
                    :quant 1.8)))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (l / lead-03
            :ARG0 (a / activity-06
                  :ARG0 (e / enzyme :name (n / name :op1 ""XO"")
                        :quant (c / concentration-quantity :quant 5.0
                              :unit (m2 / milliunit-per-milliliter))))
            :ARG2 (i / increase-01
                  :ARG0 a
                  :ARG1 (s / secrete-01
                        :ARG1 (p / protein :name (n2 / name :op1 ""IL-6"")))
                  :ARG2 (p2 / product-of :op1 2)
                  :location (c2 / cell :name (n3 / name :op1 ""NHBE""))))
      :snt2 (a2 / and
            :op2 (i2 / induce-01
                  :ARG0 (i3 / incubate-01
                        :ARG1 (c3 / cell :name (n4 / name :op1 ""HS-24""))
                        :ARG2 (e2 / enzyme :name (n5 / name :op1 ""XO"")
                              :quant (c4 / concentration-quantity :quant 20
                                    :unit (m3 / milliunit-per-milliliter))))
                  :ARG2 (i4 / increase-01
                        :ARG0 i3
                        :ARG1 (p3 / produce-01
                              :ARG1 (p4 / protein :name (n6 / name :op1 ""IL-6"")))
                        :ARG2 (p5 / product-of :op1 1.8)))))",An XO enzyme activity of 5.0 mU/ml led to a twofold increase in IL-6 secretion in NHBE cells. And incubation of HS-24 cells with XO (20 mU/ml) induced a 1.8-fold increase in IL-6 production,"(z1 / lead-03
    :ARG0 (z2 / activity-06
              :ARG0 (z3 / enzyme
                        :wiki ""XO_(g3000 / gene)""
                        :name (z4 / name
                                  :op1 ""XO""))
              :ARG1 (z5 / rate-entity-91
                        :ARG1 (z6 / mass-quantity
                                  :quant ""5.0""
                                  :unit (z7 / milligram))
                        :ARG2 (z8 / volume-quantity
                                  :quant 1
                                  :unit (z9 / milligram)))))",0.1999999999999999,0.4328358208955223,"(m / multi-sentence
        :snt1 (l / lead-01
            :ARG0 (a / activity
                  :mod (e / enzyme
                        :mod (x / xo)))
            :ARG1 (i / increase-01
                  :ARG1 (s / secretion
                        :ARG0 (i2 / il-6))
                  :degree (t / twofold)))
        :snt2 (i2 / incubate-01
            :ARG0 (c / cell
                  :mod (n / nhbe))
            :ARG1 (i3 / increase-01
                  :ARG1 (p / production
                        :ARG0 (i4 / il-6))
                  :degree (f / fold)
                  :degree (o / one-point-eight))
            :ARG2 (x2 / xo
                  :quant (m / milli-01
                        :ARG1 (u / unit
                              :op1 20))))
        :snt3 (i5 / induce-01
            :ARG0 (c2 / cell
                  :mod (h / hs-24))
            :ARG1 (i6 / increase-01
                  :ARG1 (p2 / production
                        :ARG0 (i7 / il-6))
                  :degree (f2 / fold)
                  :degree (o2 / one-point-eight))
            :ARG2 x2))","(a / and
    :op1 (l / lead-01
        :ARG0 (a2 / activity
            :ARG1-of (h / have-03
                :ARG1 (e / enzyme
                    :name (n / name :op1 ""XO""))
                :ARG2 (q / quantity :quant 5.0 :unit ""mU/ml"")))
        :ARG1 (i / increase-01
            :ARG1 (s / secrete-01
                :ARG1 (i2 / interleukin-6)
                :ARG0 (c / cell
                    :name (n2 / name :op1 ""NHBE"")))
            :degree (t / two)))
    :op2 (i3 / induce-01
        :ARG0 (i4 / incubate-01
            :ARG0 (c2 / cell
                :name (n3 / name :op1 ""HS-24""))
            :ARG1 (a3 / activity
                :ARG1-of (h2 / have-03
                    :ARG1 e
                    :ARG2 (q2 / quantity :quant 20 :unit ""mU/ml""))))
        :ARG1 (i5 / increase-01
            :ARG1 (p / produce-01
                :ARG1 i2
                :ARG0 c2)
            :degree (m / multiply-01
                :ARG1 (n4 / number :value 1.8)))))",-1.0,0.3464566929133858
bel_pmid_1036_2713.24360,"SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).","(c2 / contrast-01
    :ARG1 (s3 / suppress-01
        :ARG0 (d2 / disease
            :name (n / name
                :op1 ""SOD"")
            :ARG1-of (r / rate-entity-91
                :ARG2 (v / volume-quantity
                    :quant 250
                    :unit (m / milligram))))
        :ARG1 (a / and
            :ARG1-of (i / induce-01
                :ARG2 (s2 / small-molecule
                    :name (n5 / name
                        :op1 ""XO"")))
            :op1 (p / produce-01)
            :op2 (e / enzyme
                :name (n3 / name
                    :op1 6))
            :op2 (e2 / express-03
                :ARG1 (p2 / protein
                    :name (n4 / name
                        :op1 ""mRNA""))))
        :ARG1-of (s / significant-02))
    :ARG2 (m3 / modulate-01
        :ARG0 (r2 / rate-entity-91
            :ARG1 (c / catalase)
            :ARG2 (v2 / volume-quantity
                :quant 500
                :unit (m2 / milliliter)))
        :ARG1 (r3 / respond-01
            :ARG1 s2)
        :polarity -)
    :rel (d / describe-01
        :ARG0 (f / figure
            :ARG1-of d
            :mod 4))
    :rel (n2 / name)
    :rel 6)
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (s / suppress-01
            :ARG0 (e / enzyme :name (n / name :op1 ""SOD"")
                  :quant (c2 / concentration-quantity :quant 250
                        :unit (u / unit-per-milliliter)))
            :ARG1 (a / and
                  :op1 (p / produce-01
                        :ARG1 (p2 / protein :name (n2 / name :op1 ""IL-6"")))
                  :op2 (e2 / express-03
                        :ARG1 (n5 / nucleic-acid :name (n3 / name :op1 ""mRNA"")
                              :ARG0-of (e5 / encode-01
                                    :ARG1 p2)))
                  :ARG2-of (i / induce-01
                        :ARG0 (e3 / enzyme :name (n4 / name :op1 ""XO""))))
            :ARG1-of (s2 / significant-02))
      :ARG2 (m / modulate-01 :polarity -
            :ARG0 (e4 / enzyme :name (n6 / name :op1 ""catalase"")
                  :quant (c3 / concentration-quantity :quant 500
                        :unit u))
            :ARG1 (r2 / respond-01
                  :ARG0 p2
                  :ARG1 e3))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod 4)))","SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).","(z1 / contrast-01
    :ARG1 (z2 / suppress-01
              :ARG0 (z3 / small-molecule
                        :wiki ""Selective_serotonin_reuptake_inhibitor""
                        :name (z4 / name
                                  :op1 ""SOD"")
                        :ARG1-of (z5 / rate-entity-91
                                     :ARG2 (z6 / volume-quantity
                                               :quant 250
                                               :unit (z7 / milligram))))
              :ARG1 (z8 / and
                        :op1 (z9 / produce-01
                                 :ARG1 (z10 / protein
                                            :wiki ""Inositol_trisphosphate""
                                            :name (z11 / name
                                                       :op1 ""IL-6"")))
                        :op2 (z12 / express-02
                                  :ARG1 (z13 / protein
                                             :wiki ""Mitogen-activated_protein_kinase""
                                             :name (z14 / name
                                                        :op1 ""IL-6""
                                                        :op2 ""mRNA"")))
                        :ARG1-of (z15 / induce-01
                                      :ARG0 (z16 / small-molecule
                                                 :wiki ""XO_(g3000 / gene)""
                                                 :name (z17 / name
                                                            :op1 ""XO"")))))
    :ARG1-of (z18 / significant-02))",0.4074074074074074,0.5238095238095237,"(s / suppress-01
        :ARG1 (p / production
              :ARG1-of (i / induce-01
                    :ARG1 (e / expression
                          :ARG1-of (m / mRNA
                                :mod (i2 / IL-6))))
              :ARG0 (s2 / SOD
                    :quant (u / unit
                          :op1 250
                          :op2 U/ml)))
        :ARG2 (x / XO)
        :ARG3 (r / response
              :ARG1-of (m2 / modulate-01
                    :ARG1 (i3 / IL-6)
                    :ARG2 (c / catalase
                          :quant (u2 / unit
                                :op1 500
                                :op2 U/ml))))
        :ARG4 (f / figure
              :op1 ""4""))","(s / suppress-01
    :ARG0 (s2 / substance :name (n / name :op1 ""SOD""))
    :ARG1 (p / produce-01
        :ARG0 (s3 / substance :name (n2 / name :op1 ""IL-6""))
        :ARG1 (s3 / substance :name (n2 / name :op1 ""IL-6""))
        :ARG2 (e / express-01
            :ARG0 (m / mRNA)
            :ARG1 s3))
    :ARG2 (i / induce-01
        :ARG0 (s4 / substance :name (n3 / name :op1 ""XO""))
        :ARG1 p)
    :degree (s5 / significant)
    :mod (u / unit :quant 250 :unit ""U/ml""))
(c / contrast-01
    :ARG1 s
    :ARG2 (m2 / modulate-01 :polarity -
        :ARG0 (s6 / substance :name (n4 / name :op1 ""catalase""))
        :ARG1 (r / respond-01
            :ARG0 s3
            :ARG1 (s7 / substance :name (n5 / name :op1 ""XO""))))
    :mod (u2 / unit :quant 500 :unit ""U/ml""))
(r2 / refer-01
    :ARG1 m2
    :ARG2 (f / figure :name (n6 / name :op1 ""4"")))",-1.0,-1.0
bel_pmid_1036_2713.24536,"TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts","(m / multi-sentence
    :rel (a / and
        :op1 (e / enhance-01
            :ARG1-of (i2 / induce-01
                :ARG0 (d3 / disease
                    :name (n / name
                        :op1 6))
                :ARG2 (c2 / cell)))
        :op2 (l / level
            :mod (e2 / enzyme
                :name (n5 / name
                    :op1 ""mRNA"")))
        :op3 (l2 / level
            :mod e2))
    :rel (f / figure
        :ARG1-of (d2 / describe-01
            :ARG0 f)
        :mod 7)
    :rel (p5 / protein)
    :rel (n3 / name)
    :snt1 (i / increase-01
        :ARG0 d3
        :ARG1 (p3 / produce-01
            :ARG1 (s2 / small-molecule
                :name (n2 / name
                    :op1 6))
            :location (c / cell
                :quant (b / between
                    :op1 40
                    :op2 40)))
        :ARG1-of (s / significant-02)
        :ARG1-of (d / describe-01
            :ARG0 (c4 / contrast-01
                :ARG2 (p / possible-01
                    :ARG1 (i3 / inhibit-01
                        :ARG0 (s3 / small-molecule
                            :name (n4 / name
                                :op1 ""DMSO""))
                        :ARG1 e)
                    :polarity -))))
    :snt2 c4
    :snt3 (s5 / suggest-01
        :ARG0 (t / thing
            :ARG2-of (r / result-01)
            :mod (t2 / this))
        :ARG1 (p2 / possible-01
            :ARG1 (i4 / involve-01
                :ARG1 (e3 / enzyme
                    :name (n6 / name
                        :op1 ""ROIs""))
                :ARG2 (p4 / produce-01
                    :ARG1 (s4 / small-molecule
                        :name (n7 / name
                            :op1 6))
                    :location (c3 / cell
                        :name (n8 / name
                            :op1 ""i""
                            :op1 ""White"")
                        :part-of (l3 / lung
                            :mod (h / human)
                            :op2 3))))
            :polarity -)))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (i / increase-01
            :ARG0 (p / protein :name (n / name :op1 ""TNF-α""))
            :ARG1 (p2 / produce-01
                  :ARG1 (p3 / protein :name (n2 / name :op1 ""IL-6"")))
            :ARG2 (s / significant-02)
            :location (c / cell :name (n3 / name :op1 ""WI-38-40"")))
      :snt2 (h / have-concession-91
            :ARG1 (p4 / possible-01 :polarity -
                  :ARG1 (i2 / inhibit-01
                        :ARG0 (s3 / small-molecule :name (n4 / name :op1 ""DMSO""))
                        :ARG1 (e / enhance-01
                              :ARG1 (p5 / protein :name (n5 / name :op1 ""IL-6""))
                              :ARG2-of (i3 / induce-01
                                    :ARG0 (p6 / protein :name (n6 / name :op1 ""TNF-α"")))
                              :location (a / and
                                    :op1 (l / level
                                          :mod (p7 / protein))
                                    :op2 (l2 / level
                                          :mod (n10 / nucleic-acid :name (n7 / name :op1 ""mRNA"")))))))
            :ARG1-of (d / describe-01
                  :ARG0 (f / figure :mod 7)))
      :snt3 (s2 / suggest-01
            :ARG0 (t / thing
                  :ARG2-of (r2 / result-01)
                  :mod (t2 / this))
            :ARG1 (p8 / possible-01 :polarity -
                  :ARG1 (i4 / involve-01
                        :ARG1 (s4 / small-molecule :name (n8 / name :op1 ""ROI""))
                        :ARG2 (p9 / produce-01
                              :ARG1 (p10 / protein :name (n9 / name :op1 ""IL-6""))
                              :location (f2 / fibroblast
                                    :part-of (l3 / lung
                                          :part-of (h2 / human))))))))","TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts","(z1 / multi-sentence
    :snt1 (z2 / increase-01
              :ARG0 (z3 / protein
                        :wiki ""Transient_receptor_potential_channel_receptor_potential_channel""
                        :name (z4 / name
                                  :op1 ""TNF-a""))
              :ARG1 (z5 / produce-01
                        :ARG1 (z6 / small-molecule
                                  :wiki ""Inositol-activated_protein_kinase""
                                  :name (z7 / name
                                            :op1 ""IL-6""))
                        :location (z8 / cell
                                      :wiki ""WI-38-40""
                                      :name (z9 / name
                                                :op1 ""WI-38-40"")))
              :ARG1-of (z10 / significant-02))
    :snt2 (z11 / contrast-01
               :ARG2 (z12 / possible-01
                          :polarity -
                          :ARG1 (z13 / inhibit-01
                                     :ARG0 (z14 / small-molecule
                                                :wiki ""N,N-Dimethyltryptamine""
                                                :name (z15 / name
                                                           :op1 ""DMSO""))
                                     :ARG1 (z16 / enhance-01
                                                :ARG1 (z17 / protein)
                                                :ARG2 (z18 / protein)
                                                :ARG2-of (z19 / increase-01
                                                              :ARG1 (z20 / mRNA))
                                                :ARG1-of (z21 / induce-01
                                                              :ARG0 z3))))))",0.3624161073825503,0.4975124378109452,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (t / TNF-a)
            :ARG2 (p / production
                  :ARG1 (i2 / IL-6)
                  :ARG2 (c / cell
                        :mod (w / WI-38-40))))
        :snt2 (a / able-01
            :ARG1 (d / DMSO)
            :ARG2 (i2 / inhibit-01
                  :ARG1 (e / enhance-01
                        :ARG1 (i3 / IL-6)
                        :ARG2 (i / induce-01
                              :ARG1 t))
                  :ARG2 (l2 / level
                        :mod (p2 / protein)
                        :mod (m / mRNA))))
        :snt3 (s / suggest-01
            :ARG1 (r / result
                  :ARG1-of (t2 / these))
            :ARG2 (i4 / involve-01
                  :ARG1 (r2 / ROI)
                  :ARG2 (p3 / production
                        :ARG1 (i3)
                        :ARG2 (c2 / cell
                              :mod (f / fibroblast
                                    :mod (l2))))))","(i / increase-01
    :ARG0 (t / TNF-a)
    :ARG1 (p / produce-01
        :ARG1 (i2 / IL-6)
        :ARG2 (c / cell :name (n / name :op1 ""WI-38-40"")))
    :degree (s / significant))
(m / multi-sentence
    :snt1 (h / have-03
        :ARG0 (d / DMSO)
        :ARG1 (a / ability-01
            :ARG0 d
            :ARG1 (i3 / inhibit-01
                :ARG0 d
                :ARG1 (e / enhance-01
                    :ARG0 t
                    :ARG1 i2
                    :ARG2 (a2 / and
                        :op1 (p2 / protein)
                        :op2 (m / mRNA))
                :location (f / figure :name (n2 / name :op1 ""7"")))))
        :polarity -)
    :snt2 (s2 / suggest-01
        :ARG0 (r / result
            :mod (t2 / this))
        :ARG1 (i4 / involve-01
            :ARG0 (r2 / ROI)
            :ARG1 (p3 / produce-01
                :ARG1 i2
                :ARG2 (f2 / fibroblast
                    :mod (h2 / human)
                    :location (l / lung))))
        :polarity -))",-1.0,0.3647798742138364
bel_pmid_1036_2713.24538,"TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(c / capable-01
    :ARG0-of (d / depend-01)
    :ARG1 (d4 / dose-01
        :ARG1 (s / small-molecule
            :name (n / name
                :op1 ""A"")))
    :ARG1-of (d2 / describe-01)
    :ARG1-of (d3 / describe-01
        :ARG0 (a2 / and
            :op1 (f / figure
                :mod 4A)
            :op2 (f2 / figure
                :mod 4B)
            :op3 (f3 / figure
                :mod 4C)))
    :ARG2 (i / induce-01
        :ARG0 d4)
    :rel (n2 / name
        :ARG2 (r / release-01
            :ARG0 (a / and
                :op1 (c2 / cell
                    :name (n3 / name
                        :op1 ""RS-24""))
                :op2 (c3 / cell
                    :name (n4 / name
                        :op1 ""Dem""))))
        :op1 ""6""))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (i / induce-01
            :ARG0 (p2 / protein :name (n / name :op1 ""TNF-α""))
            :ARG2 (r / release-01
                  :ARG1 (p3 / protein :name (n2 / name :op1 ""IL-6""))
                  :ARG2 (a / and
                        :op1 (c / cell :name (n3 / name :op1 ""NHBE""))
                        :op2 (c2 / cell :name (n4 / name :op1 ""HS-24"")))))
      :manner (d / depend-01
            :ARG0 p2
            :ARG1 (d2 / dose))
      :ARG1-of (d3 / describe-01
            :ARG0 (a2 / and
                  :op1 (f / figure :mod ""5A"")
                  :op2 (f2 / figure :mod ""5C""))))","TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(z1 / possible-01
    :ARG1 (z2 / induce-01
              :ARG0 (z3 / dose-01
                        :ARG2 (z4 / small-molecule
                                  :wiki ""TNF-a""
                                  :name (z5 / name
                                            :op1 ""TNF-a"")))
              :ARG1 (z6 / release-01
                        :ARG1 (z7 / small-molecule
                                  :wiki ""IL-6""
                                  :name (z8 / name
                                            :op1 ""IL-6""))
                        :ARG2 (z9 / and
                                  :op1 (z10 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z11 / name
                                                       :op1 ""NHBE""))
                                  :op2 (z12 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z13 / name
                                                       :op1 ""HS-24""))))))",0.32,0.3571428571428571,"(s / sentence
        :snt (c / cause-01
            :ARG0 (w / was
                  :ARG1 (c2 / capable-01
                        :ARG1 (i / induce-01
                              :ARG1 (r / release-01
                                    :ARG0 (c3 / cell
                                          :mod (n / nhbe)
                                          :mod (h / hs-24))
                                    :ARG1 (i2 / il-6)))
                              :ARG0 (t / tnfa)
                              :ARG2 (d / dependently
                                    :degree (d2 / dose))))
                        :ARG2 (f / from
                              :ARG0 c3
                              :ARG1 (f2 / fig
                                    :op1 ""5""
                                    :op2 (l / list
                                          :op1 ""A""
                                          :op2 ""C""))))))","(i / induce-01
    :ARG0 (c / capable-01
        :ARG1 (t / thing :name (n / name :op1 ""TNF-a""))
        :degree (d / depend-01
            :ARG1 (d2 / dose)))
    :ARG1 (r / release-01
        :ARG0 t
        :ARG1 (t2 / thing :name (n2 / name :op1 ""IL-6""))
        :ARG2 (c2 / cell
            :mod (a / and
                :op1 (c3 / cell :name (n3 / name :op1 ""NHBE""))
                :op2 (c4 / cell :name (n4 / name :op1 ""HS-24""))))))
    :location (f / figure
        :name (n5 / name :op1 ""5"")
        :mod (a2 / and
            :op1 ""A""
            :op2 ""C"")))",-1.0,-1.0
bel_pmid_1036_2713.39152,"TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts","(m / multi-sentence
    :rel (a / and
        :op1 (e / enhance-01
            :ARG1-of (i2 / induce-01
                :ARG0 (d3 / disease
                    :name (n / name
                        :op1 6))
                :ARG2 (c2 / cell)))
        :op2 (l / level
            :mod (e2 / enzyme
                :name (n5 / name
                    :op1 ""mRNA"")))
        :op3 (l2 / level
            :mod e2))
    :rel (f / figure
        :ARG1-of (d2 / describe-01
            :ARG0 f)
        :mod 7)
    :rel (p5 / protein)
    :rel (n3 / name)
    :snt1 (i / increase-01
        :ARG0 d3
        :ARG1 (p3 / produce-01
            :ARG1 (s2 / small-molecule
                :name (n2 / name
                    :op1 6))
            :location (c / cell
                :quant (b / between
                    :op1 40
                    :op2 40)))
        :ARG1-of (s / significant-02)
        :ARG1-of (d / describe-01
            :ARG0 (c4 / contrast-01
                :ARG2 (p / possible-01
                    :ARG1 (i3 / inhibit-01
                        :ARG0 (s3 / small-molecule
                            :name (n4 / name
                                :op1 ""DMSO""))
                        :ARG1 e)
                    :polarity -))))
    :snt2 c4
    :snt3 (s5 / suggest-01
        :ARG0 (t / thing
            :ARG2-of (r / result-01)
            :mod (t2 / this))
        :ARG1 (p2 / possible-01
            :ARG1 (i4 / involve-01
                :ARG1 (e3 / enzyme
                    :name (n6 / name
                        :op1 ""ROIs""))
                :ARG2 (p4 / produce-01
                    :ARG1 (s4 / small-molecule
                        :name (n7 / name
                            :op1 6))
                    :location (c3 / cell
                        :name (n8 / name
                            :op1 ""i""
                            :op1 ""White"")
                        :part-of (l3 / lung
                            :mod (h / human)
                            :op2 3))))
            :polarity -)))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (i / increase-01
            :ARG0 (p / protein :name (n / name :op1 ""TNF-α""))
            :ARG1 (p2 / produce-01
                  :ARG1 (p3 / protein :name (n2 / name :op1 ""IL-6"")))
            :ARG2 (s / significant-02)
            :location (c / cell :name (n3 / name :op1 ""WI-38-40"")))
      :snt2 (h / have-concession-91
            :ARG1 (p4 / possible-01 :polarity -
                  :ARG1 (i2 / inhibit-01
                        :ARG0 (s3 / small-molecule :name (n4 / name :op1 ""DMSO""))
                        :ARG1 (e / enhance-01
                              :ARG1 (p5 / protein :name (n5 / name :op1 ""IL-6""))
                              :ARG2-of (i3 / induce-01
                                    :ARG0 (p6 / protein :name (n6 / name :op1 ""TNF-α"")))
                              :location (a / and
                                    :op1 (l / level
                                          :quant-of (p7 / protein))
                                    :op2 (l2 / level
                                          :quant-of (n10 / nucleic-acid :name (n7 / name :op1 ""mRNA"")))))))
            :ARG1-of (d / describe-01
                  :ARG0 (f / figure :mod 7)))
      :snt3 (s2 / suggest-01
            :ARG0 (t / thing
                  :ARG2-of (r2 / result-01)
                  :mod (t2 / this))
            :ARG1 (p8 / possible-01 :polarity -
                  :ARG1 (i4 / involve-01
                        :ARG1 (s4 / small-molecule :name (n8 / name :op1 ""ROI""))
                        :ARG2 (p9 / produce-01
                              :ARG1 (p10 / protein :name (n9 / name :op1 ""IL-6""))
                              :location (f2 / fibroblast
                                    :part-of (l3 / lung
                                          :part-of (h2 / human))))))))","TNF-a significantly increased the production of IL-6 in WI-38-40 cells. However, DMSO was not able to inhibit the TNF-a-induced IL-6 enhancement in both protein and mRNA levels (Fig. 7). These results suggest that ROIs may not be involved in the production of IL-6 in human lung fibroblasts","(z1 / multi-sentence
    :snt1 (z2 / increase-01
              :ARG0 (z3 / protein
                        :wiki ""Transient_receptor_potential_channel_receptor_potential_channel""
                        :name (z4 / name
                                  :op1 ""TNF-a""))
              :ARG1 (z5 / produce-01
                        :ARG1 (z6 / small-molecule
                                  :wiki ""Inositol-activated_protein_kinase""
                                  :name (z7 / name
                                            :op1 ""IL-6""))
                        :location (z8 / cell
                                      :wiki ""WI-38-40""
                                      :name (z9 / name
                                                :op1 ""WI-38-40"")))
              :ARG1-of (z10 / significant-02))
    :snt2 (z11 / contrast-01
               :ARG2 (z12 / possible-01
                          :polarity -
                          :ARG1 (z13 / inhibit-01
                                     :ARG0 (z14 / small-molecule
                                                :wiki ""N,N-Dimethyltryptamine""
                                                :name (z15 / name
                                                           :op1 ""DMSO""))
                                     :ARG1 (z16 / enhance-01
                                                :ARG1 (z17 / protein)
                                                :ARG2 (z18 / protein)
                                                :ARG2-of (z19 / increase-01
                                                              :ARG1 (z20 / mRNA))
                                                :ARG1-of (z21 / induce-01
                                                              :ARG0 z3))))))",0.3624161073825503,0.527363184079602,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (t / TNF-a)
            :ARG2 (p / production
                  :ARG1 (i2 / IL-6)
                  :ARG2 (c / cell
                        :mod (w / WI-38-40))))
        :snt2 (a / able-01
            :ARG1 (d / DMSO)
            :ARG2 (i2 / inhibit-01
                  :ARG1 (e / enhance-01
                        :ARG1 (i3 / IL-6)
                        :ARG2 (i / induce-01
                              :ARG1 t))
                  :ARG2 (l2 / level
                        :mod (p2 / protein)
                        :mod (m / mRNA))))
        :snt3 (s / suggest-01
            :ARG1 (r / result
                  :ARG1-of (t2 / these))
            :ARG2 (i4 / involve-01
                  :ARG1 (r2 / ROI)
                  :ARG2 (p3 / production
                        :ARG1 (i3)
                        :ARG2 (c2 / cell
                              :mod (f / fibroblast
                                    :mod (l2))))))","(i / increase-01
    :ARG0 (t / TNF-a)
    :ARG1 (p / produce-01
        :ARG1 (i2 / IL-6)
        :ARG2 (c / cell :name (n / name :op1 ""WI-38-40"")))
    :degree (s / significant))
(m / multi-sentence
    :snt1 (h / have-03
        :ARG0 (d / DMSO)
        :ARG1 (a / ability-01
            :ARG0 d
            :ARG1 (i3 / inhibit-01
                :ARG0 d
                :ARG1 (e / enhance-01
                    :ARG0 t
                    :ARG1 i2
                    :ARG2 (a2 / and
                        :op1 (p2 / protein)
                        :op2 (m / mRNA))
                :location (f / figure :name (n2 / name :op1 ""7"")))))
        :polarity -)
    :snt2 (s2 / suggest-01
        :ARG0 (r / result
            :mod (t2 / this))
        :ARG1 (i4 / involve-01
            :ARG0 (r2 / ROI)
            :ARG1 (p3 / produce-01
                :ARG1 i2
                :ARG2 (f2 / fibroblast
                    :mod (h2 / human)
                    :location (l / lung))))
        :polarity -))",-1.0,0.3522012578616352
bel_pmid_1036_2713.39154,"TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(c / capable-01
    :ARG0-of (d / depend-01)
    :ARG1 (d4 / dose-01
        :ARG1 (s / small-molecule
            :name (n / name
                :op1 ""A"")))
    :ARG1-of (d2 / describe-01)
    :ARG1-of (d3 / describe-01
        :ARG0 (a2 / and
            :op1 (f / figure
                :mod 4A)
            :op2 (f2 / figure
                :mod 4B)
            :op3 (f3 / figure
                :mod 4C)))
    :ARG2 (i / induce-01
        :ARG0 d4)
    :rel (n2 / name
        :ARG2 (r / release-01
            :ARG0 (a / and
                :op1 (c2 / cell
                    :name (n3 / name
                        :op1 ""RS-24""))
                :op2 (c3 / cell
                    :name (n4 / name
                        :op1 ""Dem""))))
        :op1 ""6""))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (i / induce-01
            :ARG0 (p2 / protein :name (n / name :op1 ""TNF-α""))
            :ARG2 (r / release-01
                  :ARG1 (p3 / protein :name (n2 / name :op1 ""IL-6""))
                  :ARG2 (a / and
                        :op1 (c / cell :name (n3 / name :op1 ""NHBE""))
                        :op2 (c2 / cell :name (n4 / name :op1 ""HS-24"")))))
      :manner (d / depend-01
            :ARG0 p2
            :ARG1 (d2 / dose))
      :ARG1-of (d3 / describe-01
            :ARG0 (a2 / and
                  :op1 (f / figure :mod ""5A"")
                  :op2 (f2 / figure :mod ""5C""))))","TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(z1 / possible-01
    :ARG1 (z2 / induce-01
              :ARG0 (z3 / dose-01
                        :ARG2 (z4 / small-molecule
                                  :wiki ""TNF-a""
                                  :name (z5 / name
                                            :op1 ""TNF-a"")))
              :ARG1 (z6 / release-01
                        :ARG1 (z7 / small-molecule
                                  :wiki ""IL-6""
                                  :name (z8 / name
                                            :op1 ""IL-6""))
                        :ARG2 (z9 / and
                                  :op1 (z10 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z11 / name
                                                       :op1 ""NHBE""))
                                  :op2 (z12 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z13 / name
                                                       :op1 ""HS-24""))))))",0.4533333333333333,0.3571428571428571,"(s / sentence
        :snt (c / cause-01
            :ARG0 (w / was
                  :ARG1 (c2 / capable-01
                        :ARG1 (i / induce-01
                              :ARG1 (r / release-01
                                    :ARG0 (c3 / cell
                                          :mod (n / nhbe)
                                          :mod (h / hs-24))
                                    :ARG1 (i2 / il-6)))
                              :ARG0 (t / tnfa)
                              :ARG2 (d / dependently
                                    :degree (d2 / dose))))
                        :ARG2 (f / from
                              :ARG0 c3
                              :ARG1 (f2 / fig
                                    :op1 ""5""
                                    :op2 (l / list
                                          :op1 ""A""
                                          :op2 ""C""))))))","(i / induce-01
    :ARG0 (c / capable-01
        :ARG1 (t / thing :name (n / name :op1 ""TNF-a""))
        :degree (d / depend-01
            :ARG1 (d2 / dose)))
    :ARG1 (r / release-01
        :ARG0 t
        :ARG1 (t2 / thing :name (n2 / name :op1 ""IL-6""))
        :ARG2 (c2 / cell
            :mod (a / and
                :op1 (c3 / cell :name (n3 / name :op1 ""NHBE""))
                :op2 (c4 / cell :name (n4 / name :op1 ""HS-24""))))))
    :location (f / figure
        :name (n5 / name :op1 ""5"")
        :mod (a2 / and
            :op1 ""A""
            :op2 ""C"")))",-1.0,-1.0
bel_pmid_1040_9724.52,"Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.","(a4 / and
    :op1 (m / mediate-01
        :ARG0 (s4 / subunit
            :name (n2 / name
                :op1 10000
                :op2 130)
            :ARG0-of (t / transfer-01
                :ARG1 (s2 / signal-07)))
        :ARG1 (s / signal-07
            :ARG0 (r / receptor
                :name (n / name
                    :op1 6))))
    :op2 (i / involve-01
        :ARG1 (a / activate-01
            :ARG1 (a5 / and
                :op1 (e / enzyme
                    :name (n3 / name
                        :op1 ""Janus""
                        :op2 ""kinases"")
                    :ARG1-of (a6 / associate-01))
                :op2 (e2 / enzyme)
                :op3 (a2 / activate-01)
                :op4 (p / protein
                    :name (n5 / name)
                    :ARG0-of (a3 / activate-01
                        :ARG1 (e3 / enzyme
                            :name (n4 / name
                                :op1 ""mitogen""
                                :op1 ""kinase""))))))
        :ARG2 s)
    :rel (t2 / translate-01
        :ARG0-of (s3 / signal-07))
    :rel (e4 / express-03)
    :rel 3)
",test,bio_amr0.8,"(a / and
      :op1 (m / mediate-01
            :ARG1 (s / signal-07
                  :ARG0 (r / receptor :name (n / name :op1 ""IL-6"")))
            :medium (p / protein :name (n2 / name :op1 ""gp130"")
                  :mod (s2 / subunit
                        :ARG2-of (t / transduce-01
                              :ARG1 (s3 / signal-07)))))
      :op2 (i / involve-01
            :ARG1 (a2 / activate-01
                  :ARG1 (a3 / and
                        :op1 (e / enzyme :name (n3 / name :op1 ""Janus-associated"" :op2 ""kinase"")
                              :ARG1-of (d / describe-01
                                    :ARG0 (e2 / enzyme :name (n4 / name :op1 ""JAK""))))
                        :op2 (p2 / protein :name (n5 / name :op1 ""signal"" :op2 ""transducer"" :op3 ""and"" :op4 ""activator"" :op5 ""of"" :op6 ""transcription-3"")
                              :ARG1-of (d2 / describe-01
                                    :ARG0 (p3 / protein :name (n6 / name :op1 ""STAT3""))))
                        :op3 (e3 / enzyme :name (n7 / name :op1 ""mitogen-activated"" :op2 ""protein"" :op3 ""kinase"")
                              :ARG1-of (d3 / describe-01
                                    :ARG0 (e4 / enzyme :name (n8 / name :op1 ""MAP""))))))
            :ARG2 s))","Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.","(z1 / and
    :op1 (z2 / facilitate-01
             :ARG0 (z3 / subunit
                       :wiki ""Pg130""
                       :name (z4 / name
                                 :op1 ""gp130"")
                       :ARG0-of (z5 / transduce-01
                                    :ARG1 (z6 / signal)))
             :ARG1 (z7 / signal-07
                       :ARG0 (z8 / receptor
                                 :wiki ""Inositol–activated_protein_kinase""
                                 :name (z9 / name
                                           :op1 ""IL-6""
                                           :op2 ""receptor""))))
    :op2 (z10 / involve-01
              :ARG1 (z11 / activate-01
                         :ARG1 (z12 / and
                                    :op1 (z13 / kinase
                                              :wiki ""JAK1""
                                              :name (z14 / name
                                                         :op1 ""JAKs"")
                                              :ARG1-of (z15 / associate-01
                                                            :ARG2 (z16 / gene
                                                                       :wiki ""Janus–associated_kinases""
                                                                       :name (z17 / name
                                                                                  :op1 ""Janus-associated""
                                                                                  :op2 ""kinases"")))
                                              :ARG0-of (z18 / transduce-01
                                                            :ARG1 (z19 / signal))
                                              :ARG0-of (z20 / activate-01
                                                            :ARG1 (z21 / enzyme
                                                                       :wiki ""STAT3_enzyme""
                                                                       :name (z22 / name
                                                                                  :op1 ""STAT3"")
                                                                       :ARG0-of (z23 / activate-01
                                                                                     :ARG1 (z24 / protein
                                                                                                :wiki ""Mitogen-activated_protein_kinase""
                                                                                                :name (z25 / name
                                                                                                           :op1 ""Mitogen-activated""
                                                                                                           :op2 ""protein""
                                                                                                           :op3 ""kinase""))))))
                                    :ARG0-of (z26 / activate-01
                                                  :ARG1 (z27 / enzyme
                                                             :wiki ""STAT3_enzyme""
                                                             :name (z28 / name
                                                                        :op1 ""STAT3"")
                                                             :ARG0-of (z29 / activate-01
                                                                           :ARG1 (z30 / gene
                                                                                      :wiki ""STAT3""
                                                                                      :name (z31 / name
                                                                                                 :op1 ""STAT3"")))))))
              :ARG2 z7))",0.4102564102564102,0.409090909090909,"(s / signal-01
        :ARG0 (r / receptor
              :mod (i / IL-6))
        :ARG1 (m / mediate-01
              :ARG0 r
              :ARG1 (t / transduce-01
                    :ARG0 (s2 / subunit
                          :mod (g / gp130)
                          :mod (s4 / signal
                                :ARG0 (i2 / involve-01
                                      :ARG0 (a / activation-01
                                            :ARG0 (k / kinase
                                                  :mod (j / Janus-associated)
                                                  :ARG1 (s5 / STAT3))
                                            :ARG1 (k2 / kinase
                                                  :mod (m / mitogen-activated)
                                                  :ARG1 (p / protein))))))))","(s / signal-01
    :ARG0 (r / receptor
        :mod (i / IL-6))
    :ARG1 (m / mediate-01
        :ARG0 r
        :ARG1 (s2 / signal-01
            :ARG0 (s3 / subunit
                :mod (g / gp130))
            :ARG1 (i2 / involve-01
                :ARG0 s2
                :ARG1 (a / and
                    :op1 (a2 / activate-01
                        :ARG0 (j / kinase
                            :mod (j2 / Janus)
                            :mod (a3 / associate-01)))
                    :op2 (s4 / signal-01
                        :ARG0 (t / transducer
                            :mod (a4 / and)
                            :mod (a5 / activator-01
                                :ARG1 (s5 / STAT3)))
                    :op3 (m2 / MAP-kinase
                        :mod (a6 / activate-01
                            :ARG1 (p / protein
                                :mod (m3 / mitogen)
                                :mod (a7 / activate-01)))))))))",-1.0,0.165289256198347
bel_pmid_1040_9724.18580,"Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.","(a4 / and
    :op1 (m / mediate-01
        :ARG0 (s4 / subunit
            :name (n2 / name
                :op1 10000
                :op2 130)
            :ARG0-of (t / transfer-01
                :ARG1 (s2 / signal-07)))
        :ARG1 (s / signal-07
            :ARG0 (r / receptor
                :name (n / name
                    :op1 6))))
    :op2 (i / involve-01
        :ARG1 (a / activate-01
            :ARG1 (a5 / and
                :op1 (e / enzyme
                    :name (n3 / name
                        :op1 ""Janus""
                        :op2 ""kinases"")
                    :ARG1-of (a6 / associate-01))
                :op2 (e2 / enzyme)
                :op3 (a2 / activate-01)
                :op4 (p / protein
                    :name (n5 / name)
                    :ARG0-of (a3 / activate-01
                        :ARG1 (e3 / enzyme
                            :name (n4 / name
                                :op1 ""mitogen""
                                :op1 ""kinase""))))))
        :ARG2 s)
    :rel (t2 / translate-01
        :ARG0-of (s3 / signal-07))
    :rel (e4 / express-03)
    :rel 3)
",test,bio_amr0.8,"(a / and
      :op1 (m / mediate-01
            :ARG1 (s / signal-07
                  :ARG0 (r / receptor :name (n / name :op1 ""IL-6"")))
            :medium (p / protein :name (n2 / name :op1 ""gp130"")
                  :mod (s2 / subunit
                        :ARG2-of (t / transduce-01
                              :ARG1 (s3 / signal-07)))))
      :op2 (i / involve-01
            :ARG1 (a2 / activate-01
                  :ARG1 (a3 / and
                        :op1 (e / enzyme :name (n3 / name :op1 ""Janus-associated"" :op2 ""kinase"")
                              :ARG1-of (d / describe-01
                                    :ARG0 (e2 / enzyme :name (n4 / name :op1 ""JAK""))))
                        :op2 (p2 / protein :name (n5 / name :op1 ""signal"" :op2 ""transducer"" :op3 ""and"" :op4 ""activator"" :op5 ""of"" :op6 ""transcription-3"")
                              :ARG1-of (d2 / describe-01
                                    :ARG0 (p3 / protein :name (n6 / name :op1 ""STAT3""))))
                        :op3 (e3 / enzyme :name (n7 / name :op1 ""mitogen-activated"" :op2 ""protein"" :op3 ""kinase"")
                              :ARG1-of (d3 / describe-01
                                    :ARG0 (e4 / enzyme :name (n8 / name :op1 ""MAP""))))))
            :ARG2 s))","Signaling by the IL-6 receptor is mediated through the signal transducing subunit gp130 and involves the activation of Janus-associated kinases (JAKs), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.","(z1 / and
    :op1 (z2 / facilitate-01
             :ARG0 (z3 / subunit
                       :wiki ""Pg130""
                       :name (z4 / name
                                 :op1 ""gp130"")
                       :ARG0-of (z5 / transduce-01
                                    :ARG1 (z6 / signal)))
             :ARG1 (z7 / signal-07
                       :ARG0 (z8 / receptor
                                 :wiki ""Inositol–activated_protein_kinase""
                                 :name (z9 / name
                                           :op1 ""IL-6""
                                           :op2 ""receptor""))))
    :op2 (z10 / involve-01
              :ARG1 (z11 / activate-01
                         :ARG1 (z12 / and
                                    :op1 (z13 / kinase
                                              :wiki ""JAK1""
                                              :name (z14 / name
                                                         :op1 ""JAKs"")
                                              :ARG1-of (z15 / associate-01
                                                            :ARG2 (z16 / gene
                                                                       :wiki ""Janus–associated_kinases""
                                                                       :name (z17 / name
                                                                                  :op1 ""Janus-associated""
                                                                                  :op2 ""kinases"")))
                                              :ARG0-of (z18 / transduce-01
                                                            :ARG1 (z19 / signal))
                                              :ARG0-of (z20 / activate-01
                                                            :ARG1 (z21 / enzyme
                                                                       :wiki ""STAT3_enzyme""
                                                                       :name (z22 / name
                                                                                  :op1 ""STAT3"")
                                                                       :ARG0-of (z23 / activate-01
                                                                                     :ARG1 (z24 / protein
                                                                                                :wiki ""Mitogen-activated_protein_kinase""
                                                                                                :name (z25 / name
                                                                                                           :op1 ""Mitogen-activated""
                                                                                                           :op2 ""protein""
                                                                                                           :op3 ""kinase""))))))
                                    :ARG0-of (z26 / activate-01
                                                  :ARG1 (z27 / enzyme
                                                             :wiki ""STAT3_enzyme""
                                                             :name (z28 / name
                                                                        :op1 ""STAT3"")
                                                             :ARG0-of (z29 / activate-01
                                                                           :ARG1 (z30 / gene
                                                                                      :wiki ""STAT3""
                                                                                      :name (z31 / name
                                                                                                 :op1 ""STAT3"")))))))
              :ARG2 z7))",0.4102564102564102,0.3787878787878788,"(s / signal-01
        :ARG0 (r / receptor
              :mod (i / IL-6))
        :ARG1 (m / mediate-01
              :ARG0 r
              :ARG1 (t / transduce-01
                    :ARG0 (s2 / subunit
                          :mod (g / gp130)
                          :mod (s4 / signal
                                :ARG0 (i2 / involve-01
                                      :ARG0 (a / activation-01
                                            :ARG0 (k / kinase
                                                  :mod (j / Janus-associated)
                                                  :ARG1 (s5 / STAT3))
                                            :ARG1 (k2 / kinase
                                                  :mod (m / mitogen-activated)
                                                  :ARG1 (p / protein))))))))","(s / signal-01
    :ARG0 (r / receptor
        :mod (i / IL-6))
    :ARG1 (m / mediate-01
        :ARG0 r
        :ARG1 (s2 / signal-01
            :ARG0 (s3 / subunit
                :mod (g / gp130))
            :ARG1 (i2 / involve-01
                :ARG0 s2
                :ARG1 (a / and
                    :op1 (a2 / activate-01
                        :ARG0 (j / kinase
                            :mod (j2 / Janus)
                            :mod (a3 / associate-01)))
                    :op2 (s4 / signal-01
                        :ARG0 (t / transducer
                            :mod (a4 / and)
                            :mod (a5 / activator-01
                                :ARG1 (s5 / STAT3)))
                    :op3 (m2 / MAP-kinase
                        :mod (a6 / activate-01
                            :ARG1 (p / protein
                                :mod (m3 / mitogen)
                                :mod (a7 / activate-01)))))))))",-1.0,0.165289256198347
bel_pmid_1040_9724.23704,"This study shows that in hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2, but not SHC, is the primary signaling event associated with the activation of MAP kinases (ERK1/2) by gp130.","(s / show-01
    :ARG0 (s4 / study-01
        :mod (t / this))
    :ARG1 (e5 / event
        :ARG0-of (s2 / signal-07)
        :ARG1-of (a3 / associate-01
            :ARG2 (a / ""activate-01""
                :ARG0 (e4 / enzyme
                    :name (n5 / name
                        :op1 a
                        :op2 (e2 / ""enzyme""
                            :name (n4 / name
                                :op1 ""MAP""
                                :op1 ""fund""
                                :op2 ""kinases""))
                        :op3 ""1/2"")
                    :part-of a)
                :ARG1 e2))
        :domain (a2 / and
            :ARG1-of (c2 / contrast-01
                :ARG2 (p2 / phosphorylate-01
                    :polarity -))
            :op1 (r / recruit-01
                :ARG1 (s3 / small-molecule
                    :name (n2 / name
                        :op1 2)
                    :name (n3 / name
                        :op1 ""SHC"")))
            :op2 (p / phosphorylate-01
                :ARG1 (e / enzyme
                    :name (n / name
                        :op1 ""tyrosine""))
                :ARG1 s3))
        :location (c / cell
            :mod (h / hepatoma))
        :mod (p3 / primary))
    :rel (e3 / enzyme
        :name (n6 / name
            :op1 ""gp""
            :op2 130)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (s2 / study-01
            :mod (t / this))
      :ARG1 (e / event
            :ARG0-of (s3 / signal-07)
            :mod (p / primary)
            :domain (a / and
                  :op1 (r / recruit-01
                        :ARG1 (p2 / protein :name (n / name :op1 ""SHP-2"")))
                  :op2 (p3 / phosphorylate-01
                        :ARG1 p2
                        :ARG2 (t2 / tyrosine))
                  :ARG1-of (c / contrast-01
                        :ARG2 (a2 / and
                              :op1 (r2 / recruit-01 :polarity -
                                    :ARG1 (p4 / protein :name (n2 / name :op1 ""SHC"")))
                              :op2 (p5 / phosphorylate-01 :polarity -
                                    :ARG1 p4
                                    :ARG2 t2))))
            :ARG1-of (a3 / associate-01
                  :ARG2 (a4 / activate-01
                        :ARG0 (p6 / protein :name (n3 / name :op1 ""gp130""))
                        :ARG1 (p7 / protein-family :name (n4 / name :op1 ""MAP"" :op2 ""kinase"")))
                  :location (c2 / cell
                        :mod (m / medical-condition :name (n6 / name :op1 ""hepatoma""))))))","This study shows that in hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2, but not SHC, is the primary signaling event associated with the activation of MAP kinases (ERK1/2) by gp130.","(z1 / show-01
    :ARG0 (z2 / study-01
              :mod (z3 / this))
    :ARG1 (z4 / event
              :ARG0-of (z5 / signify-01)
              :mod (z6 / primary)
              :ARG1-of (z7 / associate-01
                           :ARG2 (z8 / activate-01
                                     :ARG0 (z9 / enzyme
                                               :wiki ""PHLDA1/2""
                                               :name (z10 / name
                                                          :op1 ""gp130""))
                                     :ARG1 (z11 / kinase
                                                :wiki ""Mitogen-activated_protein_kinase""
                                                :name (z12 / name
                                                           :op1 ""MAP""
                                                           :op2 ""kinases""
                                                           :op3 ""1/2""))))
              :domain (z13 / contrast-01
                           :ARG1 (z14 / and
                                      :op1 (z15 / recruit-01
                                                :ARG1 (z16 / protein
                                                           :wiki ""Selective_serotonin_reuptake_inhibitor""
                                                           :name (z17 / name
                                                                      :op1 ""SHP-2"")))
                                      :op2 (z18 / phosphorylate-01
                                                :ARG1 (z19 / protein
                                                           :wiki ""Serine""
                                                           :name (z20 / name
                                                                      :op1 ""SHC""))))
                           :ARG2 (z21 / phosphorylate-01
                                      :ARG1 z19
                                      :ARG2 (z22 / tyrosine)))
              :location (z23 / cell
                             :part-of (z24 / hepatoma))))",0.564516129032258,0.534351145038168,"(s / show-01
        :ARG0 (s2 / study)
        :ARG1 (e / event
              :ARG0 (a / associate-01
                    :ARG1 (e2 / event
                          :ARG0 (a2 / activate-01
                                :ARG0 (k / kinase
                                      :ARG0-of (m / map)
                                      :ARG1 (e3 / erk1/2))
                                :ARG1 (g / gp130)))
                          :ARG1 (s3 / signal-01
                                :ARG0 (r / recruit-01
                                      :ARG1 (p / phosphorylate-01
                                            :ARG0 (t / tyrosine)
                                            :ARG1 (s4 / shp-2)))
                                :ARG1 (c / cell
                                      :mod (h / hepatoma))))
                    :ARG2 (e4 / event
                          :ARG0 (a3 / associate-01
                                :ARG1 (e5 / event
                                      :ARG0 (a4 / activate-01
                                            :ARG0 (k2 / kinase
                                                  :ARG0-of m
                                                  :ARG1 e3)
                                            :ARG1 (s5 / shc)))
                                :ARG1 (s6 / signal-01
                                      :ARG0 r
                                      :ARG1 c))))","(s / show-01
    :ARG0 (s2 / study
        :mod (t / this))
    :ARG1 (a / associate-01
        :ARG1 (e / event
            :mod (p / primary)
            :mod (s3 / signal)
            :ARG1-of (r / recruit-01)
            :ARG1-of (p2 / phosphorylate-01
                :ARG2 (t2 / tyrosine)))
        :ARG2 (a2 / activate-01
            :ARG1 (k / kinase
                :mod (m / MAP)
                :example (e2 / ERK1/2))
            :ARG0 (g / gp130)))
    :location (c / cell
        :mod (h / hepatoma))
    :condition (b / but
        :op1 (r2 / recruit-01
            :ARG1 (s4 / SHP-2))
        :op2 (n / not
            :op1 (r3 / recruit-01
                :ARG1 (s5 / SHC)))))",-1.0,-1.0
bel_pmid_1043_6166.3510,NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.,"(s2 / show-01
    :ARG0 (a2 / affect-01
        :ARG0 (m / moderate-01
            :ARG1 (p / pathway
                :ARG0-of (s3 / signal-07))
            :mod (n3 / no))
        :ARG1 (a3 / and
            :op1 (p2 / phosphorylate-01
                :ARG1 (s4 / slash
                    :op1 (e / enzyme
                        :name (n / name
                            :op1 ""ERK1""))
                    :op2 (e2 / enzyme
                        :name (n2 / name
                            :op1 ""ERK2"")))
                :ARG1-of (i / induce-01
                    :ARG0 (s5 / stress-02
                        :mod (s / shear))))
            :op2 (a / activity-06
                :ARG0 s4))
        :ARG2 (i2 / inhibit-01))
    :ARG1 m)
",test,bio_amr0.8,"(s / show-01
      :ARG0 (a3 / affect-01
            :ARG0 m2
            :ARG1 (a / and
                  :op1 (p / phosphorylate-01
                        :ARG1 (s3 / slash
                              :op1 (e2 / enzyme :name (n2 / name :op1 ""ERK1""))
                              :op2 (e3 / enzyme :name (n3 / name :op1 ""ERK2""))
                              :ARG2-of (i2 / induce-01
                                    :ARG0 (s4 / stress-02
                                          :mod (s5 / shear-01)))))
                  :op2 (a2 / activity-06
                        :ARG0 s3))
            :ARG2 (i / inhibit-01
                  :ARG1 p))
      :ARG1 (m2 / modulate-01
            :ARG0 (n / name :op1 ""NO"")
            :ARG1 (p2 / pathway
                  :ARG0-of (s2 / signal-07))))",NO modulation of the signaling pathway was shown by its inhibitory effect on shear stress-induced ERK1/ERK2 phosphorylation and activity.,"(z1 / show-01
    :ARG0 (z2 / affect-01
              :ARG0 (z3 / it)
              :ARG1 (z4 / inhibit-01
                        :ARG0 z3
                        :ARG1 (z5 / and
                                  :op1 (z6 / phosphorylate-01
                                           :ARG1 (z7 / enzyme
                                                     :wiki ""ERK1/ERK2""
                                                     :name (z8 / name
                                                               :op1 ""ERK1/ERK2"")))
                                  :op2 (z9 / activity-06
                                           :ARG1 z7)
                                  :ARG1-of (z10 / induce-01
                                                :ARG0 (z11 / stress-02
                                                           :mod (z12 / shear)))))))",0.4571428571428571,0.7317073170731706,"(m / modulation-01
        :ARG1 (p / pathway
              :mod (s / signaling))
        :ARG2 (e / effect-01
              :ARG1 (i / inhibit-01
                    :ARG1 (s2 / show-01
                          :ARG1 (p2 / phosphorylation
                                :ARG1 (e2 / ERK1/ERK2)
                                :ARG2 (s3 / shear-stress))
                          :ARG2 (a / activity))))","(n / no
    :domain (m / modulate-01
        :ARG1 (p / pathway
            :mod (s / signal-01))
        :ARG0 (e / effect
            :mod (i / inhibit-01)
            :ARG1-of (s2 / show-01)
            :ARG2 (p2 / phosphorylate-01
                :ARG1 (a / and
                    :op1 (e2 / ERK1)
                    :op2 (e3 / ERK2))
                :ARG1-of (i2 / induce-01
                    :ARG0 (s3 / stress-01
                        :mod (s4 / shear)))
                :ARG2 (a2 / activity)))))",-1.0,0.3333333333333333
bel_pmid_1044_6041.18010,"The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).","(m2 / multi-sentence
    :rel (n2 / name
        :op1 ""F-35"")
    :rel (m / manner
        :name (n5 / name
            :op1 ""Abl""))
    :rel (p2 / protein
        :name (n8 / name
            :op1 ""Great""
            :op1 ""Srcfamily""))
    :rel (k / kinase
        :ARG2-of (b / bind-01
            :ARG1 (f / focal)))
    :rel (s / ""serine/threonine-protein"")
    :snt1 (a2 / and
        :op1 (e / enzyme
            :name (n / name
                :op1 ""FAK""))
        :op2 (e2 / enzyme
            :name (n3 / name
                :op1 ""F-35"")))
    :snt2 (a / activate-01
        :ARG0 (e3 / enzyme
            :name (n6 / name
                :op1 ""Great""
                :op2 ""ever""))
        :ARG1 (e4 / enzyme
            :ARG2-of (i / include-91
                :ARG1 (a3 / and
                    :op1 e4
                    :op2 (e5 / enzyme
                        :name (n4 / name
                            :op1 ""Shc""))
                    :op2 (e6 / enzyme
                        :name e5)
                    :op3 (p4 / protein
                        :name (n10 / name
                            :op2 ""kinases""
                            :op2 ""kinase""))
                    :op4 (p5 / protein)
                    :op5 (s2 / small-molecule
                        :name (n11 / name
                            :op1 ""integrin""
                            :op2 ""link-01""
                            :op3 ""kinase""))))
            :mod (p3 / protein
                :name (n9 / name
                    :op1 ""tyrosine""))
            :mod (v / various)
            :part-of (p / protein
                :name (n7 / name)))
        :ARG1-of (d / describe-01
            :ARG0 (a4 / and
                :op1 4
                :op2 7))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (a / and
            :op1 (p / pathway :name (n / name :op1 ""FAK""))
            :op2 (p2 / pathway :name (n2 / name :op1 ""Fyn/Shc"")))
      :snt2 (a2 / activate-01
            :ARG0 (p7 / protein :name (n3 / name :op1 ""integrin""))
            :ARG1 (a3 / and
                  :op1 (e3 / enzyme :name (n10 / name :op1 ""protein"" :op2 ""tyrosine"" :op3 ""kinase"")
                        :ARG2-of (i2 / include-91
                              :ARG1 (a4 / and
                                    :op1 (e2 / enzyme :name (n4 / name :op1 ""focal"" :op2 ""adhesion"" :op3 ""kinase"")
                                          :ARG1-of (m2 / mean-01
                                                :ARG2 (n5 / name :op1 ""FAK"")))
                                    :op2 (p3 / protein-family :name (n9 / name :op1 ""Src""))
                                    :op3 (p4 / protein :name (n6 / name :op1 ""Abl""))))
                        :mod (v2 / various))
                  :op2 (e / enzyme :name (n7 / name :op1 ""serine-threonine"" :op2 ""kinase"")
                        :ARG1-of (m5 / mean-01
                              :ARG2 (e4 / enzyme :name (n8 / name :op1 ""integrin-linked"" :op2 ""kinase"")))))
            :ARG1-of (d / describe-01
                  :ARG0 (p6 / publication
                        :ARG1-of (c / cite-01
                              :ARG2 (a5 / and :op1 4 :op2 7))))))","The FAK and Fyn/Shc pathways. Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Srcfamily kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (4, 7).","(z1 / activate-01
    :ARG0 (z2 / protein
              :wiki ""Integrins""
              :name (z3 / name
                        :op1 ""Integrins""))
    :ARG1 (z4 / kinase
              :mod (z5 / protein
                       :wiki ""Threonine""
                       :name (z6 / name
                                 :op1 ""tyrosine""))
              :mod (z7 / various)
              :ARG2-of (z8 / include-91
                           :ARG1 (z9 / and
                                     :op1 (z10 / kinase
                                               :wiki ""Fyn/Shc_pathway""
                                               :name (z11 / name
                                                          :op1 ""FAK""
                                                          :op2 ""pathway""))
                                     :op2 (z12 / kinase
                                               :wiki ""BRAF/Shc_pathway""
                                               :name (z13 / name
                                                          :op1 ""Fyn/Shc""
                                                          :op2 ""pathway""))
                                     :op3 (z14 / kinase
                                               :wiki ""BRAF/Abl""
                                               :name (z15 / name
                                                          :op1 ""Abl""))
                                     :op4 (z16 / kinase
                                               :wiki ""serine-threonine_kinase""
                                               :name (z17 / name
                                                          :op1 ""serine-threonine""
                                                          :op2 ""kinase""))
                                     :op5 (z18 / kinase
                                               :wiki ""Inositol-activated_protein_kinase""
                                               :name (z19 / name
                                                          :op1 ""ILK"")
                                               :ARG1-of (z20 / link-01
                                                             :ARG2 (z21 / protein
                                                                        :wiki ""Integrin""
                                                                        :name (z22 / name
                                                                                   :op1 ""integrin-linked""
                                                                                   :op2 ""kinase""))))))
              :ARG1-of (z23 / describe-01
                            :ARG0 (z24 / and
                                       :op1 (z25 / publication
                                                 :ARG1-of (z26 / cite-01
                                                               :ARG2 4))
                                       :op2 (z27 / publication
                                                 :ARG1-of (z28 / cite-01
                                                               :ARG2 7))))))",0.3375,0.369942196531792,"(m / multi-sentence
        :snt1 (a / activate-01
            :ARG0 (i / integrin)
            :ARG1 (p / pathway
                  :mod (f / FAK)
                  :mod (f2 / Fyn/Shc)))
        :snt2 (a2 / activate-01
            :ARG0 i
            :ARG1 (p2 / protein
                  :mod (t / tyrosine)
                  :mod (k / kinase)))
        :snt3 (i2 / include-91
            :ARG0 i
            :ARG1 (k2 / kinase
                  :mod (f3 / focal
                        :mod (a2 / adhesion))
                  :mod (f4 / FAK)))
        :snt4 (a3 / activate-01
            :ARG0 i
            :ARG1 (k3 / kinase
                  :mod (s / Srcfamily)))
        :snt5 (a4 / activate-01
            :ARG0 i
            :ARG1 (a5 / Abl))
        :snt6 (a6 / activate-01
            :ARG0 i
            :ARG1 (k4 / kinase
                  :mod (s2 / serine-threonine)
                  :mod (l / linked)
                  :mod (i2 / integrin))))","(p / pathway
    :name (n / name :op1 ""FAK"" :op2 ""and"" :op3 ""Fyn/Shc"")
    :ARG1-of (a / activate-01
        :ARG0 (i / integrin)
        :ARG1 (p2 / protein-tyrosine-kinase
            :example (f / focal-adhesion-kinase :wiki ""Focal_adhesion_kinase"" :name (n2 / name :op1 ""FAK""))
            :example (s / Srcfamily-kinase)
            :example (a2 / Abl)
            :example (s2 / serine-threonine-kinase
                :name (n3 / name :op1 ""integrin-linked"" :op2 ""kinase"" :op3 ""(ILK)"")))))",-1.0,0.2321428571428571
bel_pmid_1044_6041.18018,"PTP-PEST has a COOH-terminal extension that anchors it to the cytosolic aspect of the endoplasmic reticulum. Integrin-mediated adhesion activates calpain, a protease that cleaves this extension and allows the phosphatase to relocate to focal adhesions (21).","(m2 / multi-sentence
    :rel (s / ""small-molecule""
        :name (n3 / name
            :op1 ""endoplasmic""
            :op1 ""human""
            :op2 ""reticulum""
            :part-of s))
    :rel (i2 / ionize-01)
    :snt1 (h / have-03
        :ARG0 (p2 / protein
            :name (n / name
                :op1 ""P""))
        :ARG1 (e2 / extend-01
            :ARG0-of (a3 / anchor-01
                :ARG1 p2
                :ARG2 (a4 / aspect
                    :ARG1-of (i / ionize-01
                        :value 2+)))
            :ARG1 p2
            :mod (t / terminal
                :name (n2 / name
                    :op1 ""COOH""))))
    :snt2 (a / activate-01
        :ARG0 (b / bind-01
            :ARG1-of (m / mediate-01
                :ARG0 (i3 / ionize-01)))
        :ARG1 (p / protease
            :name (n4 / name
                :op1 ""calpain"")
            :ARG0-of (a2 / allow-01
                :ARG1 (r / relocate-01
                    :ARG1 (e / enzyme
                        :name (n5 / name
                            :op1 ""phosphatase""))
                    :ARG2 (d / deposit
                        :ARG1-of (d2 / describe-01
                            :ARG0 (p3 / publication
                                :ARG1-of (c / cite-01
                                    :ARG2 21)))
                        :ARG2-of (f / focus-01)))))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (h / have-03
            :ARG0 (e4 / enzyme :name (n / name :op1 ""PTP-PEST""))
            :ARG1 (e / extend-01
                  :mod (p2 / protein-segment :name (n2 / name :op1 ""COOH-terminus""))
                  :ARG0-of (a / anchor-01
                        :ARG1 e4
                        :location (a2 / aspect
                              :mod (c / cytosol)
                              :part-of (r / reticulum
                                    :mod (e2 / endoplasm))))))
      :snt2 (a3 / activate-01
            :ARG0 (a4 / adhere-01
                  :ARG1-of (m2 / mediate-01
                        :ARG0 (p3 / protein :name (n5 / name :op1 ""integrin""))))
            :ARG1 (p / protease :name (n6 / name :op1 ""calpain"")
                  :ARG0-of (c2 / cleave-01
                        :ARG1 (e5 / extend-01
                              :mod (t / this)))
                  :ARG0-of (a5 / allow-01
                        :ARG1 (r2 / relocate-01
                              :ARG1 (e3 / enzyme :name (n4 / name :op1 ""phosphatase""))
                              :ARG2 (a6 / adhere-01
                                    :mod (f / focal)))))
            :ARG1-of (d / describe-01
                  :ARG0 (p5 / publication
                        :ARG1-of (c3 / cite-01
                              :ARG2 21)))))","PTP-PEST has a COOH-terminal extension that anchors it to the cytosolic aspect of the endoplasmic reticulum. Integrin-mediated adhesion activates calpain, a protease that cleaves this extension and allows the phosphatase to relocate to focal adhesions (21).","(z1 / have-03
    :ARG0 (z2 / protein
              :wiki ""PTP-PEST""
              :name (z3 / name
                        :op1 ""PTP-PEST""))
    :ARG1 (z4 / extend-01
              :ARG1 z2
              :ARG2 (z5 / terminus
                        :mod (z6 / string-entity
                                 :value ""COOH""))
              :ARG0-of (z7 / anchor-01
                           :ARG1 z2
                           :ARG2 (z8 / aspect
                                     :mod (z9 / cytosolic)
                                     :part-of (z10 / reticulum
                                                   :mod (z11 / endoplasmic))))))",0.3125,0.5401459854014599,"(m / multi-sentence
        :snt1 (h / have-03
            :ARG0 (p / PTP-PEST)
            :ARG1 (e / extension
                  :mod (c / COOH-terminal))
            :ARG2 (a / anchor-01
                  :ARG1 p
                  :ARG2 (a2 / aspect
                        :mod (c2 / cytosolic)
                        :mod (e2 / endoplasmic
                              :mod (r / reticulum)))))
        :snt2 (a3 / activate-01
            :ARG0 (a4 / adhesion
                  :mod (m / mediate-01
                        :ARG1 (i / integrin)))
            :ARG1 (c3 / calpain)
            :ARG2 (p2 / protease
                  :ARG1 c3
                  :ARG2 (c4 / cleave-01
                        :ARG1 (e3 / extension)
                        :ARG2 (a5 / allow-01
                              :ARG0 (p3 / phosphatase)
                              :ARG1 (r2 / relocate-01
                                    :ARG0 p3
                                    :ARG2 (a6 / adhesion
                                          :mod (f / focal)))))))","(p / possess-01
    :ARG0 (p2 / protein :name (n / name :op1 ""PTP-PEST""))
    :ARG1 (e / extension
        :mod (c / COOH-terminal)
        :ARG1-of (a / anchor-01
            :ARG2 (a2 / aspect
                :mod (c2 / cytosolic)
                :part (e2 / endoplasmic-reticulum)))))
(s / multi-sentence
    :snt1 (a3 / activate-01
        :ARG0 (a4 / adhesion
            :mod (i / integrin-mediated))
        :ARG1 (c3 / calpain
            :mod (p3 / protease)))
    :snt2 (c4 / cleave-01
        :ARG0 c3
        :ARG1 e)
    :snt3 (a5 / allow-01
        :ARG0 c4
        :ARG1 (r / relocate-01
            :ARG0 (p4 / phosphatase)
            :ARG1 (a6 / adhesion
                :mod (f / focal))))))",-1.0,-1.0
bel_pmid_1044_6041.18586,"In addition to activating FAK, some b1 and av integrins also activate the tyrosine kinase Fyn and, through it, the adapter protein Shc (4).","(a3 / activate-01
    :li 4
    :ARG0 (a / activate-01
        :ARG0 (a6 / and
            :mod (s2 / some)
            :op1 (s / small-molecule
                :name (n2 / name
                    :op1 ""b1""
                    :op1 ""tyrosine""
                    :op2 ""kinase""
                    :op3 ""Fyn""))
            :op2 (p / protein
                :name (n3 / name
                    :op1 ""av""
                    :op2 ""serotonin"")))
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""FAK"")))
    :ARG1 (p2 / protein
        :name (n4 / name
            :op1 ""Great"")
        :path (p4 / protein
            :ARG1-of (a2 / activate-01)
            :part-of (p3 / protein
                :name (n5 / name
                    :op1 ""Shc"")
                :mod (a4 / adapter))))
    :mod (a5 / also))
",test,bio_amr0.8,"(a / and
      :op1 (a2 / activate-01
            :ARG1 (e2 / enzyme :name (n / name :op1 ""FAK"")))
      :op2 (a3 / and
            :op1 (a4 / activate-01
                  :ARG0 (p4 / protein :name (n6 / name :op1 ""b1"" :op2 ""integrin"")
                        :quant (s / some))
                  :ARG1 (e / enzyme :name (n3 / name :op1 ""tyrosine"" :op2 ""kinase"" :op3 ""Fyn""))
                  :mod (a5 / also))
            :op2 (a6 / activate-01
                  :ARG0 (p5 / protein :name (n2 / name :op1 ""b1"" :op2 ""integrin"")
                        :quant s)
                  :ARG1 e
                  :mod a5)
            :ARG0-of (a7 / activate-01
                  :ARG1 (p2 / protein :name (n5 / name :op1 ""Shc"")
                        :mod (a8 / adapter))))
      :ARG1-of (d / describe-01
            :ARG0 (p3 / publication
                  :ARG1-of (c / cite-01
                        :ARG2 4))))","In addition to activating FAK, some b1 and av integrins also activate the tyrosine kinase Fyn and, through it, the adapter protein Shc (4).","(z1 / activate-01
    :ARG0 (z2 / and
              :op1 (z3 / protein
                       :wiki ""BRAF1""
                       :name (z4 / name
                                 :op1 ""b1""
                                 :op2 ""Integrins"")
                       :quant (z5 / some))
              :op2 (z6 / protein
                       :wiki ""BRAF1""
                       :name (z7 / name
                                 :op1 ""av""
                                 :op2 ""Integrins"")
                       :quant z5))
    :ARG1 (z8 / and
              :op1 (z9 / enzyme
                       :wiki ""Fyn""
                       :name (z10 / name
                                  :op1 ""Fyn"")
                       :ARG0-of (z11 / kinase-01
                                     :ARG1 (z12 / tyrosine)))
              :op2 (z13 / protein
                        :wiki ""Shc""
                        :name (z14 / name
                                   :op1 ""Shc"")
                        :ARG0-of (z15 / adapt-01)
                        :path z9))
    :mod (z16 / also)
    :ARG1-of (z17 / add-01
                  :ARG2 (z18 / activate-01
                             :ARG0 z2
                             :ARG1 (z19 / enzyme
                                        :wiki ""Fibroblast_growth_factor_receptor""
                                        :name (z20 / name
                                                   :op1 ""FAK""))))
    :ARG1-of (z21 / describe-01
                  :ARG0 (z22 / publication
                             :ARG1-of (z23 / cite-01
                                           :ARG2 4))))",0.3865546218487394,0.3689320388349514,"(s / some-01
        :ARG1 (a / activate-01
              :ARG0 (i / integrin
                    :mod (b1 / b1)
                    :mod (av / av))
              :ARG1 (f / FAK))
        :ARG1-of (a2 / also
              :op1 (a3 / activate-01
                    :ARG0 i
                    :ARG1 (k / kinase-01
                          :ARG1 (t / tyrosine)
                          :ARG0 (f2 / Fyn)))
              :op2 (p / protein
                    :mod (a4 / adapter)
                    :ARG1 (s / Shc)))
        :ARG2 (n / number
              :quant (d / date-entity
                    :year 4)))","(a / activate-01
    :ARG0 (i / integrin
        :mod (b / b1)
        :mod (a2 / av)
        :mod (s / some))
    :ARG1 (f / FAK)
    :ARG2 (f2 / Fyn
        :mod (t / tyrosine-kinase))
    :ARG3 (s2 / Shc
        :mod (p / protein
            :mod (a3 / adapter)))
    :instrument (i2 / it)
    :conjunction (a4 / activate-01
        :ARG0 i
        :ARG1 f2
        :ARG2 s2
        :instrument i2)
    :mod (a5 / addition))",-1.0,0.2022471910112359
bel_pmid_1044_6041.20870,"Rac promotes cell cycle progression, an effect that correlates with its ability to organize the cytoskeleton and promote spreading, rather than with its ability to activate MAP kinases (63).","(p2 / promote-02
    :ARG0 (r / rate)
    :ARG0-of (e / effect-03
        :ARG1-of (c5 / correlate-01
            :ARG1-of (d / describe-01
                :ARG0 (p5 / publication
                    :ARG1-of (c4 / cite-01
                        :ARG2 63)))
            :ARG2 (c / capable-01
                :ARG1 r
                :ARG1-of (i / instead-of-91
                    :ARG2 (c2 / capable-01
                        :ARG1 r
                        :ARG2 (a / activate-01
                            :ARG0 r
                            :ARG1 (e2 / enzyme
                                :name (n / name
                                    :op1 ""MAP"")
                                :mod (p4 / protein
                                    :name (n2 / name
                                        :op1 ""Bible""))))))
                :ARG2 (a2 / and
                    :op1 (o / organize-01
                        :ARG0 r
                        :ARG1 (c7 / cytoskeleton))
                    :op2 (p3 / promote-02
                        :ARG0 r
                        :ARG1 (s / spread-02))))))
    :ARG1 (p / progress-01
        :ARG1 (c6 / cycle-02
            :ARG1 (c3 / cell))))
",test,bio_amr0.8,"(p / promote-01
      :ARG0 (e / enzyme :name (n / name :op1 ""Rac""))
      :ARG1 (p2 / progress-01
            :ARG1 (c / cycle-02
                  :ARG1 (c2 / cell)))
      :ARG2-of (a / affect-01
            :ARG1-of (c3 / correlate-01
                  :ARG2 (c6 / capable-01
                        :ARG1 e
                        :ARG2 (a4 / and
                              :op1 (o / organize-01
                                    :ARG0 e
                                    :ARG1 (c4 / cytoskeleton))
                              :op2 (p3 / promote-01
                                    :ARG1 (s / spread-02)))
                        :ARG1-of (i / instead-of-91
                              :ARG2 (c7 / capable-01
                                    :ARG1 e
                                    :ARG2 (a3 / activate-01
                                          :ARG0 e
                                          :ARG1 (p4 / protein-family :name (n2 / name :op1 ""MAP"" :op2 ""kinase""))))))))
      :ARG1-of (d / describe-01
            :ARG0 (p5 / publication
                  :ARG1-of (c5 / cite-01
                        :ARG2 63))))","Rac promotes cell cycle progression, an effect that correlates with its ability to organize the cytoskeleton and promote spreading, rather than with its ability to activate MAP kinases (63).","(z1 / promote-02
    :ARG0 (z2 / protein
              :wiki ""Rac_(g3000 / gene)""
              :name (z3 / name
                        :op1 ""Rac""))
    :ARG1 (z4 / progress-01
              :ARG1 (z5 / cycle-02
                        :ARG1 (z6 / cell)))
    :ARG1-of (z7 / affect-01
                 :ARG1-of (z8 / correlate-01
                              :ARG2 (z9 / capable-01
                                        :ARG1 z2
                                        :ARG2 (z10 / and
                                                   :op1 (z11 / organize-01
                                                             :ARG0 z2
                                                             :ARG1 (z12 / cytoskeleton))
                                                   :op2 (z13 / promote-02
                                                             :ARG0 z2
                                                             :ARG1 (z14 / spread-03)))
                                        :ARG1-of (z15 / instead-of-91
                                                      :ARG2 (z16 / capable-01
                                                                 :ARG1 z2
                                                                 :ARG2 (z17 / activate-01
                                                                            :ARG0 z2
                                                                            :ARG1 (z18 / kinase
                                                                                       :wiki ""Mitogen-activated_protein_kinase""
                                                                                       :name (z19 / name
                                                                                                  :op1 ""MAP"")))))))
                 :ARG1-of (z20 / describe-01
                               :ARG0 (z21 / publication
                                          :ARG1-of (z22 / cite-01
                                                        :ARG2 63)))))",0.7924528301886792,0.7547169811320754,"(m / multi-sentence
        :snt1 (p / promote-01
            :ARG0 (r / Rac)
            :ARG1 (p2 / progression
                  :mod (c / cell
                        :mod (c2 / cycle)))
            :ARG1-of (c3 / correlate-01
                  :ARG2 (e / effect
                        :ARG1 (t / that)
                        :ARG2 (o / organize-01
                              :ARG0 r
                              :ARG1 (c4 / cytoskeleton))
                        :ARG2-of (p3 / promote-01
                              :ARG0 r
                              :ARG1 (s / spread-01)))
                  :ARG2-of (a / activate-01
                        :ARG0 r
                        :ARG1 (k / kinase
                              :mod (m / MAP)))))
        :snt2 (n / number
            :op1 ""63""))","(p / promote-01
    :ARG0 (r / rac)
    :ARG1 (p2 / progress-01
        :ARG1 (c / cycle
            :mod (c2 / cell)))
    :ARG2 (e / effect
        :ARG1-of (c3 / correlate-01
            :ARG1 (a / ability
                :poss r
                :ARG1-of (o / organize-01
                    :ARG1 (c4 / cytoskeleton)))
            :ARG2 (p3 / promote-01
                :ARG0 a
                :ARG1 (s / spread-01)))
        :mod (r2 / rather-than
            :ARG2 (a2 / ability
                :poss r
                :ARG1-of (a3 / activate-01
                    :ARG1 (k / kinase
                        :mod (m / map)))))))",-1.0,0.3820224719101124
bel_pmid_1044_6041.24730,"The FAK and Shc pathways are regulated both positively and negatively by tyrosine phosphatases. Integrin-mediated activation of ERK is suppressed in cells that lack the re- ceptor-type protein tyrosine phosphatase a or the cytosolic phosphatase SHP-2 (19). These enzymes dephosphorylate the negative regulatory site in Src-family kinases and thus, presumably, amplify both FAK and Shc signaling.","(m3 / multi-sentence
    :rel (m / mechanism
        :name (n3 / name
            :op1 ""cytosolic""
            :op2 ""phosphatase""))
    :rel (p7 / protein
        :name n3
        :name (n7 / name
            :op1 ""i"")
        :mod (t / this))
    :snt1 (r / regulate-01
        :ARG0 (e3 / enzyme
            :name (n4 / name
                :op1 ""tyrosine""
                :op2 ""phosphatases""))
        :ARG0 (p4 / protein
            :name n3
            :name (n5 / name
                :op1 ""ERK""))
        :ARG1 (a3 / and
            :op1 (e / enzyme
                :name (n / name
                    :op1 ""FAK""))
            :op2 (e2 / enzyme
                :name (n2 / name
                    :op1 ""Shc"")))
        :manner (a4 / and
            :op1 (p2 / positive)
            :op2 (n8 / negative-02)))
    :snt2 (s3 / suppress-01
        :ARG1 (a / activate-01
            :ARG1 p4
            :ARG1-of (m2 / mediate-01
                :ARG0 (i / integrate-01)))
        :ARG1-of (d / describe-01
            :ARG0 (p8 / publication
                :ARG1-of (c4 / cite-01
                    :ARG2 19)))
        :location (c2 / cell
            :ARG0-of (l / lack-01
                :ARG1 (o / or
                    :op1 (p5 / protein
                        :name (n6 / name
                            :op1 ""tyrosine""
                            :op2 ""phosphatase""
                            :op3 ""A""
                            :op3 2)
                        :ARG1-of (t2 / type-03
                            :ARG2 (c3 / certain)))
                    :op2 (p6 / protein
                        :name n3)))))
    :snt3 (p / phosphorylate-01
        :ARG0 (e4 / enzyme
            :mod t)
        :ARG0-of (c / cause-01
            :ARG1 (a2 / amplify-01
                :ARG0 e4
                :ARG1 (a5 / and
                    :op1 e3
                    :op1 (s / signal-07
                        :ARG1 p4)
                    :op2 p4)
                :ARG1-of (p3 / presume-01)))
        :ARG1 (s2 / site
            :ARG0-of (r2 / regulate-01)
            :ARG1-of (n9 / negative-02)
            :part-of (e5 / enzyme
                :mod (f / family
                    :name n7))))
    :snt4 (p9 / publication-91))
",test,bio_amr0.8,"(m / multi-sentence
      :snt2 (s / suppress-01
            :ARG1 (a3 / activate-01
                  :ARG1 (e / enzyme :name (n / name :op1 ""ERK""))
                  :ARG1-of (m2 / mediate-01
                        :ARG0 (p8 / protein :name (n5 / name :op1 ""integrin""))))
            :location (c / cell
                  :ARG0-of (l / lack-01
                        :ARG1 (o / or
                              :op1 (e5 / enzyme :name (n8 / name :op1 ""protein"" :op2 ""tyrosine"" :op3 ""phosphatase"" :op4 ""a"")
                                    :ARG1-of (t / type-03
                                          :ARG2 (r2 / receptor)))
                              :op2 (p9 / phosphatase :name (n7 / name :op1 ""SHP-2"")
                                    :mod (c2 / cytosol)))))
            :ARG1-of (d / describe-01
                  :ARG0 (p4 / publication
                        :ARG1-of (c3 / cite-01
                              :ARG2 19))))
      :snt3 (d2 / dephosphorylate-01
            :ARG1 (s2 / site
                  :ARG1-of (d3 / downregulate-01))
            :ARG2 (e3 / enzyme
                  :mod (t2 / this))
            :ARG3 (k / kinase
                  :ARG1-of (i / include-91
                        :ARG2 (p3 / protein-family :name (n6 / name :op1 ""Src""))))
            :ARG0-of (c4 / cause-01
                  :ARG1 (a4 / amplify-01
                        :ARG1 (a2 / and
                              :op1 (s3 / signal-07
                                    :ARG0 (p6 / pathway :name (n9 / name :op1 ""FAK"")))
                              :op2 (s4 / signal-07
                                    :ARG0 (p7 / pathway :name (n10 / name :op1 ""Shc"")))))
                  :ARG1-of (p5 / presume-01)))
      :snt1 (a6 / and
            :op1 (u / upregulate-01
                  :ARG1 (a / and
                        :op1 (p / pathway :name (n2 / name :op1 ""FAK""))
                        :op2 (p2 / pathway :name (n3 / name :op1 ""Shc"")))
                  :ARG2 (e2 / enzyme :name (n4 / name :op1 ""tyrosine"" :op2 ""phosphatase"")))
            :op2 (d4 / downregulate-01
                  :ARG1 a
                  :ARG2 e2)))","The FAK and Shc pathways are regulated both positively and negatively by tyrosine phosphatases. Integrin-mediated activation of ERK is suppressed in cells that lack the re- ceptor-type protein tyrosine phosphatase a or the cytosolic phosphatase SHP-2 (19). These enzymes dephosphorylate the negative regulatory site in Src-family kinases and thus, presumably, amplify both FAK and Shc signaling.","(z1 / suppress-01
    :ARG0 (z2 / enzyme
              :mod (z3 / this)
              :ARG0-of (z4 / phosphorylate-01
                           :ARG1 (z5 / site
                                     :ARG0-of (z6 / regulate-01)
                                     :ARG0-of (z7 / negative-02)
                                     :part-of (z8 / kinase
                                                  :wiki ""BRAF_(g3000 / gene)""
                                                  :name (z9 / name
                                                            :op1 ""Src-family"")
                                                  :ARG0-of (z10 / kinase-01))))
              :ARG0-of (z11 / cause-01
                            :ARG1 (z12 / inhibit-01
                                       :ARG0 z2
                                       :ARG1 (z13 / enzyme
                                                  :wiki ""ERK_(g3001 / gene)""
                                                  :name (z14 / name
                                                             :op1 ""ERK""))
                                       :ARG1-of (z15 / activate-01
                                                     :ARG0 (z16 / enzyme
                                                                :wiki ""Integrin""
                                                                :name (z17 / name
                                                                           :op1 ""Integrin""))))))
    :ARG1-of (z18 / describe-01
                  :ARG0 (z19 / publication
                             :ARG1-of (z20 / cite-01
                                           :ARG2 19)))
    :location (z21 / cell
                   :ARG0-of (z22 / lack-01
                                 :ARG1 (z23 / or
                                            :op1 (z24 / protein
                                                      :wiki ""BRAF_(g3002 / gene)""
                                                      :name (z25 / name
                                                                 :op1 ""tyrosine""
                                                                 :op2 ""phosphatase""
                                                                 :op3 ""a"")
                                                      :mod (z26 / type
                                                                :mod (z27 / protractor
                                                                          :mod (z28 / re))))
                                            :op2 (z29 / enzyme
                                                      :wiki ""SHP-2""
                                                      :name (z30 / name
                                                                 :op1 ""SHP-2"")
                                                      :mod (z31 / phosphatase
                                                                :mod (z32 / cytosolic)))))))",0.3384615384615385,0.5213675213675214,"(m / multi-sentence
        :snt1 (r / regulate-01
            :ARG0 (p / pathway
                  :mod (f / FAK)
                  :mod (s / Shc))
            :ARG1 (p2 / positive
                  :mod (t / tyrosine
                        :mod (p3 / phosphatase))))
        :snt2 (r2 / regulate-01
            :ARG0 p
            :ARG1 (n / negative
                  :mod (t2 / tyrosine
                        :mod (p4 / phosphatase))))
        :snt3 (s / suppress-01
            :ARG0 (a / activation
                  :mod (i / Integrin-mediated)
                  :ARG1 (e / ERK))
            :ARG1 (c / cell
                  :mod (l / lack-01
                        :ARG1 (p5 / protein
                              :mod (t3 / tyrosine
                                    :mod (p6 / phosphatase
                                          :ARG0-of (a2 / or
                                                :op1 (a3 / a)
                                                :op2 (p7 / phosphatase
                                                      :mod (c2 / cytosolic
                                                            :mod (s2 / SHP-2))))))))
            :ARG2 (s3 / site
                  :mod (r2 / regulatory)
                  :ARG1-of (d / dephosphorylate-01
                        :ARG0 (e2 / enzyme)
                        :ARG1 (s4 / Src-family
                              :mod (k / kinase)
                              :mod (n2 / negative)))))
        :snt4 (a4 / amplify-01
            :ARG0 (e3 / enzyme)
            :ARG1 (s5 / signaling
                  :mod (f2 / FAK)
                  :mod (s6 / Shc))))","(r / regulate-01
    :ARG1 (p / pathway
        :name (n / name
            :op1 ""FAK""
            :op2 ""Shc""))
    :ARG2 (p2 / phosphatase
        :mod (t / tyrosine))
    :manner (b / both
        :op1 (p3 / positive)
        :op2 (n2 / negative)))
(s / suppress-01
    :ARG1 (a / activate-01
        :ARG0 (i / integrin)
        :ARG1 (e / ERK))
    :location (c / cell
        :ARG1-of (l / lack-01
            :ARG2 (o / or
                :op1 (p4 / phosphatase
                    :mod (t2 / tyrosine)
                    :mod (r2 / receptor-type)
                    :mod (p5 / protein)
                    :mod (a2 / alpha))
                :op2 (p6 / phosphatase
                    :mod (c2 / cytosolic)
                    :name (n3 / name :op1 ""SHP-2""))))))
(d / dephosphorylate-01
    :ARG0 (e2 / enzyme)
    :ARG1 (s2 / site
        :mod (r3 / regulatory)
        :mod (n4 / negative)
        :location (k / kinase
            :mod (s3 / Src-family)))
(a3 / amplify-01
    :ARG1 (p7 / pathway
        :name (n5 / name
            :op1 ""FAK""
            :op2 ""Shc""))
    :manner (p8 / presume-01))",-1.0,0.2994652406417112
bel_pmid_1044_6219.5996,"Here, we report that Stat3 was specifically associated with PKC delta in vivo in an IL-6-dependent manner in several cell types. Furthermore, Stat3 was phosphorylated by PKC delta in vivo on Ser-727,","(m3 / multi-sentence
    :snt1 (r / report-01
        :ARG0 (w / we)
        :ARG1 (a2 / associate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op1 ""Stat3""))
            :ARG1-of (s3 / specific-02)
            :ARG2 (s2 / small-molecule
                :name (n2 / name
                    :op1 ""PKC""
                    :op2 ""delta""))
            :location (t / type
                :quant (s / several)
                :mod (c / cell))
            :manner (m / manner
                :ARG0-of (d / depend-01
                    :ARG1 (n3 / name
                        :op1 ""6"")))
            :mod (v / vivo))
        :location (h / here))
    :snt2 (a / and
        :op2 (p / phosphorylate-01
            :ARG0 (e2 / enzyme
                :name (n4 / name))
            :ARG2 (m2 / member
                :mod 727)
            :mod (v2 / vivo))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (r / report-01
            :ARG0 (w / we)
            :ARG1 (a / associate-01
                  :ARG1 (p / protein :name (n / name :op1 ""Stat3""))
                  :ARG2 (e / enzyme :name (n2 / name :op1 ""PKC"" :op2 ""delta""))
                  :ARG1-of (s / specific-02)
                  :manner (i / in-vivo)
                  :location (t / type-03
                        :ARG1 (c / cell)
                        :quant (s2 / several))
                  :manner (d / depend-01
                        :ARG1 (p4 / protein :name (n6 / name :op1 ""IL-6""))))
            :location (h / here))
      :snt2 (a3 / and
            :op2 (p2 / phosphorylate-01
                  :ARG1 (a2 / amino-acid :mod 727 :name (n5 / name :op1 ""serine"")
                        :part-of (p3 / protein :name (n3 / name :op1 ""Stat3"")))
                  :ARG2 (e2 / enzyme :name (n4 / name :op1 ""PKA"" :op2 ""delta"")
                        :manner (i2 / in-vivo)))))","Here, we report that Stat3 was specifically associated with PKC delta in vivo in an IL-6-dependent manner in several cell types. Furthermore, Stat3 was phosphorylated by PKC delta in vivo on Ser-727,","(z1 / report-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / associate-01
              :ARG1 (z4 / small-molecule
                        :wiki ""Strychnosine_kinase_3""
                        :name (z5 / name
                                  :op1 ""Stat3""))
              :ARG2 (z6 / protein
                        :wiki ""PHLDA-1""
                        :name (z7 / name
                                  :op1 ""PKC""
                                  :op2 ""delta""))
              :manner (z8 / specific-02)
              :location (z9 / cell
                            :mod (z10 / type
                                      :quant (z11 / several)))
              :manner (z12 / depend-01
                           :ARG0 z6
                           :ARG1 (z13 / enzyme
                                      :wiki ""IL-6""
                                      :name (z14 / name
                                                 :op1 ""IL-6"")))
              :location (z15 / vivo))
    :location (z16 / here))",0.4399999999999999,0.6000000000000001,"(m / multi-sentence
        :snt1 (r / report-01
            :ARG1 (w / we)
            :ARG2 (a / associate-01
                  :ARG1 (s / specific-02
                        :ARG1 (s2 / Stat3))
                  :ARG2 (a2 / associate-01
                        :ARG1 (p / PKC)
                        :ARG2 (d / delta))
                  :ARG3 (m2 / manner
                        :mod (d2 / dependent)
                        :mod (i / in
                              :mod (t / type
                                    :quant (s3 / several)
                                    :mod (c / cell)))))
        :snt2 (p / phosphorylate-01
            :ARG0 (s4 / Stat3)
            :ARG1 (p2 / PKC)
            :ARG2 (s5 / Ser-727)
            :mod (i2 / in
                  :mod (v / vivo))))","(r / report-01
    :ARG0 (w / we)
    :location (h / here)
    :ARG1 (a / associate-01
        :ARG0 (s / protein :name (n / name :op1 ""Stat3""))
        :ARG1 (p / protein :name (n2 / name :op1 ""PKC"" :op2 ""delta""))
        :mod (s2 / specific)
        :location (v / vivo)
        :condition (d / depend-01
            :ARG1 (m / manner)
            :ARG2 (i / interleukin :name (n3 / name :op1 ""IL-6"")))
        :ARG1-of (i2 / include-91
            :ARG2 (c / cell :mod (t / type :quant (s3 / several)))))
    :ARG2 (p2 / phosphorylate-01
        :ARG0 p
        :ARG1 s
        :location v
        :ARG2 (a2 / amino-acid :name (n4 / name :op1 ""Ser-727""))))",-1.0,0.4909090909090909
bio.chicago_2015.157,"Given that  p53 interacts with  p300/CBP ( 3,  26,  51), the same membrane was then probed with polyclonal  anti-CBP antibodies, which detect both  p300 and  CBP ( 4,  56).","(p2 / probe-01
    :ARG1 (m / membrane
        :ARG1-of (s / same-01))
    :ARG1-of (c / cause-01
        :ARG0 (i / interact-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op1 ""p53""))
            :ARG2 (s2 / slash
                :ARG1-of (i2 / ionize-01)
                :op1 (p3 / protein
                    :quant 300)
                :op2 (a / and
                    :op3 26)
                :op2 (p4 / protein
                    :name (n2 / name
                        :op1 ""CBP"")))))
    :ARG2 (v / virus
        :ARG0-of (c4 / counter-01)
        :ARG0-of (d3 / detect-01
            :ARG1 (a2 / and
                :op1 p3)
            :ARG1-of (d / describe-01
                :ARG0 (p5 / publication
                    :ARG1-of (c2 / cite-01
                        :ARG2 4)
                    :ARG1-of (d2 / describe-01
                        :ARG0 (p6 / publication
                            :ARG1-of (c3 / cite-01
                                :ARG2 56))))))
        :mod (p / polyclonal))
    :rel 51
    :rel 3
    :time (t / then))
",test,bio_amr0.8,"(c / cause-01
      :ARG0 (i / interact-01
            :ARG0 (p / protein :name (n / name :op1 ""p53""))
            :ARG1 (s / slash
                  :op1 (p2 / protein :name (n2 / name :op1 ""p300""))
                  :op2 (p3 / protein :name (n3 / name :op1 ""CBP""))))
      :ARG1 (p5 / probe-01
            :ARG0 (a2 / antibody
                  :ARG0-of (o / oppose-01
                        :ARG1 p3)
                  :mod (p7 / polyclonal)
                  :ARG0-of (d2 / detect-01
                        :ARG1 (a3 / and
                              :op1 p2
                              :op2 p3)
                        :ARG1-of (d3 / describe-01
                              :ARG0 (p8 / publication
                                    :ARG1-of (c3 / cite-01
                                          :ARG2 (a4 / and :op1 4 :op2 56))))))
            :ARG1 (m / membrane
                  :ARG1-of (s2 / same-01)))
      :ARG1-of (d / describe-01
            :ARG0 (p4 / publication
                  :ARG1-of (c2 / cite-01
                        :ARG2 (a / and :op1 3 :op2 26 :op3 51)))))","Given that  p53 interacts with  p300/CBP ( 3,  26,  51), the same membrane was then probed with polyclonal  anti-CBP antibodies, which detect both  p300 and  CBP ( 4,  56).","(z1 / cause-01
    :ARG0 (z2 / interact-01
              :ARG0 (z3 / protein
                        :wiki ""P53""
                        :name (z4 / name
                                  :op1 ""p53""))
              :ARG1 (z5 / slash
                        :op1 (z6 / protein
                                 :wiki ""P300/CBP""
                                 :name (z7 / name
                                           :op1 ""p300/CBP""))
                        :op2 (z8 / protein
                                 :wiki ""P53""
                                 :name (z9 / name
                                           :op1 ""p300/CBP""))
                        :ARG1-of (z10 / describe-01
                                      :ARG0 (z11 / and
                                                 :op1 (z12 / publication
                                                           :ARG1-of (z13 / cite-01
                                                                         :ARG2 3))
                                                 :op2 (z14 / publication
                                                           :ARG1-of (z15 / cite-01
                                                                         :ARG2 26))
                                                 :op3 (z16 / publication
                                                           :ARG1-of (z17 / cite-01
                                                                         :ARG2 51))))))
    :ARG1 (z18 / probe-01
               :ARG1 (z19 / membrane
                          :ARG1-of (z20 / same-01))
               :ARG2 (z21 / antibody
                          :ARG0-of (z22 / counter-01
                                        :ARG1 z5)
                          :mod (z23 / polyclonal)
                          :ARG0-of (z24 / detect-01
                                        :ARG1 (z25 / and
                                                   :op1 z6
                                                   :op2 z8)
                                        :ARG1-of (z26 / describe-01
                                                      :ARG0 (z27 / publication
                                                                 :ARG1-of (z28 / cite-01
                                                                               :ARG2 4))))
                          :ARG1-of (z29 / cite-01
                                        :ARG2 56)))
    :time (z30 / then))",0.562962962962963,0.5833333333333334,"(m / multi-sentence
        :snt1 (g / give-01
            :ARG1 (i / interact-01
                  :ARG0 (p / p53)
                  :ARG1 (w / with
                        :ARG1 (p2 / p300/CBP
                              :ARG1-of (d / detect-01
                                    :ARG1 (a / antibody
                                          :mod (p3 / polyclonal)
                                          :ARG1-of (p4 / probe-01
                                                :ARG0 (m2 / membrane
                                                      :mod (s / same))))
                                    :ARG2 (p5 / p300)
                                    :ARG2 (c / CBP)))))
            :ARG2 (a2 / antibody
                  :mod (p6 / polyclonal)
                  :ARG1-of (p7 / probe-01
                        :ARG0 m2
                        :ARG1 (d2 / detect-01
                              :ARG1 (p8 / p300)
                              :ARG2 c))))
        :snt2 (g2 / give-01
            :ARG1 (i2 / interact-01
                  :ARG0 p
                  :ARG1 (w2 / with
                        :ARG1 p2))
            :ARG2 (a3 / antibody
                  :mod (p9 / polyclonal)
                  :ARG1-of (p10 / probe-01
                        :ARG0 m2
                        :ARG1 (d3 / detect-01
                              :ARG1 p8
                              :ARG2 c))))","(g / give-01
    :ARG1 (i / interact-01
        :ARG0 (p / protein :name ""p53"")
        :ARG1 (p2 / protein :name ""p300/CBP""))
    :condition (p3 / probe-01
        :ARG0 (m / membrane :mod (s / same))
        :ARG1 (a / antibody
            :mod (p4 / polyclonal)
            :mod (a2 / anti)
            :mod (c / CBP))
        :time (t / then)
        :ARG2 (d / detect-01
            :ARG0 a
            :ARG1 (p5 / protein :name ""p300"")
            :ARG2 (p6 / protein :name ""CBP""))))",-1.0,0.2708333333333333
bio.chicago_2015.376,"Thus, the difference between  Knirps and other short-range  transcriptional repressors may indicate that the mechanism of repression is not identical between these proteins, even though  Giant,  Knirps, and  Kruppel all interact with the  CtBP.","(i3 / infer-01
    :ARG1 (p / possible-01
        :ARG1 (i2 / indicate-01
            :ARG0 (d / differ-02)
            :ARG1 (i / identical-01
                :ARG1 (m / mechanism
                    :ARG0-of (r3 / repress-01))
                :ARG2 (p2 / protein
                    :mod (t / this))
                :concession (i4 / interact-01
                    :ARG0 (a / and
                        :op1 (p3 / protein
                            :name (n / name
                                :op1 ""Giant""
                                :op1 ""Knirps""))
                        :op2 p3
                        :op3 (p4 / protein
                            :name (n2 / name
                                :op1 ""Kruppel"")
                            :name (n3 / name
                                :op1 ""CtBP""))))
                :polarity -)))
    :rel (r2 / repress-01
        :ARG0-of (e / express-03)
        :ARG1-of (r / range-01
            :ARG1-of (s / short-07)))
    :rel (o / other))
",test,bio_amr0.8,"(c / cause-01
      :ARG1 (p3 / possible-01
            :ARG1 (i / indicate-01
                  :ARG0 (d / differ-02
                        :ARG1 (p2 / protein :name (n / name :op1 ""Knirps""))
                        :ARG2 (p / protein
                              :ARG0-of (r / repress-01
                                    :ARG1 (t / transcribe-01))
                              :mod (o / other)
                              :mod (r2 / range
                                    :ARG1-of (s / short-07))))
                  :ARG1 (i2 / identical-01 :polarity -
                        :ARG1 (m / mechanism
                              :mod r
                              :poss p2)
                        :ARG2 (m2 / mechanism
                              :mod r
                              :poss p)
                        :concession (i3 / interact-01
                              :ARG0 (a / and
                                    :op1 (p4 / protein :name (n2 / name :op1 ""Giant""))
                                    :op2 p2
                                    :op3 (p6 / protein :name (n4 / name :op1 ""Kruppel""))
                                    :mod (a2 / all))
                              :ARG1 (p7 / protein :name (n5 / name :op1 ""CtBP"")))))))","Thus, the difference between  Knirps and other short-range  transcriptional repressors may indicate that the mechanism of repression is not identical between these proteins, even though  Giant,  Knirps, and  Kruppel all interact with the  CtBP.","(z1 / infer-01
    :ARG1 (z2 / possible-01
              :ARG1 (z3 / indicate-01
                        :ARG0 (z4 / differ-02
                                  :ARG1 (z5 / protein
                                            :wiki ""Knirps""
                                            :name (z6 / name
                                                      :op1 ""Knirps""))
                                  :ARG2 (z7 / protein
                                            :ARG0-of (z8 / repress-01
                                                         :ARG1 (z9 / transcription))
                                            :mod (z10 / other)
                                            :mod (z11 / range
                                                      :ARG1-of (z12 / short-07)))))
              :ARG1 (z13 / mechanism
                         :manner-of (z14 / repress-01)
                         :ARG1-of (z15 / identical-01
                                       :polarity -
                                       :ARG2 (z16 / mechanism
                                                  :manner-of z14)
                                       :concession (z17 / interact-01
                                                        :ARG0 (z18 / protein
                                                                   :wiki ""Large_C-Gene""
                                                                   :name (z19 / name
                                                                              :op1 ""Giant""))
                                                        :ARG1 (z20 / protein
                                                                   :wiki ""Knirps""
                                                                   :name (z21 / name
                                                                              :op1 ""Knirps""))
                                                        :ARG1-of (z22 / include-91
                                                                      :ARG2 (z23 / protein
                                                                                 :wiki ""Kruppel_(g3000 / gene)""
                                                                                 :name (z24 / name
                                                                                            :op1 ""Kruppel""))))
                                       :ARG2 (z25 / protein
                                                  :wiki ""Cyclin-dependent_protein_kinase""
                                                  :name (z26 / name
                                                             :op1 ""CtBP""))))))",0.5573770491803278,0.490566037735849,"(m / multi-sentence
        :snt1 (i / indicate-01
            :ARG1 (d / difference
                  :mod (t / that)
                  :ARG1-of (b / between
                        :op1 (p / protein
                              :name (n / name :op1 ""Knirps""))
                        :op2 (p2 / protein
                              :mod (s / short-range)
                              :mod (t2 / transcriptional)
                              :mod (r / repressor))))
                  :ARG2 (m2 / mechanism
                        :ARG1-of (i2 / identical
                              :op1 (p3 / protein
                                    :mod (t3 / these))))
                  :ARG2-of (r / repression-01))
            :ARG2 (p4 / protein
                  :mod (t4 / these)
                  :mod (i3 / identical)
                  :mod (m3 / mechanism)
                  :mod (r2 / repression)
                  :mod (s2 / short-range)
                  :mod (t5 / transcriptional)
                  :mod (o / other)))
        :snt2 (i4 / interact-01
            :ARG0 (g / Giant)
            :ARG1 (p5 / protein
                  :mod (t6 / these)
                  :mod (i5 / identical)
                  :mod (m4 / mechanism)
                  :mod (r3 / repression)
                  :mod (s3 / short-range)
                  :mod (t7 / transcriptional)
                  :mod (w / with)
                  :ARG1-of (c / CtBP))
            :ARG2 (k / Knirps))
        :snt3 (i6 / interact-01
            :ARG0 g
            :ARG1 p5
            :ARG2 (k2 / Kruppel)))","(d / difference-01
    :ARG1 (k / knirps)
    :ARG2 (r / repressor-01
        :mod (t / transcriptional)
        :range (s / short)
        :mod (o / other))
    :ARG3 (i / indicate-01
        :ARG1 (m / mechanism
            :mod (r2 / repress-01)
            :ARG1-of (i2 / identical-01
                :ARG2 (p / protein
                    :example (a / and
                        :op1 (g / giant)
                        :op2 k
                        :op3 (kr / kruppel))
                :mod (t2 / these))
            :mod (n / not)))
    :condition (i3 / interact-01
        :ARG0 a
        :ARG1 (c / ctbp))
    :mod (t3 / thus))",-1.0,0.3265306122448979
bio.chicago_2015.596,"In summary, transgenic embryos for   wg-Gal4/UAS-GFP or   ems-Gal4/UAS-GFP accurately reproduce the expression of   wg or   ems that depends on  AbdA or  AbdB.","(r / reproduce-01
    :ARG0 (e / embryo
        :beneficiary (o / or
            :op1 (c / cell
                :name (n / name
                    :op1 ""E-4""))
            :op2 (p / product
                :name (n2 / name
                    :mode ""imperative""
                    :op2 ""GFP"")))
        :mod (g / gene))
    :ARG1 (e2 / express-01
        :ARG0-of (d / depend-01
            :ARG1 (o3 / or
                :op1 (t / thing
                    :name (n3 / name
                        :op1 ""AbdA""))
                :op2 (t2 / thing
                    :name (n4 / name
                        :op1 ""AbdB""))))
        :ARG1 (o2 / or
            :op1 c
            :op1 t
            :op2 p))
    :ARG2-of (s / summarize-01)
    :manner (a / accurate)
    :rel (i / imperative))
",test,bio_amr0.8,"(s2 / summarize-01
      :ARG2 (r / reproduce-01
            :ARG0 (e / embryo
                  :mod (t2 / transgenic)
                  :poss (o / or
                        :op1 (o4 / organism :name (n / name :op1 ""wg-Gal4/UAS-GFP""))
                        :op2 (o5 / organism :name (n2 / name :op1 ""ems-Gal4/UAS-GFP""))))
            :ARG1 (e4 / express-03
                  :ARG2 (o2 / or
                        :op1 (p3 / protein :name (n3 / name :op1 ""wg""))
                        :op2 (p4 / protein :name (n4 / name :op1 ""ems"")))
                  :ARG0-of (d / depend-01
                        :ARG1 (o3 / or
                              :op1 (p / protein :name (n5 / name :op1 ""AbdA""))
                              :op2 (p2 / protein :name (n6 / name :op1 ""AbdB"")))))
            :mod (a / accurate)))","In summary, transgenic embryos for   wg-Gal4/UAS-GFP or   ems-Gal4/UAS-GFP accurately reproduce the expression of   wg or   ems that depends on  AbdA or  AbdB.","(z1 / reproduce-01
    :ARG0 (z2 / embryo
              :mod (z3 / transgenic)
              :purpose (z4 / or
                           :op1 (z5 / gene
                                    :wiki ""BRAF_(g3000 / gene)""
                                    :name (z6 / name
                                              :op1 ""wg-Gal4/UAS-GFP""))
                           :op2 (z7 / gene
                                    :wiki ""Erythropoietin""
                                    :name (z8 / name
                                              :op1 ""ems-Gal4/UAS-GFP""))
                           :op3 (z9 / gene
                                    :wiki ""BRAF_(g3001 / gene)""
                                    :name (z10 / name
                                               :op1 ""AbdA""))
                           :op4 (z11 / gene
                                     :wiki ""BRAF_(g3002 / gene)""
                                     :name (z12 / name
                                                :op1 ""AbdB"")))))",0.3902439024390243,0.3958333333333333,"(s / summary-01
    :ARG1 (r / reproduce-01
        :ARG0 (e / embryo
            :mod (t / transgenic))
        :ARG1 (e2 / expression
            :ARG0 (r2 / reproduce-01
                :ARG0 (e3 / embryo
                    :mod (t2 / transgenic))
                :ARG1 (e4 / expression
                    :ARG0 (g / gene
                        :name (w / wg)
                        :mod (g2 / Gal4/UAS-GFP)))
                :ARG2 (d / depend-01
                    :ARG1 (a / AbdA)
                    :ARG2 (a2 / AbdB))))
            :mod (a3 / accurately)))","(s / summary-01
    :ARG1 (r / reproduce-01
        :ARG0 (e / embryo
            :mod (t / transgenic)
            :ARG1-of (f / for-91
                :ARG2 (o / or
                    :op1 (c / construct-01
                        :ARG1 (g / gene :name (n / name :op1 ""wg""))
                        :ARG2 (g2 / gene :name (n2 / name :op1 ""Gal4""))
                        :ARG3 (g3 / gene :name (n3 / name :op1 ""UAS-GFP"")))
                    :op2 (c2 / construct-01
                        :ARG1 (g4 / gene :name (n4 / name :op1 ""ems""))
                        :ARG2 g2
                        :ARG3 g3))))
        :ARG1 (o2 / or
            :op1 (g5 / gene :name (n5 / name :op1 ""wg""))
            :op2 (g6 / gene :name (n6 / name :op1 ""ems"")))
        :ARG2 (d / depend-01
            :ARG1 o2
            :ARG2 (o3 / or
                :op1 (g7 / gene :name (n7 / name :op1 ""AbdA""))
                :op2 (g8 / gene :name (n8 / name :op1 ""AbdB""))))))",-1.0,0.4869565217391305
bio.chicago_2015.627,Table I        dCtBP specifically interacts with  Hairy and E( spl)mdelta  bHLH family members in directed  yeast two-hybrid assays (beta-galactosidase activity in diploid  yeast strains),"(i / interact-01
    :ARG0 (p / protein
        :name (n / name
            :op1 ""dCtBP""))
    :ARG1 (a2 / and
        :op1 (h / have-org-role-91
            :ARG1 (f / family
                :name (n3 / name
                    :op2 ""bHLH""))
            :ARG2 (m2 / member)))
    :ARG2 (a3 / ass
        :ARG1-of (d2 / direct-01)
        :ARG1-of (m / mean-01
            :ARG2 (a / activity-06
                :ARG0 (e / enzyme
                    :name (n5 / name
                        :op1 ""galactosidase""))
                :location (s2 / strain
                    :mod (y2 / yeast
                        :mod (d / diploid)))))
        :mod (h2 / hybrid
            :quant 2))
    :manner (s / specific-02)
    :rel (n2 / name
        :op1 ""Hairy"")
    :rel (f2 / family
        :name (n4 / name
            :op1 ""E""))
    :rel (y / yeast)
    :source (t / table
        :mod I))
",test,bio_amr0.8,"(i / interact-01
      :ARG0 (p3 / protein :name (n / name :op1 ""dCtBP"")
            :ARG1-of (d / describe-01
                  :ARG0 (t / table :mod ""I"")))
      :ARG1 (a / and
            :op1 (p / protein :name (n2 / name :op1 ""Hairy""))
            :op2 (m / member
                  :ARG1-of (i2 / include-91
                        :ARG2 (p2 / protein-family :name (n3 / name :op1 ""E(spl)mdelta-bHLH"")))))
      :ARG1-of (s / specific-02)
      :location (a2 / assay-01
            :mod (h / hybrid :quant 2)
            :mod (y / yeast)
            :ARG1-of (d3 / direct-01))
      :ARG1-of (m2 / mean-01
            :ARG2 (a3 / activity-06
                  :ARG0 (e / enzyme :name (n4 / name :op1 ""beta-galactosidase""))
                  :location (s3 / strain
                        :mod (d2 / diploid)
                        :mod y))))",Table I        dCtBP specifically interacts with  Hairy and E( spl)mdelta  bHLH family members in directed  yeast two-hybrid assays (beta-galactosidase activity in diploid  yeast strains),"(z1 / interact-01
    :ARG0 (z2 / enzyme
              :wiki ""Cyclin-dependent_protein_kinase""
              :name (z3 / name
                        :op1 ""dCtBP""))
    :ARG1 (z4 / member
              :part-of (z5 / family
                           :wiki ""Hairy""
                           :name (z6 / name
                                     :op1 ""Hairy""))
              :part-of (z7 / family
                           :wiki ""BRAF-rich_glycoprotein""
                           :name (z8 / name
                                     :op1 ""E(_spl)mdelta""
                                     :op2 ""bHLH"")))
    :ARG2 (z9 / assay
              :mod (z10 / yeast)
              :mod (z11 / hybrid
                        :quant 2)
              :ARG1-of (z12 / direct-01)
              :example (z13 / activity-06
                            :ARG0 (z14 / enzyme
                                       :wiki ""Beta_glycoprotein""
                                       :name (z15 / name
                                                  :op1 ""beta-galactosidase""))
                            :location (z16 / strain
                                           :mod (z17 / yeast
                                                     :mod (z18 / diploid))))))",0.4489795918367347,0.4528301886792453,"(m / multi-sentence
        :snt1 (i / interact-01
            :ARG0 (d / dCtBP)
            :ARG1 (h / Hairy)
            :ARG1 (m / member
                  :mod (f / family
                        :mod (b / bHLH)))
            :ARG1 (m2 / member
                  :mod (e / E( spl)mdelta)))
        :snt2 (a / assay-01
            :ARG0 (y / yeast)
            :ARG1 (a2 / activity
                  :mod (b2 / beta-galactosidase))
            :ARG1-of (d2 / direct-01
                  :ARG2 (y2 / yeast
                        :mod (s / strain
                              :mod (d3 / diploid))))))","(i / interact-01
    :ARG0 (p / protein :name (n / name :op1 ""dCtBP""))
    :ARG1 (p2 / protein :name (n2 / name :op1 ""Hairy""))
    :ARG2 (p3 / protein :name (n3 / name :op1 ""E(spl)mdelta""))
    :ARG3 (f / family :name (n4 / name :op1 ""bHLH""))
    :mod (s / specific)
    :location (a / assay
        :mod (y / yeast :mod (t / two) :mod (h / hybrid))
        :ARG1-of (d / direct-01)
        :condition (a2 / activity
            :ARG1 (b / beta-galactosidase)
            :location (s2 / strain
                :mod (y2 / yeast)
                :mod (d2 / diploid)))))",-1.0,0.5208333333333334
bio.chicago_2015.710,"Recent studies have demonstrated that the  Sina and  Phyl proteins form a ternary complex with  Ttk and promote ubiquitination and rapid degradation of  Ttk through the  proteasome pathway ( 14,  22).","(d2 / demonstrate-01
    :ARG0 (s / study-01
        :time (r2 / recent))
    :ARG1 (a2 / and
        :op1 (f / form-01
            :ARG0 (a / and
                :op1 (p3 / protein
                    :name (n / name
                        :op1 ""Sina""))
                :op2 (p4 / protein
                    :name (n2 / name
                        :op1 ""Phyl"")))
            :ARG1 (c2 / complex
                :accompanier (p6 / protein
                    :name (n3 / name
                        :op1 ""Ttk""))
                :mod (t / ternary)))
        :op2 (p2 / promote-01
            :ARG0 a
            :ARG1 (a3 / and
                :op1 (p / proliferate-01
                    :ARG1 p6)
                :op2 (d / degrade-01
                    :ARG1 p6
                    :manner (r / rapid)
                    :path (e / enzyme
                        :name (n4 / name
                            :op1 ""proteasome""
                            :op2 ""pathway""))))))
    :ARG1-of (c / cite-01
        :ARG2 (a4 / and
            :op1 14
            :op2 22))
    :rel (p5 / protein
        :name n2))
",test,bio_amr0.8,"(d / demonstrate-01
      :ARG0 (s / study
            :time (r / recent))
      :ARG1 (a2 / and
            :op1 (f / form-01
                  :ARG1 (c / complex
                        :mod (t / ternary))
                  :ARG2 (a / and
                        :op1 (p / protein :name (n / name :op1 ""Sina""))
                        :op2 (p2 / protein :name (n2 / name :op1 ""Phyl""))
                        :op3 (e / enzyme :name (n3 / name :op1 ""Ttk""))))
            :op2 (p3 / promote-01
                  :ARG0 (a4 / and
                        :op1 p
                        :op2 p2)
                  :ARG1 (a3 / and
                        :op1 (u / ubiquitinate-01
                              :ARG1 e)
                        :op2 (d2 / degrade-01
                              :ARG1 e
                              :mod (r2 / rapid))))
            :instrument (p4 / pathway :name (n4 / name :op1 ""proteasome"")))
      :ARG1-of (d3 / describe-01
            :ARG0 (p6 / publication
                  :ARG1-of (c2 / cite-01
                        :ARG2 (a5 / and :op1 14 :op2 22)))))","Recent studies have demonstrated that the  Sina and  Phyl proteins form a ternary complex with  Ttk and promote ubiquitination and rapid degradation of  Ttk through the  proteasome pathway ( 14,  22).","(z1 / demonstrate-01
    :ARG0 (z2 / study-01
              :time (z3 / recent))
    :ARG1 (z4 / and
              :op1 (z5 / form-01
                       :ARG0 (z6 / and
                                 :op1 (z7 / protein
                                          :wiki ""Sodium-phosphate""
                                          :name (z8 / name
                                                    :op1 ""Sina""
                                                    :op2 ""and""
                                                    :op3 ""Phyl""))
                                 :op2 (z9 / protein
                                          :wiki ""Threonine_kinase""
                                          :name (z10 / name
                                                     :op1 ""Ttk"")))
                       :ARG1 (z11 / complex
                                  :mod (z12 / ternary)))
              :op2 (z13 / promote-02
                        :ARG0 z6
                        :ARG1 (z14 / and
                                   :op1 (z15 / ubiquitinate-01
                                             :ARG1 z9)
                                   :op2 (z16 / degrade-01
                                             :ARG1 z9
                                             :manner (z17 / rapid)
                                             :path (z18 / pathway
                                                        :mod (z19 / proteasome)))))))",0.5504587155963303,0.6446280991735538,"(d / demonstrate-01
    :ARG0 (s / study-01 :mod (r / recent))
    :ARG1 (c / complex-02
        :ARG0 (f / form-01
            :ARG1 (p / protein
                :mod (n / name :op1 ""Sina""))
            :ARG2 (c2 / complex-02
                :ARG0 (f2 / form-01
                    :ARG1 (p2 / protein
                        :mod (n2 / name :op1 ""Phyl"")))
                :ARG1 (c3 / complex-02
                    :ARG0 (f3 / form-01
                        :ARG1 (p3 / protein
                            :mod (n3 / name :op1 ""Ttk""))))
                :ARG1 (p4 / promote-01
                    :ARG0 c3
                    :ARG1 (u / ubiquitination)
                    :ARG2 (d / degrade-01
                        :ARG1 (p5 / protein
                            :mod (n4 / name :op1 ""Ttk""))
                        :ARG2 (p6 / pathway
                            :mod (p7 / proteasome))))
                :ARG2 (n5 / number :op1 ""14, 22"")))))","(d / demonstrate-01 :mode evidential
    :ARG0 (s / study :mod (r / recent))
    :ARG1 (a / and
        :op1 (f / form-01
            :ARG0 (a2 / and
                :op1 (p / protein :name (n / name :op1 ""Sina""))
                :op2 (p2 / protein :name (n2 / name :op1 ""Phyl"")))
            :ARG1 (c / complex
                :mod (t / ternary)
                :ARG1-of (w / with-01
                    :ARG2 (p3 / protein :name (n3 / name :op1 ""Ttk"")))))
        :op2 (p4 / promote-01
            :ARG0 a2
            :ARG1 (a3 / and
                :op1 (u / ubiquitination-01
                    :ARG1 p3)
                :op2 (d2 / degrade-01
                    :ARG0 (p5 / pathway :name (n4 / name :op1 ""proteasome""))
                    :ARG1 p3
                    :manner (r2 / rapid))))))",-1.0,0.7017543859649122
bio.chicago_2015.830,"Brinker is an antagonist of the  Dpp-signaling because it prevents the transcription of a subset of Mad activated genes (Kirkpatrick et al., 2001  ; Rushlow et al., 2001  ; Saller and Bienz, 2001  ), but  Brinker is itself a  Dpp target (Minami et al., 1999  ) because Mad and  Schnurri heterodimers can block   brk transcription in   dpp-responsive cells (Marty et al., 2000  ).","(c4 / contrast-01
    :ARG1 (c / cause-01
        :ARG0 (p10 / prevent-01
            :ARG1 (e3 / express-03
                :ARG1 (i / include-91
                    :ARG1 (s2 / subset)
                    :ARG2 (g / gene
                        :ARG1-of (a2 / activate-01)
                        :mod (e / enzyme
                            :name (n3 / name
                                :op1 ""Dpp""))))))
        :ARG1 (a6 / antagonize-01
            :ARG1 (s / signal-07
                :ARG1 e)
            :ARG1-of (p11 / publication-91
                :ARG0 (a3 / and
                    :op1 (p / person
                        :name (n4 / name
                            :op1 ""Kirkpatrick""))
                    :op2 (p2 / person))
                :ARG0 (o / other)
                :ARG1-of (p12 / publication-91
                    :ARG0 (p7 / person
                        :mod (o2 / other))
                    :ARG4 (d / date-entity
                        :year 2001)
                    :time (d3 / date-entity
                        :year 1999))
                :ARG1-of (p13 / publication-91
                    :ARG4 o)
                :time d)))
    :ARG2 (t / target-01
        :ARG1 s
        :ARG1-of (c2 / cause-01
            :ARG0 (p8 / possible-01
                :ARG1 (b / block-01
                    :ARG0 (a5 / and
                        :op1 (e2 / enzyme
                            :name a5)
                        :op2 (r / region)
                        :op2 (g3 / gene
                            :name (n8 / name
                                :op1 ""Schnurri"")
                            :ARG0-of (p9 / predate-01
                                :ARG1 (g2 / gene))))
                    :ARG1 (e4 / express-03
                        :ARG2 g2)
                    :location (c3 / cell
                        :ARG0-of (r2 / respond-01
                            :ARG1 g2))))))
    :rel (n / name
        :op1 ""Brinker"")
    :rel (p6 / person
        :name (n9 / name
            :op1 ""Marty""))
    :rel (a4 / and
        :op1 (p3 / person
            :name (n5 / name
                :op1 ""Rushlow""))
        :op2 (p4 / person
            :name (n7 / name
                :op1 ""Bienz"")))
    :rel (d2 / date-entity
        :year 2001
        :year 2000)
    :rel (p5 / person
        :name (n6 / name
            :op1 ""Minami""))
    :rel (n2 / name)
    :rel (a / Saller)
    :rel (b2 / brk))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (c2 / cause-01
            :ARG0 (p / prevent-01
                  :ARG0 (p2 / protein :name (n / name :op1 ""brinker""))
                  :ARG1 (t / transcribe-01
                        :ARG1 (s / subset
                              :ARG2-of (i / include-91
                                    :ARG1 (g / gene
                                          :ARG1-of (a / activate-01
                                                :ARG0 (p3 / protein :name (n2 / name :op1 ""Mad""))))))))
            :ARG1 (a2 / antagonist
                  :domain p2
                  :topic (s2 / signal-07
                        :ARG0 (p4 / pathway :name (n3 / name :op1 ""Dpp""))))
            :ARG1-of (d / describe-01
                  :ARG0 (a3 / and
                        :op1 (p5 / publication-91
                              :ARG0 (a4 / and
                                    :op1 (p6 / person :name (n4 / name :op1 ""Kirkpatrick""))
                                    :op2 (p7 / person
                                          :mod (o / other)))
                              :time (d2 / date-entity :year 2001))
                        :op2 (p8 / publication-91
                              :ARG0 (a5 / and
                                    :op1 (p9 / person :name (n5 / name :op1 ""Rushlow""))
                                    :op2 p7)
                              :time d2)
                        :op3 (p10 / publication-91
                              :ARG0 (a6 / and
                                    :op1 (p11 / person :name (n6 / name :op1 ""Saller""))
                                    :op2 (p12 / person :name (n7 / name :op1 ""Bienz"")))
                              :time d2))))
      :ARG2 (c3 / cause-01
            :ARG0 (p13 / possible-01
                  :ARG1 (b / block-01
                        :ARG0 (a7 / and
                              :op1 p3
                              :op2 (p14 / protein :name (n8 / name :op1 ""Schnurri""))
                              :mod (h / heterodimer))
                        :ARG1 (t2 / transcribe-01
                              :ARG1 p2))
                  :location (c4 / cell
                        :ARG0-of (r / responsive-02
                              :ARG1 p4))
                  :ARG1-of (d3 / describe-01
                        :ARG0 (p15 / publication-91
                              :ARG0 (a8 / and
                                    :op1 (p16 / person :name (n9 / name :op1 ""Marty""))
                                    :op2 p7)
                              :time (d4 / date-entity :year 2000))))
            :ARG1 (t3 / target-01
                  :ARG0 p4
                  :ARG1 p2
                  :ARG1-of (d5 / describe-01
                        :ARG0 (p17 / publication-91
                              :ARG0 (a9 / and
                                    :op1 (p18 / person :name (n10 / name :op1 ""Minami""))
                                    :op2 p7)
                              :time (d6 / date-entity :year 1999))))))","Brinker is an antagonist of the  Dpp-signaling because it prevents the transcription of a subset of Mad activated genes (Kirkpatrick et al., 2001  ; Rushlow et al., 2001  ; Saller and Bienz, 2001  ), but  Brinker is itself a  Dpp target (Minami et al., 1999  ) because Mad and  Schnurri heterodimers can block   brk transcription in   dpp-responsive cells (Marty et al., 2000  ).","(z1 / contrast-01
    :ARG1 (z2 / antagonize-01
              :ARG0 (z3 / protein
                        :wiki ""Brinker""
                        :name (z4 / name
                                  :op1 ""Brinker""))
              :ARG1 (z5 / signal-07
                        :ARG1 (z6 / small-molecule
                                  :wiki ""DNA-dependent_protein""
                                  :wiki ""Cyclin-dependent_protein""
                                  :name (z7 / name
                                            :op1 ""Dpp"")))
              :ARG1-of (z8 / cause-01
                           :ARG0 (z9 / prevent-01
                                     :ARG0 z3
                                     :ARG1 (z10 / transcribe-01
                                                :ARG1 (z11 / gene
                                                           :mod (z12 / subset)
                                                           :ARG1-of (z13 / include-91
                                                                         :ARG2 (z14 / gene
                                                                                    :ARG1-of (z15 / activate-01
                                                                                                  :ARG0 (z16 / enzyme
                                                                                                             :wiki ""BRAK_(g3000 / gene)""
                                                                                                             :name (z17 / name
                                                                                                                        :op1 ""Mad""))))))))
                           :ARG1-of (z18 / describe-01
                                         :ARG0 (z19 / and
                                                    :op1 (z20 / person
                                                              :wiki -
                                                              :name (z21 / name
                                                                         :op1 ""Kirkpatrick""
                                                                         :op2 ""et""
                                                                         :op3 ""al."")
                                                              :time (z22 / date-entity
                                                                         :year 2001))
                                                    :op2 (z23 / person
                                                              :wiki -
                                                              :name (z24 / name
                                                                         :op1 ""Rushlow""
                                                                         :op2 ""et""
                                                                         :op3 ""al.""
                                                                         :op4 ""2001""))
                                                    :op3 (z25 / person
                                                              :wiki -
                                                              :name (z26 / name
                                                                         :op1 ""Saller""
                                                                         :op2 ""and""
                                                                         :op3 ""Bienz"")
                                                              :time (z27 / date-entity
                                                                         :year 2001)))))))",0.2764976958525345,0.3954372623574144,"(m / multi-sentence
        :snt1 (a / antagonist
            :ARG0 (b / brinker)
            :ARG1 (s / signaling
                  :ARG1 (d / Dpp))
            :ARG2 (p / prevent-01
                  :ARG0 b
                  :ARG1 (t / transcription
                        :ARG1 (g / gene
                              :mod (a2 / activate-01
                                    :ARG1 (m / Mad))))
                  :ARG2 (s2 / subset)))
        :snt2 (t / target
            :ARG0 b
            :ARG1 (d2 / Dpp)
            :ARG2 b)
        :snt3 (b2 / block-01
            :ARG0 (c / can)
            :ARG1 (h / heterodimer
                  :ARG1 (a3 / and
                        :op1 (m2 / Mad)
                        :op2 (s3 / Schnurri)))
            :ARG2 (t2 / transcription
                  :ARG1 (b3 / brk)
                  :mod (c2 / cell
                        :mod (r / responsive)
                        :ARG1-of (d3 / dpp))))
        :snt4 (r2 / reference
            :ARG0 (m3 / Marty)
            :ARG1 (y / year
                  :op1 2000))
        :snt5 (r3 / reference
            :ARG0 (m4 / Minami)
            :ARG1 (y2 / year
                  :op1 1999))
        :snt6 (r4 / reference
            :ARG0 (s4 / Saller)
            :ARG1 (y3 / year
                  :op1 2001))
        :snt7 (r5 / reference
            :ARG0 (r4 / Rushlow)
            :ARG1 (y4 / year
                  :op1 2001))
        :snt8 (r6 / reference
            :ARG0 (k / Kirkpatrick)
            :ARG1 (y5 / year
                  :op1 2001))
        :snt9 (r7 / reference
            :ARG0 (b5 / Bienz)
            :ARG1 (y6 / year
                  :op1 2001)))","(b / be-01
    :ARG1 (b2 / brinker)
    :ARG2 (a / antagonist
        :ARG1-of (p / prevent-01
            :ARG0 b2
            :ARG1 (t / transcription
                :ARG1 (s / subset
                    :part (g / gene
                        :ARG1-of (a2 / activate-01
                            :ARG0 (m / mad))))))
        :ARG2 (d / dpp-signaling))
    :ARG1-of (b3 / because-01
        :ARG2 (b4 / be-01
            :ARG1 b2
            :ARG2 (t2 / target
                :ARG1-of (d2 / dpp))
            :ARG1-of (b5 / because-01
                :ARG2 (c / can-01
                    :ARG0 (h / heterodimer
                        :consist-of (m2 / mad)
                        :consist-of (s2 / schnurri))
                    :ARG1 (b6 / block-01
                        :ARG0 h
                        :ARG1 (t3 / transcription
                            :ARG1 (b7 / brk)
                            :location (c2 / cell
                                :ARG1-of (r / respond-01
                                    :ARG0 c2
                                    :ARG1 (d3 / dpp))))))))))",-1.0,0.1958762886597938
bio.chicago_2015.901,beta-catenin contains amino- and carboxy-terminal transcriptional  activation domains and a covalent fusion of either domain with the amino terminus of  LEF-1 generates a  fusion protein that functions constitutively and activates transcription independently of a  Wnt signal ( 19). .,"(a5 / and
    :ARG1-of (d2 / describe-01
        :ARG0 (p3 / publication
            :ARG1-of (c / cite-01
                :ARG2 19)))
    :op1 (c3 / contain-01
        :ARG0 (s2 / small-molecule
            :name (n / name
                :op1 ""beta""
                :op2 ""Martin""))
        :ARG1 (a4 / and
            :op1 (d3 / domain
                :consist-of (a3 / amino)
                :part-of (e2 / enzyme
                    :name (n3 / name
                        :op3 ""transcriptional"")
                    :ARG0-of (a / activate-01)))
            :op2 (d4 / domain
                :name (n2 / name
                    :op1 ""carboxy""
                    :op2 ""terminal""))))
    :op2 (g / generate-01
        :ARG0 (f2 / fuse-01
            :ARG1 (d5 / domain
                :mod (e / either)
                :part (t / terminus
                    :part-of (p / protein
                        :name (n4 / name
                            :op1 ""F-35""))))
            :ARG2 t
            :mod (c4 / covalent))
        :ARG1 (p2 / protein
            :ARG0-of (f / function-01
                :ARG1 (c2 / constitution))
            :ARG0-of (a2 / activate-01
                :ARG1 (e4 / express-03)
                :ARG1-of (d / depend-01
                    :ARG0 (s / signal-07
                        :ARG0 (e3 / enzyme
                            :name (n5 / name
                                :op1 ""Wnt"")))
                    :polarity -))
            :ARG2-of (f3 / fuse-01)))
    :rel (l / language))
",test,bio_amr0.8,"(a / and
      :op1 (c / contain-01
            :ARG0 (p / protein :name (n / name :op1 ""beta-catenin""))
            :ARG1 (a2 / and
                  :op1 (p2 / protein-segment :name (n2 / name :op1 ""amino-terminus""))
                  :op2 (p3 / protein-segment :name (n3 / name :op1 ""carboxy-terminus""))
                  :ARG0-of (a3 / activate-01
                        :ARG1 (t / transcribe-01))))
      :op2 (g / generate-01
            :ARG0 (f / fuse-01
                  :ARG1 (o / or
                        :op1 p2
                        :op2 p3)
                  :ARG2 (p4 / protein-segment :name (n4 / name :op1 ""amino-terminus"")
                        :part-of (p5 / protein :name (n5 / name :op1 ""LEF-1"")))
                  :mod (c2 / covalent))
            :ARG1 (p6 / protein
                  :ARG3-of (f2 / fuse-01)
                  :ARG0-of (f3 / function-01
                        :manner (c3 / constitutive))
                  :ARG0-of (a4 / activate-01
                        :ARG1 t
                        :ARG0-of (d2 / depend-01 :polarity -
                              :ARG1 (s / signal-07
                                    :ARG0 (p7 / protein :name (n6 / name :op1 ""Wnt"")))))))
      :ARG1-of (d3 / describe-01
            :ARG0 (p8 / publication-91
                  :ARG1-of (c4 / cite-01
                        :ARG2 19))))",beta-catenin contains amino- and carboxy-terminal transcriptional  activation domains and a covalent fusion of either domain with the amino terminus of  LEF-1 generates a  fusion protein that functions constitutively and activates transcription independently of a  Wnt signal ( 19). .,"(z1 / and
    :op1 (z2 / contain-01
             :ARG0 (z3 / small-molecule
                       :wiki ""BRAF-catenin""
                       :name (z4 / name
                                 :op1 ""beta-catenin""))
             :ARG1 (z5 / and
                       :op1 (z6 / domain
                                :ARG0-of (z7 / activate-01)
                                :mod (z8 / amino))
                       :op2 (z9 / domain
                                :ARG0-of z7
                                :mod (z10 / terminus
                                          :mod (z11 / amino)
                                          :part-of (z12 / carboxy-terminal)))
                       :part-of (z13 / gene
                                     :wiki ""Transient_receptor_potential_channel""
                                     :name (z14 / name
                                                :op1 ""transcriptional"")))))",0.2641509433962264,0.4900662251655629,"(m / multi-sentence
        :snt1 (c / contain-01
            :ARG0 (b / beta-catenin)
            :ARG1 (d / domain
                  :mod (t / transcriptional
                        :mod (a / amino-01)
                        :mod (c2 / carboxy-01)))
            :ARG1-of (g / generate-01
                  :ARG1 (p / protein
                        :mod (f / fusion
                              :mod (d2 / domain
                                    :mod (e / either)
                                    :mod (t2 / terminus
                                          :mod (a2 / amino-01)
                                          :mod (l / LEF-1))))
                              :mod (c3 / covalent))
                        :ARG1-of (f2 / function-01
                              :ARG1 (c4 / constitutively)
                              :ARG1-of (a3 / activate-01
                                    :ARG1 (t3 / transcription)
                                    :ARG2 (i / independent
                                          :ARG1 (s / signal
                                                :mod (w / Wnt)
                                                :mod (a4 / of))))))))
        :snt2 (n / number
            :op1 19))","(b / beta-catenin
    :consist-of (d / domain
        :mod (a / amino)
        :mod (c / carboxy-terminal)
        :mod (t / transcriptional-01
            :ARG1 (a2 / activate-01
                :ARG1 d)))
    :consist-of (f / fusion-01
        :ARG1 (d2 / domain
            :mod (e / either))
        :ARG1 (t2 / terminus
            :mod (a3 / amino)
            :part (l / LEF-1))
        :result (p / protein
            :mod (f2 / fusion)
            :ARG1-of (f3 / function-01
                :ARG1 (c2 / constitutively))
            :ARG1-of (a4 / activate-01
                :ARG1 (t3 / transcription)
                :manner (i / independent)
                :condition (s / signal
                    :mod (W / Wnt)))))
    :mod (n / number :value 19))",-1.0,0.1512605042016806
bio.chicago_2015.1195,"We have previously shown that when the four  consensus PKA sites are mutated,  CI is no longer proteolyzed, regulated by  PKA, or regulated by   hedgehog signaling to activate   wg ( 7,  8).","(s / show-01
    :ARG0 (w / we)
    :ARG1 (o / or
        :purpose (a / activate-01
            :ARG1 (p3 / protein
                :name (n3 / name
                    :op1 ""wg"")))
        :ARG1-of (c / cause-01
            :ARG0 (m / mutate-01
                :ARG1 (s3 / site
                    :quant 4
                    :mod (e / enzyme
                        :name (n / name
                            :op1 ""PKA""))
                    :mod (c3 / consensus))))
        :op1 (p / phosphorylate-01
            :ARG1 e)
        :op2 (r / regulate-01
            :ARG1 e)
        :op3 (r2 / regulate-01
            :ARG0 (s2 / signal-07
                :ARG0 (h / hedgehog))
            :ARG1 s3)
        :time (n4 / no-longer))
    :ARG1-of (c2 / cite-01
        :ARG2 (a2 / and
            :op1 7
            :op2 8))
    :rel (n2 / name
        :op1 ""CI"")
    :time (p2 / previous))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (w / we)
      :ARG1 (o / or
            :op1 (p / proteolyze-00 :polarity -
                  :ARG1 (p2 / protein :name (n / name :op1 ""CI"")))
            :op2 (r / regulate-01 :polarity -
                  :ARG0 (e / enzyme :name (n2 / name :op1 ""PKA""))
                  :ARG1 p2)
            :op3 (r2 / regulate-01
                  :ARG0 (s2 / signal-07
                        :ARG0 (p3 / protein :name (n3 / name :op1 ""hedgehog"")))
                  :ARG1 p2)
            :purpose (a / activate-01
                  :ARG0 p2
                  :ARG1 (p4 / protein :name (n4 / name :op1 ""wg"")))
            :time (m2 / mutate-01
                  :ARG1 (s3 / site-01 :quant 4
                        :ARG1 e
                        :mod (c / consensus)))
            :ARG1-of (l / long-03
                  :degree (m / more)))
      :time (p5 / previous)
      :ARG1-of (d / describe-01
            :ARG0 (p6 / publication
                  :ARG1-of (c2 / cite-01
                        :ARG2 (a2 / and :op1 7 :op2 8)))))","We have previously shown that when the four  consensus PKA sites are mutated,  CI is no longer proteolyzed, regulated by  PKA, or regulated by   hedgehog signaling to activate   wg ( 7,  8).","(z1 / show-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / or
              :op1 (z4 / proteolyze-01
                       :ARG1 (z5 / small-molecule
                                 :wiki ""Cyclin-dependent_kinase""
                                 :name (z6 / name
                                           :op1 ""CI"")))
              :op2 (z7 / regulate-01
                       :ARG0 (z8 / enzyme
                                 :wiki ""PKA""
                                 :name (z9 / name
                                           :op1 ""PKA""))
                       :ARG1 z5)
              :op3 (z10 / regulate-01
                        :ARG0 (z11 / signal-07
                                   :ARG0 (z12 / hedgehog)
                                   :ARG1 (z13 / activate-01
                                              :ARG0 z12
                                              :ARG1 (z14 / enzyme
                                                         :wiki ""Wolg_(g3000 / gene)""
                                                         :name (z15 / name
                                                                    :op1 ""wg""))))
                        :ARG1 z5)
              :time (z16 / no-longer)
              :time (z17 / mutate-01
                         :ARG1 (z18 / site
                                    :quant 4
                                    :mod z8
                                    :mod (z19 / consensus)))))",0.543859649122807,0.5254237288135594,"(s / show-01
        :ARG0 (w / we)
        :ARG1 (p / previous-01)
        :ARG2 (m / mutate-01
              :ARG0 (f / four)
              :ARG1 (s2 / site
                    :mod (c / consensus)
                    :mod (p2 / PKA)))
        :ARG3 (p2 / proteolyze-01
              :ARG1 (c2 / CI))
        :ARG4 (r / regulate-01
              :ARG1 c2
              :ARG2 (p3 / PKA))
        :ARG5 (r2 / regulate-01
              :ARG1 c2
              :ARG2 (s3 / signal-01
                    :ARG1 (h / hedgehog)))
        :ARG6 (a / activate-01
              :ARG1 (w2 / wg)
              :ARG2 s3)
        :time (p4 / point-in-time
              :op1 (n / number :op1 ""7"")
              :op2 (n2 / number :op1 ""8"")))","(s / show-01 :polarity -
    :ARG0 (w / we)
    :ARG1 (m / multi-sentence
        :snt1 (m2 / mutate-01
            :ARG1 (s2 / site
                :quant 4
                :mod (c / consensus)
                :ARG1-of (p / pertain-01
                    :ARG2 (p2 / PKA))))
        :snt2 (p3 / proteolyze-01 :polarity -
            :ARG1 (c2 / CI))
        :snt3 (r / regulate-01 :polarity -
            :ARG1 c2
            :ARG0 p2)
        :snt4 (r2 / regulate-01 :polarity -
            :ARG1 c2
            :ARG0 (s3 / signal-01
                :ARG0 (h / hedgehog)
                :ARG1 (a / activate-01
                    :ARG1 (w2 / wg)))))
    :time (p4 / previous))",-1.0,0.3738317757009346
bio.chicago_2015.1205,"PKA and  MAPK lead to the activation of  CREB and to the induction of immediate-early genes, one of which--the  ubiquitin hydrolase--is neuron specific.","(l / lead-03
    :ARG0 (a2 / and
        :op1 (e2 / enzyme
            :name (n / name
                :op1 ""PKA""))
        :op2 (e3 / enzyme
            :name (n2 / name
                :op1 ""MAPK"")))
    :ARG2 (a3 / and
        :op1 (a / activate-01
            :ARG1 (p / protein
                :name (n3 / name
                    :op1 ""CREB"")))
        :op2 (i3 / induct-02
            :ARG1 (g / gene
                :ARG2-of (i2 / include-91
                    :ARG1 (g2 / gene
                        :name (n4 / name
                            :op1 ""ubiquitin""
                            :op2 ""hydrolase"")
                        :ARG1-of (s / specific-02
                            :ARG2 (n5 / neuron))))
                :mod (e / early
                    :mod (i / immediate))))))
",test,bio_amr0.8,"(l / lead-03
      :ARG0 (a / and
            :op1 (e / enzyme :name (n / name :op1 ""PKA""))
            :op2 (e2 / enzyme :name (n2 / name :op1 ""MAPK"")))
      :ARG2 (a2 / and
            :op1 (a3 / activate-01
                  :ARG0 a
                  :ARG1 (p / protein :name (n3 / name :op1 ""CREB"")))
            :op2 (i / induce-01
                  :ARG0 a
                  :ARG2 (g / gene
                        :mod (e3 / early
                              :mod (i2 / immediate))
                        :ARG2-of (i3 / include-91
                              :ARG1 (g2 / gene :quant 1 :name (n4 / name :op1 ""ubiquitin"" :op2 ""hydrolase"")
                                    :ARG1-of (s / specific-02
                                          :ARG2 (n5 / neuron))))))))","PKA and  MAPK lead to the activation of  CREB and to the induction of immediate-early genes, one of which--the  ubiquitin hydrolase--is neuron specific.","(z1 / lead-03
    :ARG0 (z2 / and
              :op1 (z3 / enzyme
                       :wiki ""PKA""
                       :name (z4 / name
                                 :op1 ""PKA""))
              :op2 (z5 / enzyme
                       :wiki ""MAPK""
                       :name (z6 / name
                                 :op1 ""MAPK"")))
    :ARG2 (z7 / and
              :op1 (z8 / activate-01
                       :ARG0 z2
                       :ARG1 (z9 / enzyme
                                 :wiki ""CREB_(g3000 / gene)""
                                 :name (z10 / name
                                            :op1 ""CREB"")))
              :op2 (z11 / induct-02
                        :ARG0 z2
                        :ARG1 (z12 / gene
                                   :quant 1
                                   :ARG2-of (z13 / include-91
                                                 :ARG1 (z14 / enzyme
                                                            :wiki ""Ubiquitin_hydrolase""
                                                            :name (z15 / name
                                                                       :op1 ""ubiquitin""
                                                                       :op2 ""hydrolase"")
                                                            :ARG1-of (z16 / specific-02
                                                                          :ARG2 (z17 / neuron)))))
                        :time (z18 / early
                                   :mod (z19 / immediate)))))",0.7083333333333334,0.7415730337078652,"(m / multi-sentence
        :snt1 (l / lead-01
            :ARG0 (a / and
                  :op1 (p / protein-kinase-a)
                  :op2 (m / mapk))
            :ARG1 (a2 / activation
                  :ARG0 (c / creb))
            :ARG2 (i / induction
                  :ARG0 c
                  :ARG1 (g / gene
                        :mod (i2 / immediate-early)
                        :ARG1-of (o / one
                              :op1 (h / hydrolase
                                    :mod (u / ubiquitin))
                              :mod (n / neuron
                                    :domain (s / specific))))))","(l / lead-01
    :ARG0 (a / and
        :op1 (p / protein :name (n / name :op1 ""PKA""))
        :op2 (m / protein :name (n2 / name :op1 ""MAPK"")))
    :ARG1 (a2 / and
        :op1 (a3 / activate-01
            :ARG1 (c / protein :name (n3 / name :op1 ""CREB"")))
        :op2 (i / induce-01
            :ARG1 (g / gene
                :mod (i2 / immediate-early)
                :ARG1-of (o / one-of
                    :op1 (u / ubiquitin-hydrolase
                        :mod (n4 / neuron)
                        :mod (s / specific))))))",-1.0,0.5783132530120482
bio.chicago_2015.1221,Coexpressing  axin inhibited the  Lef-1 reporter activation induced by  CKI  (Fig.  3 b).,"(i2 / inhibit-01
    :ARG0 (e / enzyme
        :name (n / name
            :op1 ""axin"")
        :ARG2-of (e3 / express-03))
    :ARG1 (a / activate-01
        :ARG1-of (i / induce-01
            :ARG2 (e2 / enzyme
                :name (n2 / name
                    :op1 ""histidine-rich""
                    :op1 ""CKI"")
                :ARG0-of (r / report-01))))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod (b / b))))
",test,bio_amr0.8,"(i / inhibit-01
      :ARG0 (p / protein :name (n / name :op1 ""axin"")
            :ARG2-of (c / coexpress-01))
      :ARG1 (a / activate-01
            :ARG0 (e / enzyme :name (n2 / name :op1 ""CKI""))
            :ARG1 (p3 / protein :name (n3 / name :op1 ""Lef-1"")
                  :ARG0-of (r / report-01))
            :ARG2-of (i2 / induce-01
                  :ARG0 e))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""3b"")))",Coexpressing  axin inhibited the  Lef-1 reporter activation induced by  CKI  (Fig.  3 b).,"(z1 / inhibit-01
    :ARG0 (z2 / express-01
              :ARG1 (z3 / axin))
    :ARG1 (z4 / activate-01
              :ARG1 (z5 / enzyme
                        :wiki ""Lef-1""
                        :name (z6 / name
                                  :op1 ""Lef-1""
                                  :op2 ""Reporter"")
                        :ARG0-of (z7 / report-01))
              :ARG1-of (z8 / induce-01
                           :ARG0 (z9 / small-molecule
                                     :wiki ""Cyclin-dependent_kinase""
                                     :name (z10 / name
                                                :op1 ""CKI"")))))",0.509090909090909,0.5263157894736842,"(c / coexpress-01
        :ARG0 (a / axin)
        :ARG1 (i / inhibit-01
              :ARG0 a
              :ARG1 (a2 / activate-01
                    :ARG0 (r / reporter)
                    :ARG1 (l / Lef-1)))
        :ARG2 (i2 / induce-01
              :ARG0 (a3 / activation)
              :ARG1 (c / CKI))
        :ARG3 (f / figure
              :op1 ""3""
              :op2 ""b""))","(a / and
    :op1 (c / coexpress-01
        :ARG0 (a2 / axin))
    :op2 (i / inhibit-01
        :ARG0 a2
        :ARG1 (a3 / activate-01
            :ARG0 (l / Lef-1)
            :ARG1 (r / reporter)
            :ARG2 (i2 / induce-01
                :ARG0 (c2 / CKI)
                :ARG1 a3))
        :location (f / figure
            :mod (n / number :value 3)
            :mod (b / b))))",-1.0,0.2456140350877193
pmid_1592_8660.83,"Of the 11 uveal melanoma cell lines under study, only one cell line (Ocm 1) carried a <i>BRAF</i> mutation, the common V599E (also described by Calipel <i>et al</i> and Kilic <i>et al</i>).","(c / carry-01
    :ARG0 (l / line
        :name (n2 / name
            :op1 ""Ocm""
            :op2 1)
        :quant 1
        :ARG1-of (i / include-91
            :ARG2 (l2 / line
                :ARG1-of (d2 / disease
                    :name (n / name
                        :op1 ""uveal""
                        :op2 ""melanoma""))
                :mod d2))
        :mod (o / only))
    :ARG1 (m / mutate-01
        :ARG2 (s / small-molecule
            :name (n3 / name
                :op1 ""atom""
                :op2 ""all"")
            :ARG1-of (d / describe-01
                :ARG0 (a2 / and
                    :op1 (p / person
                        :name (n4 / name
                            :op1 ""Calipel""))
                    :op2 (p2 / person
                        :name (n5 / name
                            :op1 ""Kilic""
                            :op3 ""all""
                            :op4 ""all"")))
                :mod (a / also))))
    :rel 599
    :rel 11
    :rel E
    :rel (s2 / study-01)
    :rel (c2 / common)
    :rel V)
",test,bio_amr0.8,"(i / include-91
      :ARG1 (c2 / cell-line :quant 1 :name (n3 / name :op1 ""Ocm"" :op2 ""1"")
            :mod (o / only)
            :ARG0-of (c3 / carry-01
                  :ARG1 (m / mutate-01 :value ""V599E""
                        :ARG1 (g / gene :name (n2 / name :op1 ""BRAF""))
                        :ARG1-of (d2 / describe-01
                              :ARG0 (a5 / and
                                    :op1 (p / publication-91
                                          :ARG0 (a3 / and
                                                :op1 (p2 / person :name (n4 / name :op1 ""Calipel""))
                                                :op2 (p3 / person
                                                      :mod (o2 / other))))
                                    :op2 (p6 / publication-91
                                          :ARG0 (a4 / and
                                                :op1 (p4 / person :name (n5 / name :op1 ""Kilic""))
                                                :op2 p3)))
                              :mod (a / also))
                        :mod (c4 / common))))
      :ARG2 (c / cell-line :quant 11
            :mod (m2 / medical-condition :name (n / name :op1 ""melanoma"")
                  :mod (u / uveal))
            :ARG1-of (s / study-01)))","Of the 11 uveal melanoma cell lines under study, only one cell line (Ocm 1) carried a <i>BRAF</i> mutation, the common V599E (also described by Calipel <i>et al</i> and Kilic <i>et al</i>).","(z1 / include-91
    :ARG1 (z2 / line
              :quant 1
              :mod (z3 / cell)
              :mod (z4 / only)
              :ARG1-of (z5 / include-91
                           :ARG2 (z6 / line
                                     :quant 11
                                     :mod (z7 / cell
                                              :mod (z8 / melanoma
                                                       :mod (z9 / uveal))
                                              :ARG1-of (z10 / study-01)))))
    :ARG0-of (z11 / carry-01
                  :ARG1 (z12 / mutate-01
                             :ARG1 (z13 / enzyme
                                        :wiki ""BRAF_(g3000 / gene)""
                                        :name (z14 / name
                                                   :op1 ""BRAF""))
                             :ARG2 (z15 / enzyme
                                        :wiki ""BRAF1""
                                        :name (z16 / name
                                                   :op1 ""V599E"")
                                        :ARG1-of (z17 / describe-01
                                                      :ARG0 (z18 / and
                                                                 :op1 (z19 / person
                                                                           :wiki ""Paul_Calipel""
                                                                           :name (z20 / name
                                                                                      :op1 ""Calipel""))
                                                                 :op2 (z21 / person
                                                                           :wiki ""Meinrat_Kilic""
                                                                           :name (z22 / name
                                                                                      :op1 ""Kilic"")))
                                                      :mod (z23 / also)))
                             :mod (z24 / common))))",0.4262295081967213,0.4499999999999999,"(m / multi-sentence
        :snt1 (s / study-01
            :ARG1 (l / line
                  :mod (c / cell
                        :mod (m2 / melanoma
                              :mod (u / uveal)))
                  :ARG1-of (u / under)
                  :ARG2 (n / number :op1 11)))
        :snt2 (c2 / carry-01
            :ARG1 l
            :ARG2 (m3 / mutation
                  :ARG1 (b / braf)
                  :ARG2 (c3 / common
                        :name (v / v599e)))
            :ARG3 (d / describe-01
                  :ARG1 (c4 / calipel)
                  :ARG2 (d2 / et)
                  :ARG3 (k / kilic)
                  :ARG4 d2))","(s / study-01
    :ARG1 (c / cell-line
        :quant 11
        :mod (m / melanoma
            :mod (u / uvea)))
    :ARG2 (c2 / carry-01
        :ARG0 (c3 / cell-line
            :quant 1
            :name (n / name :op1 ""Ocm"" :op2 ""1""))
        :ARG1 (m2 / mutation
            :mod (b / braf)
            :mod (v / variant
                :name (n2 / name :op1 ""V599E""))
            :mod (c4 / common)
            :described-by (a / and
                :op1 (p / person
                    :name (n3 / name :op1 ""Calipel"" :op2 ""et"" :op3 ""al""))
                :op2 (p2 / person
                    :name (n4 / name :op1 ""Kilic"" :op2 ""et"" :op3 ""al""))))))",-1.0,0.4587155963302752
pmid_1592_8660.87,"In order to assess the level of expression and the activation (by phosphorylation) of members of the MAPK pathway downstream of <i>RAS</i> and <i>BRAF</i>, Western blot analysis was performed on uveal melanoma cell lines (<xref ref-type=""table"" rid=""tbl2"">Table 2A</xref>).","(p2 / perform-02
    :purpose (a5 / assess-01
        :ARG1 (a3 / and
            :op1 (l / level
                :extent-of (e / express-03
                    :ARG1 (m / member
                        :part-of (p / pathway
                            :name (n / name
                                :op1 ""MAPK"")
                            :mod (d4 / downstream
                                :op1 (a4 / and
                                    :op1 (d2 / disease
                                        :name (n2 / name
                                            :op1 ""BRAF""))))))))
            :op2 (a / activate-01
                :ARG1 m
                :manner (p3 / phosphorylate-01))))
    :ARG1 (a2 / analyze-01
        :ARG1-of (d / describe-01
            :ARG0 (t / table
                :mod 2))
        :manner (t2 / test-01
            :mod (w / world-region
                :name (n3 / name
                    :op1 ""West""))))
    :ARG1 (l2 / line
        :mod (c / cell)
        :mod (d3 / disease
            :name (n4 / name
                :op1 ""uveal""
                :op2 ""melanoma""))))
",test,bio_amr0.8,"(p3 / perform-01
      :ARG1 (i2 / immunoblot-01
            :ARG2 (c / cell-line
                  :mod (m2 / medical-condition :name (n2 / name :op1 ""melanoma"")
                        :mod (u / uveal)))
            :purpose (a2 / assess-01
                  :ARG1 (a3 / and
                        :op1 (l / level
                              :degree-of (e / express-03
                                    :ARG2 (m / member
                                          :ARG1-of (i / include-91
                                                :ARG2 (p2 / pathway :name (n3 / name :op1 ""MAPK""))))
                                    :location (r / relative-position
                                          :op1 (g / gene :name (n4 / name :op1 ""RAS""))
                                          :op2 (g2 / gene :name (n5 / name :op1 ""BRAF""))
                                          :direction (d2 / downstream))))
                        :op2 (a4 / activate-01
                              :ARG0 (p / phosphorylate-01)
                              :ARG1 m
                              :location r)))
            :ARG1-of (d3 / describe-01
                  :ARG0 (t2 / table :mod ""2A""))))","In order to assess the level of expression and the activation (by phosphorylation) of members of the MAPK pathway downstream of <i>RAS</i> and <i>BRAF</i>, Western blot analysis was performed on uveal melanoma cell lines (<xref ref-type=""table"" rid=""tbl2"">Table 2A</xref>).","(z1 / perform-02
    :ARG1 (z2 / analyze-01
              :instrument (z3 / blot
                              :mod (z4 / world-region
                                       :wiki ""Western_world""
                                       :name (z5 / name
                                                 :op1 ""West""))))
    :ARG2 (z6 / cell
              :mod (z7 / melanoma
                       :mod (z8 / uveal))
              :mod (z9 / line))
    :purpose (z10 / assess-01
                  :ARG1 (z11 / and
                             :op1 (z12 / level
                                       :degree-of (z13 / express-01
                                                       :ARG1 z6))
                             :op2 (z14 / activate-01
                                       :ARG1 (z15 / member
                                                  :ARG0-of (z16 / have-org-role-91
                                                                :ARG1 (z17 / pathway
                                                                           :wiki ""MAPK""
                                                                           :name (z18 / name
                                                                                      :op1 ""MAPK"")
                                                                           :mod (z19 / downstream
                                                                                     :op1 (z20 / and
                                                                                               :op1 (z21 / enzyme
                                                                                                         :wiki ""BRAF_(g3000 / gene)""
                                                                                                         :name (z22 / name
                                                                                                                    :op1 ""RAS""))
                                                                                               :op2 (z23 / enzyme
                                                                                                         :wiki ""BRAF_(g3001 / gene)""
                                                                                                         :name (z24 / name
                                                                                                                    :op1 ""BRAF"")))))
                                                                :ARG2 (z25 / member))))
                             :manner (z26 / phosphorylate-01
                                          :ARG1 z15))))",0.3620689655172414,0.4259259259259259,"(m / multi-sentence
        :snt1 (a / assess-01
            :ARG0 (o / order
                  :ARG1 (l / level
                        :ARG1-of (e / expression-01)
                        :ARG2 (a2 / activation
                              :ARG1-of (m2 / member
                                    :ARG1-of (p / pathway
                                          :ARG1-of (m3 / MAPK)
                                          :ARG2 (d / downstream
                                                :ARG1-of (r / RAS)
                                                :ARG2 (b / BRAF)))))))
            :ARG1 (p2 / perform-01
                  :ARG0 (a3 / analysis
                        :ARG1 (b / blot
                              :mod (w / Western)))
                  :ARG2 (c / cell
                        :mod (m4 / melanoma)
                        :ARG1-of (l2 / line))))
        :snt2 (r2 / reference
            :ARG1 (t / table
                  :ARG1-of (x / xref
                        :ARG1 (t2 / tbl2)
                        :ARG2 (a4 / analysis))))","(p / perform-01
    :ARG0 (a / analysis
        :mod (b / blot
            :mod (w / western)))
    :ARG1 (c / cell-line
        :mod (m / melanoma
            :mod (u / uveal)))
    :instrument (a2 / assess-01
        :ARG1 (l / level
            :domain (e / expression))
        :ARG1 (a3 / activate-01
            :ARG1 (m2 / member
                :part (p2 / pathway
                    :mod (m3 / MAPK)))
            :instrument (p3 / phosphorylation)))
    :condition (d / downstream
        :ARG1 (a4 / and
            :op1 (r / RAS)
            :op2 (b2 / BRAF))))
    :location (t / table
        :name (n / name :op1 ""2A"")))",-1.0,-1.0
pmid_1592_8660.92,"The levels of total ERK were remarkably similar across all cell lines, with the exception of two cell lines Mel 285 and Mel 290, which had significantly higher levels of total ERK than the others.","(r2 / resemble-01
    :ARG1 (l / level
        :topic (e / enzyme
            :name (n / name
                :op1 ""ERK"")
            :ARG1-of (t / total-01
                :ARG1 ""ERK"")))
    :ARG1-of (r / remarkable-02)
    :ARG2-of (e2 / except-01
        :ARG1 (l4 / line
            :name (n2 / name
                :op1 ""Mel""
                :op2 285)
            :quant 2
            :consist-of (a3 / and
                :ARG0-of (h / have-03
                    :ARG1 (l2 / level
                        :ARG1-of (h2 / have-degree-91
                            :ARG2 (h3 / high-02
                                :ARG1 l2)
                            :ARG3 (m / more
                                :ARG1-of (s / significant-02))
                            :ARG4 (o / other))))
                :op1 l4
                :op2 290)
            :mod (c2 / cell)))
    :manner (a / across
        :op1 (l3 / line
            :mod (c / cell)
            :mod (a2 / all))))
",test,bio_amr0.8,"(r2 / resemble-01
      :ARG1 (l / level
            :quant-of (e / enzyme :name (n / name :op1 ""ERK"")
                  :mod (t / total)))
      :ARG1-of (r / remarkable-02)
      :location (a / across
            :op1 (c / cell-line
                  :mod (a2 / all)
                  :ARG2-of (e2 / except-01
                        :ARG1 (a3 / and
                              :op1 (c3 / cell-line :name (n3 / name :op1 ""Mel"" :op2 ""285"")
                                    :ARG0-of (h / have-03
                                          :ARG1 (l2 / level
                                                :ARG1-of (h2 / high-02
                                                      :degree (m / more)
                                                      :ARG1-of (s / significant-02)
                                                      :compared-to (c2 / cell-line
                                                            :mod (o / other)))
                                                :quant-of e)))
                              :op2 (c4 / cell-line :name (n5 / name :op1 ""Mel"" :op2 ""290"")
                                    :ARG0-of h))))))","The levels of total ERK were remarkably similar across all cell lines, with the exception of two cell lines Mel 285 and Mel 290, which had significantly higher levels of total ERK than the others.","(z1 / resemble-01
    :ARG1 (z2 / level
              :mod (z3 / enzyme
                       :wiki ""Extracellular_signal-regulated_kinase""
                       :name (z4 / name
                                 :op1 ""ERK"")
                       :mod (z5 / total)))
    :ARG2 (z6 / level
              :mod z3)
    :ARG1-of (z7 / remarkable-02)
    :location (z8 / across
                  :op1 (z9 / line
                           :mod (z10 / cell)
                           :mod (z11 / all)
                           :ARG2-of (z12 / except-01
                                         :ARG1 (z13 / and
                                                    :op1 (z14 / line
                                                              :wiki ""Mitogen-activated_protein_kinase""
                                                              :name (z15 / name
                                                                         :op1 ""Mel""
                                                                         :op2 285)
                                                              :mod (z16 / cell))
                                                    :op2 (z17 / line
                                                              :wiki ""Mitogen-activated_protein_kinase""
                                                              :name (z18 / name
                                                                         :op1 ""Mel""
                                                                         :op2 290)
                                                              :mod z16)
                                                    :ARG0-of (z19 / have-03
                                                                  :ARG1 (z20 / level
                                                                             :mod z3
                                                                             :ARG1-of (z21 / have-degree-91
                                                                                           :ARG2 (z22 / high-02
                                                                                                      :ARG1 z20
                                                                                                      :ARG1-of (z23 / significant-02))
                                                                                           :ARG3 (z24 / more)
                                                                                           :ARG4 (z25 / level
                                                                                                      :mod (z26 / other))))))))))",0.6434782608695652,0.4660194174757281,"(m / multi-sentence
        :snt1 (b / be-01
            :ARG1 (l / level
                  :mod (t / total)
                  :mod (e / ERK))
            :ARG2 (s / similar
                  :ARG1 (a / across
                        :ARG2 (c / cell-line))))
        :snt2 (h / have-03
            :ARG1 (l2 / level
                  :mod (t2 / total)
                  :mod (e2 / ERK))
            :ARG2 (h2 / high
                  :degree (s2 / significantly))
            :ARG3 (c2 / cell-line
                  :op1 (n / name :op1 ""Mel_285"")
                  :op2 (n2 / name :op1 ""Mel_290"")))
        :snt3 (e3 / exception
            :ARG1 (t3 / two
                  :mod (c3 / cell-line
                        :op1 (n3 / name :op1 ""Mel_285"")
                        :op2 (n4 / name :op1 ""Mel_290"")))
            :ARG2 (l3 / level
                  :mod (t4 / total)
                  :mod (e3 / ERK))
            :ARG3 (o / other)))","(s / similar-01
    :ARG1 (l / level
        :quant (t / total)
        :topic (e / ERK))
    :ARG2 (l2 / level
        :quant (t2 / total)
        :topic e)
    :degree (r / remarkable)
    :location (c / cell-line
        :quant (a / all))
    :except (c2 / cell-line
        :name (n / name :op1 ""Mel"" :op2 ""285"")
        :name (n2 / name :op1 ""Mel"" :op2 ""290"")
        :ARG1-of (h / have-03
            :ARG2 l2
            :degree (s / significant)
            :comparison (o / other
                :ARG1-of (m / more-02
                    :ARG1 l2)))))",-1.0,-1.0
pmid_1592_8660.94,"<xref ref-type=""fig"" rid=""fig2"">Figure 2</xref> shows that there is no significant influence of serum on the activity of ERK1/2 in these cell lines, as reported recently by <xref ref-type=""other"" rid=""bib3"">Calipel <i>et al</i> (2003)</xref>.","(s2 / show-01
    :ARG0 (f / figure
        :mod 2)
    :ARG1 (i / influence-01
        :ARG0 (s / serum)
        :ARG1 (a / activity-06
            :ARG0 (e / enzyme
                :name (n / name
                    :op1 ""ERK""
                    :op2 ""1/2""))
            :location (l / line
                :mod (c / cell)
                :mod (t / this)))
        :ARG1-of (s3 / significant-02)
        :ARG1-of (r2 / report-01
            :time (r / recent)
            :time (d / date-entity
                :year 2003))
        :polarity -)
    :ARG1 (s4 / statistic
        :value 2)
    :rel (p / publication
        :name (n2 / name)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (f / figure :mod 2)
      :ARG1 (i / influence-01
            :ARG0 (s3 / serum)
            :ARG1 (a / activity-06
                  :ARG0 (e / enzyme :name (n / name :op1 ""ERK1/2"")))
            :ARG1-of (s2 / significant-02 :polarity -)
            :location (c / cell-line
                  :mod (t / this)))
      :ARG1-of (r / report-01
            :ARG0 (p4 / publication-91
                  :ARG0 (a2 / and
                        :op1 (p / person :name (n2 / name :op1 ""Calipel""))
                        :op2 (p2 / person
                              :mod (o / other)))))
      :ARG1-of (d / describe-01
            :ARG0 (p3 / publication-91
                  :time (d2 / date-entity :year 2003))))","<xref ref-type=""fig"" rid=""fig2"">Figure 2</xref> shows that there is no significant influence of serum on the activity of ERK1/2 in these cell lines, as reported recently by <xref ref-type=""other"" rid=""bib3"">Calipel <i>et al</i> (2003)</xref>.","(z1 / show-01
    :ARG0 (z2 / figure
              :mod 2
              :ARG1-of (z3 / hyperlink-91
                           :ARG3 (z4 / url-entity
                                     :value ""Figure_2"")))
    :ARG1 (z5 / influence-01
              :polarity -
              :ARG0 (z6 / serum)
              :ARG1 (z7 / activity-06
                        :ARG0 (z8 / enzyme
                                  :wiki ""ERK1/2""
                                  :name (z9 / name
                                            :op1 ""ERK1/2""))
                        :location (z10 / line
                                       :mod (z11 / cell)
                                       :mod (z12 / this)))
              :ARG1-of (z13 / significant-02))
    :ARG1-of (z14 / report-01
                  :ARG0 (z15 / publication-91
                             :ARG0 (z16 / person
                                        :wiki ""Gerhard_Calipel""
                                        :name (z17 / name
                                                   :op1 ""Calipel"")
                                        :ARG1-of (z18 / cite-01
                                                      :ARG2 (z19 / date-entity
                                                                 :year 2003))
                                        :time (z21 / recent)))))",0.5054945054945055,0.4578313253012048,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (f / figure
                  :ARG1 (n / name :op1 ""Figure 2""))
            :ARG1 (i / influence-01
                  :ARG1 (s2 / serum)
                  :ARG2 (a / activity
                        :ARG1 (e / ERK1/2)
                        :ARG2 (c / cell-line
                              :mod (t / these))))
            :ARG2 (r / report-01
                  :ARG0 (c2 / Calipel)
                  :ARG1 (r2 / recent
                        :time (y / year :op1 2003))
                  :ARG2 (a2 / al
                        :op1 ""et"")))
        :snt2 (n2 / no
            :polarity -))","(s / show-01
    :ARG0 (f / figure :name (n / name :op1 ""2""))
    :ARG1 (i / influence-01
        :ARG1 (a / activity-01
            :ARG1 (e / ERK1/2))
        :ARG2 (s2 / serum)
        :location (c / cell-line)
        :degree (n2 / no)
        :mod (s3 / significant))
    :ARG2 (r / report-01
        :ARG0 (p / person :name (n3 / name :op1 ""Calipel"" :op2 ""et"" :op3 ""al"") :date (d / date-entity :year 2003))
        :time (r2 / recent-02)))",-1.0,-1.0
pmid_1592_8660.97,"In seven of the 19 primary tumours, less than 5% of the tumour cells stained positively for ERK1/2 and nine tumours for phosphorylated ERK1/2.","(a / and
    :location (t / tumor
        :quant 7
        :ARG1-of (i / include-91
            :ARG2 (t2 / tumor
                :quant 19
                :mod (p4 / primary))))
    :op1 (s / stain-01
        :ARG1 (c / cell
            :ARG1-of (i2 / include-91
                :ARG3 t)
            :part-of (t3 / tumor))
        :ARG2 (p3 / positive)
        :ARG2 (e / enzyme
            :name (n / name
                :op1 ""ERK""
                :op2 ""1/2"")))
    :op2 (s2 / stain-01)
    :rel (l / less-than
        :op1 (p / percentage-entity
            :value 5))
    :rel (c2 / cell
        :quant 9
        :ARG1-of (p2 / phosphorylate-01)))
",test,bio_amr0.8,"(a / and
      :op1 (s / stain-01
            :ARG1 (c / cell
                  :ARG1-of (i / include-91
                        :ARG2 (c2 / cell
                              :mod (t / tumor))
                        :ARG3 (l / less-than
                              :op1 (p / percentage-entity :value 5)))
                  :mod t)
            :manner (p2 / positive)
            :location (t3 / tumor :quant 7
                  :ARG1-of (i3 / include-91
                        :ARG2 (t4 / tumor :quant 19
                              :mod (p4 / primary))))
            :beneficiary (e / enzyme :name (n2 / name :op1 ""ERK1/2"")))
      :op2 (s2 / stain-01
            :ARG1 (t2 / tumor :quant 9
                  :ARG1-of (i2 / include-91
                        :ARG2 t4))
            :beneficiary (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                  :ARG3-of (p3 / phosphorylate-01))))","In seven of the 19 primary tumours, less than 5% of the tumour cells stained positively for ERK1/2 and nine tumours for phosphorylated ERK1/2.","(z1 / and
    :op1 (z2 / stain-01
             :ARG1 (z3 / cell
                       :ARG1-of (z4 / include-91
                                    :ARG2 (z5 / cell
                                              :mod (z6 / tumor))
                                    :ARG3 (z7 / less-than
                                              :op1 (z8 / percentage-entity
                                                       :value 5))))
             :ARG2 (z9 / protein
                       :wiki ""ERK1/2""
                       :name (z10 / name
                                  :op1 ""ERK1/2""))
             :ARG3 (z11 / cell
                        :quant 7
                        :ARG1-of (z12 / include-91
                                      :ARG2 (z13 / tumor
                                                 :quant 19
                                                 :mod (z14 / primary)))))
    :ARG2 (z15 / positive))",0.6117647058823529,0.5274725274725274,"(m / multi-sentence
        :snt1 (s / stain-01
            :ARG1 (c / cell
                  :mod (t / tumour
                        :mod (p / primary
                              :quant (n / number :op1 19)))
                  :ARG1-of (p2 / positively)
                  :ARG1-of (e / ERK1/2)))
        :snt2 (s2 / stain-01
            :ARG1 c
            :ARG1-of (p3 / phosphorylate-01
                  :ARG1 (e2 / ERK1/2))))","(p / primary-01
    :ARG1 (t / tumor
        :quant 19
        :part (t2 / tumor
            :quant 7
            :ARG1-of (l / less-than
                :ARG2 (p2 / percent
                    :quant 5))
            :ARG1-of (s / stain-01
                :ARG2 (c / cell
                    :part-of t2)
                :manner (p3 / positive)
                :ARG1 (e / ERK1/2))
            :ARG1-of (a / and-01
                :op2 (t3 / tumor
                    :quant 9
                    :ARG1-of (s2 / stain-01
                        :ARG2 (c2 / cell
                            :part-of t3)
                        :manner (p4 / positive)
                        :ARG1 (p5 / phosphorylate-01
                            :ARG1 e)))))))",-1.0,-1.0
pmid_1592_8660.98,"Despite the lack of mutations in the <i>RAS</i> and <i>BRAF</i> genes in this set of uveal melanomas, it is noteworthy that we observed phosphorylated (active) ERK1/2 expression in 10 of 19 tumours.","(n5 / note-01
    :ARG1 (o / observe-01
        :ARG0 (w2 / we)
        :ARG1 (e2 / express-03
            :ARG1-of (a / activity-06)
            :ARG2 (e / enzyme
                :name (n4 / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :location (t2 / tumor
            :quant 10
            :ARG1-of (i / include-91
                :ARG2 (t3 / tumor
                    :quant 19))))
    :concession (l / lack-01
        :ARG1 (m / mutate-01
            :ARG1 (a2 / and
                :op1 (g / gene
                    :name (n / name
                        :op1 ""shit""))
                :op2 (g2 / gene
                    :name (n2 / name))))
        :part-of (s / set
            :consist-of (d / disease
                :name (n3 / name
                    :op1 ""uveal""
                    :op2 ""melanomas""))
            :mod (t / this)))
    :rel (w / we)
    :rel (p / phosphorylate-01))
",test,bio_amr0.8,"(n / note-01
      :ARG1 (o / observe-01
            :ARG0 (w / we)
            :ARG1 (e / express-01
                  :ARG2 (e2 / enzyme :name (n2 / name :op1 ""ERK1/2"")
                        :ARG3-of (p / phosphorylate-01
                              :ARG1-of (m / mean-01
                                    :ARG2 (a / activity-06)))))
            :location (t / tumor :quant 10
                  :ARG1-of (i / include-91
                        :ARG2 (t2 / tumor :quant 19)))
            :concession (l / lack-01
                        :ARG1 (m2 / mutate-01
                              :ARG1 (a2 / and
                                    :op1 (g / gene :name (n3 / name :op1 ""RAS"")
                                          :location (s / set
                                                :mod (t3 / this)
                                                :consist-of (m3 / medical-condition :name (n5 / name :op1 ""melanoma"")
                                                      :mod (u / uveal))))
                                    :op2 (g2 / gene :name (n4 / name :op1 ""BRAF"")
                                          :location s)))))
      :ARG1-of (r / recommend-01))","Despite the lack of mutations in the <i>RAS</i> and <i>BRAF</i> genes in this set of uveal melanomas, it is noteworthy that we observed phosphorylated (active) ERK1/2 expression in 10 of 19 tumours.","(z1 / have-concession-91
    :ARG1 (z2 / note-02
              :ARG1 (z3 / observe-01
                        :ARG0 (z4 / we)
                        :ARG1 (z5 / express-03
                                  :ARG1 (z6 / enzyme
                                            :wiki ""ERK1/2""
                                            :name (z7 / name
                                                      :op1 ""ERK1/2""
                                                      :op2 ""expression"")
                                            :ARG1-of (z8 / phosphorylate-01
                                                         :ARG1-of (z9 / mean-01
                                                                      :ARG2 (z10 / activity-06
                                                                                 :ARG0 z6)))))
                        :location (z11 / tumor
                                       :quant 10
                                       :ARG1-of (z12 / include-91
                                                     :ARG2 (z13 / tumor
                                                                :quant 19))))
              :ARG1-of (z14 / notable-04))
    :ARG2 (z15 / lack-01
               :ARG1 (z16 / mutate-01
                          :ARG1 (z17 / and
                                     :op1 (z18 / gene
                                               :wiki ""BRAF_(g3000 / gene)""
                                               :name (z19 / name
                                                          :op1 ""RAS""))
                                     :op2 (z20 / gene
                                               :wiki ""BRAF_(g3001 / gene)""
                                               :name (z21 / name
                                                          :op1 ""BRAF""))))
               :location (z22 / set
                              :consist-of (z23 / melanoma
                                               :mod (z24 / uveal))
                              :mod (z25 / this))))",0.5982905982905983,0.5636363636363636,"(m / multi-sentence
        :snt1 (d / despite
            :ARG1 (l / lack-01
                  :ARG2 (m2 / mutation
                        :ARG1-of (g2 / gene
                              :name (n2 / name :op1 ""RAS""))))
            :ARG2 (l2 / lack-01
                  :ARG2 (m3 / mutation
                        :ARG1-of (g3 / gene
                              :name (n3 / name :op1 ""BRAF"")))))
        :snt2 (n / note-01
            :ARG1 (o / observe-01
                  :ARG0 (w / we)
                  :ARG1 (e / expression
                        :ARG1 (p / phosphorylate-01
                              :ARG1 (e2 / ERK1/2))
                        :ARG2 (t / tumour
                              :quant (n4 / number :op1 19)
                              :ARG1-of (o2 / observe-01
                                    :ARG0 w
                                    :ARG1 e))))))","(d / despite-91
    :ARG2 (l / lack-01
        :ARG1 (m / mutation
            :location (g / gene
                :name (n / name :op1 ""RAS"")
                :name (n2 / name :op1 ""BRAF""))
            :part (s / set
                :consist-of (m2 / melanoma
                    :mod (u / uveal)))))
    :ARG1 (o / observe-01
        :ARG0 (w / we)
        :ARG1 (e / express-01
            :ARG1 (p / phosphorylate-01
                :ARG1 (a / active)
                :ARG2 (e2 / ERK1/2))
            :location (t / tumor
                :quant 19
                :part (t2 / tumor
                    :quant 10)))
        :mod (n3 / noteworthy)))",-1.0,-1.0
pmid_1592_8660.99,There was no significant association between ERK1/2 activation and tumour location or cell type.,"(a2 / associate-01
    :ARG1 (a / activate-01
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""ERK""
                :op2 ""1/2"")))
    :ARG1-of (s / significant-02)
    :ARG2 (o / or
        :op1 (l / location
            :location-of (t / tumor))
        :op2 (t2 / type-03
            :ARG1 (c / cell)))
    :polarity -)
",test,bio_amr0.8,"(a / associate-01
      :ARG1 (a2 / activate-01
            :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2"")))
      :ARG2 (o / or
            :op1 (l / location
                  :location-of (t / tumor))
            :op2 (t2 / type-03
                  :ARG1 (c / cell)))
      :ARG1-of (s / significant-02 :polarity -))",There was no significant association between ERK1/2 activation and tumour location or cell type.,"(z1 / associate-01
    :polarity -
    :ARG1 (z2 / activate-01
              :ARG1 (z3 / enzyme
                        :wiki ""Extracellular_signal-regulated_kinase_1/2""
                        :name (z4 / name
                                  :op1 ""ERK1/2"")))
    :ARG2 (z5 / or
              :op1 (z6 / location
                       :location-of (z7 / tumor))
              :op2 (z8 / type
                       :mod (z9 / cell)))
    :ARG1-of (z10 / significant-02))",0.7555555555555555,0.8,"(s / significant
        :polarity (n / no)
        :ARG1 (a / association
              :ARG1 (b / between
                    :ARG1 (a2 / activation
                          :ARG1 (e / ERK1/2))
                    :ARG2 (a3 / location
                          :mod (t / tumour))
                    :ARG2 (a4 / type
                          :mod (c / cell)))))","(a / associate-01
    :ARG1 (a2 / activate-01
        :ARG0 (p / protein
            :name (n / name :op1 ""ERK1/2"")))
    :ARG2 (o / or
        :op1 (l / location
            :part-of (t / tumor))
        :op2 (c / cell
            :mod (t2 / type)))
    :polarity - 
    :degree (s / significant))",-1.0,0.5909090909090909
pmid_1684_6534.10,"Additional changes were seen at the protein level, such as increased expression of c-Myc, heightened phosphorylation of AKT, and decreased activation of MEK1/2 and ERK1/2.","(s / see-01
    :ARG1 (c / change-01
        :example (a3 / and
            :op1 (i / increase-01
                :ARG1 (e4 / express-03
                    :ARG1 (e / enzyme
                        :name (n / name
                            :op1 ""C""))))
            :op2 (p / phosphorylate-01
                :ARG1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""AKT""))
                :ARG1-of (h / heighten-01))
            :op3 (d / decrease-01
                :ARG1 (a / activate-01
                    :ARG1 (p3 / protein
                        :name (n3 / name
                            :op1 ""MEK""
                            :op2 ""1/2"")
                        :ARG0 (a4 / and
                            :op1 p3
                            :op2 (e3 / enzyme
                                :name (n4 / name
                                    :op1 ""ERK""
                                    :op2 ""1/2"")))))))
        :location (l / level
            :op1 (p2 / protein))
        :mod (a2 / additional)))
",test,bio_amr0.8,"(s / see-01
      :ARG1 (c / change-01
            :ARG1 (l / level
                  :quant-of (p / protein))
            :mod (a / additional)
            :example (a2 / and
                        :op1 (e / express-03
                              :ARG2 (p3 / protein :name (n / name :op1 ""c-Myc""))
                              :ARG1-of (i / increase-01))
                        :op2 (p2 / phosphorylate-01
                              :ARG1 (e2 / enzyme :name (n2 / name :op1 ""AKT""))
                              :ARG1-of (h / heighten-01))
                        :op3 (a3 / activate-01
                              :ARG1 (a4 / and
                                    :op1 (e3 / enzyme :name (n3 / name :op1 ""MEK1""))
                                    :op2 (e4 / enzyme :name (n4 / name :op1 ""MEK2""))
                                    :op3 (e5 / enzyme :name (n5 / name :op1 ""ERK1""))
                                    :op4 (e6 / enzyme :name (n6 / name :op1 ""ERK2"")))
                              :ARG1-of (d / decrease-01)))))","Additional changes were seen at the protein level, such as increased expression of c-Myc, heightened phosphorylation of AKT, and decreased activation of MEK1/2 and ERK1/2.","(z1 / see-01
    :ARG1 (z2 / change-01
              :mod (z3 / additional)
              :mod (z4 / level
                       :mod (z5 / protein))
              :example (z6 / and
                           :op1 (z7 / increase-01
                                    :ARG1 (z8 / express-02
                                              :ARG1 (z9 / small-molecule
                                                        :wiki ""Cyclin-Myc""
                                                        :name (z10 / name
                                                                   :op1 ""c-Myc""))))
                           :op2 (z11 / phosphorylate-01
                                     :ARG1 (z12 / enzyme
                                                :wiki ""AKT""
                                                :name (z13 / name
                                                           :op1 ""AKT""))
                                     :ARG1-of (z14 / heighten-01))
                           :op3 (z15 / activate-01
                                     :ARG1 (z16 / and
                                                :op1 (z17 / enzyme
                                                          :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                          :name (z18 / name
                                                                     :op1 ""MEK1/2""))
                                                :op2 (z19 / enzyme
                                                          :wiki ""ERK1/2""
                                                          :name (z20 / name
                                                                     :op1 ""ERK1/2"")))
                                     :ARG1-of (z21 / decrease-01)))))",0.5471698113207547,0.4952380952380952,"(c / change-01
        :ARG1 (s / see-01
              :ARG1 (p / protein
                    :mod (l / level))
              :ARG2 (e / expression-01
                    :ARG1 (e2 / entity
                          :name (c2 / c-Myc)))
              :ARG2 (p2 / phosphorylation-01
                    :ARG1 (e3 / entity
                          :name (a / AKT)))
              :ARG2 (a2 / activation-01
                    :ARG1 (e4 / entity
                          :name (m / MEK1/2)))
              :ARG2 (a3 / activation-01
                    :ARG1 (e5 / entity
                          :name (e6 / ERK1/2))))
        :ARG2 (i / increase-01
              :ARG1 e2)
        :ARG2 (h / heighten-01
              :ARG1 e3)
        :ARG2 (d / decrease-01
              :ARG1 (a4 / activation-01
                    :ARG1 e4))
        :ARG2 (d2 / decrease-01
              :ARG1 (a5 / activation-01
                    :ARG1 e5)))","(c / change-01
    :ARG1 (p / protein)
    :mod (a / additional)
    :ARG2 (m / multi-sentence
        :snt1 (e / express-01
            :ARG1 (c2 / c-Myc)
            :degree (i / increase-01))
        :snt2 (p2 / phosphorylate-01
            :ARG1 (a2 / AKT)
            :degree (h / heighten-01))
        :snt3 (a3 / activate-01
            :ARG1 (m2 / MEK1/2)
            :degree (d / decrease-01))
        :snt4 (a4 / activate-01
            :ARG1 (e2 / ERK1/2)
            :degree d)))",-1.0,-1.0
pmid_1684_6534.11,"These were correlated with cellular events, as MUC1 siRNA in the MDA-MB-468 line decreased proliferation and invasion, and increased stress-induced apoptosis.","(c3 / correlate-01
    :ARG1 (t / this)
    :ARG1-of (c / cause-01
        :ARG0 (a2 / and
            :op1 (d / decrease-01
                :ARG0 (e / enzyme
                    :name (n / name
                        :op1 ""MUC1""
                        :op2 ""siRNA"")
                    :part-of (l / line
                        :name (n2 / name
                            :op1 4)))
                :ARG1 (a / and
                    :op1 (p / proliferate-01)
                    :op2 (i3 / invade-01)))
            :op2 (i / increase-01
                :ARG0 e
                :ARG1 (a3 / apoptosis
                    :ARG1-of (i2 / induce-01
                        :ARG2 (s / stress-02))))))
    :ARG2 (e2 / event
        :mod (c2 / cell)))
",test,bio_amr0.8,"(c / correlate-01
      :ARG1 (t / this)
      :ARG2 (e / event
            :mod (c2 / cell))
      :ARG1-of (c4 / cause-01
            :ARG0 (a / and
                  :op1 (d / decrease-01
                        :ARG0 (n4 / nucleic-acid :name (n / name :op1 ""siRNA"")
                              :ARG0-of (e2 / encode-01
                                    :ARG1 (p / protein :name (n2 / name :op1 ""MUC1""))))
                        :ARG1 (a3 / and
                              :op1 (p2 / proliferate-01)
                              :op2 (i / invade-01)))
                  :op2 (i2 / increase-01
                        :ARG0 n4
                        :ARG1 (a2 / apoptosis
                              :ARG2-of (i3 / induce-01
                                    :ARG0 (s / stress))))
                  :location (c3 / cell-line :name (n3 / name :op1 ""MDA-MB-468"")))))","These were correlated with cellular events, as MUC1 siRNA in the MDA-MB-468 line decreased proliferation and invasion, and increased stress-induced apoptosis.","(z1 / correlate-01
    :ARG1 (z2 / this)
    :ARG2 (z3 / event
              :mod (z4 / cell))
    :ARG1-of (z5 / cause-01
                 :ARG0 (z6 / and
                           :op1 (z7 / decrease-01
                                    :ARG0 (z8 / siRNA
                                              :wiki ""Mitogen-activated_protein_kinase_1""
                                              :name (z9 / name
                                                        :op1 ""MUC1""
                                                        :op2 ""siRNA"")
                                              :part-of (z10 / line
                                                            :wiki ""MDA-MB-468""
                                                            :name (z11 / name
                                                                       :op1 ""MDA-MB-468"")))
                                    :ARG1 (z12 / and
                                               :op1 (z13 / proliferate-01)
                                               :op2 (z14 / invade-01)))
                           :op2 (z15 / increase-01
                                     :ARG0 z8
                                     :ARG1 (z16 / apoptose-01
                                                :ARG1-of (z17 / induce-01
                                                              :ARG0 (z18 / stress-02)))))))",0.6818181818181819,0.6744186046511628,"(m / multi-sentence
        :snt1 (c / correlate-01
            :ARG1 (e / event
                  :mod (c2 / cellular))
            :ARG2 (w / with
                  :ARG1 (d / decrease-01
                        :ARG1 (p / proliferation)
                        :ARG2 (l / line
                              :mod (m / MDA-MB-468)))
                  :ARG2 (i / increase-01
                        :ARG1 (a / apoptosis
                              :mod (s / stress-induced))
                        :ARG2 (i2 / invasion)))))","(c / correlate-01
    :ARG1 (e / event
        :mod (c2 / cell))
    :ARG2 (m / multi-sentence
        :snt1 (d / decrease-01
            :ARG0 (s / siRNA
                :mod (m2 / MUC1))
            :ARG1 (p / proliferate-01
                :ARG0 (l / line
                    :name (n / name :op1 ""MDA-MB-468""))))
        :snt2 (d2 / decrease-01
            :ARG0 s
            :ARG1 (i / invade-01
                :ARG0 l))
        :snt3 (i2 / increase-01
            :ARG0 s
            :ARG1 (a / apoptosis
                :mod (s2 / stress-induced)))))
    :location (l2 / line
        :name (n2 / name :op1 ""MDA-MB-468"")))",-1.0,-1.0
pmid_1684_6534.102,"Two human breast cancer cell lines, MDA-MB-468 and BT-20, were transiently transfected with a pool of four siRNA oligonucleotides directed against the MUC1 mRNA (468.siMUC1 and BT.siMUC1), or a control oligonucleotide directed against luciferase (468.siLuc and BT.siLuc).","(b / bind-01
    :ARG1 (l / line
        :name (n2 / name
            :op1 ""B"")
        :quant 2
        :mod (c / cell
            :mod (d3 / disease
                :name (n / name
                    :op1 ""cancer"")
                :mod (b2 / breast)
                :mod (h / human))))
    :ARG2 (p / pool
        :consist-of (v / virus
            :name (n4 / name
                :op1 ""siRNA"")
            :quant 4
            :ARG1-of (d / direct-01
                :ARG2 (e / enzyme
                    :name (n5 / name
                        :op1 ""MUC1""
                        :op2 ""mRNA""))))
        :consist-of (o2 / or
            :op1 v
            :op2 (n7 / nucleic-acid
                :name (n6 / name
                    :op1 ""i""
                    :op2 4))
            :op3 (o / oligonucleotide
                :ARG0-of (c2 / control-01)
                :ARG1-of (d2 / direct-01
                    :ARG2 (l2 / luciferase)))))
    :manner (t / temporary)
    :rel (n3 / name
        :op1 ""20""))
",test,bio_amr0.8,"(t / transfect-01
      :ARG1 (c / cell-line :quant 2
            :ARG1-of (m / mean-01
                  :ARG2 (a / and
                        :op1 (c3 / cell-line :name (n / name :op1 ""MDA-MB-468""))
                        :op2 (c4 / cell-line :name (n2 / name :op1 ""BT-20""))))
            :source (d3 / disease :wiki ""Breast_cancer"" :name (n8 / name :op1 ""breast"" :op2 ""cancer"")
                  :mod (h / human)))
      :ARG2 (o / or
            :op1 (p / pool
                  :consist-of (o2 / oligonucleotide :quant 4
                        :mod (n11 / nucleic-acid :name (n3 / name :op1 ""siRNA"")))
                  :ARG1-of (d / direct-01
                        :ARG2 (n12 / nucleic-acid :name (n4 / name :op1 ""mRNA"")
                              :ARG0-of (e2 / encode-01
                                    :ARG1 (p2 / protein :name (n5 / name :op1 ""MUC1"")))))
                  :ARG1-of (m2 / mean-01
                        :ARG2 (a2 / and
                              :op1 (c6 / cell-line :name (n6 / name :op1 ""468.siMUC1""))
                              :op2 (c7 / cell-line :name (n7 / name :op1 ""BT.siMUC1"")))))
            :op2 (o5 / oligonucleotide
                  :mod (c5 / control)
                  :ARG1-of (d2 / direct-01
                        :ARG2 (l / luciferase))
                  :ARG1-of (m3 / mean-01
                        :ARG2 (a3 / and
                              :op1 (c8 / cell-line :name (n9 / name :op1 ""468.siLuc""))
                              :op2 (c9 / cell-line :name (n10 / name :op1 ""BT.siLuc""))))))
      :manner (t2 / transient-02))","Two human breast cancer cell lines, MDA-MB-468 and BT-20, were transiently transfected with a pool of four siRNA oligonucleotides directed against the MUC1 mRNA (468.siMUC1 and BT.siMUC1), or a control oligonucleotide directed against luciferase (468.siLuc and BT.siLuc).","(z1 / transfect-01
    :ARG1 (z2 / cell-line
              :quant 2
              :mod (z3 / human)
              :mod (z4 / disease
                       :wiki ""Breast_cancer""
                       :name (z5 / name
                                 :op1 ""breast""
                                 :op2 ""cancer""))
              :mod (z6 / cell
                       :wiki ""BRAF_(g3000 / gene)""
                       :name (z7 / name
                                 :op1 ""MDA-MB-468""))
              :mod (z8 / cell
                       :wiki ""BRAF_(g3001 / gene)""
                       :name (z9 / name
                                 :op1 ""BT-20"")))
    :ARG2 (z10 / or
               :op1 (z11 / pool
                         :consist-of (z12 / oligonucleotide
                                          :quant 4
                                          :mod (z13 / siRNA)
                                          :ARG1-of (z14 / direct-01
                                                        :ARG2 (z15 / and
                                                                   :op1 (z16 / protein
                                                                             :wiki ""Mitogen-activated_protein_kinase_1""
                                                                             :name (z17 / name
                                                                                        :op1 ""MUC1""
                                                                                        :op2 ""mRNA""))
                                                                   :op2 (z18 / protein
                                                                             :wiki ""BRAF_(g3002 / gene)""
                                                                             :name (z19 / name
                                                                                        :op1 ""BT.siMUC1""))))))
               :op2 (z20 / oligonucleotide
                         :ARG0-of (z21 / control-01)
                         :ARG1-of (z22 / direct-01
                                       :ARG2 (z23 / enzyme
                                                  :wiki ""Lactiferase""
                                                  :name (z24 / name
                                                             :op1 ""Lactiferase""))))))",0.3717948717948718,0.2818791946308724,"(m / multi-sentence
        :snt1 (t / transfer-01
            :ARG0 (t2 / transiently)
            :ARG1 (c / cell-line
                  :mod (b / breast
                        :mod (h / human)))
            :ARG2 (p / pool
                  :mod (f / four)
                  :ARG1 (o / oligonucleotide
                        :mod (s / siRNA
                              :mod (d / direct-01
                                    :ARG1 (m / mRNA
                                          :mod (m2 / MUC1)))
                              :ARG2 (a / against)))
                  :ARG2 (c2 / control
                        :mod (d2 / direct-01
                              :ARG1 (l / luciferase))))))
        :snt2 (w / with
            :ARG0 (t3 / transfected
                  :ARG1 (l2 / line
                        :mod (c3 / cell
                              :mod (b2 / breast
                                    :mod (h2 / human))))
                  :ARG2 (p2 / pool
                        :mod (f2 / four)
                        :ARG1 (o2 / oligonucleotide
                              :mod (s2 / siRNA
                                    :mod (d3 / direct-01
                                          :ARG1 (m3 / mRNA
                                                :mod (m4 / MUC1)))
                                    :ARG2 (a2 / against)))
                        :ARG2 (c4 / control
                              :mod (d4 / direct-01
                                    :ARG1 (l2 / luciferase))))))","(t / transfected-01 :mode past
    :ARG0 (c / cell-line
        :mod (c2 / cancer
            :mod (b / breast)
            :mod (h / human))
        :name (n / name :op1 ""MDA-MB-468"" :op2 ""BT-20""))
    :ARG1 (p / pool
        :consist-of (o / oligonucleotide
            :mod (s / siRNA)
            :quant 4
            :ARG0-of (d / direct-01
                :ARG1 (m / mRNA
                    :mod (m2 / MUC1)
                    :name (n2 / name :op1 ""468.siMUC1"" :op2 ""BT.siMUC1"")))))
    :ARG2 (o2 / oligonucleotide
        :mod (c3 / control)
        :ARG0-of (d2 / direct-01
            :ARG1 (l / luciferase)
            :name (n3 / name :op1 ""468.siLuc"" :op2 ""BT.siLuc"")))
    :manner (t2 / transient))",-1.0,0.3043478260869565
pmid_1684_6534.106,"Both MDA-MB-468 and BT-20 display a less dramatic decrease of MUC1 extracellular domain compared to MUC1-CT (Figure <xref ref-type=""fig"" rid=""F1"">1a</xref>); this likely represents protein synthesized prior to transfection, and may reflect differences in the turnover rates of the two subunits.","(m / multi-sentence
    :rel (n / name
        :op1 ""4""
        :op2 ""healthy"")
    :snt1 (d3 / display-01
        :ARG0 (a / and
            :mod (b / both)
            :op2 (p / person
                :name (n2 / name
                    :op1 20)))
        :ARG1 (d / decrease-01
            :ARG1 (d4 / domain
                :name (n3 / name
                    :op1 ""MUC1"")
                :ARG1-of (i2 / ionize-01))
            :ARG1-of (c / compare-01
                :ARG2 (s / small-molecule
                    :name (n4 / name
                        :op2 ""healthy"")))
            :mod (d5 / dramatic
                :ARG2-of (h / have-degree-91
                    :ARG1 d
                    :ARG3 (l / less)))))
    :snt2 (a2 / and
        :op1 (r3 / represent-01
            :ARG0 (f / figure)
            :ARG1 (p4 / protein
                :ARG1-of (s2 / synthesize-01
                    :time (p3 / prior
                        :op1 (i / infect-01))))
            :ARG1-of (l2 / likely-01))
        :op2 (p2 / possible-01
            :ARG1 (r2 / reflect-01
                :ARG1 d
                :ARG2 (d2 / differ-02
                    :ARG1 (r / rate
                        :mod (t / turn-over-12))
                    :ARG1 (u / unit
                        :quant 2))))))
",test,bio_amr0.8,"(d / display-01
      :ARG0 (a / and
            :op1 (c / cell-line :name (n / name :op1 ""MDA-MB-468""))
            :op2 (c2 / cell-line :name (n2 / name :op1 ""BT-20"")))
      :ARG1 (d2 / decrease-01
            :ARG1 (p2 / protein-segment
                  :mod (e / extracellular)
                  :part-of (p / protein :name (n3 / name :op1 ""MUC1"")))
            :ARG2 (d3 / dramatic
                  :degree (l / less))
            :compared-to (p3 / protein-segment :name (n4 / name :op1 ""MUC1-CT"")))
      :ARG1-of (d4 / describe-01
            :ARG0 (f / figure :mod ""1a""))
      :ARG0-of (r / represent-01
            :ARG1 (p4 / protein
                  :ARG1-of (s / synthesize-01
                        :time (p6 / prior
                              :op1 (t / transfect-01))))
            :ARG1-of (l2 / likely-01))
      :ARG1-of (r2 / reflect-01
            :ARG2 (d5 / differ-02
                  :ARG1 (r3 / rate
                        :degree-of (t2 / turnover)
                        :poss (a2 / and
                              :op1 p2
                              :op2 p3)))
            :ARG1-of (p5 / possible-01)))","Both MDA-MB-468 and BT-20 display a less dramatic decrease of MUC1 extracellular domain compared to MUC1-CT (Figure <xref ref-type=""fig"" rid=""F1"">1a</xref>); this likely represents protein synthesized prior to transfection, and may reflect differences in the turnover rates of the two subunits.","(z1 / and
    :op1 (z2 / display-01
             :ARG0 (z3 / and
                       :op1 (z4 / protein
                                :wiki ""BRAF-MB-468""
                                :name (z5 / name
                                          :op1 ""MDA-MB-468""))
                       :op2 (z6 / protein
                                :wiki ""BRAF-20""
                                :name (z7 / name
                                          :op1 ""BT-20""))
                       :mod (z8 / both))
             :ARG1 (z9 / decrease-01
                       :ARG1 (z10 / domain
                                  :wiki ""MUC1""
                                  :name (z11 / name
                                             :op1 ""MUC1"")
                                  :mod (z12 / extracellular)
                                  :part-of (z13 / protein
                                                :wiki ""Mitogen-activated_protein_kinase""
                                                :name (z14 / name
                                                           :op1 ""MUC1-CT"")))
                       :ARG1-of (z15 / have-degree-91
                                     :ARG2 (z16 / dramatic)
                                     :ARG3 (z17 / less)
                                     :ARG4 (z18 / decrease-01
                                                :ARG1 z10))))
    :op2 (z19 / likely-01
              :ARG1 (z20 / represent-01
                         :ARG0 z9
                         :ARG1 (z21 / protein
                                    :ARG1-of (z22 / synthesize-01
                                                  :time (z23 / prior
                                                             :op1 (z24 / transfection-00)))))))",0.4754098360655737,0.4328358208955223,"(m / multi-sentence
        :snt1 (d / display-01
            :ARG0 (b / both
                  :op1 (m2 / MDA-MB-468)
                  :op2 (b2 / BT-20))
            :ARG1 (d2 / decrease-01
                  :ARG1 (d3 / domain
                        :mod (e / extracellular)
                        :mod (m / MUC1)))
            :ARG2 (d4 / decrease-01
                  :ARG1 (d5 / domain
                        :mod (m2 / MUC1-CT))))
        :snt2 (r / represent-01
            :ARG0 (l / likely)
            :ARG1 (p / protein)
            :ARG2 (s / synthesize-01
                  :ARG0 (p2 / prior)
                  :ARG1 (t / transfection)))
        :snt3 (r2 / reflect-01
            :ARG0 (m2 / may)
            :ARG1 (d6 / difference
                  :mod (r3 / rate)
                  :mod (t2 / turnover)
                  :ARG1-of (t3 / two)
                  :ARG2-of (s2 / subunit))))","(d / display-01
    :ARG0 (a / and
        :op1 (m / name :op1 ""MDA-MB-468"")
        :op2 (b / name :op1 ""BT-20""))
    :ARG1 (d2 / decrease-01
        :ARG1 (d3 / domain
            :part (m2 / molecule :name (n / name :op1 ""MUC1""))
            :location (e / extracellular))
        :degree (l / less)
        :mod (d4 / dramatic))
    :compared-to (m3 / molecule :name (n2 / name :op1 ""MUC1-CT""))
    :location (f / figure :name (n3 / name :op1 ""1a""))
    :time (a2 / and
        :op1 (r / represent-01
            :ARG1 (p / protein
                :ARG1-of (s / synthesize-01
                    :time (p2 / prior
                        :op1 (t / transfect-01))))
            :mod (l2 / likely))
        :op2 (m4 / may
            :ARG1 (r2 / reflect-01
                :ARG1 (d5 / difference-01
                    :ARG1 (r3 / rate-01
                        :ARG1-of (t2 / turnover-01)
                        :mod (t3 / two)
                        :part (s2 / subunit))))))",-1.0,0.4881889763779527
pmid_1684_6534.108,"By flow cytometry, 468.siMUC1 averaged 75% knockdown of MUC1 compared to 468.siLuc; and BT.siMUC1 averaged 50% knockdown relative to BT.siLuc.","(a / and
    :manner (c2 / cytometry
        :mod (f / flow-01))
    :op1 (a2 / average-01
        :ARG1 (k / knock-down-02
            :ARG1 (s / small-molecule
                :name (n / name
                    :op1 ""MUC1""))
            :ARG1-of (c / compare-01))
        :ARG2 (p / percentage-entity
            :value 75))
    :op2 (a3 / average-01
        :ARG1 (k2 / knock-down-02)
        :ARG2 (p2 / percentage-entity
            :value 50)
        :ARG2-of (r / relative-05
            :ARG3 k2))
    :rel (n2 / name
        :op1 ""no""
        :op2 ""way"")
    :rel 468
    :rel 468)
",test,bio_amr0.8,"(a / and
      :op1 (a2 / average-01
            :ARG0 (c2 / cell-line :name (n2 / name :op1 ""468.siMUC1"")
                  :compared-to (c3 / cell-line :name (n3 / name :op1 ""468.siLuc"")))
            :ARG1 (k / knock-down-02
                  :ARG1 (p2 / protein :name (n / name :op1 ""MUC1"")))
            :ARG2 (p / percentage-entity :value 75))
      :op2 (a3 / average-01
            :ARG0 (c5 / cell-line :name (n5 / name :op1 ""BT.siMUC1"")
                  :ARG1-of (r / relative-05
                        :ARG3 (c4 / cell-line :name (n4 / name :op1 ""BT.siLuc""))))
            :ARG1 (k2 / knock-down-02)
            :ARG2 (p3 / percentage-entity :value 50))
      :time (c / cytometry
            :mod (f / flow)))","By flow cytometry, 468.siMUC1 averaged 75% knockdown of MUC1 compared to 468.siLuc; and BT.siMUC1 averaged 50% knockdown relative to BT.siLuc.","(z1 / and
    :op1 (z2 / average-01
             :ARG1 (z3 / enzyme
                       :wiki ""Mitogen-activated_protein_kinase_1""
                       :name (z4 / name
                                 :op1 ""468.siMUC1""))
             :ARG2 (z5 / knock-down-03
                       :ARG1 (z6 / enzyme
                                 :wiki ""Mitogen-activated_protein_kinase_1""
                                 :name (z7 / name
                                           :op1 ""MUC1""))
                       :quant (z8 / percentage-entity
                                  :value 75)
                       :ARG1-of (z9 / compare-01
                                    :ARG2 (z10 / enzyme
                                               :wiki ""Mitogen-activated_protein_kinase_1""
                                               :name (z11 / name
                                                          :op1 ""468.siLuc"")))))
    :ARG3 (z12 / cytometer
               :mod (z13 / flow-01)))",0.2999999999999999,0.4819277108433735,"(m / multi-sentence
        :snt1 (a / average-01
            :ARG1 (k / knockdown-01
                  :ARG1 (m / MUC1)
                  :degree (p / percent
                        :quant 75))
            :ARG2 (c / compare-01
                  :ARG1 (n / number
                        :quant 468.siMUC1)
                  :ARG2 (n2 / number
                        :quant 468.siLuc)))
        :snt2 (a2 / average-01
            :ARG1 (k2 / knockdown-01
                  :ARG1 (m2 / MUC1)
                  :degree (p2 / percent
                        :quant 50))
            :ARG2 (r / relative
                  :ARG1 (n3 / number
                        :quant BT.siMUC1)
                  :ARG2 (n4 / number
                        :quant BT.siLuc))))","(b / by
    :ARG1 (f / flow-cytometry)
    :ARG2 (a / average-01
        :ARG0 (m / molecule :name (n / name :op1 ""468.siMUC1""))
        :ARG1 (p / percent :quant 75)
        :ARG2 (k / knockdown-01
            :ARG1 (m2 / molecule :name (n2 / name :op1 ""MUC1""))
            :compared-to (m3 / molecule :name (n3 / name :op1 ""468.siLuc""))))
    :ARG3 (a2 / and)
    :ARG4 (a3 / average-01
        :ARG0 (m4 / molecule :name (n4 / name :op1 ""BT.siMUC1""))
        :ARG1 (p2 / percent :quant 50)
        :ARG2 (k2 / knockdown-01
            :ARG1 m2
            :relative-to (m5 / molecule :name (n5 / name :op1 ""BT.siLuc"")))))",-1.0,0.5161290322580645
pmid_1684_6534.111,"Similar results were obtained using two independent oligonucleotides designed in our lab (data not shown), designated '882' and '956' for the initial codon recognized by each.","(o / obtain-01
    :ARG1 (t / thing
        :ARG1-of (r2 / resemble-01)
        :ARG2-of (r3 / result-01))
    :concession (s / show-01
        :ARG1 (d / data)
        :polarity -)
    :manner (u / use-01
        :ARG1 (s2 / small-molecule
            :name (n / name
                :op1 ""nucleus"")
            :quant 2
            :ARG0-of (d2 / depend-01
                :polarity -)
            :ARG1-of (d3 / design-01
                :location (l / lab
                    :poss (w / we)))
            :ARG1-of (d4 / designate-01
                :ARG2 (a / and
                    :op1 882
                    :op2 956)
                :ARG2 (c / codon
                    :ARG1-of (r / recognize-02
                        :ARG0 (e / each))
                    :mod (i / initial))))))
",test,bio_amr0.8,"(o / obtain-01
      :ARG1 (t / thing
            :ARG2-of (r / result-01)
            :ARG1-of (r2 / resemble-01))
      :manner (u / use-01
            :ARG1 (o2 / oligonucleotide :quant 2
                  :ARG0-of (d / depend-01 :polarity -)
                  :ARG1-of (d3 / describe-01
                        :ARG0 (d4 / data
                              :ARG1-of (s / show-01 :polarity -)))
                  :ARG1-of (d5 / designate-01
                        :ARG2 (a / and
                              :op1 (o3 / oligonucleotide :mod 882)
                              :op2 (o4 / oligonucleotide :mod 956))
                        :ARG1-of (c / cause-01
                              :ARG0 (c2 / codon
                                    :mod (i / initial)
                                    :ARG1-of (r3 / recognize-02
                                          :location o2))))
                  :ARG1-of (d2 / design-01
                        :location (l / laboratory
                              :poss (w / we))))))","Similar results were obtained using two independent oligonucleotides designed in our lab (data not shown), designated '882' and '956' for the initial codon recognized by each.","(z1 / obtain-01
    :ARG1 (z2 / thing
              :ARG2-of (z3 / result-01)
              :ARG1-of (z4 / resemble-01))
    :manner (z5 / use-01
                :ARG1 (z6 / oligonucleotide
                          :quant 2
                          :ARG0-of (z7 / depend-01
                                       :polarity -)
                          :ARG1-of (z8 / design-01
                                       :location (z9 / lab
                                                     :poss (z10 / we)))
                          :ARG1-of (z11 / designate-01
                                        :ARG2 (z12 / and
                                                   :op1 (z13 / codon
                                                             :li 8882)
                                                   :op2 (z14 / codon)
                                                   :beneficiary (z15 / codon
                                                                     :mod (z16 / initial)
                                                                     :ARG1-of (z17 / recognize-01
                                                                                   :ARG0 z6))))))
    :source (z18 / data
                 :ARG1-of (z19 / show-01
                               :polarity -)))",0.7191011235955057,0.6666666666666666,"(s / similar-01
        :ARG1 (r / result
              :ARG1-of (o / obtain-01
                    :ARG1 (u / use-01
                          :ARG1 (o2 / oligonucleotide
                                :mod (i / independent)
                                :ARG1-of (d / design-01
                                      :ARG1 (l / lab
                                            :poss (w / we)))
                                :ARG1-of (n / number
                                      :quant (t / two))))
                          :ARG2 (c / codon
                                :mod (i2 / initial)
                                :ARG1-of (r2 / recognize-01)))
                    :ARG2 (d2 / designate-01
                          :ARG1 '882'
                          :ARG2 (c2 / codon
                                :mod (r3 / recognize-01)))
                    :ARG2 (d3 / designate-01
                          :ARG1 '956'
                          :ARG2 (c3 / codon
                                :mod (r4 / recognize-01))))))","(o / obtain-01
    :ARG1 (r / result
        :mod (s / similar))
    :instrument (o2 / oligonucleotide
        :quant 2
        :mod (i / independent)
        :ARG1-of (d / design-01
            :ARG0 (l / lab
                :poss (w / we))))
    :ARG2 (d2 / designate-01
        :ARG1 (n / name :op1 ""'882'"")
        :ARG2 (n2 / name :op1 ""'956'"")
        :purpose (r2 / recognize-01
            :ARG1 (c / codon
                :mod (i2 / initial))
            :ARG0 (e / each)))
    :mod (d3 / data
        :ARG1-of (s2 / show-01 :polarity -)))",-1.0,0.4285714285714285
pmid_1684_6534.116,"Three genes (<i>MAP2K1</i>, <i>VEGF</i>, <i>PDGFA</i>) were altered two-fold or more after MUC1 siRNA in both MDA-MB-468 and BT-20 cells (Figure <xref ref-type=""fig"" rid=""F2"">2</xref>); two genes (<i>ITGAV</i>, <i>MMP2</i>) changed only in 468.siMUC1; and five genes (<i>TIMP3</i>, <i>RAF1</i>, <i>JUN</i>, <i>TNF</i>, <i>CDC25A</i>) only in BT.siMUC1.","(a2 / alter-01
    :quant (a4 / at-least
        :op1 (t / times
            :quant 2))
    :ARG1 (g / gene
        :quant 3)
    :rel (g2 / gene
        :name (n / name
            :op2 ""rich"")
        :name (n3 / name
            :op1 ""rich""))
    :rel 468
    :rel (f / figure)
    :rel 20
    :time (a / after
        :op1 (e / enzyme
            :name (n2 / name
                :op1 ""MUC1""
                :op2 ""siRNA"")
            :location (a3 / and
                :op1 (c / cell
                    :mod 4)
                :op2 (c2 / cell
                    :mod 4)))
        :op1 (c3 / change-01
            :ARG1 (g3 / gene
                :quant 2
                :op2 (c4 / change-01
                    :ARG1 (g4 / gene
                        :quant 5)
                    :ARG1 (g5 / gene
                        :name (n4 / name))))
            :mod (o / only))))
",test,bio_amr0.8,"(a6 / and
      :op1 (a / alter-01
            :ARG1 (g / gene :quant 3
                  :ARG1-of (m2 / mean-01
                        :ARG2 (a2 / and
                              :op1 (g2 / gene :name (n / name :op1 ""MAP2K1""))
                              :op2 (g3 / gene :name (n2 / name :op1 ""VEGF""))
                              :op3 (g4 / gene :name (n3 / name :op1 ""PDGFA"")))))
            :degree (o / or
                  :op1 (p / product-of :op1 2)
                  :op2 (m3 / more-than
                        :op1 p))
            :time (a3 / after
                  :op1 (n17 / nucleic-acid :name (n4 / name :op1 ""siRNA"")
                        :ARG0-of (e / encode-01
                              :ARG1 (p2 / protein :name (n5 / name :op1 ""MUC1"")))))
            :location (a4 / and
                  :op1 (c / cell-line :name (n6 / name :op1 ""MDA-MB-468""))
                  :op2 (c2 / cell-line :name (n7 / name :op1 ""BT-20"")))
            :ARG1-of (d / describe-01
                  :ARG0 (f / figure :mod 2)))
      :op2 (c3 / change-01
            :ARG1 (g5 / gene :quant 2
                  :ARG1-of (m4 / mean-01
                        :ARG2 (a5 / and
                              :op1 (g6 / gene :name (n8 / name :op1 ""ITGAV""))
                              :op2 (g7 / gene :name (n9 / name :op1 ""MMP2"")))))
            :mod o2
            :location (c5 / cell-line :name (n15 / name :op1 ""468.siMUC1"")))
      :op3 (c4 / change-01
            :ARG1 (g8 / gene :quant 5
                  :ARG1-of (m / mean-01
                        :ARG2 (a7 / and
                              :op1 (g9 / gene :name (n10 / name :op1 ""TIMP3""))
                              :op2 (g10 / gene :name (n11 / name :op1 ""RAF1""))
                              :op3 (g11 / gene :name (n12 / name :op1 ""JUN""))
                              :op4 (g12 / gene :name (n13 / name :op1 ""TNF""))
                              :op5 (g13 / gene :name (n14 / name :op1 ""CDC25A"")))))
            :mod (o2 / only)
            :location (c6 / cell-line :name (n16 / name :op1 ""BT.siMUC1""))))","Three genes (<i>MAP2K1</i>, <i>VEGF</i>, <i>PDGFA</i>) were altered two-fold or more after MUC1 siRNA in both MDA-MB-468 and BT-20 cells (Figure <xref ref-type=""fig"" rid=""F2"">2</xref>); two genes (<i>ITGAV</i>, <i>MMP2</i>) changed only in 468.siMUC1; and five genes (<i>TIMP3</i>, <i>RAF1</i>, <i>JUN</i>, <i>TNF</i>, <i>CDC25A</i>) only in BT.siMUC1.","(z1 / alter-01
    :ARG1 (z2 / gene
              :quant 3
              :example (z3 / and
                           :op1 (z4 / gene
                                    :wiki ""MAP2K1""
                                    :name (z5 / name
                                              :op1 ""MAP2K1""))
                           :op2 (z6 / gene
                                    :wiki ""BRAF1""
                                    :name (z7 / name
                                              :op1 ""VEGGF""))
                           :op3 (z8 / gene
                                    :wiki ""PHLDA-MB-468""
                                    :name (z9 / name
                                              :op1 ""PDA-MB-468""))
                           :op4 (z10 / cell
                                     :wiki ""BRAF-20""
                                     :name (z11 / name
                                                :op1 ""BT-20""))))
    :time (z12 / after
               :op1 (z13 / or
                         :op1 (z14 / product-of
                                   :op1 2
                                   :op2 (z15 / more))
                         :op2 (z16 / change-01
                                   :ARG1 (z17 / gene
                                              :quant 2
                                              :example (z18 / gene
                                                            :wiki ""ITGAV""
                                                            :name (z19 / name
                                                                       :op1 ""ITGAV""))
                                              :example (z20 / gene
                                                            :wiki ""MMP2""
                                                            :name (z21 / name
                                                                       :op1 ""MMP2"")))
                                   :location (z22 / cell
                                                  :wiki ""BRAF1""
                                                  :name (z23 / name
                                                             :op1 ""BRAF1""))))
               :op3 (z24 / gene
                         :quant 5
                         :example (z25 / gene
                                       :wiki ""BRAF1""
                                       :name (z26 / name
                                                  :op1 ""TIMP3"")
                                       :example (z27 / gene
                                                     :wiki ""BRAF1""
                                                     :name (z28 / name
                                                                :op1 ""BRAF1""))
                                       :example (z29 / gene
                                                     :wiki ""BRAF1""
                                                     :name (z30 / name
                                                                :op1 ""JUN""))
                                       :example (z31 / gene
                                                     :wiki ""TNF/TNF""
                                                     :name (z32 / name
                                                                :op1 ""TNF""))
                                       :example (z33 / gene
                                                     :wiki ""CDC25A""
                                                     :name (z34 / name
                                                                :op1 ""CDC25A"")))
                         :location (z35 / cell
                                        :wiki ""BRAF-20""
                                        :name (z36 / name
                                                   :op1 ""BT-20"")))))",0.2758620689655172,0.2527472527472527,"(m / multi-sentence
        :snt1 (a / alter-01
            :ARG1 (g / gene
                  :quant (t / three)
                  :mod (a2 / after
                        :ARG1 (s / siRNA
                              :mod (m / MUC1))))
            :ARG2 (f / fold
                  :op1 (n / number :op1 ""2""))
            :mod (c / cell
                  :mod (m2 / MDA-MB-468)
                  :mod (b / BT-20)))
        :snt2 (c2 / change-01
            :ARG1 (g2 / gene
                  :quant (t2 / two)
                  :mod (a3 / only)
                  :mod (s2 / in
                        :ARG1 (n2 / name :op1 ""468.siMUC1"")))
            :ARG2 (g3 / gene
                  :quant (f2 / five)
                  :mod (a4 / only)
                  :mod (s3 / in
                        :ARG1 (n3 / name :op1 ""BT.siMUC1"")))))","(a / alter-01
    :ARG1 (g / gene
        :name (n / name :op1 ""MAP2K1"" :op2 ""VEGF"" :op3 ""PDGFA""))
    :ARG2 (m / multiply-01
        :ARG1 (t / two)
        :ARG2 (f / fold))
    :ARG3 (m2 / more)
    :time (a2 / after
        :ARG1 (s / siRNA
            :mod (m3 / MUC1)))
    :location (b / both
        :op1 (c / cell
            :name (n2 / name :op1 ""MDA-MB-468""))
        :op2 (c2 / cell
            :name (n3 / name :op1 ""BT-20"")))
    :mod (f2 / figure
        :name (n4 / name :op1 ""2"")))
(and / and
    :op1 (c3 / change-01
        :ARG1 (g2 / gene
            :name (n5 / name :op1 ""ITGAV"" :op2 ""MMP2""))
        :location (c4 / cell
            :name (n6 / name :op1 ""468.siMUC1"")))
    :op2 (c5 / change-01
        :ARG1 (g3 / gene
            :name (n7 / name :op1 ""TIMP3"" :op2 ""RAF1"" :op3 ""JUN"" :op4 ""TNF"" :op5 ""CDC25A""))
        :location (c6 / cell
            :name (n8 / name :op1 ""BT.siMUC1""))))",-1.0,0.29
pmid_1684_6534.118,"Three genes whose transcription was changed by less than two-fold are shown, two of which (<i>PDGFB </i>and <i>ITGB1</i>) are listed because they relate closely to genes altered by two-fold (<i>PDGFA </i>and <i>ITGAV</i>).","(s / show-01
    :ARG1 (g / gene
        :quant 3
        :ARG2-of (e / express-03
            :ARG1-of (c2 / change-01
                :ARG2 (l / less-than
                    :op1 (p / product-of
                        :op1 2))))
        :ARG2-of (i / include-91
            :ARG1 (g2 / gene
                :quant 2
                :ARG1-of (l2 / list-01
                    :ARG1-of (c / cause-01
                        :ARG0 (r / relate-01
                            :ARG1 g
                            :ARG1-of (c3 / close-10)
                            :ARG2 (g3 / gene
                                :ARG1-of (a / alter-01
                                    :ARG2 (p2 / product-of
                                        :op1 2
                                        :op2 g2))))))
                :mod (p3 / protein
                    :name (n / name))))))
",test,bio_amr0.8,"(s / show-01
      :ARG1 (g / gene :quant 3
            :ARG1-of (t / transcribe-01
                  :ARG1-of (c / change-01
                        :ARG2 (l / less-than
                              :op1 (p / product-of :op1 2))))
            :ARG2-of (i / include-91
                  :ARG1 (g2 / gene :quant 2
                        :ARG1-of (m / mean-01
                              :ARG2 (a / and
                                    :op1 (g3 / gene :name (n / name :op1 ""PDGFB""))
                                    :op2 (g4 / gene :name (n2 / name :op1 ""ITGB1""))))
                        :ARG1-of (l2 / list-01
                              :ARG1-of (c2 / cause-01
                                    :ARG0 (r / relate-01
                                          :ARG1 g2
                                          :ARG2 (g5 / gene
                                                :ARG1-of (a2 / alter-01
                                                      :degree p)
                                                :ARG1-of (m2 / mean-01
                                                      :ARG2 (a3 / and
                                                            :op1 (g6 / gene :name (n3 / name :op1 ""PDGFA""))
                                                            :op2 (g7 / gene :name (n4 / name :op1 ""ITGAV"")))))
                                          :manner (c3 / close-10))))))))","Three genes whose transcription was changed by less than two-fold are shown, two of which (<i>PDGFB </i>and <i>ITGB1</i>) are listed because they relate closely to genes altered by two-fold (<i>PDGFA </i>and <i>ITGAV</i>).","(z1 / show-01
    :ARG1 (z2 / gene
              :quant 3
              :ARG1-of (z3 / include-91
                           :ARG2 (z4 / gene
                                     :quant 2
                                     :ARG2-of (z5 / list-01
                                                  :ARG1-of (z6 / cause-01
                                                               :ARG0 (z7 / relate-01
                                                                         :ARG1 z2
                                                                         :ARG2 (z8 / gene
                                                                                   :ARG1-of (z9 / alter-01
                                                                                                :ARG2 (z10 / less-than
                                                                                                           :op1 (z11 / product-of
                                                                                                                     :op1 2
                                                                                                                     :op2 z5)))
                                                                                   :example (z12 / and
                                                                                                 :op1 (z13 / gene
                                                                                                           :wiki ""PHLDA-Gene""
                                                                                                           :name (z14 / name
                                                                                                                      :op1 ""PDGFA""))
                                                                                                 :op2 (z15 / gene
                                                                                                           :wiki ""ITGAV""
                                                                                                           :name (z16 / name
                                                                                                                      :op1 ""ITGAV""))))
                                                                         :ARG1-of (z17 / close-10)))))))
    :ARG1-of (z18 / transcription-01
                  :ARG1-of (z19 / change-01
                                :ARG2 (z20 / less-than
                                           :op1 (z21 / product-of
                                                     :op1 2
                                                     :op2 z5)))))",0.5263157894736842,0.5346534653465346,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (g / gene
                  :quant (t / three)
                  :mod (c / change-01
                        :ARG1 g
                        :ARG2 (l / less-than
                              :op1 (f / fold
                                    :op1 two
                                    :op2 (n / number :op1 2))))
                  :ARG2 (t2 / transcription
                        :ARG1 g))
            :ARG2 (l2 / list-01
                  :ARG1 (r / relate-01
                        :ARG1 (l3 / list-01
                              :ARG1 (n2 / name :op1 ""PDGFB""))
                        :ARG2 (l4 / list-01
                              :ARG1 (n3 / name :op1 ""ITGB1""))))
            :ARG2-of (a / alter-01
                  :ARG1 (g2 / gene
                        :mod (c2 / change-01
                              :ARG1 g2
                              :ARG2 (f2 / fold
                                    :op1 two))
                        :ARG2 (l5 / list-01
                              :ARG1 (n4 / name :op1 ""PDGFA""))
                        :ARG2 (l6 / list-01
                              :ARG1 (n5 / name :op1 ""ITGAV""))))))
        :snt2 (h / have-rel-role-91
            :ARG1 (g3 / gene)
            :ARG2 (f3 / father)))","(g / gene
    :quant (n / number :value 3)
    :ARG1-of (c / change-01
        :ARG1 (t / transcription)
        :degree (l / less
            :quant (n2 / number :value 2)
            :unit (f / fold)))
    :example (s / show-01
        :ARG1 g)
    :example (l2 / list-01
        :ARG1 (g2 / gene
            :name (n3 / name :op1 ""PDGFB"")
            :name (n4 / name :op1 ""ITGB1""))
        :reason (r / relate-01
            :ARG1 g2
            :ARG2 (g3 / gene
                :name (n5 / name :op1 ""PDGFA"")
                :name (n6 / name :op1 ""ITGAV""))
            :degree (c2 / close)
            :ARG1-of (a / alter-01
                :degree (t2 / two
                    :unit f)))))
    :quant (n7 / number :value 2))",-1.0,-1.0
pmid_1684_6534.121,"This gene encodes MEK1, one of the primary regulators of the ERK1/2 MAPK pathway [<xref ref-type=""bibr"" rid=""B33"">33</xref>], a network that has been linked several times to MUC1 [<xref ref-type=""bibr"" rid=""B12"">12</xref>,<xref ref-type=""bibr"" rid=""B34"">34</xref>-<xref ref-type=""bibr"" rid=""B36"">36</xref>].","(e / encode-01
    :ARG0 (g / gene
        :mod (t / this))
    :ARG1 (p3 / protein
        :name (n / name
            :op1 ""MEK1"")
        :ARG1-of (i / include-91
            :ARG2 (r / regulate-01
                :ARG1 (p / pathway
                    :name (n2 / name
                        :op1 ""ERK""
                        :op2 ""1/2""
                        :op3 ""MAPK""))
                :mod (p2 / primary)))
        :domain (n4 / network
            :ARG1-of (l / link-01
                :ARG2 (e2 / enzyme
                    :name (n3 / name
                        :op1 ""MUC1""))
                :frequency (s / several)))))
",test,bio_amr0.8,"(e / encode-01
      :ARG0 (g / gene
            :mod (t / this))
      :ARG1 (e2 / enzyme :name (n / name :op1 ""MEK1"")
            :ARG1-of (i / include-91
                  :ARG2 (m / molecular-physical-entity
                        :ARG0-of (r / regulate-01
                              :ARG1 (p2 / pathway :name (n2 / name :op1 ""ERK1/2"" :op2 ""MAPK"")
                                    :mod (n3 / network
                                          :ARG1-of (l / link-01
                                                :ARG2 (p4 / protein :name (n4 / name :op1 ""MUC1""))
                                                :frequency (s / several)
                                                :ARG1-of (d2 / describe-01
                                                      :ARG0 (a / and
                                                            :op1 (p5 / publication
                                                                  :ARG1-of (c2 / cite-01
                                                                        :ARG2 12))
                                                            :op2 (p6 / publication
                                                                  :ARG1-of (c3 / cite-01
                                                                        :ARG2 (v / value-interval :op1 34 :op2 36)))))))))
                        :mod (p / primary))
                  :ARG1-of (d / describe-01
                        :ARG0 (p3 / publication
                              :ARG1-of (c / cite-01
                                    :ARG2 33))))))","This gene encodes MEK1, one of the primary regulators of the ERK1/2 MAPK pathway [<xref ref-type=""bibr"" rid=""B33"">33</xref>], a network that has been linked several times to MUC1 [<xref ref-type=""bibr"" rid=""B12"">12</xref>,<xref ref-type=""bibr"" rid=""B34"">34</xref>-<xref ref-type=""bibr"" rid=""B36"">36</xref>].","(z1 / encode-01
    :ARG0 (z2 / gene
              :mod (z3 / this))
    :ARG1 (z4 / enzyme
              :wiki ""Mitogen-activated_protein_kinase_1""
              :name (z5 / name
                        :op1 ""MEK1"")
              :ARG1-of (z6 / include-91
                           :ARG2 (z7 / enzyme
                                     :wiki ""Mitogen-activated_protein_kinase_1""
                                     :name (z8 / name
                                               :op1 ""MAPK""
                                               :op2 ""pathway"")
                                     :mod (z9 / slash
                                              :op1 (z10 / enzyme
                                                        :wiki ""ERK1/2""
                                                        :name (z11 / name
                                                                   :op1 ""ERK1/2""
                                                                   :op2 ""MAPK""
                                                                   :op3 ""pathway"")))
                                     :ARG0-of (z12 / regulate-01
                                                   :mod (z13 / primary)))))
    :domain (z14 / network
                 :ARG1-of (z15 / link-01
                               :ARG2 (z16 / enzyme
                                          :wiki ""Mitogen-activated_protein_kinase_1""
                                          :name (z17 / name
                                                     :op1 ""MUC1"")
                                          :ARG1-of (z18 / hyperlink-91
                                                        :ARG3 (z19 / url-entity
                                                                   :value 12)
                                                        :ARG4 (z20 / type
                                                                   :mod (z21 / string-entity
                                                                             :value 12))))
                               :ARG1-of (z22 / link-01
                                             :ARG2 (z23 / enzyme
                                                        :wiki ""Mitogen-activated_protein_kinase_1""
                                                        :name (z24 / name
                                                                   :op1 ""MUC1"")
                                                        :ARG1-of (z25 / hyperlink-91
                                                                      :ARG3 (z26 / url-entity
                                                                                 :value 34)
                                                                      :ARG4 z20)
                                                        :ARG1-of (z27 / link-01
                                                                      :ARG3 (z28 / enzyme
                                                                                 :value 36)
                                                                      :frequency (z29 / several)))))))",0.3970588235294117,0.4842105263157894,"(e / encode-01
        :ARG0 (g / gene)
        :ARG1 (m / MEK1)
        :mod (r / regulator
              :ARG1-of (p / primary))
        :ARG1-of (p2 / pathway
              :mod (m2 / MAPK
                    :mod (e2 / ERK1/2)))
        :ARG1-of (l / link-01
              :ARG1 (n / network
                    :mod (t / that)
                    :ARG1-of (h / have-03
                          :ARG1 (b / be-01
                                :ARG1 (l2 / link-01
                                      :ARG1 (t2 / time
                                            :quant (s / several)
                                            :op1 (l3 / link-01
                                                  :ARG1 (m3 / MUC1))))))))
        :ARG1-of (l4 / link-01
              :ARG1 (t3 / time
                    :op1 (l5 / link-01
                          :ARG1 (m4 / MUC1))))","(e / encode-01
    :ARG0 (g / gene
        :mod (t / this))
    :ARG1 (m / MEK1
        :ARG1-of (r / regulate-01
            :ARG0 m
            :ARG1 (p / pathway
                :mod (n / network)
                :name (n2 / name :op1 ""ERK1/2"" :op2 ""MAPK"")
                :ARG1-of (l / link-01
                    :ARG2 (m2 / MUC1)
                    :time (s / several)
                    :ARG1-of (h / have-org-role-91
                        :ARG2 (t2 / time
                            :op1 (r2 / reference :id ""B12"")
                            :op2 (r3 / reference :id ""B34"")
                            :op3 (r4 / reference :id ""B36"")))))))
    :ARG1-of (h2 / have-org-role-91
        :ARG2 (r5 / reference :id ""B33"")))",-1.0,0.4077669902912621
pmid_1684_6534.122,"We examined MEK1 and MEK2 levels by western blot to confirm decreased protein in MUC1 siRNA-treated cells (Figure <xref ref-type=""fig"" rid=""F3"">3a</xref>), and found that not only were total MEK1/2 levels lower in 468.siMUC1 and BT.siMUC1 compared to controls (0.48 and 0.68 relative to siLuc, respectively), but so were the basal amounts of active (phosphorylated) MEK1/2 (pMEK1/2; 0.12 and 0.42 relative to siLuc, respectively).","(a4 / and
    :op1 (e4 / examine-01
        :purpose (c3 / confirm-01
            :ARG0 (w2 / we)
            :ARG1 (d / decrease-01
                :ARG1 (p4 / protein)
                :location (c / cell
                    :ARG1-of (t2 / treat-04
                        :ARG2 (e / enzyme
                            :name (n / name
                                :op1 ""MEK1""))))))
        :ARG0 w2
        :ARG1 (a3 / and
            :op1 (l / level
                :mod e)
            :op2 (l2 / level
                :mod (p3 / protein
                    :name (n2 / name
                        :op1 ""MUC1""
                        :op2 ""siRNA"")
                    :name (n5 / name
                        :op1 ""hmm""
                        :value ""1/2""))))
        :instrument (b2 / blot
            :mod (w3 / world-region
                :name (n4 / name
                    :op1 ""Western""))))
    :op2 (f2 / find-01
        :ARG0 w2
        :ARG1 (h / have-degree-91
            :ARG1 (l3 / level
                :ARG1-of (r / relative-05
                    :ARG2 (w / way))
                :ARG2-of (t / total-01)
                :mod (e2 / enzyme
                    :name n))
            :ARG1-of (c2 / compare-01
                :ARG2 (a5 / and
                    :op1 r
                    :op2 (r2 / relative-05
                        :ARG2-of (r4 / relative-05
                            :ARG1 0.42)
                        :value 3)))
            :ARG2 (l4 / low-04)
            :ARG3 (m / more)))
    :rel (p2 / protein
        :name (n3 / name
            :op1 ""MEK2""))
    :rel (a2 / amount
        :ARG1-of c2
        :ARG1-of (r3 / relative-05
            :ARG2 a5)
        :mod (b / basal)
        :quant-of (e3 / enzyme
            :name (n7 / name
                :op3 ""1/2"")
            :ARG0-of (a / activity-06)
            :ARG1-of (p / phosphorylate-01)
            :domain e2))
    :rel (c4 / control-01)
    :rel (f / figure)
    :rel 0.48
    :rel ""1/2""
    :rel 0.68
    :rel (n6 / name)
    :rel 468
    :rel 0.12)
",test,bio_amr0.8,"(a / and
      :op1 (e / examine-01
            :ARG0 (w / we)
            :ARG1 (a2 / and
                  :op1 (l / level
                        :quant-of (e2 / enzyme :name (n / name :op1 ""MEK1"")))
                  :op2 (l2 / level
                        :quant-of (e3 / enzyme :name (n2 / name :op1 ""MEK2""))))
            :manner (i / immunoblot-01)
            :purpose (c / confirm-01
                  :ARG0 w
                  :ARG1 (p / protein
                        :ARG1-of (d / decrease-01
                              :location (c2 / cell
                                    :ARG1-of (t2 / treat-04
                                          :ARG2 (n11 / nucleic-acid :name (n4 / name :op1 ""siRNA"")
                                                :ARG0-of (e4 / encode-01
                                                      :ARG1 (p2 / protein :name (n5 / name :op1 ""MUC1"")))))))))
            :ARG1-of (d2 / describe-01
                  :ARG0 (f / figure :mod ""3a"")))
      :op2 (f2 / find-01
            :ARG0 w
            :ARG1 (a3 / and
                  :op1 (a4 / and
                        :op1 (l3 / level
                              :quant-of e2)
                        :op2 (l4 / level
                              :quant-of e3)
                        :mod (t3 / total)
                        :ARG1-of (l5 / low-04
                              :degree (m / more)
                              :compared-to (c3 / control))
                        :ARG1-of (m2 / mean-01
                              :ARG2 (a14 / and
                                    :op1 (l6 / level :quant 0.48)
                                    :op2 (l7 / level :quant 0.68)
                                    :manner r2
                                    :ARG1-of (r3 / relative-05
                                          :ARG3 (c6 / cell-line :name (n8 / name :op1 ""siLuc"")))
                                    :mod t3)))
                  :op2 (a7 / and
                        :op1 (a8 / amount
                              :quant-of (e5 / enzyme :name (n9 / name :op1 ""MEK1"")
                                    :ARG1-of (a10 / activate-01
                                          :ARG1-of (m3 / mean-01
                                                :ARG2 (p3 / phosphorylate-01
                                                      :ARG3 e5)))))
                        :op2 (a9 / amount
                              :quant-of (e6 / enzyme :name (n10 / name :op1 ""MEK2"")
                                    :ARG1-of (a11 / activate-01
                                          :ARG1-of (m5 / mean-01
                                                :ARG2 (p4 / phosphorylate-01
                                                      :ARG3 e6)))))
                        :mod (b / basal)
                        :ARG1-of l5
                        :ARG1-of (m4 / mean-01
                              :ARG2 (a12 / and
                                    :op1 (a6 / amount :quant 0.12)
                                    :op2 (a13 / amount :quant 0.42)
                                    :manner (r2 / respective)
                                    :ARG1-of r3
                                    :mod b))))
            :location (a5 / and
                  :op1 (c4 / cell-line :name (n6 / name :op1 ""468.siMUC1""))
                  :op2 (c5 / cell-line :name (n7 / name :op1 ""BT.siMUC1"")))))","We examined MEK1 and MEK2 levels by western blot to confirm decreased protein in MUC1 siRNA-treated cells (Figure <xref ref-type=""fig"" rid=""F3"">3a</xref>), and found that not only were total MEK1/2 levels lower in 468.siMUC1 and BT.siMUC1 compared to controls (0.48 and 0.68 relative to siLuc, respectively), but so were the basal amounts of active (phosphorylated) MEK1/2 (pMEK1/2; 0.12 and 0.42 relative to siLuc, respectively).","(z1 / and
    :op1 (z2 / examine-01
             :ARG0 (z3 / we)
             :ARG1 (z4 / and
                       :op1 (z5 / level
                                :mod (z6 / enzyme
                                         :wiki ""Mitogen-activated_protein_kinase_1""
                                         :name (z7 / name
                                                   :op1 ""MEK1"")))
                       :op2 (z8 / level
                                :mod (z9 / enzyme
                                         :wiki ""Mitogen-activated_protein_kinase_2""
                                         :name (z10 / name
                                                    :op1 ""MEK2"")))))
    :instrument (z11 / blot
                     :mod (z12 / west))
    :purpose (z13 / confirm-01
                  :ARG0 z3
                  :ARG1 (z14 / protein
                             :ARG1-of (z15 / decrease-01)
                             :location (z16 / cell
                                            :ARG1-of (z17 / treat-04
                                                          :ARG2 (z18 / siRNA))))))",0.2617801047120419,0.3295019157088122,"(m / multi-sentence
        :snt1 (e / examine-01
            :ARG0 (w / we)
            :ARG1 (l / level
                  :ARG0-of (m2 / mek1)
                  :ARG0-of (m3 / mek2)
                  :mod (d / decrease-01
                        :ARG1 (p / protein
                              :mod (m4 / muc1
                                    :ARG1-of (t / treat-01
                                          :ARG1 (c / cell
                                                :ARG1-of (s / sirna-01
                                                      :ARG0-of (f / find-01
                                                            :ARG1 (t2 / total
                                                                  :ARG0-of (l2 / lower-02
                                                                        :ARG1 (l3 / level
                                                                              :ARG0-of (m5 / mek1)
                                                                              :ARG0-of (m6 / mek2)
                                                                              :mod (c2 / compare-01
                                                                                    :ARG1 (c3 / control
                                                                                          :mod (b / bt.siMUC1)
                                                                                          :mod (f2 / 468.siMUC1)
                                                                                          :mod (s2 / siLuc))))
                                                                        :degree (n / number
                                                                              :op1 0.48))
                                                                  :ARG1 (l4 / level
                                                                        :ARG0-of (b2 / basal-02
                                                                              :ARG1 (a / amount
                                                                                    :mod (p2 / phosphorylate-01
                                                                                          :ARG1 (m7 / mek1)
                                                                                          :ARG1 (m8 / mek2)
                                                                                          :mod (a2 / active
                                                                                                :ARG1 (p3 / pMEK1/2)
                                                                                                :degree (n2 / number
                                                                                                      :op1 0.12))))
                                                                              :degree (n3 / number
                                                                                    :op1 0.42)))))))))))
        :snt2 (f3 / figure
            :op1 (x / xref
                  :ref-type ""fig""
                  :rid ""F3"")
            :op2 ""3a""))","(e / examine-01
    :ARG0 (w / we)
    :ARG1 (l / level
        :mod (p / protein)
        :ARG1-of (d / decrease-01)
        :location (c / cell
            :mod (t / treat-01
                :ARG1 (s / siRNA
                    :mod (m / MUC1)))))
    :instrument (b / blot-01
        :mod (w2 / western))
    :ARG2 (a / and
        :op1 (m2 / MEK1)
        :op2 (m3 / MEK2))
    :purpose (c2 / confirm-01)
    :medium (f / figure
        :mod (x / xref
            :ref-type ""fig""
            :rid ""F3""
            :op1 ""3a"")))
(f2 / find-01
    :ARG0 w
    :ARG1 (l2 / level
        :mod (p2 / protein)
        :ARG1-of (d2 / decrease-01)
        :location (c2 / cell
            :mod (t2 / treat-01
                :ARG1 s)
            :name (n / name
                :op1 ""468.siMUC1""
                :op2 ""BT.siMUC1""))
        :compared-to (c3 / control
            :mod (s2 / siLuc))
        :quant (r / relative-quantity
            :op1 ""0.48""
            :op2 ""0.68""))
    :ARG2 (a2 / and
        :op1 (m4 / MEK1)
        :op2 (m5 / MEK2))
    :condition (n2 / not-only)
    :concession (b2 / but)
    :degree (s3 / so)
    :mod (a3 / active
        :mod (p3 / phosphorylate-01))
    :quant (r2 / relative-quantity
        :op1 ""0.12""
        :op2 ""0.42""))",-1.0,-1.0
pmid_1684_6534.123,"Both 468.siMUC1 and BT.siMUC1 also showed reduced activation of ERK1/2 (dpERK1/2; 0.21 and 0.27 relative to siLuc, respectively), as would be expected with diminished signaling through MEK1/2; total ERK1/2 levels remain unchanged.","(m / multi-sentence
    :rel (a / ""1/2""
        :op2 ""1/2"")
    :rel (n3 / name
        :op2 ""culture"")
    :rel 468
    :rel 0.21
    :snt1 (s / show-01
        :ARG1 (r / reduce-01
            :ARG1 (a2 / activate-01
                :ARG1 (e / enzyme
                    :name (n / name
                        :op1 ""ERK""
                        :op1 ""yuan""
                        :op2 ""1/2"")
                    :quant (p / product-of
                        :ARG1-of (r2 / relative-05
                            :ARG2 (p2 / protein
                                :name (n4 / name)))
                        :op1 (e2 / enzyme
                            :name (n2 / name))
                        :op2 0.27)))
            :ARG1-of (e4 / expect-01
                :ARG0 (s2 / signal-07
                    :ARG0 (p3 / protein
                        :name (n5 / name
                            :op1 ""MEK""))
                    :ARG1-of (d / diminish-01))))
        :mod (a3 / also))
    :snt2 (r3 / remain-01
        :ARG1 (l / level
            :ARG2-of (t / total-01)
            :mod (e3 / enzyme
                :name (n6 / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :ARG3 (c / change-01
            :ARG1 l
            :polarity -)))
",test,bio_amr0.8,"(m2 / multi-sentence
      :snt1 (s / show-01
            :ARG0 (a / and
                  :op1 (c3 / cell-line :name (n7 / name :op1 ""468.siMUC1""))
                  :op2 (c4 / cell-line :name (n8 / name :op1 ""BT.siMUC1"")))
            :ARG1 (a3 / activate-01
                  :ARG1 (s2 / slash
                        :op1 (e / enzyme :name (n / name :op1 ""ERK1""))
                        :op2 (e2 / enzyme :name (n2 / name :op1 ""ERK2""))
                        :ARG3-of (p / phosphorylate-01
                              :mod (d3 / dual)))
                  :ARG1-of (r / reduce-01)
                  :ARG1-of (m / mean-01
                        :ARG2 (a4 / and
                              :op1 (a5 / activate-01 :degree 0.21)
                              :op2 (a6 / activate-01 :degree 0.27)
                              :manner (r2 / respective)
                              :ARG1-of (r4 / relative-05
                                    :ARG3 (c5 / cell-line :name (n9 / name :op1 ""siLuc""))))))
            :mod (a2 / also)
            :ARG1-of (e3 / expect-01
                  :ARG1-of (c / cause-01
                        :ARG0 (s3 / signal-07
                              :ARG0 (s4 / slash
                                    :op1 (e4 / enzyme :name (n3 / name :op1 ""MEK1""))
                                    :op2 (e5 / enzyme :name (n4 / name :op1 ""MEK2"")))
                              :ARG1-of (d / diminish-01)))))
      :snt2 (r3 / remain-01
            :ARG1 (l2 / level
                  :mod (t / total)
                  :quant-of s2)
            :ARG3 (c2 / change-01 :polarity -)))","Both 468.siMUC1 and BT.siMUC1 also showed reduced activation of ERK1/2 (dpERK1/2; 0.21 and 0.27 relative to siLuc, respectively), as would be expected with diminished signaling through MEK1/2; total ERK1/2 levels remain unchanged.","(z1 / show-01
    :ARG0 (z2 / and
              :op1 (z3 / enzyme
                       :wiki ""BRAF1""
                       :name (z4 / name
                                 :op1 ""BRAF1""))
              :op2 (z5 / enzyme
                       :wiki ""BRAF1""
                       :name (z6 / name
                                 :op1 ""BT.siMUC1""))
              :mod (z7 / both))
    :ARG1 (z8 / activate-01
              :ARG1 (z9 / enzyme
                        :wiki ""Extracellular_signal–regulated_kinase_1/2""
                        :name (z10 / name
                                   :op1 ""ERK1/2"")
                        :example (z11 / and
                                      :op1 (z12 / enzyme
                                                :wiki ""PHLDA1""
                                                :name (z13 / name
                                                           :op1 ""DEPERK1/2""))
                                      :op2 (z14 / enzyme
                                                :wiki ""BRAF1/2""
                                                :name (z15 / name
                                                           :op1 ""0.21""
                                                           :op2 ""0.27"")
                                                :ARG1-of (z16 / relative-05
                                                              :ARG2 (z17 / enzyme
                                                                         :wiki ""BRAF1/2""
                                                                         :name (z18 / name
                                                                                    :op1 ""siLuc""))))))
              :ARG1-of (z19 / reduce-01)
              :ARG1-of (z20 / expect-01
                            :ARG1-of (z21 / cause-01
                                          :ARG0 (z22 / diminish-01
                                                     :ARG1 (z23 / signal-07
                                                                :ARG0 (z24 / enzyme
                                                                           :wiki ""Mitogen-activated_protein_kinase_kinase_1/2""
                                                                           :name (z25 / name
                                                                                      :op1 ""MEK1/2""))))))))",0.3157894736842105,0.3552631578947368,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (b / both
                  :op1 (n / name :op1 ""468.siMUC1"")
                  :op2 (n2 / name :op1 ""BT.siMUC1""))
            :ARG1 (r / reduce-01
                  :ARG0 b
                  :ARG1 (a / activation
                        :ARG0 (e / ERK1/2)
                        :ARG1 (d / diminish-01
                              :ARG0 (s2 / signal-01
                                    :ARG0 (t / through
                                          :ARG0 (m / MEK1/2)))
                              :ARG1 (s3 / siLuc))))
            :ARG2 (d2 / dpERK1/2
                  :ARG1 e
                  :degree (n3 / number :quant 0.21))
            :ARG3 (d3 / dpERK1/2
                  :ARG1 e
                  :degree (n4 / number :quant 0.27))
            :ARG4 (r2 / remain-01
                  :ARG1 (l / level
                        :ARG0 (t2 / total)
                        :ARG1 (e2 / ERK1/2))))
        :snt2 (u / unchanged))","(b / both
    :op1 (s / show-01
        :ARG0 (m / molecule :name (n / name :op1 ""468.siMUC1""))
        :ARG1 (r / reduce-01
            :ARG1 (a / activate-01
                :ARG1 (m2 / molecule :name (n2 / name :op1 ""ERK1/2""))
                :ARG2 (m3 / molecule :name (n3 / name :op1 ""dpERK1/2""))
                :degree (a2 / and
                    :op1 (n4 / number :value 0.21)
                    :op2 (n5 / number :value 0.27))
                :compared-to (m4 / molecule :name (n6 / name :op1 ""siLuc"")))))
    :op2 (s2 / show-01
        :ARG0 (m5 / molecule :name (n7 / name :op1 ""BT.siMUC1""))
        :ARG1 r)
    :mod (a3 / also)
    :condition (e / expect-01
        :ARG1 (d / diminish-01
            :ARG1 (s3 / signal-01
                :ARG1 (t / through-01
                    :ARG1 (m6 / molecule :name (n8 / name :op1 ""MEK1/2""))))))
    :concession (r2 / remain-01
        :ARG1 (l / level
            :mod (t2 / total)
            :domain (m7 / molecule :name (n9 / name :op1 ""ERK1/2"")))
        :ARG2 (c / change-01 :polarity -)))",-1.0,0.4
pmid_1684_6534.125,"Notably, MUC1 siRNA impairs this important oncogenic pathway in MDA-MB-468 cells, as 468.siMUC1 display less pMEK1/2 in response to EGF than do 468.siLuc (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(i / impede-01
    :ARG0 (e / enzyme
        :name (n / name
            :op1 ""MUC1""
            :op2 ""siRNA""))
    :ARG1 (p / pathway
        :ARG1-of (i2 / important-01)
        :location (c2 / cell
            :name (n2 / name
                :op1 4
                :op2 ""B"")
            :mod (u / url-entity
                :value 3))
        :mod (p3 / proto-oncogene)
        :mod (t / this))
    :ARG1-of (n6 / notable-04)
    :ARG1-of (c / cause-01
        :ARG0 (d2 / display-01
            :ARG0 e
            :ARG1 (e2 / enzyme
                :name (n3 / name
                    :op1 ""pMEK""
                    :op2 ""1/2"")
                :ARG1-of (h / have-quant-91
                    :ARG3 (l / less)))
            :ARG2-of (r / respond-01
                :ARG0 d2)))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod u))
    :rel (d3 / display-01
        :ARG1 (w / way
            :name (n5 / name
                :op1 4)
            :part-of c2)
        :ARG4 (p2 / protein
            :name (n4 / name
                :op1 ""EGF""))))
",test,bio_amr0.8,"(i / impair-01
      :ARG0 (n11 / nucleic-acid :name (n / name :op1 ""siRNA"")
            :ARG0-of (e3 / encode-01
                  :ARG1 (p / protein :name (n2 / name :op1 ""MUC1""))))
      :ARG1 (p2 / pathway
            :mod (t / this)
            :mod (i2 / important)
            :ARG0-of (c / cause-01
                  :ARG1 (d4 / disease :wiki ""Cancer"" :name (n10 / name :op1 ""cancer""))))
      :location (c3 / cell-line :name (n3 / name :op1 ""MDA-MB-468""))
      :ARG1-of (n4 / notable-04)
      :ARG1-of (c4 / cause-01
            :ARG0 (d / display-01
                  :ARG0 (c5 / cell-line :name (n8 / name :op1 ""468.siMUC1""))
                  :ARG1 (s / slash
                        :op1 (e / enzyme :name (n5 / name :op1 ""MEK1""))
                        :op2 (e2 / enzyme :name (n6 / name :op1 ""MEK2""))
                        :ARG3-of (p3 / phosphorylate-01)
                        :quant (l / less))
                  :ARG2-of (r2 / respond-01
                        :ARG1 (p4 / protein :name (n7 / name :op1 ""EGF"")))
                  :compared-to (d2 / display-01
                        :ARG0 (c6 / cell-line :name (n9 / name :op1 ""468.siLuc""))
                        :ARG1 (s3 / slash
                              :op1 e
                              :op2 e2))))
      :ARG1-of (d3 / describe-01
            :ARG0 (f / figure :mod ""3b"")))","Notably, MUC1 siRNA impairs this important oncogenic pathway in MDA-MB-468 cells, as 468.siMUC1 display less pMEK1/2 in response to EGF than do 468.siLuc (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(z1 / impair-01
    :ARG0 (z2 / small-molecule
              :wiki ""Mitogen-activated_protein_kinase_1""
              :name (z3 / name
                        :op1 ""MUC1""
                        :op2 ""siRNA""))
    :ARG1 (z4 / pathway
              :mod (z5 / oncogenic)
              :ARG1-of (z6 / important-01)
              :mod (z7 / this))
    :ARG1-of (z8 / note-01)
    :location (z9 / cell
                  :wiki ""Mitogen-activated_protein_kinase_1""
                  :name (z10 / name
                             :op1 ""MDA-MB-468""))
    :ARG1-of (z11 / cause-01
                  :ARG0 (z12 / display-01
                             :ARG0 (z13 / enzyme
                                        :wiki ""Mitogen-activated_protein_kinase_1/2""
                                        :name (z14 / name
                                                   :op1 ""pMEK1/2""))
                             :ARG1-of (z15 / have-quant-91
                                           :ARG3 (z16 / less)
                                           :ARG4 (z17 / enzyme
                                                      :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                      :name (z18 / name
                                                                 :op1 ""468.siMUC1"")))
                             :ARG0-of (z19 / respond-01
                                           :ARG1 (z20 / small-molecule
                                                      :wiki ""EGF_(g3000 / gene)""
                                                      :name (z21 / name
                                                                 :op1 ""EGF""))))
                  :ARG1-of (z22 / describe-01
                                :ARG0 (z23 / figure
                                           :mod ""3b""
                                           :ARG1-of (z24 / hyperlink-91
                                                         :ARG3 (z25 / url-entity
                                                                    :value ""xref_ref-type=fig""
                                                                    :ARG1-of (z26 / rid-01)))))))",0.3561643835616438,0.3724137931034483,"(m / multi-sentence
        :snt1 (i / impair-01
            :ARG1 (p / pathway
                  :mod (o / oncogenic))
            :ARG2 (s / siRNA
                  :mod (m / MUC1)))
        :snt2 (d / display-01
            :ARG0 (d2 / do-02
                  :ARG0 (d3 / do-02
                        :ARG0 (d4 / do-02
                              :ARG0 (d5 / do-02
                                    :ARG0 (d6 / do-02
                                          :ARG0 (d7 / do-02
                                                :ARG0 (d8 / do-02
                                                      :ARG0 (d9 / do-02
                                                            :ARG0 (d10 / do-02
                                                                  :ARG0 (d11 / do-02
                                                                        :ARG0 (d12 / do-02
                                                                              :ARG0 (d13 / do-02
                                                                                    :ARG0 (d14 / do-02
                                                                                          :ARG0 (d15 / do-02
                                                                                                :ARG0 (d16 / do-02
                                                                                                      :ARG0 (d17 / do-02
                                                                                                            :ARG0 (d18 / do-02
                                                                                                                  :ARG0 (d19 / do-02
                                                                                                                        :ARG0 (d20 / do-02
                                                                                                                              :ARG0 (d21 / do-02
                                                                                                                                    :ARG0 (d22 / do-02
                                                                                                                                          :ARG0 (d23 / do-02
                                                                                                                                                :ARG0 (d24 / do-02
                                                                                                                                                      :ARG0 (d25 / do-02
                                                                                                                                                            :ARG0 (d26 / do-02
                                                                                                                                                                  :ARG0 (d27 / do-02
                                                                                                                                                                        :ARG0 (d28 / do-02
                                                                                                                                                                              :ARG0 (d29 / do-02
                                                                                                                                                                                    :ARG0 (d30 / do-02
                                                                                                                                                                                          :ARG0 (d31 / do-02
                                                                                                                                                                                                :ARG0 (d32 / do-02
                                                                                                                                                                                                      :ARG0 (d33 / do-02
                                                                                                                                                                                                            :ARG0 (d34 / do-02
                                                                                                                                                                                                                  :ARG0 (d35 / do-02
                                                                                                                                                                                                                        :ARG0 (d36 / do-02
                                                                                                                                                                                                                              :ARG0 (d37 / do-02
                                                                                                                                                                                                                                    :ARG0 (d38 / do-02
                                                                                                                                                                                                                                          :ARG0 (d39 / do-02
                                                                                                                                                                                                                                                :ARG0 (d40 / do-02
                                                                                                                                                                                                                                                      :ARG0 (d41 / do-02
                                                                                                                                                                                                                                                            :ARG0 (d42 / do-02
                                                                                                                                                                                                                                                                  :ARG0 (d43 / do-02
                                                                                                                                                                                                                                                                        :ARG0 (d44 / do-02
                                                                                                                                                                                                                                                                              :ARG0 (d45 / do-02
                                                                                                                                                                                                                                                                                    :ARG0 (d46 / do-02
                                                                                                                                                                                                                                                                                          :ARG0 (d47 / do-02
                                                                                                                                                                                                                                                                                                :ARG0 (d48 / do-02
                                                                                                                                                                                                                                                                                                      :ARG0 (d49 / do-02
                                                                                                                                                                                                                                                                                                            :ARG0 (d50 / do-02
                                                                                                                                                                                                                                                                                                                  :ARG0 (d51 / do-02
                                                                                                                                                                                                                                                                                                                        :ARG0 (d52 / do-02
                                                                                                                                                                                                                                                                                                                              :ARG0 (d53 / do-02
                                                                                                                                                                                                                                                                                                                                    :ARG0 (d54 / do-02
                                                                                                                                                                                                                                                                                                                                          :ARG0 (d55 / do-02
                                                                                                                                                                                                                                                                                                                                                :ARG0 (d56 / do-02
                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d57 / do-02
                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d58 / do-02
                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d59 / do-02
                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d60 / do-02
                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d61 / do-02
                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d62 / do-02
                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d63 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d64 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d65 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d66 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d67 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d68 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d69 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d70 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d71 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d72 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d73 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d74 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d75 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d76 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d77 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d78 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d79 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d80 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d81 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d82 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d83 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d84 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d85 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d86 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d87 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d88 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d89 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d90 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d91 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d92 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d93 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d94 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d95 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d96 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d97 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d98 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d99 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d100 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d101 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d102 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d103 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d104 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d105 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d106 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d107 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d108 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d109 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d110 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d111 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d112 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d113 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d114 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d115 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d116 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d117 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d118 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d119 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d120 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d121 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d122 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d123 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d124 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d125 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d126 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d127 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d128 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d129 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d130 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d131 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d132 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d133 / do-02","(n / note-01
    :ARG1 (i / impair-01
        :ARG0 (s / siRNA
            :mod (m / MUC1))
        :ARG1 (p / pathway
            :mod (o / oncogenic)
            :mod (i2 / important))
        :location (c / cell
            :name (n / name :op1 ""MDA-MB-468""))
        :time (r / respond-01
            :ARG1 (d / display-01
                :ARG0 (s2 / siMUC1
                    :mod (n2 / number :value 468))
                :ARG1 (l / less
                    :op1 (p2 / pMEK1/2))
                :compared-to (d2 / do-02
                    :ARG1 (s3 / siLuc
                        :mod (n3 / number :value 468))))
            :ARG2 (e / EGF))
        :mod (n4 / notable))
    :medium (f / figure
        :name (n5 / name :op1 ""3b"")))",-1.0,-1.0
pmid_1684_6534.128,"Specifically, B-Raf is thought to be the main activator of MEK under normal conditions; Raf-1 activates MEK in response to stimulus [<xref ref-type=""bibr"" rid=""B38"">38</xref>].","(a3 / and
    :ARG1-of (s / specific-02)
    :op1 (t / think-01
        :ARG1 (a / activate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op1 ""MEK"")
                :name (n2 / name
                    :op1 ""B-Raf""))
            :condition (c / condition
                :ARG1-of (n3 / normal-02))
            :mod (m / main)))
    :op2 (a2 / activate-01
        :ARG1 e
        :ARG2-of (r / respond-01
            :ARG1 (s2 / stimulus))))
",test,bio_amr0.8,"(a2 / and
      :op1 (t2 / think-01
            :ARG1 (a3 / activate-01
                  :ARG0 (e / enzyme :name (n / name :op1 ""B-Raf""))
                  :ARG1 (e3 / enzyme :name (n3 / name :op1 ""MEK""))
                  :mod (m / main)
                  :condition (n4 / normal)))
      :op2 (a4 / activate-01
            :ARG0 (e4 / enzyme :name (n5 / name :op1 ""Raf-1""))
            :ARG1 e3
            :ARG2-of (r / respond-01
                  :ARG1 (s / stimulus)))
      :ARG1-of (s2 / specific-02)
      :ARG1-of (d / describe-01
            :ARG0 (p / publication
                  :ARG1-of (c / cite-01
                        :ARG2 38))))","Specifically, B-Raf is thought to be the main activator of MEK under normal conditions; Raf-1 activates MEK in response to stimulus [<xref ref-type=""bibr"" rid=""B38"">38</xref>].","(z1 / think-01
    :ARG1 (z2 / activity-06
              :ARG0 (z3 / enzyme
                        :wiki ""BRAF_(g3000 / gene)""
                        :name (z4 / name
                                  :op1 ""B-Raf""))
              :ARG1 (z5 / enzyme
                        :wiki ""Mitogen-activated_protein_kinase""
                        :name (z6 / name
                                  :op1 ""MEK""))
              :mod (z7 / main)
              :condition (z8 / condition
                             :ARG1-of (z9 / normal-02)))
    :ARG1-of (z10 / specific-02)
    :ARG1-of (z11 / mean-01
                  :ARG2 (z12 / activate-01
                             :ARG0 (z13 / enzyme
                                        :wiki ""BRAF1""
                                        :name (z14 / name
                                                   :op1 ""Raf-1""))
                             :ARG1 z5
                             :ARG2-of (z15 / respond-01
                                           :ARG1 (z16 / stimulus)))))",0.55,0.6285714285714286,"(s / specific-01
    :ARG1 (b / be-01
        :ARG1 (a / activator
            :ARG0 (r / Raf-1)
            :ARG1 (m / MEK
                :ARG0-of (a2 / activate-01
                    :ARG1 (r2 / response
                        :ARG1-of (s2 / stimulus
                            :ARG0-of (x / xref
                                :ARG1 (b2 / bibr
                                    :ARG1-of (r3 / rid
                                        :op1 ""B38"")))))))))
    :ARG2 (m2 / MEK
        :ARG0-of (a3 / activate-01
            :ARG1 (b2 / B-Raf)
            :ARG1-of (c / condition
                :ARG1 (n / normal)))))","(t / think-01
    :ARG1 (a / activate-01
        :ARG0 (b / b-raf)
        :ARG1 (m / mek)
        :time (c / condition-03
            :ARG1 (n / normal)))
    :mod (s / specific)
    :ARG2 (a2 / activate-01
        :ARG0 (r / raf-1)
        :ARG1 m
        :time (r2 / respond-01
            :ARG1 (s2 / stimulus)))
    :source (r3 / reference-10
        :mod (n2 / number :value 38)))",-1.0,0.3478260869565217
pmid_1684_6534.129,"Thus, it appears that basal pMEK1/2 levels are not greatly affected by Raf-1 overexpression in BT.siMUC1 cells, likely because MEK is regulated primarily by B-Raf under normal growth conditions.","(i / infer-01
    :ARG1 (a2 / appear-02
        :ARG1 (a / affect-01
            :ARG0 (e / engineer-01
                :ARG1 (e3 / enzyme
                    :name (n2 / name
                        :op1 ""B-Raf""
                        :op2 ""1/2"")
                    :name (n3 / name
                        :op1 ""serine""))
                :location (c2 / cell
                    :name (n4 / name
                        :op1 ""you""
                        :op1 ""siMUC1"")
                    :mod (s / small-molecule
                        :name (n5 / name))))
            :ARG1 (l / level
                :consist-of (e2 / enzyme
                    :name (n / name
                        :op1 ""pMEK""
                        :op1 ""serine""))
                :mod (b / basal))
            :ARG1-of (c / cause-01
                :ARG0 (r / regulate-01
                    :ARG0 e3
                    :ARG1 e2
                    :condition (c3 / condition
                        :ARG1-of (n6 / normal-02)
                        :mod (g2 / grow-01))
                    :mod (p / primary))
                :ARG1-of (l2 / likely-01))
            :degree (g / great)
            :polarity -)))
",test,bio_amr0.8,"(c2 / cause-01
      :ARG0 (r / regulate-01
            :ARG0 (e2 / enzyme :name (n3 / name :op1 ""B-Raf""))
            :ARG1 (e5 / enzyme :name (n / name :op1 ""MEK""))
            :ARG1-of (l2 / likely-01)
            :manner (p / primary)
            :condition (g2 / grow-01
                  :ARG1-of (n7 / normal-02)))
      :ARG1 (a / appear-02
            :ARG1 (a2 / affect-01 :polarity -
                  :ARG0 (o / overexpress-01
                        :ARG1 (e / enzyme :name (n2 / name :op1 ""Raf-1""))
                        :location (c / cell-line :name (n6 / name :op1 ""BT.siMUC1"")))
                  :ARG1 (l / level
                        :quant-of (s / slash
                              :op1 (e3 / enzyme :name (n4 / name :op1 ""MEK1""))
                              :op2 (e4 / enzyme :name (n5 / name :op1 ""MEK2""))
                              :ARG3-of (p2 / phosphorylate-01))
                        :mod (b / basal))
                  :extent (g / great))))","Thus, it appears that basal pMEK1/2 levels are not greatly affected by Raf-1 overexpression in BT.siMUC1 cells, likely because MEK is regulated primarily by B-Raf under normal growth conditions.","(z1 / infer-01
    :ARG1 (z2 / appear-02
              :ARG1 (z3 / affect-01
                        :polarity -
                        :ARG0 (z4 / overexpress-00
                                  :ARG0 (z5 / cell
                                            :wiki ""BRAF_(g3000 / gene)""
                                            :name (z6 / name
                                                      :op1 ""BRAF""))
                                  :ARG1 (z7 / enzyme
                                            :wiki ""BRAF1""
                                            :name (z8 / name
                                                      :op1 ""Raf-1""))
                                  :location (z9 / cell
                                                :wiki ""BRAF1""
                                                :name (z10 / name
                                                           :op1 ""BT.siMUC1"")))
                        :ARG1 (z11 / level
                                   :mod (z12 / enzyme
                                             :wiki ""PHLDA1/2""
                                             :name (z13 / name
                                                        :op1 ""pMEK1/2"")
                                             :mod (z14 / basal)))
                        :degree (z15 / great))
              :ARG1-of (z16 / likely-01
                            :ARG1-of (z17 / cause-01
                                          :ARG0 (z18 / regulate-01
                                                     :ARG0 (z19 / enzyme
                                                                :wiki ""BRAF_(g3001 / gene)""
                                                                :name (z20 / name
                                                                           :op1 ""B-Raf""))
                                                     :ARG1 z12
                                                     :mod (z21 / primary)
                                                     :condition (z22 / condition
                                                                     :mod (z23 / grow-01)
                                                                     :ARG1-of (z24 / normal-02)))))))",0.4033613445378151,0.4347826086956522,"(m / multi-sentence
        :snt1 (a / appear-01
            :ARG1 (l / level
                  :mod (b / basal)
                  :mod (m2 / mek1/2
                        :mod (p / p))))
        :snt2 (a2 / affect-01
            :ARG1 l
            :ARG2 (o / overexpression
                  :ARG1 (r / raf-1))
            :ARG3 (c / cell
                  :mod (b2 / bt.simuc1)))
        :snt3 (r2 / regulate-01
            :ARG1 (m3 / mek)
            :ARG2 (b3 / b-raf)
            :ARG3 (c2 / condition
                  :mod (g / growth)
                  :mod (n / normal))))","(a / appear-01
    :ARG1 (a2 / affect-01
        :ARG0 (o / overexpress-01
            :ARG0 (g / gene :name (n / name :op1 ""Raf-1""))
            :ARG1 (c / cell :name (n2 / name :op1 ""BT.siMUC1"")))
        :ARG1 (l / level
            :mod (b / basal)
            :ARG1-of (p / protein :name (n3 / name :op1 ""pMEK1/2""))))
    :degree (n4 / not)
    :degree (g2 / great)
    :condition (r / regulate-01
        :ARG0 (g3 / gene :name (n5 / name :op1 ""B-Raf""))
        :ARG1 (g4 / gene :name (n6 / name :op1 ""MEK""))
        :time (c2 / condition
            :mod (n / normal)
            :ARG1-of (g3 / grow-01)))
    :concession (l2 / likely)
    :mode (t / thus))",-1.0,-1.0
pmid_1684_6534.130,"In contrast, when the cells are stimulated (EGF), increased Raf-1 levels in BT.siMUC1 leads to heightened pMEK1/2 (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(c2 / contrast-01
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :ARG1-of (r / refer-03
                :ARG0 (p2 / publication
                    :name (n2 / name
                        :op2 ""siMUC1"")))))
    :ARG2 (l / lead-03
        :ARG0 (i / increase-01
            :ARG1 (l2 / level
                :mod (e / enzyme
                    :name n2)))
        :ARG2 (h / heighten-01
            :ARG1 (e2 / enzyme
                :name (n3 / name
                    :mod ""1/2""
                    :op1 ""pMEK"")))
        :time (s / stimulate-01
            :ARG1 (c / cell)))
    :rel (n / name
        :op1 ""Raf-1"")
    :rel (p / protein
        :name l2))
",test,bio_amr0.8,"(c / contrast-01
      :ARG2 (l / lead-03
            :ARG0 (l2 / level
                  :quant-of (e / enzyme :name (n / name :op1 ""Raf-1""))
                  :location (c2 / cell-line :name (n2 / name :op1 ""BT.siMUC1""))
                  :ARG1-of (i / increase-01))
            :ARG2 (s / slash
                  :op1 (e2 / enzyme :name (n3 / name :op1 ""MEK1""))
                  :op2 (e3 / enzyme :name (n4 / name :op1 ""MEK2""))
                  :ARG3-of (p / phosphorylate-01)
                  :ARG1-of (h / heighten-01))
            :time (s2 / stimulate-01
                  :ARG1 (c3 / cell)
                  :ARG2 (p2 / protein :name (n5 / name :op1 ""EGF""))))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""3b"")))","In contrast, when the cells are stimulated (EGF), increased Raf-1 levels in BT.siMUC1 leads to heightened pMEK1/2 (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(z1 / contrast-01
    :ARG2 (z2 / lead-03
              :ARG0 (z3 / increase-01
                        :ARG1 (z4 / level
                                  :mod (z5 / small-molecule
                                           :wiki ""BRAF_(g3000 / gene)""
                                           :name (z6 / name
                                                     :op1 ""Raf-1"")))
                        :location (z7 / small-molecule
                                      :wiki ""BRAF_(g3001 / gene)""
                                      :name (z8 / name
                                                :op1 ""BT.siMUC1"")))
              :ARG2 (z9 / increase-01
                        :ARG1 (z10 / protein
                                   :wiki ""PHLDA1/2""
                                   :name (z11 / name
                                              :op1 ""pMEK1/2"")
                                   :ARG1-of (z12 / heighten-01)))
              :time (z13 / stimulate-01
                         :ARG1 (z14 / cell)
                         :ARG2 (z15 / enzyme
                                    :wiki ""Erythropoietin""
                                    :name (z16 / name
                                               :op1 ""EGF""))))
    :ARG1-of (z17 / describe-01
                  :ARG0 (z18 / figure
                             :mod ""3b""
                             :ARG1-of (z19 / hyperlink-91
                                           :ARG3 (z20 / url-entity
                                                      :value ""xref"")))))",0.4791666666666666,0.3953488372093023,"(s / sentence
        :ARG0 (c / contrast-01
              :ARG1 (w / when
                    :ARG1 (s2 / stimulate-01
                          :ARG0 (c2 / cell)
                          :ARG1 (e / EGF)))
              :ARG2 (l / lead-01
                    :ARG0 (l2 / level
                          :mod (r / Raf-1)
                          :mod (i / increase-01))
                    :ARG1 (b / BT.siMUC1)))
        :ARG1 (h / heighten-01
              :ARG1 (p / pMEK1/2)
              :ARG2 (f / figure
                    :ARG1-of (x / xref
                          :ref-type ""fig""
                          :rid ""F3""
                          :op1 ""3b""))))","(i / increase-01
    :ARG1 (l / level
        :quant (r / Raf-1)
        :location (b / BT.siMUC1))
    :ARG2 (h / heighten-01
        :ARG1 (p / pMEK1/2))
    :time (w / when
        :ARG1 (s / stimulate-01
            :ARG1 (c / cell)))
    :condition (e / EGF)
    :contrast (c2 / contrast)
    :mod (f / figure
        :ARG1-of (x / xref
            :ref-type ""fig""
            :rid ""F3""
            :op1 ""3b"")))",-1.0,-1.0
pmid_1684_6534.133,"As several of the genes shown in Figure <xref ref-type=""fig"" rid=""F2"">2</xref> are important in regulating proliferation and survival, and because of the recently described role of MUC1 in modulating apoptosis in response to cellular stresses [<xref ref-type=""bibr"" rid=""B20"">20</xref>,<xref ref-type=""bibr"" rid=""B21"">21</xref>,<xref ref-type=""bibr"" rid=""B24"">24</xref>], we first analyzed whether MUC1 siRNA would alter apoptosis in these lines.","(a2 / analyze-01
    :ARG0 (w / we)
    :ARG1 (t2 / truth-value
        :polarity-of (a / alter-01
            :ARG0 (s3 / small-molecule
                :name (n2 / name
                    :op1 ""MUC1""
                    :op2 ""siRNA""))
            :ARG1 (a5 / apoptosis)
            :location (l / line
                :mod (t / this))))
    :ARG1-of (c2 / cause-01
        :ARG0 (i / important-01
            :ARG1 (g / gene
                :quant (s / several)
                :ARG1-of (i2 / include-91
                    :ARG2 (g2 / gene
                        :ARG1-of (s2 / show-01
                            :ARG0 (f / figure))
                        :value 2)))
            :ARG2 (r2 / regulate-01
                :ARG0 g
                :ARG1 (a3 / and
                    :op1 (p / proliferate-01)
                    :op2 (s5 / survive-01))))
        :ARG0 (r4 / role
            :ARG0-of (m / modulate-01
                :ARG1 (p2 / proliferate-01)
                :ARG2-of (r3 / respond-01
                    :ARG1 (s4 / stress-02
                        :ARG1 (c3 / cell))))
            :ARG1-of (d / describe-01
                :time (r / recent))
            :domain s3
            :poss (p3 / protein
                :name (n / name
                    :op1 ""MUC1""))))
    :ord (o / ordinal-entity
        :value 1)
    :rel (c / cause-01
        :ARG0 (a4 / and
            :op1 i
            :op2 c2)))
",test,bio_amr0.8,"(a / analyze-01
      :ARG0 (w / we)
      :ARG1 (a2 / alter-01 :mode interrogative
            :ARG0 (n3 / nucleic-acid :name (n / name :op1 ""siRNA"")
                  :ARG0-of (e / encode-01
                        :ARG1 (p / protein :name (n2 / name :op1 ""MUC1""))))
            :ARG1 (a3 / apoptosis)
            :location (c / cell-line
                  :mod (t / this)))
      :time (f / first)
      :ARG1-of (c2 / cause-01
            :ARG0 (a4 / and
                  :op1 (i / important
                        :domain (g / gene
                              :quant (s / several)
                              :ARG1-of (i2 / include-91
                                    :ARG2 (g2 / gene
                                          :ARG1-of (s2 / show-01
                                                :medium (f2 / figure :mod 2)))))
                        :purpose (r2 / regulate-01
                              :ARG1 (a5 / and
                                    :op1 (p2 / proliferate-01)
                                    :op2 (s3 / survive-01))))
                  :op2 (p3 / play-02
                        :ARG0 p
                        :ARG1 (m / modulate-01
                              :ARG0 p
                              :ARG1 a3
                              :ARG2-of (r3 / respond-01
                                    :ARG1 (s4 / stress
                                          :mod (c3 / cell))))
                        :ARG1-of (d / describe-01
                              :time (r4 / recent)))
                  :ARG1-of (d2 / describe-01
                        :ARG0 (a6 / and
                              :op1 (p4 / publication
                                    :ARG1-of (c4 / cite-01
                                          :ARG2 20))
                              :op2 (p5 / publication
                                    :ARG1-of (c5 / cite-01
                                          :ARG2 21))
                              :op3 (p6 / publication
                                    :ARG1-of (c6 / cite-01
                                          :ARG2 24)))))))","As several of the genes shown in Figure <xref ref-type=""fig"" rid=""F2"">2</xref> are important in regulating proliferation and survival, and because of the recently described role of MUC1 in modulating apoptosis in response to cellular stresses [<xref ref-type=""bibr"" rid=""B20"">20</xref>,<xref ref-type=""bibr"" rid=""B21"">21</xref>,<xref ref-type=""bibr"" rid=""B24"">24</xref>], we first analyzed whether MUC1 siRNA would alter apoptosis in these lines.","(z1 / analyze-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / truth-value
              :polarity-of (z4 / alter-01
                               :ARG0 (z5 / small-molecule
                                         :wiki ""Mitogen-activated_protein_kinase_1""
                                         :name (z6 / name
                                                   :op1 ""MUC1""
                                                   :op2 ""siRNA""))
                               :ARG1 (z7 / apoptose-01)
                               :ARG2-of (z8 / respond-01
                                            :ARG1 (z9 / stress-02
                                                      :ARG1 (z10 / cell)))))
    :ord (z11 / ordinal-entity
              :value 1)
    :ARG1-of (z12 / cause-01
                  :ARG0 (z13 / and
                             :op1 (z14 / important-01
                                       :ARG1 (z15 / gene
                                                  :quant (z16 / several)
                                                  :ARG1-of (z17 / include-91
                                                                :ARG2 (z18 / gene
                                                                           :ARG1-of (z19 / show-01
                                                                                         :ARG0 (z20 / figure
                                                                                                    :mod 2
                                                                                                    :ARG1-of (z21 / hyperlink-91
                                                                                                                  :ARG3 (z22 / url-entity
                                                                                                                             :value ""xREF"")))))))
                                       :ARG2 (z23 / regulate-01
                                                  :ARG0 z15
                                                  :ARG1 (z24 / and
                                                             :op1 (z25 / proliferate-01)
                                                             :op2 (z26 / survive-01)))))
                  :op2 (z27 / describe-01
                            :ARG1 (z28 / role
                                       :poss z5
                                       :ARG0-of (z29 / modulate-01
                                                     :ARG1 z7
                                                     :ARG2-of (z30 / respond-01
                                                                   :ARG1 (z31 / stress-02
                                                                              :ARG1 z10))))
                            :time (z32 / recent))))",0.4814814814814815,0.5180722891566265,"(m / multi-sentence
        :snt1 (a / analyze-01
            :ARG0 (w / we)
            :ARG1 (a2 / alter-01
                  :ARG0 (a3 / apoptosis)
                  :ARG1 (l / line
                        :mod (t / these)))
            :ARG2 (f / first
                  :ARG1 (d / describe-01
                        :ARG0 (r / role
                              :ARG1 (m2 / MUC1)
                              :ARG2 (a4 / apoptosis
                                    :ARG1 (r2 / response
                                          :ARG1 (s / stress
                                                :mod (c / cellular)))))))
            :ARG3 (g / gene
                  :mod (s2 / several)
                  :ARG1-of (s3 / show-01
                        :ARG0 (f2 / figure
                              :mod (n / number :op1 ""2"")))))
        :snt2 (r / regulate-01
            :ARG0 g
            :ARG1 (p / proliferation)
            :ARG2 (s4 / survival)))","(a / analyze-01 :mode realis
    :ARG0 (w / we)
    :ARG1 (a2 / alter-01
        :ARG1 (a3 / apoptosis)
        :ARG2 (l / line
            :mod (t / this)))
    :ARG1-of (f / first-02)
    :condition (m / multi-sentence
        :snt1 (i / important-01
            :ARG1 (g / gene
                :quant (s / several)
                :ARG1-of (s2 / show-01
                    :ARG1 (f2 / figure :name (n / name :op1 ""2""))))
            :ARG2 (r / regulate-01
                :ARG1 (p / proliferation)
                :ARG2 (s3 / survival-01)))
        :snt2 (b / because
            :op1 (r2 / role-01
                :ARG1 (m2 / MUC1)
                :ARG2 (m3 / modulate-01
                    :ARG1 (a4 / apoptosis)
                    :ARG2 (r3 / respond-01
                        :ARG1 (s4 / stress-01
                            :mod (c / cell)))))
            :op2 (d / describe-01
                :ARG1 r2
                :ARG2 (r4 / recent)))))",-1.0,0.3698630136986301
pmid_1684_6534.134,"Although there was no change in basal apoptosis in either line (Figure <xref ref-type=""fig"" rid=""F4"">4a</xref>), we observed that the cell lines responded differently when trypsinized for re-plating 24 hours after transfection (Figure <xref ref-type=""fig"" rid=""F4"">4b</xref>).","(o / observe-01
    :ARG0 (w / we)
    :ARG1 (r / respond-01
        :ARG0 (l2 / line
            :mod (c / cell))
        :ARG1 (d2 / differ-02)
        :ARG1 (c4 / culture
            :mod (c3 / culture))
        :time (a / after
            :quant (t / temporal-quantity
                :quant 24
                :unit (h / hour))
            :op1 (e2 / express-03
                :ARG1 l2
                :ARG2 c3)))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :value ""F4""))
    :concession f
    :rel (c2 / change-01
        :ARG1 (a2 / apoptosis
            :mod (b / basal))
        :location (l / line
            :mod (e / either))
        :polarity -))
",test,bio_amr0.8,"(h2 / have-concession-91
      :ARG1 (o / observe-01
            :ARG0 (w / we)
            :ARG1 (r / respond-01
                  :ARG0 c2
                  :ARG1-of (d2 / differ-01)
                  :time (t2 / trypsinize-00
                        :ARG1 c2
                        :purpose (r2 / replate-00)
                        :time (a2 / after
                              :op1 (t3 / transfect-01
                                    :ARG1 c2)
                              :quant (t / temporal-quantity :quant 24
                                    :unit (h / hour)))))
            :ARG1-of (d3 / describe-01
                  :ARG0 (f2 / figure :mod ""4b"")))
      :ARG2 (c / change-01 :polarity -
            :ARG1 (a / apoptosis
                  :mod (b / basal))
            :location (c2 / cell-line
                  :mod (e / either))
            :ARG1-of (d / describe-01
                  :ARG0 (f / figure :mod ""4a""))))","Although there was no change in basal apoptosis in either line (Figure <xref ref-type=""fig"" rid=""F4"">4a</xref>), we observed that the cell lines responded differently when trypsinized for re-plating 24 hours after transfection (Figure <xref ref-type=""fig"" rid=""F4"">4b</xref>).","(z1 / have-concession-91
    :ARG1 (z2 / observe-01
              :ARG0 (z3 / we)
              :ARG1 (z4 / respond-01
                        :ARG0 (z5 / line
                                  :mod (z6 / cell))
                        :ARG1 (z7 / try-01
                                  :ARG1 (z8 / plate-01
                                            :purpose (z9 / replate-01
                                                         :ARG1 z5)
                                            :time (z10 / after
                                                       :op1 (z11 / transfect-01)
                                                       :quant (z12 / temporal-quantity
                                                                   :quant 24
                                                                   :unit (z13 / hour)))))
                        :ARG1-of (z14 / differ-02))))",0.5066666666666666,0.4943820224719101,"(m / multi-sentence
        :snt1 (o / observe-01
            :ARG0 (w / we)
            :ARG1 (d / differ-02
                  :ARG1 (r / respond-01
                        :ARG0 (l / line)
                        :ARG2 (t / trypsinize-01
                              :ARG1 (c / cell)
                              :ARG2 (p / plate-01
                                    :ARG1 (r2 / re-01)
                                    :time (a / after
                                          :op1 (t2 / transfection)
                                          :op2 (h / hour
                                                :quant 24)))))
                  :ARG2 (c2 / change-01
                        :ARG1 (a2 / apoptosis)
                        :ARG2 (b / basal)))
            :ARG2 (f / figure
                  :ARG1 (x / xref
                        :ref-type ""fig""
                        :rid ""F4""
                        :op1 ""4b""))))
        :snt2 (a3 / although
            :op1 (c3 / change-01
                  :ARG1 (a4 / apoptosis)
                  :ARG2 (b2 / basal))
            :op2 (l2 / line
                  :mod (e / either)
                  :mod (n / no)))","(a / although
    :ARG1 (c / change-01
        :ARG0 (a2 / apoptosis
            :mod (b / basal))
        :ARG1 (l / line
            :mod (e / either))
        :polarity -)
    :ARG2 (o / observe-01
        :ARG0 (w / we)
        :ARG1 (r / respond-01
            :ARG0 (l2 / line
                :mod (c2 / cell))
            :ARG1 (d / different)
            :time (a3 / after
                :op1 (t / transfuse-01
                    :time (h / hour
                        :quant 24)))
            :purpose (r2 / re-plate-01
                :instrument (t2 / trypsinize-01)))
        :location (f / figure
            :mod (n / name :op1 ""4b""))))",-1.0,0.3488372093023255
pmid_1684_6534.137,"In agreement with the patterns seen with trypsinization, BT.siLuc and BT.siMUC1 respond similarly to all treatments (data not shown), while 468.siMUC1 die more readily than 468.siLuc in response to trypsin, G418, hydrogen peroxide, or celecoxib, a chemotherapeutic that targets the cyclooxygenase-2 (COX-2) pathway (Figure <xref ref-type=""fig"" rid=""F4"">4c</xref>); these data were confirmed with two independent siRNA constructs (data not shown).","(m2 / multi-sentence
    :rel (f / figure
        :ARG7 4)
    :rel (t5 / trypsinization)
    :rel 468
    :snt1 (c4 / contrast-01
        :ARG1 (r3 / respond-01
            :ARG0 (a3 / and
                :op1 (s3 / small-molecule
                    :name (n / name
                        :op1 ""wow""))
                :op2 (s4 / small-molecule
                    :name (n2 / name
                        :op1 ""Britain""
                        :op2 ""hair""))
                :op2 (s5 / small-molecule
                    :name (n3 / name
                        :op1 ""G""
                        :op2 418)))
            :ARG1 (r2 / resemble-01
                :ARG2 (t3 / treat-03
                    :mod (a2 / all)))
            :ARG2-of (a / agree-01
                :ARG1 (p2 / pattern-01
                    :ARG1-of (s / see-01))))
        :ARG2 (d4 / die-01
            :ARG1 s3
            :ARG1-of (h / have-degree-91
                :ARG2 (r / ready)
                :ARG3 (m / more)
                :ARG4 (d5 / die-01
                    :op3 (p3 / person
                        :name (n4 / name
                            :op1 ""hydrogen""
                            :op2 ""peroxide""))))
            :ARG2-of (r4 / respond-01
                :ARG1 (o / or
                    :op1 (t4 / trypsin)
                    :op2 s5
                    :op3 p3
                    :op4 (p4 / protein
                        :name (n5 / name
                            :op1 ""celecoxib"")
                        :ARG0-of (t / target-01
                            :ARG1 (p / pathway
                                :mod (s6 / small-molecule
                                    :name (n6 / name
                                        :op1 ""cyclooxygenase""))))
                        :mod (c / chemotherapeutic)))))
        :concession (s2 / show-01
            :ARG1 (d2 / data)
            :polarity -))
    :snt2 (c2 / confirm-01
        :ARG0 (c3 / construct-01
            :quant 2
            :ARG0-of (d3 / depend-01
                :polarity -)
            :ARG1 (e / enzyme
                :name (n7 / name
                    :op1 ""siRNA"")))
        :ARG1 (d / data
            :mod (t2 / this))
        :mode imperative))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (c / contrast-01
            :ARG1 (r / respond-01
                  :ARG0 (a / and
                        :op1 (c2 / cell-line :name (n2 / name :op1 ""BT.siLuc""))
                        :op2 (c3 / cell-line :name (n3 / name :op1 ""BT.siMUC1"")))
                  :ARG1 (t / treat-04
                        :mod (a2 / all))
                  :ARG1-of (r2 / resemble-01)
                  :ARG1-of (d / describe-01
                        :ARG0 (d2 / data
                              :ARG1-of (s / show-01 :polarity -))))
            :ARG2 (d3 / die-01
                  :ARG1 (c4 / cell-line :name (n4 / name :op1 ""468.siMUC1""))
                  :manner (r3 / ready-02
                        :degree (m2 / more)
                        :compared-to (c5 / cell-line :name (n5 / name :op1 ""468.siLuc"")))
                  :ARG2-of (r4 / respond-01
                        :ARG1 (o / or
                              :op1 (e / enzyme :name (n / name :op1 ""trypsin""))
                              :op2 (s2 / small-molecule :name (n6 / name :op1 ""G418""))
                              :op3 (s3 / small-molecule :name (n7 / name :op1 ""hydrogen"" :op2 ""peroxide""))
                              :op4 (s4 / small-molecule :name (n8 / name :op1 ""celecoxib"")
                                    :mod (s5 / small-molecule
                                          :mod (c6 / chemotherapy)
                                          :ARG0-of (t2 / target-01
                                                :ARG1 (p / pathway :name (n9 / name :op1 ""cyclooxygenase-2""))))))))
            :ARG1-of (d4 / describe-01
                  :ARG0 (f / figure :mod ""4c""))
            :ARG0-of (a3 / agree-01
                  :ARG2 (p2 / pattern
                        :ARG1-of (s7 / see-01
                              :time (t4 / trypsinize-00)))))
      :snt2 (c7 / confirm-01
            :ARG0 (c8 / construct :quant 2
                  :mod (n11 / nucleic-acid :name (n10 / name :op1 ""siRNA""))
                  :ARG0-of (d6 / depend-01 :polarity -))
            :ARG1 (d5 / data
                  :mod (t3 / this))
            :ARG1-of (d7 / describe-01
                  :ARG0 (d8 / data
                        :ARG1-of (s6 / show-01 :polarity -)))))","In agreement with the patterns seen with trypsinization, BT.siLuc and BT.siMUC1 respond similarly to all treatments (data not shown), while 468.siMUC1 die more readily than 468.siLuc in response to trypsin, G418, hydrogen peroxide, or celecoxib, a chemotherapeutic that targets the cyclooxygenase-2 (COX-2) pathway (Figure <xref ref-type=""fig"" rid=""F4"">4c</xref>); these data were confirmed with two independent siRNA constructs (data not shown).","(z1 / contrast-01
    :ARG1 (z2 / respond-01
              :ARG0 (z3 / and
                        :op1 (z4 / small-molecule
                                 :wiki ""BRAF-activated_protein_kinase""
                                 :name (z5 / name
                                           :op1 ""BT.siLuc""))
                        :op2 (z6 / small-molecule
                                 :wiki ""BRAF-activated_protein_kinase""
                                 :name (z7 / name
                                           :op1 ""BT.siLuc"")))
              :ARG1 (z8 / or
                        :op1 (z9 / small-molecule
                                 :wiki ""Trypsin""
                                 :name (z10 / name
                                            :op1 ""trypsin""
                                            :op2 ""G418""))
                        :op2 (z11 / small-molecule
                                  :wiki ""Hydrogen_peroxide""
                                  :name (z12 / name
                                             :op1 ""hydrogen""
                                             :op2 ""peroxide""))
                        :op3 (z13 / small-molecule
                                  :wiki ""Celecoxib""
                                  :name (z14 / name
                                             :op1 ""celecoxib"")
                                  :mod (z15 / chemotherapeutic
                                            :ARG0-of (z16 / target-01
                                                          :ARG1 (z17 / pathway
                                                                     :wiki ""Cyclooxygenase-2""
                                                                     :name (z18 / name
                                                                                :op1 ""cyclooxygenase-2""
                                                                                :op2 ""pathway"")))))))
    :ARG2 (z19 / resemble-01
               :ARG1 z3
               :ARG2 (z20 / treat-03
                          :mod (z21 / all)))
    :ARG1-of (z22 / agree-01
                  :ARG2 (z23 / pattern
                             :ARG1-of (z24 / see-01
                                           :ARG0 (z25 / thing
                                                      :ARG1-of (z26 / cause-01
                                                                    :ARG0 (z27 / try-01
                                                                               :ARG1 (z28 / small-molecule
                                                                                          :wiki ""Trypsinize-00_)_)_)_)_)_)_)_)""
                                                                                          :ARG2 (z29 / die-01
                                                                                                     :ARG1 (z30 / small-molecule
                                                                                                                :wiki ""BRAF-activated_protein_kinase_1""
                                                                                                                :name (z31 / name
                                                                                                                           :op1 ""468.siMUC1""))
                                                                                                     :ARG1-of (z32 / have-degree-91
                                                                                                                   :ARG2 (z33 / ready-02
                                                                                                                              :ARG1 z29)
                                                                                                                   :ARG3 (z34 / more)
                                                                                                                   :ARG4 (z35 / die-01
                                                                                                                              :ARG1 (z36 / small-molecule
                                                                                                                                         :wiki ""BRAF-activated_protein_kinase_1""
                                                                                                                                         :name (z37 / name
                                                                                                                                                    :op1 ""468.siLuc"")))))
                                                                                          :ARG1-of (z38 / confirm-01
                                                                                                        :ARG0 (z39 / construct
                                                                                                                   :quant 2
                                                                                                                   :consist-of (z40 / siRNA)
                                                                                                                   :ARG0-of (z41 / depend-01
                                                                                                                                 :polarity -)
                                                                                                                   :ARG1-of (z42 / show-01
                                                                                                                                 :polarity -)))))))))))",0.4035087719298245,0.4336283185840707,"(m / multi-sentence
        :snt1 (a / agree-01
            :ARG1 (p / pattern
                  :mod (s / see-01
                        :ARG1 (t / trypsinization)))
            :ARG2 (r / respond-01
                  :ARG1 (b / BT.siLuc)
                  :ARG2 (b2 / BT.siMUC1)
                  :ARG3 (t2 / treatment)))
        :snt2 (d / die-01
            :ARG1 (m / more)
            :ARG2 (r2 / readily)
            :ARG3 (d2 / 468.siMUC1)
            :ARG4 (r3 / response
                  :ARG1 (t3 / trypsin)
                  :ARG2 (G418)
                  :ARG3 (h / hydrogen_peroxide)
                  :ARG4 (c / celecoxib
                        :mod (t4 / target-01
                              :ARG1 (p2 / pathway
                                    :mod (c2 / cyclooxygenase-2)))))))","(a / agree-01
    :ARG1 (p / pattern
        :ARG1-of (s / see-01
            :ARG0 (t / trypsinization)))
    :ARG2 (r / respond-01
        :ARG0 (a2 / and
            :op1 (b / name :op1 ""BT.siLuc"")
            :op2 (b2 / name :op1 ""BT.siMUC1""))
        :ARG1 (t2 / treatment
            :mod (a3 / all))
        :mod (s2 / similar))
    :time (w / while
        :op1 (d / die-01
            :ARG0 (n / name :op1 ""468.siMUC1"")
            :ARG1-of (m / more
                :op1 (r2 / readily)
                :op2 (t3 / than
                    :op1 (n2 / name :op1 ""468.siLuc""))))
        :op2 (r3 / respond-01
            :ARG0 n
            :ARG1 (a4 / and
                :op1 (t4 / trypsin)
                :op2 (g / name :op1 ""G418"")
                :op3 (h / hydrogen-peroxide)
                :op4 (c / celecoxib)
                :op5 (c2 / chemotherapeutic
                    :ARG1-of (t5 / target-01
                        :ARG1 (p2 / pathway
                            :mod (c3 / cyclooxygenase-2)
                            :mod (c4 / COX-2)
                            :location (f / figure :wiki - :name (n3 / name :op1 ""4c""))))))))
    :condition (c5 / confirm-01
        :ARG1 (d2 / data)
        :ARG2 (c6 / construct
            :mod (i / independent)
            :mod (s3 / siRNA)
            :quant (t6 / two))))",-1.0,0.3283582089552239
pmid_1684_6534.141,"This result disagrees with MUC1 activation of the AKT pathway in rat 3Y1 cells [<xref ref-type=""bibr"" rid=""B18"">18</xref>], and may reflect regulation more appropriate to breast cancer cells; this is supported by activation of AKT in response to MUC1 siRNA in other lines [<xref ref-type=""bibr"" rid=""B21"">21</xref>].","(m2 / multi-sentence
    :rel (n / name
        :op1 ""MUC1"")
    :rel 3Y1
    :snt1 (a3 / and
        :op1 (d / disagree-01
            :ARG0 (t / thing
                :ARG2-of (r5 / result-01)
                :mod (t2 / this))
            :ARG2 (a / activate-01
                :ARG1 (p / pathway
                    :name (n2 / name
                        :op1 ""AKT""))
                :location (c / cell
                    :mod (r / rat))))
        :op2 (p2 / possible-01
            :ARG1 (r2 / reflect-01
                :ARG1 t
                :ARG2 (r3 / regulate-01
                    :ARG1-of (h / have-degree-91
                        :ARG2 (a4 / appropriate-02
                            :ARG1 r3
                            :ARG2 (c2 / cell
                                :mod (d2 / disease
                                    :name (n3 / name
                                        :op1 ""breast""
                                        :op2 ""cancer""))))
                        :ARG3 (m / more))))))
    :snt2 (s2 / support-01
        :ARG0 (a2 / activate-01
            :ARG1 (e / enzyme
                :name (n4 / name
                    :op1 ""AKT""))
            :ARG2-of (r4 / respond-01
                :ARG1 (s / small-molecule
                    :name (n5 / name
                        :op1 ""MUC1""
                        :op2 ""siRNA"")))
            :location (l / line
                :mod (o / other)))
        :ARG1 r2)
    :value 21)
",test,bio_amr0.8,"(a / and
      :op1 (d3 / disagree-01
            :ARG0 (t / thing
                  :mod (t2 / this)
                  :ARG2-of (r / result-01))
            :ARG1 (a2 / activate-01
                  :ARG0 (p / protein :name (n2 / name :op1 ""MUC1""))
                  :ARG1 (p2 / pathway :name (n3 / name :op1 ""AKT""))
                  :location (c / cell :name (n4 / name :op1 ""3Y1"")
                        :source (r2 / rat)))
            :ARG1-of (d4 / describe-01
                  :ARG0 (p3 / publication
                        :ARG1-of (c2 / cite-01
                              :ARG2 18))))
      :op2 (p4 / possible-01
            :ARG1 (r3 / reflect-01
                  :ARG1 t
                  :ARG2 (r4 / regulate-01
                        :ARG1-of (a3 / appropriate-02
                              :ARG2 (c3 / cell
                                    :source (d2 / disease :wiki ""Breast_cancer"" :name (n / name :op1 ""breast"" :op2 ""cancer"")))
                              :degree (m / more)))))
      :ARG1-of (s / support-01
            :ARG0 (a4 / activate-01
                  :ARG1 p2
                  :ARG2-of (r5 / respond-01
                        :ARG1 (n6 / nucleic-acid :name (n5 / name :op1 ""siRNA"")
                              :ARG0-of (e / encode-01
                                    :ARG1 p)))
                  :location (c5 / cell-line
                        :mod (o / other)))
            :ARG1-of (d / describe-01
                  :ARG0 (p5 / publication
                        :ARG1-of (c6 / cite-01
                              :ARG2 21)))))","This result disagrees with MUC1 activation of the AKT pathway in rat 3Y1 cells [<xref ref-type=""bibr"" rid=""B18"">18</xref>], and may reflect regulation more appropriate to breast cancer cells; this is supported by activation of AKT in response to MUC1 siRNA in other lines [<xref ref-type=""bibr"" rid=""B21"">21</xref>].","(z1 / and
    :op1 (z2 / disagree-01
             :ARG0 (z3 / result
                       :mod (z4 / this))
             :ARG1 (z5 / activate-01
                       :ARG1 (z6 / pathway
                                 :wiki ""Mitogen-activated_protein_kinase_kinase""
                                 :name (z7 / name
                                           :op1 ""MUC1""))
                       :ARG2 (z8 / enzyme
                                 :wiki ""AKT1""
                                 :name (z9 / name
                                           :op1 ""AKT""))
                       :location (z10 / cell
                                      :wiki ""3Y1""
                                      :name (z11 / name
                                                 :op1 ""3Y1"")
                                      :part-of (z12 / rat)))
             :ARG1-of (z13 / describe-01
                           :ARG0 (z14 / thing
                                      :ARG1-of (z15 / cite-01
                                                    :ARG2 18)))))",0.3697478991596639,0.5194805194805195,"(m / multi-sentence
        :snt1 (d / disagree-01
            :ARG0 (r / result)
            :ARG1 (a / activate-01
                  :ARG0 (m / MUC1)
                  :ARG1 (p / pathway
                        :mod (a2 / AKT)))
            :ARG2 (c / cell
                  :mod (r2 / rat)
                  :mod (c2 / 3Y1))))
        :snt2 (r / reflect-01
            :ARG0 (m2 / may)
            :ARG1 (r3 / regulation
                  :mod (a3 / appropriate)
                  :ARG1 (c3 / cell
                        :mod (c4 / cancer)
                        :mod (b / breast)))
            :ARG2 (s / support-01
                  :ARG0 (t / this)
                  :ARG1 (a4 / activate-01
                        :ARG0 (a5 / AKT)
                        :ARG1 (r4 / response
                              :ARG1 (s2 / siRNA)
                              :ARG2 (l / line
                                    :mod (o / other))))))","(d / disagree-01
    :ARG1 (r / result
        :mod (t / this))
    :ARG2 (a / activate-01
        :ARG0 (m / molecule :wiki ""Mucin_1"" :name (n / name :op1 ""MUC1""))
        :ARG1 (p / pathway :wiki ""PI3K/AKT/mTOR_pathway"" :name (n2 / name :op1 ""AKT""))
        :location (c / cell
            :mod (r2 / rat)
            :name (n3 / name :op1 ""3Y1"")))
    :ARG3 (r3 / reflect-01
        :ARG1 (r4 / regulate-01
            :ARG1 a
            :ARG2 (c2 / cell
                :mod (b / breast)
                :mod (c3 / cancer)))
        :mod (m2 / more)
        :mod (a2 / appropriate))
    :condition (s / support-01
        :ARG1 r3
        :ARG2 (a3 / activate-01
            :ARG0 p
            :ARG1 (m3 / molecule :wiki ""Small_interfering_RNA"" :name (n4 / name :op1 ""siRNA""))
            :ARG2-of (r5 / respond-01
                :ARG0 (m4 / molecule :wiki ""Mucin_1"" :name (n5 / name :op1 ""MUC1"")))
            :location (c4 / cell
                :mod (o / other)
                :mod (l / line)))))",-1.0,0.4533333333333333
pmid_1684_6534.148,"468.siMUC1 cells show a significant decrease in [<sup>3</sup>H]thymidine incorporation compared to 468.siLuc, while intriguingly, BT.siMUC1 cells show a significant increase in proliferation (Figure <xref ref-type=""fig"" rid=""F5"">5a</xref>).","(c4 / contrast-01
    :ARG1 (s / show-01
        :ARG0 (c / cell
            :name (n / name)
            :mod (s5 / small-molecule
                :name (n3 / name
                    :op1 ""siMUC1"")))
        :ARG1 (d / decrease-01
            :ARG1 (i / incorporate-02
                :ARG1 (t / thymidine)
                :ARG2 c)
            :ARG1-of (s3 / significant-02)
            :ARG1-of (c3 / compare-01
                :ARG2 (c2 / cell
                    :name (n2 / name
                        :op1 ""wow"")
                    :quant 468
                    :mod s5))))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure
            :mod 5))
    :ARG2 (s2 / show-01
        :ARG0 c2
        :ARG0-of (i3 / intrigue-01)
        :ARG1 (i2 / increase-01
            :ARG1 (p / proliferate-01)
            :ARG1-of (s4 / significant-02)))
    :rel 468)
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (s / show-01
            :ARG0 (c3 / cell-line :name (n / name :op1 ""468.siMUC1""))
            :ARG1 (d2 / decrease-01
                  :ARG1 (i / incorporate-02
                        :ARG1 (s5 / small-molecule :name (n3 / name :op1 ""3H-thymidine"")))
                  :ARG1-of (s3 / significant-02))
            :compared-to (s2 / show-01
                  :ARG0 (c2 / cell-line :name (n2 / name :op1 ""468.siLuc""))))
      :ARG2 (s4 / show-01
            :ARG0 (c4 / cell-line :name (n4 / name :op1 ""BT.siMUC1""))
            :ARG1 (i2 / increase-01
                  :ARG1 (p / proliferate-01)
                  :ARG1-of s3)
            :ARG0-of (i3 / intrigue-01))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""5a"")))","468.siMUC1 cells show a significant decrease in [<sup>3</sup>H]thymidine incorporation compared to 468.siLuc, while intriguingly, BT.siMUC1 cells show a significant increase in proliferation (Figure <xref ref-type=""fig"" rid=""F5"">5a</xref>).","(z1 / contrast-01
    :ARG1 (z2 / show-01
              :ARG0 (z3 / cell
                        :mod (z4 / small-molecule
                                 :wiki ""Mitogen-activated_protein_kinase_1""
                                 :name (z5 / name
                                           :op1 ""468.siMUC1"")))
              :ARG1 (z6 / decrease-01
                        :ARG1 (z7 / incorporate-01
                                  :ARG1 (z8 / small-molecule
                                            :wiki ""Thymidine""
                                            :name (z9 / name
                                                      :op1 ""HTHymidine"")))
                        :ARG1-of (z10 / significant-02)
                        :ARG1-of (z11 / compare-01
                                      :ARG2 (z12 / cell
                                                 :mod (x1000 / show-01
                                                             :ARG0 (z14 / cell
                                                                        :mod (z15 / small-molecule
                                                                                  :wiki ""Bisulfide""
                                                                                  :name (z16 / name
                                                                                             :op1 ""BT.siLuc"")))
                                                             :ARG1 (z17 / increase-01
                                                                        :ARG1 (z18 / proliferate-01)
                                                                        :ARG1-of (z19 / significant-02))
                                                             :ARG1-of (z20 / describe-01
                                                                           :ARG0 (z21 / figure
                                                                                      :mod ""5a""
                                                                                      :ARG1-of (z22 / hyperlink-91
                                                                                                    :ARG3 (z23 / url-entity
                                                                                                               :value ""xref""))))
                                                             :ARG0-of (z24 / intrigue-01)))))))",0.4799999999999999,0.608695652173913,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (c / cell-line
                  :name (n / name :op1 ""468.siMUC1""))
            :ARG1 (d / decrease-01
                  :ARG1 (i / incorporation
                        :ARG1 [<sup>3</sup>H]thymidine)))
        :snt2 (s2 / show-01
            :ARG0 c
            :ARG1 (i2 / increase-01
                  :ARG1 (p / proliferation))
            :ARG2 (c2 / cell-line
                  :name (n2 / name :op1 ""BT.siMUC1"")))
        :snt3 (f / figure
            :ARG1 (x / xref
                  :ref-type ""fig""
                  :rid ""F5"")
            :ARG2 (a / alpha
                  :op1 ""5a"")))","(c / compare-01
    :ARG1 (d / decrease-01
        :ARG1 (i / incorporate-01
            :ARG0 (c2 / cell :name (n / name :op1 ""468.siMUC1""))
            :ARG1 (t / thymidine :mod (h / hydrogen :quant 3)))
        :degree (s / significant))
    :ARG2 (i2 / increase-01
        :ARG1 (p / proliferate-01
            :ARG0 (c3 / cell :name (n2 / name :op1 ""BT.siMUC1"")))
        :degree (s2 / significant))
    :ARG3 (i3 / incorporate-01
        :ARG0 (c4 / cell :name (n3 / name :op1 ""468.siLuc""))
        :ARG1 t)
    :conj (w / while)
    :mod (i4 / intrigue-01))",-1.0,0.3720930232558139
pmid_1684_6534.157,"Interestingly, 468.siMUC1 cells display somewhat decreased invasion on collagen IV, laminin, and fibronectin matrices, and on a no-matrix control (Figure <xref ref-type=""fig"" rid=""F5"">5c</xref>), which is in agreement with the trend towards decreased metastasis observed in Muc1<sup>-/- </sup>× MMTV-PyV MT mice [<xref ref-type=""bibr"" rid=""B8"">8</xref>].","(d3 / display-01
    :li 468
    :ARG0 (c / cell
        :name (n / name
            :op1 ""siMUC1""))
    :ARG1 (i3 / invade-01
        :ARG1 (a2 / and
            :op1 (p / protein
                :name (n2 / name
                    :op1 4))
            :op2 (p2 / protein
                :name (n3 / name
                    :op1 ""laminin""))
            :op2 (m / matrices)
            :op3 (p3 / protein
                :name (n4 / name
                    :op1 ""fibronectin""
                    :op1 ""PyV""
                    :op2 ""MT""))
            :op4 (c3 / control-01
                :ARG1 (m2 / matrix
                    :polarity -)))
        :ARG1-of (d / decrease-01
            :degree (s / somewhat)))
    :mod (i2 / interesting)
    :rel (f / figure
        :ARG0-of (a / agree-01
            :ARG1 (t / trend-01
                :ARG1 (m3 / metastasis
                    :ARG1-of (d2 / decrease-01)
                    :ARG1-of (o / observe-01
                        :location (m4 / mouse
                            :name n4))))))
    :rel (i / i)
    :rel (c2 / collagen))
",test,bio_amr0.8,"(d / display-01
      :ARG0 (c / cell-line :name (n / name :op1 ""468.siMUC1""))
      :ARG1 (i2 / invade-01
            :ARG0 c
            :ARG1 (a / and
                  :op1 (p4 / protein :name (n5 / name :op1 ""collagen"" :op2 ""IV""))
                  :op2 (l / laminin)
                  :op3 (m / matrix
                        :mod (f / fibronectin))
                  :op4 (c3 / control-01
                        :ARG1 (m2 / matrix :polarity -)))
            :ARG1-of (d2 / describe-01
                  :ARG0 (f2 / figure :mod ""5c""))
            :ARG1-of (d5 / decrease-01
                  :degree (s / somewhat)))
      :ARG2-of (i / interest-01)
      :ARG0-of (a2 / agree-01
            :ARG2 (t / trend-01
                  :ARG1 (m3 / metastasis
                        :ARG1-of (d3 / decrease-01)
                        :ARG1-of (o / observe-01
                              :location (p2 / protein :name (n2 / name :op1 ""Muc1"")
                                    :ARG2-of (m4 / mutate-01 :mod ""-/-""))
                              :location (m5 / mouse
                                    :mod (p3 / protein :name (n3 / name :op1 ""PyV"" :op2 ""MT"")
                                          :mod (o2 / organism :name (n4 / name :op1 ""MMTV""))))
                              :ARG1-of (d4 / describe-01
                                    :ARG0 (p / publication
                                          :ARG0-of (c4 / cite-01
                                                :ARG1 8))))))))","Interestingly, 468.siMUC1 cells display somewhat decreased invasion on collagen IV, laminin, and fibronectin matrices, and on a no-matrix control (Figure <xref ref-type=""fig"" rid=""F5"">5c</xref>), which is in agreement with the trend towards decreased metastasis observed in Muc1<sup>-/- </sup>× MMTV-PyV MT mice [<xref ref-type=""bibr"" rid=""B8"">8</xref>].","(z1 / display-01
    :ARG0 (z2 / cell
              :mod (z3 / small-molecule
                       :wiki ""Simian_factor_receptor_1""
                       :name (z4 / name
                                 :op1 ""Simian""
                                 :op2 ""factor""
                                 :op3 ""RNA1"")))
    :ARG1 (z5 / invade-01
              :ARG0 z2
              :ARG1 (z6 / and
                        :op1 (z7 / matrix
                                 :mod (z8 / collagen
                                          :mod (z9 / string-entity
                                                   :value ""IV""))
                                 :mod (z10 / laminin)
                                 :mod (z11 / fibronectin))
                        :op2 (z12 / matrix
                                  :mod (z13 / matrix
                                            :mod (z14 / fibronectin)))))
    :manner (z15 / control-01
                 :manner (z16 / matrix
                              :polarity -))
    :ARG1-of (z17 / agree-01
                  :ARG2 (z18 / trend-01
                             :ARG2 (z19 / metastasis
                                        :ARG1-of (z20 / decrease-01)
                                        :ARG1-of (z21 / observe-01
                                                      :ARG0 (z22 / mouse
                                                                 :wiki ""Muc1""
                                                                 :name (z23 / name
                                                                            :op1 ""Muc1"")
                                                                 :mod (z24 / protein
                                                                           :wiki ""Mitogen-activated_protein_kinase""
                                                                           :name (z25 / name
                                                                                      :op1 ""MMTV-PyV""
                                                                                      :op2 ""MT""))
                                                                 :mod (z26 / value-interval
                                                                           :op1 8
                                                                           :op2 z10)))))
                  :degree (z27 / somewhat)))",0.3888888888888889,0.4817518248175182,"(m / multi-sentence
        :snt1 (d / display-01
            :ARG0 (c / cell
                  :mod (s / siMUC1)
                  :mod (t / 468))
            :ARG1 (i / invasion
                  :ARG0 c
                  :ARG1 (d2 / decrease-01
                        :ARG1 (m2 / matrix
                              :mod (c2 / collagen-IV)
                              :mod (l / laminin)
                              :mod (f / fibronectin))))
            :ARG2 (c3 / control
                  :mod (n / no-matrix)))
        :snt2 (a / agree-01
            :ARG1 (t2 / trend
                  :ARG1 (d3 / decrease-01
                        :ARG1 (m3 / metastasis
                              :ARG1 (o / observe-01
                                    :ARG0 (m4 / Muc1-/-)
                                    :ARG1 (m5 / MMTV-PyV-MT)
                                    :ARG2 (m6 / mouse
                                          :quant (t3 / two)
                                          :ARG1-of (x / cross-01
                                                :ARG2 m4
                                                :ARG3 m5)))))))
        :snt3 (r / reference
            :ARG1 (f2 / figure
                  :ARG2 (x / xref
                        :ref-type ""fig""
                        :rid ""F5""
                        :op1 ""5c"")))
        :snt4 (r2 / reference
            :ARG1 (b / bibr
                  :ARG2 (x2 / xref
                        :ref-type ""bibr""
                        :rid ""B8""
                        :op1 ""8"")))","(d / display-01
    :ARG0 (c / cell
        :name (n / name :op1 ""468.siMUC1""))
    :ARG1 (i / invade-01
        :ARG1 (m / matrix
            :mod (c2 / collagen
                :mod (i2 / iv))
            :mod (l / laminin)
            :mod (f / fibronectin)
            :mod (n2 / no))
        :degree (s / somewhat)
        :direction (d2 / decrease))
    :condition (a / agree-01
        :ARG1 (t / trend
            :direction (d3 / decrease)
            :ARG1 (m2 / metastasis))
        :ARG2 (o / observe-01
            :ARG0 (m3 / mouse
                :mod (m4 / Muc1)
                :mod (m5 / MMTV-PyV MT))))
    :mod (i3 / interesting))",-1.0,0.3025210084033613
pmid_1684_6534.158,"<sec-title level=""2"">Transfection of MUC1 rescues the 468.siMUC1 phenotype</sec-title>","(r / rescue-01
    :ARG0 (t / transfer-01
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""MUC1""))
        :mode imperative)
    :ARG1 (s / species
        :name (n2 / name))
    :rel 468
    :rel 2)
",test,bio_amr0.8,"(r / rescue-01
      :ARG0 (t / transfect-01
            :ARG1 (p2 / protein :name (n / name :op1 ""MUC1"")))
      :ARG1 (p / phenotype
            :mod (c / cell-line :name (n2 / name :op1 ""468.siMUC1""))))","<sec-title level=""2"">Transfection of MUC1 rescues the 468.siMUC1 phenotype</sec-title>","(z1 / rescue-01
    :ARG0 (z2 / infect-01
              :ARG2 (z3 / enzyme
                        :wiki ""Mitogen-activated_protein_kinase_1""
                        :name (z4 / name
                                  :op1 ""MUC1"")))
    :ARG1 (z5 / phenotype
              :mod (z6 / gene
                       :wiki ""Mitogen-activated_protein_kinase_1""
                       :name (z7 / name
                                 :op1 ""468.siMUC1""))))",0.5882352941176471,0.5,"(m / multi-sentence
        :snt1 (r / rescue-01
            :ARG0 (t / transfection
                  :ARG1 (m2 / MUC1))
            :ARG1 (p / phenotype
                  :mod (p2 / 468.siMUC1))))
        :snt2 (n / name
            :op1 ""Transfection of MUC1 rescues the 468.siMUC1 phenotype"")","(t / title :level 2
    :content (r / rescue-01
        :ARG0 (t2 / transfect-01
            :ARG1 (p / protein :name ""MUC1""))
        :ARG1 (p2 / phenotype
            :name ""468.siMUC1"")))",-1.0,0.4827586206896552
pmid_1684_6534.159,"To determine if the above effects are specific to MUC1, we created stable transfectants of the MDA-MB-468 line using empty vector (468.Neo) or a full-length MUC1 construct (468.MUC1Δ8) that is resistant to one of the independent MUC1-directed oligonucleotides ('882').","(c2 / create-01
    :purpose (d2 / determine-01
        :ARG0 (w / we)
        :ARG1 (t / truth-value
            :polarity-of (s3 / specific-02
                :ARG1 (a2 / affect-01
                    :location (a / above))
                :ARG2 (p / protein
                    :name (n / name
                        :op1 ""MUC1"")))))
    :ARG0 w
    :ARG1 (v2 / virus
        :ARG1-of (s4 / stable-03)
        :mod (l / line
            :name (n2 / name
                :op1 4)))
    :ARG2-of (u / use-01
        :ARG1 (o / or
            :op1 (v / vector
                :ARG1-of (e / empty-02)
                :mod 468)
            :op2 (c / construct
                :ARG0-of (r / resist-01
                    :ARG1 (s / small-molecule
                        :quant 1
                        :ARG1-of (i / include-91
                            :ARG2 (s2 / small-molecule
                                :name (n3 / name
                                    :op1 ""idiot""
                                    :op2 ""gene"")
                                :quant 468
                                :ARG0-of (d / depend-01)
                                :ARG1-of (d3 / direct-01)))))
                :ARG1-of (l2 / long-03
                    :mod (f / full))
                :mod p
                :mod 882))))
",test,bio_amr0.8,"(c / create-01
      :ARG0 (w / we)
      :ARG1 (t / transfect-01
            :ARG1 (c2 / cell-line :name (n / name :op1 ""MDA-MB-468""))
            :ARG1-of (s2 / stable-02))
      :ARG2 (o / or
            :op1 (v / vector :name (n3 / name :op1 ""468.Neo"")
                  :ARG1-of (e / empty-02))
            :op2 (c3 / construct-01
                  :ARG2 p2
                  :ARG1-of (m / mean-01
                        :ARG2 (c4 / cell-line :name (n4 / name :op1 ""468.MUC1Δ8"")))
                  :ARG0-of (r / resist-01
                        :ARG1 (o2 / oligonucleotide :mod 882
                              :ARG1-of (i / include-91
                                    :ARG2 (o3 / oligonucleotide
                                          :ARG1-of (d2 / direct-01
                                                :ARG0 p2)
                                          :ARG0-of (d3 / depend-01 :polarity -)))))
                  :ARG1-of (l / long-03
                        :mod (f / full))))
      :purpose (d / determine-01
            :ARG0 w
            :ARG1 (s / specific-02 :mode interrogative
                  :ARG1 (a / affect-02
                        :mod (a2 / above))
                  :ARG2 (p2 / protein :name (n2 / name :op1 ""MUC1"")))))","To determine if the above effects are specific to MUC1, we created stable transfectants of the MDA-MB-468 line using empty vector (468.Neo) or a full-length MUC1 construct (468.MUC1Δ8) that is resistant to one of the independent MUC1-directed oligonucleotides ('882').","(z1 / create-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / transfectant
              :ARG1-of (z4 / stable-03)
              :mod (z5 / line
                       :wiki ""MDA-MB-468""
                       :name (z6 / name
                                 :op1 ""MDA-MB-468"")))
    :ARG2-of (z7 / use-01
                 :ARG1 (z8 / or
                           :op1 (z9 / vector
                                    :ARG1-of (z10 / empty-02)
                                    :ARG1-of (z11 / name-01
                                                  :ARG2 (z12 / product-of
                                                             :op1 ""468.Neo"")
                                                  :op2 (z13 / construct
                                                            :ARG1-of (z14 / long-03
                                                                          :ARG2 (z15 / full-09))
                                                            :mod (z16 / enzyme
                                                                      :wiki ""MUC1""
                                                                      :name (z17 / name
                                                                                 :op1 ""MUC1Δ8""))
                                                            :ARG0-of (z18 / resist-01
                                                                          :ARG1 (z19 / oligonucleotide
                                                                                     :quant 1
                                                                                     :ARG1-of (z20 / include-91
                                                                                                   :ARG2 (z21 / oligonucleotide
                                                                                                              :ARG1-of (z22 / direct-01
                                                                                                                            :ARG0 z16
                                                                                                                            :ARG2 z16)
                                                                                                              :ARG1-of (z23 / depend-01
                                                                                                                            :polarity -)
                                                                                                              :ARG1-of (z24 / name-01
                                                                                                                            :ARG2 8)))))))))))",0.4390243902439024,0.5039370078740157,"(m / multi-sentence
        :snt1 (d / determine-01
            :ARG1 (e / effect
                  :mod (a / above))
            :ARG2 (s / specific-02
                  :ARG1 (m2 / MUC1))
            :ARG3 (c / create-01
                  :ARG1 (t / transfectant
                        :ARG1 (l / line
                              :mod (m / MDA-MB-468)))
                  :ARG2 (v / vector
                        :mod (e2 / empty))
                  :ARG3 (c2 / construct
                        :mod (f / full-length)
                        :ARG1 (m3 / MUC1)
                        :ARG2 (r / resistant-02
                              :ARG1 (o / oligonucleotide
                                    :ARG1 (d2 / direct-01
                                          :ARG1 m3)
                                    :ARG2 (n / name :op1 ""'882'""))))))
        :snt2 (u / use-01
            :ARG1 (t2 / transfectant
                  :ARG1 (l2 / line
                        :mod (m4 / MDA-MB-468)))
            :ARG2 (v2 / vector
                  :mod (e3 / empty))
            :ARG3 (c3 / construct
                  :mod (f2 / full-length)
                  :ARG1 (m5 / MUC1Δ8)
                  :ARG2 (r2 / resistant-02
                        :ARG1 (o2 / oligonucleotide
                              :ARG1 (d3 / direct-01
                                    :ARG1 m5)
                              :ARG2 (n2 / name :op1 ""'882'""))))))","(d / determine-01
    :ARG1 (e / effect
        :location (a / above))
    :ARG2 (s / specific-02
        :ARG1 e
        :ARG2 (m / molecule :name (n / name :op1 ""MUC1"")))
    :ARG0 (w / we)
    :purpose (c / create-01
        :ARG0 w
        :ARG1 (t / transfectant
            :mod (s2 / stable)
            :ARG1-of (o / of-02
                :ARG2 (l / line
                    :name (n2 / name :op1 ""MDA-MB-468""))))
        :instrument (v / vector
            :mod (e2 / empty)
            :name (n3 / name :op1 ""468.Neo""))
        :instrument (c2 / construct
            :mod (f / full-length)
            :ARG1-of (o2 / of-02
                :ARG2 m)
            :name (n4 / name :op1 ""468.MUC1Δ8""))
        :condition (r / resist-01
            :ARG0 c2
            :ARG1 (o3 / oligonucleotide
                :ARG1-of (d2 / direct-01
                    :ARG0 (m2 / molecule :name (n5 / name :op1 ""MUC1"")))
                :mod (i / independent)
                :name (n6 / name :op1 ""'882'"")))))",-1.0,0.3875968992248063
pmid_1684_6534.161,"As expected, 468.MUC1Δ8 cells show higher levels of both the MUC1 extracellular domain and the MUC1-CT than do 468.Neo (Figure <xref ref-type=""fig"" rid=""F6"">6a</xref>).","(s / show-01
    :ARG0 (c2 / cell-line
        :name (n / name
            :op1 ""CHO-K1""))
    :ARG1 (l / level
        :ARG1-of (h / have-degree-91
            :ARG2 (h3 / high-02)
            :ARG3 (m / more))
        :quant-of (a2 / and
            :op1 (d3 / domain
                :name (n3 / name
                    :op1 ""MUC1"")
                :ARG1-of (i / ionize-01
                    :mod (a / absolute)))
            :op2 (c / cell
                :name (n2 / name)
                :mod (h2 / healthy)
                :mod 4)
            :op2 (p / person
                :name n2)))
    :ARG1-of (e / expect-01)
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :ARG1-of (d2 / describe-01
                :ARG0 (p2 / publication
                    :name n2))))
    :rel (c3 / chapter
        :mod 6)
    :rel 468)
",test,bio_amr0.8,"(s3 / show-01
      :ARG0 (c / cell-line :name (n2 / name :op1 ""468.MUC1Δ8""))
      :ARG1 (a2 / and
            :op1 (l / level
                  :quant-of (p / protein-segment :name (n4 / name :op1 ""MUC1"")))
            :op2 (l2 / level
                  :quant-of (p2 / protein-segment :name (n3 / name :op1 ""MUC1-CT"")))
            :ARG1-of (h / high-02
                  :degree (m / more)
                  :compared-to c2)
            :mod (d / domain
                  :mod (e2 / extracellular)))
      :compared-to (c2 / cell-line :name (n / name :op1 ""468.Neo""))
      :ARG1-of (e / expect-01)
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod ""6a"")))","As expected, 468.MUC1Δ8 cells show higher levels of both the MUC1 extracellular domain and the MUC1-CT than do 468.Neo (Figure <xref ref-type=""fig"" rid=""F6"">6a</xref>).","(z1 / show-01
    :ARG0 (z2 / cell
              :mod (z3 / enzyme
                       :wiki ""MUC1Δ8""
                       :name (z4 / name
                                 :op1 ""MUC1Δ8"")))
    :ARG1 (z5 / level
              :ARG1-of (z6 / have-degree-91
                           :ARG2 (z7 / high-02)
                           :ARG3 (z8 / more)
                           :ARG4 (z9 / level
                                     :quant-of (z10 / and
                                                    :op1 (z11 / protein
                                                              :wiki ""MUC1_extracellular_domain""
                                                              :name (z12 / name
                                                                         :op1 ""MUC1""
                                                                         :op2 ""extracellular""
                                                                         :op3 ""domain""))
                                                    :op2 (z13 / protein
                                                              :wiki ""MUC1-CT""
                                                              :name (z14 / name
                                                                         :op1 ""MUC1-CT""))))))
    :ARG1-of (z15 / have-quant-91
                  :ARG3 (z16 / more)
                  :ARG4 (z17 / level
                             :quant-of z10
                             :ARG1-of (z18 / show-01
                                           :ARG0 (z19 / cell
                                                      :mod ""468.Neo""))
                             :ARG1-of (z20 / describe-01
                                           :ARG0 (z21 / figure
                                                      :mod ""6a""
                                                      :ARG1-of (z22 / hyperlink-91
                                                                    :ARG3 (z23 / url-entity
                                                                               :value ""xref"")))))))",0.2828282828282828,0.391304347826087,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (c / cell
                  :mod (e2 / expected))
            :ARG1 (l / level
                  :ARG1-of (h / high
                        :degree (l2 / level
                              :ARG1-of (d / domain
                                    :mod (e / extracellular)
                                    :mod (m / MUC1))))
                  :ARG1-of (h2 / high
                        :degree (l3 / level
                              :ARG1-of (c2 / CT
                                    :mod (m2 / MUC1)))))
            :ARG2 (n / Neo
                  :mod (d2 / do
                        :ARG1 (f / figure
                              :ARG1-of (x / xref
                                    :ref-type ""fig""
                                    :rid ""F6"")
                              :op1 ""6a"")))))","(e / expect-01 :mode interrogative
    :ARG1 (s / show-01
        :ARG0 (c / cell :name (n / name :op1 ""468.MUC1Δ8""))
        :ARG1 (l / level-01
            :degree (h / high-02)
            :ARG1 (a / and
                :op1 (d / domain
                    :mod (m / molecule :name (n2 / name :op1 ""MUC1""))
                    :location (e2 / extracellular))
                :op2 (m2 / molecule :name (n3 / name :op1 ""MUC1-CT"")))))
    :concession (c2 / cell :name (n4 / name :op1 ""468.Neo""))
    :medium (f / figure :name (n5 / name :op1 ""6a"")))",-1.0,0.5301204819277109
pmid_1684_6534.162,"Note that 468.Neo have MUC1 expression comparable to parental MDA-MB-468; the exposures in Figure <xref ref-type=""fig"" rid=""F6"">6a</xref> are lighter than those in Figure <xref ref-type=""fig"" rid=""F1"">1a</xref>, in order to clearly show the relative levels of MUC1 in the stable transfectants.","(m2 / multi-sentence
    :rel (a / F6)
    :rel 468
    :snt1 (n5 / note-01
        :ARG0 (y / you)
        :ARG1 (h / have-03
            :ARG0 (p2 / person
                :name (n / name
                    :op1 ""Neo""))
            :ARG1 (e2 / express-03
                :ARG1-of (c2 / comparable-03
                    :ARG2 (p4 / person
                        :name (n3 / name
                            :op1 4)
                        :ARG0-of (h3 / have-rel-role-91
                            :ARG1 (p3 / person
                                :name (n2 / name
                                    :op1 ""MUC1""))
                            :ARG2 (p / parent))))
                :ARG2 4))
        :mode imperative)
    :snt2 (h2 / have-degree-91
        :ARG1 (e / expose-01
            :purpose (s / show-01
                :ARG1 (l / level
                    :ARG1-of (r / relative-05)
                    :location (v / virus
                        :ARG1-of (s2 / stable-03))
                    :mod (p5 / protein
                        :name (n4 / name
                            :op1 ""MUC1"")))
                :ARG1-of (c / clear-06))
            :location (f / figure))
        :ARG2 (l2 / light-06
            :ARG1 e)
        :ARG3 (m / more)
        :ARG4 (t / that
            :location (f2 / figure))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (n / note-01
            :ARG1 (e3 / express-03
                  :ARG2 p2
                  :ARG3 (c2 / cell-line :name (n4 / name :op1 ""468.Neo""))
                  :ARG1-of (c5 / comparable-03
                        :ARG2 (c3 / cell-line :name (n5 / name :op1 ""MDA-MB-468"")
                              :mod (p / parent)))))
      :snt2 (l / light-06
            :ARG1 (e / exposure
                  :medium (f / figure :mod ""6a""))
            :degree (m2 / more)
            :compared-to (e2 / expose-01
                  :source (f2 / figure :mod ""1a""))
            :purpose (s / show-01
                  :ARG0 e
                  :ARG1 (l2 / level
                        :quant-of (p2 / protein :name (n2 / name :op1 ""MUC1""))
                        :ARG1-of (r / relative-05))
                  :ARG1-of (c / clear-06)
                  :location (c4 / cell
                        :ARG1-of (s2 / stable-02)
                        :ARG1-of (t / transfect-01)))))","Note that 468.Neo have MUC1 expression comparable to parental MDA-MB-468; the exposures in Figure <xref ref-type=""fig"" rid=""F6"">6a</xref> are lighter than those in Figure <xref ref-type=""fig"" rid=""F1"">1a</xref>, in order to clearly show the relative levels of MUC1 in the stable transfectants.","(z1 / note-01
    :mode imperative
    :ARG0 (z2 / you)
    :ARG1 (z3 / and
              :op1 (z4 / have-03
                       :ARG0 (z5 / small-molecule
                                 :wiki ""Neostatin""
                                 :name (z6 / name
                                           :op1 ""Neo""))
                       :ARG1 (z7 / express-03
                                 :ARG1 (z8 / enzyme
                                           :wiki ""Mitogen-activated_protein_kinase_1""
                                           :name (z9 / name
                                                     :op1 ""MUC1""))
                                 :ARG1-of (z10 / comparable-03
                                               :ARG2 (z11 / express-101
                                                          :ARG1 (z12 / enzyme
                                                                     :wiki ""Mitogen-activated_protein_kinase-activated_protein_kinase""
                                                                     :name (z13 / name
                                                                                :op1 ""MDA-MB-468"")
                                                                     :mod (z14 / parental)))))))
    :op2 (z15 / have-degree-91
              :ARG1 (z16 / expose-01
                         :ARG1 z5
                         :location (z17 / figure
                                        :mod ""6a""
                                        :ARG1-of (z18 / hyperlink-91
                                                      :ARG3 (z19 / url-entity
                                                                 :value ""xREF""))))
              :ARG2 (z20 / light-06
                         :ARG1 z16)
              :ARG3 (z21 / more)
              :ARG4 (z22 / expose-01
                         :ARG1 z5
                         :location z17
                         :mod (z23 / figure
                                   :mod ""1a""
                                   :ARG1-of (z24 / hyperlink-91
                                                 :ARG3 (z25 / url-entity
                                                            :value ""xREF"")))))
    :purpose (z26 / show-01
                  :ARG0 z16
                  :ARG1 (z27 / level
                             :ARG1-of (z28 / relative-05
                                           :ARG2 (z29 / level
                                                      :quant-of z8))
                             :location (z30 / transfectant
                                            :ARG1-of (z31 / stable-03)))
                  :ARG1-of (z32 / clear-06)))",0.3181818181818182,0.4297520661157025,"(m / multi-sentence
        :snt1 (n / note-01
            :ARG1 (c / compare-01
                  :ARG1 (e / expression-01
                        :ARG1 (n2 / Neo)
                        :ARG2 (c2 / comparable-01
                              :ARG1 (e2 / expression-01
                                    :ARG1 (p / parental
                                          :ARG1 (m / MDA-MB-468))))
                        :ARG3 (l / lighter
                              :ARG1 (e3 / exposure
                                    :ARG1 (f / figure
                                          :op1 (x / xref
                                                :ref-type ""fig""
                                                :rid ""F6"")
                                          :op2 (a / a))))
                              :ARG2 (e4 / exposure
                                    :ARG1 (f2 / figure
                                          :op1 (x2 / xref
                                                :ref-type ""fig""
                                                :rid ""F1"")
                                          :op2 (a2 / a))))
                        :ARG4 (s / show-01
                              :ARG1 (l2 / level
                                    :ARG1 (r / relative)
                                    :ARG2 (m2 / MUC1)
                                    :ARG3 (t / transfectant
                                          :mod (s2 / stable)))))))
        :snt2 (c3 / clearly
            :ARG1 (s3 / show-01
                  :ARG1 (l3 / level
                        :ARG1 (r2 / relative)
                        :ARG2 (m3 / MUC1)
                        :ARG3 (t2 / transfectant
                              :mod (s4 / stable))))))","(n / note-01
    :ARG1 (c / compare-01
        :ARG1 (e / express-01
            :ARG0 (n2 / name :op1 ""468.Neo"")
            :ARG1 (m / molecule :name (n3 / name :op1 ""MUC1"")))
        :ARG2 (e2 / express-01
            :ARG0 (m2 / molecule :name (n4 / name :op1 ""MDA-MB-468""))
            :ARG1 m))
    :ARG2 (l / light-02
        :ARG1 (e3 / exposure-01
            :location (f / figure :name (n5 / name :op1 ""6a"")))
        :ARG2 (e4 / exposure-01
            :location (f2 / figure :name (n6 / name :op1 ""1a"")))
        :purpose (s / show-01
            :ARG1 (l2 / level-01
                :ARG1 m
                :mod (r / relative))
            :ARG2 (t / transfectant-01
                :mod (s2 / stable)))))",-1.0,0.2941176470588235
pmid_1684_6534.163,"After MUC1 siRNA, 468.MUC1Δ8 lose some MUC1 (likely endogenous protein, which is not siRNA-resistant) but retain high-level expression, while 468.Neo show a decrease in MUC1 levels similar to parental 468.siMUC1 cells (Figures <xref ref-type=""fig"" rid=""F6"">6a,b</xref>).","(c4 / contrast-01
    :ARG1 (c3 / contrast-01
        :ARG1 (l4 / lose-02
            :ARG0 (s5 / source
                :name (n3 / name))
            :ARG1 (p2 / protein
                :name (n / name
                    :op1 ""MUC1"")
                :ARG0-of (r2 / resist-01
                    :ARG1 (s3 / small-molecule
                        :name (n4 / name
                            :op1 ""siRNA""))
                    :polarity -)
                :ARG1-of (s / shit-01)
                :ARG1-of (l3 / likely-01)))
        :ARG1-of (d2 / describe-01
            :ARG0 (f / figure
                :mod 6))
        :ARG2 (r3 / retain-01
            :ARG0 s5
            :ARG1 (e2 / express-03
                :mod (l / level
                    :ARG1-of (h2 / high-02))))
        :time (a / after))
    :ARG2 (s2 / show-01
        :ARG0 s5
        :ARG1 (d / decrease-01
            :ARG1 (l2 / level
                :ARG1-of (r / resemble-01
                    :ARG2 (c / cell
                        :ARG0-of (h / have-rel-role-91
                            :ARG1 s3
                            :ARG2 (p / parental))
                        :mod s5)
                    :ARG2 (c2 / cell
                        :name (n5 / name
                            :op1 ""F6"")
                        :ARG0-of h))
                :mod (e / enzyme
                    :name n))))
    :rel (n2 / name
        :op1 ""MUC1Δ8"")
    :rel (s4 / some))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (c5 / contrast-01
            :ARG1 (l / lose-02
                  :ARG0 (c2 / cell-line :name (n2 / name :op1 ""468.MUC1Δ8""))
                  :ARG1 (p3 / protein :name (n3 / name :op1 ""MUC1"")
                        :mod (s2 / some)
                        :ARG1-of (m / mean-01
                              :ARG2 (l3 / likely-01
                                    :ARG1 (p2 / protein
                                          :mod (m2 / monocot)
                                          :ARG0-of (r / resist-01 :polarity -
                                                :ARG1 n6)))))
                  :ARG2 (r3 / retain-01
                        :ARG0 c2
                        :ARG1 (e / express-03)
                        :ARG1-of (h / high-02))
                  :time (a / after
                        :op1 (n6 / nucleic-acid :name (n / name :op1 ""siRNA"")
                              :ARG0-of (e2 / encode-01
                                    :ARG1 p3)))))
      :ARG2 (s / show-01
            :ARG0 (c3 / cell-line :name (n4 / name :op1 ""468.Neo""))
            :ARG1 (d / decrease-01
                  :ARG1 (l2 / level
                        :quant-of p3)
                  :ARG1-of (r4 / resemble-01
                        :ARG2 (c4 / cell-line :name (n5 / name :op1 ""468.siMUC1"")
                              :mod (p / parent)))))
      :ARG1-of (d2 / describe-01
            :ARG0 (a2 / and
                  :op1 (f / figure :mod ""6a"")
                  :op2 (f2 / figure :mod ""6b""))))","After MUC1 siRNA, 468.MUC1Δ8 lose some MUC1 (likely endogenous protein, which is not siRNA-resistant) but retain high-level expression, while 468.Neo show a decrease in MUC1 levels similar to parental 468.siMUC1 cells (Figures <xref ref-type=""fig"" rid=""F6"">6a,b</xref>).","(z1 / contrast-01
    :ARG1 (z2 / lose-02
              :ARG0 (z3 / enzyme
                        :wiki ""Mitogen-activated_protein_kinase_1""
                        :name (z4 / name
                                  :op1 ""MUC1Δ8"")
                        :mod (z5 / protein
                                 :ARG1-of (z6 / likely-01)
                                 :mod (z7 / endogenous)
                                 :ARG0-of (z8 / resist-01
                                              :polarity -
                                              :ARG1 (z9 / siRNA)))
                        :quant (z10 / some))
              :ARG1 (z11 / level
                         :quant-of (z12 / enzyme
                                        :wiki ""Mitogen-activated_protein_kinase_1""
                                        :name (z13 / name
                                                   :op1 ""MUC1""))))
    :ARG2 (z14 / retain-01
               :ARG0 z3
               :ARG1 (z15 / express-01
                          :ARG1 z12
                          :mod (z16 / level
                                    :ARG1-of (z17 / high-02)))))",0.3418803418803419,0.4429530201342282,"(m / multi-sentence
        :snt1 (l / lose-01
            :ARG0 (4 / 468.MUC1Δ8)
            :ARG1 (s / some
                  :ARG1-of (l2 / lose-01
                        :ARG0 (p / protein
                              :mod (e / endogenous)
                              :mod (l3 / likely))
                        :ARG1 (m / MUC1
                              :mod (s2 / siRNA-resistant))))
            :ARG1-of (r / retain-01
                  :ARG0 4
                  :ARG1 (e2 / expression
                        :degree (h / high-level))))
        :snt2 (s3 / show-01
            :ARG0 (4.2 / 468.Neo)
            :ARG1 (d / decrease-01
                  :ARG1 (l4 / level
                        :mod (m2 / MUC1))
                  :ARG2 (c / cell
                        :mod (p2 / parental)
                        :mod (s4 / siMUC1))))
        :snt3 (f / figure
            :ARG0 (x / xref
                  :ref-type ""fig""
                  :rid ""F6"")
            :ARG1 (a / and
                  :op1 (6a / 6a)
                  :op2 (6b / 6b))))","(a / after
    :op1 (s / siRNA
        :ARG1 (m / MUC1))
    :op2 (l / lose-01
        :ARG0 (m2 / MUC1Δ8)
        :ARG1 (m3 / MUC1
            :mod (s2 / some))
        :condition (p / protein
            :mod (e / endogenous)
            :mod (l2 / likely)
            :mod (r / resistant
                :polarity -
                :ARG1 (s3 / siRNA))))
    :op3 (r2 / retain-01
        :ARG0 m2
        :ARG1 (e2 / expression
            :degree (h / high)
            :ARG1 m3))
    :op4 (s4 / show-01
        :ARG0 (n / 468.Neo)
        :ARG1 (d / decrease-01
            :ARG1 (l3 / level
                :ARG1 m3)
            :degree (s5 / similar
                :ARG1 (c / cell
                    :mod (p2 / parental)
                    :mod (s6 / 468.siMUC1))))
        :location (f / figure
            :mod (n2 / name :op1 ""6a,b""))))",-1.0,0.3206106870229007
pmid_1684_6534.164,"The difference in the amount of MUC1 knockdown between 468.Neo and 468.MUC1Δ8 is highlighted by the purple shading in Figure <xref ref-type=""fig"" rid=""F6"">6b</xref>.","(h / highlight-01
    :ARG0 (s / shade-01
        :ARG1-of (p3 / purple-02)
        :location (f / figure
            :mod (s2 / source
                :name (n4 / name
                    :op1 ""MUC1""))))
    :ARG1 (d / differ-02
        :ARG1 (a2 / amount
            :mod (k / knock-down-02
                :ARG1 (p / person
                    :name (n / name
                        :op1 ""MUC1""))))
        :ARG2 (k2 / knock-down-02
            :ARG1 (t / thing
                :name (n3 / name))))
    :rel (a / 468
        :ARG1 (p2 / person
            :name (n2 / name
                :op1 ""Neo"")))
    :rel 468)
",test,bio_amr0.8,"(h / highlight-01
      :ARG0 (s / shade-01
            :ARG0 (p / purple))
      :ARG1 (d / differ-02
            :ARG1 (a / amount-01)
            :ARG2 (c2 / cell-line :name (n3 / name :op1 ""468.MUC1Δ8""))
            :ARG3 (k / knock-down-02
                  :ARG1 (p2 / protein :name (n / name :op1 ""MUC1"")))
            :ARG1 (c / cell-line :name (n2 / name :op1 ""468.Neo"")))
      :medium (f / figure :mod ""6b""))","The difference in the amount of MUC1 knockdown between 468.Neo and 468.MUC1Δ8 is highlighted by the purple shading in Figure <xref ref-type=""fig"" rid=""F6"">6b</xref>.","(z1 / highlight-01
    :ARG0 (z2 / shade-01
              :ARG1 (z3 / figure
                        :mod (z4 / figure))
              :ARG1-of (z5 / purple-02))
    :ARG1-of (z6 / cause-01
                 :ARG0 (z7 / differ-02
                           :ARG1 (z8 / amount
                                     :quant-of (z9 / knock-down-03
                                                   :ARG1 (z10 / enzyme
                                                              :wiki ""Mitogen-activated_protein_kinase_1""
                                                              :name (z11 / name
                                                                         :op1 ""MUC1""
                                                                         :op2 ""Neo""))))
                           :ARG2 (z12 / amount
                                      :quant-of z9)
                           :ARG3 (z13 / knock-down-03
                                      :ARG1 z10)
                           :ARG4 (z14 / knock-down-03
                                      :ARG1 z10))))",0.2857142857142857,0.417910447761194,"(m / multi-sentence
        :snt1 (h / highlight-01
            :ARG1 (d / difference
                  :mod (a / amount
                        :mod (k / knockdown
                              :mod (m / MUC1))))
            :ARG2 (s / shade-01
                  :ARG1 (c / color :op1 ""purple""))
            :ARG3 (f / figure
                  :ARG1-of (x / xref
                        :ref-type ""fig""
                        :rid ""F6"")
                  :ARG2 (b / b)))
        :snt2 (i / in
            :ARG1 d
            :ARG2 (a2 / and
                  :op1 (n / name :op1 ""468.Neo"")
                  :op2 (n2 / name :op1 ""468.MUC1Δ8""))))","(d / difference-01
    :ARG1 (a / amount
        :quant (m / MUC1
            :mod (k / knockdown-01)))
    :ARG2 (a2 / amount
        :quant (m2 / MUC1
            :mod (k2 / knockdown-01
                :ARG1 (n / name :op1 ""468.MUC1Δ8""))))
    :ARG1-of (c / compare-01
        :ARG2 (n2 / name :op1 ""468.Neo""))
    :location (f / figure
        :name (n3 / name :op1 ""6b""))
    :mod (h / highlight-01
        :ARG1 (s / shade
            :mod (p / purple))))",-1.0,0.3225806451612903
pmid_1684_6534.167,"Similarly, analysis of apoptosis in trypsinized cells indicates that the increased apoptosis seen in parental 468.siMUC1 cells is also present in the 468.Neo line after MUC1 siRNA (Figure <xref ref-type=""fig"" rid=""F6"">6d</xref>; 43.6% in control versus 59.6% in MUC1 siRNA).","(i2 / indicate-01
    :ARG0 (a3 / analyze-01
        :ARG1 (a4 / apoptosis
            :location (c / cell
                :mod (b / benefit))))
    :ARG1 (p4 / present-02
        :ARG1 (a5 / apoptosis
            :ARG1-of (i / increase-01)
            :ARG1-of (s / see-01
                :location (c2 / cell
                    :name (n / name
                        :op1 ""siMUC1"")
                    :ARG0-of (h / have-rel-role-91
                        :ARG2 (p / parent)))))
        :ARG2 c
        :mod (a2 / also)
        :mod (l / line
            :name (n2 / name
                :op1 ""neo-Nazism""
                :op1 ""MUC1""
                :op2 ""siRNA""
                :op2 ""siRNA"")
            :time (a / after
                :op1 (e / enzyme
                    :name n2))))
    :ARG1-of (r / resemble-01)
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod (v / versus
                :op1 (p2 / percentage-entity
                    :value 43.6)
                :op2 (p3 / percentage-entity
                    :value 59.6))))
    :rel (c3 / control-01)
    :rel 468)
",test,bio_amr0.8,"(i / indicate-01
      :ARG0 (a / analyze-01
            :ARG1 (a2 / apoptosis
                  :ARG1-of (p5 / present-02
                        :ARG2 (c / cell
                              :ARG1-of (t / trypsinize-00)))))
      :ARG1 (p6 / present-02
            :ARG1 (a3 / apoptosis
                  :ARG1-of (s / see-01
                        :location (c2 / cell-line :name (n / name :op1 ""468.siMUC1"")
                              :mod (p3 / parent)))
                  :ARG1-of (i2 / increase-01))
            :ARG2 (c3 / cell-line :name (n2 / name :op1 ""468.Neo""))
            :mod (a4 / also)
            :time (a5 / after
                  :op1 n5)
            :mod (c4 / control-01
                  :location (n5 / nucleic-acid :name (n3 / name :op1 ""siRNA"")
                        :ARG0-of (e / encode-01
                              :ARG1 (p4 / protein :name (n4 / name :op1 ""MUC1"")))))
            :ARG1-of (m / mean-01
                  :ARG2 (p / percentage-entity :value 43.6
                        :compared-to (p2 / percentage-entity :value 59.6))))
      :ARG1-of (r / resemble-01)
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""6d"")))","Similarly, analysis of apoptosis in trypsinized cells indicates that the increased apoptosis seen in parental 468.siMUC1 cells is also present in the 468.Neo line after MUC1 siRNA (Figure <xref ref-type=""fig"" rid=""F6"">6d</xref>; 43.6% in control versus 59.6% in MUC1 siRNA).","(z1 / indicate-01
    :ARG0 (z2 / analyze-01
              :ARG1 (z3 / apoptose-01
                        :ARG1 (z4 / cell
                                  :ARG1-of (z5 / try-01psinize-01))))
    :ARG1 (z6 / present-02
              :ARG1 (z7 / apoptose
                        :ARG1-of (z8 / increase-01)
                        :ARG1-of (z9 / see-01
                                     :location (z10 / cell
                                                    :wiki ""468.siMUC1""
                                                    :name (z11 / name
                                                               :op1 ""468.siMUC1""
                                                               :op2 ""cell"")
                                                    :ARG0-of (z12 / have-rel-role-91
                                                                  :ARG2 (z13 / parental)))))
              :ARG2 (z14 / line
                         :mod (z15 / gene
                                   :wiki ""Neogenenzum_serine""
                                   :name (z16 / name
                                              :op1 ""neo"")
                                   :time (z17 / after
                                              :op1 (z18 / siRNA
                                                        :wiki ""Mitogen-activated_protein_kinase_1""
                                                        :name (z19 / name
                                                                   :op1 ""MUC1""
                                                                   :op2 ""siRNA""))))))
    :mod (z20 / also)
    :ARG1-of (z21 / describe-01
                  :ARG0 (z22 / and
                             :op1 (z23 / figure
                                       :mod (z24 / value-interval
                                                 :op1 ""6d""
                                                 :ARG1-of (z25 / hyperlink-91
                                                               :ARG3 (z26 / url-entity
                                                                          :value ""xref"")))
                                       :op2 (z27 / percentage-entity
                                                 :value ""43.6""
                                                 :time (z28 / control-01))
                                       :op3 (z29 / percentage-entity
                                                 :value ""59.6""
                                                 :time z28
                                                 :ARG1-of (z30 / compare-01
                                                               :ARG2 (z31 / percentage-entity
                                                                          :value ""43.6""
                                                                          :time (z32 / control-01
                                                                                     :ARG1 z18))))))))",0.3888888888888889,0.4960000000000001,"(m / multi-sentence
        :snt1 (a / analysis
            :ARG1 (a2 / apoptosis
                  :ARG1-of (i / indicate-01
                        :ARG1 (c / cell
                              :ARG1-of (t / trypsinize-01)))
                  :ARG1-of (s / see-01
                        :ARG1 (a3 / apoptosis
                              :ARG1-of (p / parental
                                    :ARG1 (c2 / cell
                                          :mod (n / name :op1 ""468.siMUC1""))))
                  :ARG1-of (p2 / present-01
                        :ARG1 (l / line
                              :mod (n2 / name :op1 ""468.Neo""))
                        :ARG2 (a4 / apoptosis
                              :ARG1-of (m / MUC1
                                    :ARG1 (s2 / siRNA)))))
            :ARG2 (f / figure
                  :op1 (x / xref
                        :ref-type ""fig""
                        :rid ""F6"")
                  :op2 ""6d"")
            :ARG3 (p3 / percent
                  :quant 43.6
                  :ARG1 (c3 / control))
            :ARG4 (p4 / percent
                  :quant 59.6
                  :ARG1 (s3 / MUC1
                        :ARG1 (s4 / siRNA)))))
        :snt2 (s5 / similar-01))","(a / analysis
    :mod (s / similar-02)
    :ARG1 (a2 / apoptosis
        :location (c / cell
            :mod (t / trypsinize-01)))
    :ARG2 (i / indicate-01
        :ARG1 (a3 / apoptosis
            :degree (i2 / increase-01)
            :location (c2 / cell
                :name (n / name :op1 ""468.siMUC1"")
                :poss (p / parent)))
        :ARG2 (p2 / present-01
            :ARG1 a3
            :location (c3 / cell
                :name (n2 / name :op1 ""468.Neo""))
            :time (a4 / after
                :ARG1 (s2 / siRNA
                    :mod (m / molecule :name (n3 / name :op1 ""MUC1""))))))
    :medium (f / figure
        :mod (n4 / name :op1 ""6d"")
        :mod (p3 / percent
            :quant 43.6
            :ARG1-of (c4 / contrast-01
                :ARG2 (p4 / percent
                    :quant 59.6
                    :ARG1-of (s3 / siRNA
                        :mod m))))))",-1.0,0.3305785123966942
pmid_1901_8267.1,<i>KRAS</i> or <i>BRAF</i> mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer (PMID:19018267),"(p / predict-01
    :ARG0 (s2 / status
        :mod (m / mutate-01
            :ARG3 (i / i)))
    :ARG1 (s / sensitive-03
        :ARG1 (i2 / inhibit-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op1 ""MEK""))
            :part-of (d / disease
                :name (n2 / name
                    :op1 ""ovarian""
                    :op2 ""cancer""))))
    :ARG1-of (u / useful-05)
    :ARG1-of (p2 / publication-91
        :ARG0 i
        :ARG3 19018267
        :ARG4 (j / journal
            :name (n3 / name))
        :ARG4 n3))
",test,bio_amr0.8,"(u / useful-05
      :ARG1 (o / or
            :op1 (s / status
                  :mod (m / mutate-01
                        :ARG1 (g2 / gene :name (n4 / name :op1 ""KRAS""))))
            :op2 (s2 / status
                  :mod (m2 / mutate-01
                        :ARG1 (g / gene :name (n3 / name :op1 ""BRAF"")))))
      :ARG2 (p / predict-01
            :ARG0 o
            :ARG1 (s3 / sensitive-03
                  :ARG1 (i / inhibit-01
                        :ARG1 (e / enzyme :name (n / name :op1 ""MEK""))
                        :location (d / disease :wiki ""Ovarian_cancer"" :name (n2 / name :op1 ""ovarian"" :op2 ""cancer"")))))
      :ARG1-of (d2 / describe-01
            :ARG0 (p2 / publication-91
                  :ARG8 ""PMID19018267"")))",<i>KRAS</i> or <i>BRAF</i> mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer (PMID:19018267),"(z1 / predict-01
    :ARG0 (z2 / status
              :mod (z3 / mutate-01)
              :mod (z4 / or
                       :op1 (z5 / enzyme
                                :wiki ""BRAF_(g3000 / gene)""
                                :name (z6 / name
                                          :op1 ""KRAS""))
                       :op2 (z7 / enzyme
                                :wiki ""BRAF_(g3001 / gene)""
                                :name (z8 / name
                                          :op1 ""BRAF""))))
    :ARG1 (z9 / sensitive-03
              :ARG1 (z10 / inhibit-01
                         :ARG1 (z11 / enzyme
                                    :wiki ""Mitogen-activated_protein_kinase""
                                    :name (z12 / name
                                               :op1 ""MEK"")))
              :ARG2 (z13 / disease
                         :wiki ""Ovary_cancer""
                         :name (z14 / name
                                    :op1 ""ovarian""
                                    :op2 ""cancer""))))",0.4337349397590361,0.375,"(m / multi-sentence
        :snt1 (i / is-01
            :ARG1 (s / status
                  :mod (m2 / mutation
                        :ARG1 (k / KRAS)
                        :ARG1 (b / BRAF)))
            :ARG2 (p / predictor
                  :mod (u / useful)
                  :ARG1 (s2 / sensitivity
                        :ARG1 (i2 / inhibition
                              :ARG1 (m3 / MEK))))
            :ARG3 (c / cancer
                  :mod (o / ovarian)))
        :snt2 (p2 / PMID:19018267))","(p / predict-01
    :ARG1 (s / sensitivity
        :ARG1 (c / cancer :mod (o / organ :name (n / name :op1 ""ovary"")))
        :ARG2 (i / inhibit-01
            :ARG1 (m / molecule :name (n2 / name :op1 ""MEK""))))
    :ARG2 (s2 / status
        :ARG1 (m2 / mutate-01
            :ARG1 (g / gene :name (n3 / name :op1 ""KRAS""))
            :ARG1 (g2 / gene :name (n4 / name :op1 ""BRAF""))))
    :mod (u / useful)
    :source (p2 / publication
        :id ""PMID:19018267""))",-1.0,0.4819277108433735
pmid_1901_8267.124,Somatic mutations of either <i>KRAS</i> or <i>BRAF</i> were identified in 12 (20.6%) out of 58 ovarian carcinomas.,"(i / identify-01
    :ARG1 (m / mutate-01
        :ARG1-of (s / sick-05)
        :ARG2 (o / or
            :op1 (l / location
                :name (n / name
                    :op1 ""atom""))
            :op2 (l2 / location
                :name (n2 / name
                    :op1 ""BRAF""))))
    :ARG2 (c / cancer
        :ARG1-of (i2 / include-91
            :ARG2 (c2 / cancer
                :quant 58
                :location (o2 / ovary))
            :ARG3 (p / percentage-entity
                :value 20.6
                :value 12))))
",test,bio_amr0.8,"(i / identify-01
      :ARG1 (m / mutate-01
            :ARG1 (o / or
                  :op1 (g / gene :name (n / name :op1 ""KRAS""))
                  :op2 (g2 / gene :name (n2 / name :op1 ""BRAF"")))
            :mod (s / somatic))
      :location (c / carcinoma :quant 12
            :ARG1-of (i2 / include-91
                  :ARG2 (c2 / carcinoma :quant 58
                        :mod (o2 / ovary))
                  :ARG3 (p / percentage-entity :value 20.6))))",Somatic mutations of either <i>KRAS</i> or <i>BRAF</i> were identified in 12 (20.6%) out of 58 ovarian carcinomas.,"(z1 / identify-01
    :ARG1 (z2 / mutate-01
              :ARG1 (z3 / or
                        :op1 (z4 / enzyme
                                 :wiki ""BRAF_(g3000 / gene)""
                                 :name (z5 / name
                                           :op1 ""KRAS""))
                        :op2 (z6 / enzyme
                                 :wiki ""BRAF_(g3001 / gene)""
                                 :name (z7 / name
                                           :op1 ""BRAF"")))
              :mod (z8 / somatic))
    :location (z9 / include-91
                  :ARG1 (z10 / tumor
                             :quant 12
                             :ARG1-of (z11 / include-91
                                           :ARG2 (z12 / tumor
                                                      :quant 58
                                                      :mod (z13 / carcinoma
                                                                :mod (z14 / ovary))))
                             :ARG1-of (z15 / include-91
                                           :ARG2 (z16 / tumor
                                                      :quant 58
                                                      :mod z13)))
                  :ARG3 (z17 / percentage-entity
                             :value ""20.6"")))",0.5675675675675677,0.5483870967741935,"(m / multi-sentence
        :snt1 (i / identify-01
            :ARG0 (m2 / mutation
                  :mod (s / somatic))
            :ARG1 (o / ovarian carcinoma
                  :quant (n / number
                        :op1 58)
                  :ARG2-of (i2 / in
                        :ARG1 (n2 / number
                              :op1 12
                              :op2 (p / percentage
                                    :op1 20.6))))))
        :snt2 (u / use-01
            :ARG0 (e / either
                  :op1 (k / KRAS)
                  :op2 (b / BRAF))
            :ARG1 m2))","(i / identify-01
    :ARG1 (m / mutation
        :mod (s / somatic)
        :ARG1-of (o / or
            :op1 (g / gene :name (n / name :op1 ""KRAS""))
            :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
    :ARG2 (c / carcinoma
        :mod (o2 / ovary)
        :quant 58)
    :ARG3 (p / percentage-entity :value 20.6)
    :time (o3 / out-of
        :op1 12
        :op2 c))",-1.0,0.6885245901639343
pmid_1901_8267.130,The frequency of either <i>KRAS</i> or <i>BRAF</i> mutations in conventional serous high-grade carcinomas (4.0% : 1/25) was significantly lower than in the other histological type (32.2% : 10/31).,"(l / low-04
    :ARG1 (f / frequency
        :mod (m2 / mutate-01
            :quant (p / percentage-entity
                :value 4.0
                :value ""1/25"")
            :mod (o / or
                :op2 (c2 / convenience)))
        :mod (m3 / mutate-01
            :ARG1 (c / cancer
                :mod (g / grade
                    :ARG1-of (h2 / high-02))
                :mod (s / serous)
                :mod (c3 / convention))
            :mod c2))
    :ARG1-of (s2 / significant-02)
    :ARG2-of (h / have-degree-91
        :ARG1 f
        :ARG3 (m / more
            :ARG1-of s2)
        :ARG4 (t / type
            :ARG4 (p2 / percentage-entity
                :value 32.2
                :value ""10/31"")
            :mod (h3 / history)
            :mod (o2 / other)))
    :rel (n / name
        :op1 ""Christianity""))
",test,bio_amr0.8,"(l2 / low-04
      :ARG1 (o3 / or
            :op1 (h3 / have-frequency-91
                  :ARG1 (m2 / mutate-01
                        :ARG1 (g / gene :name (n / name :op1 ""KRAS""))))
            :op2 (h4 / have-frequency-91
                  :ARG1 (m3 / mutate-01
                        :ARG1 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
            :location (c / carcinoma :quant 1
                  :ARG1-of (i / include-91
                        :ARG2 (c3 / carcinoma :quant 25
                              :mod (g3 / grade
                                    :ARG1-of (h / high-02))
                              :mod (s / serum
                                    :mod (c2 / conventional)))
                        :ARG3 (p / percentage-entity :value 4)))
            :compared-to (t / type :quant 10
                  :ARG1-of (i2 / include-91
                        :ARG2 (t2 / type :quant 31
                              :mod (h2 / histology)
                              :mod (o2 / other))
                        :ARG3 (p2 / percentage-entity :value 32.2))))
      :degree (m / more))",The frequency of either <i>KRAS</i> or <i>BRAF</i> mutations in conventional serous high-grade carcinomas (4.0% : 1/25) was significantly lower than in the other histological type (32.2% : 10/31).,"(z1 / have-degree-91
    :ARG1 (z2 / frequency
              :poss (z3 / mutate-01
                        :ARG1 (z4 / or
                                  :op1 (z5 / enzyme
                                           :wiki ""Kocharogen_receptor_potential_channel""
                                           :name (z6 / name
                                                     :op1 ""KRAS""))
                                  :op2 (z7 / enzyme
                                           :wiki ""BRAF_(g3000 / gene)""
                                           :name (z8 / name
                                                     :op1 ""BRAF"")))
                        :location (z9 / carcinoma
                                      :mod (z10 / serous
                                                :ARG1-of (z11 / high-02-grade-05))
                                      :mod (z12 / conventional)
                                      :mod (z13 / grade))))
    :ARG1-of (z14 / mean-01
                  :ARG2 (z15 / percentage-entity
                             :value ""4.0""
                             :ARG1-of (z16 / mean-01
                                           :ARG2 (z17 / percentage-entity
                                                      :value ""1/25"")))))",0.2448979591836734,0.3018867924528302,"(m / multi-sentence
        :snt1 (l / lower-02
            :ARG1 (f / frequency
                  :mod (e / either
                        :op1 (m2 / mutation
                              :ARG0 (k / Kras)
                              :mod (c / conventional)
                              :mod (s / serous)
                              :mod (h / high-grade)
                              :mod (c2 / carcinoma)))
                        :op2 (m3 / mutation
                              :ARG0 (b / Braf)))
                  :ARG1 (p / percent
                        :op1 4.0
                        :op2 (r / ratio
                              :op1 1
                              :op2 25))))
        :snt2 (l2 / lower-02
            :ARG1 (f2 / frequency
                  :mod (o / other)
                  :mod (t / type
                        :mod (h2 / histological)))
            :ARG2 (p2 / percent
                  :op1 32.2
                  :op2 (r2 / ratio
                        :op1 10
                        :op2 31))))","(l / lower-02
    :degree (s / significant)
    :ARG1 (f / frequency
        :mod (e / either
            :op1 (m / mutate-01
                :ARG1 (g / gene :name (n / name :op1 ""KRAS"")))
            :op2 (m2 / mutate-01
                :ARG1 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
        :location (c / carcinoma
            :mod (s2 / serous)
            :mod (h / high)
            :mod (g3 / grade)
            :mod (c2 / conventional)
            :quant (p / percentage :value 4.0)
            :quant (r / ratio :op1 1 :op2 25)))
    :ARG2 (f2 / frequency
        :location (t / type
            :mod (h2 / histological)
            :mod (o / other)
            :quant (p2 / percentage :value 32.2)
            :quant (r2 / ratio :op1 10 :op2 31))))",-1.0,0.3571428571428571
pmid_1901_8267.131,"<sec-title level=""2"">Relationship between <i>KRAS/BRAF</i> mutations and p-ERK1/2 expression or clinicopathological factors</sec-title>","(r / relation-03
    :li 2
    :ARG0 (m / mutate-01
        :mode expressive)
    :ARG1 (o / or
        :op1 (e / express-03
            :ARG2 ""1/2"")
        :op2 (f / factor
            :mod (p / pathology)))
    :rel (n2 / name
        :op1 ""ass""
        :op2 ""he"")
    :rel (n / name))
",test,bio_amr0.8,"(r / relation-03
      :ARG0 (m / mutate-01
            :ARG1 (s / slash
                  :op1 (g / gene :name (n / name :op1 ""KRAS""))
                  :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
      :ARG2 (o / or
            :op1 (e / express-03
                  :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                        :ARG3-of (p / phosphorylate-01)))
            :op2 (f / factor
                  :mod (c / clinicopathologic))))","<sec-title level=""2"">Relationship between <i>KRAS/BRAF</i> mutations and p-ERK1/2 expression or clinicopathological factors</sec-title>","(z1 / relation-03
    :ARG0 (z2 / mutate-01
              :ARG1 (z3 / enzyme
                        :wiki ""BRAF_(g3000 / gene)""
                        :name (z4 / name
                                  :op1 ""KRAS/BRAF"")))
    :ARG1 (z5 / or
              :op1 (z6 / express-03
                       :ARG1 (z7 / enzyme
                                 :wiki ""P-ERK1/2""
                                 :name (z8 / name
                                           :op1 ""p-ERK1/2""
                                           :op2 ""expression"")))
              :op2 (z9 / factor
                       :mod (z10 / clinicopathology))))",0.4285714285714285,0.4230769230769231,"(m / multi-sentence
        :snt1 (r / relate-01
            :ARG1 (m2 / mutation
                  :mod (k / Kras/Braf))
            :ARG2 (e / expression
                  :mod (p / p-ERK1/2)))
        :snt2 (r2 / relate-01
            :ARG1 m2
            :ARG2 (f / factor
                  :mod (c / clinicopathological))))","(r / relationship
    :ARG1 (m / mutation
        :ARG1-of (a / and
            :op1 (g / gene :name (n / name :op1 ""KRAS""))
            :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
    :ARG2 (e / express-01
        :ARG1 (p / protein :name (n3 / name :op1 ""p-ERK1/2"")))
    :ARG3 (f / factor
        :mod (c / clinicopathological))
    :mod (t / title
        :level 2))",-1.0,0.5245901639344263
pmid_1901_8267.132,"The immunoreactivity of active p-ERK1/2 was detected in both the nucleus and the cytoplasm of the tumour cells (<xref ref-type=""fig"" rid=""fig2"">Figure 2</xref>).","(d2 / detect-01
    :ARG1 (p / phosphorylate-01)
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 2))
    :location (a2 / and
        :op1 (n2 / nucleus
            :part-of (c / cell
                :mod (t / tumor)
                :part (c2 / cytoplasm)))
        :op2 c2)
    :rel (e / enzyme
        :name (n / name
            :op1 ""P""
            :op2 ""1/2"")
        :ARG0-of (a / activity-06)))
",test,bio_amr0.8,"(d / detect-01
      :ARG1 (i / immunoreact-00
            :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2"")
                  :ARG3-of (p / phosphorylate-01)
                  :ARG1-of (a / activate-01)))
      :location (a2 / and
            :op1 (n2 / nucleus
                  :part-of (c / cell
                        :mod (t / tumor)))
            :op2 (c2 / cytoplasm
                  :part-of c))
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod 2)))","The immunoreactivity of active p-ERK1/2 was detected in both the nucleus and the cytoplasm of the tumour cells (<xref ref-type=""fig"" rid=""fig2"">Figure 2</xref>).","(z1 / detect-01
    :ARG1 (z2 / immunoreactivity
              :poss (z3 / enzyme
                        :wiki ""P-ERK1/2""
                        :name (z4 / name
                                  :op1 ""p-ERK1/2"")
                        :ARG0-of (z5 / activity-06)
                        :part-of (z6 / cell
                                     :part-of (z7 / tumor
                                                  :part z8))))
    :location (z8 / and
                  :op1 (z9 / nucleus)
                  :op2 (z10 / cytoplasm)))",0.3529411764705882,0.6181818181818182,"(m / multi-sentence
        :snt1 (d / detect-01
            :ARG1 (i / immunoreactivity)
            :ARG2 (a / active
                  :ARG1 (p / p-ERK1/2))
            :ARG3 (c / cell
                  :mod (t / tumour))
            :ARG4 (n / nucleus)
            :ARG4 (c2 / cytoplasm))
        :snt2 (r / refer
            :ARG1 (f / figure
                  :name (n2 / name :op1 ""Figure 2"")
                  :ARG1-of (x / xref
                        :ref-type ""fig""
                        :rid ""fig2""))))","(d / detect-01
    :ARG1 (i / immunoreactivity
        :mod (a / active)
        :mod (p / protein :name (n / name :op1 ""p-ERK1/2"")))
    :location (a2 / and
        :op1 (n2 / nucleus)
        :op2 (c / cytoplasm))
    :ARG2 (c2 / cell
        :mod (t / tumor))
    :medium (f / figure :name (n3 / name :op1 ""2"")))",-1.0,0.4814814814814815
pmid_1901_8267.134,Positive active p-ERK1/2 was identified in 27 (46.6%) out of 58 ovarian carcinomas.,"(i / identify-01
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""P""
            :op2 ""1/2"")
        :ARG0-of (a / activity-06)
        :mod (p2 / positive))
    :location (c / cancer
        :quant (p / percentage-entity
            :value 46.6
            :value 27)
        :ARG1-of (i2 / include-91
            :ARG2 (c2 / cancer
                :quant 58
                :location (o / ovary)))))
",test,bio_amr0.8,"(i / identify-01
      :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2"")
            :ARG3-of (p / phosphorylate-01)
            :ARG1-of (a / activate-01)
            :mod (p2 / positive))
      :location (c / carcinoma :quant 27
            :ARG1-of (i2 / include-91
                  :ARG2 (c2 / carcinoma :quant 58
                        :mod (o / ovary))
                  :ARG3 (p3 / percentage-entity :value 46.6))))",Positive active p-ERK1/2 was identified in 27 (46.6%) out of 58 ovarian carcinomas.,"(z1 / identify-01
    :ARG1 (z2 / enzyme
              :wiki ""P-ERK1/2""
              :name (z3 / name
                        :op1 ""p-ERK1/2"")
              :ARG0-of (z4 / activity-06
                           :ARG1-of (z5 / positive-02)))
    :location (z6 / include-91
                  :ARG1 (z7 / tumor
                            :quant 27
                            :ARG1-of (z8 / include-91
                                         :ARG2 (z9 / tumor
                                                   :quant 58
                                                   :mod (z10 / carcinoma
                                                             :mod (z11 / ovary))))
                            :ARG1-of (z12 / include-91
                                          :ARG2 z9))
                  :ARG1-of (z13 / include-91
                                :ARG2 (z14 / tumor
                                           :quant ""46.6""
                                           :ARG1-of (z15 / include-91
                                                         :ARG2 z9)))))",0.3174603174603174,0.5098039215686274,"(i / identify-01
    :ARG1 (p / positive
        :mod (a / active
            :ARG1 (e / ERK1/2
                :mod (o / ovarian
                    :mod (c / carcinoma
                        :quant (n / number
                            :quant 27
                            :op1 ""out of""
                            :op2 58))))))","(i / identify-01
    :ARG1 (p / protein
        :name (n / name :op1 ""p-ERK1/2"")
        :mod (a / active)
        :mod (p2 / positive))
    :location (c / carcinoma
        :mod (o / organ
            :name (n2 / name :op1 ""ovary""))
        :quant 58)
    :ARG2 (c2 / carcinoma
        :mod o
        :quant 27
        :part (p3 / percent
            :quant 46.6)))",-1.0,0.3846153846153846
pmid_1901_8267.135,The patients were stratified into two groups depending on the mutational status of <i>KRAS/BRAF</i>.,"(r / relative-position
    :ARG2 (g / group
        :quant 2
        :ARG0-of (d / depend-01
            :ARG1 (s / status
                :mod (m / mutate-01)
                :mod (b / broadcast-program
                    :name (n / name
                        :op1 ""Social""
                        :op2 ""telecommunication""
                        :op3 ""System"")))))
    :op1 (p / patient))
",test,bio_amr0.8,"(s / stratify-01
      :ARG1 (p2 / person
            :ARG0-of (h / have-rel-role-91
                  :ARG2 (p / patient)))
      :manner (g / group :quant 2)
      :ARG0-of (d / depend-01
            :ARG1 (s2 / status
                  :mod (m / mutate-01)
                  :poss (s3 / slash
                        :op1 (g2 / gene :name (n / name :op1 ""KRAS""))
                        :op2 (g3 / gene :name (n2 / name :op1 ""BRAF""))))))",The patients were stratified into two groups depending on the mutational status of <i>KRAS/BRAF</i>.,"(z1 / stratify-01
    :ARG1 (z2 / patient)
    :ARG2 (z3 / group
              :quant 2
              :ARG0-of (z4 / depend-01
                           :ARG1 (z5 / status
                                     :mod (z6 / mutational)
                                     :poss (z7 / slash
                                               :op1 (z8 / disease
                                                        :wiki ""Cancer_risk_factor_receptor""
                                                        :name (z9 / name
                                                                  :op1 ""KRAS/BRAF""))
                                               :op2 (z10 / disease
                                                         :wiki ""HIV/AIDS""
                                                         :name (z11 / name
                                                                    :op1 ""HIV/AIDS"")))))))",0.5,0.3673469387755102,"(s / stratify-01
        :ARG0 (p / patient)
        :ARG1 (g / group
              :quant (t / two)
              :ARG1-of (d / depend-01
                    :ARG1 (s2 / status
                          :mod (m / mutational
                                :mod (s3 / status
                                      :ARG1-of (k / KRAS/BRAF)))))))","(s / stratify-01
    :ARG1 (p / patient)
    :ARG2 (g / group
        :quant 2)
    :ARG3 (s2 / status
        :mod (m / mutation)
        :domain (k / kras-braf))
    :condition (d / depend-01
        :ARG1 p
        :ARG2 s2))",-1.0,0.3043478260869565
pmid_1901_8267.136,"The relationships between <i>KRAS/BRAF</i> mutations and clinicopathological factors, including p-ERK1/2 expression are shown in <xref ref-type=""table"" rid=""tbl2"">Table 2</xref>.","(s / show-01
    :ARG1 (r / relation-03
        :ARG1 (m / mutate-01
            :ARG2 (a / and
                :op1 (l / language
                    :name (n / name))
                :op2 (c2 / company
                    :name (n2 / name
                        :op1 ""BRAF"")))
            :mod l)
        :ARG1 (f / factor
            :ARG2-of (i / include-91
                :ARG1 (e2 / express-03
                    :ARG2 (e / enzyme
                        :name (n3 / name
                            :op1 ""1/2""))))
            :mod (c / clinic)))
    :medium (t / table
        :mod 2))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (t / table :mod 2)
      :ARG1 (a2 / and
            :op1 (r / relation-03
                  :ARG0 (m / mutate-01
                        :ARG1 (s2 / slash
                              :op1 (g / gene :name (n / name :op1 ""KRAS""))
                              :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
                  :ARG2 (f / factor
                        :mod (c / clinicopathologic)
                        :ARG2-of (i / include-01
                              :ARG1 (e / express-03
                                    :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                                          :ARG3-of (p / phosphorylate-01))))))))","The relationships between <i>KRAS/BRAF</i> mutations and clinicopathological factors, including p-ERK1/2 expression are shown in <xref ref-type=""table"" rid=""tbl2"">Table 2</xref>.","(z1 / show-01
    :ARG1 (z2 / relation-03
              :ARG0 (z3 / mutate-01
                        :ARG1 (z4 / slash
                                  :op1 (z5 / enzyme
                                           :wiki ""KRAS/BRAF""
                                           :name (z6 / name
                                                     :op1 ""KRAS/BRAF""))
                                  :op2 (z7 / factor
                                           :mod (z8 / clinicopathy)
                                           :ARG2-of (z9 / include-01
                                                        :ARG1 (z10 / express-03
                                                                   :ARG1 (z11 / enzyme
                                                                              :wiki ""P-ERK1/2""
                                                                              :name (z12 / name
                                                                                         :op1 ""p-ERK1/2""
                                                                                         :op2 ""expression"")))))))
              :ARG2 (z13 / factor
                         :mod z8))
    :medium (z14 / table
                 :mod 2
                 :ARG1-of (z15 / hyperlink-91
                               :ARG3 (z16 / url-entity
                                          :value ""Table_2""))))",0.4210526315789473,0.4857142857142857,"(s / show-01
    :ARG0 (r / relationship
        :ARG1 (m / mutation
            :ARG1-of (k / KRAS))
        :ARG2 (f / factor
            :mod (c / clinicopathological))
        :mod (e / expression
            :ARG1-of (p / p-ERK1/2)))
    :ARG1 (t / table
        :ARG1-of (s2 / show-01
            :ARG0 (r2 / relationship
                :ARG1 (m2 / mutation
                    :ARG1-of (b / BRAF)))
            :ARG2 (f2 / factor
                :mod (c2 / clinicopathological))
            :mod (e2 / expression
                :ARG1-of (p2 / p-ERK1/2))))","(r / represent-01
    :ARG1 (r2 / relationship
        :ARG1 (m / mutate-01
            :ARG1 (g / gene
                :name (n / name :op1 ""KRAS"" :op2 ""BRAF"")))
        :ARG2 (f / factor
            :mod (c / clinicopathological)
            :include (e / express-01
                :ARG1 (p / protein
                    :name (n2 / name :op1 ""p-ERK1/2"")))))
    :location (t / table
        :name (n3 / name :op1 ""Table"" :op2 ""2"")))",-1.0,0.3636363636363636
pmid_1901_8267.138,"The results in <xref ref-type=""table"" rid=""tbl2"">Table 2</xref> show that <i>KRAS/BRAF</i> mutation is correlated significantly with FIGO stage I, II (<i>P</i><0.001), and p-ERK1/2 (<i>P</i><0.001).","(s / show-01
    :ARG0 (t3 / thing
        :ARG2-of (r / result-01
            :location (t / table)))
    :ARG1 (c2 / correlate-01
        :ARG1 (m / mutate-01
            :ARG1 (c / continent
                :name (n / name)))
        :ARG1-of (s2 / significant-02)
        :ARG2 (a2 / and
            :op1 (s3 / stage
                :mod I)
            :op2 (s5 / stage
                :mod (a / II)
                :mod (e / enzyme
                    :name (n3 / name
                        :op1 ""idiot""
                        :op1 ""RNA""))
                :mod (p / protein
                    :name (n4 / name)))
            :op2 ""1/2""
            :value 0.001))
    :rel (t2 / table
        :mod 2)
    :rel (n2 / name
        :op1 ""FIGO"")
    :rel (s4 / stage))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (t2 / thing
            :ARG2-of (r / result-01
                  :location (t / table :mod 2)))
      :ARG1 (a / and
            :op1 (c / correlate-01
                  :ARG1 (m / mutate-01
                        :ARG1 (s5 / slash
                              :op1 (g / gene :name (n / name :op1 ""KRAS""))
                              :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
                  :ARG2 (a3 / and
                        :op1 (s3 / stage :mod ""I"")
                        :op2 (s4 / stage :mod ""II"")
                        :mod (o / organization :name (n3 / name :op1 ""FIGO"")))
                  :ARG1-of (s6 / statistical-test-91
                        :ARG2 (l / less-than :op1 0.001)))
            :op2 (c2 / correlate-01
                  :ARG1 m
                  :ARG2 (e / enzyme :name (n4 / name :op1 ""ERK1/2"")
                        :ARG3-of (p2 / phosphorylate-01))
                  :ARG1-of (s7 / statistical-test-91
                        :ARG2 l))
            :ARG1-of (s2 / significant-02)))","The results in <xref ref-type=""table"" rid=""tbl2"">Table 2</xref> show that <i>KRAS/BRAF</i> mutation is correlated significantly with FIGO stage I, II (<i>P</i><0.001), and p-ERK1/2 (<i>P</i><0.001).","(z1 / show-01
    :ARG0 (z2 / thing
              :ARG2-of (z3 / result-01
                           :ARG1 (z4 / table
                                     :mod 2
                                     :ARG1-of (z5 / hyperlink-91
                                                  :ARG3 (z6 / url-entity
                                                            :value ""Table"")))))
    :ARG1 (z7 / correlate-01
              :ARG1 (z8 / mutate-01
                        :ARG2 (z9 / slash
                                  :op1 (z10 / enzyme
                                            :wiki ""BRAF_(g3000 / gene)""
                                            :name (z11 / name
                                                       :op1 ""KRAS/BRAF""))
                                  :op2 (z12 / enzyme
                                            :wiki ""BRAF_(g3001 / gene)""
                                            :name (z13 / name
                                                       :op1 ""p-ERK1/2""))))
              :ARG2 (z14 / and
                         :op1 (z15 / stage
                                   :mod (z16 / organization
                                             :wiki ""Fibroblast_growth_factor_receptor""
                                             :name (z17 / name
                                                        :op1 ""FIGO""))
                                   :mod (z18 / stage
                                             :mod (z19 / value-interval
                                                       :op1 1
                                                       :op2 2)))
                         :op2 (z20 / stage
                                   :mod z16
                                   :mod z18
                                   :mod (z21 / value-interval
                                             :op1 ""0.001""
                                             :op2 ""0.001""))))
    :ARG1-of (z22 / significant-02))",0.4035087719298245,0.4313725490196078,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (r / result
                  :mod (t / table
                        :xref (x / xref
                              :ref-type ""table""
                              :rid ""tbl2""
                              :op1 ""Table 2"")))
            :ARG2 (c / correlate-01
                  :ARG1 (m2 / mutation
                        :mod (k / KRAS/BRAF))
                  :ARG2 (s2 / stage
                        :mod (f / FIGO)
                        :mod (i / I))
                  :ARG2 (s3 / stage
                        :mod (f2 / FIGO)
                        :mod (i2 / II))
                  :ARG2 (p / p-ERK1/2))
            :ARG3 (s4 / significantly)
            :ARG4 (p2 / P
                  :op1 0.001))
        :snt2 (n / name
            :op1 ""The results""))","(s / show-01
    :ARG0 (r / result
        :location (t / table :name (n / name :op1 ""2"")))
    :ARG1 (c / correlate-01
        :ARG1 (m / mutate-01
            :ARG0 (g / gene :name (n2 / name :op1 ""KRAS"" :op2 ""/"" :op3 ""BRAF"")))
        :ARG2 (s2 / stage-01
            :ARG1 (d / disease :wiki ""Cancer"" :name (n3 / name :op1 ""FIGO""))
            :mod (i / include-91
                :ARG1 (s3 / stage :name (n4 / name :op1 ""I""))
                :ARG2 (s4 / stage :name (n5 / name :op1 ""II""))))
        :ARG3 (p / protein :name (n6 / name :op1 ""p-ERK1/2""))
        :degree (s5 / significant)
        :mod (a / and))
    :condition (l / less-than
        :ARG1 (v / value :quant 0.001)
        :ARG2 (p2 / probability)))",-1.0,0.3893805309734512
pmid_1901_8267.139,"In addition, there were significant correlations between <i>KRAS/BRA</i>F mutations and pathological grade (<i>P</i>=0.004), and histological subtype (<i>P</i>=0.014).","(a / and
    :op2 (c2 / correlate-01
        :ARG1 (m2 / mutate-01
            :ARG1 (m / manner
                :name (n / name
                    :op1 ""other"")))
        :ARG1-of (s2 / significant-02)
        :ARG2 (g / grade
            :ARG1-of (c / cause-01
                :ARG0 m)
            :mod (p / pathology))
        :ARG3 (s3 / subtype
            :mod (h / history))
        :mod (s / score-entity
            :ARG1-of (h2 / hyperlink-91
                :ARG2 0.004)
            :value 0.004))
    :rel 0.014)
",test,bio_amr0.8,"(a / and
      :op2 (a2 / and
            :op1 (c / correlate-01
                  :ARG1 (m / mutate-01
                        :ARG1 (s3 / slash
                              :op1 (g / gene :name (n / name :op1 ""KRAS""))
                              :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
                  :ARG2 (g3 / grade
                        :mod (p / pathology))
                  :ARG1-of (s4 / statistical-test-91
                        :ARG2 0.004))
            :op2 (c2 / correlate-01
                  :ARG1 m
                  :ARG2 (s2 / subtype
                        :mod (h / histology))
                  :ARG1-of (s5 / statistical-test-91
                        :ARG2 0.014))
            :ARG1-of (s / significant-02)))","In addition, there were significant correlations between <i>KRAS/BRA</i>F mutations and pathological grade (<i>P</i>=0.004), and histological subtype (<i>P</i>=0.014).","(z1 / correlate-01
    :ARG1 (z2 / mutate-01
              :ARG2 (z3 / enzyme
                        :wiki ""Fibroblast_growth_factor_receptor""
                        :name (z4 / name
                                  :op1 ""KRAS/BRA"")))
    :ARG2 (z5 / and
              :op1 (z6 / grade
                       :mod (z7 / pathology)
                       :ARG1-of (z8 / statistical-test-91
                                    :ARG2 ""0.004""))
              :op2 (z9 / subtype
                       :mod (z10 / histology)
                       :ARG1-of (z11 / statistical-test-91
                                     :ARG2 ""0.014"")))
    :ARG1-of (z12 / significant-02))",0.4776119402985074,0.4,"(m / multi-sentence
        :snt1 (c / correlate-01
            :ARG1 (m2 / mutation
                  :ARG0 (k / kras/bra))
            :ARG2 (g / grade
                  :mod (p / pathological))
            :degree (s / significant)
            :ARG3 (p2 / p=0.004))
        :snt2 (c2 / correlate-01
            :ARG1 m2
            :ARG2 (s2 / subtype
                  :mod (h / histological))
            :degree s
            :ARG3 (p3 / p=0.014)))","(c / correlate-01
    :ARG1 (m / mutate-01
        :ARG1 (g / gene
            :name (n / name :op1 ""KRAS"" :op2 ""BRAF"")))
    :ARG2 (g2 / grade-01
        :mod (p / pathological)
        :ARG1-of (s / significant-02))
    :ARG3 (s2 / subtype
        :mod (h / histological)
        :ARG1-of (s3 / significant-02))
    :time (t / there)
    :location (a / addition)
    :mod (w / were)
    :ARG1-of (e / equal-01
        :ARG2 (n2 / number :value 0.004))
    :ARG2-of (e2 / equal-01
        :ARG2 (n3 / number :value 0.014)))",-1.0,0.3116883116883117
pmid_1901_8267.140,"<sec-title level=""2"">Effect of <i>KRAS/BRAF</i> mutations or p-ERK1/2 on the prognosis of ovarian carcinomas</sec-title>","(a / affect-01
    :li 2
    :ARG0 (o / or
        :op1 (m / mutate-01
            :ARG2 (e / enzyme
                :name (n / name)))
        :op3 (p2 / protein
            :name (n2 / name)
            :mod ""1/2""))
    :ARG1 (p / prognosis
        :mod (c / cancer
            :location (o2 / ovary))))
",test,bio_amr0.8,"(a / affect-01
      :ARG0 (o / or
            :op1 (m / mutate-01
                  :ARG1 (s / slash
                        :op1 (g / gene :name (n / name :op1 ""KRAS""))
                        :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
            :op2 (e / enzyme :name (n3 / name :op1 ""ERK1/2"")
                  :ARG3-of (p2 / phosphorylate-01)))
      :ARG1 (p / prognosis
            :mod (c / carcinoma
                  :mod (o2 / ovary))))","<sec-title level=""2"">Effect of <i>KRAS/BRAF</i> mutations or p-ERK1/2 on the prognosis of ovarian carcinomas</sec-title>","(z1 / affect-01
    :ARG0 (z2 / mutate-01
              :ARG1 (z3 / enzyme
                        :wiki ""BRAF_(g3000 / gene)""
                        :name (z4 / name
                                  :op1 ""KRAS/BRAF"")))
    :ARG1 (z5 / prognosis
              :poss (z6 / tumor
                        :wiki ""Cancer""
                        :name (z7 / name
                                  :op1 ""ovarian""
                                  :op2 ""carcinomas""))))",0.28,0.5384615384615384,"(e / effect
    :domain (m / mutation
        :ARG0 (k / kras/braf)
        :mod (o / or
            :op1 (p / phosphorylate-01
                :ARG1 (e2 / erk1/2)))
        :ARG1 (p2 / prognosis
            :mod (c / carcinoma
                :mod (o2 / ovarian)))))","(e / effect-01
    :ARG1 (m / mutate-01
        :ARG1 (g / gene
            :name (n / name :op1 ""KRAS"" :op2 ""/"" :op3 ""BRAF"")))
    :ARG2 (p / prognose-01
        :ARG1 (c / carcinoma
            :location (o / organ
                :name (n2 / name :op1 ""ovary"")))
        :ARG1-of (h / have-03
            :ARG2 (p2 / protein
                :name (n3 / name :op1 ""p-ERK1/2""))))
    :mod (t / title
        :level 2))",-1.0,0.3278688524590163
pmid_1901_8267.141,"Next, we examined the prognostic effect of <i>KRAS/BRAF</i> mutations and p-ERK1/2 expression.","(e / examine-01
    :ARG0 (w / we)
    :ARG1 (a / affect-01
        :ARG0 (a2 / and
            :op1 (m / mutate-01
                :ARG1 (l / language
                    :name (n / name
                        :op1 ""i""))
                :mode expressive)
            :op2 (e2 / express-03
                :ARG2 ""1/2""))
        :ARG2 (p / predict-01))
    :rel (l2 / location
        :name (n2 / name
            :mod ""executive""
            :op2 ""he""))
    :time (n3 / next))
",test,bio_amr0.8,"(e / examine-01
      :ARG0 (w / we)
      :ARG1 (a / affect-01
            :ARG0 (a2 / and
                  :op1 (m / mutate-01
                        :ARG1 (s / slash
                              :op1 (g / gene :name (n / name :op1 ""KRAS""))
                              :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
                  :op2 (e2 / express-03
                        :ARG2 (e3 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                              :ARG3-of (p2 / phosphorylate-01))))
            :mod (p / prognostic))
      :time (n4 / next))","Next, we examined the prognostic effect of <i>KRAS/BRAF</i> mutations and p-ERK1/2 expression.","(z1 / examine-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / affect-01
              :ARG0 (z4 / and
                        :op1 (z5 / mutate-01
                                 :ARG1 (z6 / enzyme
                                           :wiki ""BRAF_(g3000 / gene)""
                                           :name (z7 / name
                                                     :op1 ""KRAS/BRAF"")))
                        :op2 (z8 / express-02
                                 :ARG1 (z9 / enzyme
                                           :wiki ""P-ERK1/2""
                                           :name (z10 / name
                                                      :op1 ""p-ERK1/2""
                                                      :op2 ""expression""))))
              :ARG1 (z11 / prognostic-01))
    :time (z12 / next))",0.46875,0.5079365079365079,"(e / examine-01
    :ARG0 (w / we)
    :ARG1 (e2 / effect-01
        :ARG1 (p / prognostic
            :mod (e3 / expression
                :ARG1 (a / and
                    :op1 (m / mutation
                        :ARG1 (k / KRAS/BRAF))
                    :op2 (e4 / expression
                        :ARG1 (p2 / phosphorylate-01
                            :ARG1 (e5 / ERK1/2)))))))","(e / examine-01
    :ARG0 (w / we)
    :ARG1 (e2 / effect-01
        :ARG1-of (p / prognostic-01)
        :ARG2 (m / mutation
            :ARG1 (g / gene
                :name (n / name :op1 ""KRAS"" :op2 ""/"" :op3 ""BRAF""))))
    :ARG2 (e3 / express-01
        :ARG1 (p2 / protein
            :name (n2 / name :op1 ""p-ERK1/2""))))
    :time (n3 / next))",-1.0,-1.0
pmid_1901_8267.144,"There was no significant relationship between <i>KRAS/BRAF</i> mutations or p-ERK1/2 expression and overall survival in patients with ovarian carcinoma (<i>P</i>=0.2460, <i>P</i>=0.9339, respectively).","(r / relation-03
    :ARG0 (o / or
        :op1 (m / mutate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op2 ""near""))
            :mod (g / generation
                :value 0.2460))
        :op2 (e2 / express-03
            :ARG2 (p2 / protein
                :name (n2 / name
                    :op1 ""1/2"")))
        :op3 (s2 / survive-01
            :ARG1 (p / patient
                :ARG0-of (h / have-03
                    :ARG1 (d / disease
                        :name (n3 / name
                            :op1 ""ovarian""
                            :op2 ""carcinoma""))))
            :mod (o2 / overall)))
    :ARG1-of (s / significant-02)
    :polarity -
    :rel (h2 / hyperlink-91
        :ARG2 (n4 / number
            :quant-of h2))
    :rel 0.9339)
",test,bio_amr0.8,"(r / relation-03 :polarity -
      :ARG0 (o4 / or
            :op1 (m / mutate-01
                  :ARG1 (s3 / slash
                        :op1 (g / gene :name (n / name :op1 ""KRAS""))
                        :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
            :op2 (e / express-03
                  :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                        :ARG3-of (p / phosphorylate-01)))
            :mod (r2 / respective)
            :ARG1-of (s4 / statistical-test-91
                  :ARG2 0.2460))
      :ARG2 (s2 / survive-01
            :ARG0 (p5 / person
                  :ARG0-of (h / have-rel-role-91
                        :ARG2 (p2 / patient))
                  :ARG0-of (h2 / have-03
                        :ARG1 (c / carcinoma
                              :mod (o3 / ovary))))
            :mod (o2 / overall)
            :ARG1-of (s5 / statistical-test-91
                  :ARG2 0.9339))
      :ARG1-of (s / significant-02))","There was no significant relationship between <i>KRAS/BRAF</i> mutations or p-ERK1/2 expression and overall survival in patients with ovarian carcinoma (<i>P</i>=0.2460, <i>P</i>=0.9339, respectively).","(z1 / relation-03
    :polarity -
    :ARG1 (z2 / or
              :op1 (z3 / mutate-01
                       :ARG1 (z4 / slash
                                 :op1 (z5 / enzyme
                                          :wiki ""BRAF_(g3000 / gene)""
                                          :name (z6 / name
                                                    :op1 ""KRAS/BRAF""))
                                 :op2 (z7 / express-03
                                          :ARG1 (z8 / enzyme
                                                    :wiki ""P-ERK1/2""
                                                    :name (z9 / name
                                                              :op1 ""p-ERK1/2"")))))
              :op2 (z10 / survive-01
                        :ARG0 (z11 / patient
                                   :ARG0-of (z12 / have-03
                                                 :ARG1 (z13 / disease
                                                            :wiki ""Cancer""
                                                            :name (z14 / name
                                                                       :op1 ""ovarian""
                                                                       :op2 ""carcinoma""))))
                        :ARG1-of (z15 / mean-01
                                      :ARG2 (z16 / and
                                                 :op1 (z17 / statistical-test-91
                                                           :ARG2 ""0.2460""
                                                           :ARG3 ""0.2460"")
                                                 :op2 ""0.9339""
                                                 :ARG3 ""0.2460""))
                        :mod (z18 / overall)))
    :ARG2 (z19 / survive-01
               :ARG0 z11
               :mod z18)
    :ARG1-of (z20 / significant-02))",0.4444444444444444,0.4081632653061224,"(s / sentence
        :topic (r / relationship
                :ARG1 (m / mutation
                        :ARG0 (k / KRAS/BRAF))
                :ARG2 (e / expression
                        :ARG0 (p / protein
                                :ARG0-of (e2 / express-01
                                        :ARG1 (p2 / phosphorylated
                                                :ARG0 (e3 / ERK1/2))))
                        :mod (s2 / significant))
                :ARG3 (s3 / survival
                        :ARG1 (p3 / patient
                                :mod (o / ovarian)
                                :ARG1-of (c / carcinoma)))
                :mod (o2 / overall))
        :condition (p / probability-01
                :ARG1 (e4 / equal
                        :ARG1 (n / number
                                :quant 0))
                :ARG2 (n2 / number
                        :quant (s4 / significant))
                :ARG3 (n3 / number
                        :quant (r2 / respectively))))","(r / relate-01
    :ARG1 (m / mutate-01
        :ARG1 (g / gene
            :name (n / name :op1 ""KRAS"" :op2 ""/"" :op3 ""BRAF""))
        :ARG2 (e / express-01
            :ARG1 (p / protein
                :name (n2 / name :op1 ""p-ERK1/2""))))
    :ARG2 (s / survive-01
        :ARG1 (p2 / patient
            :ARG1-of (h / have-03
                :ARG2 (c / carcinoma
                    :mod (o / organ
                        :name (n3 / name :op1 ""ovary""))))))
    :degree (n4 / negate-01)
    :mod (s2 / significant)
    :time (t / temporal-quantity :quant 0.2460)
    :time (t2 / temporal-quantity :quant 0.9339))",-1.0,0.2736842105263158
pmid_1901_8267.145,"Univariate analysis showed that only FIGO stage III, IV affected the overall survival of patients with ovarian carcinoma significantly(<i>P</i>=0.014).","(s / show-01
    :ARG0 (a2 / analyze-01
        :manner (v / variable))
    :ARG1 (a / affect-01
        :ARG0 (a3 / and
            :op1 (s3 / stage
                :mod (o / only))
            :op2 (s4 / stage
                :mod s3
                :mod 3
                :mod 4))
        :ARG1 (s6 / survive-01
            :ARG0 (p / patient
                :ARG0-of (h / have-03
                    :ARG1 (d / disease
                        :name (n2 / name
                            :op1 ""ovarian""
                            :op2 ""carcinoma""))))
            :mod (o2 / overall))
        :ARG1-of (s2 / significant-02))
    :ARG1-of (s5 / statistical-test-91
        :ARG2 0.014)
    :rel (n / name
        :op1 ""FIGO""))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (a / analyze-01
            :mod (u / univariate))
      :ARG1 (a2 / affect-01
            :ARG0 (a3 / and
                  :op1 (s2 / stage :mod ""III"")
                  :op2 (s3 / stage :mod ""IV"")
                  :mod (o / organization :name (n / name :op1 ""FIGO""))
                  :mod (o4 / only))
            :ARG1 (s4 / survive-01
                  :ARG0 (p3 / person
                        :ARG0-of (h2 / have-rel-role-91
                              :ARG2 (p / patient))
                        :ARG0-of (h / have-03
                              :ARG1 (c / carcinoma
                                    :mod (o3 / ovary))))
                  :mod (o2 / overall))
            :ARG1-of (s5 / significant-02)
            :ARG1-of (s6 / statistical-test-91
                  :ARG2 0.014)))","Univariate analysis showed that only FIGO stage III, IV affected the overall survival of patients with ovarian carcinoma significantly(<i>P</i>=0.014).","(z1 / show-01
    :ARG0 (z2 / analyze-01
              :manner (z3 / variable
                          :polarity -))
    :ARG1 (z4 / affect-01
              :ARG0 (z5 / and
                        :op1 (z6 / stage
                                 :mod 3
                                 :part-of (z7 / disease
                                              :wiki ""Fibrocystic_ovary_cancer""
                                              :name (z8 / name
                                                        :op1 ""FIGO"")))
                        :op2 (z9 / stage
                                 :mod 4
                                 :part-of z7)
                        :mod (z10 / only))
              :ARG1 (z11 / survive-01
                         :ARG0 (z12 / patient
                                    :ARG0-of (z13 / have-03
                                                  :ARG1 (z14 / disease
                                                             :wiki ""Ovary_carcinoma""
                                                             :name (z15 / name
                                                                        :op1 ""ovarian""
                                                                        :op2 ""carcinoma""))))
                         :mod (z16 / overall))
              :ARG1-of (z17 / significant-02)))",0.5783132530120483,0.5925925925925927,"(a / analysis
        :ARG0 (s / show-01
              :ARG1 (o / only)
              :ARG2 (s2 / stage
                    :mod (f / FIGO)
                    :mod (i / III)
                    :mod (i2 / IV)))
        :ARG1 (a2 / affect-01
              :ARG1 (s3 / survival
                    :mod (o2 / overall))
              :ARG2 (p / patient
                    :mod (c / carcinoma
                          :mod (o3 / ovarian))))
        :ARG3 (s4 / significantly
              :degree (p2 / positive-01
                    :ARG1 (e / equal
                          :op1 (n / number :op1 0.014)
                          :op2 (i2 / i)))))","(a / affect-01
    :ARG0 (s / stage
        :mod (f / FIGO)
        :degree (o / or
            :op1 (n / number :value 3)
            :op2 (n2 / number :value 4)))
    :ARG1 (s2 / survive-01
        :ARG1 (p / patient
            :ARG0-of (h / have-03
                :ARG1 (c / carcinoma
                    :mod (o2 / organ
                        :name (n3 / name :op1 ""ovary""))))))
    :ARG2 (a2 / analysis
        :mod (u / univariate)
        :ARG1-of (s3 / show-01))
    :degree (s4 / significant
        :mod (p2 / probability
            :value 0.014)))",-1.0,0.325
pmid_1901_8267.146,"<sec-title level=""2"">Effects of ERK1/2 inactivation on ovarian carcinoma <i>in vitro</i></sec-title>","(a2 / affect-01
    :ARG0 (a / activate-01
        :li 2
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""ERK""
                :op2 ""1/2"")))
    :ARG1 (d / disease
        :name (n2 / name
            :op1 ""carcinoma"")
        :mod (o / ovary))
    :mod (i / in-vitro))
",test,bio_amr0.8,"(a / affect-01
      :ARG0 (a2 / activate-01 :polarity -
            :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2"")))
      :ARG1 (c / carcinoma
            :mod (o / ovary))
      :manner (i / in-vitro))","<sec-title level=""2"">Effects of ERK1/2 inactivation on ovarian carcinoma <i>in vitro</i></sec-title>","(z1 / affect-01
    :ARG0 (z2 / activate-01
              :ARG1 (z3 / enzyme
                        :wiki ""ERK1/2""
                        :name (z4 / name
                                  :op1 ""ERK1/2"")))
    :ARG1 (z5 / carcinoma
              :mod (z6 / ovary)
              :mod (z7 / in-vitro)))",0.6875,0.5,"(e / effect-01
    :ARG1 (i / inactivation
        :ARG0 (e2 / ERK1/2))
    :ARG2 (c / carcinoma
        :mod (o / ovarian)
        :mod (i2 / in-vitro)))","(e / effect
    :ARG1 (i / inactivate-01
        :ARG1 (p / protein
            :name (n / name
                :op1 ""ERK1""
                :op2 ""/""
                :op3 ""2"")))
    :ARG2 (c / carcinoma
        :location (o / organ
            :name (n2 / name :op1 ""ovary"")))
    :location (v / vitro)
    :mod (t / title
        :level 2))",-1.0,0.2051282051282051
pmid_1901_8267.148,"Mutational status was correlated with growth inhibition and apoptosis induction by the MEK inhibitor CI-1040 that prevented activation of the downstream target, ERK1/2.","(c / correlate-01
    :ARG1 (s / status
        :mod (g / gene))
    :ARG2 (a2 / and
        :op1 (i2 / inhibit-01
            :ARG1 (g2 / grow-01))
        :op2 (i / induce-01
            :ARG2 (a3 / apoptosis)))
    :rel (i3 / inhibit-01
        :ARG0-of (p / prevent-01
            :ARG1 (a / activate-01
                :ARG1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""MEK""
                        :op1 ""ERK""
                        :op2 ""1/2"")
                    :ARG1-of (t / target-01
                        :mod (d / downstream)))))
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""i""
                :op2 1040)
            :name n2)))
",test,bio_amr0.8,"(c / correlate-01
      :ARG0 (s2 / small-molecule :name (n2 / name :op1 ""CI-1040"")
            :ARG0-of (i / inhibit-01
                  :ARG1 (p2 / protein-family :name (n / name :op1 ""MEK"")))
            :ARG0-of (p / prevent-01
                  :ARG1 (a3 / activate-01
                        :ARG1 (t2 / target
                              :ARG1-of (m2 / mean-01
                                    :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")))
                              :location (d / downstream)))))
      :ARG1 (s / status
            :mod (m / mutate-01))
      :ARG2 (a / and
            :op1 (i2 / inhibit-01
                  :ARG1 (g / grow-01))
            :op2 (i3 / induce-01
                  :ARG2 (a2 / apoptosis))))","Mutational status was correlated with growth inhibition and apoptosis induction by the MEK inhibitor CI-1040 that prevented activation of the downstream target, ERK1/2.","(z1 / correlate-01
    :ARG1 (z2 / status
              :mod (z3 / mutational))
    :ARG2 (z4 / and
              :op1 (z5 / inhibit-01
                       :ARG0 (z6 / inhibitor
                                 :wiki ""C-1040""
                                 :name (z7 / name
                                           :op1 ""CI-1040"")
                                 :ARG0-of (z8 / prevent-01
                                              :ARG1 (z9 / activate-01
                                                        :ARG1 (z10 / enzyme
                                                                   :wiki ""ERK1/2""
                                                                   :name (z11 / name
                                                                              :op1 ""ERK1/2"")
                                                                   :ARG1-of (z12 / target-01
                                                                                 :mod (z13 / downstream))))))
                       :ARG1 (z14 / grow-01))
              :op2 (z15 / induce-01
                        :ARG0 z6
                        :ARG2 (z16 / apoptose-01))))",0.6,0.6024096385542168,"(m / mutational-status
        :ARG1 (c / correlate-01
              :ARG1 (s / status
                    :ARG1-of (w / was)
                    :ARG2 (g / growth-inhibition
                          :ARG1-of (a / and
                                :op1 (i / induce-01
                                      :ARG1 (a2 / apoptosis)
                                      :ARG2 (i2 / inhibit-01
                                            :ARG1 (m2 / MEK-inhibitor
                                                  :ARG1-of (p / prevent-01
                                                        :ARG1 (a3 / activation)
                                                        :ARG2 (t / target
                                                              :mod (d / downstream)
                                                              :ARG1-of (e / ERK1/2))))))))))","(m / multi-sentence
    :snt1 (c / correlate-01
        :ARG1 (s / status
            :mod (m / mutation))
        :ARG2 (a / and
            :op1 (i / inhibit-01
                :ARG1 (g / grow-01))
            :op2 (i2 / induce-01
                :ARG1 (a2 / apoptosis))))
    :snt2 (p / prevent-01
        :ARG0 (t / thing
            :name (n / name :op1 ""CI-1040"")
            :mod (i3 / inhibitor
                :mod (m2 / MEK)))
        :ARG1 (a3 / activate-01
            :ARG1 (t2 / target
                :mod (d / downstream)
                :name (n2 / name :op1 ""ERK1/2"")))))",-1.0,-1.0
pmid_1901_8267.149,"Western blot analysis showed a dose-dependent effect on the expression of active ERK1/2 in ES2 cells, and active ERK1/2 was not detectable 6 h after treating the cells with CI-1040 at a concentration of 5 <i>μ</i><sc>M</sc> (<xref ref-type=""fig"" rid=""fig4"">Figure 4</xref>).","(a5 / and
    :op1 (s / show-01
        :ARG0 (a4 / analyze-01
            :manner (b / blot
                :mod (w / world-region
                    :name (n / name
                        :op1 ""West""))))
        :ARG1 (a2 / affect-01
            :ARG1 (e2 / express-03
                :ARG1 (e / enzyme
                    :name (n2 / name
                        :op1 ""ERK""
                        :op2 ""1/2"")
                    :ARG0-of (a / activity-06))
                :location (c / cell
                    :name (n3 / name
                        :op1 ""ES2"")))
            :ARG1-of (d / depend-01
                :ARG0 (d3 / dose-01))))
    :op2 (p / possible-01
        :ARG1 (d2 / detect-01
            :quant (c3 / concentration-quantity
                :quant 6
                :unit (h / hour))
            :ARG1 e
            :time (a3 / after
                :op1 (t / treat-03
                    :ARG1 c
                    :ARG1-of (c2 / concentrate-02)
                    :ARG2 (s2 / small-molecule
                        :name (n4 / name
                            :op1 40)))))
        :polarity -)
    :op3 (f / figure
        :mod 4)
    :rel 5)
",test,bio_amr0.8,"(a / and
      :op1 (s / show-01
            :ARG0 (a2 / analyze-01
                  :manner (i / immunoblot-01))
            :ARG1 (a3 / affect-01
                  :ARG1 (e / express-03
                        :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                              :ARG1-of (a4 / activate-01)
                              :location (c / cell-line :name (n4 / name :op1 ""ES2""))))
                  :ARG0-of (d / depend-01
                        :ARG1 (d2 / dose))))
      :op2 (p / possible-01 :polarity -
            :ARG1 (d3 / detect-01
                  :ARG1 e2
                  :time (a5 / after
                        :op1 (t3 / treat-04
                              :ARG1 c
                              :ARG2 (s2 / small-molecule :name (n5 / name :op1 ""CI-1040"")
                                    :quant (c3 / concentration-quantity :quant 5
                                          :unit (m / micromolar))))
                        :quant (t2 / temporal-quantity :quant 6
                              :unit (h / hour)))))
      :ARG1-of (d4 / describe-01
            :ARG0 (f / figure :mod 4)))","Western blot analysis showed a dose-dependent effect on the expression of active ERK1/2 in ES2 cells, and active ERK1/2 was not detectable 6 h after treating the cells with CI-1040 at a concentration of 5 <i>μ</i><sc>M</sc> (<xref ref-type=""fig"" rid=""fig4"">Figure 4</xref>).","(z1 / and
    :op1 (z2 / show-01
             :ARG0 (z3 / analyze-01
                       :ARG1 (z4 / blot
                                 :mod (z5 / world-region
                                          :wiki ""Western_world""
                                          :name (z6 / name
                                                    :op1 ""West""))))
             :ARG1 (z7 / affect-01
                       :ARG0 (z8 / enzyme
                                 :wiki ""Erythropoietin""
                                 :name (z9 / name
                                           :op1 ""ERK1/2"")
                                 :ARG0-of (z10 / activity-06))
                       :ARG1 (z11 / express-03
                                  :ARG1 z8
                                  :location (z12 / cell
                                                 :wiki ""Escherichia_coli""
                                                 :name (z13 / name
                                                            :op1 ""ES2""))))
             :ARG0-of (z14 / depend-01
                           :ARG1 (z15 / dose))))",0.3789473684210526,0.4915254237288135,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (a / analysis
                  :ARG1 (b / blot
                        :mod (w / western))
                  :ARG2 (e / effect-01
                        :ARG1 (d / dose-dependent)
                        :ARG2 (e2 / expression
                              :ARG1 (a2 / active
                                    :ARG1 (e3 / ERK1/2))))
                  :ARG3 (c / cell
                        :mod (e4 / ES2))))
        :snt2 (d / detect-01
            :ARG1 (a3 / active
                  :ARG1 (e5 / ERK1/2))
            :ARG2 (t / treat-01
                  :ARG1 (c2 / cell)
                  :ARG2 (c3 / CI-1040)
                  :ARG3 (c4 / concentration
                        :quant (n / number :op1 5)
                        :unit (m2 / micro)
                        :unit (m3 / M)))
            :time (a4 / after
                  :op1 (t2 / treat-01)
                  :op2 (n2 / number :op1 6)
                  :unit (h / hour))
            :polarity (n3 / not))
        :snt3 (r / refer
            :ARG1 (f / figure
                  :ARG1-of (x / xref
                        :ref-type ""fig""
                        :rid ""fig4"")
                  :op1 ""Figure 4"")))","(s / show-01
    :ARG0 (a / analyze-01
        :ARG0 (w / western-blot)
        :ARG1 (e / effect
            :mod (d / depend-01
                :ARG1 (d2 / dose))
            :ARG1-of (e2 / express-01
                :ARG1 (e3 / ERK1/2
                    :mod (a2 / active))
                :ARG2 (c / cell
                    :name (n / name :op1 ""ES2""))))))
    :ARG1 (a3 / and
        :op1 (d3 / detect-01
            :ARG1 e3
            :ARG2 c
            :time (a4 / after
                :op1 (t / treat-01
                    :ARG0 (t2 / time
                        :quant 6
                        :unit (h / hour))
                    :ARG1 c
                    :ARG2 (c2 / CI-1040))
                :op2 (c3 / concentrate-01
                    :ARG1 c2
                    :ARG2 (m / measure-01
                        :ARG1 (n2 / number :value 5)
                        :ARG2 (u / unit :name (n3 / name :op1 ""μM""))))))
        :op2 (r / refer-01
            :ARG1 (f / figure
                :name (n4 / name :op1 ""4"")))))",-1.0,-1.0
pmid_1901_8267.152,It is likely that <i>KRAS/BRAF</i> mutation is not the only determinant for activating ERK1/2.,"(l2 / likely-01
    :ARG1 (d / determine-01
        :ARG0 (m / mutate-01
            :mod (l / language
                :name (n / name
                    :op1 ""atom""
                    :op2 ""BRAF"")))
        :ARG1 (a / activate-01
            :ARG1 (e / enzyme
                :name (n2 / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :mod (o / only
            :polarity -)))
",test,bio_amr0.8,"(l / likely-01
      :ARG1 (d / determine-01 :polarity -
            :ARG0 (m / mutate-01
                  :ARG1 (s / slash
                        :op1 (g / gene :name (n / name :op1 ""KRAS""))
                        :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
            :ARG1 (a / activate-01
                  :ARG1 (e / enzyme :name (n3 / name :op1 ""ERK1/2"")))
            :mod (o / only)))",It is likely that <i>KRAS/BRAF</i> mutation is not the only determinant for activating ERK1/2.,"(z1 / likely-01
    :ARG1 (z2 / determine-01
              :ARG0 (z3 / mutate-01
                        :ARG1 (z4 / slash
                                  :op1 (z5 / enzyme
                                           :wiki ""BRAF_(g3000 / gene)""
                                           :name (z6 / name
                                                     :op1 ""KRAS/BRAF""))
                                  :op2 (z7 / enzyme
                                           :wiki ""BRAF_(g3001 / gene)""
                                           :name (z8 / name
                                                     :op1 ""ERK1/2""))))
              :ARG1 (z9 / activate-01
                        :ARG1 (z10 / enzyme
                                   :wiki ""ERK1/2""
                                   :name (z11 / name
                                              :op1 ""ERK1/2"")))
              :mod (z12 / only
                        :polarity -)))",0.5762711864406779,0.4313725490196078,"(s / sentence
        :snt (l / likely-01
              :ARG1 (m / mutation
                    :ARG0 (i / it)
                    :mod (d / determine-01
                          :ARG1 (a / activate-01
                                :ARG0 (e / ERK1/2))))))","(l / likely-01
    :ARG1 (m / mutate-01
        :ARG0 (g / gene
            :name (n / name :op1 ""KRAS/BRAF""))
        :ARG1 (g2 / gene
            :name (n2 / name :op1 ""ERK1/2""))
        :ARG2 (a / activate-01
            :ARG0 m
            :ARG1 g2)
        :mod (o / only :polarity -)
        :ARG1-of (d / determinant-01)))",-1.0,0.4705882352941176
pmid_1901_8267.153,"Therefore, we analysed p-ERK1/2 expression in each of the cell lines listed in <xref ref-type=""fig"" rid=""fig5"">Figure 5</xref>.","(c / cause-01
    :ARG1 (a / analyze-01
        :ARG0 (w / we)
        :ARG1 (e3 / express-03
            :ARG2 (e2 / enzyme
                :name (n / name
                    :op1 ""P""
                    :op2 ""1/2""))
            :location (l / line
                :ARG1-of (l2 / list-01
                    :ARG2 (f / figure
                        :mod 5))
                :mod (c2 / cell)
                :mod (e / each)))))
",test,bio_amr0.8,"(c / cause-01
      :ARG1 (a / analyze-01
            :ARG0 (w / we)
            :ARG1 (e / express-03
                  :ARG2 (e2 / enzyme :name (n / name :op1 ""ERK1/2"")
                        :ARG3-of (p / phosphorylate-01))
                  :ARG3 (c2 / cell-line
                        :mod (e3 / each)
                        :ARG1-of (l / list-01
                              :ARG2 (f / figure :mod 5))))))","Therefore, we analysed p-ERK1/2 expression in each of the cell lines listed in <xref ref-type=""fig"" rid=""fig5"">Figure 5</xref>.","(z1 / cause-01
    :ARG1 (z2 / analyze-01
              :ARG0 (z3 / we)
              :ARG1 (z4 / express-03
                        :ARG1 (z5 / enzyme
                                  :wiki ""P-ERK1/2""
                                  :name (z6 / name
                                            :op1 ""p-ERK1/2""
                                            :op2 ""expression""))
                        :location (z7 / line
                                      :mod (z8 / cell)
                                      :mod (z9 / each)
                                      :ARG1-of (z10 / list-01
                                                    :ARG2 (z11 / figure
                                                               :mod 5
                                                               :ARG1-of (z12 / hyperlink-91
                                                                             :ARG3 (z13 / url-entity
                                                                                        :value ""Figure""))))))))",0.5283018867924527,0.6382978723404256,"(m / multi-sentence
        :snt1 (a / analyse-01
            :ARG0 (w / we)
            :ARG1 (e / expression
                  :ARG0-of (a2 / analyse-01
                        :ARG1 (e2 / expression
                              :ARG0-of (p / phosphorylate-01
                                    :ARG1 (e3 / ERK1/2
                                          :mod (p2 / phosphorylate-01
                                                :ARG1 (c / cell-line
                                                      :mod (l / list-01
                                                            :ARG1 (c2 / cell-line
                                                                  :mod (f / figure
                                                                        :ARG1 (n / name :op1 ""Figure 5""))))))))))","(a / analyze-01
    :ARG0 (w / we)
    :ARG1 (e / express-01
        :ARG1 (p / protein
            :name (n / name :op1 ""p-ERK1/2"")))
    :ARG2 (c / cell-line
        :quant (e2 / each)
        :ARG1-of (l / list-01
            :location (f / figure
                :mod (n2 / name :op1 ""5"")
                :ARG1-of (r / refer-01
                    :ARG0 (x / xref
                        :mod (t / type :name (n3 / name :op1 ""fig""))
                        :mod (i / id :name (n4 / name :op1 ""fig5"")))))))
    :condition (t2 / therefore))",-1.0,0.3278688524590163
pmid_1901_8267.154,"Only four of these cell lines, MDAH2774, ES2, MPSC1, and POC1, strongly expressed p-ERK1/2.","(e / express-03
    :ARG1-of (s / strong-02)
    :ARG2 (a / and
        :op1 (l2 / line
            :name (n / name
                :op1 ""MDAH""
                :op2 2774)
            :mod (c / cell))
        :op2 l2
        :op3 (l3 / line
            :name (n2 / name
                :op1 ""ES2"")
            :mod (c2 / cell))
        :op4 (p3 / protein))
    :ARG2 ""1/2""
    :rel (l / line
        :quant 4
        :ARG1-of (i / include-91
            :ARG2 l2
            :ARG2 l3)
        :mod c2
        :mod (o / only)
        :mod (p / protein
            :name (n3 / name
                :op1 ""MPSC1""))
        :mod (p2 / protein
            :name (n4 / name
                :op1 ""POC1""
                :op1 ""P""))
        :mod p3)
    :rel (t / this))
",test,bio_amr0.8,"(e / express-03
      :ARG2 (e2 / enzyme :name (n5 / name :op1 ""ERK1/2"")
            :ARG3-of (p / phosphorylate-01))
      :ARG3 (c / cell-line :quant 4
            :mod (o / only)
            :ARG1-of (i / include-91
                  :ARG2 (c2 / cell-line
                        :mod (t / this)))
            :ARG1-of (m / mean-01
                  :ARG2 (a / and
                        :op1 (c3 / cell-line :name (n / name :op1 ""MDAH2774""))
                        :op2 (c4 / cell-line :name (n2 / name :op1 ""ES2""))
                        :op3 (c5 / cell-line :name (n3 / name :op1 ""MPSC1""))
                        :op4 (c6 / cell-line :name (n4 / name :op1 ""POC1"")))))
      :ARG1-of (s / strong-02))","Only four of these cell lines, MDAH2774, ES2, MPSC1, and POC1, strongly expressed p-ERK1/2.","(z1 / express-03
    :ARG0 (z2 / cell-line
              :quant 4
              :mod (z3 / only)
              :ARG1-of (z4 / include-91
                           :ARG2 (z5 / cell-line
                                     :mod (z6 / this)))
              :ARG2-of (z7 / include-91
                           :ARG1 (z8 / and
                                     :op1 (z9 / cell-line
                                              :wiki ""Mitogen-activated_protein_kinase_2774""
                                              :name (z10 / name
                                                         :op1 ""MDAH2774""))
                                     :op2 (z11 / cell-line
                                               :wiki ""Mitogen-activated_protein_kinase_2""
                                               :name (z12 / name
                                                          :op1 ""ES2""))
                                     :op3 (z13 / cell-line
                                               :wiki ""Mitogen-activated_protein_kinase_1""
                                               :name (z14 / name
                                                          :op1 ""MPSC1""))
                                     :op4 (z15 / cell-line
                                               :wiki ""PHLDA1""
                                               :name (z16 / name
                                                          :op1 ""POC1""))))))",0.5517241379310345,0.3578947368421052,"(s / sentence
        :snt (e / express-01
              :ARG1 (c / cell-line
                    :quant (f / four)
                    :mod (t / this))
              :ARG2 (p / protein
                    :ARG1 (e2 / express-01
                          :ARG1 (p2 / phosphorylate-01
                                :ARG1 (e3 / ERK1/2)
                                :ARG2 (c2 / cell-line
                                      :name (n / name :op1 ""MDAH2774"")))
                          :ARG2 (c3 / cell-line
                                :name (n2 / name :op1 ""ES2"")))
                    :ARG2 (c4 / cell-line
                          :name (n3 / name :op1 ""MPSC1""))
                    :ARG2 (c5 / cell-line
                          :name (n4 / name :op1 ""POC1"")))))","(o / only
    :quant (f / four)
    :ARG1 (l / line
        :mod (c / cell)
        :example (a / and
            :op1 (m / name :op1 ""MDAH2774"")
            :op2 (e / name :op1 ""ES2"")
            :op3 (mp / name :op1 ""MPSC1"")
            :op4 (p / name :op1 ""POC1""))
        :ARG1-of (e2 / express-01
            :degree (s / strong)
            :ARG2 (p2 / protein
                :name (n / name :op1 ""p-ERK1/2"")))))",-1.0,0.3636363636363636
pmid_1901_8267.155,SKOV3 and A2780 showed weak expression of ERK1/2.These results suggest that activation of ERK1/2 may depend on <i>KRAS/BRAF</i> mutation in ovarian cancer cells.,"(m / multi-sentence
    :rel (n / name
        :op1 ""SKOV3"")
    :rel (n4 / name)
    :snt1 (s / show-01
        :ARG0 (a2 / and
            :op2 (c2 / company
                :name (n2 / name
                    :op1 ""A""
                    :op2 2780)))
        :ARG1 (e3 / express-03
            :ARG1-of (w / weak-02)
            :ARG2 (e / enzyme
                :name (n3 / name
                    :op1 ""ERK""
                    :op2 ""1/2""))))
    :snt2 (s2 / suggest-01
        :ARG0 (t / thing
            :ARG2-of (r / result-01)
            :mod (t2 / this))
        :ARG1 (p / possible-01
            :ARG1 (d / depend-01
                :ARG0 (a / activate-01
                    :ARG1 (e2 / enzyme
                        :name (n5 / name
                            :op1 ""1/2"")))
                :ARG1 (m2 / mutate-01
                    :ARG1 e2
                    :location (c / cell
                        :mod (d2 / disease
                            :name (n6 / name
                                :op1 ""ovary""
                                :op2 ""cancer"")
                            :mod ""ovary"")))))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (s / show-01
            :ARG0 (a / and
                  :op1 (c / cell-line :name (n2 / name :op1 ""SKOV3""))
                  :op2 (c2 / cell-line :name (n3 / name :op1 ""A2780"")))
            :ARG1 (e / express-03
                  :ARG2 (e2 / enzyme :name (n4 / name :op1 ""ERK1/2""))
                  :ARG1-of (w / weak-02)))
      :snt2 (s2 / suggest-01
            :ARG0 (t2 / thing
                  :ARG2-of (r / result-01)
                  :mod (t / this))
            :ARG1 (p / possible-01
                  :ARG1 (d2 / depend-01
                        :ARG0 (a2 / activate-01
                              :ARG1 (e3 / enzyme :name (n5 / name :op1 ""ERK1/2"")))
                        :ARG1 (m2 / mutate-01
                              :ARG1 (s3 / slash
                                    :op1 (g / gene :name (n6 / name :op1 ""KRAS""))
                                    :op2 (g2 / gene :name (n7 / name :op1 ""BRAF"")))
                              :location (c3 / cell
                                    :mod (d / disease :wiki ""Ovarian_cancer"" :name (n / name :op1 ""ovarian"" :op2 ""cancer""))))))))",SKOV3 and A2780 showed weak expression of ERK1/2.These results suggest that activation of ERK1/2 may depend on <i>KRAS/BRAF</i> mutation in ovarian cancer cells.,"(z1 / show-01
    :ARG0 (z2 / and
              :op1 (z3 / enzyme
                       :wiki ""SKOV3""
                       :name (z4 / name
                                 :op1 ""SKOV3""))
              :op2 (z5 / enzyme
                       :wiki ""BRAF_(g3000 / gene)""
                       :name (z6 / name
                                 :op1 ""A2780"")))
    :ARG1 (z7 / express-01
              :ARG1 (z8 / enzyme
                        :wiki ""ERK1/2""
                        :name (z9 / name
                                  :op1 ""ERK1/2""))
              :ARG1-of (z10 / weak-02)))",0.3010752688172042,0.6290322580645161,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (a / and
                  :op1 (s2 / SKOV3)
                  :op2 (a2 / A2780))
            :ARG1 (e / expression
                  :ARG0 (e2 / ERK1/2))
            :degree (w / weak))
        :snt2 (s3 / suggest-01
            :ARG1 (a3 / activation
                  :ARG0 (e2 / ERK1/2))
            :ARG2 (d / depend-01
                  :ARG1 (m / mutation
                        :ARG1 (k / KRAS/BRAF))
                  :ARG2 (c / cell
                        :mod (o / ovarian)
                        :mod (c2 / cancer)))))","(s / suggest-01
    :ARG1 (d / depend-01
        :ARG1 (a / activate-01
            :ARG0 (r / result
                :mod (t / this))
            :ARG1 (p / protein
                :name (n / name :op1 ""ERK1/2"")))
        :ARG2 (m / mutate-01
            :ARG1 (g / gene
                :name (n2 / name :op1 ""KRAS"" :op2 ""BRAF""))
            :location (c / cell
                :mod (o / organ
                    :name (n3 / name :op1 ""ovary""))
                :mod (c2 / cancer))))
    :ARG0 (e / express-01
        :ARG0 (a2 / and
            :op1 (c3 / cell-line
                :name (n4 / name :op1 ""SKOV3""))
            :op2 (c4 / cell-line
                :name (n5 / name :op1 ""A2780"")))
        :ARG1 p
        :degree (w / weak)))",-1.0,0.4827586206896551
pmid_1901_8267.157,"We found that CI-1040 significantly reduced cellular proliferation and induced apoptosis in cell lines with either <i>KRAS</i> or <i>BRAF</i> mutations in comparison with cell lines with wild-type sequences (<xref ref-type=""fig"" rid=""fig6"">Figure 6</xref>, <xref ref-type=""other"" rid=""sup1"">Supplementary Figure 1</xref>).","(f3 / find-01
    :ARG0 (w / we)
    :ARG1 (a / and
        :ARG1-of (c3 / compare-01
            :ARG2 (l2 / line
                :ARG1-of (s / sequence-01
                    :ARG1-of (t / type-03
                        :mod (w2 / wild)))))
        :op1 (r / reduce-01
            :ARG1 (p / proliferate-01
                :ARG0 (c / cell))
            :ARG1-of (s2 / significant-02)
            :accompanier (m / mutate-01
                :ARG1 (o / or
                    :op1 (e / Region
                        :name (n2 / name))
                    :op2 (l3 / location
                        :name (n3 / name
                            :op1 ""convenient"")))))
        :op2 (i / induce-01
            :ARG2 (a2 / apoptosis)
            :location (l / line
                :example (f2 / figure
                    :ARG1-of (s3 / supplement-01)
                    :mod 1)
                :mod (c2 / cell))))
    :example (f / figure
        :li 6
        :ARG1-of 6)
    :rel (n / name
        :op1 ""10""
        :op2 ""1040""))
",test,bio_amr0.8,"(f / find-01
      :ARG0 (w / we)
      :ARG1 (a2 / and
            :op1 (r / reduce-01
                  :ARG0 (s / small-molecule :name (n / name :op1 ""CI-1040""))
                  :ARG1 (p / proliferate-01
                        :ARG0 (c / cell))
                  :ARG2 (s2 / significant-02))
            :op2 (i / induce-01
                  :ARG0 s
                  :ARG2 (a / apoptosis))
            :location (c2 / cell-line
                  :ARG0-of (h / have-03
                        :ARG1 (o / or
                              :op1 (m / mutate-01
                                    :ARG1 (g / gene :name (n2 / name :op1 ""KRAS"")))
                              :op2 (m2 / mutate-01
                                    :ARG1 (g2 / gene :name (n3 / name :op1 ""BRAF"")))))
                  :compared-to (c3 / cell-line
                        :ARG0-of (h2 / have-03
                              :ARG1 (s3 / sequence
                                    :mod (w2 / wild-type))))))
      :ARG1-of (d / describe-01
            :ARG0 (a3 / and
                  :op1 (f2 / figure :mod 6)
                  :op2 (f3 / figure :mod 1
                        :ARG1-of (s4 / supplement-01)))))","We found that CI-1040 significantly reduced cellular proliferation and induced apoptosis in cell lines with either <i>KRAS</i> or <i>BRAF</i> mutations in comparison with cell lines with wild-type sequences (<xref ref-type=""fig"" rid=""fig6"">Figure 6</xref>, <xref ref-type=""other"" rid=""sup1"">Supplementary Figure 1</xref>).","(z1 / find-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / and
              :op1 (z4 / reduce-01
                       :ARG0 (z5 / small-molecule
                                 :wiki ""Mitogen-activated_protein_kinase_1040""
                                 :name (z6 / name
                                           :op1 ""CI-1040""))
                       :ARG1 (z7 / proliferate-01
                                 :ARG0 (z8 / cell))
                       :ARG1-of (z9 / significant-02))
              :op2 (z10 / induce-01
                        :ARG0 z5
                        :ARG1 (z11 / apoptose-01))
              :location (z12 / line
                             :mod z8
                             :ARG0-of (z13 / have-03
                                           :ARG1 (z14 / mutate-01
                                                      :ARG1 (z15 / or
                                                                 :op1 (z16 / enzyme
                                                                           :wiki ""KRAS""
                                                                           :name (z17 / name
                                                                                      :op1 ""KRAS""))
                                                                 :op2 (z18 / enzyme
                                                                           :wiki ""BRAF_(g3000 / gene)""
                                                                           :name (z19 / name
                                                                                      :op1 ""BRAF""))))))
              :ARG1-of (z20 / compare-01
                            :ARG2 (z21 / line
                                       :mod z8
                                       :ARG0-of (z22 / have-03
                                                     :ARG1 (z23 / sequence
                                                                :mod (z24 / type
                                                                          :mod (z25 / wild))))))))",0.5454545454545455,0.4406779661016949,"(m / multi-sentence
        :snt1 (f / find-01
            :ARG0 (w / we)
            :ARG1 (r / reduce-01
                  :ARG1 (p / proliferation
                        :mod (c / cellular))
                  :ARG2 (a / apoptosis
                        :ARG1 (c2 / cell-line
                              :mod (m2 / mutation
                                    :ARG1 (k / KRAS))
                              :mod (m3 / mutation
                                    :ARG1 (b / BRAF))))
                  :ARG2-of (c3 / compare-01
                        :ARG1 (c4 / cell-line
                              :mod (s / sequence
                                    :mod (w2 / wild-type))))
                  :ARG2 (c5 / CI-1040))
            :ARG2 (f2 / figure
                  :name (n / name :op1 ""6"")
                  :mod (s2 / supplementary
                        :mod (f3 / figure
                              :name (n2 / name :op1 ""1""))))))
        :snt2 (n3 / null))","(f / find-01
    :ARG0 (w / we)
    :ARG1 (r / reduce-01
        :ARG0 (c / CI-1040)
        :ARG1 (p / proliferate-01
            :ARG1 (c2 / cell))
        :ARG2 (i / induce-01
            :ARG0 c
            :ARG1 (a / apoptosis
                :location (c3 / cell-line
                    :mod (e / either)
                    :ARG1-of (m / mutate-01
                        :ARG1 (k / KRAS))
                    :ARG1-of (m2 / mutate-01
                        :ARG1 (b / BRAF)))
                :compared-to (c4 / cell-line
                    :ARG1-of (h / have-03
                        :ARG2 (s / sequence
                            :mod (w2 / wild-type)))))))
    :time (c5 / compare-01
        :ARG1 c3
        :ARG2 c4)
    :medium (f2 / figure :wiki -
        :name (n / name :op1 ""6""))
    :medium (f3 / figure :wiki -
        :name (n2 / name :op1 ""Supplementary Figure 1"")))",-1.0,0.4521739130434782
pmid_1901_8267.158,"<sec-title level=""2"">Effects of CI-1040 ERK1/2 inactivation on ovarian carcinomas <i>in vivo</i></sec-title>","(a2 / affect-01
    :ARG0 (a / activate-01
        :ARG0 (e / enzyme
            :name (n / name
                :op1 1040))
        :mod ""1/2"")
    :ARG1 (c / cancer
        :location (o / ovary))
    :mod (i / in-vitro)
    :rel 2)
",test,bio_amr0.8,"(a / affect-01
      :ARG0 (a2 / activate-01 :polarity -
            :ARG0 (s / small-molecule :name (n2 / name :op1 ""CI-1040""))
            :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2"")))
      :ARG1 (c / carcinoma
            :mod (o / ovary))
      :manner (i / in-vivo))","<sec-title level=""2"">Effects of CI-1040 ERK1/2 inactivation on ovarian carcinomas <i>in vivo</i></sec-title>","(z1 / affect-01
    :ARG0 (z2 / activate-01
              :ARG1 (z3 / enzyme
                        :wiki ""ERK1/2""
                        :name (z4 / name
                                  :op1 ""ERK1/2""
                                  :op2 ""ERK1/2"")
                        :mod (z5 / small-molecule
                                 :wiki ""Selective_receptor_potential_channel_inhibitor""
                                 :name (z6 / name
                                           :op1 ""CI-1040""))))
    :ARG1 (z7 / carcinoma
              :mod (z8 / ovary))
    :mod (z9 / vivo))",0.5454545454545454,0.3783783783783783,"(e / effect-01
    :ARG1 (i / inactivation
        :ARG1 (e2 / ERK1/2
            :mod (c / ci-1040)))
    :ARG2 (c2 / carcinoma
        :mod (o / ovarian))
    :ARG3 (i2 / in-vivo))","(e / effect-01
    :ARG1 (i / inactivate-01
        :ARG1 (c / compound :name (n / name :op1 ""CI-1040"" :op2 ""ERK1/2""))
        :location (v / vivo))
    :ARG2 (c2 / carcinoma
        :location (o / organ :name (n2 / name :op1 ""ovary"")))
    :mod (t / title
        :level 2))",-1.0,0.3255813953488372
pmid_1901_8267.163,"Histological examination of the tumours after CI-1040 treatment showed inactivation of p-ERK1/2 in tumour cells based on immunohistochemistry (<xref ref-type=""fig"" rid=""fig7"">Figure 7C and D</xref>).","(s / show-01
    :ARG0 (e2 / examine-01
        :ARG1 (t2 / tumor
            :part (c / cell))
        :mod (h / history)
        :time (a2 / after
            :op1 (t / treat-03
                :name (p / plus
                    :op2 1040))))
    :ARG1 (a / activate-01
        :ARG1 (e / enzyme
            :name (n2 / name
                :op1 ""P""
                :op2 ""1/2""))
        :ARG1-of (b / base-02
            :ARG2 (i / immunohistochemistry))
        :location c)
    :rel (n / name
        :op1 p)
    :source (a3 / and
        :op1 (f / figure
            :mod 7)
        :op2 (f2 / figure
            :mod 10)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (e / examine-01
            :ARG1 (t / tumor)
            :mod (h / histologic)
            :time (a / after
                  :op1 (t2 / treat-04
                        :ARG2 (s2 / small-molecule :name (n / name :op1 ""CI-1040"")))))
      :ARG1 (a2 / activate-01 :polarity -
            :ARG1 (e2 / enzyme :name (n2 / name :op1 ""ERK1/2"")
                  :ARG3-of (p / phosphorylate-01))
            :location (c / cell
                  :mod t)
            :ARG1-of (b / base-02
                  :ARG2 (i / immunohistochemistry)))
      :ARG1-of (d / describe-01
            :ARG0 (a3 / and
                  :op1 (f / figure :mod ""7C"")
                  :op2 (f2 / figure :mod ""7D""))))","Histological examination of the tumours after CI-1040 treatment showed inactivation of p-ERK1/2 in tumour cells based on immunohistochemistry (<xref ref-type=""fig"" rid=""fig7"">Figure 7C and D</xref>).","(z1 / show-01
    :ARG0 (z2 / examine-01
              :ARG1 (z3 / tumor)
              :manner (z4 / histology)
              :time (z5 / after
                        :op1 (z6 / treat-03
                                 :ARG2 (z7 / product
                                           :wiki ""CI-1040_anti-inflammatory_drug""
                                           :name (z8 / name
                                                     :op1 ""CI-1040"")))))
    :ARG1 (z9 / activate-01
              :ARG0 (z10 / cell
                         :part-of z3)
              :ARG1 (z11 / enzyme
                         :wiki ""P-ERK1/2""
                         :name (z12 / name
                                    :op1 ""p-ERK1/2""))
              :location z3
              :ARG1-of (z13 / base-02
                            :ARG2 (z14 / immunohistochemistry))))",0.5263157894736842,0.4938271604938271,"(e / examine-01
    :ARG0 (h / histological)
    :ARG1 (t / tumour
        :mod (a / after
            :ARG1 (t2 / treat-01
                :ARG0 (c / CI-1040)
                :ARG1 (s / show-01
                    :ARG1 (i / inactivation
                        :ARG1 (p / p-ERK1/2)
                        :ARG2 (c2 / cell
                            :mod (t3 / tumour)))
                    :ARG2 (b / based-on
                        :ARG1 (i2 / immunohistochemistry
                            :ARG1 (f / figure
                                :ARG1 (n / name :op1 ""7C"")
                                :ARG2 (n2 / name :op1 ""7D""))))))))","(e / examine-01
    :ARG0 (p / person
        :ARG0-of (h / have-org-role-91
            :ARG1 (f / field :name (n / name :op1 ""Histology""))))
    :ARG1 (t / tumor)
    :ARG2 (a / after
        :op1 (t2 / treat-01
            :ARG1 t
            :ARG2 (c / compound :name (n2 / name :op1 ""CI-1040""))))
    :ARG3 (s / show-01
        :ARG1 (i / inactivate-01
            :ARG1 (p2 / protein :name (n3 / name :op1 ""p-ERK1/2""))
            :location (c2 / cell
                :mod (t3 / tumor)))
        :instrument (i2 / immunohistochemistry)
        :ARG2 (b / base-02
            :ARG1 i
            :ARG2 (f2 / figure :name (n4 / name :op1 ""7C"" :op2 ""and"" :op3 ""D"")))))",-1.0,0.4666666666666667
pmid_1956_8237.9,We identified Src as a kinase that is associated with ERK1/2 activation in UM.,"(i / identify-01
    :ARG0 (w / we)
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""Src""))
    :ARG2 (k / kinase
        :ARG1-of (a2 / associate-01
            :ARG2 (a / activate-01
                :ARG1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""ERK""
                        :op2 ""1/2""))
                :part-of (e3 / enzyme
                    :name (n3 / name
                        :op1 ""UM""))))))
",test,bio_amr0.8,"(i / identify-01
      :ARG0 (w / we)
      :ARG1 (p / protein :name (n / name :op1 ""Src""))
      :ARG2 (k / kinase
            :ARG1-of (a / associate-01
                  :ARG2 (a2 / activate-01
                        :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2""))
                        :location (m / medical-condition :name (n3 / name :op1 ""melanoma"")
                              :mod (u / uveal))))))",We identified Src as a kinase that is associated with ERK1/2 activation in UM.,"(z1 / identify-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / small-molecule
              :wiki ""Selective_serotonin_reuptake_inhibitor""
              :name (z4 / name
                        :op1 ""Src""))
    :ARG2 (z5 / kinase
              :ARG1-of (z6 / associate-01
                           :ARG2 (z7 / activate-01
                                     :ARG1 (z8 / enzyme
                                               :wiki ""ERK1/2""
                                               :name (z9 / name
                                                         :op1 ""ERK1/2""))
                                     :location (z10 / enzyme
                                                    :wiki ""Mitogen-activated_protein_kinase""
                                                    :name (z11 / name
                                                               :op1 ""UM""))))))",0.6545454545454545,0.6037735849056604,"(i / identify-01
    :ARG0 (w / we)
    :ARG1 (k / kinase
        :ARG0-of (a / associate-01
            :ARG1 (s / Src))
        :ARG1-of (a2 / activate-01
            :ARG1 (e / ERK1/2)
            :ARG2 (u / UM))))","(i / identify-01
    :ARG0 (w / we)
    :ARG1 (s / Src)
    :ARG2 (k / kinase
        :ARG1-of (a / associate-01
            :ARG2 (a2 / and
                :op1 (e / ERK1/2)
                :op2 (a3 / activate-01
                    :ARG1 e))
            :location (u / UM))))",-1.0,-1.0
pmid_1956_8237.10,"However, low Src levels and reduced ERK1/2 activation in metastatic cell lines suggest that proliferation in metastases can become independent of Src and RAS/RAF/MEK/ERK signalling.","(c2 / contrast-01
    :ARG2 (s3 / suggest-01
        :ARG0 (a2 / and
            :op1 (l / level
                :ARG1-of (l4 / low-04))
            :op2 (r / reduce-01
                :ARG1 (a / activate-01
                    :ARG1 (e / enzyme
                        :name (n / name
                            :op1 ""ERK""))
                    :location (l2 / line
                        :mod (c / cell
                            :mod (m / metastatic)))
                    :mod ""1/2"")))
        :ARG1 (p / possible-01
            :ARG1 (b / become-01
                :ARG1 (p2 / proliferate-01
                    :ARG0 (l3 / location
                        :mod c))
                :ARG2 (d / depend-01
                    :ARG0 p2
                    :ARG1 (a3 / and
                        :op1 (d2 / disease
                            :name (n2 / name
                                :op1 ""RAS""))
                        :op2 (p3 / ""protein""
                            :name (n3 / name
                                :op1 ""RAF""))
                        :op2 (s / signal-07
                            :ARG0 e
                            :ARG1 a3)
                        :op3 (e2 / enzyme
                            :name (n4 / name
                                :op1 p3))
                        :op4 (e3 / enzyme
                            :name (n5 / name
                                :op1 ""MEK""))
                        :op5 (p4 / protein
                            :name (n6 / name
                                :op1 ""ERK""))
                        :op6 (s2 / signal-07
                            :ARG0 e
                            :ARG1 p4)))))))
",test,bio_amr0.8,"(h / have-concession-91
      :ARG1 (s / suggest-01
            :ARG0 (a / and
                  :op1 (l / level
                        :ARG1-of (l2 / low-04)
                        :quant-of (p / protein :name (n / name :op1 ""Src"")))
                  :op2 (a4 / activate-01
                        :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2""))
                        :ARG1-of (r / reduce-01))
                  :location (c / cell-line
                        :ARG1-of (m / metastasize-101)))
            :ARG1 (p2 / possible-01
                  :ARG1 (b / become-01
                        :ARG1 (p3 / proliferate-01
                              :location m)
                        :ARG2 (d / depend-01 :polarity -
                              :ARG0 p3
                              :ARG1 (a3 / and
                                    :op1 p
                                    :op2 (s2 / signal-07
                                          :ARG0 (p4 / pathway :name (n3 / name :op1 ""RAS/RAF/MEK/ERK"")))))))))","However, low Src levels and reduced ERK1/2 activation in metastatic cell lines suggest that proliferation in metastases can become independent of Src and RAS/RAF/MEK/ERK signalling.","(z1 / contrast-01
    :ARG2 (z2 / suggest-01
              :ARG0 (z3 / and
                        :op1 (z4 / level
                                 :ARG1-of (z5 / low-04)
                                 :quant-of (z6 / small-molecule
                                               :wiki ""Selective_serotonin_reuptake_inhibitor""
                                               :name (z7 / name
                                                         :op1 ""Src"")))
                        :op2 (z8 / activate-01
                                 :ARG1 (z9 / enzyme
                                           :wiki ""ERK1/2""
                                           :name (z10 / name
                                                      :op1 ""ERK1/2""))
                                 :location (z11 / line
                                                :consist-of (z12 / cell
                                                                 :mod (z13 / metastatic)))))
              :ARG1-of (z14 / reduce-01))
    :ARG1 (z15 / possible-01
               :ARG1 (z16 / become-01
                          :ARG1 (z17 / proliferate-01
                                     :ARG0 z13)
                          :ARG2 (z18 / depend-01
                                     :polarity -
                                     :ARG0 z17
                                     :ARG1 (z19 / and
                                                :op1 (z20 / signal-07
                                                          :ARG0 (z21 / and
                                                                     :op1 z6
                                                                     :op2 (z22 / enzyme
                                                                               :wiki ""BRAF_(g3000 / gene)""
                                                                               :name (z23 / name
                                                                                          :op1 ""RAS""))
                                                                     :op3 (z24 / enzyme
                                                                               :wiki ""BRAF_(g3001 / gene)""
                                                                               :name (z25 / name
                                                                                          :op1 ""RAF""))
                                                                     :op4 (z26 / signal-07
                                                                               :ARG0 (z27 / enzyme
                                                                                          :wiki ""MEK""
                                                                                          :name (z28 / name
                                                                                                     :op1 ""MEK"")))
                                                                     :op5 (z29 / signal-07
                                                                               :ARG0 (z30 / enzyme
                                                                                          :wiki ""ERK""
                                                                                          :name (z31 / name
                                                                                                     :op1 ""ERK""))))))))))",0.4566929133858268,0.4628099173553719,"(m / multi-sentence
        :snt1 (s / suggest-01
            :ARG1 (l / level
                  :mod (s2 / Src))
            :ARG2 (a / activation
                  :ARG1 (e / ERK1/2))
            :ARG3 (p / proliferation
                  :ARG1-of (i / independent-02
                        :ARG2 (s3 / signalling
                              :ARG1-of (m2 / metastasis)
                              :mod (r / reduced
                                    :ARG1 (l2 / level
                                          :mod (e2 / ERK1/2)
                                          :mod (c / cell
                                                :mod (m3 / metastatic))))))))
        :snt2 (b / become-01
            :ARG1 (p2 / proliferation
                  :ARG1-of (i2 / independent-02
                        :ARG2 (s4 / signalling
                              :ARG1-of (m4 / metastasis)
                              :mod (r2 / reduced
                                    :ARG1 (l3 / level
                                          :mod (e3 / ERK1/2)
                                          :mod (c2 / cell
                                                :mod (m5 / metastatic))))))))","(h / however
    :op1 (a / and
        :op1 (r / reduce-01
            :ARG1 (a2 / activate-01
                :ARG1 (e / ERK1/2)
                :ARG0 (l / level
                    :degree (l2 / low)
                    :domain (s / Src))))
        :op2 (s2 / suggest-01
            :ARG0 (l3 / line
                :mod (c / cell)
                :mod (m / metastatic))
            :ARG1 (b / become-01
                :ARG1 (p / proliferate-01
                    :location (m2 / metastasis))
                :ARG2 (i / independent
                    :domain (a3 / and
                        :op1 (s3 / Src)
                        :op2 (s4 / signal-01
                            :ARG1 (a4 / and
                                :op1 (r2 / RAS)
                                :op2 (r3 / RAF)
                                :op3 (m3 / MEK)
                                :op4 (e2 / ERK)))))))))",-1.0,-1.0
pmid_1956_8237.93,"<sec-title level=""2"">ERK1/2 activation in UM</sec-title>","(a / activate-01
    :ARG1 (r / reactor
        :name (n / name)
        :ARG1-of (s / secure-02))
    :mod (p / product-of
        :op1 ""1/2"")
    :rel 2)
",test,bio_amr0.8,"(a / activate-01
      :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2""))
      :location (m / medical-condition :name (n2 / name :op1 ""melanoma"")
            :mod (u / uveal)))","<sec-title level=""2"">ERK1/2 activation in UM</sec-title>","(z1 / activate-01
    :ARG1 (z2 / enzyme
              :wiki ""ERK1/2""
              :name (z3 / name
                        :op1 ""ERK1/2""))
    :ARG2 (z4 / enzyme
              :wiki ""Mitogen-activated_protein_kinase""
              :name (z5 / name
                        :op1 ""UM"")))",0.4285714285714285,0.3846153846153846,"(e / erk1/2-activation
    :ARG1 (u / um))","(a / activate-01
    :ARG1 (e / ERK1/2)
    :location (u / UM)
    :medium (t / text
        :mod (s / section
            :level 2)))",-1.0,-1.0
pmid_1956_8237.96,"UMs displaying activated ERK1/2 as well as phosphorylated HSP27 were most common, whereas signals for phosphorylated ERK1/2 were low in metastasis tissue (MET1-3) and metastatic UM cell lines (OMM1, OMM2.3 and OMM2.5) (<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>).","(c3 / contrast-01
    :ARG1 (h / have-degree-91
        :ARG1 (a2 / and
            :op1 (e / enzyme
                :name (n / name
                    :op1 ""ERK""
                    :op2 ""1/2"")
                :ARG1-of (a / activate-01))
            :op2 (p3 / protein
                :name (n3 / name
                    :op1 ""HSP27"")
                :ARG1-of (p / phosphorylate-01)))
        :ARG2 (c2 / common)
        :ARG3 (m3 / most))
    :ARG2 (l4 / low-04
        :ARG1 (s / signal-07
            :ARG1 (e2 / enzyme
                :name (n2 / name
                    :op1 ""ERK""
                    :op2 ""1/2""
                    :op2 ""wise"")))
        :location (a3 / and
            :op1 (t / tissue
                :mod (m / metastasis))
            :op2 (l / line
                :name (n6 / name
                    :op1 ""UM"")
                :mod (c / cell))
            :op2 (a4 / and
                :op1 (l2 / line
                    :name c
                    :name (n7 / name
                        :op1 ""OMM1""))
                :op2 l2
                :op3 (l3 / line
                    :name (n8 / name
                        :op1 ""OMM""
                        :op2 ""2.3"")
                    :mod 2.5))))
    :ARG2 (f / figure
        :mod 1)
    :rel (p4 / protein
        :name (n4 / name)
        :name (n5 / name
            :op1 ""MET""
            :op2 ""1-3"")
        :ARG1-of (p2 / phosphorylate-01))
    :rel (d / display-01)
    :rel (m2 / metastatic))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (c2 / common
            :domain (m4 / medical-condition :name (n / name :op1 ""melanoma"")
                  :mod (u / uveal)
                  :ARG0-of (d2 / display-01
                        :ARG1 (a / and
                              :op1 (e / enzyme :name (n2 / name :op1 ""ERK1/2"")
                                    :ARG1-of (a2 / activate-01))
                              :op2 (p2 / protein :name (n3 / name :op1 ""HSP27"")
                                    :ARG3-of (p / phosphorylate-01)))))
            :degree (m / most))
      :ARG2 (l / low-04
            :ARG1 (s / signal-07
                  :beneficiary (e2 / enzyme :name (n4 / name :op1 ""ERK1/2"")
                        :ARG3-of (p3 / phosphorylate-01)))
            :location (a3 / and
                  :op1 (t / tissue
                        :ARG1-of (m2 / metastasize-101)
                        :ARG1-of (l2 / label-01
                              :ARG2 (t2 / thing :name (n5 / name :op1 ""MET"")
                                    :value (v / value-interval :op1 1 :op2 3))))
                  :op2 (c3 / cell-line
                        :mod m4
                        :mod m2
                        :ARG1-of (m3 / mean-01
                              :ARG2 (a4 / and
                                    :op1 (c4 / cell-line :name (n6 / name :op1 ""OMM1""))
                                    :op2 (c5 / cell-line :name (n7 / name :op1 ""OMM2.3""))
                                    :op3 (c6 / cell-line :name (n8 / name :op1 ""OMM2.5"")))))))
      :ARG1-of (d3 / describe-01
            :ARG0 (f / figure :mod 1)))","UMs displaying activated ERK1/2 as well as phosphorylated HSP27 were most common, whereas signals for phosphorylated ERK1/2 were low in metastasis tissue (MET1-3) and metastatic UM cell lines (OMM1, OMM2.3 and OMM2.5) (<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>).","(z1 / contrast-01
    :ARG1 (z2 / have-degree-91
              :ARG1 (z3 / display-01
                        :ARG0 (z4 / enzyme
                                  :wiki ""Umegla_(m3000 / multivitamin)""
                                  :name (z5 / name
                                            :op1 ""UMs"")
                                  :ARG0-of (z6 / display-01
                                               :ARG1 (z7 / and
                                                         :op1 (z8 / enzyme
                                                                  :wiki ""ERK1/2""
                                                                  :name (z9 / name
                                                                            :op1 ""ERK1/2"")
                                                                  :ARG1-of (z10 / activate-01))
                                                         :op2 (z11 / enzyme
                                                                   :wiki ""HSP27""
                                                                   :name (z12 / name
                                                                              :op1 ""HSP27"")
                                                                   :ARG1-of (z13 / phosphorylate-01))))))
              :ARG2 (z14 / common)
              :ARG3 (z15 / most))
    :ARG2 (z16 / low-04
               :ARG1 (z17 / signal-07
                          :ARG1 (z18 / enzyme
                                     :wiki ""ERK1/2""
                                     :name (z19 / name
                                                :op1 ""ERK1/2"")
                                     :ARG1-of (z20 / phosphorylate-01)))
               :location (z21 / and
                              :op1 (z22 / tissue
                                        :ARG0-of (z23 / metastase-01)
                                        :example (z24 / enzyme
                                                      :wiki ""Mitogen-activated_protein_kinase_1/3""
                                                      :name (z25 / name
                                                                 :op1 ""MET1-3"")))
                              :op2 (z26 / cell-line
                                        :wiki ""OMM1/3""
                                        :name (z27 / name
                                                   :op1 ""OMM1""
                                                   :op2 "",""
                                                   :op3 ""OMM2.3""
                                                   :op4 ""and""
                                                   :op5 ""OMM2.5"")
                                        :ARG0-of (z28 / display-01
                                                      :ARG1 (z29 / cell
                                                                 :mod z5)))))
    :ARG1-of (z30 / describe-01
                  :ARG0 (z31 / figure
                             :mod 1
                             :ARG1-of (z32 / hyperlink-91
                                           :ARG3 (z33 / url-entity
                                                      :value ""ref-type=fig"")))))",0.4117647058823529,0.3614457831325302,"(m / multi-sentence
        :snt1 (d / display-01
            :ARG0 (u / um)
            :ARG1 (a / activate-01
                  :ARG0 (e / erk1/2)
                  :ARG1 (p / phosphorylate-01
                        :ARG1 (h / hsp27))))
        :snt2 (c / common-01
            :ARG1 (m2 / most)
            :ARG2 (s / signal-01
                  :ARG1 (p2 / phosphorylate-01
                        :ARG1 (e2 / erk1/2))))
        :snt3 (l / low-02
            :ARG1 (s2 / signal-01
                  :ARG1 p2)
            :ARG2 (t / tissue
                  :mod (m3 / metastasis)))
        :snt4 (l2 / low-02
            :ARG1 s2
            :ARG2 (l3 / line
                  :mod (c2 / cell
                        :mod (u2 / um
                              :mod (m4 / metastatic)))))
        :snt5 (r / reference
            :ARG1 (f / figure
                  :ARG1 (n / number :op1 ""1""))
            :ARG2 (x / xref
                  :ARG1 f)))","(d / display-01
    :ARG0 (u / UM)
    :ARG1 (a / and
        :op1 (e / ERK1/2
            :mod (a2 / activate-01))
        :op2 (h / HSP27
            :mod (p / phosphorylate-01)))
    :ARG1-of (c / common-02
        :degree (m / most))
    :contrast (s / signal
        :ARG1 (e2 / ERK1/2
            :mod (p2 / phosphorylate-01))
        :location (a3 / and
            :op1 (t / tissue
                :mod (m2 / metastasis)
                :name (n / name :op1 ""MET1-3""))
            :op2 (l / line
                :mod (c2 / cell)
                :mod (m3 / metastatic)
                :mod (u2 / UM)
                :name (n2 / name :op1 ""OMM1"" :op2 ""OMM2.3"" :op3 ""OMM2.5"")))
        :degree (l2 / low))
    :medium (f / figure
        :name (n3 / name :op1 ""1"")))",-1.0,-1.0
pmid_1956_8237.97,"Remarkably, two of the metastatic cell lines (OMM2.3, OMM2.5) are derived from the same patient as cell line Mel270 but contained far less activated ERK1/2.","(r / remarkable-02
    :ARG0 (d / derive-01
        :ARG1 (l2 / line
            :quant 2
            :ARG1-of (i / include-91
                :ARG2 (l3 / line
                    :name (n / name
                        :op2 ""2.3"")
                    :name (n2 / name
                        :op1 ""OMM""
                        :op2 ""2.5"")
                    :mod (c / cell)
                    :mod (m / metastatic)))
            :mod (c2 / cell))
        :ARG1-of (c5 / contrast-01
            :ARG2 (c4 / contain-01
                :ARG0 l2
                :ARG1 (e / enzyme
                    :name (n4 / name
                        :op1 ""ERK""
                        :op2 ""1/2"")
                    :ARG1-of (h / have-quant-91
                        :ARG2 (a / activate-01
                            :ARG1 e)
                        :ARG3 (l / less
                            :quant (f / far))))))
        :ARG2 (p / patient
            :ARG1-of (s / same-01
                :ARG2 (l4 / line
                    :name (n3 / name
                        :op1 ""Mel""
                        :op2 270)
                    :mod (c3 / cell))))))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (d / derive-01
            :ARG1 (c2 / cell-line :quant 2
                  :ARG1-of (m2 / mean-01
                        :ARG2 (a / and
                              :op1 (c4 / cell-line :name (n / name :op1 ""OMM2.3""))
                              :op2 (c5 / cell-line :name (n2 / name :op1 ""OMM2.5"")))
                        :ARG1-of (m / metastasize-101))
                  :ARG1-of (i / include-91
                        :ARG2 (c3 / cell-line)))
            :ARG2 (p / person
                  :ARG0-of (h / have-rel-role-91
                        :ARG2 (p2 / patient))
                  :ARG1-of (s / same-01))
            :ARG4 (c6 / cell-line :name (n3 / name :op1 ""Mel270"")))
      :ARG2 (c7 / contain-01
            :ARG0 c2
            :ARG1 (e / enzyme :name (n4 / name :op1 ""ERK1/2"")
                  :ARG1-of (a2 / activate-01)
                  :quant (l / less
                        :degree (f / far))))
      :ARG1-of (r / remarkable-02))","Remarkably, two of the metastatic cell lines (OMM2.3, OMM2.5) are derived from the same patient as cell line Mel270 but contained far less activated ERK1/2.","(z1 / contrast-01
    :ARG1 (z2 / derive-01
              :ARG1 (z3 / cell-line
                        :quant 2
                        :ARG1-of (z4 / include-91
                                     :ARG2 (z5 / cell-line
                                               :wiki ""Omelebrus_erythrocyte""
                                               :name (z6 / name
                                                         :op1 ""OMM2.3"")
                                               :ARG1-of (z7 / metastate-01
                                                            :ARG1 z9)))
                        :ARG1-of (z8 / include-91
                                     :ARG2 (z9 / cell-line
                                               :wiki ""Omelebrus_erythrocyte""
                                               :name (z10 / name
                                                          :op1 ""OMM2.5""))))
              :ARG2 (z11 / patient
                         :ARG1-of (z12 / same-01
                                       :ARG2 (z13 / cell-line
                                                  :wiki ""Mel270""
                                                  :name (z14 / name
                                                             :op1 ""Mel270""))))))",0.3695652173913044,0.3392857142857143,"(r / remarkably
        :ARG1 (d / derive-01
              :ARG0 (l / line
                    :mod (c / cell
                          :mod (m / metastatic))
                    :ARG1 (n / name :op1 ""OMM2.3""))
              :ARG1 (p / patient
                    :mod (s / same)
                    :ARG1-of (l2 / line
                          :mod (c2 / cell
                                :mod (m2 / metastatic))
                          :ARG1 (n2 / name :op1 ""Mel270""))))
        :ARG2 (c3 / contain-01
              :ARG1 l
              :ARG2 (e / ERK1/2
                    :mod (a / activate-01
                          :ARG1 (f / far)
                          :ARG2 (l3 / less)))))","(r / remarkable-01
    :ARG1 (d / derive-01
        :ARG1 (c / cell-line
            :name (n / name :op1 ""OMM2.3"" :op2 ""OMM2.5"")
            :mod (m / metastatic))
        :ARG2 (p / patient
            :ARG0-of (h / have-03
                :ARG1 (c2 / cell-line
                    :name (n2 / name :op1 ""Mel270""))))
        :ARG1-of (c3 / contain-01
            :ARG2 (e / ERK1/2
                :ARG1-of (a / activate-01)
                :quant (l / less
                    :degree (f / far))))))",-1.0,-1.0
pmid_1956_8237.99,Reduction of ERK1/2 activation in metastatic cell lines compared with that in primary UM cell lines provides a model to identify the underlying mechanism of ERK1/2 activation in the absence of <i>BRAF</i> and <i>NRAS</i> mutations.,"(p2 / provide-01
    :ARG0 (r / reduce-01
        :ARG1 (a2 / activate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :ARG1-of (c2 / compare-01
            :ARG2 (a3 / activate-01))
        :location (l / line
            :mod (c / carrier
                :name (n2 / name
                    :op1 ""UM"")
                :mod (p / primary)
                :mod (l3 / location
                    :name (n3 / name
                        :op1 ""i"")
                    :op2 (m4 / mutate-01
                        :ARG1 l3)))))
    :ARG1 (m2 / model
        :purpose (i / identify-01
            :ARG1 (m / mechanism
                :ARG0-of (u / underlie-01)
                :mod (a4 / activate-01
                    :ARG1 e
                    :condition (a / absent-01
                        :ARG1 (a5 / and
                            :op1 (m3 / mutate-01
                                :ARG2 e)))))))
    :rel (o / option
        :name n3)
    :rel (l2 / load))
",test,bio_amr0.8,"(p / provide-01
      :ARG0 (r / reduce-01
            :ARG1 (a / activate-01
                  :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2""))
                  :location (c / cell-line
                        :ARG1-of (m / metastasize-101)))
            :ARG1-of (c2 / compare-01
                  :ARG2 (r2 / reduce-01
                        :ARG1 a
                        :location (c3 / cell-line
                              :mod (m6 / medical-condition :name (n2 / name :op1 ""melanoma"")
                                    :mod (u / uveal)
                                    :mod (p2 / primary))))))
      :ARG1 (m2 / model-01
            :purpose (i / identify-01
                  :ARG1 (m3 / mechanism
                        :ARG1-of (u2 / underlie-01)
                        :mod (a2 / activate-01
                              :ARG1 e
                              :condition (a3 / absent-01
                                    :ARG1 (a4 / and
                                          :op1 (m4 / mutate-01
                                                :ARG1 (g / gene :name (n3 / name :op1 ""BRAF"")))
                                          :op2 (m5 / mutate-01
                                                :ARG1 (g2 / gene :name (n4 / name :op1 ""NRAS""))))))))))",Reduction of ERK1/2 activation in metastatic cell lines compared with that in primary UM cell lines provides a model to identify the underlying mechanism of ERK1/2 activation in the absence of <i>BRAF</i> and <i>NRAS</i> mutations.,"(z1 / provide-01
    :ARG0 (z2 / reduce-01
              :ARG1 (z3 / activate-01
                        :ARG1 (z4 / enzyme
                                  :wiki ""ERK1/2""
                                  :name (z5 / name
                                            :op1 ""ERK1/2""))
                        :location (z6 / line
                                      :mod (z7 / cell
                                               :mod (z8 / metastatic))))
              :ARG1-of (z9 / compare-01
                           :ARG2 (z10 / activate-01
                                      :ARG1 z4
                                      :location (z11 / line
                                                     :mod (z12 / cell
                                                               :mod (z13 / primary)
                                                               :mod (z14 / cell
                                                                         :wiki ""Mitogen-activated_protein_kinase""
                                                                         :name (z15 / name
                                                                                    :op1 ""UM""))))))))",0.3789473684210526,0.5689655172413793,"(m / multi-sentence
        :snt1 (c / compare-01
            :ARG1 (a / activate-01
                  :ARG0 (e / ERK1/2)
                  :ARG1 (l / line
                        :mod (m2 / metastatic))
                  :ARG1-of (c2 / compare-01
                        :ARG2 (l2 / line
                              :mod (p / primary)
                              :ARG1-of (u / UM))))
            :ARG2 (m3 / model
                  :ARG1 (i / identify-01
                        :ARG1 (m4 / mechanism
                              :ARG1-of (a2 / activate-01
                                    :ARG0 (e2 / ERK1/2)
                                    :ARG1 (l3 / line
                                          :mod (u2 / underlying)
                                          :ARG1-of (i2 / in
                                                :ARG2 (a3 / absence
                                                      :op1 (b / BRAF)
                                                      :op2 (n / NRAS)
                                                      :mod (m5 / mutation))))))))
        :snt2 (p2 / provide-01
            :ARG0 (r / reduction
                  :ARG1 (a4 / activate-01
                        :ARG0 (e3 / ERK1/2)
                        :ARG1 (l4 / line
                              :mod (m6 / metastatic))))
            :ARG1 (m7 / model
                  :ARG1 (i3 / identify-01
                        :ARG1 (m8 / mechanism
                              :ARG1-of (a5 / activate-01
                                    :ARG0 (e4 / ERK1/2)
                                    :ARG1 (l5 / line
                                          :mod (u3 / underlying)
                                          :ARG1-of (i4 / in
                                                :ARG2 (a6 / absence
                                                      :op1 (b2 / BRAF)
                                                      :op2 (n2 / NRAS)
                                                      :mod (m9 / mutation)))))))))","(r / reduce-01
    :ARG1 (a / activate-01
        :ARG0 (e / ERK1/2)
        :ARG1 (c / cell-line
            :mod (m / metastatic)))
    :ARG2 (a2 / activate-01
        :ARG0 e
        :ARG1 (c2 / cell-line
            :mod (p / primary)
            :mod (u / UM)))
    :purpose (p2 / provide-01
        :ARG1 (m2 / model
            :purpose (i / identify-01
                :ARG1 (m3 / mechanism
                    :mod (u2 / underlying)
                    :ARG1-of (a3 / activate-01
                        :ARG0 e
                        :ARG1 (c3 / cell-line
                            :mod (a4 / absent)
                            :ARG1-of (m4 / mutation-01
                                :ARG1 (b / BRAF)
                                :ARG2 (n / NRAS)))))))))",-1.0,-1.0
pmid_1956_8237.101,"The UM cell lines displayed a high kinase activity, whereas the metastatic UM cell lines displayed a low kinase activity, although the same amount of lysate was incubated (<xref ref-type=""fig"" rid=""fig2"">Figure 2A</xref>).","(c3 / contrast-01
    :ARG1 (d3 / display-01
        :ARG0 (l / line
            :consist-of (c / cell
                :name (n / name
                    :op1 ""UM"")))
        :ARG1 (a / activity-06
            :ARG0 l
            :ARG1 (k / kinase)
            :ARG1-of (h / high-02)))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 2))
    :ARG2 (d4 / display-01
        :ARG0 (l2 / line
            :consist-of (c2 / cell
                :mod (d2 / disease
                    :name (n2 / name
                        :op1 ""UM""))
                :mod (b / bastard)))
        :ARG1 (a2 / activity-06
            :ARG0 l
            :ARG1 (k2 / kinase)
            :ARG1-of (l3 / low-04))
        :concession (e / express-03
            :ARG1 (l4 / lysate
                :quant (a3 / amount
                    :ARG1-of (s / same-01))))))
",test,bio_amr0.8,"(h2 / have-concession-91
      :ARG1 (c / contrast-01
            :ARG1 (d / display-01
                  :ARG0 (c2 / cell-line
                        :mod (m3 / medical-condition :name (n / name :op1 ""melanoma"")
                              :mod (u / uveal)))
                  :ARG1 (a / activity-06
                        :ARG0 (k / kinase)
                        :ARG1-of (h / high-02)))
            :ARG2 (d3 / display-01
                  :ARG0 (c3 / cell-line
                        :mod (m2 / medical-condition :name (n2 / name :op1 ""melanoma"")
                              :ARG1-of (m / metastasize-101)))
                  :ARG1 (a2 / activity-06
                        :ARG0 k
                        :ARG1-of (l / low-04))))
      :ARG2 (i / incubate-01
            :ARG1 (a3 / amount
                  :quant-of (l2 / lysate)
                  :ARG1-of (s / same-01)))
      :ARG1-of (d5 / describe-01
            :ARG0 (f / figure :mod ""2A"")))","The UM cell lines displayed a high kinase activity, whereas the metastatic UM cell lines displayed a low kinase activity, although the same amount of lysate was incubated (<xref ref-type=""fig"" rid=""fig2"">Figure 2A</xref>).","(z1 / contrast-01
    :ARG1 (z2 / display-01
              :ARG0 (z3 / cell-line
                        :wiki ""Mucicelumab""
                        :name (z4 / name
                                  :op1 ""UM""
                                  :op2 ""cell""))
              :ARG1 (z5 / activity-06
                        :ARG0 z3
                        :ARG1 (z6 / kinase
                                  :ARG1-of (z7 / high-02))))
    :ARG2 (z8 / display-01
              :ARG0 (z9 / cell-line
                        :wiki ""Mucicelumab""
                        :name (z10 / name
                                   :op1 ""UM""
                                   :op2 ""cell""
                                   :op3 ""line"")
                        :ARG1-of (z11 / metastate-01))
              :ARG1 (z12 / activity-06
                         :ARG0 z3
                         :ARG1 (z13 / kinase
                                    :ARG1-of (z14 / low-04))))
    :concession (z15 / incubate-01
                     :ARG1 (z16 / amount
                                :ARG1-of (z17 / same-01)
                                :quant-of (z18 / lysate)))
    :ARG1-of (z19 / hyperlink-91
                  :ARG3 (z20 / url-entity
                             :value ""Figure_2A"")))",0.4646464646464646,0.4848484848484848,"(m / multi-sentence
        :snt1 (d / display-01
            :ARG1 (l / line
                  :mod (c / cell)
                  :mod (u / UM))
            :ARG2 (a / activity
                  :mod (k / kinase)
                  :degree (h / high)))
        :snt2 (d2 / display-01
            :ARG1 (l2 / line
                  :mod (c2 / cell)
                  :mod (u2 / UM)
                  :mod (m / metastatic))
            :ARG2 (a2 / activity
                  :mod (k2 / kinase)
                  :degree (l3 / low)))
        :snt3 (i / incubate-01
            :ARG1 (a3 / amount)
            :ARG2 (l4 / lysate)
            :time (x / xref
                  :ref-type ""fig""
                  :rid ""fig2"")))","(c / contrast-01
    :ARG1 (d / display-01
        :ARG0 (l / line
            :mod (c2 / cell)
            :mod (u / university :wiki ""University_of_Michigan"" :name (n / name :op1 ""UM"")))
        :ARG1 (a / activity
            :mod (k / kinase)
            :degree (h / high)))
    :ARG2 (d2 / display-01
        :ARG0 (l2 / line
            :mod (c3 / cell)
            :mod (u2 / university :wiki ""University_of_Michigan"" :name (n2 / name :op1 ""UM""))
            :mod (m / metastatic))
        :ARG1 (a2 / activity
            :mod (k2 / kinase)
            :degree (l3 / low)))
    :ARG3 (i / incubate-01
        :ARG1 (a3 / amount
            :mod (s / same)
            :ARG1-of (l4 / lysate))
        :time (w / while)
        :location (f / figure :wiki - :name (n3 / name :op1 ""2A"")))
    :mode (a4 / although))",-1.0,0.3925233644859813
pmid_1956_8237.102,"After normalisation, we could analyse the kinase data and identify nine substrates that were significantly differentially phosphorylated between primary and metastatic UM cell lines (<xref ref-type=""fig"" rid=""fig2"">Figure 2B</xref>, <xref ref-type=""table"" rid=""tbl1"">Table 1</xref>).","(p2 / possible-01
    :ARG1 (a3 / and
        :op1 (a2 / analyze-01
            :ARG0 (w / we)
            :ARG1 (d / data
                :topic (k / kinase)))
        :op2 (i / identify-01
            :ARG0 w
            :ARG1 (p / phosphorylate-01
                :quant 9
                :ARG1-of (d4 / differ-02
                    :ARG1-of (s / significant-02))
                :ARG2-of (o / obligate-01)
                :location (b2 / between
                    :op1 (l / line
                        :mod (c / cell
                            :name (n / name
                                :op1 ""UM"")))
                    :op2 (l2 / line
                        :mod (c2 / cell
                            :mod (b / benefit
                                :ARG0-of (f2 / fund-01
                                    :ARG1 b)))
                        :mod f2)))))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure
            :ARG1-of (d3 / describe-01
                :ARG0 (t / table
                    :mod 1))
            :mod 2))
    :rel (o2 / obligate-01
        :ARG2 b)
    :rel (p3 / primary)
    :time (a / after
        :op1 (n2 / normalize-01)))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (a / and
            :op1 (a2 / analyze-01
                  :ARG0 (w / we)
                  :ARG1 (d / data
                        :topic (k / kinase)))
            :op2 (i / identify-01
                  :ARG0 w
                  :ARG1 (s / substrate :quant 9
                        :ARG3-of (p2 / phosphorylate-01
                              :ARG1-of (s2 / significant-02)
                              :manner (d2 / differential)
                              :location (a3 / and
                                    :op1 (c / cell-line
                                          :mod (m2 / medical-condition :name (n / name :op1 ""melanoma"")
                                                :mod (u / uveal)
                                                :mod (p3 / primary)))
                                    :op2 (c2 / cell-line
                                          :mod (m3 / medical-condition :name (n2 / name :op1 ""melanoma"")
                                                :mod (u2 / uveal)
                                                :ARG1-of (m / metastasize-101))))))))
      :time (a4 / after
            :op1 (n3 / normalize-01))
      :ARG1-of (d5 / describe-01
            :ARG0 (a5 / and
                  :op1 (f / figure :mod ""2B"")
                  :op2 (t / table :mod 1))))","After normalisation, we could analyse the kinase data and identify nine substrates that were significantly differentially phosphorylated between primary and metastatic UM cell lines (<xref ref-type=""fig"" rid=""fig2"">Figure 2B</xref>, <xref ref-type=""table"" rid=""tbl1"">Table 1</xref>).","(z1 / possible-01
    :ARG1 (z2 / and
              :op1 (z3 / analyze-01
                       :ARG0 (z4 / we)
                       :ARG1 (z5 / data
                                 :topic (z6 / kinase)))
              :op2 (z7 / identify-01
                       :ARG0 z4
                       :ARG1 (z8 / substrate
                                 :quant 9
                                 :ARG1-of (z9 / phosphorylate-01
                                              :ARG0 (z10 / between
                                                         :op1 (z11 / line
                                                                   :mod (z12 / cell
                                                                             :mod (z13 / primary))
                                                                   :mod (z14 / cell
                                                                             :wiki ""Mitogen-activated_protein_kinase""
                                                                             :name (z15 / name
                                                                                        :op1 ""UM"")))
                                                         :op2 (z16 / line
                                                                   :mod (z17 / metastatic)
                                                                   :mod z14))
                                              :ARG1-of (z18 / differ-02
                                                            :ARG1-of (z19 / significant-02)))))))",0.5048543689320388,0.5166666666666667,"(m / multi-sentence
        :snt1 (a / after
            :ARG1 (n / normalisation))
        :snt2 (c / could
            :ARG0 (w / we)
            :ARG1 (a2 / analyse-01
                  :ARG0 w
                  :ARG1 (d / data
                        :mod (k / kinase))
                  :ARG2 (i / identify-01
                        :ARG0 w
                        :ARG1 (s / substrate
                              :quant (n2 / nine)
                              :ARG1-of (d2 / differentially
                                    :ARG1 (p / phosphorylate-01
                                          :ARG0 s
                                          :ARG1 (b / between
                                                :ARG1 (l / line
                                                      :mod (c2 / cell
                                                            :mod (u / um
                                                                  :mod (m / metastatic)
                                                                  :mod (p2 / primary))))
                                                :ARG2 (l2 / line
                                                      :mod (c3 / cell
                                                            :mod (u2 / um
                                                                  :mod (m2 / metastatic)
                                                                  :mod (p3 / primary)))))))))))
        :snt3 (x / xref
            :ref-type ""fig""
            :rid ""fig2""
            :ARG1 (f / figure
                  :mod (n / name :op1 ""2B"")))
        :snt4 (x2 / xref
            :ref-type ""table""
            :rid ""tbl1""
            :ARG1 (t / table
                  :mod (n2 / name :op1 ""1""))))","(n / normalize-01
    :ARG1 (d / data
        :mod (k / kinase))
    :time (a / after)
    :result (m / multi-sentence
        :snt1 (a2 / analyze-01
            :ARG0 (w / we)
            :ARG1 d)
        :snt2 (i / identify-01
            :ARG0 w
            :ARG1 (s / substrate
                :quant (n2 / number :value 9)
                :ARG1-of (p / phosphorylate-01
                    :ARG2 (c / cell-line
                        :mod (u / UM)
                        :mod (m2 / metastatic)
                        :mod (p2 / primary))
                    :degree (d2 / different-02
                        :degree (s2 / significant)
                        :mod (d3 / differential)))
                :location (r / reference
                    :mod (f / figure :value ""2B"")
                    :mod (t / table :value ""1""))))))",-1.0,0.3364485981308411
pmid_1956_8237.103,"Primary UM and metastatic tissue also showed differential phosphorylation of these nine peptides, although not as clearly as observed in the cell lines (<xref ref-type=""fig"" rid=""fig2"">Figure 2C</xref>).","(s / show-01
    :ARG0 (a2 / and
        :op1 (d3 / disease
            :name (n / name
                :op1 ""UM""
                :op2 (p / ""park""
                    :part-of d3)))
        :op2 (t2 / tissue
            :ARG1-of (f2 / full-09
                :ARG2 (d4 / disease
                    :name (n2 / name
                        :op1 ""metastatic"")))))
    :ARG1 (p2 / phosphorylate-01
        :ARG1 (p4 / protein
            :quant 9
            :mod (t / this))
        :ARG1-of (h / have-degree-91
            :ARG2 (c2 / clear-06)
            :ARG3 (e / equal)
            :ARG4 (o / observe-01
                :ARG1 p2
                :location (l / line
                    :mod (c / cell)))
            :polarity -)
        :mod (d2 / differential))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 2))
    :mod (a / also)
    :rel (p3 / primary))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (a / and
            :op1 (m2 / medical-condition :name (n / name :op1 ""melanoma"")
                  :mod (u / uveal)
                  :mod (p / primary))
            :op2 (t / tissue
                  :ARG1-of (m / metastasize-101)))
      :ARG1 (p2 / phosphorylate-01
            :ARG1 (p3 / peptide :quant 9
                  :mod (t2 / this))
            :mod (d2 / differential))
      :concession (c / clear-06 :polarity -
            :ARG1 s
            :compared-to (p4 / phosphorylate-01
                  :ARG1-of (o / observe-01
                        :location (c2 / cell-line))))
      :mod (a2 / also)
      :ARG1-of (d3 / describe-01
            :ARG0 (f / figure :mod ""2C"")))","Primary UM and metastatic tissue also showed differential phosphorylation of these nine peptides, although not as clearly as observed in the cell lines (<xref ref-type=""fig"" rid=""fig2"">Figure 2C</xref>).","(z1 / show-01
    :ARG0 (z2 / and
              :op1 (z3 / tissue
                       :mod (z4 / primary)
                       :mod (z5 / uterine)
                       :mod (z6 / primary))
              :op2 (z7 / tissue
                       :ARG1-of (z8 / metastate-01)))
    :ARG1 (z9 / phosphorylate-01
              :ARG1 (z10 / peptide
                         :quant 9
                         :mod (z11 / this))
              :ARG1-of (z12 / differ-02))
    :mod (z13 / also)
    :concession (z14 / have-degree-91
                     :ARG1 (z15 / phosphorylate-01
                                :ARG1 z10)
                     :ARG2 (z16 / clear-08
                                :ARG1 z15)
                     :ARG3 (z17 / equal
                                :polarity -)
                     :ARG4 (z18 / observe-01
                                :ARG1 z15
                                :location (z19 / line
                                               :mod (z20 / cell))))
    :ARG1-of (z21 / describe-01
                  :ARG0 (z22 / figure
                             :mod ""2C""
                             :ARG1-of (z23 / hyperlink-91
                                           :ARG3 (z24 / url-entity
                                                      :value ""xref"")))))",0.5625000000000001,0.5531914893617021,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (t / tissue
                  :mod (p / primary))
            :ARG1 (p2 / phosphorylation
                  :ARG0 (t2 / tissue
                        :mod (m / metastatic))
                  :ARG1 (p3 / peptide
                        :quant (n / number :op1 9)))
            :degree (d / differential))
        :snt2 (o / observe-01
            :ARG1 (c / clearly)
            :ARG2 (l / line
                  :ARG1-of (c2 / cell-01)))
        :snt3 (r / refer
            :ARG1 c
            :ARG2 (f / figure
                  :ARG1-of (x / xref
                        :ref-type ""fig""
                        :rid ""fig2"")
                  :op1 ""Figure 2C"")))","(p / primary
    :mod (u / UM)
    :ARG1-of (s / show-01
        :ARG0 (t / tissue
            :mod (m / metastatic))
        :ARG1 (d / differential
            :mod (p2 / phosphorylation))
        :ARG2 (p3 / peptide
            :quant 9)
        :mod (a / also))
    :condition (o / observe-01
        :ARG1 s
        :location (c / cell-line)
        :degree (c2 / clear-02 :polarity -)
        :concession (a2 / although))
    :medium (f / figure
        :name (n / name :op1 ""2C"")
        :mod (x / xref
            :ref-type ""fig""
            :rid ""fig2"")))",-1.0,0.35
pmid_1956_8237.109,"We added PP1 and PP2 (10 <i>μ</i><sc>M</sc>) to lysates of primary UM tissue and of a primary UM cell line and measured the inhibitory effect of these Src inhibitors using kinase array (<xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(a5 / and
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 3))
    :op1 (a / add-02
        :ARG0 (w / we)
        :ARG1 (a3 / and
            :op1 (p2 / protein
                :name (n / name
                    :op1 ""PP1""))
            :op2 (p3 / protein
                :name (n2 / name
                    :op1 ""PP2""
                    :op3 ""phosphate"")))
        :ARG2 (a4 / and
            :op1 (s / site
                :name (n3 / name
                    :op1 ""fund""
                    :op2 ""of"")
                :part-of (t2 / tissue
                    :mod (d2 / disease
                        :name (n4 / name
                            :op1 ""UM""))
                    :mod (p / primary)))
            :op2 (l / line
                :mod (c / cell
                    :mod d2)
                :mod d2)))
    :op2 (m / measure-01
        :ARG0 w
        :ARG1 (a2 / affect-01
            :ARG2 (i / inhibit-01))
        :instrument (u / use-01
            :ARG1 (a6 / array
                :instrument-of (i2 / inhibit-01
                    :ARG1 (s2 / small-molecule
                        :name (n5 / name
                            :op1 ""Src"")))
                :mod (k / kinase))))
    :rel (t / this)
    :rel 10)
",test,bio_amr0.8,"(a / and
      :op1 (a2 / add-02
            :ARG0 (w / we)
            :ARG1 (a3 / and
                  :op1 (s / small-molecule)
                  :op2 (s2 / small-molecule)
                  :quant (c2 / concentration-quantity :quant 10
                        :unit (m / micromolar)))
            :ARG2 (a7 / and
                  :op1 (l / lysate
                        :source (t / tissue
                              :mod (m3 / medical-condition :name (n3 / name :op1 ""melanoma"")
                                    :mod (u / uveal)
                                    :mod (p / primary))))
                  :op1 (l2 / lysate
                        :source (c / cell-line
                              :mod m3))))
      :op2 (m2 / measure-01
            :ARG0 w
            :ARG1 (a5 / affect-01
                  :ARG0 (s3 / small-molecule
                        :ARG0-of (i2 / inhibit-01
                              :ARG1 (p2 / protein-family :name (n4 / name :op1 ""Src""))))
                  :ARG2 (i / inhibit-01))
            :instrument (a6 / array-01
                  :ARG1 (k / kinase)))
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod ""3A"")))","We added PP1 and PP2 (10 <i>μ</i><sc>M</sc>) to lysates of primary UM tissue and of a primary UM cell line and measured the inhibitory effect of these Src inhibitors using kinase array (<xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(z1 / and
    :op1 (z2 / add-02
             :ARG0 (z3 / we)
             :ARG1 (z4 / and
                       :op1 (z5 / enzyme
                                :wiki ""Cyclin-dependent_protein""
                                :wiki ""PP1""
                                :name (z6 / name
                                          :op1 ""PP1""))
                       :op2 (z7 / enzyme
                                :wiki ""PP2""
                                :name (z8 / name
                                          :op1 ""PP2""))
                       :ARG1-of (z9 / equal-01
                                    :ARG2 (z10 / molecular-mass
                                               :quant 10
                                               :unit (z11 / microsievert))))
             :ARG2 (z12 / and
                        :op1 (z13 / tissue
                                  :part-of (z14 / cell
                                                :mod (z15 / primary)
                                                :part-of (z16 / university
                                                              :wiki ""University_of_Maryland""
                                                              :name (z17 / name
                                                                         :op1 ""UM""))))
                        :op2 (z18 / line
                                  :consist-of (z19 / cell
                                                   :mod z15)))))",0.3148148148148148,0.5230769230769231,"(m / multi-sentence
        :snt1 (a / add-01
            :ARG0 (w / we)
            :ARG1 (p / pp1)
            :ARG2 (p2 / pp2
                  :quant (m2 / million)))
        :snt2 (l / lysate-01
            :ARG0 (t / tissue
                  :mod (u / um
                        :mod (p2 / primary)))
            :ARG1 (c / cell-line
                  :mod (u2 / um
                        :mod (p3 / primary))))
        :snt3 (m3 / measure-01
            :ARG0 (i / inhibit-01
                  :ARG1 (e / effect
                        :mod (i2 / inhibitory)))
            :ARG1 (a2 / array
                  :ARG0 (k / kinase)
                  :ARG1 (f / figure
                        :op1 ""3A"")))
        :snt4 (u3 / use-01
            :ARG0 (i3 / inhibitor
                  :mod (s / src))
            :ARG1 a2))","(a / add-01
    :ARG0 (w / we)
    :ARG1 (m / molecule
        :name (n / name :op1 ""PP1"")
        :mod (m2 / molecule
            :name (n2 / name :op1 ""PP2"")
            :quant (q / quantity
                :unit (u / unit :name (n3 / name :op1 ""μM""))
                :value 10))))
    :ARG2 (l / lysate
        :source (t / tissue
            :mod (u2 / um-01)
            :mod (p / primary))
        :source (c / cell-line
            :mod (u3 / um-01)
            :mod (p2 / primary)))
    :ARG3 (m3 / measure-01
        :ARG0 w
        :ARG1 (e / effect
            :mod (i / inhibit-01
                :ARG1 (k / kinase
                    :mod (a / array))
                :ARG0 (m4 / molecule
                    :name (n4 / name :op1 ""Src"")
                    :mod (i2 / inhibitor-01))))
        :instrument (r / refer-01
            :ARG1 (f / figure
                :name (n5 / name :op1 ""3A""))
            :mode (x / external))))",-1.0,-1.0
pmid_1956_8237.110,"A total of seven out of nine substrates that identified Src in the first screen displayed a significantly reduced phosphorylation when PP1 or PP2 were added to lysates of UM1 and Mel270 (<xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(d2 / display-01
    :ARG0 (e / enzyme
        :name (n / name
            :op1 ""Src"")
        :quant 7
        :ARG1-of (t / total-01)
        :ARG2-of t)
    :ARG1 (r / reduce-01
        :ARG1 (p / phosphorylate-01
            :ARG1 e)
        :ARG1-of (s2 / significant-02)
        :condition (a / add-02
            :ARG1 (o / or
                :op1 (p2 / protein
                    :name (n2 / name
                        :op1 ""PP1""))
                :op2 (p3 / protein
                    :name (n3 / name
                        :op1 ""PP2"")))
            :ARG2 (a2 / and
                :part-of (e3 / enzyme
                    :name (n4 / name
                        :op1 ""UM1"")
                    :name (n5 / name
                        :op1 ""Mel""
                        :op2 270)))))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 3))
    :rel (i2 / include-91
        :ARG2 (e2 / enzyme
            :quant 9
            :ARG0-of (i / identify-01
                :location (s / screen
                    :ord (o2 / ordinal-entity
                        :value 1))))))
",test,bio_amr0.8,"(d / display-01
      :ARG0 (s / substrate :quant 7
            :ARG1-of (i2 / include-91
                  :ARG2 (s3 / substrate :quant 9
                        :ARG0-of (i / identify-01
                              :ARG1 (p / protein :name (n / name :op1 ""Src""))
                              :location (s2 / screen
                                    :ord (o / ordinal-entity :value 1)))))
            :ARG1-of (t / total-01))
      :ARG1 (p2 / phosphorylate-01
            :ARG1-of (r / reduce-01
                  :ARG2 (s4 / significant-02)))
      :time (a / add-02
            :ARG1 (o2 / or
                  :op1 (p3 / protein :name (n2 / name :op1 ""PP1""))
                  :op2 (p4 / protein :name (n3 / name :op1 ""PP2"")))
            :ARG2 (a3 / and
                  :op1 (l / lysate
                        :source (t2 / thing :name (n4 / name :op1 ""UM1"")))
                  :op2 (l2 / lysate
                        :source (c / cell-line :name (n5 / name :op1 ""Mel270"")))))
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod ""3A"")))","A total of seven out of nine substrates that identified Src in the first screen displayed a significantly reduced phosphorylation when PP1 or PP2 were added to lysates of UM1 and Mel270 (<xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(z1 / display-01
    :ARG0 (z2 / substrate
              :quant 7
              :ARG1-of (z3 / include-91
                           :ARG2 (z4 / substrate
                                     :quant 9
                                     :ARG0-of (z5 / identify-01
                                                  :ARG1 (z6 / small-molecule
                                                            :wiki ""Selective_serotonin_reuptake_inhibitor""
                                                            :name (z7 / name
                                                                      :op1 ""Src""))
                                                  :location (z8 / screen
                                                                :ord (z9 / ordinal-entity
                                                                         :value 1)))))
              :ARG2-of (z10 / total-01))
    :ARG1-of (z11 / total-01))",0.4175824175824176,0.5528455284552846,"(m / multi-sentence
        :snt1 (d / display-01
            :ARG0 (s / substrate
                  :quant (t / total
                        :op1 seven))
            :ARG1 (r / reduce-01
                  :ARG1 (p / phosphorylation
                        :ARG1-of (i / identify-01
                              :ARG1 (s2 / Src)
                              :ARG2 (s3 / substrate
                                    :mod (n / number
                                          :op1 nine)
                                    :mod (f / first
                                          :mod (s4 / screen)))))
                  :ARG2 (a / add-01
                        :ARG1 (p2 / PP1)
                        :ARG2 (l / lysate
                              :mod (u / UM1)
                              :mod (m / Mel270))))
            :ARG2 (f2 / figure
                  :op1 ""3A""
                  :op2 (x / xref
                        :ref-type ""fig""
                        :rid ""fig3"")))
        :snt2 (n2 / none))","(s / show-01
    :ARG1 (r / reduce-01
        :ARG1 (p / phosphorylate-01
            :ARG1 (s2 / substrate
                :quant (n / number :value 7)
                :part-of (n2 / number :value 9)
                :ARG1-of (i / identify-01
                    :ARG0 (s3 / Src))))
        :degree (s4 / significant))
    :ARG2 (a / add-01
        :ARG1 (o / or
            :op1 (p2 / PP1)
            :op2 (p3 / PP2))
        :ARG2 (l / lysate
            :part-of (a2 / and
                :op1 (u / UM1)
                :op2 (m / Mel270))))
    :time (f / first
        :ARG1-of (s5 / screen-01))
    :location (f2 / figure
        :name (n3 / name :op1 ""3A"")
        :mod (x / xref
            :ref-type ""fig""
            :rid ""fig3"")))",-1.0,0.2831858407079646
pmid_1956_8237.112,"The peptide representing FAK1 Y576/Y577 is a genuine substrate for Src, which was not detected in the UM cell line comparison, but phosphorylation was significantly downregulated by PP1 and PP2 treatments.","(s2 / substrate
    :beneficiary (e / enzyme
        :name (n2 / name
            :op1 ""Src""))
    :domain (p / peptide
        :name (n / name
            :op1 ""FAK1""
            :op2 ""basic""
            :op3 577)
        :ARG0-of (r / represent-01)
        :ARG1-of (d / detect-01
            :ARG1-of (c3 / contrast-01
                :ARG2 (d2 / down-03
                    :ARG0 (a / and
                        :ARG2-of (t / treat-04)
                        :op1 (p3 / protein
                            :name (n4 / name
                                :op1 ""PP1""))
                        :op2 (p4 / protein
                            :name (n5 / name
                                :op1 ""PP2"")))
                    :ARG1 (p2 / phosphorylate-01)
                    :ARG1-of (s / significant-02)))
            :location (c2 / compare-01
                :ARG1 (l / line
                    :name (n3 / name
                        :op1 ""UM"")
                    :mod (c / cell)))
            :polarity -))
    :mod (g / genuine))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (s / substrate
            :mod (g / genuine)
            :domain (p / peptide
                  :ARG0-of (r / represent-01
                        :ARG1 (o / or
                              :op1 (a / amino-acid :mod 576 :name (n / name :op1 ""tyrosine""))
                              :op2 (a2 / amino-acid :mod 577 :name (n2 / name :op1 ""tyrosine""))
                              :part-of (e / enzyme :mod 1 :name (n3 / name :op1 ""FAK"")))))
            :beneficiary (p2 / protein :name (n4 / name :op1 ""Src""))
            :ARG1-of (d / detect-01 :polarity -
                  :time (c2 / compare-01
                        :ARG1 (c3 / cell-line
                              :mod (m / medical-condition :name (n5 / name :op1 ""melanoma"")
                                    :mod (u / uveal))))))
      :ARG2 (d3 / downregulate-01
            :ARG1 (p3 / phosphorylate-01)
            :ARG2 (t / treat-04
                  :ARG2 (a3 / and
                        :op1 (p4 / protein :name (n6 / name :op1 ""PP1""))
                        :op2 (p5 / protein :name (n7 / name :op1 ""PP2""))))
            :ARG1-of (s4 / significant-02)))","The peptide representing FAK1 Y576/Y577 is a genuine substrate for Src, which was not detected in the UM cell line comparison, but phosphorylation was significantly downregulated by PP1 and PP2 treatments.","(z1 / contrast-01
    :ARG1 (z2 / substrate
              :mod (z3 / genuine)
              :domain (z4 / peptide
                          :ARG0-of (z5 / represent-01
                                       :ARG1 (z6 / enzyme
                                                 :wiki ""Fibroblast_growth_factor_receptor_1""
                                                 :name (z7 / name
                                                           :op1 ""FAK1""
                                                           :op2 ""Y576/Y577""))))
              :purpose (z8 / enzyme
                           :wiki ""Selective_protein_receptor""
                           :name (z9 / name
                                     :op1 ""Src"")
                           :ARG1-of (z10 / detect-01
                                         :polarity -
                                         :ARG0 (z11 / compare-01
                                                    :ARG1 (z12 / cell-line
                                                               :wiki ""Mitogen-activated_protein_kinase""
                                                               :name (z13 / name
                                                                          :op1 ""UM""
                                                                          :op2 ""cell""
                                                                          :op3 ""line"")))))))",0.3333333333333333,0.423728813559322,"(m / multi-sentence
        :snt1 (r / represent-01
            :ARG0 (p / peptide)
            :ARG1 (f / FAK1
                  :ARG1-of (y / Y576/Y577)))
        :snt2 (s / substrate-01
            :ARG0 p
            :ARG1 (s2 / src)
            :mod (g / genuine))
        :snt3 (d / detect-01
            :ARG0 s2
            :ARG1 (c / comparison
                  :ARG1-of (l / line
                        :mod (u / UM))))
        :snt4 (d2 / downregulate-01
            :ARG0 (p2 / phosphorylation)
            :ARG1 (t / treatment
                  :ARG1-of (p3 / PP1))
            :ARG1-of (t2 / treatment
                  :ARG1-of (p4 / PP2))))","(p / peptide
    :mod (r / represent-01
        :ARG1 (f / FAK1
            :mod (y / Y576/Y577)))
    :ARG1-of (s / substrate-01
        :ARG2 (g / genuine)
        :ARG0 (s2 / Src))
    :ARG1-of (d / detect-01
        :polarity -
        :location (c / comparison
            :ARG1 (l / line
                :mod (c2 / cell)
                :mod (u / UM))))
    :ARG1-of (p2 / phosphorylate-01
        :ARG1-of (d2 / downregulate-01
            :degree (s3 / significant)
            :instrument (a / and
                :op1 (t / treatment
                    :mod (p3 / PP1))
                :op2 (t2 / treatment
                    :mod (p4 / PP2))))
        :ARG1-of (c3 / contrast-01)))",-1.0,-1.0
pmid_1956_8237.114,"The kinase activity of metastasis tissue and UM tissue differed marginally (<xref ref-type=""fig"" rid=""fig2"">Figure 2C</xref>), and incubation with PP1 (10 <i>μ</i><sc>M</sc>) resulted in a decimation of kinase activity similar to the inhibition that we observed in UM tissue (<xref ref-type=""fig"" rid=""fig3"">Figure 3B</xref>).","(a3 / and
    :op1 (d2 / differ-02
        :ARG1 (a / activity-06
            :ARG0 (k / kinase)
            :ARG0 (t / tissue
                :mod (m2 / metastasis)))
        :ARG1-of (m / marginal-02)
        :ARG2 (t2 / tissue
            :mod (d3 / disease
                :name (n / name
                    :op1 ""UM"")))
        :example (f / figure
            :mod 3
            :value 10))
    :op2 (r2 / result-01
        :ARG1 a3
        :ARG2 (d / decimate-01
            :ARG1 (a2 / activity-06
                :ARG0 (k2 / kinase))
            :ARG1-of (r / resemble-01
                :ARG2 (i / inhibit-01
                    :ARG1-of (o / observe-01
                        :ARG0 (w / we)
                        :location (t3 / tissue
                            :mod d3))))))
    :rel (c / culture
        :name (n2 / name
            :op1 ""PP1"")))
",test,bio_amr0.8,"(a / and
      :op1 (d / differ-02
            :ARG1 (t2 / tissue
                  :mod (m4 / medical-condition :name (n / name :op1 ""melanoma"")
                        :mod (u / uveal)))
            :ARG2 (t / tissue
                  :ARG1-of (m / metastasize-101))
            :ARG3 (a2 / activity-06
                  :mod (k / kinase))
            :ARG1-of (m2 / marginal-02)
            :ARG1-of (d3 / describe-01
                  :ARG0 (f / figure :mod ""2C"")))
      :op2 (r / result-01
            :ARG1 (i / incubate-01
                  :ARG2 (s / small-molecule
                        :quant (c / concentration-quantity :quant 10
                              :unit (m3 / micromolar))))
            :ARG2 (d4 / decimate-01
                  :ARG1 (a4 / activity-06
                        :mod (k2 / kinase)
                        :ARG1-of (r2 / resemble-01
                              :ARG2 (i2 / inhibit-01
                                    :ARG1-of (o / observe-01
                                          :ARG0 (w / we)
                                          :location t2)))))
            :ARG1-of (d5 / describe-01
                  :ARG0 (f2 / figure :mod ""3B""))))","The kinase activity of metastasis tissue and UM tissue differed marginally (<xref ref-type=""fig"" rid=""fig2"">Figure 2C</xref>), and incubation with PP1 (10 <i>μ</i><sc>M</sc>) resulted in a decimation of kinase activity similar to the inhibition that we observed in UM tissue (<xref ref-type=""fig"" rid=""fig3"">Figure 3B</xref>).","(z1 / and
    :op1 (z2 / differ-02
             :ARG1 (z3 / activity-06
                       :ARG0 (z4 / kinase)
                       :ARG1 (z5 / tissue
                                 :ARG0-of (z6 / metastasis-01)))
             :ARG2 (z7 / activity-06
                       :ARG0 (z8 / tissue
                                 :ARG0-of z6
                                 :mod (z9 / disease
                                          :wiki ""Mitogen-activated_protein_kinase""
                                          :name (z10 / name
                                                     :op1 ""UM""))))
             :ARG1-of (z11 / describe-01
                           :ARG0 (z12 / figure
                                      :mod ""Figure_2C""))
             :degree (z13 / marginal-02))
    :op2 (z14 / result-01
              :ARG1 (z15 / incubate-01
                         :ARG2 (z16 / enzyme
                                    :wiki ""PP1""
                                    :name (z17 / name
                                               :op1 ""PP1"")
                                    :ARG1-of (z18 / resemble-01
                                                  :ARG2 (z19 / inhibit-01
                                                             :ARG1-of (z20 / observe-01
                                                                           :ARG0 (z21 / we)
                                                                           :location z7)))))
              :ARG2 (z22 / decimate-01
                         :ARG1 (z23 / activity-06
                                    :ARG0 (z24 / kinase)))))",0.5765765765765766,0.5283018867924528,"(m / multi-sentence
        :snt1 (d / differ-01
            :ARG1 (a / activity
                  :mod (k / kinase)
                  :ARG1-of (t / tissue
                        :mod (m / metastasis)))
            :ARG2 (t2 / tissue
                  :mod (u / UM)))
        :snt2 (r / result-01
            :ARG1 (d2 / decimation
                  :ARG1 (a2 / activity
                        :mod (k2 / kinase)))
            :ARG2 (i / inhibition
                  :ARG1 (o / observe-01
                        :ARG0 (w / we)
                        :ARG1 (t3 / tissue
                              :mod (u2 / UM))))
            :ARG3 (i2 / incubation
                  :ARG1 (w2 / with
                        :ARG2 (p / PP1
                              :quant (10 / 10
                                    :unit (m2 / micro
                                          :unit (m3 / M)))))))","(a / and
    :op1 (d / differ-01
        :ARG1 (a2 / activity
            :mod (k / kinase))
        :ARG2 (t / tissue
            :mod (m / metastasis))
        :ARG3 (t2 / tissue
            :mod (u / UM))
        :degree (m2 / marginal)
        :ARG4 (f / figure :name (n / name :op1 ""2C"")))
    :op2 (r / result-01
        :ARG1 (d2 / decimate-01
            :ARG1 a2
            :ARG2 (i / inhibit-01
                :ARG1 a2
                :ARG2 (t3 / tissue
                    :mod u)
                :ARG0 (w / we)
                :ARG1-of (o / observe-01))
            :mod (p / PP1)
            :mod (m3 / measure-quantity :quant 10 :unit ""μM""))
        :ARG2-of (i2 / incubate-01)
        :ARG3 (f2 / figure :name (n2 / name :op1 ""3B""))))",-1.0,0.3333333333333333
pmid_1956_8237.115,"To validate Src activity, Mel270 was transfected with two siRNA constructs that target Src and reduced kinase activity (<xref ref-type=""fig"" rid=""fig3"">Figure 3B</xref>).","(e2 / express-03
    :purpose (v / validate-01
        :ARG1 (a / activity-06
            :ARG0 (s / small-molecule
                :name (n2 / name
                    :op1 ""siRNA""
                    :op1 ""Src""))))
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""Mel""
            :op2 270))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 3))
    :ARG2 (c / construct-01
        :quant 2
        :ARG0-of (t / target-01
            :ARG1 e)
        :ARG0-of (r / reduce-01
            :ARG1 (a2 / activity-06))
        :ARG2 (s2 / small-molecule
            :name (n3 / name
                :op1 ""kinase""))))
",test,bio_amr0.8,"(a / and
      :op1 (t / transfect-01
            :ARG1 (c / cell-line :name (n / name :op1 ""Mel270""))
            :ARG2 (c2 / construct :quant 2
                  :mod (n4 / nucleic-acid :name (n2 / name :op1 ""siRNA""))
                  :ARG0-of (t2 / target-01
                        :ARG1 (p / protein :name (n3 / name :op1 ""Src"")))))
      :op2 (r2 / reduce-01
            :ARG1 (a2 / activity-06
                  :mod (k / kinase)))
      :purpose (v / validate-01
            :ARG1 (a3 / activity-06
                  :ARG0 p))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""3B"")))","To validate Src activity, Mel270 was transfected with two siRNA constructs that target Src and reduced kinase activity (<xref ref-type=""fig"" rid=""fig3"">Figure 3B</xref>).","(z1 / transfect-01
    :ARG1 (z2 / enzyme
              :wiki ""Mitogen-activated_protein_kinase""
              :name (z3 / name
                        :op1 ""Mel270""))
    :ARG2 (z4 / construct
              :quant 2
              :consist-of (z5 / siRNA)
              :ARG0-of (z6 / target-01
                           :ARG1 (z7 / small-molecule
                                     :wiki ""Selective_serotonin_reuptake_inhibitor""
                                     :name (z8 / name
                                               :op1 ""Src"")))
              :ARG0-of (z9 / reduce-01
                           :ARG1 (z10 / activity-06
                                      :ARG0 z7
                                      :ARG1 (z11 / kinase))))
    :ARG1-of (z12 / describe-01
                  :ARG0 (z13 / figure
                             :mod ""3B""
                             :ARG1-of (z14 / hyperlink-91
                                           :ARG3 (z15 / url-entity
                                                      :value ""xref"")))))",0.4473684210526316,0.4736842105263157,"(m / multi-sentence
        :snt1 (v / validate-01
            :ARG0 (a / activity
                  :mod (s / Src))
            :ARG1 (m / Mel270)
            :ARG2 (t / transfected
                  :ARG1 m
                  :ARG2 (c / construct
                        :ARG1 (s2 / siRNA)
                        :ARG2 (t2 / target-01
                              :ARG1 s))
                  :ARG3 (r / reduce-01
                        :ARG1 (k / kinase-activity))))
            :ARG1-of (f / figure
                  :ARG2 (x / xref
                        :ref-type ""fig""
                        :rid ""fig3""
                        :ARG1 (f2 / figure
                              :name (n / name :op1 ""Figure 3B""))))))","(v / validate-01
    :ARG1 (a / activity
        :ARG0-of (s / src))
    :ARG2 (t / transfect-01
        :ARG0 (m / mel270)
        :ARG1 (c / construct
            :quant 2
            :mod (s2 / sirna)
            :ARG1-of (t2 / target-01
                :ARG1 s))
        :result (r / reduce-01
            :ARG1 (a2 / activity
                :ARG0-of (k / kinase))
            :ARG2 (f / figure
                :mod (n / number :value 3)
                :mod (l / letter :value ""B"")
                :ARG1-of (x / xref
                    :ref-type ""fig""
                    :rid ""fig3"")))))",-1.0,0.2933333333333333
pmid_1956_8237.117,"To investigate whether Src contributes to ERK1/2 activation in Mel270, we analysed the two Src siRNA-transfected cell cultures with the MAPK antibody array.","(a2 / analyze-01
    :purpose (i / investigate-01
        :ARG0 (w / we)
        :ARG1 (t / truth-value
            :polarity-of (c2 / contribute-01
                :ARG0 (e / enzyme
                    :name (n / name
                        :op1 ""Src""))
                :ARG1 (a / activate-01
                    :ARG1 (e2 / enzyme
                        :name (n2 / name
                            :op1 ""ERK""
                            :op2 ""1/2""))
                    :location (w2 / world-region
                        :name (n3 / name
                            :op1 ""Mel""
                            :op2 270))))))
    :ARG0 w
    :ARG1 (c3 / culture
        :quant 2
        :mod (c / cell
            :ARG1-of (e4 / express-03
                :ARG2 (s / small-molecule
                    :name (n4 / name
                        :op1 ""Src""
                        :op2 ""siRNA"")))))
    :instrument (a4 / array
        :mod (a3 / antibody
            :mod (e3 / enzyme
                :name (n5 / name
                    :op1 ""MAPK"")))))
",test,bio_amr0.8,"(a / analyze-01
      :ARG0 (w / we)
      :ARG1 (c / culture :quant 2
            :mod (c2 / cell)
            :ARG1-of (t / transfect-01
                  :ARG2 (n6 / nucleic-acid :name (n / name :op1 ""siRNA"")))
            :mod (p2 / protein :name (n3 / name :op1 ""Src"")))
      :instrument (a2 / array-01
            :ARG1 (a3 / antibody
                  :ARG0-of (c5 / counter-01
                        :ARG1 (e2 / enzyme :name (n2 / name :op1 ""MAPK"")))))
      :purpose (i / investigate-01
            :ARG0 w
            :ARG1 (c3 / contribute-01 :mode interrogative
                  :ARG0 p2
                  :ARG1 (a4 / activate-01
                        :ARG1 (e / enzyme :name (n4 / name :op1 ""ERK1/2""))
                        :location (c4 / cell-line :name (n5 / name :op1 ""Mel270""))))))","To investigate whether Src contributes to ERK1/2 activation in Mel270, we analysed the two Src siRNA-transfected cell cultures with the MAPK antibody array.","(z1 / analyze-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / culture
              :quant 2
              :mod (z4 / cell)
              :ARG1-of (z5 / transfect-01
                           :ARG2 (z6 / siRNA
                                     :mod (z13 / contribute-01
                                               :ARG0 (z14 / small-molecule
                                                          :wiki ""Selective_serotonin_reuptake_inhibitor""
                                                          :name (z15 / name
                                                                     :op1 ""Src""))
                                               :ARG2 (z16 / activate-01
                                                          :ARG1 (z17 / enzyme
                                                                     :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                                     :name (z18 / name
                                                                                :op1 ""ERK1/2""))
                                                          :location (z19 / enzyme
                                                                         :wiki ""Mitogen-activated_protein_kinase""
                                                                         :name (z20 / name
                                                                                    :op1 ""Mel270"")))))))
    :instrument (z7 / array
                    :consist-of (z8 / antibody
                                    :mod (z9 / enzyme
                                             :wiki ""MAPK""
                                             :name (z10 / name
                                                        :op1 ""MAPK""))))
    :purpose (z11 / investigate-01
                  :ARG0 z2
                  :ARG1 (z12 / truth-value
                             :polarity-of z13)))",0.5294117647058824,0.4271844660194175,"(s / sentence
        :ARG0 (i / investigate-01
              :ARG1 (c / contribute-01
                    :ARG1 (s2 / Src)
                    :ARG2 (a / activation
                          :ARG1 (e / ERK1/2)))
              :ARG2 (a2 / analyse-01
                    :ARG1 (c2 / culture
                          :ARG1 (c3 / cell
                                :mod (t / transfected
                                      :ARG1 (s3 / siRNA
                                            :mod (t2 / two))))
                          :mod (a3 / antibody
                                :mod (a4 / array
                                      :mod (m / MAPK)))))
              :ARG3 (m2 / Mel270)
              :condition (w / whether))","(i / investigate-01
    :purpose (c / contribute-01
        :ARG0 (s / Src)
        :ARG1 (a / activate-01
            :ARG0 s
            :ARG1 (p / protein
                :name (n / name :op1 ""ERK1"" :op2 ""/"" :op3 ""2""))
            :location (m / Mel270)))
    :ARG1 (a2 / analyze-01
        :ARG0 (w / we)
        :ARG1 (c2 / culture-01
            :mod (c3 / cell)
            :ARG1-of (t / transfected-01
                :ARG1 (s2 / siRNA
                    :mod (s3 / Src))
                :ARG2 (t2 / two)))
        :instrument (a3 / array-01
            :mod (a4 / antibody)
            :mod (m2 / MAPK))))",-1.0,0.3516483516483516
pmid_1956_8237.131,"A western analysis of Src expression in UM and metastasis tissue revealed a very high Src expression in only one out of three primary UM, whereas all three metastasis tissues displayed medium expression of Src protein (<xref ref-type=""fig"" rid=""fig6"">Figure 6C</xref>).","(c / contrast-01
    :ARG1 (r / reveal-01
        :ARG0 (a2 / analyze-01
            :ARG1 (e / express-03
                :ARG2 (p2 / protein
                    :name (n3 / name
                        :op1 ""Src""))
                :location (a3 / and
                    :op1 (t / tissue
                        :mod (d2 / disease
                            :name (n2 / name
                                :op1 ""UM"")))
                    :op2 (t2 / tissue
                        :mod (m2 / metastasis))))
            :mod (w / world-region
                :name (n / name
                    :op1 ""West"")))
        :ARG1 (e2 / express-03
            :quant (o / one
                :ARG1-of (i / include-91)
                :mod (o2 / only))
            :ARG1-of (h / high-02
                :degree (v / very))
            :ARG2 d2))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 6))
    :ARG2 (d3 / display-01
        :ARG0 (t3 / tissue
            :quant 3
            :mod (a / all))
        :ARG1 (e3 / express-03
            :ARG1 p2
            :mod (m / medium)))
    :rel (p / primary))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (r / reveal-01
            :ARG0 (a / analyze-01
                  :ARG1 (e / express-03
                        :ARG2 (p / protein :name (n2 / name :op1 ""Src""))
                        :ARG3 (a2 / and
                              :op1 (m6 / medical-condition :name (n3 / name :op1 ""melanoma"")
                                    :mod (u / uveal))
                              :op2 (t / tissue
                                    :mod (m / metastasis))))
                  :mod (w / western))
            :ARG1 (e2 / express-03
                  :ARG2 p
                  :ARG3 (m4 / medical-condition :quant 1 :name (n4 / name :op1 ""melanoma"")
                        :ARG1-of (i / include-91
                              :ARG2 (m5 / medical-condition :quant 3 :name (n5 / name :op1 ""melanoma"")
                                    :mod (p2 / primary)
                                    :mod u))
                        :mod u)
                  :ARG1-of (h / high-02
                        :degree (v / very))
                  :mod (o / only)))
      :ARG2 (d4 / display-01
            :ARG0 (t2 / tissue :quant 3
                  :ARG1-of (m2 / metastasize-101)
                  :mod (a3 / all))
            :ARG1 (e3 / express-03
                  :ARG2 p
                  :degree (m3 / medium)))
      :ARG1-of (d5 / describe-01
            :ARG0 (f / figure :mod ""6C"")))","A western analysis of Src expression in UM and metastasis tissue revealed a very high Src expression in only one out of three primary UM, whereas all three metastasis tissues displayed medium expression of Src protein (<xref ref-type=""fig"" rid=""fig6"">Figure 6C</xref>).","(z1 / contrast-01
    :ARG1 (z2 / reveal-01
              :ARG0 (z3 / analyze-01
                        :ARG0 (z4 / world-region
                                  :wiki ""Western_world""
                                  :name (z5 / name
                                            :op1 ""West""))
                        :ARG1 (z6 / express-01
                                  :ARG1 (z7 / protein
                                            :wiki ""Selective_receptor_potential_channel_channel""
                                            :name (z8 / name
                                                      :op1 ""Src""))
                                  :location (z9 / and
                                                :op1 (z10 / tissue
                                                          :mod (z11 / disease
                                                                    :wiki ""Mitogen-activated_protein_receptor""
                                                                    :name (z12 / name
                                                                               :op1 ""UM"")))
                                                :op2 (z13 / tissue
                                                          :ARG0-of (z14 / metastase-01)))))
              :ARG1 (z15 / express-01
                         :ARG1 z7
                         :ARG1-of (z16 / high-02
                                       :degree (z17 / very))
                         :location (z18 / tissue
                                        :quant 1
                                        :ARG1-of (z19 / include-91
                                                      :ARG2 (z20 / tissue
                                                                 :quant 3
                                                                 :mod (z21 / primary)
                                                                 :mod z10)
                                                      :mod (z22 / only))))))",0.4251968503937008,0.5777777777777777,"(m / multi-sentence
        :snt1 (r / reveal-01
            :ARG0 (a / analysis
                  :mod (w / western))
            :ARG1 (e / expression
                  :ARG0 (s / Src)
                  :ARG1 (t / tissue
                        :mod (m / metastasis)
                        :mod (u / UM)
                        :mod (p / primary
                              :quant (t2 / three)))
                  :ARG2 (h / high
                        :degree (v / very)))
            :ARG2 (t2 / tissue
                  :mod (m2 / metastasis)
                  :mod (u2 / UM)
                  :mod (p2 / primary
                        :quant (t3 / three)))
            :ARG3 (e2 / expression
                  :ARG0 s
                  :ARG1 t2
                  :ARG2 (m3 / medium)))
        :snt2 (d / display-01
            :ARG0 (t4 / tissue
                  :mod (m4 / metastasis)
                  :mod (t5 / three))
            :ARG1 (e3 / expression
                  :ARG0 s
                  :ARG1 (p3 / protein
                        :mod (S / Src)))
            :ARG2 (e4 / expression
                  :ARG0 s
                  :ARG1 (p4 / protein
                        :mod (S2 / Src)))
            :ARG3 (x / xref
                  :ref-type ""fig""
                  :rid ""fig6""
                  :ARG1 (f / figure
                        :mod (c / cite
                              :op1 ""Figure 6C"")))))","(a / analysis
    :mod (w / western)
    :ARG1 (e / express-01
        :ARG1 (s / src)
        :location (u / UM)
        :location (m / metastasis
            :mod (t / tissue)))
    :ARG2 (r / reveal-01
        :ARG0 a
        :ARG1 (e2 / express-01
            :ARG1 s
            :degree (h / high
                :degree (v / very))
            :location (u2 / UM
                :quant (o / one)
                :part (t2 / three
                    :mod (p / primary)))
            :contrast (e3 / express-01
                :ARG1 s
                :degree (m2 / medium)
                :location (m3 / metastasis
                    :mod (t3 / tissue)
                    :quant (t4 / three)))))
    :medium (f / figure
        :name (n / name
            :op1 ""6C"")
        :mod (x / xref
            :ref-type ""fig""
            :rid ""fig6"")))",-1.0,0.24
pmid_1991_9690.11,"There is a high level of ERK1/2 phosphorylation in WM9 cells, indicating an activated Ras-Raf-MEK-ERK1/2 MAPK pathway.","(p / phosphorylate-01
    :ARG0-of (i / indicate-01
        :ARG1 (e2 / enzyme
            :name (n2 / name
                :op1 ""B-Raf""
                :op2 ""MAPK""
                :op3 ""pathway"")
            :ARG1-of (a / activate-01)))
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""ERK""
            :op2 ""1/2""))
    :location (c / cell
        :name (n3 / name
            :op1 ""WM9""))
    :mod (l / level
        :ARG1-of (h / high-02))
    :rel ""1/2"")
",test,bio_amr0.8,"(l2 / level
      :ARG1-of (h / high-02)
      :quant-of (p / phosphorylate-01
            :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2""))
            :location (c / cell-line :name (n3 / name :op1 ""WM9"")))
      :ARG0-of (i / indicate-01
            :ARG1 (p3 / pathway :name (n4 / name :op1 ""Ras-Raf-MEK-ERK1/2"" :op2 ""MAPK"")
                  :ARG1-of (a / activate-01))))","There is a high level of ERK1/2 phosphorylation in WM9 cells, indicating an activated Ras-Raf-MEK-ERK1/2 MAPK pathway.","(z1 / phosphorylate-01
    :ARG1 (z2 / enzyme
              :wiki ""Extracellular_signal–regulated_kinase_1/2""
              :name (z3 / name
                        :op1 ""ERK1/2""
                        :op2 ""phosphorylate""
                        :op3 ""phosphorylate""))
    :location (z4 / cell
                  :wiki ""Mitogen-activated_protein_kinase""
                  :name (z5 / name
                            :op1 ""WM9""))
    :ARG0-of (z6 / indicate-01
                 :ARG1 (z7 / activate-01
                           :ARG1 (z8 / pathway
                                     :wiki ""BRAF/MEK""
                                     :name (z9 / name
                                               :op1 ""Ras-Raf-MEK-ERK1/2""
                                               :op2 ""MAPK"")))))",0.4150943396226415,0.5454545454545454,"(s / sentence
        :snt (i / indicate-01
              :ARG1 (l / level
                    :mod (h / high))
              :ARG2 (p / phosphorylation
                    :ARG1 (e / ERK1/2))
              :ARG3 (c / cell
                    :mod (w / WM9)))
        :snt (a / activate-01
              :ARG0 (p2 / pathway
                    :mod (m / MAPK
                          :mod (e2 / ERK1/2
                                :mod (r / Ras-Raf-MEK-ERK1/2))))))","(e / exist-01
    :ARG1 (l / level
        :degree (h / high)
        :topic (p / phosphorylate-01
            :ARG1 (e2 / ERK1/2))
        :location (c / cell
            :name (n / name :op1 ""WM9""))))
    :condition (i / indicate-01
        :ARG1 (a / activate-01
            :ARG1 (p2 / pathway
                :name (n2 / name :op1 ""Ras-Raf-MEK-ERK1/2"" :op2 ""MAPK"")))))",-1.0,-1.0
pmid_1991_9690.12,"Treatment of WM9 cells with 30 μM U0126 MEK inhibitor, decreased ERK1/2 phosphorylation and resulted in a decrease in HIF-1α expression.","(a / and
    :op1 (t / treat-03
        :ARG1 (c / cell-line))
    :op2 (d / decrease-01
        :ARG0 t
        :ARG1 (p / phosphorylate-01
            :ARG1 (e3 / enzyme
                :name (n3 / name
                    :op1 ""ERK""
                    :op2 ""1/2""))))
    :op3 (r / result-01
        :ARG1 t
        :ARG2 (d2 / decrease-01
            :ARG1 (e5 / express-03
                :ARG2 (e4 / enzyme
                    :name (n4 / name
                        :op1 1)))))
    :rel (b / binding-affinity-91
        :ARG2 (c2 / concentration-quantity
            :quant 30
            :mod 0126
            :unit (n5 / nanomolar)))
    :rel (e2 / enzyme
        :name (n2 / name
            :op1 ""MEK""))
    :rel (i / inhibit-01
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""WM9"")
            :name n4)))
",test,bio_amr0.8,"(a / and
      :op1 (d / decrease-01
            :ARG0 (t2 / treat-04
                  :ARG1 (c / cell-line :name (n3 / name :op1 ""WM9""))
                  :ARG2 (s2 / small-molecule :name (n4 / name :op1 ""U0126"")
                        :ARG0-of (i2 / inhibit-01
                              :ARG1 (p / protein-family :name (n5 / name :op1 ""MEK"")))
                        :quant (c2 / concentration-quantity :quant 30
                              :unit (m / micromolar))))
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (e2 / enzyme :name (n6 / name :op1 ""ERK1/2""))))
      :op2 (r / result-01
            :ARG1 t2
            :ARG2 (d2 / decrease-01
                  :ARG1 (e3 / express-03
                        :ARG2 (p3 / protein :name (n7 / name :op1 ""HIF-1α""))))))","Treatment of WM9 cells with 30 μM U0126 MEK inhibitor, decreased ERK1/2 phosphorylation and resulted in a decrease in HIF-1α expression.","(z1 / decrease-01
    :ARG0 (z2 / treat-03
              :ARG1 (z3 / cell
                        :wiki ""Mitogen-activated_protein_kinase""
                        :name (z4 / name
                                  :op1 ""WM9""))
              :ARG2 (z5 / inhibitor
                        :wiki ""U0126_inhibitor""
                        :name (z6 / name
                                  :op1 ""U0126""
                                  :op2 ""MEK"")
                        :quant (z7 / product-of
                                   :op1 (z8 / mass-quantity
                                            :quant 30
                                            :unit (z9 / microgram))
                                   :op2 (z10 / mass-quantity
                                             :quant 1
                                             :unit (z11 / milligram))))))",0.2894736842105263,0.5,"(t / treatment-01
    :ARG0 (c / cell-line :wiki ""WM9"")
    :ARG1 (i / inhibit-01
        :ARG0 c
        :ARG1 (m / mek-inhibitor
            :quant (n / number :op1 30 :op2 ""μM"")))
    :ARG2 (d / decrease-01
        :ARG1 (p / phosphorylation
            :ARG0 (e / erk1/2))
        :ARG2 (e2 / expression
            :ARG1 (h / hif-1α))))","(t / treat-01
    :ARG0 (c / chemical
          :name (n / name :op1 ""U0126"" :op2 ""MEK"" :op3 ""inhibitor"")
          :quant (q / quantity :value 30 :unit ""μM""))
    :ARG1 (c2 / cell
          :name (n2 / name :op1 ""WM9""))
    :result (a / and
        :op1 (d / decrease-01
              :ARG1 (p / phosphorylate-01
                    :ARG1 (m / molecule
                          :name (n3 / name :op1 ""ERK1/2""))))
        :op2 (d2 / decrease-01
              :ARG1 (e / express-01
                    :ARG1 (m2 / molecule
                          :name (n4 / name :op1 ""HIF-1α""))))))",-1.0,0.5176470588235293
pmid_1991_9690.13,"However, a 24 h treatment with 10 μM U0126 totally eliminated Erk1/2 phosphorylation, but did not change HIF-1alpha levels.","(c2 / contrast-01
    :ARG2 (c3 / contrast-01
        :ARG1 (e / eliminate-01
            :ARG0 (t2 / treat-04
                :ARG1 (s2 / small-molecule
                    :name (n2 / name
                        :op1 10)
                    :mod 0126
                    :unit (n5 / nanomolar))
                :ARG2 (s / small-molecule
                    :name (n / name)
                    :name n2))
            :ARG1 (p / phosphorylate-01
                :ARG1 (e2 / enzyme
                    :name (n3 / name
                        :op1 ""Erk""
                        :op2 ""1/2"")
                    :name (n4 / name
                        :op1 1)))
            :degree (t / total))
        :ARG2 (c / change-01
            :ARG0 t2
            :ARG1 (l / level
                :mod e2)
            :polarity -))
    :rel 24)
",test,bio_amr0.8,"(c / contrast-01
      :ARG2 (c2 / contrast-01
            :ARG1 (e / eliminate-01
                  :ARG0 (t / treat-04
                        :ARG2 (s / small-molecule :name (n / name :op1 ""U0126"")
                              :quant (c3 / concentration-quantity :quant 10
                                    :unit (m / micromolar)))
                        :duration (t2 / temporal-quantity :quant 24
                              :unit (h / hour)))
                  :ARG1 (p / phosphorylate-01
                        :ARG1 (e2 / enzyme :name (n2 / name :op1 ""ERK1/2"")))
                  :degree (t3 / total))
            :ARG2 (c4 / change-01 :polarity -
                  :ARG0 t
                  :ARG1 (l / level
                        :quant-of (p2 / protein :name (n3 / name :op1 ""HIF-1alpha""))))))","However, a 24 h treatment with 10 μM U0126 totally eliminated Erk1/2 phosphorylation, but did not change HIF-1alpha levels.","(z1 / contrast-01
    :ARG2 (z2 / contrast-01
              :ARG1 (z3 / eliminate-01
                        :ARG0 (z4 / treat-03
                                  :ARG2 (z5 / small-molecule
                                            :wiki ""U-N-Dimethyltryptamine""
                                            :name (z6 / name
                                                      :op1 ""U0126"")
                                            :quant (z7 / concentration-quantity
                                                       :quant 10
                                                       :unit (z8 / microsievert)
                                                       :unit (z9 / milligram)))
                                  :duration (z10 / temporal-quantity
                                                 :quant 24
                                                 :unit (z11 / hour))))
              :ARG1 (z12 / phosphorylate-01
                         :ARG1 (z13 / enzyme
                                    :wiki ""Erk1/2_phosphorylate-01""
                                    :ARG1 (z14 / enzyme
                                               :wiki ""Erk1/2""
                                               :name (z15 / name
                                                          :op1 ""Erk1/2"")))
                         :degree (z16 / total)))
    :ARG2 (z17 / change-01
               :polarity -
               :ARG0 z4
               :ARG1 (z18 / level
                          :mod (z19 / enzyme
                                    :wiki ""Histidine-activated_protein_kinase_1""
                                    :name (z20 / name
                                               :op1 ""HIF-1alpha"")))))",0.5744680851063829,0.5476190476190476,"(s / sentence
        :ARG0 (e / eliminate-01
              :ARG1 (p / phosphorylation
                    :ARG1 (e2 / Erk1/2)))
        :ARG1 (c / change-01
              :ARG1 (l / level
                    :ARG1 (h / HIF-1alpha)))
        :time (t / time
              :duration (h2 / hour
                    :quant 24))
        :mod (t2 / treatment
              :ARG1 (u / U0126
                    :quant 10
                    :unit (m / microM))))","(e / eliminate-01
    :ARG1 (p / phosphorylate-01
        :ARG1 (m / molecule
            :name (n / name :op1 ""Erk1/2"")))
    :time (t / treat-01
        :ARG1 (m2 / molecule
            :name (n2 / name :op1 ""U0126""))
        :ARG2 (t2 / time :quant 24 :unit ""h"")
        :degree (a / amount-01
            :quant 10
            :unit ""μM""))
    :mod (t3 / total)
    :condition (c / contrast-01
        :ARG1 (c2 / change-01
            :ARG0 (m3 / molecule
                :name (n3 / name :op1 ""HIF-1alpha""))
            :polarity -)
        :ARG2 (h / however)))",-1.0,0.4691358024691358
pmid_1991_9690.52,"Figure <xref ref-type=""fig"" rid=""F1"">1A</xref> shows that HIF-1α protein is highly expressed in WM9 cells relative to normal human melanocyte (HEMn-LP), but radial growth phase (SbCl2), and vertical growth phase (WM1366) also express a higher amount of HIF-1α protein relative to human melanocytes.","(s / show-01
    :ARG0 (f / figure
        :mod (u / url-entity))
    :ARG1 (c2 / contrast-01
        :ARG1 (e2 / express-03
            :ARG1 (p3 / protein
                :name (n / name
                    :op1 ""ha""))
            :ARG1-of (r2 / relative-05
                :ARG2 (m / melanocyte
                    :ARG1-of (n4 / normal-02)
                    :mod (h4 / human)))
            :degree (h2 / high-02)
            :location (c / cell
                :name (n2 / name
                    :op1 ""WM9"")))
        :ARG2 (e / express-01
            :ARG0 (a3 / and
                :op1 (p / phase
                    :name (n3 / name
                        :op1 ""SbCl2"")
                    :mod (g / grow-01)
                    :mod (r / radial))
                :op2 (p2 / phase
                    :mod (g2 / grow-01
                        :mod (v / vertical))
                    :mod 1366))
            :ARG1 (a2 / amount
                :ARG1-of (h / have-degree-91
                    :ARG2 (h3 / high-02)
                    :ARG3 (m3 / more))
                :quant-of (p4 / protein
                    :name n
                    :ARG1-of (r3 / relative-05
                        :ARG2 (m2 / melanocytes
                            :part-of (h5 / human)))
                    :part p3))
            :mod (a / also))))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (f / figure :mod ""1A"")
      :ARG1 (c / contrast-01
            :ARG1 (e / express-03
                  :ARG2 (p / protein :name (n / name :op1 ""HIF-1α""))
                  :ARG3 (c2 / cell-line :name (n2 / name :op1 ""WM9""))
                  :ARG1-of (h2 / high-02)
                  :ARG1-of (r / relative-05
                        :ARG3 (m3 / melanocyte
                              :ARG1-of (n9 / normal-02)
                              :mod (h3 / human)
                              :ARG1-of (m2 / mean-01
                                    :ARG2 (c7 / cell-line :name (n8 / name :op1 ""HEMn-LP""))))))
            :ARG2 (e2 / express-03
                  :ARG2 (a3 / amount-01
                        :ARG1 p
                        :ARG1-of (h / high-02
                              :degree (m / more)))
                  :ARG3 (a / and
                        :op1 (p2 / phase
                              :mod (g / grow-01
                                    :manner (r2 / radius))
                              :example (c4 / cell-line :name (n5 / name :op1 ""SbCI2"")))
                        :op2 (p3 / phase
                              :mod (g2 / grow-01
                                    :manner (v / vertical))
                              :example (c5 / cell-line :name (n6 / name :op1 ""WM1366""))))
                  :mod (a2 / also)
                  :ARG1-of (r3 / relative-05
                        :mod (m4 / melanocyte
                              :mod h3)))))","Figure <xref ref-type=""fig"" rid=""F1"">1A</xref> shows that HIF-1α protein is highly expressed in WM9 cells relative to normal human melanocyte (HEMn-LP), but radial growth phase (SbCl2), and vertical growth phase (WM1366) also express a higher amount of HIF-1α protein relative to human melanocytes.","(z1 / contrast-01
    :ARG1 (z2 / show-01
              :ARG0 (z3 / figure
                        :mod ""1A"")
              :ARG1 (z4 / express-03
                        :ARG1 (z5 / protein
                                  :wiki ""HIF-1α""
                                  :name (z6 / name
                                            :op1 ""HIF-1α""
                                            :op2 ""protein""))
                        :ARG1-of (z7 / high-02)
                        :location (z8 / cell
                                      :wiki ""WBC1""
                                      :name (z9 / name
                                                :op1 ""WM9""))
                        :ARG1-of (z10 / relative-05
                                      :ARG2 (z11 / melanocyte
                                                 :ARG1-of (z12 / normal-02)
                                                 :mod (z13 / human)
                                                 :ARG1-of (z14 / normal-02)
                                                 :ARG1-of (z15 / mean-01
                                                               :ARG2 (z16 / enzyme
                                                                          :wiki ""Histidine-rich_amino_acid""
                                                                          :name (z17 / name
                                                                                     :op1 ""HEMn-LP""))))))))",0.3620689655172414,0.4583333333333333,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (f / figure
                  :ARG1 (x / xref
                        :ref-type ""fig""
                        :rid ""F1"")
                  :ARG2 (p / protein
                        :ARG1-of (e / express-01
                              :ARG0 p
                              :ARG1 (c / cell
                                    :mod (w / wm9)
                                    :mod (h / human
                                          :ARG0-of (m / melanocyte
                                                :mod (n / normal)
                                                :mod (l / lp))))
                              :ARG2 (h2 / hif-1α))))
            :ARG1 (r / relative-to
                  :ARG2 (h3 / human
                        :ARG0-of (m2 / melanocyte))))
        :snt2 (e2 / express-01
            :ARG0 (p2 / protein
                  :ARG1-of (h4 / higher
                        :ARG1 (a / amount)
                        :ARG2 (h5 / hif-1α)))
            :ARG2 (h6 / human
                  :ARG0-of (m3 / melanocyte)))
        :snt3 (e3 / express-01
            :ARG0 (p3 / protein
                  :ARG1-of (h7 / higher
                        :ARG1 (a2 / amount)
                        :ARG2 (h8 / hif-1α)))
            :ARG2 (p4 / phase
                  :mod (g / growth
                        :mod (r / radial)
                        :ARG0-of (s2 / sbcl2)))
            :ARG2-of (e4 / express-01
                  :ARG0 p3
                  :ARG1 (c2 / cell
                        :mod (g2 / growth
                              :mod (v / vertical)
                              :mod (p5 / phase
                                    :ARG0-of (w2 / wm1366)))))))","(s / show-01
    :ARG0 (f / figure :name (n / name :op1 ""1A""))
    :ARG1 (e / express-01
        :ARG0 (p / protein :name (n2 / name :op1 ""HIF-1α""))
        :ARG1 (c / cell :name (n3 / name :op1 ""WM9""))
        :degree (h / high)
        :compared-to (c2 / cell
            :mod (h2 / human)
            :mod (m / melanocyte)
            :name (n4 / name :op1 ""HEMn-LP"")))
    :ARG2 (e2 / express-01
        :ARG0 p
        :ARG1 (p2 / phase
            :mod (r / radial)
            :mod (g / growth)
            :name (n5 / name :op1 ""SbCl2""))
        :degree (h3 / high)
        :compared-to c2)
    :ARG3 (e3 / express-01
        :ARG0 p
        :ARG1 (p3 / phase
            :mod (v / vertical)
            :mod g
            :name (n6 / name :op1 ""WM1366""))
        :degree h3
        :compared-to c2)
    :conjunction (a / and))",-1.0,0.3703703703703704
pmid_1991_9690.57,"Initially we used semi-quantitative RT-PCR to assess expression of HIF-1α full length (FL) and a splice variant HIF-1α785 that is missing the acetylation site lys<sup>532 </sup>due to lack of exon 11 (Fig. <xref ref-type=""fig"" rid=""F2"">2A</xref>).","(u / use-01
    :ARG0 (w / we)
    :ARG1-of (d / describe-01
        :ARG0 (f / figure))
    :ARG2 (a2 / assess-01
        :ARG0 w
        :ARG1 (e6 / express-03
            :ARG1 (a / and
                :op1 (e2 / enzyme
                    :name (n3 / name
                        :op1 ""no""
                        :op1 ""histidine-rich""
                        :op2 2
                        :op2 ""full""))
                :op2 (e3 / enzyme
                    :name (n4 / name)
                    :mod (s2 / splice))
                :op3 (e4 / enzyme
                    :name (n6 / name
                        :op1 ""exon""
                        :op2 11)
                    :ARG0-of (m / miss-01
                        :ARG1 (l / lack-01
                            :ARG1 e4))))))
    :rel (e / enzyme
        :name (n / name
            :op3 ""phosphate"")
        :name (n2 / name
            :op1 ""food""
            :op2 ""son""
            :op2 (t / ""tax""
                :purpose n2)))
    :rel (e5 / enzyme
        :name (n5 / name
            :op1 785
            :op1 ""acetylation""
            :op2 ""site""
            :op3 532))
    :rel (s / semi)
    :time (i / initial))
",test,bio_amr0.8,"(u / use-01
      :ARG0 (w / we)
      :ARG1 (t / thing :name (n / name :op1 ""RT-PCR"")
            :mod (q / quantitative
                  :degree (s / semi)))
      :ARG2 (a / assess-01
            :ARG0 w
            :ARG1 (a2 / and
                  :op1 (e / express-03
                        :ARG2 (p / protein :name (n2 / name :op1 ""HIF-1α""))
                        :ARG1-of (l / long-03
                              :degree (f / full)))
                  :op2 (v / variant
                        :ARG1-of (s2 / splice-01)
                        :ARG1-of (m2 / mean-01
                              :ARG2 (p2 / protein :name (n4 / name :op1 ""HIF-1α785"")))
                        :ARG0-of (m / miss-01
                              :ARG1 (s3 / site-01
                                    :ARG0-of (a4 / acetylate-01)
                                    :mod (a3 / amino-acid :mod 532 :name (n3 / name :op1 ""lysine"")))
                              :ARG1-of (c / cause-01
                                    :ARG0 (l2 / lack-01
                                          :ARG1 (e2 / exon :mod 11)))))))
      :time (i / initial)
      :ARG1-of (d / describe-01
            :ARG0 (f2 / figure :mod ""2A"")))","Initially we used semi-quantitative RT-PCR to assess expression of HIF-1α full length (FL) and a splice variant HIF-1α785 that is missing the acetylation site lys<sup>532 </sup>due to lack of exon 11 (Fig. <xref ref-type=""fig"" rid=""F2"">2A</xref>).","(z1 / use-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / enzyme
              :wiki ""RT-PCR""
              :name (z4 / name
                        :op1 ""RT-PCR"")
              :mod (z5 / quantitative
                       :degree (z6 / semi)))
    :ARG2 (z7 / assess-01
              :ARG0 z2
              :ARG1 (z8 / express-01
                        :ARG1 (z9 / and
                                  :op1 (z10 / enzyme
                                            :wiki ""Inositol-activated_protein_kinase""
                                            :name (z11 / name
                                                       :op1 ""HIF-1α""
                                                       :op2 ""full-length""
                                                       :op3 ""(F3000 / FL)""))
                                  :op2 (z12 / enzyme
                                            :wiki ""HIF-1α785""
                                            :name (z13 / name
                                                       :op1 ""HIF-1α785"")
                                            :mod (z14 / variant
                                                      :mod (z15 / splice-01)
                                                      :ARG0-of (z16 / miss-01
                                                                    :ARG1 (z17 / enzyme
                                                                               :wiki ""Lys532""
                                                                               :name (z18 / name
                                                                                          :op1 ""Lys""
                                                                                          :op2 ""532"")
                                                                               :part-of (z19 / site
                                                                                             :mod (z20 / acetylation)))
                                                                    :ARG1-of (z21 / cause-01
                                                                                  :ARG0 (z22 / lack-01
                                                                                             :ARG1 (z23 / exon
                                                                                                        :mod 11
                                                                                                        :part-of (z24 / enzyme
                                                                                                                      :wiki ""Fibroblast_growth_factor_receptor_2A""
                                                                                                                      :name (z25 / name
                                                                                                                                 :op1 ""exon""
                                                                                                                                 :op2 ""11""))))))))))))",0.46875,0.3779527559055118,"(s / sentence
        :ARG0 (w / we)
        :ARG1 (u / use-01
              :ARG1 (a / assess-01
                    :ARG1 (e / expression
                          :ARG1 (f / full
                                :mod (l / length
                                      :mod (h / HIF-1α)))
                          :ARG1 (v / variant
                                :mod (s2 / splice)
                                :ARG1 (h2 / HIF-1α785
                                      :mod (m / missing
                                            :ARG1 (s3 / site
                                                  :mod (a2 / acetylation)
                                                  :ARG1 (l2 / lys<sup>532</sup>)))
                                      :ARG1-of (d / due-to
                                            :ARG1 (l3 / lack
                                                  :ARG1 (e2 / exon
                                                        :mod (n / number :op1 ""11"")))))))
              :ARG2 (r / RT-PCR
                    :mod (s4 / semi-quantitative)))
        :ARG2 (f2 / figure
              :mod (x / xref
                    :ref-type ""fig""
                    :rid ""F2""
                    :op1 ""2A"")))","(i / initially
    :op1 (u / use-01
        :ARG0 (w / we)
        :ARG1 (a / assess-01
            :ARG0 w
            :ARG1 (e / express-01
                :ARG1 (a2 / and
                    :op1 (h / have-org-role-91
                        :ARG0 (h2 / hif-1α)
                        :ARG1 (f / full-length))
                    :op2 (s / splice-01
                        :ARG0 (v / variant
                            :mod (h3 / hif-1α785))
                        :ARG1 (m / miss-01
                            :ARG1 (s2 / site
                                :mod (a3 / acetylation))
                            :due-to (l / lack-01
                                :ARG1 (e2 / exon-11)))))))
        :instrument (r / rt-pcr
            :mod (s3 / semi-quantitative)))
    :op2 (f2 / figure :wiki -
        :name (n / name :op1 ""2A"")))",-1.0,0.2777777777777778
pmid_1991_9690.61,"Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref> shows that human melanoma cell lines express both full-length and the 785 splice variant HIF-1α mRNA at a level that appeared to be higher than normal human melanocytes.","(s / show-01
    :ARG0 (f / figure)
    :ARG1 (e / express-01
        :quant (l / level
            :ARG1-of (h2 / high-02
                :ARG1-of (a / appear-02)
                :ARG2-of (h / have-degree-91
                    :ARG1 l
                    :ARG3 (m2 / more)
                    :ARG4 (c2 / cell
                        :ARG1-of (n3 / normal-02)
                        :mod (h3 / human)))))
        :ARG0 (l2 / line
            :consist-of (c / cell
                :mod h3))
        :ARG1 (o / organization
            :name (n2 / name
                :op1 785
                :op2 (m3 / ""mutate-01""
                    :ARG2 (s2 / splice)))
            :ARG1-of m3
            :mod (l3 / long-03
                :mod (f2 / full))))
    :rel (n / name
        :op1 ""Dem""
        :op2 ""mRNA"")
    :rel (m / melanoma))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (f / figure :mod ""2B"")
      :ARG1 (e / express-03
            :ARG2 (a / and
                  :op1 (n6 / nucleic-acid :name (n2 / name :op1 ""mRNA"")
                        :ARG0-of (e2 / encode-01
                              :ARG1 (p / protein :name (n3 / name :op1 ""HIF-1α"")
                                    :ARG1-of (l3 / long-03
                                          :degree (f2 / full)))))
                  :op2 (n7 / nucleic-acid :name (n4 / name :op1 ""mRNA"")
                        :ARG0-of (e3 / encode-01
                              :ARG1 (v / variant
                                    :ARG1-of (s2 / splice-01)
                                    :ARG1-of (m2 / mean-01
                                          :ARG2 (p2 / protein :name (n5 / name :op1 ""HIF-1α785"")))))))
            :ARG3 (c / cell-line
                  :mod (m4 / medical-condition :name (n / name :op1 ""melanoma""))
                  :mod (h2 / human))
            :manner (l2 / level
                  :ARG1-of (a2 / appear-01)
                  :ARG1-of (h / high-02
                        :degree (m / more)
                        :compared-to (m3 / melanocyte
                              :ARG1-of (n8 / normal-02)
                              :mod (h3 / human))))))","Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref> shows that human melanoma cell lines express both full-length and the 785 splice variant HIF-1α mRNA at a level that appeared to be higher than normal human melanocytes.","(z1 / show-01
    :ARG0 (z2 / figure
              :mod ""2B"")
    :ARG1 (z3 / express-01
              :ARG0 (z4 / cell
                        :mod (z5 / melanoma
                                 :mod (z6 / human)))
              :ARG1 (z7 / and
                        :op1 (z8 / protein
                                 :wiki ""Mitogen-activated_protein_kinase_1α""
                                 :name (z9 / name
                                           :op1 ""HIF-1α""
                                           :op2 ""mRNA"")
                                 :ARG1-of (z10 / long-03
                                               :degree (z11 / full)))
                        :op2 (z12 / protein
                                  :wiki ""HIF-1α""
                                  :name (z13 / name
                                             :op1 ""HIF-1α""
                                             :op2 ""mRNA"")
                                  :ARG1-of (z14 / mutate-01
                                                :ARG2 (z15 / splice-01))
                                  :ARG1-of (z16 / statistical-test-91
                                                :ARG2 785))))
    :ARG2 (z17 / level
               :ARG1-of (z18 / have-degree-91
                             :ARG2 (z19 / high-02
                                        :ARG1 z17)
                             :ARG3 (z20 / more)
                             :ARG4 (z21 / level
                                        :ARG1-of (z22 / appear-02))
                             :ARG4 (z23 / melanocyte
                                        :ARG1-of (z24 / normal-02)
                                        :mod z6))))",0.3770491803278689,0.336283185840708,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (f / figure
                  :ARG1 (i / id
                        :op1 ""2B"")
                  :ARG2 (c / cell-line
                        :mod (h / human
                              :mod (m / melanoma)))
                  :ARG3 (e / express-01
                        :ARG0 c
                        :ARG1 (a / and
                              :op1 (f2 / full-length
                                    :mod (v / variant
                                          :ARG1 (m2 / mRNA
                                                :mod (h2 / HIF-1α
                                                      :mod (h3 / human))))
                                    :mod (l / level
                                          :ARG1 (a2 / appear-01
                                                :ARG1 (h4 / higher
                                                      :mod (n / normal
                                                            :mod (m3 / melanocyte))))))))))","(s / show-01
    :ARG0 (f / figure :name (n / name :op1 ""2B""))
    :ARG1 (a / and
        :op1 (e / express-01
            :ARG0 (l / line
                :mod (c / cell
                    :mod (m / melanoma
                        :mod (h / human))))
            :ARG1 (m2 / mRNA
                :mod (h2 / HIF-1α)
                :mod (f2 / full-length)))
        :op2 (e2 / express-01
            :ARG0 l
            :ARG1 (m3 / mRNA
                :mod h2
                :mod (v / variant
                    :mod (s / splice)
                    :mod (n2 / number :value 785))))
    :ARG2 (a2 / appear-01
        :ARG1 (h3 / high-02
            :degree (t / than
                :op1 (e3 / express-01
                    :ARG0 (m4 / melanocyte
                        :mod (h4 / human)
                        :mod (n3 / normal))
                    :ARG1 (m5 / mRNA
                        :mod h2
                        :mod f2)
                    :ARG1-of (t2 / than-01
                        :ARG2 e2))
                :op2 e3))))",-1.0,-1.0
pmid_1991_9690.71,"In contrast overexpression of both HIF-1αFL and HIF-α785 in SbCl2 resulted in a large and significant 3-fold increase in Matrigel invasion relative to mock or Lacz transfected cells (Fig. <xref ref-type=""fig"" rid=""F4"">4B</xref>).","(c3 / contrast-01
    :ARG2 (r2 / result-01
        :ARG1 (e / engineer-01
            :ARG1 (a / and
                :op1 (s2 / small-molecule
                    :name (n / name
                        :op1 ""histidine-rich""
                        :op2 ""healthy""))
                :op2 (s3 / small-molecule
                    :name (n2 / name
                        :op1 ""HIF""
                        :op3 785))))
        :ARG1-of (d / describe-01
            :ARG0 (f / figure
                :ARG7 4
                :mode imperative
                :polite +))
        :ARG2 (i / increase-01
            :ARG1 (i2 / invade-01
                :ARG0 (d2 / disease
                    :name (n4 / name
                        :op1 ""Matrigel"")))
            :ARG1-of (s / significant-02)
            :ARG1-of (r / relative-05
                :ARG2 (o / or
                    :op1 (c / cell
                        :ARG1-of (e3 / express-03
                            :ARG2 (e2 / enzyme
                                :name (n5 / name
                                    :op1 ""Lacz"")))
                        :ARG1-of (m / mock-01))
                    :op2 (c2 / cell
                        :ARG1-of (e4 / express-03
                            :ARG2 e2))))
            :ARG3 (t / times
                :quant 3)
            :mod (l / large)))
    :rel (s4 / small-molecule
        :name (n3 / name
            :op1 ""SbCl2"")))
",test,bio_amr0.8,"(c / contrast-01
      :ARG2 (r / result-01
            :ARG1 (o / overexpress-01
                  :ARG1 (a / and
                        :op1 (p / protein :name (n / name :op1 ""HIF-1α"")
                              :ARG1-of (l4 / long-03
                                    :degree (f / full)))
                        :op2 (p2 / protein :name (n2 / name :op1 ""HIF-1α785"")))
                  :location (c2 / cell-line :name (n3 / name :op1 ""SbCl2"")))
            :ARG2 (i / increase-01
                  :ARG1 (i2 / invade-01
                        :ARG0 (p4 / protein :name (n4 / name :op1 ""matrigel"")))
                  :ARG2 (p3 / product-of :op1 3)
                  :mod (l3 / large)
                  :ARG1-of (s / significant-02)
                  :ARG1-of (r2 / relative-05
                        :ARG3 (t2 / transfect-01
                              :ARG1 (c5 / cell)
                              :ARG2 (o3 / or
                                    :op1 (v / vector
                                          :mod (m / mock))
                                    :op2 (p5 / protein :name (n6 / name :op1 ""lacz"")))))))
      :ARG1-of (d / describe-01
            :ARG0 (f2 / figure :mod ""4B"")))","In contrast overexpression of both HIF-1αFL and HIF-α785 in SbCl2 resulted in a large and significant 3-fold increase in Matrigel invasion relative to mock or Lacz transfected cells (Fig. <xref ref-type=""fig"" rid=""F4"">4B</xref>).","(z1 / result-01
    :ARG1 (z2 / overexpress-01
              :ARG1 (z3 / and
                        :op1 (z4 / small-molecule
                                 :wiki ""Inositol_trisphosphate_receptor_1""
                                 :name (z5 / name
                                           :op1 ""HIF-1αFL""))
                        :op2 (z6 / small-molecule
                                 :wiki ""SbCl2""
                                 :name (z7 / name
                                           :op1 ""HIF-α785""))
                        :part-of (z8 / small-molecule
                                     :wiki ""SbCl2""
                                     :name (z9 / name
                                               :op1 ""SbCl2""))))
    :ARG2 (z10 / increase-01
               :ARG1 (z11 / invade-01
                          :ARG0 (z12 / matrigel))
               :ARG2 (z13 / times
                          :quant 3
                          :ARG1-of (z14 / significant-02)
                          :mod (z15 / large)
                          :ARG1-of (z16 / compare-01
                                        :ARG2 (z17 / or
                                                   :op1 (z18 / cell
                                                             :ARG1-of (z19 / mock-01)
                                                             :ARG1-of (z20 / transfect-01
                                                                           :ARG2 (z21 / enzyme
                                                                                      :wiki ""Lactin-activated_protein_kinase""
                                                                                      :name (z22 / name
                                                                                                 :op1 ""Lacz""))))
                                                   :op2 (z23 / cell
                                                             :ARG1-of (z24 / transfect-01
                                                                           :ARG2 z21))))))
    :ARG1-of (z25 / describe-01
                  :ARG0 (z26 / figure
                             :mod ""Fig.4B""))
    :ARG1-of (z27 / contrast-01))",0.359375,0.4848484848484848,"(m / multi-sentence
        :snt1 (c / contrast-01
            :ARG1 (o / overexpression-01
                  :ARG0 (h / HIF-1αFL)
                  :ARG1 (a / and
                        :op1 (h2 / HIF-α785)
                        :op2 (r / result-01
                              :ARG0 (i / in
                                    :ARG1 (c2 / cell-line :wiki ""SbCl2"" :name (n / name :op1 ""SbCl2"")))
                              :ARG1 (i2 / increase-01
                                    :ARG1 (i3 / invasion
                                          :mod (m / Matrigel))
                                    :ARG2 (f / fold
                                          :quant 3)
                                    :ARG3 (r2 / relative-to
                                          :op1 (c3 / cell
                                                :mod (m2 / mock))
                                          :op2 (c4 / cell
                                                :mod (t / transfected
                                                      :ARG1 (l / Lacz))))))))
        :snt2 (f / figure
            :ARG1 (x / xref
                  :ref-type ""fig""
                  :rid ""F4"")
            :op1 ""4B""))","(r / result-01
    :ARG1 (i / increase-01
        :ARG1 (i2 / invade-01
            :ARG1 (c / cell
                :mod (t / transfected-01
                    :ARG1 (m / mock)
                    :ARG2 (l / Lacz)))
            :ARG2 (m2 / Matrigel))
        :degree (l2 / large)
        :degree (s / significant)
        :quant (f / fold-01 :op1 3))
    :ARG2 (o / overexpress-01
        :ARG1 (a / and
            :op1 (h / HIF-1αFL)
            :op2 (h2 / HIF-α785))
        :location (s2 / SbCl2))
    :condition (c2 / contrast-01)
    :mod (f2 / figure :wiki - :name (n / name :op1 ""4B"")))",-1.0,0.3047619047619048
pmid_1991_9690.80,These knock down studies suggest that increased non-hypoxic expression of HIF-1α plays an important role in key malignant properties exhibited by these human melanoma cells.,"(s2 / suggest-01
    :ARG0 (s / study-01
        :ARG0-of (k2 / knock-down-02)
        :mod (t / this))
    :ARG1 (p / play-02
        :ARG0 (e4 / express-03
            :ARG1 (e2 / enzyme
                :name (n / name
                    :op1 ""Hindu""))
            :ARG1-of (i2 / increase-01)
            :mod (e / Defense
                :polarity -))
        :ARG1 (r / role
            :ARG1-of (i / important-01))
        :topic (p2 / property
            :ARG1-of (k / key-02)
            :ARG1-of (e3 / exhibit-01
                :ARG0 (c / cell
                    :mod (m2 / melanoma)
                    :mod (h / human)
                    :mod (t2 / this)))
            :mod (m / malignant))))
",test,bio_amr0.8,"(s / suggest-01
      :ARG0 (s2 / study-01
            :ARG1 (k / knock-down-02)
            :mod (t / this))
      :ARG1 (p / play-02
            :ARG0 (e / express-03
                  :ARG2 (p2 / protein :wiki ""HIF1A""
                        :name (n / name :op1 ""HIF-1α""))
                  :mod (h / hypoxic :polarity -)
                  :ARG1-of (i / increase-01))
            :ARG1 (r / role
                  :mod (i2 / important)
                  :topic (p3 / property
                        :ARG1-of (m / malignant-02)
                        :ARG1-of (k2 / key-02)
                        :ARG1-of (e2 / exhibit-01
                              :ARG0 (c / cell
                                    :mod (m2 / medical-condition :wiki ""Melanoma""
                                          :name (n2 / name :op1 ""melanoma""))
                                    :mod (h2 / human)
                                    :mod (t2 / this)))))))",These knock down studies suggest that increased non-hypoxic expression of HIF-1α plays an important role in key malignant properties exhibited by these human melanoma cells.,"(z1 / suggest-01
    :ARG0 (z2 / study
              :mod (z3 / this)
              :ARG0-of (z4 / knock-down-05))
    :ARG1 (z5 / play-02
              :ARG0 (z6 / increase-01
                        :ARG1 (z7 / express-02
                                  :ARG1 (z8 / small-molecule
                                            :wiki ""Histidine-rich_factor_receptor_1""
                                            :name (z9 / name
                                                      :op1 ""HIF-1α""))
                                  :mod (z10 / hypoxic
                                            :polarity -)))
              :ARG1 (z11 / role
                         :ARG1-of (z12 / important-01)
                         :topic (z13 / property
                                     :ARG1-of (z14 / key-02)
                                     :mod (z15 / malignant)
                                     :ARG1-of (z16 / exhibit-01
                                                   :ARG0 (z17 / cell
                                                              :mod (z18 / melanoma)
                                                              :mod (z19 / human)
                                                              :mod (z20 / this)))))))",0.6,0.6741573033707866,"(s / suggest-01
        :ARG0 (s2 / study-01
              :ARG1 (k / knock-down-01
                    :ARG1 (e / expression-01
                          :ARG1 (i / increase-01
                                :ARG1 (e2 / expression-01
                                      :ARG1 (h / HIF-1α)
                                      :ARG2 (n / non-hypoxic)))
                          :ARG2 (p / play-01
                                :ARG1 (r / role
                                      :ARG1 (p2 / property
                                            :mod (m / malignant)
                                            :mod (k2 / key))
                                      :ARG2 (c / cell
                                            :mod (m2 / melanoma)
                                            :mod (h2 / human))))
                                :ARG2 (e2 / exhibit-01
                                      :ARG1 c))))
              :ARG2 (t / that)))","(s / suggest-01
    :ARG0 (s2 / study
        :mod (k / knock-down)
        :mod (t / this))
    :ARG1 (p / play-01
        :ARG0 (e / express-01
            :ARG1 (h / hif-1α)
            :ARG2 (c / cell
                :mod (h2 / human)
                :mod (m / melanoma))
            :degree (i / increase-01)
            :condition (n / non-hypoxic))
        :ARG1 (r / role
            :mod (i2 / important)
            :ARG1-of (e2 / exhibit-01
                :ARG0 c
                :ARG1 (p2 / property
                    :mod (m2 / malignant)
                    :mod (k2 / key))))))",-1.0,0.4761904761904763
pmid_1991_9690.82,"Hypoxia independent expression of HIF-1α is thought to be regulated by growth signaling pathways [<xref ref-type=""bibr"" rid=""B18"">18</xref>,<xref ref-type=""bibr"" rid=""B19"">19</xref>] and the majority of melanomas have constitutively active ERK1/2 MAPK pathway due to BRAF or N-Ras mutations [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>].","(a2 / and
    :op1 (t / think-01
        :ARG1 (r / regulate-01
            :ARG0 (s2 / stage
                :ARG0-of (s / signal-07
                    :ARG1 (g / grow-01)))
            :ARG1 (e3 / express-03
                :ARG0-of (d / depend-01)
                :ARG1 (e / enzyme
                    :name (n3 / name
                        :op1 ""ERK""
                        :op1 ""BRAF""
                        :op2 ""white""
                        :op2 ""1/2""
                        :op3 ""MAPK"")))))
    :op2 (h / have-03
        :ARG0 (d3 / disease
            :name (n4 / name
                :op1 ""kilogram""))
        :ARG1 (p / pathway
            :ARG0-of (a / activity-06
                :ARG1-of (c2 / constitute-01))
            :mod (e2 / enzyme
                :name n3))
        :ARG1-of (c / cause-01
            :ARG0 (o / or
                :op1 (m2 / mutate-01
                    :ARG1 e)
                :op2 (m3 / mutate-01
                    :ARG1 e2))))
    :rel (n / name
        :op1 ""Hypoxia"")
    :rel (n2 / name
        :op1 ""histidine-rich"")
    :rel (d2 / disease
        :name n3
        :quant (m / majority))
    :rel (n5 / name
        :op1 ""nuke""))
",test,bio_amr0.8,"(a2 / and
      :op1 (t / think-01
            :ARG1 (r / regulate-01
                  :ARG0 (p3 / pathway
                        :ARG0-of (s / signal-07
                              :ARG1 (g / grow-01)))
                  :ARG1 (e / express-03
                        :ARG2 (p2 / protein :name (n2 / name :op1 ""HIF-1α""))
                        :ARG0-of (d / depend-01 :polarity -
                              :ARG1 (h / hypoxia))))
            :ARG1-of (d2 / describe-01
                  :ARG0 (p4 / publication
                        :ARG1-of (c / cite-01
                              :ARG2 (a / and :op1 18 :op2 19)))))
      :op2 (h2 / have-03
            :ARG0 (m4 / medical-condition :name (n3 / name :op1 ""melanoma"")
                  :quant (m / majority)
                  :ARG1-of (i / include-91
                        :ARG2 (m5 / medical-condition :name (n4 / name :op1 ""melanoma""))))
            :ARG1 (p5 / pathway :name (n5 / name :op1 ""ERK1/2"" :op2 ""MAPK"")
                  :mod (c2 / constitutive)
                  :ARG1-of (c3 / cause-01
                        :ARG0 (o / or
                              :op1 (m2 / mutate-01
                                    :ARG1 (e2 / enzyme :name (n6 / name :op1 ""BRAF"")))
                              :op2 (m3 / mutate-01
                                    :ARG1 (e3 / enzyme :name (n7 / name :op1 ""N-Ras"")))))
                  :ARG0-of (a5 / activity-06))
            :ARG1-of (d5 / describe-01
                  :ARG0 (p6 / publication
                        :ARG1-of (c4 / cite-01
                              :ARG2 (a4 / and :op1 14 :op2 15))))))","Hypoxia independent expression of HIF-1α is thought to be regulated by growth signaling pathways [<xref ref-type=""bibr"" rid=""B18"">18</xref>,<xref ref-type=""bibr"" rid=""B19"">19</xref>] and the majority of melanomas have constitutively active ERK1/2 MAPK pathway due to BRAF or N-Ras mutations [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>].","(z1 / think-01
    :ARG1 (z2 / regulate-01
              :ARG0 (z3 / pathway
                        :ARG0-of (z4 / signal-07
                                     :ARG1 (z5 / grow-01))
                        :ARG0-of (z6 / channel-01
                                     :ARG1 (z7 / protein
                                               :wiki ""Mitogen-activated_protein_kinase_1""
                                               :name (z8 / name
                                                         :op1 ""HIF-1α"")
                                               :ARG1-of (z9 / express-01
                                                            :ARG0-of (z10 / depend-01
                                                                          :polarity -
                                                                          :ARG0 (z11 / hypoxia))))))
              :ARG1-of (z12 / hyperlink-91
                            :ARG3 (z13 / url-entity
                                       :value 18))))",0.2372881355932203,0.4313725490196078,"(m / multi-sentence
        :snt1 (t / think-01
            :ARG0 (e / expression
                  :ARG1 (i / independent
                        :ARG1-of (h / hypoxia))
                  :ARG2 (h2 / HIF-1α)))
        :snt2 (r / regulate-01
            :ARG0 (p / pathway
                  :mod (s / signaling)
                  :mod (g / growth))
            :ARG1 e)
        :snt3 (h3 / have-03
            :ARG0 (m2 / majority)
            :ARG1 (m3 / melanoma)
            :ARG2 (a / active
                  :ARG1 (p2 / pathway
                        :mod (m4 / MAPK)
                        :mod (e2 / ERK1/2)))
            :ARG3 (d / due-to
                  :ARG1 (m5 / mutation
                        :mod (b / BRAF)
                        :mod (n / N-Ras))))
        :snt4 (c / constitutively)
        :snt5 (a2 / and
            :op1 (x / xref
                  :ref-type ""bibr""
                  :rid ""B18""
                  :op1 ""18"")
            :op2 (x2 / xref
                  :ref-type ""bibr""
                  :rid ""B19""
                  :op1 ""19""))
        :snt6 (a3 / and
            :op1 (x3 / xref
                  :ref-type ""bibr""
                  :rid ""B14""
                  :op1 ""14"")
            :op2 (x4 / xref
                  :ref-type ""bibr""
                  :rid ""B15""
                  :op1 ""15"")))","(t / think-01
    :ARG1 (r / regulate-01
        :ARG1 (e / express-01
            :ARG0 (h / HIF-1α)
            :condition (i / independent
                :ARG1 (h2 / hypoxia)))
        :ARG2 (p / pathway
            :mod (g / grow-01)
            :mod (s / signal-01)))
    :source (p2 / person
        :quant (m / majority)
        :ARG0-of (h3 / have-03
            :ARG1 (p3 / pathway
                :mod (a / active-04
                    :degree (c / constant))
                :mod (m2 / MAPK)
                :mod (e2 / ERK1/2)
                :ARG1-of (d / due-01
                    :ARG2 (m3 / mutation
                        :ARG1 (o / or
                            :op1 (b / BRAF)
                            :op2 (n / N-Ras)))))))",-1.0,-1.0
pmid_1991_9690.83,"Therefore, we determined whether HIF-1α expression in human metastatic melanoma WM9 cells was dependent on activation of ERK1/2 MAPK signaling.","(c / cause-01
    :ARG1 (d2 / determine-01
        :ARG0 (w / we)
        :ARG1 (t / truth-value
            :polarity-of (d / depend-01
                :ARG0 (c2 / cell
                    :name (n / name
                        :op1 ""CHO-K1"")
                    :ARG1-of (e3 / express-03
                        :ARG1 (e / enzyme
                            :name (n4 / name
                                :op1 ""ERK"")
                            :ARG0-of (e4 / express-03
                                :ARG1 e)))
                    :part-of (d3 / disease
                        :name (n3 / name
                            :op1 ""melanoma"")
                        :mod (m / metastatic)))
                :ARG1 (a / activate-01))))
    :rel (n2 / name
        :op1 ""histidine-rich""
        :op1 ""WM9"")
    :rel (e2 / enzyme
        :name (n5 / name
            :op2 ""1/2""
            :op3 ""MAPK""))
    :rel (h / human))
",test,bio_amr0.8,"(c / cause-01
      :ARG1 (d / determine-01
            :ARG0 (w / we)
            :ARG1 (d2 / depend-01 :mode interrogative
                  :ARG0 (e / express-03
                        :ARG2 (p2 / protein :name (n2 / name :op1 ""HIF-1α""))
                        :ARG3 (c2 / cell-line :name (n3 / name :op1 ""WM9"")
                              :mod (m / medical-condition :name (n4 / name :op1 ""melanoma""))
                              :mod (h / human)
                              :ARG1-of (m2 / metastasize-101)))
                  :ARG1 (a / activate-01
                        :ARG1 (s / signal-07
                              :ARG0 (p3 / pathway :name (n5 / name :op1 ""ERK1/2"" :op2 ""MAPK"")))))))","Therefore, we determined whether HIF-1α expression in human metastatic melanoma WM9 cells was dependent on activation of ERK1/2 MAPK signaling.","(z1 / cause-01
    :ARG1 (z2 / determine-01
              :ARG0 (z3 / we)
              :ARG1 (z4 / truth-value
                        :polarity-of (z5 / depend-01
                                         :ARG0 (z6 / express-03
                                                   :ARG1 (z7 / small-molecule
                                                             :wiki ""Histidine-rich_factor_receptor_1""
                                                             :name (z8 / name
                                                                       :op1 ""HIF-1α""))
                                                   :location (z9 / cell
                                                                 :wiki ""Mitogen-activated_protein_kinase""
                                                                 :name (z10 / name
                                                                            :op1 ""WM9"")
                                                                 :part-of (z11 / melanoma
                                                                               :mod (z12 / metastatic)
                                                                               :mod (z13 / human))))
                                         :ARG1 (z14 / activate-01
                                                    :ARG1 (z15 / activate-01
                                                               :ARG1 (z16 / channel-01
                                                                          :ARG1 (z17 / protein
                                                                                     :wiki ""ERK1/2""
                                                                                     :name (z18 / name
                                                                                                :op1 ""ERK1/2""
                                                                                                :op2 ""MAPK"")))))))))",0.4578313253012048,0.3720930232558139,"(d / determine-01
    :ARG0 (w / we)
    :ARG1 (e / expression
        :ARG0 (h / HIF-1α)
        :ARG1 (c / cell
            :mod (m / metastatic)
            :mod (m2 / melanoma
                :mod (h2 / human
                    :mod (w2 / WM9))))
        :ARG2 (d2 / depend-01
            :ARG1 (a / activation
                :ARG0 (s / signal
                    :mod (m3 / MAPK)
                    :mod (e2 / ERK1/2))))))","(d / determine-01
    :ARG0 (w / we)
    :ARG1 (d2 / depend-01
        :ARG1 (e / express-01
            :ARG0 (p / protein :name ""HIF-1α"")
            :ARG1 (c / cell
                :mod (m / melanoma
                    :mod (m2 / metastatic)
                    :mod (h / human))
                :name ""WM9""))
        :ARG2 (a / activate-01
            :ARG1 (s / signal-01
                :mod (m3 / MAPK)
                :mod (e2 / ERK1/2))))
    :condition (t / therefore))",-1.0,-1.0
pmid_1991_9690.84,"These cells have an active ERK1/2 MAPK pathway as evidenced by the high phosphorylation of ERK (Fig. <xref ref-type=""fig"" rid=""F6"">6A</xref>).","(h / have-03
    :ARG0 (c / cell
        :mod (t / this))
    :ARG1 (p / pathway
        :ARG0-of (a / activity-06)
        :mod (e / enzyme
            :name (n / name
                :op1 ""ERK""
                :op3 ""MAPK"")))
    :ARG1-of (e2 / evidence-01
        :ARG0 (p2 / phosphorylate-01
            :ARG1 e
            :ARG1-of (h2 / high-02)))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 6))
    :rel (n2 / name
        :op2 ""1/2""))
",test,bio_amr0.8,"(h / have-03
      :ARG0 (c / cell
            :mod (t / this))
      :ARG1 (p4 / pathway :name (n3 / name :op1 ""ERK1/2"" :op2 ""MAPK"")
            :ARG0-of (a2 / activity-06))
      :ARG1-of (e / evidence-01
            :ARG0 (p2 / phosphorylate-01
                  :ARG1 (e2 / enzyme :name (n2 / name :op1 ""ERK""))
                  :ARG1-of (h2 / high-02)))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""6A"")))","These cells have an active ERK1/2 MAPK pathway as evidenced by the high phosphorylation of ERK (Fig. <xref ref-type=""fig"" rid=""F6"">6A</xref>).","(z1 / have-03
    :ARG0 (z2 / cell
              :mod (z3 / this))
    :ARG1 (z4 / pathway
              :mod (z5 / enzyme
                       :wiki ""Mitogen-activated_protein_kinase_1/2""
                       :name (z6 / name
                                 :op1 ""ERK1/2""
                                 :op2 ""MAPK""))
              :ARG0-of (z7 / activity-06))
    :ARG0-of (z8 / evidence-01
                 :ARG1 (z9 / phosphorylate-01
                           :ARG1 (z10 / enzyme
                                      :wiki ""ERK1/6""
                                      :name (z11 / name
                                                 :op1 ""ERK""
                                                 :op2 ""6A""))
                           :ARG1-of (z12 / high-02)))
    :ARG1-of (z13 / describe-01
                  :ARG0 (z14 / figure
                             :mod (z15 / url-entity
                                       :value ""Fig.""))))",0.6363636363636365,0.711864406779661,"(s / sentence
        :snt (h / have-03
            :ARG0 (c / cell)
            :ARG1 (p / pathway
                  :mod (a / active)
                  :ARG1 (m / mapk-pathway
                        :ARG1 (e / erk1/2)
                        :ARG1-of (p2 / phosphorylation
                              :ARG1 (e2 / erk
                                    :mod (h2 / high)
                                    :ARG1-of (f / fig
                                          :ref-type ""fig""
                                          :rid ""F6""
                                          :op1 ""6A"")))))))","(e / evidence-01
    :ARG1 (h / have-03
        :ARG0 (c / cell
            :mod (t / this))
        :ARG1 (p / pathway
            :mod (a / active)
            :name (n / name
                :op1 ""ERK1/2""
                :op2 ""MAPK"")))
    :ARG2 (p2 / phosphorylate-01
        :ARG1 (e2 / ERK)
        :degree (h2 / high))
    :source (f / figure
        :name (n2 / name :op1 ""6A"")))",-1.0,0.5
pmid_1991_9690.85,"Treatment of WM9 cells with 30 μM U0126, a selective U0126 MEK inhibitor, decreased ERK1/2 phosphorylation and led to a time-dependent decrease in HIF-1α protein expression (Fig. <xref ref-type=""fig"" rid=""F6"">6A</xref>).","(a / and
    :ARG1-of (d4 / describe-01
        :ARG0 (f / figure
            :mod 6))
    :op1 (d / decrease-01
        :ARG0 (t2 / treat-03
            :ARG1 (c / cell-line
                :name (n / name
                    :op1 ""WM9""))
            :ARG2 (p2 / protein
                :name (n3 / name
                    :op1 ""MEK"")
                :quant (c2 / concentration-quantity
                    :quant 30
                    :unit (n7 / nanomolar))
                :ARG1-of (s / select-01)))
        :ARG1 (p / phosphorylate-01
            :ARG1 (e2 / enzyme
                :name (n4 / name
                    :op1 ""ERK""
                    :op2 ""1/2""))))
    :op2 (l / lead-03
        :ARG0 t2
        :ARG2 (d2 / decrease-01
            :ARG0-of (d3 / depend-01
                :ARG1 (t / time))
            :ARG1 (e3 / express-03
                :ARG2 (p3 / protein
                    :name (n6 / name
                        :op1 10
                        :op2 ""histidine-rich"")))))
    :rel (n5 / name
        :op1 ""10"")
    :rel (e / enzyme
        :name (n2 / name)
        :ARG0-of (i / inhibit-01
            :ARG1 e)))
",test,bio_amr0.8,"(a / and
      :op1 (d / decrease-01
            :ARG0 (t2 / treat-04
                  :ARG1 (c / cell-line :name (n3 / name :op1 ""WM9""))
                  :ARG2 (s2 / small-molecule :name (n4 / name :op1 ""U0126"")
                        :quant (c2 / concentration-quantity :quant 30
                              :unit (m / micromolar))
                        :ARG1-of (m2 / mean-01
                              :ARG2 (s3 / small-molecule :name (n5 / name :op1 ""U0126"")
                                    :ARG0-of (i / inhibit-01
                                          :ARG1 (p / protein-family :name (n2 / name :op1 ""MEK"")))
                                    :ARG0-of (s / select-01)))))
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (e / enzyme :name (n6 / name :op1 ""ERK1/2""))))
      :op2 (l / lead-03
            :ARG1 t2
            :ARG2 (d2 / decrease-01
                  :ARG1 (e2 / express-03
                        :ARG2 (p3 / protein :name (n7 / name :op1 ""HIF-1α"")))
                  :ARG0-of (d3 / depend-01
                        :ARG1 (t3 / time))))
      :ARG1-of (d4 / describe-01
            :ARG0 (f / figure :mod ""6A"")))","Treatment of WM9 cells with 30 μM U0126, a selective U0126 MEK inhibitor, decreased ERK1/2 phosphorylation and led to a time-dependent decrease in HIF-1α protein expression (Fig. <xref ref-type=""fig"" rid=""F6"">6A</xref>).","(z1 / and
    :op1 (z2 / decrease-01
             :ARG0 (z3 / treat-03
                       :ARG1 (z4 / cell
                                 :wiki ""Mitogen-activated_protein_kinase_1""
                                 :name (z5 / name
                                           :op1 ""WM9""))
                       :ARG2 (z6 / inhibitor
                                 :wiki ""U0126""
                                 :name (z7 / name
                                           :op1 ""U0126"")
                                 :ARG0-of (z8 / inhibit-01
                                              :ARG1 (z9 / enzyme
                                                        :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                        :name (z10 / name
                                                                   :op1 ""MEK"")))
                                 :ARG1-of (z11 / select-01))
                       :quant (z12 / product-of
                                   :op1 (z13 / concentration-quantity
                                             :quant 30
                                             :unit (z14 / μM))
                                   :op2 (z15 / concentration-quantity
                                             :quant 1
                                             :unit (z16 / nanomolar)))))
    :ARG1 (z17 / phosphorylate-01
               :ARG1 (z18 / protein
                          :wiki ""ERK1/2""
                          :name (z19 / name
                                     :op1 ""ERK1/2""))))",0.3928571428571428,0.5396825396825397,"(t / treatment-01
    :ARG0 (c / cell-line :wiki ""WM9"")
    :ARG1 (d / decrease-01
        :ARG1 (p / phosphorylation
            :ARG0 (e / ERK1/2))
        :time (d2 / depend
            :ARG1 (d3 / decrease-01
                :ARG1 (e2 / expression
                    :ARG0 (p2 / protein
                        :mod (a / alpha)
                        :mod (h / HIF-1))))))","(t / treat-01
    :ARG0 (c / chemical
        :name (n / name :op1 ""U0126"")
        :mod (c2 / chemical
            :name (n2 / name :op1 ""U0126"")
            :mod (i / inhibit-01
                :ARG1 (p / protein
                    :name (n3 / name :op1 ""MEK""))
                :mod (s / selective))))
    :ARG1 (c3 / cell
        :name (n4 / name :op1 ""WM9""))
    :ARG2 (m / measure-01
        :ARG1 (u / unit-of-measure :name (n5 / name :op1 ""μM""))
        :value 30)
    :result (a / and
        :op1 (d / decrease-01
            :ARG1 (p2 / phosphorylate-01
                :ARG1 (p3 / protein
                    :name (n6 / name :op1 ""ERK1/2""))))
        :op2 (l / lead-01
            :ARG1 (d2 / decrease-01
                :ARG1 (e / express-01
                    :ARG1 (p4 / protein
                        :name (n7 / name :op1 ""HIF-1α""))
                    :ARG2 (t2 / time
                        :mod (d3 / depend-01)))
                :mod (t3 / time)))))
    :medium (f / figure
        :name (n8 / name :op1 ""6A"")))",-1.0,-1.0
pmid_1991_9690.88,"At 24 h of treatment, 10 μM U0126 completely suppressed the phosphorylation of ERK1/2, yet there was minimal change in the level of HIF-1α relative to control cells.","(s2 / suppress-01
    :ARG0 (s / small-molecule
        :name (n / name
            :op1 10
            :op2 ""U""
            :op3 0126)
        :quant 10)
    :ARG1 (p / phosphorylate-01
        :ARG1 (e / enzyme
            :name (n2 / name
                :op1 ""ERK""
                :op2 ""1/2"")))
    :ARG1-of (c3 / complete-02)
    :concession-of (c2 / change-01
        :ARG1 (l / level
            :mod (e2 / enzyme
                :name (n3 / name
                    :op1 1)))
        :ARG1-of (m / minimal-02)
        :ARG1-of (r / relative-05
            :ARG3 (c / cell
                :ARG0-of (c4 / control-01))))
    :time (t2 / treat-03
        :duration (t / temporal-quantity
            :quant 24
            :unit (h / hour))))
",test,bio_amr0.8,"(s2 / suppress-01
      :ARG0 (s / small-molecule :name (n / name :op1 ""U0126"")
            :quant (c / concentration-quantity :quant 10
                  :unit (m / micromolar)))
      :ARG1 (p / phosphorylate-01
            :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2"")))
      :ARG1-of (c2 / complete-02)
      :ARG1-of (c3 / contrast-01
            :ARG2 (c4 / charge-03
                  :ARG1 (l / level
                        :quant-of (p2 / protein :name (n3 / name :op1 ""HIF-1α"")))
                  :ARG1-of (m2 / minimal-02)
                  :ARG1-of (r / relative-05
                        :ARG3 (c5 / cell
                              :mod (c6 / control)))))
      :time (a / after
            :op1 (t / treat-04)
            :quant (t2 / temporal-quantity :quant 24
                  :unit (h / hour))))","At 24 h of treatment, 10 μM U0126 completely suppressed the phosphorylation of ERK1/2, yet there was minimal change in the level of HIF-1α relative to control cells.","(z1 / suppress-01
    :ARG0 (z2 / small-molecule
              :wiki ""U-N-Dimethyltryptamine""
              :name (z3 / name
                        :op1 ""U0126"")
              :quant (z4 / product-of
                         :op1 10
                         :op2 (z5 / molecular-mass
                                  :quant 1
                                  :unit (z6 / milligram))))
    :ARG1 (z7 / phosphorylate-01
              :ARG1 (z8 / enzyme
                        :wiki ""ERK1/2""
                        :name (z9 / name
                                  :op1 ""ERK1/2"")))
    :ARG1-of (z10 / complete-02)
    :time (z11 / treat-03
               :duration (z12 / temporal-quantity
                              :quant 24
                              :unit (z13 / hour)))
    :concession-of (z14 / change-01
                        :ARG1 (z15 / level
                                   :mod (z16 / enzyme
                                             :wiki ""Histidine-activated_protein_kinase_1α""
                                             :name (z17 / name
                                                        :op1 ""HIF-1α""))
                                   :ARG1-of (z18 / relative-05
                                                 :ARG2 (z19 / level
                                                            :mod (z20 / cell
                                                                      :ARG0-of (z21 / control-01)))))
                        :ARG1-of (z22 / minimal-02)))",0.4901960784313725,0.4946236559139784,"(m / multi-sentence
        :snt1 (s / suppress-01
            :ARG1 (p / phosphorylation
                  :ARG0 (u / u0126)
                  :ARG1 (e / erk1/2))
            :ARG2 (h / hif-1α)
            :degree (c / complete))
        :snt2 (c2 / change-01
            :ARG1 (l / level
                  :ARG1-of (c3 / compare-01
                        :ARG2 (c4 / cell
                              :mod (r / relative)
                              :ARG1-of (c5 / control-01))))
            :ARG2 (m2 / minimal)))","(t / treat-01
    :time (h / hour :quant 24)
    :ARG1 (c / chemical
        :name (n / name :op1 ""U0126"")
        :quant (m / measure :quant 10 :unit ""μM""))
    :result (s / suppress-01
        :ARG1 (p / phosphorylate-01
            :ARG1 (p2 / protein
                :name (n2 / name :op1 ""ERK1/2""))))
    :contrast (c2 / change-01
        :ARG1 (l / level
            :ARG1 (p3 / protein
                :name (n3 / name :op1 ""HIF-1α"")))
        :degree (m2 / minimal)
        :compared-to (c3 / cell
            :mod (c4 / control)))).",-1.0,0.4827586206896552
pmid_1991_9690.90,We also used siRNA specifically targeting MEK1 and 2 in WM9 cells to inhibit ERK1/2 phosphorylation.,"(u / use-01
    :ARG0 (w / we)
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""SSRI"")
        :ARG0-of (t / target-01
            :ARG1 (a2 / and
                :op1 (p2 / protein
                    :name (n2 / name
                        :op1 ""MEK1"")))
            :ARG1-of (s / specific-02)
            :ARG2 (i / inhibit-01
                :ARG0 e
                :ARG1 (p / phosphorylate-01
                    :ARG1 (e2 / enzyme
                        :name (n4 / name
                            :op1 ""ERK""
                            :op2 ""1/2""))))
            :location (c / cell-line
                :name (n3 / name
                    :op1 ""WM9""))))
    :mod (a / also)
    :rel (n5 / name
        :op2 ""2""))
",test,bio_amr0.8,"(u / use-01
      :ARG0 (w / we)
      :ARG1 (n6 / nucleic-acid :name (n / name :op1 ""siRNA"")
            :ARG0-of (t / target-01
                  :ARG1 (a2 / and
                        :op1 (e / enzyme :name (n2 / name :op1 ""MEK1""))
                        :op2 (e2 / enzyme :name (n3 / name :op1 ""MEK2"")))
                  :location (c / cell-line :name (n4 / name :op1 ""WM9""))
                  :manner (s / specific-02)))
      :ARG2 (i / inhibit-01
            :ARG0 n6
            :ARG1 (p / phosphorylate-01
                  :ARG1 (e3 / enzyme :name (n5 / name :op1 ""ERK1/2""))))
      :mod (a / also))",We also used siRNA specifically targeting MEK1 and 2 in WM9 cells to inhibit ERK1/2 phosphorylation.,"(z1 / use-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / siRNA
              :ARG0-of (z4 / target-01
                           :ARG1 (z5 / and
                                     :op1 (z6 / protein
                                              :wiki ""Mitogen-activated_protein_kinase_1""
                                              :name (z7 / name
                                                        :op1 ""MEK1""))
                                     :op2 (z8 / protein
                                              :wiki ""Mitogen-activated_protein_kinase_2""
                                              :name (z9 / name
                                                        :op1 ""MEK1""
                                                        :op2 ""2""))
                                     :location (z10 / cell
                                                    :wiki ""Mitogen-activated_protein_kinase_9""
                                                    :name (z11 / name
                                                               :op1 ""WM9"")))
                           :ARG1-of (z12 / specific-02))
              :purpose (z13 / inhibit-01
                            :ARG0 z3
                            :ARG1 (z14 / phosphorylate-01
                                       :ARG1 (z15 / enzyme
                                                  :wiki ""ERK1/2""
                                                  :name (z16 / name
                                                             :op1 ""ERK1/2"")))))
    :mod (z17 / also))",0.6046511627906977,0.5783132530120483,"(s / specific-01
        :ARG1 (t / target-01
              :ARG1 (m / MEK1)
              :ARG1 (m2 / MEK2))
        :ARG2 (i / inhibit-01
              :ARG1 (p / phosphorylation-01
                    :ARG1 (e / ERK1/2))
              :ARG2 (c / cell
                    :ARG1 (w / WM9)))
        :mod (u / use-01
              :ARG1 (w2 / we)
              :ARG2 t))","(u / use-01
    :ARG0 (w / we)
    :ARG1 (s / siRNA
        :mod (s2 / specific)
        :ARG0-of (t / target-01
            :ARG1 (a / and
                :op1 (m / MEK1)
                :op2 (m2 / MEK2))))
    :location (c / cell
        :name (n / name :op1 ""WM9""))
    :purpose (i / inhibit-01
        :ARG1 (p / phosphorylation
            :ARG1 (a2 / and
                :op1 (e / ERK1)
                :op2 (e2 / ERK2))))
    :mod (a3 / also))",-1.0,0.5066666666666667
pmid_1991_9690.91,Treatment of WM9 cells with siRNA targeting MEK1 and 2 consistently decreased its expression by greater than 90% and also decreased ERK1/2 phosphorylation.,"(a3 / and
    :op1 (d / decrease-01
        :ARG0 (t2 / treat-03
            :ARG1 (c / cell-line)
            :ARG2 (e / enzyme
                :name (n / name
                    :op1 ""WM9"")))
        :ARG1 (e5 / express-03
            :ARG2 c)
        :ARG1-of (c2 / consistent-02)
        :ARG2 (m / more-than
            :op1 (p / percentage-entity
                :value 90)))
    :op2 (d2 / decrease-01
        :ARG0 t2
        :ARG1 (p2 / phosphorylate-01
            :ARG1 (e4 / enzyme
                :name (n4 / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :mod (a / also))
    :rel (e2 / enzyme
        :name (n2 / name
            :op1 ""SSRI"")
        :ARG0-of (t / target-01
            :ARG1 (a2 / and
                :op1 (e3 / enzyme
                    :name (n3 / name
                        :op1 ""MEK1""))
                :op2 (p3 / protein
                    :mod 2)))))
",test,bio_amr0.8,"(a / and
      :op1 (d / decrease-01
            :ARG0 (t / treat-04
                  :ARG1 (c / cell-line :name (n / name :op1 ""WM9""))
                  :ARG2 (n6 / nucleic-acid :name (n2 / name :op1 ""siRNA"")
                        :ARG0-of (t2 / target-01
                              :ARG1 (a2 / and
                                    :op1 (e / enzyme :name (n3 / name :op1 ""MEK1""))
                                    :op2 (e2 / enzyme :name (n4 / name :op1 ""MEK2""))))))
            :ARG1 (e3 / express-03
                  :ARG3 c)
            :ARG2 (m / more-than
                  :op1 (p / percentage-entity :value 90))
            :manner (c2 / consistent-02))
      :op2 (d2 / decrease-01
            :ARG0 t
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (e4 / enzyme :name (n5 / name :op1 ""ERK1/2"")))
            :mod (a3 / also)))",Treatment of WM9 cells with siRNA targeting MEK1 and 2 consistently decreased its expression by greater than 90% and also decreased ERK1/2 phosphorylation.,"(z1 / and
    :op1 (z2 / decrease-01
             :ARG0 (z3 / treat-03
                       :ARG1 (z4 / cell
                                 :wiki ""Mitogen-activated_protein_kinase_1""
                                 :name (z5 / name
                                           :op1 ""MEK1"")
                                 :part-of (z6 / cell
                                              :wiki ""Mitogen-activated_protein_kinase""
                                              :name (z7 / name
                                                        :op1 ""WM9"")))
                       :ARG2 (z8 / siRNA
                                 :ARG0-of (z9 / target-01
                                              :ARG1 (z10 / and
                                                         :op1 (z11 / protein
                                                                   :wiki ""Mitogen-activated_protein_kinase_1""
                                                                   :name (z12 / name
                                                                              :op1 ""MEK1""
                                                                              :op2 ""and""
                                                                              :op3 ""2""))))))
             :ARG1 (z13 / express-01
                        :ARG1 z5)
             :ARG2 (z14 / more-than
                        :op1 (z15 / percentage-entity
                                  :value 90)))
    :op2 (z16 / decrease-01
              :ARG0 z3
              :ARG1 (z17 / phosphorylate-01
                         :ARG1 (z18 / enzyme
                                    :wiki ""ERK1/2""
                                    :name (z19 / name
                                               :op1 ""ERK1/2"")))
              :mod (z20 / also))
    :ARG1-of (z21 / consistent-02))",0.5981308411214953,0.6346153846153846,"(t / treatment-01
    :ARG0 (c / cell :wiki ""WM9"")
    :ARG1 (d / decrease-01
        :ARG1 (e / expression
            :ARG0-of (i / it))
        :degree (g / greater-than
            :op1 90
            :op2 (p / percent)))
    :ARG2 (d2 / decrease-01
        :ARG1 (p2 / phosphorylation
            :ARG0-of (e2 / ERK1/2))
        :degree (a / also)
        :ARG2 (s / siRNA
            :ARG1 (t2 / target-01
                :ARG0 s
                :ARG1 (m / MEK1)
                :ARG1 (m2 / MEK2)))))","(t / treat-01
    :ARG1 (c / cell :name (n / name :op1 ""WM9""))
    :ARG2 (s / siRNA
        :ARG0-of (t2 / target-01
            :ARG1 (a / and
                :op1 (m / MEK1)
                :op2 (m2 / MEK2))))
    :result (a2 / and
        :op1 (d / decrease-01
            :ARG1 (e / express-01
                :ARG0 c
                :degree (g / greater-than
                    :op1 (p / percent :quant 90)))
            :consistently (c2 / consistent))
        :op2 (d2 / decrease-01
            :ARG1 (p2 / phosphorylate-01
                :ARG1 (a3 / and
                    :op1 (e2 / ERK1)
                    :op2 (e3 / ERK2))))))",-1.0,0.4516129032258064
pmid_2000_3375.1,Aurora-A overexpression enhances cell-aggregation of Ha-<i>ras </i>transformants through the MEK/ERK signaling pathway (PMID:20003375),"(e3 / enhance-01
    :ARG0 (e2 / engineer-01
        :ARG1-of (o / over-03))
    :ARG1 (a / aggregate-01
        :ARG0 (s2 / small-molecule
            :name (n / name
                :op1 ""et-cetera"")
            :ARG1-of e2)
        :ARG1 (c / cell))
    :ARG1-of (d / describe-01
        :ARG0 (p3 / publication-91
            :ARG1 (t / theory
                :name (n4 / name))
            :mod 20003375))
    :manner (p / pathway
        :ARG0-of (s / signal-07
            :ARG1 (p2 / protein
                :name (n3 / name
                    :op1 ""ERK"")))
        :mod (e4 / enzyme
            :name (n2 / name
                :op1 ""MEK"")))
    :rel (e / engineer-01))
",test,bio_amr0.8,"(e / enhance-01
      :ARG0 (o / overexpress-01
            :ARG1 (e2 / enzyme :name (n / name :op1 ""Aurora-A"")))
      :ARG1 (a / aggregate-01
            :ARG1 (c3 / cell
                  :ARG2-of (t / transform-01
                        :ARG0 (g / gene :name (n2 / name :op1 ""Ha-ras"")))))
      :manner (s / signal-07
            :ARG0 (p / pathway :name (n3 / name :op1 ""MEK/ERK"")))
      :ARG1-of (d / describe-01
            :ARG0 (p2 / publication-91
                  :ARG8 ""PMID20003375"")))",Aurora-A overexpression enhances cell-aggregation of Ha-<i>ras </i>transformants through the MEK/ERK signaling pathway (PMID:20003375),"(z1 / enhance-01
    :ARG0 (z2 / overexpress-00
              :ARG1 (z3 / enzyme
                        :wiki ""Aurora-A""
                        :name (z4 / name
                                  :op1 ""Aurora-A"")))
    :ARG1 (z5 / assimilate-01
              :ARG1 (z6 / protein
                        :wiki ""BRAF_(g3000 / gene)""
                        :name (z7 / name
                                  :op1 ""Ha-ras"")
                        :ARG0-of (z8 / transform-01
                                     :path (z9 / pathway
                                               :ARG0-of (z10 / channel-01
                                                             :ARG1 (z11 / and
                                                                        :op1 (z12 / enzyme
                                                                                  :wiki ""Mitogen-activated_protein_kinase""
                                                                                  :name (z13 / name
                                                                                             :op1 ""MEK""))
                                                                        :op2 (z14 / enzyme
                                                                                  :wiki ""ERK""
                                                                                  :name (z15 / name
                                                                                             :op1 ""ERK""))))))))
    :ARG2 (z16 / cell))",0.3055555555555556,0.4444444444444445,"(e / enhance-01
        :ARG1 (a / aggregation
              :ARG1 (c / cell
                    :mod (o / overexpression
                          :ARG1 (p / protein
                                :name (n / name :op1 ""Aurora-A""))))
              :ARG2 (t / transformant
                    :mod (h / Ha-<i>ras</i>)))
        :ARG2 (p2 / pathway
              :mod (s / signaling
                    :ARG1 (m / MEK/ERK)))
        :ARG3 (p3 / PMID :op1 ""20003375""))","(a / augment-01
    :ARG1 (o / overexpress-01
        :ARG0 (p / protein :name (n / name :op1 ""Aurora-A"")))
    :ARG2 (c / cause-01
        :ARG0 o
        :ARG1 (e / enhance-01
            :ARG0 o
            :ARG1 (a2 / aggregate-01
                :ARG1 (c2 / cell
                    :mod (t / transform-01
                        :ARG0 (p2 / protein :name (n2 / name :op1 ""Ha-ras"")))))
            :instrument (p3 / pathway
                :mod (s / signaling)
                :consist-of (m / multi-sentence
                    :snt1 (p4 / protein :name (n3 / name :op1 ""MEK""))
                    :snt2 (p5 / protein :name (n4 / name :op1 ""ERK""))))))
    :source (p6 / publication
        :id ""PMID:20003375""))",-1.0,0.4675324675324675
pmid_2000_3375.16,"Finally, the Ras/MEK/ERK signaling pathway is responsible for Aurora-A induced aggregation of the Ras<sup>V12 </sup>transformants.","(r / responsible-01
    :ARG0 (p / pathway
        :ARG0-of (s / signal-07)
        :domain (s2 / slash
            :op1 (e / enzyme
                :name (n / name
                    :op1 ""Ras""))
            :op2 (e2 / enzyme
                :name (n2 / name
                    :op1 ""MEK""))
            :op3 (e3 / enzyme
                :name (n3 / name
                    :op1 ""ERK""))))
    :ARG1 (s3 / small-molecule
        :name (n4 / name)
        :quant (m / multiple)
        :ARG1-of (i / induce-01
            :ARG2 p)
        :mode expressive)
    :mod (f / final))
",test,bio_amr0.8,"(r / responsible-01 :li ""-1""
      :ARG0 (p / pathway :name (n / name :op1 ""Ras/MEK/ERK"")
            :ARG0-of (s / signal-07))
      :ARG1 (a / aggregate-01
            :ARG1 (c / cell
                  :ARG1-of (t / transform-01
                        :ARG0 (e2 / enzyme :name (n3 / name :op1 ""Ras"")
                              :ARG2-of (m / mutate-01 :value ""V12""))))
            :ARG2-of (i / induce-01
                  :ARG0 (e / enzyme :name (n2 / name :op1 ""Aurora-A"")))))","Finally, the Ras/MEK/ERK signaling pathway is responsible for Aurora-A induced aggregation of the Ras<sup>V12 </sup>transformants.","(z1 / responsible-01
    :ARG0 (z2 / pathway
              :ARG0-of (z3 / channel-01
                           :ARG1 (z4 / slash
                                     :op1 (z5 / enzyme
                                              :wiki ""Mitogen-activated_protein_kinase""
                                              :name (z6 / name
                                                        :op1 ""Ras/MEK""))
                                     :op2 (z7 / enzyme
                                              :wiki ""ERK""
                                              :name (z8 / name
                                                        :op1 ""ERK"")))))
    :ARG1 (z9 / aggregation-01
              :ARG1 (z10 / transformant
                         :wiki ""BRAF_(g3000 / gene)""
                         :name (z11 / name
                                    :op1 ""Ras""
                                    :op2 ""V12""))
              :ARG1-of (z12 / induce-01
                            :ARG0 (z13 / enzyme
                                       :wiki ""Aurora-A""
                                       :name (z14 / name
                                                  :op1 ""Aurora-A"")))))",0.2352941176470588,0.303030303030303,"(s / signal-01
        :ARG1 (p / pathway
              :mod (s2 / signaling)
              :mod (r / responsible-01
                    :ARG1 (a / aggregate-01
                          :ARG1 (i / induce-01
                                :ARG1 (a2 / Aurora-A)
                                :ARG2 (t / transformant
                                      :mod (r2 / Ras<sup>V12</sup>))))
                    :ARG2 (p2 / pathway
                          :mod (r3 / Ras/MEK/ERK))))
        :ARG0 (r4 / responsible-01
              :ARG1 (p3 / pathway
                    :mod (s3 / signaling)
                    :mod (r5 / responsible-01
                          :ARG1 (a3 / aggregate-01
                                :ARG1 (i2 / induce-01
                                      :ARG1 a2
                                      :ARG2 t)
                                :ARG2 (t2 / transformant
                                      :mod (r6 / Ras<sup>V12</sup>))))
                          :ARG2 (p4 / pathway
                                :mod (r7 / Ras/MEK/ERK))))","(r / responsible-01
    :ARG1 (p / pathway
        :name (n / name :op1 ""Ras"" :op2 ""/"" :op3 ""MEK"" :op4 ""/"" :op5 ""ERK"" :op6 ""signaling""))
    :ARG2 (a / aggregate-01
        :ARG1 (t / transformant
            :mod (r2 / Ras
                :mod (v / version
                    :value 12)))
        :ARG0 (a2 / Aurora-A))
    :time (f / finally))",-1.0,0.2142857142857142
pmid_2000_3375.111,"Aurora-A overexpression accompanied with Ha-<i>ras </i>codon 12 mutation has been reported in bladder cancers [<xref ref-type=""bibr"" rid=""B41"">41</xref>].","(r / report-01
    :ARG1 (m / mutate-01
        :name (n / name
            :op1 ""ha""
            :op2 12)
        :ARG1-of (e / engineer-01
            :ARG1-of (o / over-03)))
    :location (d / disease
        :name (n2 / name
            :op1 ""cancer"")
        :mod (b / bladder))
    :rel (a / accompany-01))
",test,bio_amr0.8,"(r / report-01
      :ARG1 (a / accompany-01
            :ARG0 (m / mutate-01
                  :ARG1 (c2 / codon :mod 12
                        :part-of (g / gene
                              :name (n3 / name :op1 ""Ha-ras""))))
            :ARG1 (o / overexpress-01
                  :ARG1 (e / enzyme
                        :name (n / name :op1 ""Aurora-A"")))
            :location (d / disease :wiki ""Cancer""
                  :name (n4 / name :op1 ""cancer"")
                  :mod (b / bladder)))
      :ARG1-of (d2 / describe-01
            :ARG0 (p / publication-91
                  :ARG1-of (c / cite-01 :ARG2 41))))","Aurora-A overexpression accompanied with Ha-<i>ras </i>codon 12 mutation has been reported in bladder cancers [<xref ref-type=""bibr"" rid=""B41"">41</xref>].","(z1 / report-01
    :ARG1 (z2 / overexpress-00
              :ARG1 (z3 / enzyme
                        :wiki ""Aurora-A""
                        :name (z4 / name
                                  :op1 ""Aurora-A"")
                        :ARG1-of (z5 / accompany-01
                                     :ARG0 (z6 / mutate-01
                                               :ARG1 (z7 / enzyme
                                                         :wiki ""BRAF-12""
                                                         :name (z8 / name
                                                                   :op1 ""Ha-ras""))))))
    :location (z9 / disease
                  :wiki ""Cancer""
                  :name (z10 / name
                             :op1 ""bladder""
                             :op2 ""cancer"")))",0.4193548387096774,0.3214285714285714,"(e / accompany-01
    :ARG0 (o / overexpression
        :ARG1 (a / Aurora-A))
    :ARG1 (m / mutation
        :ARG1 (c / codon-12
            :mod (h / Ha-<i>ras</i>)))
    :ARG1-of (r / report-01
        :ARG1 (c2 / cancer
            :mod (b / bladder)))
    :ARG2 (r2 / reference
        :ARG1 (n / number-entity
            :value ""41""
            :mod (b2 / bib-reference
                :ref-type ""bibr""
                :rid ""B41""))))","(a / accompany-01
    :ARG1 (o / overexpress-01
        :ARG0 (p / protein :name (n / name :op1 ""Aurora-A"")))
    :ARG2 (m / mutate-01
        :ARG1 (g / gene :name (n2 / name :op1 ""Ha-ras""))
        :ARG2 (c / codon :name (n3 / name :op1 ""12"")))
    :location (c2 / cancer
        :location (b / body-part :name (n4 / name :op1 ""bladder"")))
    :time (r / report-01
        :ARG1 a
        :source (r2 / reference :mod (n5 / number :value 41))))",-1.0,0.3943661971830985
pmid_2000_3375.112,"In this study, Ha-<i>ras</i><sup>V12 </sup>mutation was detected in the tumour part of the bladder cancer specimen by SNP-real-time PCR and verified by sequence analysis (Figure <xref ref-type=""fig"" rid=""F1"">1A</xref>, Gly12 -> Val 12).","(a2 / and
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 12))
    :op1 (d2 / detect-01
        :location (p / part
            :part-of (t2 / tumor)
            :part-of (s2 / specimen
                :mod (d3 / disease
                    :name (n2 / name
                        :op1 ""bladder""
                        :op2 ""cancer"")
                    :part ""bladder""))))
    :op2 (v / verify-01
        :ARG0 (a / analyze-01
            :ARG1 (s / sequence)))
    :rel (n / name
        :op1 ""ha"")
    :rel (e / enzyme
        :name (n3 / name
            :op2 ""PCR""))
    :time (s3 / study-01
        :mod (t / this)))
",test,bio_amr0.8,"(a2 / and
      :op1 (d3 / detect-01
            :ARG1 (m2 / mutate-01 :value ""V12""
                  :ARG2 (e / enzyme :name (n3 / name :op1 ""Ha-ras"")))
            :ARG2 (p / polymorphism
                  :mod (n2 / nucleotide
                        :ARG1-of (s / single-02))
                  :ARG1-of (a / analyze-01
                        :manner (r / real-time)
                        :mod (r2 / react-01
                              :ARG0 (p2 / polymerase)
                              :mod (c / chain)
                              :subevent (t / transcribe-01
                                    :ARG1-of (r3 / reverse-01)))))
            :location (t2 / tumor
                  :part-of (s2 / specimen
                        :mod (d4 / disease :wiki ""Cancer"" :name (n4 / name :op1 ""cancer"")
                              :mod (b2 / bladder)))))
      :op2 (v / verify-01
            :ARG1 m2
            :manner (a3 / analyze-01
                  :mod (s3 / sequence)))
      :medium (s4 / study-01
            :mod (t3 / this))
      :ARG1-of (d5 / describe-01
            :ARG0 (f / figure :mod ""1A"")
            :ARG2 (m3 / mutate-01
                  :ARG1 (a4 / amino-acid :mod 12 :name (n5 / name :op1 ""glycine""))
                  :ARG2 (a5 / amino-acid :mod 12 :name (n6 / name :op1 ""valine"")))))","In this study, Ha-<i>ras</i><sup>V12 </sup>mutation was detected in the tumour part of the bladder cancer specimen by SNP-real-time PCR and verified by sequence analysis (Figure <xref ref-type=""fig"" rid=""F1"">1A</xref>, Gly12 -> Val 12).","(z1 / and
    :op1 (z2 / detect-01
             :ARG0 (z3 / PCR
                       :mod (z4 / nucleic-acid
                                :wiki ""SNP""
                                :name (z5 / name
                                          :op1 ""SNP-real-time""))
                       :mod (z6 / nucleic-acid
                                :wiki ""DNA-acid""
                                :wiki ""Histidine""
                                :name (z7 / name
                                          :op1 ""Ha-ras"")))
             :ARG1 (z8 / mutate-01
                       :ARG1 (z9 / enzyme
                                 :wiki ""BRAF-1A""
                                 :name (z10 / name
                                            :op1 ""Ha-RA"")))
             :location (z11 / part
                            :part-of (z12 / tumor)
                            :part-of (z13 / specimen
                                          :mod (z14 / disease
                                                    :wiki ""bladder_cancer""
                                                    :name (z15 / name
                                                               :op1 ""bladder""
                                                               :op2 ""cancer""))))))",0.2702702702702703,0.3454545454545454,"(m / multi-sentence
        :snt1 (d / detect-01
            :ARG1 (m2 / mutation
                  :ARG0 (h / ha-01
                        :ARG1 (v / v12)))
            :ARG2 (p / part
                  :mod (t / tumour
                        :mod (c / cancer
                              :mod (b / bladder))))
            :ARG3 (s / specimen
                  :mod (c2 / cancer
                        :mod (b2 / bladder))))
        :snt2 (v2 / verify-01
            :ARG1 (m2 / mutation)
            :ARG2 (a / analysis
                  :mod (s2 / sequence))
            :ARG3 (f / figure
                  :mod (x / xref
                        :ref-type ""fig""
                        :rid ""F1""
                        :op1 ""1A""))
            :ARG4 (g / gly12
                  :op1 ""->""
                  :op2 (v3 / val-12))))","(d / detect-01
    :ARG1 (m / mutate-01
        :ARG1 (g / gene
            :name (n / name :op1 ""Ha-"" :op2 ""ras"" :op3 ""V12"")))
    :location (p / part
        :part-of (s / specimen
            :part-of (c / cancer
                :location (b / bladder))))
    :instrument (p2 / PCR
        :mod (r / real-time)
        :mod (s2 / SNP))
    :time (t / this
        :mod (s3 / study))
    :mode (v / verify-01
        :instrument (a / analyze-01
            :mod (s4 / sequence)))
    :medium (f / figure
        :name (n2 / name :op1 ""1A""))
    :result (c2 / cause-01
        :ARG0 (a2 / amino-acid
            :name (n3 / name :op1 ""Gly12""))
        :ARG1 (a3 / amino-acid
            :name (n4 / name :op1 ""Val"" :op2 ""12""))))",-1.0,0.3387096774193548
pmid_2000_3375.113,"The Aurora-A protein overexpression was detected in the same cancer part of the bladder tissue compared to the normal part by IHC staining (Figure <xref ref-type=""fig"" rid=""F1"">1B</xref>, T vs. N).","(d2 / detect-01
    :ARG1 (e / express-03
        :ARG1 (p3 / protein
            :name (n / name
                :op1 ""A"")))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :name (n3 / name
                :op1 ""North""
                :op2 ""West"")
            :mod (v / versus
                :op1 p3
                :op2 p3)))
    :location (p / part
        :ARG1-of (c2 / compare-01
            :ARG2 (p2 / part
                :ARG1-of (n4 / normal-02)))
        :ARG1-of (s / same-01)
        :part-of (t / tissue
            :part-of (b / bladder)))
    :manner (s2 / stain-01
        :ARG0 (o / organization
            :name (n2 / name
                :op1 ""IHC"")))
    :rel (c / cancer))
",test,bio_amr0.8,"(d / detect-01
      :ARG1 (o / overexpress-01
            :ARG1 (e / enzyme :name (n / name :op1 ""Aurora-A"")))
      :manner (s2 / stain-01
            :ARG2 (i / immunohistochemistry))
      :ARG1-of (d3 / describe-01
            :ARG0 (f2 / figure :mod ""1B""))
      :location (p2 / part
            :part-of (t / tissue
                  :mod (b / bladder))
            :ARG1-of (c2 / compare-01
                  :ARG2 (p4 / part
                        :ARG1-of (n4 / normal-02)))
            :ARG1-of (s / same-01)
            :mod (d2 / disease :wiki ""Cancer"" :name (n2 / name :op1 ""cancer""))))","The Aurora-A protein overexpression was detected in the same cancer part of the bladder tissue compared to the normal part by IHC staining (Figure <xref ref-type=""fig"" rid=""F1"">1B</xref>, T vs. N).","(z1 / detect-01
    :ARG1 (z2 / protein
              :wiki ""BRAF_(g3000 / gene)""
              :name (z3 / name
                        :op1 ""Aurora-A"")
              :ARG1-of (z4 / overexpress-01))
    :location (z5 / part
                  :part-of (z6 / tissue
                               :part-of (z7 / bladder))
                  :part-of (z8 / tumor
                               :part z10)
                  :ARG1-of (z9 / same-01
                               :ARG2 (z10 / part
                                          :part-of (z11 / tissue
                                                        :part-of (z12 / bladder)
                                                        :part z14))))
    :ARG1-of (z13 / compare-01
                  :ARG2 (z14 / part
                             :ARG1-of (z15 / normal-02))))",0.4507042253521127,0.5925925925925926,"(e / exist-01
        :ARG1 (d / detect-01
              :ARG1 (p / protein
                    :mod (o / overexpression
                          :ARG1 (a / aurora-a)))
              :ARG2 (p2 / part
                    :mod (c / cancer
                          :mod (s / same)
                          :mod (p3 / part
                                :mod (t / tissue
                                      :mod (b / bladder))))
                    :ARG1-of (c2 / compare-01
                          :ARG2 (p4 / part
                                :mod (n / normal))))
              :ARG3 (s2 / stain-01
                    :ARG1 (i / ihc)
                    :ARG2 (f / figure
                          :op1 ""1B"")
                    :ARG3 (t / time
                          :op1 ""vs.""
                          :op2 (n2 / name :op1 ""N"")))))","(d / detect-01
    :ARG1 (o / overexpress-01
        :ARG1 (p / protein
            :name (n / name :op1 ""Aurora-A"")))
    :location (p2 / part
        :part-of (c / cancer)
        :location (t / tissue
            :part-of (b / bladder)))
    :instrument (s / stain-01
        :mod (i / IHC))
    :time (s2 / same)
    :compared-to (p3 / part
        :mod (n2 / normal)
        :location t)
    :medium (f / figure
        :name (n3 / name :op1 ""1B""))
    :ARG2 (c2 / compare-01
        :ARG1 (t2 / thing
            :name (n4 / name :op1 ""T""))
        :ARG2 (n5 / thing
            :name (n6 / name :op1 ""N""))))",-1.0,0.4146341463414634
pmid_2000_3375.114,"Similarly, Ki-<i>ras </i>codon 12 mutation and higher expression level of Aurora-A were only detected in the cancer part of the colon tissue (Figure <xref ref-type=""fig"" rid=""F1"">1C</xref> and <xref ref-type=""fig"" rid=""F1"">1D</xref>).","(d2 / detect-01
    :ARG1 (a / and
        :ARG1 (s / small-molecule
            :name (n / name
                :op1 ""atomic""
                :op2 12))
        :op1 (m2 / mutate-01)
        :op2 (l / level
            :ARG1-of (h / have-degree-91
                :ARG2 (h2 / high-02
                    :ARG1 l)
                :ARG3 (m / more))
            :ARG2-of (e / express-03)))
    :ARG1-of (r / resemble-01)
    :ARG1-of (d / describe-01
        :ARG0 (a2 / and
            :op1 (f / figure)
            :op2 (f2 / figure
                :value 2)))
    :location (p / part
        :mod (d3 / disease
            :name (n3 / name
                :op1 ""cancer""))
        :part-of (t / tissue
            :part-of (c / colon)))
    :mod (o / only)
    :rel (n2 / name
        :ARG0 (i / i)
        :op1 ""it"")
    :rel 1)
",test,bio_amr0.8,"(r / resemble-01
      :ARG2 (d / detect-01
            :ARG1 (a / and
                  :op1 (m / mutate-01
                        :ARG1 (c3 / codon :mod 12
                              :part-of (g / gene :name (n2 / name :op1 ""Ki-ras""))))
                  :op2 (l / level
                        :degree-of (e / express-03
                              :ARG2 (e2 / enzyme :name (n3 / name :op1 ""Aurora-A"")))
                        :ARG1-of (h / high-02
                              :degree (m2 / more))))
            :location (p / part
                  :mod (d2 / disease :wiki ""Cancer"" :name (n4 / name :op1 ""cancer""))
                  :part-of (t / tissue
                        :mod (c2 / colon)))
            :manner (o / only)
            :ARG1-of (d3 / describe-01
                  :ARG0 (a3 / and
                        :op1 (f / figure :mod ""1C"")
                        :op2 (f2 / figure :mod ""1D"")))))","Similarly, Ki-<i>ras </i>codon 12 mutation and higher expression level of Aurora-A were only detected in the cancer part of the colon tissue (Figure <xref ref-type=""fig"" rid=""F1"">1C</xref> and <xref ref-type=""fig"" rid=""F1"">1D</xref>).","(z1 / resemble-01
    :ARG2 (z2 / detect-01
              :ARG1 (z3 / and
                        :op1 (z4 / mutate-01
                                 :ARG1 (z5 / enzyme
                                           :wiki ""Ki-ras""
                                           :name (z6 / name
                                                     :op1 ""Ki-ras""))
                                 :ARG2 (z7 / codon
                                           :mod 12))
                        :op2 (z8 / level
                                 :mod (z9 / express-01
                                          :ARG1 (z10 / enzyme
                                                     :wiki ""Aurora-A""
                                                     :name (z11 / name
                                                                :op1 ""Aurora-A"")))
                                 :ARG1-of (z12 / have-degree-91
                                               :ARG2 (z13 / high-02)
                                               :ARG3 (z14 / more)))))
    :location (z15 / part
                   :part-of (z16 / tissue
                                 :part-of (z17 / colon))
                   :mod (z18 / cancer))
    :mod (z19 / only))",0.4347826086956521,0.5048543689320388,"(m / multi-sentence
        :snt1 (d / detect-01
            :ARG0 (o / only)
            :ARG1 (m2 / mutation
                  :ARG1 (c / codon
                        :op1 ""Ki-<i>ras</i>""
                        :op2 12))
            :ARG2 (e / expression
                  :ARG1 (l / level
                        :ARG1-of (h / higher)
                        :ARG0 (a / Aurora-A))))
        :snt2 (d2 / detect-01
            :ARG0 o
            :ARG1 (d3 / detect-01
                  :ARG0 o
                  :ARG1 (p / part
                        :mod (c2 / cancer)
                        :mod (t / tissue
                              :mod (c3 / colon))))
                  :ARG2 (f / figure
                        :op1 ""1C""))
            :ARG2 (d4 / detect-01
                  :ARG0 o
                  :ARG1 (p2 / part
                        :mod (c4 / cancer)
                        :mod (t2 / tissue
                              :mod (c5 / colon))))
                  :ARG2 (f2 / figure
                        :op1 ""1D"")))","(d / detect-01
    :ARG1 (a / and
        :op1 (m / mutate-01
            :ARG1 (c / codon
                :name (n / name :op1 ""12""))
            :ARG2 (k / protein :name (n2 / name :op1 ""Ki-ras"")))
        :op2 (e / express-01
            :ARG1 (p / protein :name (n3 / name :op1 ""Aurora-A""))
            :degree (h / high)))
    :location (p2 / part
        :part-of (t / tissue
            :part-of (c2 / colon))
        :mod (c3 / cancer))
    :mod (s / similar-02)
    :ARG2 (f / figure
        :name (n4 / name :op1 ""1C"" :op2 ""1D"")))",-1.0,0.4395604395604395
pmid_2000_3375.118,"Stable cell lines were established by transfecting Vector DNA, wild-type Aurora-A or kinase-inactivated Aurora-A into 7-4 cells, which was derived from NIH/3T3 cells harboring the inducible Ha-<i>ras</i><sup>V12 </sup>oncogene [<xref ref-type=""bibr"" rid=""B23"">23</xref>], designated Vector, WT and KD cell line, respectively.","(e2 / establish-01
    :ARG1 (l / line
        :ARG1-of (d2 / designate-01
            :ARG2 (a2 / and
                :op1 (n9 / nucleic-acid
                    :name (n2 / name)
                    :name (n4 / name
                        :op1 ""Aurango"")
                    :mod (w / wild-type))
                :op2 (e / enzyme
                    :name (n6 / name
                        :op1 ""ha"")
                    :ARG0-of (t / tolerate-01
                        :ARG1-of (p / possible-01
                            :polarity -)))
                :op3 (c4 / cell)
                :op4 (c5 / cell
                    :name (n7 / name
                        :op1 ""KD""))
                :op5 (l2 / line
                    :mod n7)))
        :mod (c / cell
            :ARG1-of (s / stable-03)))
    :manner (e3 / express-03
        :ARG2 (o / or
            :op1 (n8 / nucleic-acid
                :name (n / name
                    :op1 ""Vector""
                    :op2 ""DNA""))
            :op2 n9)
        :ARG2 (c2 / cell
            :quant 7
            :ARG1-of (d / derive-01
                :ARG2 (c3 / cell
                    :name (n3 / name
                        :op1 ""3T3"")
                    :ARG0-of (h / harbor-01
                        :ARG1 e)
                    :part-of (r / research-institute
                        :name (n5 / name
                            :op1 ""NIH""))))))
    :rel (k / kinase
        :ARG1-of (a / activate-01)))
",test,bio_amr0.8,"(e / establish-01
      :ARG1 (c / cell-line
            :ARG1-of (s / stable-03))
      :manner (t / transfect-01
            :ARG1 (c2 / cell
                  :mod (b / between :op1 7 :op2 4)
                  :ARG1-of (d3 / derive-01
                        :ARG2 (c3 / cell-line :name (n3 / name :op1 ""NIH/3T3"")
                              :ARG0-of (h / harbor-01
                                    :ARG1 (a / and
                                          :op1 (g / gene :name (n5 / name :op1 ""Ha-ras"")
                                                :ARG1-of (d4 / describe-01
                                                      :ARG0 (p / publication-91
                                                            :ARG1-of (c4 / cite-01
                                                                  :ARG2 23)))
                                                :ARG2-of (m / mutate-01 :value ""V12"")
                                                :ARG2-of (i / induce-01
                                                      :ARG1-of (p2 / possible-01))
                                                :ARG0-of (c7 / cause-01
                                                      :ARG1 (d / disease :wiki ""Cancer"" :name (n7 / name :op1 ""cancer""))))
                                          :op2 (d5 / designate-01
                                                :ARG1 (v2 / vector))
                                          :op3 (a2 / and
                                                :op1 (c5 / cell-line
                                                      :mod (w3 / wild-type))
                                                :op2 (c6 / cell-line
                                                      :mod (k3 / knock-down-02))))
                                    :manner (r / respective)))))
            :ARG2 (o / or
                  :op1 (n4 / nucleic-acid :wiki ""DNA"" :name (n6 / name :op1 ""DNA"")
                        :mod (v / vector))
                  :op2 (e2 / enzyme :name (n / name :op1 ""Aurora-A"")
                        :mod (w / wild-type))
                  :op3 (e3 / enzyme :name (n2 / name :op1 ""Aurora-A"")
                        :ARG1-of (d2 / deactivate-01
                              :ARG0 (k / kinase))))))","Stable cell lines were established by transfecting Vector DNA, wild-type Aurora-A or kinase-inactivated Aurora-A into 7-4 cells, which was derived from NIH/3T3 cells harboring the inducible Ha-<i>ras</i><sup>V12 </sup>oncogene [<xref ref-type=""bibr"" rid=""B23"">23</xref>], designated Vector, WT and KD cell line, respectively.","(z1 / establish-01
    :ARG1 (z2 / line
              :mod (z3 / cell)
              :ARG1-of (z4 / stable-03))
    :manner (z5 / transfect-01
                :ARG1 (z6 / cell
                          :quant (z7 / between
                                     :op1 7
                                     :op2 4)
                          :ARG1-of (z8 / derive-01
                                       :ARG2 (z9 / cell
                                                 :ARG0-of (z10 / harbor-01
                                                               :ARG1 (z11 / enzyme
                                                                          :wiki ""BRAF_(g3000 / gene)""
                                                                          :name (z12 / name
                                                                                     :op1 ""Ha-ras"")
                                                                          :ARG1-of (z13 / inhibit-01
                                                                                        :ARG1-of (z14 / possible-01
                                                                                                      :polarity -))
                                                                          :mod (z15 / oncogene
                                                                                    :wiki ""BRAF_(g3001 / gene)""
                                                                                    :name (z16 / name
                                                                                               :op1 ""V12""
                                                                                               :op2 ""oncogene"")))))))
                :ARG2-of (z17 / designate-01
                              :ARG1 (z18 / and
                                         :op1 (z19 / cell-line
                                                   :wiki ""Vector_DNA""
                                                   :name (z20 / name
                                                              :op1 ""Vector""
                                                              :op2 ""DNA""))
                                         :op2 (z21 / cell-line
                                                   :wiki ""Aurora-A""
                                                   :name (z22 / name
                                                              :op1 ""Aurora-A"")
                                                   :mod (z23 / wild-type))
                                         :op3 (z24 / cell-line
                                                   :wiki ""WT_(g3002 / gene)""
                                                   :name (z25 / name
                                                              :op1 ""WT""
                                                              :op2 ""cell""
                                                              :op3 ""line""))
                                         :op4 (z26 / cell-line
                                                   :wiki ""KD_(g3003 / gene)""
                                                   :name (z27 / name
                                                              :op1 ""KD""))))))",0.3473053892215568,0.3333333333333333,"(m / multi-sentence
        :snt1 (e / establish-01
            :ARG1 (l / line
                  :mod (c / cell
                        :mod (s / stable)))
            :ARG2 (t / transfect-01
                  :ARG1 (d / DNA
                        :mod (v / vector)))
            :ARG3 (a / and
                  :op1 (a2 / Aurora-A
                        :mod (w / wild-type))
                  :op2 (a3 / Aurora-A
                        :mod (k / kinase-inactivated))))
        :snt2 (d2 / derive-01
            :ARG1 (c2 / cell
                  :mod (t2 / 7-4))
            :ARG2 (c3 / cell
                  :mod (n / NIH/3T3)
                  :ARG1-of (h / harbor-01
                        :ARG1 (o / oncogene
                              :ARG1 (h2 / Ha-<i>ras</i><sup>V12</sup>)
                              :ARG2 (i / inducible))))
            :ARG3 (d3 / designate-01
                  :ARG1 c2
                  :ARG2 (l2 / line
                        :op1 (v2 / Vector)
                        :op2 (w2 / WT)
                        :op3 (k2 / KD)))))","(e / establish-01
    :ARG1 (c / cell-line
        :mod (s / stable)
        :name (n / name
            :op1 ""Vector""
            :op2 ""WT""
            :op3 ""KD""))
    :ARG2 (c2 / cell
        :name (n2 / name :op1 ""7-4"")
        :ARG1-of (d / derive-01
            :ARG2 (c3 / cell
                :name (n3 / name :op1 ""NIH/3T3"")
                :ARG1-of (h / harbor-01
                    :ARG2 (o / oncogene
                        :name (n4 / name :op1 ""Ha-rasV12"")
                        :mod (i / inducible))))))
    :instrument (t / transfact-01
        :ARG1 (d2 / DNA
            :mod (v / vector))
        :ARG1 (a / Aurora-A
            :mod (w / wild-type))
        :ARG1 (a2 / Aurora-A
            :mod (k / kinase
                :mod (i2 / inactive))))
    :concession (d3 / designate-01
        :ARG1 c
        :ARG2 n))",-1.0,0.2876712328767123
pmid_2000_3375.119,"The expression levels of Ha-<i>ras</i><sup>V12 </sup>in Vector, WT and KD cells in the presence of IPTG were much higher compared to the cells without IPTG (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>).","(h / have-degree-91
    :ARG1 (l / level
        :ARG1-of (p / present-02
            :ARG2 (s / small-molecule
                :name (n3 / name
                    :op1 ""IPTG"")
                :polarity -))
        :mod (v / virus
            :name (n / name
                :op2 ""healthy""
                :op3 ""Vector""))
        :mod (c / cell
            :mod v)
        :mod (c2 / cell
            :name (n2 / name
                :op1 ""KD""))
        :quant-of (e / express-03))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 2))
    :ARG2 (h2 / high-02
        :ARG1 l)
    :ARG3 (m / more
        :quant (m2 / much))
    :ARG4 (c3 / cell
        :ARG1-of (p2 / present-02)))
",test,bio_amr0.8,"(h / high-02
      :ARG1 (l / level
            :degree-of (e / express-03
                  :ARG2 (g / gene :name (n / name :op1 ""Ha-ras"")
                        :ARG2-of (m3 / mutate-01 :value ""V12""))
                  :ARG3 (a2 / and
                        :op1 (c / cell
                              :mod (v / vector))
                        :op2 (c2 / cell
                              :mod (w / wild-type))
                        :op3 (c3 / cell
                              :mod (k / knock-down-02))))
            :condition (s2 / small-molecule :name (n2 / name :op1 ""IPTG"")))
      :degree (m / more
            :degree (m2 / much))
      :compared-to (l2 / level
            :degree-of (e3 / express-03
                  :ARG3 (c4 / cell
                        :ARG0-of (l3 / lack-01
                              :ARG1 s2))))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""2A"")))","The expression levels of Ha-<i>ras</i><sup>V12 </sup>in Vector, WT and KD cells in the presence of IPTG were much higher compared to the cells without IPTG (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>).","(z1 / have-degree-91
    :ARG1 (z2 / level
              :mod (z3 / express-03
                       :ARG0 (z4 / cell
                                 :mod (z5 / and
                                          :op1 (z6 / gene
                                                   :wiki ""Ha-ras""
                                                   :name (z7 / name
                                                             :op1 ""Ha-ras""))
                                          :op2 (z8 / gene
                                                   :wiki ""BRAF_(g3000 / gene)""
                                                   :name (z9 / name
                                                             :op1 ""WT""))
                                          :op3 (z10 / gene
                                                    :wiki ""Mitogen-activated_protein_kinase""
                                                    :name (z11 / name
                                                               :op1 ""KD"")))
                                 :part-of (z12 / cell
                                               :mod (z13 / gene
                                                         :wiki ""DNA_(g3001 / gene)""
                                                         :name (z14 / name
                                                                    :op1 ""Vector""))))))
    :ARG1 (z15 / present-02
               :ARG1 (z16 / small-molecule
                          :wiki ""Inositol_trisphosphate_receptor_2A""
                          :name (z17 / name
                                     :op1 ""IPTG""))))",0.2340425531914893,0.3010752688172043,"(e / expression-level
        :ARG0 (l / level
              :mod (e2 / expression
                    :mod (c / cell
                          :mod (p / presence
                                :ARG1 (i / IPTG))))
              :mod (c2 / compare-01
                    :ARG1 (c3 / cell
                          :mod (w / with
                                :ARG1 (c4 / cell
                                      :mod (w2 / without
                                            :ARG1 (i2 / IPTG)))))))
        :ARG1 (h / Ha-<i>ras</i><sup>V12</sup>)
        :ARG2 (v / vector)
        :ARG3 (w3 / WT)
        :ARG4 (k / KD)
        :mod (m / much)
        :degree (h2 / high)
        :mod (c5 / compare-01
              :ARG1 (c6 / cell
                    :mod (w4 / with
                          :ARG1 (c7 / cell
                                :mod (w5 / without
                                      :ARG1 (i3 / IPTG)))))
              :ARG2 (f / figure
                    :ARG1-of (x / xref
                          :ref-type ""fig""
                          :rid ""F2""
                          :op1 ""2A""))))","(e / express-01
    :ARG1 (l / level
        :mod (h / have-property-91
            :ARG1 (r / ras
                :mod (v / version
                    :mod (h2 / have-degree-91
                        :ARG1 (n / number :value 12)))))
        :location (c / cell
            :mod (v2 / vector)
            :mod (w / wild-type)
            :mod (k / knockdown))
        :location (p / presence-01
            :ARG1 (i / IPTG)))
    :degree (h3 / high-02
        :degree (m / more)
        :compared-to (c2 / cell
            :ARG1-of (w2 / without-01
                :ARG1 i)))
    :ARG2-of (c3 / compare-01
        :ARG1 l
        :ARG2 (f / figure
            :mod (n2 / number :value 2)
            :mod (a / a)))).",-1.0,0.2499999999999999
pmid_2000_3375.122,"Consistently, our data showed the level of phosphorylated H3S10 (p-H3S10 detected by anti-p-H3S10 antibody) in WT cells (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 2, 1.8 fold) was higher than in Vector cells (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 1, 1.0 fold) and KD cells (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 3, 0.9 fold) in the absent of IPTG where Ras was not overexpressed.","(s / show-01
    :ARG0 (d / data
        :poss (w / we))
    :ARG1 (h / have-degree-91
        :ARG1 (l5 / level
            :mod (p / phosphorylate-01
                :ARG1 (s2 / small-molecule
                    :name (n / name
                        :op1 ""F2"")
                    :ARG1-of (d2 / detect-01
                        :ARG0 (a3 / antibody
                            :ARG0-of (o / oppose-01))))))
        :ARG2 (h2 / high-02)
        :ARG3 (m / more
            :quant 1.8)
        :ARG4 (l6 / level
            :location-of (a / absent-01
                :ARG1 (e / enzyme
                    :name (n5 / name
                        :op1 ""IPTG""
                        :op1 ""Ras"")
                    :ARG2-of (e2 / express-03
                        :polarity -)))
            :mod (l / laboratory
                :name (n3 / name
                    :op1 ""WT""))
            :mod (c2 / cell
                :mod (c / carrier
                    :name (n4 / name
                        :op1 ""KD"")))
            :mod (l3 / lane
                :mod 1)
            :mod (f2 / figure)
            :mod (l4 / lane
                :mod 3))
        :location (a2 / and
            :op1 c2
            :op2 (c3 / cell
                :mod c)))
    :ARG1-of (c5 / consistent-02)
    :rel (s3 / small-molecule
        :name (n2 / name)
        :ARG0-of o)
    :rel (c4 / cell-line
        :name n3)
    :rel (l2 / lane
        :mod 2)
    :rel 0.9
    :rel (f / figure)
    :rel 1.0)
",test,bio_amr0.8,"(s / show-01
      :ARG0 (d / data
            :poss (w / we))
      :ARG1 (h / high-02
            :ARG1 (l / level
                  :quant-of (a5 / amino-acid :mod 10 :name (n / name :op1 ""serine"")
                        :ARG3-of (p2 / phosphorylate-01)
                        :ARG1-of (d2 / detect-01
                              :ARG0 (a / antibody
                                    :ARG0-of (c5 / counter-01
                                          :ARG1 a5)))
                        :part-of (p / protein :name (n5 / name :op1 ""H3"")))
                  :ARG1-of (d3 / describe-01
                        :part-of (l2 / lane :mod 2
                              :part-of (f2 / figure :mod ""2A""))
                        :quant (p4 / product-of :op1 1.8))
                  :location (c / cell
                        :mod (w2 / wild-type)))
            :degree (m / more)
            :compared-to (a3 / and
                  :op1 (c2 / cell
                        :mod (v / vector)
                        :ARG1-of (d4 / describe-01
                              :part-of (l3 / lane :mod 1
                                    :part-of f2)
                              :quant (p5 / product-of :op1 1.0)))
                  :op2 (c3 / cell
                        :mod (k / knock-down-02)
                        :ARG1-of (d5 / describe-01
                              :part-of (l4 / lane :mod 3
                                    :part-of f2)
                              :quant (p6 / product-of :op1 0.9))))
            :condition (a6 / and
                  :op1 (a7 / absent-01
                        :ARG1 (s2 / small-molecule :name (n3 / name :op1 ""IPTG"")))
                  :op2 (o / overexpress-01 :polarity -
                        :ARG1 (e2 / enzyme :name (n4 / name :op1 ""Ras"")))))
      :manner (c4 / consistent-02))","Consistently, our data showed the level of phosphorylated H3S10 (p-H3S10 detected by anti-p-H3S10 antibody) in WT cells (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 2, 1.8 fold) was higher than in Vector cells (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 1, 1.0 fold) and KD cells (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 3, 0.9 fold) in the absent of IPTG where Ras was not overexpressed.","(z1 / show-01
    :ARG0 (z2 / data
              :poss (z3 / we))
    :ARG1 (z4 / have-degree-91
              :ARG1 (z5 / level
                        :consist-of (z6 / protein
                                        :wiki ""Histidine-rich_glycoprotein""
                                        :name (z7 / name
                                                  :op1 ""H3S10"")
                                        :ARG1-of (z8 / phosphorylate-01)
                                        :ARG1-of (z9 / detect-01
                                                     :ARG0 (z10 / antibody
                                                                :ARG0-of (z11 / counter-01
                                                                              :ARG1 z6)))))
              :ARG2 (z12 / high-02
                         :ARG1 z5)
              :ARG3 (z13 / more)
              :ARG4 (z14 / level
                         :consist-of z6
                         :location (z15 / and
                                        :op1 (z16 / cell
                                                  :mod (z17 / tumor
                                                            :wiki ""WT""
                                                            :name (z18 / name
                                                                       :op1 ""WT""))
                                                  :ARG0-of (z19 / have-03
                                                                :ARG1 (z20 / cell
                                                                           :wiki ""2A""
                                                                           :name (z21 / name
                                                                                      :op1 ""2A"")))
                                                  :ARG0-of (z22 / have-03
                                                                :ARG1 (z23 / lane
                                                                           :mod 2)
                                                                :ARG0-of (z24 / have-03
                                                                              :ARG1 (z25 / fold
                                                                                         :quant ""1.8"")))
                                                  :ARG0-of (z26 / have-03
                                                                :ARG1 (z27 / cell
                                                                           :wiki ""Vector_cell""
                                                                           :name (z28 / name
                                                                                      :op1 ""Vector""
                                                                                      :op2 ""Cell"")
                                                                           :ARG0-of (z29 / have-03
                                                                                         :ARG1 (z30 / cell
                                                                                                    :wiki ""KD_cell""
                                                                                                    :name (z31 / name
                                                                                                               :op1 ""KD"")
                                                                                                    :ARG0-of (z32 / have-03
                                                                                                                  :ARG1 (z33 / cell
                                                                                                                             :wiki ""2A""
                                                                                                                             :name (z34 / name
                                                                                                                                        :op1 ""2A""))
                                                                                                                  :ARG0-of (z35 / have-03
                                                                                                                                :ARG1 (z36 / lane
                                                                                                                                           :mod 3)
                                                                                                                                :ARG0-of (z37 / have-03
                                                                                                                                              :ARG1 (z38 / fold
                                                                                                                                                         :quant ""0.9""))))))))))
                         :op2 (z39 / absent-01
                                   :ARG1 (z40 / small-molecule
                                              :wiki ""Inositol_trisphosphate_receptor""
                                              :name (z41 / name
                                                         :op1 ""IPTG""))
                                   :ARG0-of (z42 / cause-01
                                                 :ARG1 (z43 / enzyme
                                                            :wiki ""Ras_(g3000 / gene)""
                                                            :name (z44 / name
                                                                       :op1 ""Ras"")
                                                            :ARG1-of (z45 / overexpress-00
                                                                          :polarity -)))))))",0.3267326732673267,0.3647058823529411,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (d / data
                  :mod (o / our))
            :ARG2 (l / level
                  :mod (p / phosphorylate-01
                        :ARG1 (h / H3S10
                              :mod (p2 / phosphorylate-01
                                    :ARG1 (a / antibody
                                          :mod (a2 / anti))))
                        :ARG2 (c / cell
                              :mod (w / WT)))
                  :mod (h2 / higher
                        :degree (t / than)
                        :ARG2 (c2 / cell
                              :mod (v / Vector)))
                  :mod (h3 / higher
                        :degree (t2 / than)
                        :ARG2 (c3 / cell
                              :mod (k / KD))))
            :ARG3 (f / fold
                  :ARG1 (n / number
                        :quant 1.8)
                  :mod (l2 / lane
                        :mod (f2 / figure
                              :op1 ""2A"")
                        :op2 2))
            :ARG3 (f3 / fold
                  :ARG1 (n2 / number
                        :quant 1.0)
                  :mod (l3 / lane
                        :mod (f4 / figure
                              :op1 ""2A"")
                        :op2 1))
            :ARG3 (f5 / fold
                  :ARG1 (n3 / number
                        :quant 0.9)
                  :mod (l4 / lane
                        :mod (f6 / figure
                              :op1 ""2A"")
                        :op2 3)))
        :snt2 (w / where
            :ARG1 (r / Ras
                  :ARG1-of (o2 / overexpress-01))
            :ARG2 (i / IPTG
                  :mod (a3 / absent)))","(s / show-01
    :ARG0 (d / data
        :poss (w / we))
    :ARG1 (c / compare-01
        :ARG1 (l / level
            :ARG1-of (p / phosphorylate-01
                :ARG1 (h / h3s10
                    :mod (p2 / p
                        :mod (h2 / h3s10))))
            :location (c2 / cell
                :mod (w2 / wild-type)))
        :ARG2 (l2 / level
            :ARG1-of p
            :location (c3 / cell
                :mod (v / vector)))
        :ARG3 (l3 / level
            :ARG1-of p
            :location (c4 / cell
                :mod (k / kd)))
        :manner (c5 / consistent))
    :condition (a / absent-01
        :ARG1 (i / iptg)
        :ARG2 (o / overexpress-01
            :ARG0 (r / ras)
            :ARG1 (c6 / cell
                :mod w2
                :mod v
                :mod k))))",-1.0,0.3
pmid_2000_3375.124,"In the presence of IPTG, where Ras<sup>V12 </sup>protein was overexpressed, the level of phosphorylated H3S10 was increased both in Vector (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 4, 2.8 fold), WT (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 5, 3.8 fold) and KD (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 6, 2.8 fold) cells.","(i / increase-01
    :ARG1 (l4 / level)
    :condition (p2 / present-02
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""IPTG"")))
    :location (a2 / and
        :op1 (v / virus)
        :op2 (e2 / enzyme
            :name (n3 / name)))
    :location (c / cell
        :mod (l3 / lane
            :mod (l2 / lane
                :extent (f2 / fold-03
                    :ARG2 2.8)
                :mod 5)
            :mod v
            :mod 6))
    :mod (f / figure)
    :rel (p3 / protein
        :name (n2 / name
            :op1 ""H3S10"")
        :ARG1-of (e3 / express-03)
        :ARG1-of (p / phosphorylate-01))
    :rel (l / lane
        :mod 4)
    :rel 2
    :rel 3.8
    :rel (a / F2))
",test,bio_amr0.8,"(i / increase-01
      :ARG1 (l / level
            :quant-of (a3 / amino-acid :mod 10 :name (n / name :op1 ""serine"")
                  :ARG3-of (p2 / phosphorylate-01)
                  :part-of (p / protein :name (n4 / name :op1 ""H3""))))
      :location (a4 / and
            :op1 (c / cell
                  :mod (v / vector
                        :ARG1-of (d / describe-01
                              :ARG0 (l2 / lane :mod 4
                                    :part-of (f2 / figure :mod ""2A""))
                              :quant (p4 / product-of :op1 2.8))))
            :op2 (c2 / cell
                  :mod (w / wild-type
                        :ARG1-of (d2 / describe-01
                              :ARG0 (l3 / lane :mod 5
                                    :part-of f2)
                              :quant (p5 / product-of :op1 3.8))))
            :op3 (c3 / cell
                  :mod (k / knock-down-02
                        :ARG1-of (d3 / describe-01
                              :ARG0 (l4 / lane :mod 6
                                    :part-of f2)
                              :quant (p6 / product-of :op1 2.8)))))
      :condition (a5 / and
            :op1 (s / small-molecule :name (n2 / name :op1 ""IPTG""))
            :op2 (o / overexpress-01
                  :ARG1 (e / enzyme :name (n3 / name :op1 ""Ras"")
                        :ARG2-of (m / mutate-01 :value ""V12"")))))","In the presence of IPTG, where Ras<sup>V12 </sup>protein was overexpressed, the level of phosphorylated H3S10 was increased both in Vector (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 4, 2.8 fold), WT (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 5, 3.8 fold) and KD (Figure <xref ref-type=""fig"" rid=""F2"">2A</xref>, lane 6, 2.8 fold) cells.","(z1 / increase-01
    :ARG1 (z2 / level
              :quant-of (z3 / protein
                            :wiki ""Histidine-activated_protein_kinase_10""
                            :name (z4 / name
                                      :op1 ""H3S10"")
                            :ARG1-of (z5 / phosphorylate-01)))
    :condition (z6 / present-02
                   :ARG1 (z7 / small-molecule
                             :wiki ""Inositol_trisphosphate_receptor""
                             :name (z8 / name
                                       :op1 ""IPTG"")
                             :location-of (z9 / overexpress-01
                                              :ARG1 (z10 / protein
                                                         :wiki ""BRAF_(g3000 / gene)""
                                                         :name (z11 / name
                                                                    :op1 ""Ras""
                                                                    :op2 ""V12""))))))",0.2772277227722772,0.2542372881355932,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (l / level
                  :mod (p / phosphorylate-01
                        :ARG1 (h / H3S10)
                        :ARG2 (i2 / increase-01
                              :ARG1 (p2 / presence
                                    :mod (i3 / IPTG))
                              :ARG2 (o / overexpress-01
                                    :ARG1 (p3 / protein
                                          :mod (r / Ras<sup>V12</sup>))))
                        :degree (f / fold
                              :value 2.8)))
            :ARG2 (c / cell
                  :mod (v / Vector
                        :mod (f2 / Figure
                              :op1 ""2A""
                              :op2 (l2 / lane 4)))
                  :mod (w / WT
                        :mod (f3 / Figure
                              :op1 ""2A""
                              :op2 (l3 / lane 5)))
                  :mod (k / KD
                        :mod (f4 / Figure
                              :op1 ""2A""
                              :op2 (l4 / lane 6)))
                  :mod (i4 / increase-01
                        :ARG1 (p4 / presence
                              :mod (i5 / IPTG))
                        :ARG2 (o2 / overexpress-01
                              :ARG1 (p5 / protein
                                    :mod (r2 / Ras<sup>V12</sup>))))
                        :ARG2 (f5 / fold
                              :value 3.8))))
        :snt2 (c2 / cell))","(p / presence-01
    :location (i / IPTG)
    :condition (o / overexpress-01
        :ARG1 (p2 / protein
            :name (n / name :op1 ""Ras"" :op2 ""V12"")))
    :result (i2 / increase-01
        :ARG1 (l / level
            :ARG1-of (p3 / phosphorylate-01
                :ARG1 (h / H3S10)))
        :location (a / and
            :op1 (c / cell
                :mod (v / vector)
                :quant (f / fold :quant 2.8)
                :location (f2 / figure :mod (n2 / name :op1 ""2A"") :mod (l2 / lane :quant 4)))
            :op2 (c2 / cell
                :mod (w / wild-type)
                :quant (f3 / fold :quant 3.8)
                :location (f4 / figure :mod (n3 / name :op1 ""2A"") :mod (l3 / lane :quant 5)))
            :op3 (c3 / cell
                :mod (k / kinase-domain :polarity -)
                :quant (f5 / fold :quant 2.8)
                :location (f6 / figure :mod (n4 / name :op1 ""2A"") :mod (l4 / lane :quant 6))))))",-1.0,0.3714285714285714
pmid_2000_3375.128,"Taken together, both Aurora-A and mutant Ras<sup>V12 </sup>overexpression can induce focus formation.","(p2 / possible-01
    :ARG1 (i / induce-01
        :ARG0 (a / and
            :op1 (p / person
                :name (n / name
                    :op1 ""The""))
            :op2 (p3 / protein
                :name (n2 / name
                    :op1 ""i""
                    :op2 ""Duncan"")
                :mod (m / mutant)))
        :ARG1 (f2 / form-01
            :ARG1 (f / focus-01)))
    :ARG1-of (t / take-01
        :mod (t2 / together)))
",test,bio_amr0.8,"(h / have-condition-91
      :ARG1 (p / possible-01
            :ARG1 (i / induce-01
                  :ARG0 (a / and
                        :op1 (o / overexpress-01
                              :ARG1 (e / enzyme :name (n / name :op1 ""Aurora-A"")))
                        :op2 (o2 / overexpress-01
                              :ARG1 (e2 / enzyme :name (n2 / name :op1 ""Ras"")
                                    :ARG2-of (m / mutate-01 :value ""V12""))))
                  :ARG2 (f / form-01
                        :ARG1 (f2 / focus))))
      :ARG2 (t / take-01
            :ARG1 a
            :mod (t2 / together)))","Taken together, both Aurora-A and mutant Ras<sup>V12 </sup>overexpression can induce focus formation.","(z1 / possible-01
    :ARG1 (z2 / induce-01
              :ARG0 (z3 / and
                        :op1 (z4 / enzyme
                                 :wiki ""Aurabenzodibenzodibenzodibenzodibenzodioxin""
                                 :name (z5 / name
                                           :op1 ""Aurora-A""))
                        :op2 (z6 / enzyme
                                 :wiki ""BRAF-V12""
                                 :name (z7 / name
                                           :op1 ""Ras""
                                           :op2 ""V12"")
                                 :mod (z8 / mutant)))
              :ARG1 (z9 / form-01
                        :ARG1 (z10 / focus-01)))
    :manner (z11 / together))",0.3934426229508196,0.3934426229508196,"(s / sentence
        :topic (t / together
              :op1 (a / and
                    :op1 (a2 / Aurora-A)
                    :op2 (m / mutant
                          :ARG1 (r / Ras<sup>V12</sup>))))
        :ARG1 (i / induce-01
              :ARG1 (f / focus-01
                    :ARG1 (f2 / formation))))","(t / together-91
    :ARG1 (a / and
        :op1 (o / overexpress-01
            :ARG0 (p / protein
                :name (n / name :op1 ""Aurora-A"")))
        :op2 (i / induce-01
            :ARG0 (o2 / overexpress-01
                :ARG0 (p2 / protein
                    :mod (m / mutant)
                    :name (n2 / name :op1 ""Ras"" :op2 ""V12"")))
            :ARG1 (f / focus-formation-91))))",-1.0,0.4067796610169491
pmid_2000_3375.129,Further induction of focus formation was detected when these two genes were overexpressed simultaneously.,"(d / detect-01
    :ARG1 (i / induct-02
        :ARG1 (f2 / form-01
            :ARG1 (f / focus-01))
        :degree (f3 / further))
    :time (e / express-03
        :ARG1 (g / gene
            :quant 2
            :mod (t / this))
        :mod (s / simultaneous)))
",test,bio_amr0.8,"(d / detect-01
      :ARG1 (i / induce-01
            :ARG2 (f2 / form-01
                  :ARG1 (f3 / focus))
            :degree (f / further))
      :condition (o / overexpress-01
            :ARG1 (g / gene :quant 2
                  :mod (t / this))
            :mod (s / simultaneous)))",Further induction of focus formation was detected when these two genes were overexpressed simultaneously.,"(z1 / detect-01
    :ARG1 (z2 / induce-01
              :ARG1 (z3 / form-01
                        :ARG1 (z4 / focus-01))
              :degree (z5 / further))
    :time (z6 / overexpress-01
              :ARG1 (z7 / gene
                        :quant 2
                        :mod (z8 / this))
              :mod (z9 / simultaneous)))",0.7894736842105263,0.6842105263157895,"(f / focus-01
    :ARG1 (d / detect-01
        :ARG1 (i / induction
            :mod (f2 / further))
        :ARG2 (f2 / form-01
            :ARG1 (f3 / focus
                :mod (d2 / detect-01
                    :ARG1 (w / when
                        :op1 (g / gene
                            :ARG1-of (o / overexpress-01
                                :ARG0 (t / two)
                                :ARG1 (s / simultaneous))))))))","(i / induce-01 :mode more
    :ARG1 (f / focus-01
        :ARG1-of (f2 / form-03))
    :time (w / when
        :ARG1 (a / and
            :op1 (o / overexpress-01
                :ARG1 (g / gene))
            :op2 (o2 / overexpress-01
                :ARG1 (g2 / gene)))
        :ARG2 (s / simultaneous-01)))",-1.0,0.3
pmid_2000_3375.131,"Growth rate of Vector, WT and KD cells were decreased when mutant Ras was overexpressed (Fig. <xref ref-type=""fig"" rid=""F2"">2D</xref>).","(d / decrease-01
    :ARG1 (r / rate
        :mod (g / grow-01
            :ARG1 (a / and
                :op1 (c / cell
                    :mod (v / virus
                        :name (n / name
                            :op1 ""WT"")))
                :op2 (c2 / cell
                    :mod v)
                :op3 (c3 / cell
                    :mod (e2 / ethnic-group
                        :name (n2 / name
                            :op1 ""KD""))))))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure))
    :condition (e3 / express-03
        :ARG1 (e / enzyme
            :name (n3 / name
                :op1 ""Ras"")
            :mod (m / mutant))))
",test,bio_amr0.8,"(d / decrease-01
      :ARG1 (a / and
            :op1 (r / rate
                  :degree-of (g / grow-01
                        :ARG1 (c / cell
                              :mod (v / vector))))
            :op2 (r2 / rate
                  :degree-of (g2 / grow-01
                        :ARG1 (c2 / cell
                              :mod (w / wild-type))))
            :op3 (r3 / rate
                  :degree-of (g3 / grow-01
                        :ARG1 (c3 / cell
                              :mod (k / knock-down-02)))))
      :time (o / overexpress-01
            :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")
                  :ARG2-of (m / mutate-01)))
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod ""2D"")))","Growth rate of Vector, WT and KD cells were decreased when mutant Ras was overexpressed (Fig. <xref ref-type=""fig"" rid=""F2"">2D</xref>).","(z1 / decrease-01
    :ARG1 (z2 / rate
              :mod (z3 / grow-01
                       :ARG1 (z4 / cell
                                 :mod (z5 / and
                                          :op1 (z6 / vector)
                                          :op2 (z7 / cell
                                                   :wiki ""WT_(g3000 / gene)""
                                                   :name (z8 / name
                                                             :op1 ""WT""))
                                          :op3 (z9 / cell
                                                   :wiki ""KD_(g3001 / gene)""
                                                   :name (z10 / name
                                                              :op1 ""KD"")))))))",0.3076923076923076,0.4050632911392405,"(s / sentence
        :ARG0 (d / decrease-01
              :ARG1 (r / rate
                    :mod (g / growth)
                    :mod (c / cell
                          :ARG0-of (o / overexpress-01
                                :ARG1 (m / mutant
                                      :mod (r2 / Ras))))
                    :mod (v / Vector)
                    :mod (w / WT)
                    :mod (k / KD)))
        :ARG1 (f / figure
              :ARG0-of (r2 / reference-01
                    :ARG1 (f2 / fig)
                    :ARG2 ""F2"")
              :ARG1 (d2 / 2D)))","(g / grow-01
    :ARG1 (c / cell
        :mod (v / vector)
        :mod (w / wt)
        :mod (k / kd))
    :ARG2 (r / rate)
    :time (w2 / when
        :ARG1 (o / overexpress-01
            :ARG0 (m / mutant
                :mod (r2 / ras))))
    :degree (d / decrease-01)
    :mod (f / figure :wiki -
        :name (n / name :op1 ""2D"")))",-1.0,0.2898550724637681
pmid_2000_3375.133,"<sec-title level=""2"">Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the Ras<sup>V12 </sup>transformants</sec-title>","(i / increase-01
    :li 2
    :ARG0 (e / engineer-01
        :ARG1-of (o / over-03))
    :ARG1 (a2 / and
        :op1 (s2 / status
            :ARG1-of (p / phosphorylate-01)
            :domain (a3 / and
                :op1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""MEK""))
                :op2 (p2 / protein
                    :name (n4 / name
                        :op1 ""AKT""
                        :op1 ""RalA""))))
        :op2 (a / activity-06
            :ARG0 p2))
    :rel (n / name
        :op1 ""a"")
    :rel (s / slash
        :op1 e2
        :op2 (e3 / enzyme
            :name (n3 / name
                :op1 ""ERK""))))
",test,bio_amr0.8,"(i / increase-01
      :ARG0 (o / overexpress-01
            :ARG1 (e2 / enzyme :name (n / name :op1 ""Aurora-A"")))
      :ARG1 (a2 / and
            :op1 (s / status
                  :mod (p / phosphorylate-01)
                  :poss (a / and
                        :op1 (p2 / pathway :name (n2 / name :op1 ""MEK/ERK""))
                        :op2 (p4 / pathway :name (n3 / name :op1 ""AKT""))))
            :op2 (a3 / activity-06
                  :ARG0 (p3 / protein :name (n4 / name :op1 ""RalA""))
                  :location (e3 / enzyme :name (n5 / name :op1 ""Ras"")
                        :ARG2-of (t / transform-01 :value ""V12"")))))","<sec-title level=""2"">Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the Ras<sup>V12 </sup>transformants</sec-title>","(z1 / increase-01
    :ARG0 (z2 / overexpress-00
              :ARG1 (z3 / enzyme
                        :wiki ""Aurora-A""
                        :name (z4 / name
                                  :op1 ""Aurora-A"")))
    :ARG1 (z5 / status
              :mod (z6 / phosphorylate-01
                       :ARG1 (z7 / and
                                 :op1 (z8 / enzyme
                                          :wiki ""Mitogen-activated_protein_kinase""
                                          :name (z9 / name
                                                    :op1 ""MEK/ERK""))
                                 :op2 (z10 / enzyme
                                           :wiki ""AKT""
                                           :name (z11 / name
                                                      :op1 ""AKT""))
                                 :op3 (z12 / enzyme
                                           :wiki ""BRAF-activated_protein_kinase""
                                           :name (z13 / name
                                                      :op1 ""Ras""
                                                      :op2 ""V12""
                                                      :op3 ""transformants""))))))",0.4102564102564102,0.4146341463414634,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (o / overexpression
                  :ARG0 (a / Aurora-A))
            :ARG2 (s / status
                  :ARG1 (p / phosphorylation
                        :ARG1 (m / MEK/ERK)))
            :ARG2-of (a2 / as-well-as
                  :op1 (a3 / activity
                        :ARG1 (r / RalA)))
            :ARG2-of (a4 / as-well-as
                  :op1 (a5 / activity
                        :ARG1 (t / transformant
                              :mod (v / V12
                                    :op1 ""Ras""))))))
        :snt2 (n / name
            :op1 ""Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the RasV12 transformants""))","(o / overexpress-01
    :ARG0 (a / aurora-A)
    :ARG1 (i / increase-01
        :ARG1 (p / phosphorylate-01
            :ARG1 (s / status
                :mod (m / MEK/ERK)
                :mod (a2 / AKT)))
        :ARG2 (a3 / activity
            :mod (r / RalA)
            :location (t / transformant
                :mod (r2 / Ras^V12))))
    :medium (t2 / text
        :mod (t3 / title
            :level 2)))",-1.0,-1.0
pmid_2000_3375.134,"To clarify the effects of Aurora-A on the signaling pathways related to Ras overexpression, three downstream signaling pathways of Ras, Raf/MEK, PI3K/AKT and RalGDS/Ral A were investigated.","(i / investigate-01
    :purpose (c / clarify-10
        :ARG1 (a / affect-01
            :ARG1-of (r / relate-01
                :ARG2 (e / engineer-01
                    :ARG1 (e2 / enzyme
                        :name (n / name
                            :op1 ""Ras"")
                        :poss (a2 / and
                            :mod e2
                            :op1 (e4 / enzyme
                                :name (n2 / name
                                    :op1 ""B-Raf""))
                            :op2 e4
                            :op3 (e5 / enzyme
                                :name (n3 / name
                                    :op1 ""B-Raf""))
                            :op4 (e6 / enzyme
                                :name (n4 / name
                                    :op2 ""MEK""))
                            :op5 (p / protein
                                :name (n5 / name
                                    :op1 ""PI3K"")
                                :name (n6 / name
                                    :op1 ""AKT""))
                            :op6 (p2 / protein)
                            :op7 (p3 / protein
                                :name (n7 / name
                                    :op1 ""RalGDS""
                                    :op2 ""A""
                                    :op2 ""A""))))))))
    :ARG1 (e3 / enzyme
        :quant 3
        :ARG0-of (s / signal-07)
        :mod (d / downstream))
    :rel (u / Russia)
    :rel (s2 / signal-07))
",test,bio_amr0.8,"(i / investigate-01
      :ARG1 (p / pathway :quant 3
            :location (d / downstream)
            :ARG0-of (s / signal-07
                  :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")))
            :ARG1-of (m / mean-01
                  :ARG2 (a / and
                        :op1 (p2 / pathway :name (n2 / name :op1 ""Raf/MEK""))
                        :op2 (p3 / pathway :name (n3 / name :op1 ""PI3K/AKT""))
                        :op3 (p4 / pathway :name (n4 / name :op1 ""RalGDS/RalA"")))))
      :ARG2 (c / clarify-10
            :ARG1 (a2 / affect-01
                  :ARG0 (e2 / enzyme :name (n5 / name :op1 ""Aurora-A""))
                  :ARG1 (p6 / pathway
                        :ARG0-of s
                        :ARG1-of (r / relate-01
                              :ARG2 (o / overexpress-01
                                    :ARG2 e))))))","To clarify the effects of Aurora-A on the signaling pathways related to Ras overexpression, three downstream signaling pathways of Ras, Raf/MEK, PI3K/AKT and RalGDS/Ral A were investigated.","(z1 / investigate-01
    :ARG1 (z2 / pathway
              :quant 3
              :ARG0-of (z3 / signal-07
                           :ARG1 (z4 / enzyme
                                     :wiki ""Ras_(g3000 / gene)""
                                     :name (z5 / name
                                               :op1 ""Ras"")))
              :consist-of (z6 / and
                              :op1 (z7 / enzyme
                                       :wiki ""BRAF/MEK""
                                       :name (z8 / name
                                                 :op1 ""Raf/MEK""))
                              :op2 (z9 / enzyme
                                       :wiki ""PHLDA/AKT""
                                       :name (z10 / name
                                                  :op1 ""PI3K/AKT""))
                              :op3 (z11 / enzyme
                                        :wiki ""RalGDS/Ral_A""
                                        :name (z12 / name
                                                   :op1 ""RalGDS/Ral""
                                                   :op2 ""A""))))
    :direction (z13 / downstream))",0.4418604651162791,0.3392857142857142,"(c / clarify-01
        :ARG0 (e / effect-01
              :ARG1 (a / Aurora-A))
        :ARG1 (p / pathway
              :mod (s / signal-01
                    :ARG1 (r / relate-01
                          :ARG1 (o / overexpression
                                :ARG1 (r2 / Ras))))
              :mod (d / downstream
                    :ARG1 (p2 / pathway
                          :mod (r2 / Raf/MEK)
                          :mod (p3 / PI3K/AKT)
                          :mod (r3 / RalGDS/Ral_A)))))","(i / investigate-01
    :ARG0 (w / we)
    :ARG1 (p / pathway
        :mod (s / signal-01)
        :ARG1-of (d / downstream-01
            :ARG1 (r / Ras))
        :example (p2 / pathway
            :name (n / name :op1 ""Raf"" :op2 ""/"" :op3 ""MEK""))
        :example (p3 / pathway
            :name (n2 / name :op1 ""PI3K"" :op2 ""/"" :op3 ""AKT""))
        :example (p4 / pathway
            :name (n3 / name :op1 ""RalGDS"" :op2 ""/"" :op3 ""Ral"" :op4 ""A"")))
    :purpose (c / clarify-01
        :ARG1 (e / effect
            :ARG0 (a / Aurora-A)
            :ARG1 p
            :ARG2 (o / overexpress-01
                :ARG0 r))))",-1.0,0.2978723404255319
pmid_2000_3375.136,"P-MEK levels in each cell line were further increased after IPTG induction (Ras<sup>V12 </sup>is over-expressed) (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 4, 5, and 6).","(i / increase-01
    :ARG1 (l2 / level
        :location (l3 / line
            :mod (c / cell)
            :mod (e / each))
        :mod (p / protein
            :name (n3 / name
                :op1 ""serine"")))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod (l / lane
                :mod 4)
            :mod 5
            :mod 6))
    :degree (f2 / further)
    :rel (e2 / enzyme
        :name (n / name
            :op1 ""BP""))
    :rel (n2 / name)
    :time (a / after
        :op1 (i2 / induct-02
            :ARG1 (e3 / enzyme
                :name (n4 / name
                    :op1 ""IPTG"")
                :ARG1-of (e4 / express-01
                    :extent (o / over))))))
",test,bio_amr0.8,"(i / increase-01
      :ARG1 (l / level
            :location (c / cell-line
                  :mod (e2 / each))
            :quant-of (e / enzyme :name (n / name :op1 ""MEK"")
                  :ARG3-of (p / phosphorylate-01)))
      :degree (f / further)
      :time (a / after
            :op1 (i2 / induce-01
                  :ARG2 (s / small-molecule :name (n2 / name :op1 ""IPTG""))))
      :ARG1-of (m / mean-01
            :ARG2 (o / overexpress-01
                  :ARG1 (e3 / enzyme :name (n3 / name :op1 ""Ras"")
                        :ARG2-of (m2 / mutate-01 :value ""V12""))))
      :ARG1-of (d / describe-01
            :ARG0 (a2 / and
                  :op1 (l2 / lane :mod 4)
                  :op2 (l3 / lane :mod 5)
                  :op3 (l4 / lane :mod 6)
                  :part-of (f2 / figure :mod ""3A""))))","P-MEK levels in each cell line were further increased after IPTG induction (Ras<sup>V12 </sup>is over-expressed) (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 4, 5, and 6).","(z1 / increase-01
    :ARG1 (z2 / level
              :mod (z3 / enzyme
                       :wiki ""P-meK""
                       :name (z4 / name
                                 :op1 ""P-MEK""))
              :location (z5 / line
                            :mod (z6 / cell)
                            :mod (z7 / each)))
    :degree (z8 / further)
    :time (z9 / after
              :op1 (z10 / induct-02
                        :ARG1 (z11 / small-molecule
                                   :wiki ""Inositol_trisphosphate_receptor""
                                   :name (z12 / name
                                              :op1 ""IPTG""))))
    :ARG1-of (z13 / cause-01
                  :ARG0 (z14 / overexpress-01
                             :ARG1 (z15 / enzyme
                                        :wiki ""BRAF-activated_protein_kinase""
                                        :name (z16 / name
                                                   :op1 ""Ras"")
                                        :ARG1-of (z17 / color-01)))))",0.4444444444444445,0.4086021505376344,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (l / level
                  :mod (p / P-MEK))
            :ARG2 (c / cell-line))
        :snt2 (i2 / increase-01
            :ARG1 (l2 / level
                  :mod (p2 / P-MEK))
            :ARG2 (c2 / cell-line)
            :ARG3 (i3 / induction
                  :ARG1 p2
                  :ARG2 (i4 / IPTG)))
        :snt3 (o / over-express-01
            :ARG1 (r / Ras
                  :mod (v / V12)))
        :snt4 (x / xref
            :ref-type ""fig""
            :rid ""F3""
            :ARG1 (f / figure
                  :op1 ""3A""))
        :snt5 (l / lane
            :op1 4
            :op2 5
            :op3 6))","(i / increase-01
    :ARG1 (l / level
        :quant (p / protein :name (n / name :op1 ""P-MEK"")))
    :location (c / cell-line
        :quant (e / each))
    :time (a / after
        :op1 (i2 / induce-01
            :ARG1 (i3 / IPTG)))
    :mod (f / further)
    :condition (o / over-express-01
        :ARG1 (r / Ras :mod (v / version :value 12)))
    :accompanying (f2 / figure
        :mod (n2 / name :op1 ""3A"")
        :location (l2 / lane
            :op1 ""4""
            :op2 ""5""
            :op3 ""6"")))",-1.0,0.3181818181818182
pmid_2000_3375.137,"The same phenomenon was also been observed in p-ERK1/2 (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>).","(o / observe-01
    :ARG1 (p / phenomenon
        :ARG1-of (s / same-01))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure))
    :location (e / enzyme
        :name (n / name
            :op1 ""League""
            :op2 ""of""
            :op3 3)
        :mod ""1/2"")
    :mod (a / also))
",test,bio_amr0.8,"(o / observe-01
      :ARG1 (p / phenomenon
            :ARG1-of (s / same-01))
      :mod (a / also)
      :condition (s2 / slash
            :op1 (e / enzyme :name (n / name :op1 ""ERK1""))
            :op2 (e2 / enzyme :name (n2 / name :op1 ""ERK2""))
            :ARG3-of (p2 / phosphorylate-01))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""3A"")))","The same phenomenon was also been observed in p-ERK1/2 (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>).","(z1 / observe-01
    :ARG1 (z2 / phenomenon
              :ARG1-of (z3 / same-01))
    :mod (z4 / also)
    :location (z5 / enzyme
                  :wiki ""P-ERK1/2""
                  :name (z6 / name
                            :op1 ""p-ERK1/2""))
    :ARG1-of (z7 / describe-01
                 :ARG0 (z8 / figure
                           :ARG1-of (z9 / hyperlink-91
                                        :ARG3 (z10 / url-entity
                                                   :value ""3A"")))))",0.5306122448979592,0.5777777777777778,"(s / same
    :ARG1 (p / phenomenon
        :ARG1-of (o / observe-01
            :ARG1 (b / be-01
                :ARG1 (w / we)
                :ARG2 (o2 / observe-01
                    :ARG1 (e / ERK1/2
                        :mod (p2 / phosphorylate-01))
                    :ARG2 (f / figure
                        :ARG1-of (r / reference-01
                            :ARG2 (f2 / F3
                                :ref-type ""fig""))))))))","(o / observe-01
    :ARG1 (p / phenomenon
        :mod (s / same))
    :location (p2 / protein
        :name (n / name :op1 ""p-ERK1/2""))
    :time (p3 / past)
    :mode (a / also)
    :medium (f / figure
        :name (n2 / name :op1 ""3A"")))",-1.0,0.3913043478260869
pmid_2000_3375.138,These results indicated that Aurora-A may further increase Ras induced MEK/ERK phosphorylation.,"(i2 / indicate-01
    :ARG0 (t / thing
        :ARG2-of (r / result-01)
        :mod (t2 / this))
    :ARG1 (p2 / possible-01
        :ARG1 (i / increase-01
            :ARG0 (o2 / occasion)
            :ARG1 (p / phosphorylate-01
                :ARG1 (s / slash
                    :op1 (e2 / enzyme
                        :name (n3 / name
                            :op1 ""MEK""))
                    :op2 (e3 / enzyme
                        :name (n4 / name
                            :op1 ""ERK"")))
                :ARG1-of (i3 / induce-01
                    :ARG2 (e / enzyme
                        :name (n2 / name
                            :op1 ""Ras""))))
            :degree (f / further)))
    :rel (o / occasion
        :name (n / name
            :op1 ""Aurora"")))
",test,bio_amr0.8,"(i / indicate-01
      :ARG0 (t / thing
            :ARG2-of (r / result-01)
            :mod (t2 / this))
      :ARG1 (p3 / possible-01
            :ARG1 (i2 / increase-01
                  :ARG0 (e2 / enzyme :name (n3 / name :op1 ""Aurora-A""))
                  :ARG1 (p5 / phosphorylate-01
                        :ARG1 (p / pathway :name (n2 / name :op1 ""MEK/ERK""))
                        :ARG2-of (i3 / induce-01
                              :ARG0 (e / enzyme :name (n / name :op1 ""Ras""))))
                  :degree (f / further))))",These results indicated that Aurora-A may further increase Ras induced MEK/ERK phosphorylation.,"(z1 / indicate-01
    :ARG0 (z2 / thing
              :ARG2-of (z3 / result-01)
              :mod (z4 / this))
    :ARG1 (z5 / possible-01
              :ARG1 (z6 / increase-01
                        :ARG0 (z7 / enzyme
                                  :wiki ""Auragonine_A""
                                  :name (z8 / name
                                            :op1 ""Aurora-A""))
                        :ARG1 (z9 / phosphorylate-01
                                  :ARG1 (z10 / enzyme
                                             :wiki ""Mitogen-activated_protein_kinase""
                                             :name (z11 / name
                                                        :op1 ""MEK/ERK""))
                                  :ARG2-of (z12 / induce-01
                                                :ARG0 (z13 / enzyme
                                                           :wiki ""Ras–activated_protein_kinase""
                                                           :name (z14 / name
                                                                      :op1 ""Ras""))))
                        :degree (z15 / further))))",0.7826086956521738,0.56,"(r / result
    :ARG1 (i / indicate-01
        :ARG0 (t / this)
        :ARG1 (i2 / increase-01
            :ARG0 (a / Aurora-A)
            :ARG1 (p / phosphorylation
                :ARG1 (p2 / phosphorylation
                    :ARG1 (m / MEK/ERK)
                    :ARG0-of (i3 / induce-01
                        :ARG1 (r2 / Ras)))))))","(i / indicate-01
    :ARG0 (r / result :mod (t / this))
    :ARG1 (i2 / increase-01
        :ARG0 (p / protein :name (n / name :op1 ""Aurora-A""))
        :ARG1 (p2 / phosphorylate-01
            :ARG0 (p3 / protein :name (n2 / name :op1 ""MEK/ERK""))
            :ARG1-of (i3 / induce-01
                :ARG0 (p4 / protein :name (n3 / name :op1 ""Ras""))))))",-1.0,0.6666666666666666
pmid_2000_3375.139,The effect of Aurora-A on the PI3K/AKT pathway was evaluated by detecting phosphorylation of AKT (p-AKT).,"(e2 / evaluate-01
    :ARG1 (a / affect-01
        :ARG0 (p / pathway
            :name (n2 / name
                :op1 ""A""
                :op1 ""PI3K""
                :op1 ""AKT""))
        :ARG2 (e / enzyme
            :name n2))
    :manner (d / detect-01
        :ARG1 (p2 / phosphorylate-01
            :ARG1 e))
    :rel (n / name)
    :rel (e3 / expressive))
",test,bio_amr0.8,"(e / evaluate-01
      :ARG1 (a / affect-01
            :ARG0 (e3 / enzyme :name (n2 / name :op1 ""Aurora-A""))
            :ARG1 (p4 / pathway :name (n3 / name :op1 ""PI3K/AKT"")))
      :manner (d / detect-01
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (e2 / enzyme :name (n / name :op1 ""AKT"")))))",The effect of Aurora-A on the PI3K/AKT pathway was evaluated by detecting phosphorylation of AKT (p-AKT).,"(z1 / evaluate-01
    :ARG1 (z2 / affect-01
              :ARG0 (z3 / enzyme
                        :wiki ""Aurora-A""
                        :name (z4 / name
                                  :op1 ""Aurora-A""))
              :ARG1 (z5 / pathway
                        :mod (z6 / enzyme
                                 :wiki ""PHLDA3K/AKT""
                                 :name (z7 / name
                                           :op1 ""PI3K/AKT"")))
              :ARG2 (z8 / phosphorylate-01
                        :ARG1 (z9 / enzyme
                                  :wiki ""AKT""
                                  :name (z10 / name
                                             :op1 ""AKT""))))
    :manner (z11 / detect-01
                 :ARG1 (z12 / phosphorylate-01
                            :ARG1 z9)))",0.5925925925925926,0.5652173913043478,"(e / effect
    :ARG1 (a / affect-01
        :ARG0 (a2 / Aurora-A)
        :ARG1 (p / pathway
            :mod (p2 / PI3K/AKT))
        :ARG2 (e2 / evaluate-01
            :ARG1 (d / detect-01
                :ARG1 (p2 / phosphorylation
                    :ARG1 (a3 / AKT))))))","(e / effect-01
    :ARG0 (p / protein :name ""Aurora-A"")
    :ARG1 (p2 / pathway :name ""PI3K/AKT"")
    :ARG2 (e2 / evaluate-01
        :ARG0 (p3 / person :ARG0-of (d / detect-01
            :ARG1 (p4 / phosphorylation-01
                :ARG1 (p5 / protein :name ""AKT"")
                :mod (p6 / protein :name ""p-AKT""))))))",-1.0,0.3111111111111111
pmid_2000_3375.140,"The p-AKT level was also higher in WT cells (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 2, 2.1 fold) compared to Vector and KD cells (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 1, 1.0 fold and lane 3, 1.1 fold, respectively).","(h / have-degree-91
    :ARG1 (l6 / level
        :mod (p2 / person
            :mod (c4 / city
                :name (n / name
                    :op1 ""T-Mobile"")
                :name (n2 / name
                    :op1 ""WT""))))
    :ARG1-of (c5 / compare-01
        :ARG2 (a2 / and
            :mod (p / percentage-entity
                :quant 1.0
                :value 2.1)
            :op1 (c2 / cell
                :mod (l / laboratory
                    :name n))
            :op2 (c3 / cell
                :mod (e / ethnic-group
                    :name (n3 / name
                        :op1 ""Vector"")))))
    :ARG1-of (d / describe-01
        :ARG0 (a3 / and
            :op1 (l3 / lane
                :mod (l2 / lane
                    :mod 2
                    :mod l
                    :mod 3)
                :mod 1)
            :op2 (l4 / lane
                :mod (f2 / figure))
            :op3 l4
            :op4 (l5 / lane
                :mod a2
                :mod 3)))
    :ARG2 (h2 / high-02
        :ARG1 l6)
    :ARG3 (m / more)
    :location (c / cell
        :mod c4)
    :mod (a / also)
    :rel 1.1
    :rel (f / figure))
",test,bio_amr0.8,"(h / high-02
      :ARG1 (l / level
            :quant-of (e / enzyme :name (n / name :op1 ""AKT"")
                  :ARG3-of (p / phosphorylate-01)))
      :degree (m / more)
      :mod (a / also)
      :location (c / cell
            :mod (w / wild-type)
            :ARG1-of (d / describe-01
                  :ARG0 (l2 / lane :mod 2
                        :part-of (f / figure :mod ""3A""))
                  :ARG2 (p2 / product-of :op1 2.1)))
      :compared-to (a2 / and
            :op1 (c2 / cell
                  :mod (v / vector)
                  :ARG1-of (d2 / describe-01
                        :ARG0 (l3 / lane :mod 1
                              :part-of f)
                        :ARG2 (p3 / product-of :op1 1.0)))
            :op2 (c3 / cell
                  :mod (k / knock-down-02)
                  :ARG1-of (d3 / describe-01
                        :ARG0 (l4 / lane :mod 3
                              :part-of f)
                        :ARG2 (p4 / product-of :op1 1.1)))))","The p-AKT level was also higher in WT cells (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 2, 2.1 fold) compared to Vector and KD cells (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 1, 1.0 fold and lane 3, 1.1 fold, respectively).","(z1 / have-degree-91
    :ARG1 (z2 / level
              :mod (z3 / enzyme
                       :wiki ""P-AKT""
                       :name (z4 / name
                                 :op1 ""p-AKT"")))
    :ARG2 (z5 / high-02
              :ARG1 z2)
    :ARG3 (z6 / more)
    :ARG4 (z7 / cell
              :mod (z8 / small-molecule
                       :wiki ""WT_cell""
                       :name (z9 / name
                                 :op1 ""WT""))
              :ARG0-of (z10 / have-03
                            :ARG1 (z11 / and
                                       :op1 (z12 / cell
                                                 :wiki ""3A_(t3000 / threonine)""
                                                 :name (z13 / name
                                                            :op1 ""3A""))
                                       :op2 (z14 / lane
                                                 :mod 2)
                                       :op3 (z15 / lane
                                                 :mod 3)
                                       :op4 (z16 / fold
                                                 :quant ""2.1""))))
    :ARG1-of (z17 / compare-01
                  :ARG2 (z18 / and
                             :op1 (z19 / cell
                                       :mod (z20 / vector))
                             :op2 (z21 / cell
                                       :mod (z22 / molecular-physical-entity
                                                 :wiki ""KD_(g3001 / gene)""
                                                 :name (z23 / name
                                                            :op1 ""KD"")))
                             :ARG0-of (z24 / have-03
                                           :ARG1 (z25 / and
                                                      :op1 (z26 / cell
                                                                :mod z12)
                                                      :op2 (z27 / cell
                                                                :mod (z28 / molecular-physical-entity
                                                                          :wiki ""3A_(t3002 / threonine)""
                                                                          :name (z29 / name
                                                                                     :op1 ""3A"")))
                                                      :op3 (z30 / lane
                                                                :mod 1)
                                                      :op4 (z31 / fold
                                                                :quant ""1.0"")
                                                      :op5 (z32 / lane
                                                                :mod 3)
                                                      :op6 (z33 / fold
                                                                :quant ""1.1""))))))",0.2074074074074074,0.3220338983050847,"(m / multi-sentence
        :snt1 (h / higher-01
            :ARG1 (l / level
                  :mod (a / also)
                  :ARG1-of (w / was
                        :ARG1 (p / p-AKT)))
            :ARG2 (c / cell
                  :mod (w / WT))
            :degree (h2 / high))
        :snt2 (c2 / compare-01
            :ARG1 (l2 / lane
                  :op1 (n / number :op1 ""2""))
            :ARG2 (c3 / cell
                  :mod (v / Vector))
            :ARG3 (c4 / cell
                  :mod (k / KD)))
        :snt3 (f / fold
            :ARG1 (n2 / number :op1 ""2.1"")
            :ARG2 (l3 / lane
                  :op1 (n3 / number :op1 ""1"")))
        :snt4 (c5 / compare-01
            :ARG1 (l4 / lane
                  :op1 (n4 / number :op1 ""1""))
            :ARG2 (c6 / cell
                  :mod (v2 / Vector)))
        :snt5 (f2 / fold
            :ARG1 (n5 / number :op1 ""1.0"")
            :ARG2 (l5 / lane
                  :op1 (n6 / number :op1 ""3"")))
        :snt6 (f3 / fold
            :ARG1 (n7 / number :op1 ""1.1"")
            :ARG2 (l6 / lane
                  :op1 (n8 / number :op1 ""3""))))","(c / compare-01
    :ARG1 (l / level
        :ARG1-of (h / high-02
            :degree (a / also))
        :topic (p / p-AKT)
        :location (c2 / cell
            :mod (w / wild-type)))
    :ARG2 (l2 / level
        :ARG1-of (h2 / high-02
            :degree (f / fold
                :quant 1.0))
        :topic p
        :location (c3 / cell
            :mod (v / vector)))
    :ARG3 (l3 / level
        :ARG1-of (h3 / high-02
            :degree (f2 / fold
                :quant 1.1))
        :topic p
        :location (c4 / cell
            :mod (k / knockdown)))
    :degree (f3 / fold
        :quant 2.1)
    :location (c5 / cell
        :mod w)
    :medium (f4 / figure
        :name ""3A""
        :mod (l4 / lane
            :quant 2))
    :medium (f5 / figure
        :name ""3A""
        :mod (l5 / lane
            :quant 1))
    :medium (f6 / figure
        :name ""3A""
        :mod (l6 / lane
            :quant 3)))",-1.0,0.2241379310344827
pmid_2000_3375.141,"Upon IPTG induction, Ras<sup>V12 </sup>overexpression increased the level of p-AKT in Vector and KD cells (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 4, 1.8 fold and lane 6, 2.1 fold, respectively).","(i / increase-01
    :ARG0 (i2 / induct-02
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""IPTG"")))
    :ARG1 (l5 / level)
    :ARG1-of (d / describe-01
        :ARG0 (a3 / and
            :mod (f / figure
                :mod (a / action))
            :op1 (l2 / lane
                :mod 4)
            :op2 (l3 / lane)
            :op3 l3
            :op4 (l4 / lane
                :mod 6)))
    :ARG2 (p2 / plus
        :op1 (p / percentage-entity
            :quant 1.8))
    :location (a2 / and
        :op1 (l / laboratory
            :name (n3 / name
                :op1 ""P""
                :op1 ""Vector""))
        :op2 (c / cell
            :mod (e2 / ethnic-group
                :name (n4 / name
                    :op1 ""KD"")))
        :op3 (c2 / cell
            :mod e2))
    :rel (s2 / suppress-01
        :mod (s / small-molecule
            :name (n2 / name)))
    :rel 2.1
    :time i2)
",test,bio_amr0.8,"(i / increase-01
      :ARG0 (o / overexpress-01
            :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")
                  :ARG2-of (m / mutate-01 :value ""V12""))
            :location (a / and
                  :op1 (c / cell
                        :mod (v / vector)
                        :ARG1-of (d / describe-01
                              :ARG0 (l2 / lane :mod 4
                                    :part-of (f / figure :mod ""3A""))
                              :ARG2 (p2 / product-of :op1 1.8)))
                  :op2 (c2 / cell
                        :mod (k / knock-down-02)
                        :ARG1-of (d2 / describe-01
                              :ARG0 (l3 / lane :mod 6
                                    :part-of f)
                              :ARG2 (p3 / product-of :op1 2.1)))))
      :ARG1 (l / level
            :quant-of (e2 / enzyme :name (n2 / name :op1 ""AKT"")
                  :ARG3-of (p / phosphorylate-01)))
      :condition (i2 / induce-01
            :ARG2 (s / small-molecule :name (n3 / name :op1 ""IPTG""))))","Upon IPTG induction, Ras<sup>V12 </sup>overexpression increased the level of p-AKT in Vector and KD cells (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 4, 1.8 fold and lane 6, 2.1 fold, respectively).","(z1 / increase-01
    :ARG0 (z2 / release-01
              :ARG1 (z3 / enzyme
                        :wiki ""Mitogen-activated_protein_kinase_kinase""
                        :name (z4 / name
                                  :op1 ""Ras""
                                  :op2 ""V12""
                                  :op3 ""overexpression"")))
    :ARG1 (z5 / level
              :mod (z6 / enzyme
                       :wiki ""P-AKT""
                       :name (z7 / name
                                 :op1 ""p-AKT"")))
    :location (z8 / cell
                  :wiki ""Mitogen-activated_protein_kinase""
                  :name (z9 / name
                            :op1 ""Vector""))
    :location (z10 / cell
                   :wiki ""Mitogen-activated_protein_kinase""
                   :name (z11 / name
                              :op1 ""KD"")))",0.2528735632183908,0.2857142857142857,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (l / level
                  :mod (p / phosphorylate-01
                        :ARG1 (a / AKT)
                        :ARG2 (v / vector))
                  :mod (i2 / increase-01
                        :ARG1 (o / overexpression
                              :ARG1 (r / Ras<sup>V12</sup>))
                        :ARG2 (l2 / level
                              :mod (i3 / increase-01
                                    :ARG1 (p2 / phosphorylate-01
                                          :ARG1 a
                                          :ARG2 (v2 / vector))
                                    :ARG2 (c / cell
                                          :mod (k / knockdown-01)))))))
        :snt2 (f / figure
            :ARG1 (x / xref
                  :ref-type ""fig""
                  :rid ""F3"")
            :ARG2 (l3 / lane
                  :op1 (n / number :op1 ""4"")
                  :op2 (f2 / fold :op1 ""1.8""))
            :ARG2-of (i4 / increase-01
                  :ARG1 l2
                  :ARG2 (l4 / lane
                        :op1 (n2 / number :op1 ""6"")
                        :op2 (f3 / fold :op1 ""2.1"")))))","(i / increase-01
    :ARG0 (o / overexpress-01
        :ARG0 (r / ras
            :mod (v / version
                :value 12)))
    :ARG1 (l / level
        :ARG1-of (p / phosphorylate-01
            :ARG0 (a / AKT)))
    :time (u / upon
        :op1 (i2 / induce-01
            :ARG1 (i3 / IPTG)))
    :location (c / cell
        :mod (v2 / vector)
        :mod (k / KD))
    :degree (f / fold
        :value 1.8
        :location (l2 / lane
            :value 4))
    :degree (f2 / fold
        :value 2.1
        :location (l3 / lane
            :value 6))
    :accompanier (f3 / figure
        :value ""3A""))",-1.0,0.2474226804123711
pmid_2000_3375.143,The RalGDS/RalA signaling pathway was determined by detecting the activity of RalA using GST-RalBD pull-down assay.,"(d2 / determine-01
    :ARG0 (d / detect-01
        :ARG1 (a / activity-06
            :ARG0 (p2 / pathway
                :name (s / signal-07)))
        :ARG2-of (u / use-01
            :ARG1 (a2 / ass
                :instrument-of (p3 / pull-01
                    :ARG1 p2
                    :direction (d3 / down))
                :op2 p2)))
    :ARG1 (p / pathway
        :name (n / name
            :op1 ""RalGDS"")
        :ARG0-of s)
    :rel (n2 / name
        :op1 ""RalA""))
",test,bio_amr0.8,"(d / determine-01
      :ARG1 (p / pathway :name (n / name :op1 ""RalGDS/RalA"")
            :ARG0-of (s / signal-07))
      :manner (d2 / detect-01
            :ARG1 (a / activity-06
                  :ARG0 (p2 / protein :name (n2 / name :op1 ""RalA"")))
            :manner (u / use-01
                  :ARG1 (a2 / assay-01
                        :manner (p3 / pull-down-08
                              :ARG3 (p4 / protein :name (n3 / name :op1 ""GST-RalBD"")))))))",The RalGDS/RalA signaling pathway was determined by detecting the activity of RalA using GST-RalBD pull-down assay.,"(z1 / determine-01
    :ARG1 (z2 / pathway
              :ARG0-of (z3 / signal-07)
              :mod (z4 / slash
                       :op1 (z5 / small-molecule
                                :wiki ""RalGDS""
                                :name (z6 / name
                                          :op1 ""RalGDS""))
                       :op2 (z7 / small-molecule
                                :wiki ""RalA""
                                :name (z8 / name
                                          :op1 ""RalA""))))
    :manner (z9 / detect-01
                :ARG1 (z10 / activity-06
                           :ARG0 z7)
                :instrument (z11 / assay
                                 :instrument-of (z12 / pull-down-03
                                                     :ARG1 (z13 / enzyme
                                                                :wiki ""RalBD""
                                                                :name (z14 / name
                                                                           :op1 ""GST-RalBD""))))))",0.4375,0.4482758620689655,"(d / determine-01
    :ARG0 (p / pathway
        :mod (s / signaling)
        :mod (r / RalGDS/RalA))
    :ARG1 (d2 / detect-01
        :ARG0 (a / activity
            :ARG1 (r2 / RalA))
        :ARG1 (a2 / assay
            :mod (p2 / pull-down)
            :ARG1 (a3 / assay
                :mod (g / GST-RalBD)))))","(d / determine-01
    :ARG0 (p / pathway
        :name (n / name
            :op1 ""RalGDS""
            :op2 ""/""
            :op3 ""RalA""
            :op4 ""signaling""))
    :ARG1 (a / activity
        :ARG1-of (d2 / detect-01
            :instrument (a2 / assay
                :mod (p2 / pull-down)
                :mod (g / GST-RalBD))
            :ARG1 (r / RalA))))",-1.0,0.2352941176470588
pmid_2000_3375.146,"Co-expression of Ras<sup>V12 </sup>and wild-type Aurora-A in WT cells increase the activity of RalA of Ras<sup>V12 </sup>(Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 5, 3.7 fold).","(i / increase-01
    :ARG1 (a / activity-06
        :ARG0 (e / enzyme
            :name (n / name)
            :part-of (c / cell
                :mod (m2 / member)))
        :ARG0 (e2 / enzyme
            :name (n2 / name
                :op1 ""RalA"")
            :mod (w / wild-type)))
    :ARG1-of (m / mean-01
        :ARG2 (f / figure
            :location (l / lane
                :mod 5)
            :mod (p / product-of
                :op1 3.7
                :op2 2)))
    :rel (e3 / express-03
        :ARG1 e)
    :rel (n3 / name
        :op1 ""West""))
",test,bio_amr0.8,"(i / increase-01
      :ARG0 (c / coexpress-01
            :ARG2 (a / and
                  :op1 (e / enzyme :name (n2 / name :op1 ""Ras"")
                        :ARG2-of (m / mutate-01 :value ""V12""))
                  :op2 (e2 / enzyme :name (n3 / name :op1 ""Aurora-A"")
                        :mod w))
            :ARG3 (c2 / cell
                  :mod (w / wild-type)))
      :ARG1 (a2 / activity-06
            :ARG0 (p2 / protein :name (n / name :op1 ""RalA"")
                  :location (c3 / cell
                        :mod e)))
      :ARG1-of (d / describe-01
            :ARG0 (l / lane :mod 5
                  :part-of (f / figure :mod ""3A""))
            :ARG2 (p3 / product-of :op1 3.7)))","Co-expression of Ras<sup>V12 </sup>and wild-type Aurora-A in WT cells increase the activity of RalA of Ras<sup>V12 </sup>(Figure <xref ref-type=""fig"" rid=""F3"">3A</xref>, lane 5, 3.7 fold).","(z1 / increase-01
    :ARG0 (z2 / coexpress-01
              :ARG1 (z3 / enzyme
                        :wiki ""BRAF-12""
                        :name (z4 / name
                                  :op1 ""Ras""
                                  :op2 ""V12"")
                        :part z12)
              :ARG2 (z5 / enzyme
                        :wiki ""Aurora-A""
                        :name (z6 / name
                                  :op1 ""Aurora-A"")
                        :mod (z7 / wild-type))
              :location (z8 / cell
                            :mod (z9 / small-molecule
                                     :wiki ""WT_cell""
                                     :name (z10 / name
                                                :op1 ""WT""))))
    :ARG1 (z11 / activity-06
               :ARG0 (z12 / enzyme
                          :wiki ""BRAF-3A""
                          :name (z13 / name
                                     :op1 ""RalA"")
                          :ARG1-of (z14 / figure-03
                                        :ARG0 (z15 / figure
                                                   :mod (z16 / lane
                                                             :mod 5)))
                          :ARG1-of (z17 / mean-01
                                        :ARG2 (z18 / product-of
                                                   :op1 (z19 / times
                                                             :quant ""3.7""
                                                             :op2 (z20 / times
                                                                       :quant ""3.7"")))))))",0.3578947368421052,0.358974358974359,"(m / multi-sentence
        :snt1 (c / co-expression
            :ARG0 (a / and
                  :op1 (r / Ras<sup>V12</sup>)
                  :op2 (a2 / Aurora-A
                        :ARG0-of (i / increase-01
                              :ARG1 (a3 / activity
                                    :ARG0-of (r2 / RalA
                                          :ARG1-of (o / of
                                                :op1 (r3 / Ras<sup>V12</sup>))
                                          :degree (f / fold
                                                :value 3.7)))
                              :ARG2 (c2 / cell
                                    :ARG0-of (w / wild-type))))
                        :ARG1-of (i2 / increase-01
                              :ARG1 a3
                              :ARG2 (c3 / cell
                                    :ARG0-of (w2 / wild-type)))))
        :snt2 (i3 / increase-01
            :ARG1 (a4 / activity
                  :ARG0-of (r4 / RalA
                        :ARG1-of (o2 / of
                              :op1 (r5 / Ras<sup>V12</sup>))
                        :degree (f2 / fold
                              :value 3.7)))
            :ARG2 (c4 / cell
                  :ARG0-of (w3 / wild-type)))
        :snt3 (f3 / figure
            :ARG1 (l / lane
                  :op1 5)
            :ARG2 (x / xref
                  :ref-type ""fig""
                  :rid ""F3"")
            :ARG3 (a5 / activity
                  :ARG0-of (r6 / RalA
                        :ARG1-of (o3 / of
                              :op1 (r7 / Ras<sup>V12</sup>))
                        :degree (f3 / fold
                              :value 3.7)))))","(i / increase-01
    :ARG0 (c / co-express-01
        :ARG1 (r / Ras :mod (v / version :op1 ""12""))
        :ARG2 (a / Aurora-A
            :mod (w / wild)
            :mod (t / type)))
    :ARG1 (a2 / activity
        :poss (r2 / RalA
            :poss r))
    :location (c2 / cell
        :mod (w2 / wild)
        :mod (t2 / type))
    :degree (f / fold
        :quant 3.7)
    :time (l / lane
        :quant 5)
    :medium (f2 / figure
        :mod (n / number :value 3)
        :mod (l2 / letter :op1 ""A"")))",-1.0,0.1927710843373493
pmid_2000_3375.147,"Taken together, both Aurora-A and Ras<sup>V12 </sup>increased the levels of p-MEK, pERK1/2, and p-AKT and the activation of RalA.","(i2 / increase-01
    :ARG0 (a2 / and
        :op1 (i / incident
            :name (n / name))
        :op2 (o / organization
            :name (n2 / name
                :op1 12)))
    :ARG1 (a3 / and
        :op1 (l / level
            :mod (e / enzyme
                :name (n3 / name
                    :op1 ""P"")))
        :op2 (e2 / enzyme
            :name (n4 / name
                :op1 ""P"")
            :mod ""1/2"")
        :op3 (p / protein
            :name (n5 / name
                :op1 ""RalA""
                :op4 ""et-cetera""))
        :op4 (a / activate-01))
    :ARG1-of (t / take-01
        :mod (t2 / together)))
",test,bio_amr0.8,"(h / have-condition-91
      :ARG1 (i / increase-01
            :ARG0 (a / and
                  :op1 (e / enzyme :name (n2 / name :op1 ""Aurora-A""))
                  :op2 (e2 / enzyme :name (n3 / name :op1 ""Ras"")
                        :ARG2-of (m / mutate-01 :value ""V12"")))
            :ARG1 (a2 / and
                  :op1 (l / level
                        :quant-of (e3 / enzyme :name (n4 / name :op1 ""MEK"")
                              :ARG3-of (p2 / phosphorylate-01)))
                  :op2 (l2 / level
                        :quant-of (s / slash
                              :op1 (e4 / enzyme :name (n5 / name :op1 ""ERK1""))
                              :op2 (e5 / enzyme :name (n6 / name :op1 ""ERK2""))
                              :ARG3-of p2))
                  :op3 (l3 / level
                        :quant-of (e6 / enzyme :name (n7 / name :op1 ""AKT"")
                              :ARG3-of p2))
                  :op4 (a3 / activate-01
                        :ARG1 (p3 / protein :name (n / name :op1 ""RalA"")))))
      :ARG2 (t / take-01
            :ARG1 a
            :mod (t2 / together)))","Taken together, both Aurora-A and Ras<sup>V12 </sup>increased the levels of p-MEK, pERK1/2, and p-AKT and the activation of RalA.","(z1 / increase-01
    :ARG0 (z2 / and
              :op1 (z3 / enzyme
                       :wiki ""BRAF_(g3000 / gene)""
                       :name (z4 / name
                                 :op1 ""Aurora-A""))
              :op2 (z5 / enzyme
                       :wiki ""BRAF_(g3001 / gene)""
                       :name (z6 / name
                                 :op1 ""Ras""))
              :op3 (z7 / enzyme
                       :wiki ""BRAF_(g3002 / gene)""
                       :name (z8 / name
                                 :op1 ""V12"")))
    :mod (z9 / both)
    :ARG1-of (z10 / take-04
                  :ARG3 (z11 / together)))",0.2150537634408602,0.3846153846153846,"(t / together
    :op1 (t2 / take-01
        :ARG1 (a / Aurora-A)
        :ARG2 (r / Ras
            :mod (v / V12)))
    :op2 (i / increase-01
        :ARG1 (l / level
            :mod (p / phosphorylate-01
                :ARG1 (m / MEK)
                :ARG2 (p2 / p))
            :mod (p3 / phosphorylate-01
                :ARG1 (e / ERK1/2)
                :ARG2 (p4 / p))
            :mod (p5 / phosphorylate-01
                :ARG1 (a2 / AKT)
                :ARG2 (p6 / p)))
        :ARG2 (a3 / activate-01
            :ARG1 (r2 / RalA))))","(t / together-01
    :ARG1 (i / increase-01
        :ARG0 (a / and
            :op1 (p / protein :name (n / name :op1 ""Aurora-A""))
            :op2 (r / protein :name (n2 / name :op1 ""Ras"" :op2 ""V12"")))
        :ARG1 (a2 / and
            :op1 (l / level
                :ARG1 (p2 / protein :name (n3 / name :op1 ""p-MEK"")))
            :op2 (l2 / level
                :ARG1 (p3 / protein :name (n4 / name :op1 ""pERK1/2"")))
            :op3 (l3 / level
                :ARG1 (p4 / protein :name (n5 / name :op1 ""p-AKT"")))
            :op4 (a3 / activate-01
                :ARG1 (p5 / protein :name (n6 / name :op1 ""RalA""))))))",-1.0,0.6071428571428572
pmid_2000_3375.148,This induction was further enhanced when Aurora-A and Ras<sup>V12 </sup>were overexpressed simultaneously.,"(e / enhance-01
    :ARG0 (d / distress-01
        :ARG1 (a / and
            :op1 (o / organization
                :name (n / name
                    :op1 ""A""))
            :op2 (o2 / organization
                :name (n2 / name
                    :op1 ""i""
                    :op2 ""Duncan""
                    :op3 ""Smith"")))
        :ARG1-of (o3 / over-03)
        :mod (s / simultaneous))
    :ARG1 (i / induct-02
        :mod (t / this))
    :degree (f / further))
",test,bio_amr0.8,"(e2 / enhance-01
      :ARG1 (i / induce-01
            :mod (t / this))
      :degree (f / further)
      :time (o / overexpress-01
            :ARG1 (a / and
                  :op1 (e / enzyme :name (n2 / name :op1 ""Aurora-A""))
                  :op2 (e3 / enzyme :name (n3 / name :op1 ""Ras"")
                        :ARG2-of (m / mutate-01 :value ""V12"")))
            :mod (s / simultaneous)))",This induction was further enhanced when Aurora-A and Ras<sup>V12 </sup>were overexpressed simultaneously.,"(z1 / enhance-01
    :ARG0 (z2 / overexpress-01
              :ARG1 (z3 / and
                        :op1 (z4 / enzyme
                                 :wiki ""BRAF-A""
                                 :name (z5 / name
                                           :op1 ""Aurora-A""))
                        :op2 (z6 / enzyme
                                 :wiki ""BRAF-V12""
                                 :name (z7 / name
                                           :op1 ""Ras-V12"")))
              :mod (z8 / simultaneous))
    :ARG1 (z9 / induct-02
              :mod (z10 / this))
    :degree (z11 / further))",0.6415094339622641,0.5454545454545454,"(s / sentence
        :ARG0 (i / induce-01
              :ARG1 (w / was
                    :ARG1-of (e / enhance-01
                          :ARG1 (a / Aurora-A)
                          :ARG2 (r / Ras<sup>V12</sup>)))
              :ARG2 (s2 / simultaneous
                    :op1 (o / overexpress-01
                          :ARG1 a)
                    :op2 (o2 / overexpress-01
                          :ARG1 r))))","(i / induce-01
    :ARG1 (t / this)
    :time (w / when
        :ARG1 (a / and
            :op1 (o / overexpress-01
                :ARG1 (a2 / aurora-A))
            :op2 (o2 / overexpress-01
                :ARG1 (r / ras
                    :mod (v / v12)))))
    :degree (f / further)
    :manner (e / enhance-01))",-1.0,0.3673469387755101
pmid_2000_3375.152,"Our results confirmed that wild-type-Aurora-A enhance Ras downstream signaling pathways including MEK/ERK, AKT and RalA.","(c / confirm-01
    :ARG0 (t / thing
        :ARG2-of (r / result-01
            :ARG0 (w / we)))
    :ARG1 (e / enhance-01
        :ARG0 ""amr-unknown""
        :ARG1 (e2 / enzyme
            :name (n / name)
            :mod (t2 / type
                :mod (w2 / wild)))
        :ARG1 (e3 / enzyme
            :ARG0-of (s / signal-07)
            :ARG2-of (i / include-01
                :ARG1 (s2 / slash
                    :op1 (e5 / enzyme
                        :name (n4 / name
                            :op1 ""ERK""))
                    :op2 (e4 / enzyme
                        :name (n3 / name
                            :op1 ""MEK"")))
                :ARG1 (a / and
                    :op1 e4
                    :op2 (p / protein
                        :name (n5 / name
                            :op1 ""AKT""
                            :op1 ""RalA""))))
            :mod (d / downstream)))
    :rel (n2 / name
        :op1 ""amr-unknown""
        :op1 ""Ras""))
",test,bio_amr0.8,"(c / confirm-01
      :ARG0 (t / thing
            :poss (w / we)
            :ARG2-of (r / result-01))
      :ARG1 (e2 / enhance-01
            :ARG0 (e4 / enzyme :name (n3 / name :op1 ""Aurora-A"")
                  :mod (w2 / wild-type))
            :ARG1 (p3 / pathway
                  :location (d / downstream)
                  :ARG0-of (s / signal-07
                        :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")))
                  :ARG2-of (i / include-91
                        :ARG1 (a / and
                              :op1 (p / pathway :name (n2 / name :op1 ""MEK/ERK""))
                              :op2 (p2 / pathway :name (n4 / name :op1 ""AKT""))
                              :op3 (p4 / pathway :name (n5 / name :op1 ""RalA"")))))))","Our results confirmed that wild-type-Aurora-A enhance Ras downstream signaling pathways including MEK/ERK, AKT and RalA.","(z1 / confirm-01
    :ARG0 (z2 / thing
              :ARG2-of (z3 / result-01
                           :ARG0 (z4 / we)))
    :ARG1 (z5 / enhance-01
              :ARG0 (z6 / small-molecule
                        :wiki ""Aurora-Aurora_glycoprotein""
                        :name (z7 / name
                                  :op1 ""Aurora-A"")
                        :mod (z8 / wild-type))
              :ARG1 (z9 / pathway
                        :wiki ""Ras–regulated_protein_system""
                        :name (z10 / name
                                   :op1 ""Ras""
                                   :op2 ""downstream""
                                   :op3 ""signaling""
                                   :op4 ""pathway"")
                        :ARG2-of (z11 / include-01
                                      :ARG1 (z12 / and
                                                 :op1 (z13 / enzyme
                                                           :wiki ""Mitogen-activated_protein_kinase""
                                                           :name (z14 / name
                                                                      :op1 ""MEK/ERK""))
                                                 :op2 (z15 / enzyme
                                                           :wiki ""AKT""
                                                           :name (z16 / name
                                                                      :op1 ""AKT""))
                                                 :op3 (z17 / enzyme
                                                           :wiki ""RalA""
                                                           :name (z18 / name
                                                                      :op1 ""RalA"")))))))",0.5833333333333334,0.4848484848484848,"(m / multi-sentence
        :snt1 (c / confirm-01
            :ARG0 (r / result)
            :ARG1 (e / enhance-01
                  :ARG0 (a / Aurora-A
                        :mod (w / wild-type))
                  :ARG1 (p / pathway
                        :ARG1-of (s / signal-01
                              :ARG1 (d / downstream
                                    :mod (r2 / Ras))))
                  :ARG1-of (i / include-91
                        :op1 (m2 / MEK/ERK)
                        :op2 (a2 / AKT)
                        :op3 (r3 / RalA)))))","(c / confirm-01
    :ARG0 (r / result
        :poss (w / we))
    :ARG1 (e / enhance-01
        :ARG0 (a / Aurora-A
            :mod (w2 / wild)
            :mod (t / type))
        :ARG1 (p / pathway
            :mod (s / signal-01
                :ARG1 (r2 / Ras))
            :include (m / MEK/ERK)
            :include (a2 / AKT)
            :include (r3 / RalA))))",-1.0,-1.0
pmid_2000_3375.153,"<sec-title level=""2"">The MEK/ERK pathway is involved in WT cell aggregation</sec-title>","(i / involve-01
    :li 2
    :ARG1 (p / pathway
        :name (e / enzyme
            :name (n / name
                :op1 ""MEK""))
        :mod e)
    :ARG2 (m / migrate-01
        :ARG0 (c / cell
            :name (n2 / name)))
    :rel (n3 / name
        :op1 ""ERK""
        :op1 ""serine""))
",test,bio_amr0.8,"(i / involve-01
      :ARG1 (p / pathway :name (n / name :op1 ""MEK/ERK""))
      :ARG2 (a / aggregate-01
            :ARG1 (c / cell
                  :mod (w / wild-type))))","<sec-title level=""2"">The MEK/ERK pathway is involved in WT cell aggregation</sec-title>","(z1 / involve-01
    :ARG1 (z2 / pathway
              :wiki ""Mitogen-activated_protein_kinase/activated_protein_kinase""
              :name (z3 / name
                        :op1 ""MEK/ERK"")
              :part-of (z4 / cell
                           :mod (z5 / small-molecule
                                    :wiki ""WT_cell""
                                    :name (z6 / name
                                              :op1 ""WT""))))
    :ARG2 (z7 / aggregation-01
              :ARG1 z4))",0.5625,0.3529411764705882,"(t / title
    :level ""2""
    :content ""The MEK/ERK pathway is involved in WT cell aggregation""
    :ARG0 (i / involve-01
        :ARG1 (p / pathway
            :mod (m / MEK/ERK))
        :ARG2 (a / aggregate-01
            :ARG1 (c / cell
                :mod (w / wild-type)))))","(i / involve-01
    :ARG1 (p / pathway
        :name (n / name
            :op1 ""MEK/ERK""))
    :ARG2 (a / aggregate-01
        :ARG1 (c / cell
            :mod (w / wild-type)))
    :mod (t / title
        :level 2))",-1.0,0.7586206896551724
pmid_2000_3375.154,"The involvement of MEK/ERK, PI3K/AKT and RalGDS/RalA signaling pathways in Aurora-A-related cell aggregation (Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref>, WT + IPTG) was clarified by treatment of the cells with the following inhibitors: FTI-277, a farnesylation inhibitor of Ras; PD-98059, the inhibitor of MEK kinase and LY-294002, the inhibitor of PI3K kinase and RalASa94A, a mutant of Ral.","(c3 / clarify-10
    :ARG0 (t2 / treat-04
        :ARG1 (c2 / cell)
        :ARG2 (c / cell
            :ARG1-of (r / relate-01
                :ARG2 (p4 / protein)))
        :ARG2 (s4 / small-molecule
            :ARG0-of (i / inhibit-01)
            :ARG0-of (i2 / inhibit-01)
            :ARG0-of (i3 / inhibit-01)
            :ARG1-of (f3 / follow-04)
            :domain (t / thing
                :name f3
                :ARG1 (a2 / and
                    :op1 (e / enzyme
                        :name (n / name
                            :op1 ""MEK""))
                    :op2 (e2 / enzyme
                        :name (n2 / name
                            :op1 ""PI3K""
                            :op2 ""kinase""))
                    :op3 (p2 / protein
                        :name (n5 / name
                            :op1 ""RalA""))
                    :op4 p4))))
    :ARG1 (i4 / involve-01
        :ARG1 (s2 / slash
            :op1 e
            :op2 e2
            :op3 (s3 / slash
                :op1 e
                :op2 p2
                :op3 (p3 / protein
                    :name (n6 / name
                        :op1 ""AKT""))))
        :location (j / join-04
            :ARG1 c))
    :ARG1-of (d / describe-01
        :ARG0 (f2 / figure))
    :rel (p / protein
        :name (n3 / name
            :op1 ""ERK"")
        :name (n4 / name))
    :rel (k / kinase
        :name (n9 / name
            :op1 277))
    :rel (n10 / name
        :op1 ""II"")
    :rel (a / and
        :op2 (p5 / protein
            :name (n7 / name
                :op1 ""IPTG""))
        :op4 (m / mechanism
            :ARG0-of (s / signal-07)))
    :rel (p6 / protein
        :name (n8 / name
            :op1 ""RalASa94A""
            :op1 ""Ral""
            :op2 ""kinase"")
        :name (n11 / name
            :op1 ""Ras"")
        :ARG2-of (m2 / mutate-01))
    :rel (f / farnesylation)
    :rel 98059
    :rel 294002)
",test,bio_amr0.8,"(c / clarify-10
      :ARG1 (i2 / involve-01
            :ARG1 (a / and
                  :op1 (p / pathway :name (n / name :op1 ""MEK/ERK""))
                  :op2 (p2 / pathway :name (n2 / name :op1 ""PI3K/AKT""))
                  :op3 (p3 / pathway :name (n5 / name :op1 ""RalGDS/RalA""))
                  :ARG0-of (s / signal-07))
            :ARG2 (a2 / aggregate-01
                  :ARG1 (c2 / cell)
                  :ARG1-of (r / relate-01
                        :ARG2 (e2 / enzyme :name (n6 / name :op1 ""Aurora-A""))))
            :ARG1-of (d / describe-01
                  :ARG0 (f / figure :mod ""2B"")))
      :manner (t2 / treat-04
            :ARG1 c2
            :ARG2 (m / molecular-physical-entity
                  :ARG0-of (i3 / inhibit-01)
                  :ARG1-of (f2 / follow-01)
                  :ARG1-of (m2 / mean-01
                        :ARG2 (a3 / and
                              :op1 (s2 / small-molecule :name (n7 / name :op1 ""FTI-277"")
                                    :ARG0-of (i4 / inhibit-01
                                          :ARG1 (p4 / protein-family :name (n3 / name :op1 ""Ras""))
                                          :ARG2-of (f3 / farnesylate-01)))
                              :op2 (s3 / small-molecule :name (n8 / name :op1 ""PD-98059"")
                                    :ARG0-of (i5 / inhibit-01
                                          :ARG1 (k / kinase :name (n4 / name :op1 ""MEK""))))
                              :op3 (s4 / small-molecule :name (n9 / name :op1 ""LY-294002"")
                                    :ARG0-of (i6 / inhibit-01
                                          :ARG1 (a4 / and
                                                :op1 (k2 / kinase :name (n10 / name :op1 ""PI3K""))
                                                :op1 (p5 / protein :name (n11 / name :op1 ""RalASa94A"")
                                                      :ARG3-of (m6 / mutate-01
                                                            :ARG1 (p6 / protein :name (n12 / name :op1 ""Ral""))))))))))))","The involvement of MEK/ERK, PI3K/AKT and RalGDS/RalA signaling pathways in Aurora-A-related cell aggregation (Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref>, WT + IPTG) was clarified by treatment of the cells with the following inhibitors: FTI-277, a farnesylation inhibitor of Ras; PD-98059, the inhibitor of MEK kinase and LY-294002, the inhibitor of PI3K kinase and RalASa94A, a mutant of Ral.","(z1 / clarify-10
    :ARG0 (z2 / treat-04
              :ARG1 (z3 / cell)
              :ARG2 (z4 / inhibitor
                        :ARG1-of (z5 / follow-04
                                     :ARG2 (z6 / and
                                               :op1 (z7 / inhibitor
                                                        :wiki ""Fritonavir/ritonavir""
                                                        :name (z8 / name
                                                                  :op1 ""FTI-277"")
                                                        :ARG0-of (z9 / inhibit-01
                                                                     :ARG1 (z10 / enzyme
                                                                                :wiki ""Ras_threonine_kinase""
                                                                                :name (z11 / name
                                                                                           :op1 ""Ras""))
                                                                     :ARG2 (z12 / farnesylate-01)))
                                               :op2 (z13 / inhibitor
                                                         :wiki ""PD-98059""
                                                         :name (z14 / name
                                                                    :op1 ""PD-98059"")
                                                         :ARG0-of (z15 / inhibit-01
                                                                       :ARG1 (z16 / kinase
                                                                                  :wiki ""Mitogen-activated_protein_kinase""
                                                                                  :name (z17 / name
                                                                                             :op1 ""MEK"")))))
                                     :op3 (z18 / inhibitor
                                               :wiki ""LY-294002""
                                               :name (z19 / name
                                                          :op1 ""LY-294002"")
                                               :ARG0-of (z20 / inhibit-01
                                                             :ARG1 (z21 / kinase
                                                                        :wiki ""PI3K""
                                                                        :name (z22 / name
                                                                                   :op1 ""PI3K""))))
                                     :op4 (z23 / mutant
                                               :wiki ""RalASa94A""
                                               :name (z24 / name
                                                          :op1 ""RalASa94A"")
                                               :domain (z25 / enzyme
                                                            :wiki ""RalASa94A""
                                                            :name (z26 / name
                                                                       :op1 ""RalASa94A"")))))))",0.3625730994152046,0.3222748815165877,"(m / multi-sentence
        :snt1 (c / clarify-01
            :ARG0 (i / involvement
                  :ARG1 (p / pathway
                        :mod (s / signal
                              :ARG0 (m2 / MEK/ERK)
                              :ARG1 (p2 / PI3K/AKT)
                              :ARG2 (r / RalGDS/RalA)))
                  :ARG2 (a / aggregation
                        :ARG1 (c2 / cell
                              :mod (a2 / Aurora-A-related))))
            :ARG1 (t / treatment-01
                  :ARG0 (c3 / cell)
                  :ARG1 (i2 / inhibitor
                        :ARG0 (f / FTI-277)
                        :ARG1 (f2 / farnesylation
                              :ARG1 (i3 / inhibitor
                                    :ARG0 (r2 / Ras))))
                  :ARG1 (i4 / inhibitor
                        :ARG0 (p3 / PD-98059)
                        :ARG1 (k / kinase
                              :ARG1 (m3 / MEK)))
                  :ARG1 (i5 / inhibitor
                        :ARG0 (l / LY-294002)
                        :ARG1 (k2 / kinase
                              :ARG1 (p4 / PI3K)))
                  :ARG1 (a3 / RalASa94A)
                  :ARG1 (m4 / mutant
                        :ARG1 (r3 / Ral))))
        :snt2 (c4 / clarify-01
            :ARG0 (i6 / involvement
                  :ARG1 (p5 / pathway
                        :mod (s4 / signal
                              :ARG0 (m5 / MEK/ERK)
                              :ARG1 (p6 / PI3K/AKT)
                              :ARG2 (r4 / RalGDS/RalA)))
                  :ARG2 (a4 / aggregation
                        :ARG1 (c5 / cell
                              :mod (a5 / Aurora-A-related))))
            :ARG1 (t2 / treatment-01
                  :ARG0 (c6 / cell)
                  :ARG1 (i7 / inhibitor
                        :ARG0 (f3 / FTI-277)
                        :ARG1 (f4 / farnesylation
                              :ARG1 (i8 / inhibitor
                                    :ARG0 (r5 / Ras))))
                  :ARG1 (i9 / inhibitor
                        :ARG0 (p7 / PD-98059)
                        :ARG1 (k3 / kinase
                              :ARG1 (m6 / MEK)))
                  :ARG1 (i10 / inhibitor
                        :ARG0 (l2 / LY-294002)
                        :ARG1 (k4 / kinase
                              :ARG1 (p8 / PI3K)))
                  :ARG1 (a6 / RalASa94A)
                  :ARG1 (m7 / mutant
                        :ARG1 (r6 / Ral)))))","(i / involve-01
    :ARG1 (p / pathway
        :mod (s / signal)
        :example (m / multi-slash
            :op1 (m2 / molecule :name (n / name :op1 ""MEK"" :op2 ""ERK""))
            :op2 (m3 / molecule :name (n2 / name :op1 ""PI3K"" :op2 ""AKT""))
            :op3 (m4 / molecule :name (n3 / name :op1 ""RalGDS"" :op2 ""RalA""))))
    :ARG2 (a / aggregate-01
        :ARG1 (c / cell)
        :mod (r / relate-01
            :ARG1 (m5 / molecule :name (n4 / name :op1 ""Aurora"" :op2 ""A""))))
    :location (f / figure :name (n5 / name :op1 ""2B""))
    :ARG1-of (c / clarify-01
        :instrument (t / treat-01
            :ARG1 c
            :ARG2 (i2 / inhibitor
                :example (m6 / multi-slash
                    :op1 (i3 / inhibitor :name (n6 / name :op1 ""FTI-277"")
                        :purpose (f2 / farnesylation-01
                            :ARG0 i3
                            :ARG1 (m7 / molecule :name (n7 / name :op1 ""Ras""))))
                    :op2 (i4 / inhibitor :name (n8 / name :op1 ""PD-98059"")
                        :purpose (i5 / inhibit-01
                            :ARG0 i4
                            :ARG1 (k / kinase :name (n9 / name :op1 ""MEK""))))
                    :op3 (i6 / inhibitor :name (n10 / name :op1 ""LY-294002"")
                        :purpose (i7 / inhibit-01
                            :ARG0 i6
                            :ARG1 (k2 / kinase :name (n11 / name :op1 ""PI3K""))))
                    :op4 (m8 / mutant :name (n12 / name :op1 ""RalASa94A"")
                        :mod (m9 / molecule :name (n13 / name :op1 ""Ral""))))))))",-1.0,-1.0
pmid_2000_3375.155,"FTI-277 restrains Ras protein as a non-farnesylated form and inhibits p-ERK1/2 expression dose-dependently but had no effect on p-AKT (Figure <xref ref-type=""fig"" rid=""F4"">4A</xref>, lanes 2 and 3).","(c / contrast-01
    :ARG1 (a3 / and
        :op1 (r / restrain-01
            :ARG1 (p2 / protein
                :name (n / name
                    :op1 ""Ras""))
            :prep-as (f2 / form
                :ARG1-of (p / phosphorylate-01
                    :polarity -)
                :domain p2))
        :op2 (i / inhibit-01
            :ARG0 (p3 / protein)
            :ARG0-of (d / depend-01)
            :ARG1 (d3 / dose-01
                :ARG2 (e2 / express-03
                    :ARG2 ""1/2""))))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure
            :location (a4 / and
                :mod 3
                :op1 (p5 / publication
                    :name n)
                :op2 (l / lane
                    :mod 2))
            :source p5))
    :ARG2 (a2 / affect-01
        :ARG0 p3
        :ARG1 (p4 / protein
            :name (n3 / name
                :op1 ""P""))
        :polarity -)
    :rel (e / enzyme
        :name (n2 / name))
    :rel (a / TKI258))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (a / and
            :op1 (r / restrain-01
                  :ARG0 (s2 / small-molecule :name (n2 / name :op1 ""FTI-277""))
                  :ARG1 (p / protein-family :name (n / name :op1 ""Ras""))
                  :manner (f2 / form
                        :ARG1-of (f / farnesylate-01 :polarity -)))
            :op2 (i / inhibit-01
                  :ARG0 s2
                  :ARG1 (e / express-03
                        :ARG2 (s / slash
                              :op1 (e2 / enzyme :name (n3 / name :op1 ""ERK1""))
                              :op2 (e3 / enzyme :name (n4 / name :op1 ""ERK2""))
                              :ARG3-of (p2 / phosphorylate-01)))
                  :manner (d / depend-01
                        :ARG1 (d2 / dose))))
      :ARG2 (a2 / affect-01 :polarity -
            :ARG0 s2
            :ARG1 (e4 / enzyme :name (n5 / name :op1 ""AKT"")
                  :ARG3-of p2))
      :ARG1-of (d3 / describe-01
            :ARG0 (a3 / and
                  :op1 (l / lane :mod 2)
                  :op2 (l2 / lane :mod 3)
                  :part-of (f3 / figure :mod ""4A""))))","FTI-277 restrains Ras protein as a non-farnesylated form and inhibits p-ERK1/2 expression dose-dependently but had no effect on p-AKT (Figure <xref ref-type=""fig"" rid=""F4"">4A</xref>, lanes 2 and 3).","(z1 / contrast-01
    :ARG1 (z2 / and
              :op1 (z3 / restrain-01
                       :ARG0 (z4 / small-molecule
                                 :wiki ""Fibroblast_growth_factor_receptor""
                                 :name (z5 / name
                                           :op1 ""FTI-277""))
                       :ARG1 (z6 / protein
                                 :wiki ""Ras_protein""
                                 :name (z7 / name
                                           :op1 ""Ras""
                                           :op2 ""protein""))
                       :manner (z8 / form
                                   :ARG1-of (z9 / resemble-01
                                                :ARG2 (z10 / form
                                                           :ARG1-of (z11 / fluorize-01
                                                                         :polarity -))))))
    :op2 (z12 / inhibit-01
              :ARG0 z4
              :ARG1 (z13 / express-02
                         :ARG1 (z14 / enzyme
                                    :wiki ""Extracellular_signal-regulated_kinase_1/2""
                                    :name (z15 / name
                                               :op1 ""p-ERK1/2"")))
              :ARG1-of (z16 / depend-01
                            :ARG0 (z17 / dose))))",0.4299065420560747,0.4705882352941176,"(m / multi-sentence
        :snt1 (r / restrain-01
            :ARG0 (f / form
                  :mod (n / non-farnesylated))
            :ARG1 (p / protein
                  :mod (r2 / Ras)))
        :snt2 (i / inhibit-01
            :ARG0 f
            :ARG1 (e / expression
                  :ARG1-of (p2 / phosphorylate-01
                        :ARG0 (e2 / ERK1/2)
                        :ARG1 (p3 / protein))))
        :snt3 (h / have-03
            :ARG0 (f2 / form
                  :mod (e3 / effect))
            :ARG1 (e4 / effect
                  :mod (a / AKT)
                  :ARG1-of (o / on
                        :ARG1 (p4 / phosphorylate-01
                              :ARG0 (e5 / ERK1/2)
                              :ARG1 (p5 / protein))))
            :ARG2 (n2 / none))
        :snt4 (f3 / figure
            :ARG0 (x / xref
                  :ref-type ""fig""
                  :rid ""F4"")
            :op1 (l / lane
                  :op1 2
                  :op2 3)))","(r / restrain-01
    :ARG0 (f / FTI-277)
    :ARG1 (p / protein
        :name (n / name :op1 ""Ras"")
        :mod (f2 / form
            :mod (n2 / non-farnesylated)))
    :ARG2 (i / inhibit-01
        :ARG0 f
        :ARG1 (e / express-01
            :ARG1 (p2 / protein
                :name (n3 / name :op1 ""p-ERK1/2""))
            :manner (d / dose-dependently)))
    :ARG3 (h / have-effect-91 :polarity -
        :ARG0 f
        :ARG1 (e2 / express-01
            :ARG1 (p3 / protein
                :name (n4 / name :op1 ""p-AKT""))))
    :condition (a / and)
    :location (f3 / figure
        :name (n5 / name :op1 ""4A"")
        :part (l / lane
            :op1 ""2""
            :op2 ""3""))
    :mod (b / but))",-1.0,0.3185840707964602
pmid_2000_3375.156,"PD-98059 decreased the phosphorylation of ERK1/2 (p-ERK1/2) but had no effect on other signaling pathways (Figure <xref ref-type=""fig"" rid=""F4"">4A</xref>, lanes 4 and 5).","(c / contrast-01
    :ARG1 (d / decrease-01
        :ARG1 (p / phosphorylate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op2 ""1/2""))))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure
            :example (a2 / and
                :op1 (l / lane
                    :mod 4)
                :op2 (f2 / figure
                    :mod 5))))
    :ARG2 (a / affect-01
        :ARG1 (m / mechanism
            :ARG0-of (s / signal-07)
            :mod (o / other))
        :polarity -)
    :rel 98059)
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (d / decrease-01
            :ARG0 (s3 / small-molecule :name (n / name :op1 ""PD-98059""))
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (s / slash
                        :op1 (e / enzyme :name (n2 / name :op1 ""ERK1""))
                        :op2 (e2 / enzyme :name (n3 / name :op1 ""ERK2"")))))
      :ARG2 (a / affect-01 :polarity -
            :ARG0 s3
            :ARG1 (p3 / pathway
                  :ARG0-of (s2 / signal-07)
                  :mod (o / other)))
      :ARG1-of (d2 / describe-01
            :ARG0 (a2 / and
                  :op1 (l2 / lane :mod 4)
                  :op2 (l3 / lane :mod 5)
                  :part-of (f / figure :mod ""4A""))))","PD-98059 decreased the phosphorylation of ERK1/2 (p-ERK1/2) but had no effect on other signaling pathways (Figure <xref ref-type=""fig"" rid=""F4"">4A</xref>, lanes 4 and 5).","(z1 / contrast-01
    :ARG1 (z2 / decrease-01
              :ARG0 (z3 / small-molecule
                        :wiki ""PHLDA-98059""
                        :name (z4 / name
                                  :op1 ""PD-98059""))
              :ARG1 (z5 / phosphorylate-01
                        :ARG1 (z6 / enzyme
                                  :wiki ""ERK1/2""
                                  :name (z7 / name
                                            :op1 ""ERK1/2""))))
    :ARG2 (z8 / affect-01
              :polarity -
              :ARG0 z3
              :ARG1 (z9 / pathway
                        :ARG0-of (z10 / signal-07)
                        :mod (z11 / other)))
    :ARG1-of (z12 / describe-01
                  :ARG0 (z13 / figure
                             :mod (z14 / lane
                                       :mod 4)
                             :mod (z15 / lane
                                       :mod 5))))",0.5569620253164557,0.5135135135135135,"(m / multi-sentence
        :snt1 (d / decrease-01
            :ARG1 (p / phosphorylation
                  :ARG1-of (e / ERK1/2
                        :mod (p2 / positive
                              :mod (p3 / phosphorylation))))
            :ARG2 (p2 / PD-98059))
        :snt2 (h / have-03
            :ARG0 p2
            :ARG1 (e2 / effect-01
                  :ARG2 (p3 / pathway
                        :mod (o / other)))
            :ARG2 (n / none)))","(d / decrease-01
    :ARG0 (c / chemical :wiki ""PD-98059"" :name (n / name :op1 ""PD-98059""))
    :ARG1 (p / phosphorylate-01
        :ARG1 (m / molecule
            :name (n2 / name :op1 ""ERK1/2"" :op2 ""p-ERK1/2""))))
    :ARG1-of (h / have-effect-on-91 :polarity -
        :ARG2 (s / signaling-pathway
            :mod (o / other)))
    :time (f / figure
        :name (n3 / name :op1 ""4A"")
        :location (l / lane
            :op1 ""4""
            :op2 ""5""))
    :ARG1-of (c2 / contrast-01))",-1.0,-1.0
pmid_2000_3375.158,"In summary, in WT cells Aurora-A increases the expression of p-ERK1/2 in a Ras dependent manner.","(i / increase-01
    :ARG1 (e2 / express-03
        :ARG1 (e / enzyme
            :name (n3 / name
                :op1 ""P""
                :op2 ""1/2"")
            :ARG0-of (d / depend-01
                :ARG1 (p / protein
                    :name (n4 / name
                        :op1 ""serine""
                        :op1 ""Ras"")))))
    :ARG2-of (s / summarize-01)
    :location (c / cell-line
        :part-of (v / variable
            :name (n2 / name
                :op1 ""Al-Qaeda"")))
    :rel (n / name))
",test,bio_amr0.8,"(i / increase-01
      :ARG0 (e5 / enzyme :name (n2 / name :op1 ""Aurora-A""))
      :ARG1 (e2 / express-03
            :ARG2 (s2 / slash
                  :op1 (e3 / enzyme :name (n3 / name :op1 ""ERK1""))
                  :op2 (e4 / enzyme :name (n4 / name :op1 ""ERK2""))
                  :ARG3-of (p2 / phosphorylate-01))
            :ARG3 (c / cell
                  :mod (w / wild-type)))
      :manner (d / depend-01
            :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")))
      :ARG2-of (s / summarize-01))","In summary, in WT cells Aurora-A increases the expression of p-ERK1/2 in a Ras dependent manner.","(z1 / increase-01
    :ARG0 (z2 / enzyme
              :wiki ""Aurabenzumabenzumabenzumab""
              :name (z3 / name
                        :op1 ""Aurora-A""))
    :ARG1 (z4 / express-03
              :ARG1 (z5 / enzyme
                        :wiki ""P-ERK1/2""
                        :name (z6 / name
                                  :op1 ""p-ERK1/2"")))
    :location (z7 / cell
                  :mod (z8 / small-molecule
                           :wiki ""WT_cell""
                           :name (z9 / name
                                     :op1 ""WT"")))
    :manner (z10 / depend-01
                 :ARG0 z2
                 :ARG1 (z11 / enzyme
                            :wiki ""Ras–activated_protein_kinase""
                            :name (z12 / name
                                       :op1 ""Ras"")))
    :ARG1-of (z13 / summarize-01))",0.4507042253521127,0.3999999999999999,"(s / summary-01
    :ARG1 (i / in
        :ARG1 (c / cell
            :mod (w / wild-type))
        :ARG2 (i2 / increase-01
            :ARG1 (a / Aurora-A)
            :ARG2 (e / expression
                :ARG1 (p / phosphorylate-01
                    :ARG1 (e2 / ERK1/2)
                    :ARG2 (r / Ras)
                    :mod (d / dependent))))))","(s / summarize-01
    :ARG1 (i / increase-01
        :ARG0 (a / aurora-A)
        :ARG1 (e / express-01
            :ARG1 (p / p-ERK1/2)
            :location (c / cell
                :mod (w / wild-type)))
        :manner (d / depend-01
            :ARG1 (r / Ras))))",-1.0,-1.0
pmid_2000_3375.159,"However, FTI-277 does not reduce the p-AKT in WT cells co-expressing Ras<sup>V12 </sup>and wild-type Aurora-A. Wild-type Aurora-A activates RalA (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref> and <xref ref-type=""fig"" rid=""F3"">3B</xref>) and phosphorylates RalA at serine194 to promote cellular transformation and migration [<xref ref-type=""bibr"" rid=""B38"">38</xref>].","(c3 / contrast-01
    :ARG2 (r / reduce-01
        :ARG0 (e / enzyme
            :name (n / name
                :op1 ""FTI""))
        :ARG1 (p4 / protein
            :name (n4 / name
                :op2 ""F3"")
            :ARG1-of (e5 / express-03
                :ARG2 (c / cell
                    :part-of (s / small-molecule
                        :name (n8 / name))))
            :mod (n3 / name
                :op1 ""P""))
        :location (a2 / and
            :mod (f / figure)
            :op1 e
            :op2 (a / activate-01
                :ARG0 (p3 / protein
                    :name (n2 / name
                        :op1 ""A"")
                    :name n3
                    :mod (w / wild)
                    :op3 (p / phosphorylate-01
                        :ARG0-of (p2 / promote-02
                            :ARG1 (a3 / and
                                :op1 (t / transform-01
                                    :ARG1 (c2 / cell))
                                :op2 (m / migrate-01
                                    :ARG0 c2)))
                        :ARG1 p3
                        :location (e3 / enzyme
                            :name (n6 / name
                                :op1 ""Russia""))
                        :location (e4 / enzyme
                            :name (n7 / name
                                :op1 ""serine""
                                :op2 194))))
                :ARG1 (e2 / enzyme
                    :name (n5 / name
                        :op1 ""amr-unknown""))))
        :polarity -)
    :rel (p5 / proto-oncogene))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (h / have-concession-91
            :ARG1 (r / reduce-01 :polarity -
                  :ARG0 (s / small-molecule :name (n2 / name :op1 ""FTI-277""))
                  :ARG1 (e2 / enzyme :name (n3 / name :op1 ""AKT"")
                        :ARG3-of (p / phosphorylate-01))
                  :location (c / cell
                        :mod (w / wild-type)
                        :ARG3-of (c2 / coexpress-01
                              :ARG2 (a / and
                                    :op1 (e / enzyme :name (n / name :op1 ""Ras"")
                                          :ARG2-of (m3 / mutate-01 :value ""V12""))
                                    :op2 (e3 / enzyme :name (n4 / name :op1 ""Aurora-A"")
                                          :mod w))))))
      :snt2 (a2 / and
            :op1 (a3 / activate-01
                  :ARG0 (e4 / enzyme :name (n5 / name :op1 ""Aurora-A""))
                  :ARG1 (p4 / protein :name (n6 / name :op1 ""RalA""))
                  :ARG1-of (d / describe-01
                        :ARG0 (a4 / and
                              :op1 (f / figure :mod ""3A"")
                              :op2 (f2 / figure :mod ""3B""))))
            :op2 (p5 / phosphorylate-01
                  :ARG1 (a5 / amino-acid :mod 194 :name (n7 / name :op1 ""serine"")
                        :part-of p4)
                  :ARG2 e4
                  :purpose (p6 / promote-02
                        :ARG0 e4
                        :ARG1 (a6 / and
                              :op1 (t / transform-01
                                    :ARG1 (c3 / cell))
                              :op2 (m4 / migrate-01
                                    :ARG0 c3))))
            :ARG1-of (d2 / describe-01
                  :ARG0 (p7 / publication
                        :ARG1-of (c4 / cite-01
                              :ARG2 38)))))","However, FTI-277 does not reduce the p-AKT in WT cells co-expressing Ras<sup>V12 </sup>and wild-type Aurora-A. Wild-type Aurora-A activates RalA (Figure <xref ref-type=""fig"" rid=""F3"">3A</xref> and <xref ref-type=""fig"" rid=""F3"">3B</xref>) and phosphorylates RalA at serine194 to promote cellular transformation and migration [<xref ref-type=""bibr"" rid=""B38"">38</xref>].","(z1 / contrast-01
    :ARG2 (z2 / reduce-01
              :polarity -
              :ARG0 (z3 / small-molecule
                        :wiki ""Fibroblast_growth_factor_receptor""
                        :name (z4 / name
                                  :op1 ""FTI-277""))
              :ARG1 (z5 / enzyme
                        :wiki ""P-AKT""
                        :name (z6 / name
                                  :op1 ""p-AKT"")
                        :part-of (z7 / cell
                                     :mod (z8 / water)
                                     :mod (z9 / tumor
                                              :wiki ""WT""
                                              :name (z10 / name
                                                         :op1 ""WT"")))
                        :ARG0-of (z11 / coexpress-01
                                      :ARG1 (z12 / and
                                                 :op1 (z13 / protein
                                                           :wiki ""BRAF_(g3000 / gene)""
                                                           :name (z14 / name
                                                                      :op1 ""Ras""
                                                                      :op2 ""V12""))
                                                 :op2 (z15 / enzyme
                                                           :wiki ""Aurora-A""
                                                           :name (z16 / name
                                                                      :op1 ""Aurora-A"")
                                                           :mod (z17 / wild-type))))))
    :ARG0-of (z18 / cause-01
                  :ARG1 (z19 / and
                             :op1 (z20 / activate-01
                                       :ARG0 z15
                                       :ARG1 (z21 / enzyme
                                                  :wiki ""BRAF_(g3001 / gene)""
                                                  :name (z22 / name
                                                             :op1 ""RalA"")
                                                  :ARG1-of (z23 / figure-03
                                                                :ARG0 (z24 / and
                                                                           :op1 (z25 / figure
                                                                                     :mod 3A
                                                                                     :ARG1-of (z26 / hyperlink-91
                                                                                                   :ARG3 (z27 / url-entity
                                                                                                              :value ""xref"")))
                                                                           :op2 (z28 / figure
                                                                                     :mod 3B
                                                                                     :ARG1-of (z29 / hyperlink-91
                                                                                                   :ARG3 (z30 / url-entity
                                                                                                              :value ""xref"")))))))
                             :op2 (z31 / phosphorylate-01
                                       :ARG0 z15
                                       :ARG1 z21
                                       :location (z32 / serine194)
                                       :purpose (z33 / promote-02
                                                     :ARG0 z21
                                                     :ARG1 (z34 / and
                                                                :op1 (z35 / transform-01
                                                                          :ARG1 (z36 / cell))
                                                                :op2 (z37 / migrate-01
                                                                          :ARG1 z36)))))))",0.4301075268817204,0.3536585365853658,"(m / multi-sentence
        :snt1 (r / reduce-01
            :ARG1 (p / p-AKT)
            :ARG2 (c / cell
                  :ARG1-of (w / WT)))
        :snt2 (c2 / co-express-01
            :ARG1 (c3 / cell
                  :ARG1-of (w2 / wild-type)
                  :ARG2 (r2 / Ras
                        :mod (f / FTI-277)))
            :ARG2 (a / Aurora-A))
        :snt3 (a2 / activate-01
            :ARG0 (w3 / wild-type)
            :ARG1 (r3 / RalA))
        :snt4 (p2 / phosphorylate-01
            :ARG0 w3
            :ARG1 r3
            :ARG2 (s / serine194))
        :snt5 (p3 / promote-01
            :ARG0 w3
            :ARG1 (t / transformation)
            :ARG1 (m / migration))
        :snt6 (c4 / cite-01
            :ARG0 (r4 / reference
                  :ARG1 (b / bibr
                        :op1 ""38""))))","(h / however
    :op1 (r / reduce-01 :polarity -
        :ARG0 (f / fti-277)
        :ARG1 (p / p-akt)
        :location (c / cell
            :mod (w / wild-type)
            :ARG1-of (e / express-01
                :ARG0 c
                :ARG1 (a / and
                    :op1 (r2 / ras :mod (v / v12))
                    :op2 (a2 / aurora-a :mod w)))))
    :op2 (a3 / activate-01
        :ARG0 a2
        :ARG1 (r3 / rala)
        :location (f2 / figure :mod (n / number :value 3 :unit (a4 / a)))
        :location (f3 / figure :mod (n2 / number :value 3 :unit (b / b))))
    :op3 (p2 / phosphorylate-01
        :ARG0 a2
        :ARG1 r3
        :location (s / serine :mod (n3 / number :value 194))
        :purpose (a5 / and
            :op1 (p3 / promote-01
                :ARG0 a2
                :ARG1 (t / transform-01
                    :ARG0 c
                    :ARG1 c))
            :op2 (m / migrate-01
                :ARG0 c
                :ARG1 c))
        :source (b2 / bibliography :mod (n4 / number :value 38)))).",-1.0,0.2716049382716049
pmid_2000_3375.161,"Consistent with a previous report [<xref ref-type=""bibr"" rid=""B38"">38</xref>], only RalAS194A could reduce the Ral A activity (Figure <xref ref-type=""fig"" rid=""F4"">4B</xref>, lane 3).","(p / possible-01
    :ARG1 (r / reduce-01
        :ARG0 (p3 / product
            :name (n / name
                :op1 ""RalAS""
                :op2 194
                :op3 ""A"")
            :mod (o / only))
        :ARG1 (a / activity-06
            :ARG0 p3))
    :ARG1-of (c / consistent-01
        :ARG2 (r2 / report-01
            :time (p2 / previous)))
    :ARG1-of (m / mean-01
        :ARG2 (f / figure
            :location (l / lane
                :mod 3))))
",test,bio_amr0.8,"(c / consistent-01
      :ARG1 (p2 / possible-01
            :ARG1 (r / reduce-01
                  :ARG0 (p3 / protein :name (n / name :op1 ""RalAS194A"")
                        :mod (o / only))
                  :ARG1 (a / activity-06
                        :ARG0 (p4 / protein :name (n2 / name :op1 ""RalA""))))
            :ARG1-of (d2 / describe-01
                  :ARG0 (l / lane :mod 3
                        :part-of (f / figure :mod ""4B""))))
      :ARG2 (r2 / report
            :time (p / previous)
            :ARG1-of (d / describe-01
                  :ARG0 (p5 / publication
                        :ARG1-of (c2 / cite-01
                              :ARG2 38)))))","Consistent with a previous report [<xref ref-type=""bibr"" rid=""B38"">38</xref>], only RalAS194A could reduce the Ral A activity (Figure <xref ref-type=""fig"" rid=""F4"">4B</xref>, lane 3).","(z1 / possible-01
    :ARG1 (z2 / reduce-01
              :ARG0 (z3 / enzyme
                        :wiki ""BRAF-activated_protein_kinase""
                        :name (z4 / name
                                  :op1 ""RalAS194A"")
                        :mod (z5 / only))
              :ARG1 (z6 / activity-06
                        :ARG0 (z7 / enzyme
                                  :wiki ""BRAF-activated_protein_kinase""
                                  :name (z8 / name
                                            :op1 ""RalAS194A""))))
    :ARG1-of (z9 / consistent-01
                 :ARG2 (z10 / report-01
                            :time (z11 / previous)
                            :ARG1-of (z12 / describe-01
                                          :ARG0 (z13 / figure
                                                     :mod (z14 / lane
                                                               :mod 3))))))",0.5797101449275363,0.4615384615384615,"(m / multi-sentence
        :snt1 (c / consistent-01
            :ARG1 (r / report
                  :mod (p / previous)))
        :snt2 (r / reduce-01
            :ARG1 (r2 / RalAS194A)
            :ARG2 (a / activity
                  :ARG1-of (r3 / RalA))
            :degree (c2 / could))
        :snt3 (f / figure
            :mod (l / lane)
            :ARG1 (x / xref
                  :ref-type ""fig""
                  :rid ""F4"")
            :ARG2 (x2 / xref
                  :ref-type ""bibr""
                  :rid ""B38"")
            :mod (f2 / figure
                  :mod (b / be-01
                        :ARG1 (r4 / report
                              :mod (p2 / previous))))))","(c / consistent-01
    :ARG1 (r / report-01
        :ARG0 (p / person
            :mod (p2 / previous))
        :mod (x / xref
            :ref-type ""bibr""
            :rid ""B38""
            :op1 ""38""))
    :ARG2 (r2 / reduce-01
        :ARG0 (r3 / RalAS194A)
        :ARG1 (a / activity
            :ARG0 (r4 / Ral_A))
        :location (f / figure
            :mod (x2 / xref
                :ref-type ""fig""
                :rid ""F4""
                :op1 ""4B"")
            :location (l / lane
                :quant 3))))",-1.0,0.2352941176470588
pmid_2000_3375.166,"Taken together, the Ras/MEK/ERK signaling pathway but not the PI3K/AKT or RalGDS/RalA pathway is responsible for Aurora-A induced cell aggregation.","(r / responsible-01
    :ARG0 (p / pathway
        :ARG0-of (s / signal-07
            :ARG1 (s2 / slash
                :op1 (e / enzyme
                    :name (n / name
                        :op1 ""Ras"")
                    :name (n5 / name
                        :op1 ""PI3K""))
                :op2 (e2 / enzyme
                    :name (n2 / name
                        :op2 ""MEK"")))))
    :ARG1 (m / migrate-01
        :ARG0 (c / cell)
        :ARG1-of (i / induce-01))
    :ARG1-of (c2 / contrast-01
        :ARG2 (p2 / pathway
            :example (o / or
                :op1 p
                :op2 (p4 / protein
                    :name (n6 / name
                        :op1 ""AKT""))
                :op3 (p5 / protein
                    :name (n7 / name
                        :op1 ""RalA"")))
            :polarity -))
    :ARG1-of (t / take-01
        :mod (t2 / together))
    :rel (e3 / enzyme
        :name (n3 / name
            :op1 ""ERK""))
    :rel (p3 / protein
        :name (n4 / name)))
",test,bio_amr0.8,"(h / have-condition-91
      :ARG1 (c / contrast-01
            :ARG1 (r / responsible-01
                  :ARG0 (p2 / pathway :name (n2 / name :op1 ""Ras/MEK/ERK"")
                        :ARG0-of (s / signal-07))
                  :ARG1 (a / aggregate-01
                        :ARG1 (c2 / cell)
                        :ARG2-of (i / induce-01
                              :ARG0 (e / enzyme :name (n3 / name :op1 ""Aurora-A"")))))
            :ARG2 (r2 / responsible-01 :polarity -
                  :ARG0 (o / or
                        :op1 (p / pathway :name (n / name :op1 ""PI3K/AKT""))
                        :op2 (p4 / pathway :name (n4 / name :op1 ""RalGDS/RalA"")))
                  :ARG1 a))
      :ARG2 (t / take-01
            :ARG1 p2
            :mod (t2 / together)))","Taken together, the Ras/MEK/ERK signaling pathway but not the PI3K/AKT or RalGDS/RalA pathway is responsible for Aurora-A induced cell aggregation.","(z1 / contrast-01
    :ARG1 (z2 / responsible-01
              :ARG0 (z3 / pathway
                        :ARG0-of (z4 / stimulate-01
                                     :ARG0 z13)
                        :mod (z5 / protein
                                 :wiki ""BRAF_(g3000 / gene)""
                                 :name (z6 / name
                                           :op1 ""Ras/MEK/ERK"")))
              :ARG1 (z7 / aggregation
                        :mod (z8 / cell)
                        :ARG1-of (z9 / induce-01
                                     :ARG0 (z10 / enzyme
                                                :wiki ""Aurora-A""
                                                :name (z11 / name
                                                           :op1 ""Aurora-A"")))))
    :ARG2 (z12 / responsible-01
               :polarity -
               :ARG0 (z13 / pathway
                          :ARG0-of z4
                          :mod (z14 / enzyme
                                    :wiki ""PHLDA/AKT""
                                    :name (z15 / name
                                               :op1 ""PI3K/AKT"")))
               :ARG1 z7)
    :ARG1 z7)",0.4186046511627907,0.3495145631067961,"(t / together
    :ARG1 (p / pathway
        :ARG0 (s / signal-01
            :ARG1 (r / Ras/MEK/ERK)
            :ARG1-of (r2 / responsible-01
                :ARG2 (a / aggregate-01
                    :ARG1 (c / cell)
                    :ARG1-of (i / induce-01
                        :ARG1 (a2 / Aurora-A)))))))
(t2 / together
    :ARG1 (p2 / pathway
        :ARG0 (s2 / signal-01
            :ARG1 (r3 / Ras/MEK/ERK)
            :ARG1-of (r4 / responsible-01
                :ARG2 (a3 / aggregate-01
                    :ARG1 (c2 / cell)
                    :ARG1-of (i2 / induce-01
                        :ARG1 (a4 / Aurora-A)))))))
(t3 / together
    :ARG1 (p3 / pathway
        :ARG0 (s3 / signal-01
            :ARG1 (r5 / Ras/MEK/ERK)
            :ARG1-of (r6 / responsible-01
                :ARG2 (a5 / aggregate-01
                    :ARG1 (c3 / cell)
                    :ARG1-of (i3 / induce-01
                        :ARG1 (a6 / Aurora-A)))))))","(t / take-02
    :ARG1 (t2 / together)
    :ARG2 (r / responsible-01
        :ARG1 (p / pathway
            :name (n / name :op1 ""Ras"" :op2 ""/"" :op3 ""MEK"" :op4 ""/"" :op5 ""ERK"" :op6 ""signaling"")
            :mod (b / but)
            :mod (n2 / not)
            :ARG1-of (r2 / responsible-01
                :ARG1 (p2 / pathway
                    :name (n3 / name :op1 ""PI3K"" :op2 ""/"" :op3 ""AKT""))
                :ARG1-of (r3 / responsible-01
                    :ARG1 (p3 / pathway
                        :name (n4 / name :op1 ""RalGDS"" :op2 ""/"" :op3 ""RalA"")))))
        :ARG2 (i / induce-01
            :ARG0 (a / Aurora-A)
            :ARG1 (a2 / aggregate-01
                :ARG1 (c / cell)))))",-1.0,0.3516483516483516
